data_6rk3_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6rk3 _Structure_validation_residue.Date_analyzed 2020-03-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.8 mtt . . . . . 0 N--CA 1.482 1.166 0 CA-C-O 120.776 0.322 . . . . 0.0 110.643 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 61.0 mt -93.97 131.77 39.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.446 -174.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 p -88.91 158.14 18.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.954 174.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.419 ' O ' HG21 ' A' ' 37' ' ' VAL . 15.8 m -71.28 -3.27 3.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -173.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -99.68 6.57 45.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.459 0.647 . . . . 0.0 109.895 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -124.31 88.94 2.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.244 0.545 . . . . 0.0 111.177 -177.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -142.06 156.3 45.4 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.026 177.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -139.95 165.77 26.44 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.7 t -57.19 -15.24 5.32 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.087 0.47 . . . . 0.0 111.169 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.42 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -147.95 113.72 0.65 Allowed Glycine 0 N--CA 1.435 -1.368 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 165.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 55.4 tp -151.63 134.61 15.77 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.595 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 1.1 p -98.46 124.44 43.17 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.356 0.598 . . . . 0.0 112.262 -176.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.0 mp -127.49 138.99 53.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.983 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.7 p -100.24 110.32 22.56 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.164 0.507 . . . . 0.0 110.301 176.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.5 p -155.03 156.83 4.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -177.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 61.16 24.59 14.69 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.712 0.291 . . . . 0.0 110.887 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 16.0 m120 65.45 30.18 10.95 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.211 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -145.05 163.98 32.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.306 178.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 13.8 pt -105.97 125.77 61.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.199 0.523 . . . . 0.0 109.886 176.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.595 ' O ' ' HA ' ' A' ' 12' ' ' THR . 82.1 m95 -117.77 161.44 19.69 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.803 -169.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -132.02 101.63 5.5 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.606 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.42 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 89.9 t -62.74 116.55 2.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.901 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.4 mm -88.95 -36.14 8.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.242 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -162.71 113.78 1.51 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.788 -177.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 39' ' ' SER . 19.8 p90 -102.87 146.37 28.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.0 0.429 . . . . 0.0 111.014 -176.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -123.47 104.58 9.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.408 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -77.49 96.26 4.68 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 175.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.4 p -104.1 136.18 38.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.614 -171.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -117.94 89.75 34.97 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.456 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.36 -11.31 31.08 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.736 2.291 . . . . 0.0 113.121 -175.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.46 26.23 25.95 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.446 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -92.93 -11.84 32.37 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.33 0.586 . . . . 0.0 110.354 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.04 -19.85 17.52 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 -176.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.5 m -129.28 140.49 51.41 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.77 152.56 20.09 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.204 0.525 . . . . 0.0 110.824 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -131.64 167.1 20.02 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.929 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.419 HG21 ' O ' ' A' ' 4' ' ' VAL . 46.1 t -132.4 102.47 5.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 120.725 0.297 . . . . 0.0 110.428 178.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -77.45 99.26 5.57 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 25' ' ' PHE . 18.2 m -103.4 126.03 50.32 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.547 -175.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.5 tppt? -84.68 110.22 18.59 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 173.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.01 144.06 40.9 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.893 0.854 . . . . 0.0 112.121 -172.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 42' ' ' ARG . 18.6 ttt180 -100.19 130.15 46.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.519 -175.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -64.48 112.29 3.07 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 173.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.6 tt -71.34 -14.08 62.08 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.209 0.528 . . . . 0.0 110.635 -171.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 -86.82 -45.28 11.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.497 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.4 p -101.24 -20.52 15.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.059 0.457 . . . . 0.0 111.868 -173.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.15 10.15 75.34 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.86 -176.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.71 145.4 38.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.116 0.484 . . . . 0.0 111.961 -175.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.6 mm -100.09 113.43 35.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.428 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.502 ' HG2' ' H ' ' A' ' 51' ' ' GLU . 31.8 tt0 -133.32 176.38 8.57 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.502 ' H ' ' HG2' ' A' ' 50' ' ' GLN . 9.6 pt-20 -138.26 142.35 39.87 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.937 0.398 . . . . 0.0 110.24 173.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -130.41 134.08 46.85 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.363 -177.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.4 p -98.19 110.34 22.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.048 0.451 . . . . 0.0 110.857 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -84.64 147.98 26.67 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.917 178.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.63 ' HD3' ' OE2' ' A' ' 58' ' ' GLU . 44.4 ttt180 -112.92 128.96 56.61 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.93 -174.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.3 125.76 24.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.605 178.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.43 -15.88 32.23 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.928 -178.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.63 ' OE2' ' HD3' ' A' ' 55' ' ' ARG . 42.8 mt-10 -119.26 99.71 6.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.899 0.38 . . . . 0.0 110.19 177.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -76.84 153.38 34.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.955 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.0 m -120.4 162.8 18.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.073 0.464 . . . . 0.0 111.446 -176.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -84.07 132.87 46.75 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.425 -177.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -79.07 151.75 23.97 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.688 2.259 . . . . 0.0 112.334 176.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -118.99 114.52 22.67 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.387 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 64.8 mtt -94.15 118.12 31.09 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 48.9 mm -89.35 127.57 41.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.582 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -103.23 118.0 35.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.522 -174.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -102.42 125.72 49.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.787 0.327 . . . . 0.0 110.408 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 71.0 mtt-85 -126.18 115.03 19.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.964 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 69' ' ' ARG . 13.3 ptm180 -85.49 117.82 24.64 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.369 0.604 . . . . 0.0 109.683 175.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.61 ' SD ' HD13 ' A' ' 113' ' ' ILE . 31.1 mtt -120.75 143.68 48.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.697 -174.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -77.3 132.72 38.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.777 176.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -73.37 104.26 4.32 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.23 -174.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 60.8 mt -99.06 -175.66 3.1 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 172.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -144.04 149.65 36.99 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.644 0.735 . . . . 0.0 112.518 -170.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' A' ' 79' ' ' ASN . . . -151.27 -154.23 0.53 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.661 178.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -79.86 152.06 29.88 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -82.27 66.65 3.84 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 117.858 -2.115 . . . . 0.0 112.787 -174.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -129.14 -31.79 2.08 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 156.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.567 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 81.9 m-20 -141.04 130.34 23.63 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.653 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.406 ' O ' ' HA ' ' A' ' 92' ' ' GLU . 30.1 m170 -110.69 141.52 43.83 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 175.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.412 ' O ' ' HB2' ' A' ' 73' ' ' LEU . 41.5 t -87.52 130.52 37.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.922 -177.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.438 ' CE1' HD11 ' A' ' 93' ' ' LEU . 83.0 m-85 -124.26 128.39 49.09 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 174.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 25.8 ttt -94.34 112.0 23.77 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.46 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.509 ' HB3' ' H ' ' A' ' 89' ' ' GLU . 25.0 t70 -58.59 110.05 0.91 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.168 177.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -80.59 -4.51 54.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.7 -177.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -70.19 -50.7 37.55 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 173.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.6 p -171.85 93.56 0.15 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 165.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 49.79 29.37 3.2 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 159.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.509 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 42.9 mt-10 -100.12 105.97 17.65 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 121.584 -0.697 . . . . 0.0 111.346 176.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -70.08 125.02 25.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.919 0.39 . . . . 0.0 110.22 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 46.6 m -128.16 125.33 38.88 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.161 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 80' ' ' HIS . 32.3 mt-10 -104.58 131.74 51.64 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.8 0.333 . . . . 0.0 110.769 -177.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.567 ' O ' ' HA ' ' A' ' 79' ' ' ASN . 42.3 mt -100.28 146.56 26.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.575 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.624 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 8.3 t -88.08 166.31 14.52 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.924 -172.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.7 t -51.1 -42.8 60.88 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -171.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -55.1 -45.89 75.5 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -178.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -71.8 -39.89 69.57 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.25 0.548 . . . . 0.0 109.562 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.624 ' HG ' ' O ' ' A' ' 94' ' ' SER . 56.8 mt -60.2 -28.16 67.75 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.851 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -57.82 -43.95 86.08 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.914 0.388 . . . . 0.0 110.913 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -80.17 -43.33 21.76 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.692 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.94 -27.57 69.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.99 177.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 22.3 mt -75.07 -14.44 60.58 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 122.308 -0.245 . . . . 0.0 111.096 177.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -74.6 -43.92 53.24 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.401 ' HB3' HG13 ' A' ' 129' ' ' VAL . 40.9 m-85 -138.18 116.74 12.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.431 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.448 HD21 ' C ' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -170.78 157.99 5.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.302 0.572 . . . . 0.0 111.113 176.141 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.454 ' HD3' ' O ' ' A' ' 130' ' ' GLU . 31.5 mmmt -130.1 139.29 50.95 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.775 172.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -73.21 127.35 32.36 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.28 -0.36 71.64 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.079 -175.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.429 ' SD ' ' HG3' ' A' ' 126' ' ' PRO . 42.1 ttm -87.47 144.18 26.86 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.679 0.276 . . . . 0.0 111.145 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 70' ' ' MET . 45.3 mt-10 -85.51 122.63 29.91 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.963 177.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 24.9 m -112.34 156.34 13.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -101.31 99.27 9.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.086 0.47 . . . . 0.0 110.176 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.61 HD13 ' SD ' ' A' ' 70' ' ' MET . 54.6 mt -83.24 127.11 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.49 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.508 ' O ' HG12 ' A' ' 121' ' ' ILE . 17.6 tt0 -100.31 112.34 24.67 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.392 -174.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 25.7 p -116.16 155.75 27.69 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.857 -176.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -132.69 109.46 9.72 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 172.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 60.46 31.48 20.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.029 0.442 . . . . 0.0 110.853 -175.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.68 -12.95 65.51 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.715 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -86.18 126.94 34.61 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 25.5 m -67.67 117.05 9.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.637 0.256 . . . . 0.0 110.658 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 114' ' ' GLN . 12.9 pt -105.64 -23.35 4.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.813 0.34 . . . . 0.0 111.047 178.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -170.65 166.41 39.6 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.013 176.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 61.1 t -133.19 126.11 52.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -107.4 113.38 26.69 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.936 0.398 . . . . 0.0 110.962 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.403 ' N ' HD22 ' A' ' 125' ' ' LEU . 3.0 mm? -81.02 149.95 67.67 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 173.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.429 ' HG3' ' SD ' ' A' ' 109' ' ' MET . 9.8 Cg_endo -53.38 137.67 64.78 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.559 2.173 . . . . 0.0 111.417 176.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.597 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 31.8 mmtp -61.28 -27.93 68.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.715 -172.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.5 p -124.61 107.46 11.04 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.194 0.521 . . . . 0.0 110.394 174.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.401 HG13 ' HB3' ' A' ' 104' ' ' TYR . 7.1 p -107.27 144.96 15.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.457 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.454 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 35.7 mt-10 -110.36 113.36 25.96 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.906 0.384 . . . . 0.0 110.381 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 73.6 mt -120.5 129.41 53.83 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.406 -176.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.6 m -72.42 131.21 42.28 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.143 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 170' ' ' ASP . 9.6 p -84.16 112.96 22.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.749 0.785 . . . . 0.0 110.515 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.439 ' O ' ' HB ' ' A' ' 153' ' ' THR . 31.9 p -115.81 119.53 36.31 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.184 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 77.37 87.81 0.07 Allowed 'General case' 0 C--O 1.237 0.413 0 O-C-N 123.991 0.807 . . . . 0.0 110.904 -177.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 12.8 t -151.03 152.88 34.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.81 172.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -114.02 109.74 49.36 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 120.73 0.3 . . . . 0.0 111.393 -177.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 164' ' ' LEU . 12.4 Cg_exo -70.87 -176.39 1.78 Allowed 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 123.66 2.907 . . . . 0.0 111.601 172.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 122.99 35.54 0.72 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.059 -1.067 . . . . 0.0 113.246 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.1 tp . . . . . 0 CA--C 1.538 0.518 0 CA-C-O 121.258 0.552 . . . . 0.0 109.994 173.287 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 29.6 p . . . . . 0 N--CA 1.45 -0.458 0 CA-C-O 120.945 0.403 . . . . 0.0 111.746 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.8 ttpp -132.58 161.06 34.82 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 176.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 34.9 p -72.49 107.69 5.16 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.159 0.504 . . . . 0.0 110.513 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -107.32 164.08 12.49 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.386 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.439 ' HB ' ' O ' ' A' ' 134' ' ' THR . 22.4 m -119.19 136.03 54.39 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.857 175.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 12.4 m -100.77 174.29 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.0 175.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -56.16 -29.01 60.22 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 59.3 p -72.71 -19.31 61.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.986 0.422 . . . . 0.0 111.484 -177.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 100.22 -3.12 56.67 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -174.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -75.63 144.57 41.65 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.871 0.367 . . . . 0.0 110.688 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 18.9 m -106.07 122.71 46.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.3 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.85 158.58 43.85 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -177.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -88.85 108.86 19.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.069 -174.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 32.7 m -102.72 147.36 33.94 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.586 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.15 144.83 56.93 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.289 1.993 . . . . 0.0 111.51 172.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' A' ' 138' ' ' PRO . 77.2 mt -63.0 -7.78 5.99 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -172.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -100.55 10.5 41.1 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 93.9 t -87.78 131.87 34.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.532 0.206 . . . . 0.0 110.55 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -110.73 154.2 24.22 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.996 0.427 . . . . 0.0 110.934 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -59.83 127.13 30.41 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.731 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 112.26 -20.9 20.7 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.429 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.445 ' O ' HG12 ' A' ' 133' ' ' VAL . 2.2 m-20 -64.13 143.39 57.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.851 0.358 . . . . 0.0 110.761 177.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 61.8 t -95.09 110.32 23.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.315 0.579 . . . . 0.0 109.843 177.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 47.8 mt -87.35 129.33 35.06 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.5 -176.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.551 ' O ' ' HB ' ' A' ' 182' ' ' ILE . 40.8 mt -94.43 127.96 46.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 59.8 mt -126.39 138.33 54.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.78 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.597 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 0.2 OUTLIER -80.98 91.39 6.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.655 177.557 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.64 133.52 49.51 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.627 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 120.46 -40.33 2.2 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -115.07 -28.87 6.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.24 0.543 . . . . 0.0 110.254 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 88.45 19.34 52.69 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.111 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 19.3 t -79.31 130.83 35.84 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.8 0.333 . . . . 0.0 110.111 -177.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -76.67 127.42 32.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.322 0.582 . . . . 0.0 111.163 -177.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.551 ' HB ' ' O ' ' A' ' 173' ' ' ILE . 59.7 mt -105.8 153.68 7.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 173.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 16.2 p -74.69 146.34 42.4 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.252 0.548 . . . . 0.0 111.113 -168.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -55.93 142.16 36.67 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.077 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.648 -1.085 . . . . 0.0 112.238 -179.005 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ttt . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 121.073 0.463 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.6 mp -111.88 130.7 65.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.0 t -111.78 174.0 6.09 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 22.9 m -72.33 0.91 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -172.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -93.13 -1.57 56.25 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.017 0.437 . . . . 0.0 110.225 176.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -111.06 88.92 2.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.104 -176.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -141.47 147.56 38.06 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 175.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -130.11 174.96 9.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.729 -0.214 . . . . 0.0 110.496 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.4 t -57.84 -24.48 57.62 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 121.343 0.592 . . . . 0.0 110.234 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.622 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -147.13 116.33 0.84 Allowed Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 169.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 57.8 tp -145.94 130.99 18.29 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 1.7 p -92.87 127.21 38.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.925 0.393 . . . . 0.0 111.957 -177.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mp -127.19 139.69 51.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.247 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.8 t -99.74 107.89 20.08 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.5 p -151.22 150.18 13.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -176.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.8 23.95 14.27 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.803 0.335 . . . . 0.0 110.474 -176.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.7 m120 62.12 33.4 16.99 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.878 -178.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -140.97 162.28 35.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.029 176.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 11.8 pt -104.92 121.0 56.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.344 0.592 . . . . 0.0 110.292 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.561 ' O ' ' HA ' ' A' ' 12' ' ' THR . 70.9 m95 -115.77 164.38 14.46 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.838 -172.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -140.42 109.27 6.01 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 120.935 0.397 . . . . 0.0 110.209 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.622 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 94.2 t -58.66 122.03 7.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.128 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 81.4 mt -87.58 -38.5 12.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.517 174.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -163.2 144.44 9.56 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.24 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -125.24 138.54 54.11 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.095 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -109.52 98.68 8.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.144 175.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 21.5 t-160 -81.08 98.13 7.86 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.9 131.34 48.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.401 0.62 . . . . 0.0 111.458 -174.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.435 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -111.86 101.54 51.68 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.292 -177.818 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -65.87 -46.81 4.4 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.776 2.317 . . . . 0.0 112.47 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.02 17.55 6.28 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.92 -177.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -105.66 10.42 32.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.997 0.427 . . . . 0.0 110.271 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.57 -43.21 3.22 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 -176.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.2 m -89.3 98.33 11.71 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.851 0.358 . . . . 0.0 110.098 176.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -86.73 171.5 10.88 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.504 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -142.13 164.25 30.66 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.355 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 48.0 t -127.95 107.05 15.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.594 -176.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -80.5 98.17 7.46 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 173.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.6 p -104.97 135.81 45.62 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.99 0.424 . . . . 0.0 111.489 -175.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -95.95 109.87 22.17 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 175.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.439 ' H ' HD22 ' A' ' 41' ' ' LEU . 1.4 pt? -132.5 145.61 51.3 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.405 0.621 . . . . 0.0 111.369 -172.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 22.0 ttp180 -106.39 132.1 52.81 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.657 -175.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -62.03 119.32 8.66 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 172.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.2 tt -64.86 -28.05 69.29 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.795 -171.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 52.9 mtt-85 -85.11 -43.65 13.68 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -176.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.6 p -102.05 -9.68 20.37 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -172.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.22 18.94 75.39 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.41 -178.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.472 ' O ' ' HA ' ' A' ' 42' ' ' ARG . . . -77.01 131.31 38.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.745 0.307 . . . . 0.0 111.553 -177.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.3 mm -89.89 102.14 12.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.062 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.444 ' HG2' ' N ' ' A' ' 51' ' ' GLU . 36.0 tt0 -116.13 169.2 9.45 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.444 ' N ' ' HG2' ' A' ' 50' ' ' GLN . 6.6 pt-20 -136.59 130.05 31.74 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.346 0.593 . . . . 0.0 110.541 172.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -123.22 146.49 47.78 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.306 -176.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 55.3 m -107.55 111.03 23.1 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.979 0.418 . . . . 0.0 110.862 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -85.37 142.43 29.3 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.802 177.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 55' ' ' ARG . 36.7 mtp-105 -113.38 135.15 54.17 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.083 -173.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.11 129.34 40.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.478 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.73 -18.37 29.48 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.353 -175.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -99.81 134.81 42.17 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -87.34 133.83 33.65 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.354 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.2 t -94.13 134.99 29.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.331 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -101.47 112.93 65.79 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.885 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.0 163.64 34.93 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.58 2.186 . . . . 0.0 112.606 -177.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -121.89 109.57 14.81 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.701 177.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 64.2 mtt -84.65 109.35 17.93 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.039 0.447 . . . . 0.0 110.903 -177.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.474 HD11 ' CD1' ' A' ' 121' ' ' ILE . 34.6 mm -90.38 120.94 40.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.928 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -94.9 109.27 21.29 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -89.09 131.04 35.43 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.903 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 52.2 mtt180 -130.44 170.39 14.26 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -130.18 125.37 34.81 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.02 0.438 . . . . 0.0 110.07 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.5 ' CB ' ' HB3' ' A' ' 82' ' ' PHE . 2.0 mpt? -117.49 143.22 46.27 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.347 -176.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -84.78 139.46 31.93 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.74 173.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.53 ' CD1' ' HA ' ' A' ' 107' ' ' GLU . 32.7 t80 -71.63 110.15 6.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.861 -176.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.8 mp -100.69 -174.66 2.69 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 169.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -143.02 147.82 35.74 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.437 0.637 . . . . 0.0 111.759 -169.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.5 -165.95 2.38 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.805 176.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -72.51 146.17 46.99 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 174.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.66 68.45 3.0 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 118.683 -1.722 . . . . 0.0 112.857 -171.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -128.13 -33.05 2.21 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 161.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.414 ' OD1' ' HB3' ' A' ' 92' ' ' GLU . 28.3 t30 -143.26 136.82 28.41 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 113.359 -1.746 . . . . 0.0 109.267 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.44 ' ND1' HD21 ' A' ' 98' ' ' LEU . 55.7 m170 -117.58 148.41 41.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.771 0.32 . . . . 0.0 110.539 178.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 45.7 t -100.17 132.23 46.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.079 -176.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.5 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 71.6 m-85 -130.19 124.72 33.25 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 176.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 90.6 mmm -99.7 117.73 34.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.724 0.297 . . . . 0.0 111.52 -175.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.513 ' OD2' ' HB3' ' A' ' 86' ' ' GLU . 11.5 t70 -67.63 127.67 33.61 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.496 -178.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -79.64 -16.59 55.5 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.202 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.513 ' HB3' ' OD2' ' A' ' 84' ' ' ASP . 11.6 tp10 -66.92 -52.69 40.06 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 56.0 p -171.43 91.71 0.14 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 167.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 47.41 28.05 1.04 Allowed 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 162.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.453 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 28.0 mm-40 -83.42 101.31 11.28 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 118.392 0.542 . . . . 0.0 110.083 176.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -73.65 96.47 2.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.856 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.9 m -95.6 129.32 42.83 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.476 -175.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.414 ' HB3' ' OD1' ' A' ' 79' ' ' ASN . 35.5 mt-10 -106.68 137.67 44.27 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.931 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.474 HD11 ' CE1' ' A' ' 82' ' ' PHE . 64.7 mt -119.72 133.57 55.57 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.027 0.441 . . . . 0.0 111.189 -178.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.603 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 49.8 m -90.81 179.72 5.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.023 -176.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.0 p -47.73 -41.14 22.32 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -174.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -55.23 -38.14 68.09 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.038 0.446 . . . . 0.0 111.621 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -85.68 -34.96 21.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.041 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 94' ' ' SER . 20.8 mt -63.63 -22.51 66.94 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.288 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -59.77 -42.77 94.03 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.477 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -66.74 -38.38 86.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.621 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.579 ' O ' HD12 ' A' ' 105' ' ' LEU . 53.5 mt-10 -63.1 -36.4 83.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.097 175.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 82.3 mt -62.42 -21.23 65.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.917 0.389 . . . . 0.0 110.34 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -80.96 -50.99 9.03 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 171.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -142.79 118.53 10.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.546 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.579 HD12 ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -154.17 144.74 22.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.996 0.427 . . . . 0.0 110.312 172.415 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.43 ' HB2' ' HE1' ' A' ' 109' ' ' MET . 27.9 mmmt -144.42 139.86 28.64 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 175.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.53 ' HA ' ' CD1' ' A' ' 72' ' ' TYR . 29.0 tt0 -74.44 129.72 38.29 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.091 -177.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.54 1.24 71.64 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.49 -177.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.43 ' HE1' ' HB2' ' A' ' 106' ' ' LYS . 50.0 ttm -67.74 144.05 55.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.06 0.457 . . . . 0.0 111.501 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -92.59 104.28 16.59 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.822 174.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 26.3 m -105.49 158.76 5.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.704 0.288 . . . . 0.0 110.75 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -111.72 103.39 11.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.834 0.35 . . . . 0.0 110.098 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 60.4 mt -96.52 127.35 48.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.958 0.409 . . . . 0.0 110.394 -177.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.472 ' O ' HG12 ' A' ' 121' ' ' ILE . 76.5 mt-30 -91.04 120.02 31.68 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.928 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 62.4 p -116.32 145.72 42.97 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.319 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -124.98 98.89 5.88 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 60.38 41.8 15.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.691 -173.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 88.93 -18.69 42.55 Favored Glycine 0 CA--C 1.516 0.151 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.874 178.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -82.43 123.68 29.36 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.658 0.266 . . . . 0.0 110.767 -177.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 42.5 p -69.57 107.88 3.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.883 0.373 . . . . 0.0 110.455 178.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.474 ' CD1' HD11 ' A' ' 65' ' ' ILE . 21.6 pt -93.94 -28.35 4.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.022 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -164.19 155.05 26.23 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.325 178.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.6 t -120.68 123.27 69.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -106.14 123.27 47.76 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 120.956 0.408 . . . . 0.0 110.351 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 75.2 mt -97.08 148.54 34.54 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.725 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.23 135.46 64.92 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.034 2.489 . . . . 0.0 112.123 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 62.5 mttm -67.5 -16.03 63.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.894 -173.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 18.6 p -127.06 109.83 12.3 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.945 0.402 . . . . 0.0 110.671 175.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 12.3 p -120.69 141.79 39.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.513 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -104.02 104.47 14.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.35 0.595 . . . . 0.0 110.784 -178.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 78.0 mt -119.41 129.65 54.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.479 -177.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 3.1 m -75.04 134.09 41.47 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.49 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.7 p -79.35 109.1 13.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.683 0.754 . . . . 0.0 109.944 174.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.434 ' O ' ' HB3' ' A' ' 135' ' ' GLU . 36.3 p -114.5 115.36 27.12 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.552 -177.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.434 ' HB3' ' O ' ' A' ' 134' ' ' THR . 15.9 tp10 77.52 101.65 0.07 Allowed 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.928 0.871 . . . . 0.0 110.841 -177.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 14.6 t -150.75 153.74 36.08 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.616 -1.175 . . . . 0.0 108.343 175.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -82.39 147.01 55.41 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-O 120.889 0.376 . . . . 0.0 110.903 -174.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.11 -179.76 2.83 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 123.101 2.534 . . . . 0.0 112.162 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 119.35 32.53 1.23 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.005 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.9 tt . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 121.467 0.651 . . . . 0.0 110.636 176.914 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 24.1 p . . . . . 0 N--CA 1.448 -0.548 0 CA-C-O 121.112 0.482 . . . . 0.0 111.462 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -129.78 150.1 51.23 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.926 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 18.5 m -73.8 99.83 3.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.092 0.472 . . . . 0.0 111.447 -175.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -104.94 164.94 11.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.782 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 25.9 m -125.75 130.32 51.25 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.004 175.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 14.6 m -86.99 175.01 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.599 -0.441 . . . . 0.0 110.811 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -57.03 -30.0 63.86 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 64.9 p -72.72 -20.18 61.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.766 0.317 . . . . 0.0 111.477 -177.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 102.78 -1.11 48.59 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.617 -175.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -74.49 129.98 38.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.88 0.372 . . . . 0.0 110.856 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.8 p -91.82 131.94 36.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.709 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -148.71 153.59 38.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.913 0.387 . . . . 0.0 110.321 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -87.83 101.18 13.46 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.205 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 31.7 m -95.86 144.93 28.67 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.635 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.86 150.02 24.14 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 122.478 2.119 . . . . 0.0 111.433 175.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 65.0 mt -61.71 -22.01 64.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.714 -169.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -79.21 -17.15 55.39 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 63.4 t -65.5 131.21 31.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.63 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -119.53 159.02 25.13 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.414 -176.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -57.15 123.58 15.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.666 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 109.95 -12.62 31.95 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.774 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.567 ' OD1' ' HD3' ' A' ' 184' ' ' ARG . 26.2 t70 -68.03 141.02 56.33 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.741 0.305 . . . . 0.0 110.64 178.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 3.7 p -86.1 108.21 17.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.716 0.77 . . . . 0.0 110.425 177.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 85.3 mt -91.59 119.12 31.21 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.256 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.573 ' O ' ' HB ' ' A' ' 182' ' ' ILE . 56.0 mt -90.57 104.47 15.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 173.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 37.1 mt -95.75 130.92 43.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 C-N-CA 120.414 -0.514 . . . . 0.0 109.854 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.553 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 23.3 t-20 -80.07 89.55 5.39 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.976 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 4.7 m -61.43 129.55 41.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.658 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 115.55 -41.98 2.02 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -177.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -106.94 -33.66 7.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.199 0.523 . . . . 0.0 110.086 176.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 95.01 10.78 57.18 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.487 177.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.81 131.18 47.96 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -178.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -100.0 112.41 24.69 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.227 0.537 . . . . 0.0 110.839 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.573 ' HB ' ' O ' ' A' ' 173' ' ' ILE . 4.0 mp -107.63 134.93 47.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 43.0 t -113.43 165.63 12.28 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.477 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ARG . . . . . 0.567 ' HD3' ' OD1' ' A' ' 170' ' ' ASP . 30.1 mmt180 69.82 25.7 4.97 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 123.69 0.618 . . . . 0.0 112.095 174.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.626 -1.097 . . . . 0.0 113.009 177.987 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mmt . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 120.947 0.403 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 60' ' ' VAL . 44.4 mm -109.29 145.06 16.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.673 178.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.6 t -94.23 156.28 16.62 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 176.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.9 m -71.69 1.36 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.269 0.557 . . . . 0.0 110.827 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -107.22 11.29 29.47 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.447 176.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -126.92 88.5 2.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.026 0.441 . . . . 0.0 111.041 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -139.86 152.34 46.39 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.372 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.473 ' HG2' ' HG ' ' A' ' 11' ' ' LEU . 19.3 ptpt -143.6 178.19 7.96 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.6 p -56.11 -12.97 1.71 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.514 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -160.19 115.56 0.67 Allowed Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.04 172.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.473 ' HG ' ' HG2' ' A' ' 8' ' ' LYS . 8.9 mt -148.66 138.91 22.44 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 122.541 0.336 . . . . 0.0 110.293 174.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 2.9 m -95.28 115.49 27.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.189 0.519 . . . . 0.0 110.743 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.432 HG23 ' O ' ' A' ' 61' ' ' GLU . 1.9 mp -120.95 140.7 44.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.209 -176.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.7 t -98.91 118.0 34.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.953 0.406 . . . . 0.0 110.336 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.7 p -153.09 144.89 15.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 62.45 28.54 16.85 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 122.627 0.371 . . . . 0.0 110.661 -176.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.6 m120 62.52 25.22 15.02 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.396 -177.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.99 159.2 39.44 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 176.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 10.5 pt -106.46 122.96 60.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.233 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.518 ' O ' ' HA ' ' A' ' 12' ' ' THR . 33.3 m95 -119.63 165.52 14.36 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.772 -172.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -128.03 104.88 8.03 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.713 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.514 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 77.3 t -62.8 106.15 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.554 178.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.0 mm -85.0 -33.43 8.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.713 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -152.52 147.08 25.79 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.328 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -136.03 141.87 44.37 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.636 -177.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -124.52 106.35 10.09 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.078 177.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 16.1 t60 -74.07 89.61 1.97 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 176.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.5 p -92.83 128.15 44.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.894 -172.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.3 pttt -126.11 102.57 27.44 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.765 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -57.26 -47.2 23.47 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.357 2.704 . . . . 0.0 112.469 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.72 4.02 17.6 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.763 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -84.8 -12.42 53.66 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.075 0.464 . . . . 0.0 110.183 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.35 -42.25 1.29 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.659 176.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.0 m -99.84 134.34 42.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.868 0.366 . . . . 0.0 110.952 -177.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.55 153.97 18.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.173 0.511 . . . . 0.0 110.887 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -133.76 168.77 18.11 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.264 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 48.2 t -130.32 103.86 8.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 120.992 0.425 . . . . 0.0 110.083 176.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -82.37 98.82 9.04 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.7 p -110.03 139.0 45.63 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.817 -173.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -95.53 114.97 26.78 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 174.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.403 HD21 ' H ' ' A' ' 41' ' ' LEU . 0.9 OUTLIER -136.91 141.88 42.72 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.727 0.775 . . . . 0.0 111.316 -171.335 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -98.73 130.04 45.19 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.621 -176.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -64.24 114.14 4.04 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 171.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.417 HD22 ' OE1' ' A' ' 114' ' ' GLN . 7.8 tt -70.24 -22.16 62.93 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.726 -170.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -83.01 -46.45 12.84 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.4 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.7 p -97.24 -14.27 21.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.196 0.522 . . . . 0.0 111.908 -174.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.9 24.79 71.0 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.952 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.35 133.46 33.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.861 0.363 . . . . 0.0 111.784 -175.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.6 mm -93.36 109.85 22.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.107 178.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -136.78 177.41 7.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.841 0.353 . . . . 0.0 110.44 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -137.98 146.81 43.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.111 0.481 . . . . 0.0 110.517 173.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -135.07 171.41 14.47 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.309 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.8 t -127.77 118.31 23.52 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.416 0.626 . . . . 0.0 110.828 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -85.23 151.79 23.81 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.497 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -123.78 130.38 52.53 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.326 0.584 . . . . 0.0 111.795 -173.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.94 138.48 58.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.112 176.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.92 -19.21 28.17 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 111.341 -0.703 . . . . 0.0 111.341 -174.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -126.25 150.77 48.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.024 0.44 . . . . 0.0 110.415 176.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 20.1 pttm -89.33 152.13 21.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.29 -175.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.413 ' HB ' ' HB ' ' A' ' 2' ' ' ILE . 64.4 t -102.53 136.44 34.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.348 -178.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.432 ' O ' HG23 ' A' ' 13' ' ' ILE . 7.1 tp10 -88.52 121.2 70.29 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.738 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.27 151.64 20.53 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.244 1.963 . . . . 0.0 112.048 175.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.68 116.8 30.01 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.402 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 61.8 mtt -96.73 110.25 22.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.472 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 54.8 mt -109.85 138.93 35.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.839 0.352 . . . . 0.0 111.07 -176.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -112.85 139.51 48.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.441 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -117.09 127.01 53.73 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 177.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.509 ' HG2' ' OE2' ' A' ' 86' ' ' GLU . 40.6 mtm180 -135.82 165.39 25.72 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -127.84 125.65 40.15 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.18 0.514 . . . . 0.0 111.262 -176.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.543 ' HG3' ' HA ' ' A' ' 84' ' ' ASP . 1.9 mpt? -119.92 141.02 49.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.557 -176.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -79.31 140.47 37.54 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.102 177.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -74.58 111.59 9.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.745 -174.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -104.86 -179.64 4.0 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 167.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -145.5 142.14 28.95 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.487 -171.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.72 -170.74 3.53 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.664 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -60.67 131.19 49.94 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.68 68.84 2.44 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 119.153 -1.499 . . . . 0.0 114.322 -165.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -126.76 -30.42 2.77 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 154.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.449 ' OD1' ' HB3' ' A' ' 92' ' ' GLU . 55.7 t30 -133.53 132.38 40.87 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 113.59 -1.641 . . . . 0.0 109.477 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.616 ' CD2' ' HG ' ' A' ' 98' ' ' LEU . 14.5 m-70 -124.23 143.65 50.41 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 55.7 t -92.56 134.17 31.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.026 -175.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.504 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 74.4 m-85 -128.9 126.12 39.04 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 174.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.0 mmt -99.15 117.92 34.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.777 0.323 . . . . 0.0 111.332 -175.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.543 ' HA ' ' HG3' ' A' ' 70' ' ' MET . 23.0 t70 -60.23 115.39 3.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.088 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -72.56 -18.75 61.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.315 -176.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.509 ' OE2' ' HG2' ' A' ' 68' ' ' ARG . 46.3 mt-10 -71.76 -45.78 60.56 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 120.669 -0.412 . . . . 0.0 109.949 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.4 p -169.42 91.3 0.23 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 168.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 47.51 28.19 1.12 Allowed 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 156.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.505 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 37.2 tt0 -93.79 118.14 31.03 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 118.711 0.687 . . . . 0.0 110.809 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -77.61 112.63 14.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.264 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 43.0 m -110.21 119.28 38.77 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.37 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.449 ' HB3' ' OD1' ' A' ' 79' ' ' ASN . 36.3 mt-10 -99.19 127.77 45.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.314 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 39.9 mt -118.89 148.9 42.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.018 0.437 . . . . 0.0 111.004 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.2 m -89.99 166.57 13.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.089 -174.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.8 t -55.52 -31.54 62.15 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.462 -177.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -50.35 -49.24 54.65 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.605 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -77.98 -40.67 38.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.362 0.601 . . . . 0.0 109.74 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.616 ' HG ' ' CD2' ' A' ' 80' ' ' HIS . 4.3 mm? -66.09 -13.82 60.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.88 -174.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -57.77 -39.03 76.48 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.915 0.388 . . . . 0.0 110.106 172.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.566 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 8.4 tp10 -78.09 -43.43 29.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.746 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.462 ' O ' HD12 ' A' ' 105' ' ' LEU . 1.2 mp0 -57.47 -46.21 83.93 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.654 175.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 82.4 mt -67.92 -9.07 42.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.98 0.419 . . . . 0.0 111.116 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.566 ' HB3' ' O ' ' A' ' 100' ' ' GLU . 23.1 t30 -78.73 -50.2 11.78 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 173.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -141.1 116.7 10.24 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.293 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.462 HD12 ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -171.64 167.46 6.53 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.251 0.548 . . . . 0.0 111.818 178.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -141.67 143.67 33.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.842 168.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.5 mp0 -65.09 123.29 19.11 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 175.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.34 -13.43 47.89 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.039 -175.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.421 ' SD ' ' HG2' ' A' ' 126' ' ' PRO . 44.2 ttm -76.67 136.67 39.13 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -98.89 126.54 44.59 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.229 0.538 . . . . 0.0 111.142 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 31.4 m -106.71 160.05 6.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.905 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -100.14 100.86 11.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.065 0.46 . . . . 0.0 110.263 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.42 HD11 ' SD ' ' A' ' 70' ' ' MET . 65.1 mt -83.17 129.01 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.581 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.462 ' HG2' HD13 ' A' ' 121' ' ' ILE . 35.3 tt0 -106.8 117.36 33.84 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.925 -176.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 16.5 p -116.19 153.18 32.31 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.088 -174.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -130.03 99.39 5.06 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.935 176.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 61.97 31.79 17.96 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.374 0.607 . . . . 0.0 110.312 -174.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 93.78 -16.69 60.25 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.399 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -80.86 114.86 20.04 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 29.6 m -63.57 112.37 2.77 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.782 0.325 . . . . 0.0 110.604 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.462 HD13 ' HG2' ' A' ' 114' ' ' GLN . 38.7 pt -97.65 -23.97 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.04 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -170.47 163.46 36.68 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.016 -1.087 . . . . 0.0 112.848 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.3 t -127.63 126.63 67.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -106.59 120.6 42.38 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.76 -176.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.423 ' N ' HD21 ' A' ' 125' ' ' LEU . 1.9 mm? -86.18 150.21 51.67 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.421 ' HG2' ' SD ' ' A' ' 109' ' ' MET . 71.9 Cg_exo -51.42 130.89 34.59 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.697 2.265 . . . . 0.0 111.602 174.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 34.8 mmtp -62.37 -27.25 68.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.329 -170.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 34.9 p -121.32 112.73 18.95 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.97 176.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.1 p -114.8 137.03 49.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.164 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -109.32 99.03 8.34 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.226 0.536 . . . . 0.0 110.703 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.2 mt -106.9 142.05 37.14 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.056 0.455 . . . . 0.0 111.272 -173.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.4 m -84.14 133.7 34.61 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.037 176.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.6 p -87.34 112.37 23.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.629 0.728 . . . . 0.0 111.029 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 27.5 p -111.15 119.66 39.71 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.316 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 75.11 108.27 0.07 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.873 0.844 . . . . 0.0 111.041 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 8.9 t -150.55 153.44 35.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.673 178.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.443 ' O ' ' HD2' ' A' ' 150' ' ' LYS . 52.5 mt-10 -84.2 150.43 57.86 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.245 -176.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.29 179.9 6.07 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.51 2.14 . . . . 0.0 111.863 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 119.81 27.92 2.0 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.431 -177.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.9 tt . . . . . 0 C--N 1.33 -0.266 0 CA-C-O 121.277 0.56 . . . . 0.0 110.447 176.614 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 23.0 p . . . . . 0 N--CA 1.453 -0.279 0 CA-C-O 120.892 0.377 . . . . 0.0 110.507 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.443 ' HD2' ' O ' ' A' ' 137' ' ' GLU . 59.6 pttt -133.41 145.86 50.68 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.524 177.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 9.1 t -73.18 118.66 16.4 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.109 0.481 . . . . 0.0 110.338 -176.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -124.02 164.22 19.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.013 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 33.4 m -120.54 135.98 54.92 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 9.7 m -98.73 173.94 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.284 177.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -52.81 -31.23 37.69 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 68.5 p -74.42 -12.6 60.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.712 0.291 . . . . 0.0 111.721 -176.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 95.48 -4.72 66.93 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.015 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -75.53 144.91 41.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.992 0.425 . . . . 0.0 110.603 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 23.3 m -107.24 122.44 46.55 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.178 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.07 161.62 37.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.696 0.284 . . . . 0.0 110.302 -177.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -92.1 111.49 23.06 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.083 -175.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 27.4 m -101.14 155.81 35.89 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.228 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -58.2 152.09 55.12 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.357 2.038 . . . . 0.0 111.4 174.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 72.6 mt -64.08 -18.33 64.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.468 -169.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -91.28 -1.94 57.54 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -176.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 85.8 t -73.11 135.6 27.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.957 0.408 . . . . 0.0 110.694 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -113.98 151.51 32.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.193 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -63.33 125.7 25.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.115 0.483 . . . . 0.0 110.683 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 109.54 -10.5 32.93 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.19 -176.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.582 ' OD2' ' HD3' ' A' ' 184' ' ' ARG . 19.1 t70 -73.39 148.19 43.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.597 0.237 . . . . 0.0 110.676 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.467 ' O ' ' HD2' ' A' ' 184' ' ' ARG . 60.7 t -105.33 99.97 9.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.197 0.522 . . . . 0.0 110.51 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.486 HD22 ' H ' ' A' ' 172' ' ' LEU . 0.7 OUTLIER -96.01 141.17 29.73 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.603 -177.718 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 59.2 mt -99.22 130.54 48.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.344 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 43.9 mm -117.87 141.43 36.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.579 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 23.6 t-20 -87.85 98.81 11.68 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 177.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.21 127.06 31.23 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.518 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 111.02 -37.25 3.81 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.652 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -104.78 -23.84 12.99 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.099 0.476 . . . . 0.0 110.359 176.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 73.88 17.53 79.36 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.201 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 9.6 p -84.42 152.37 24.06 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.873 0.368 . . . . 0.0 110.633 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -97.33 124.79 41.58 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.19 0.519 . . . . 0.0 110.671 -175.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.454 ' N ' HD12 ' A' ' 182' ' ' ILE . 2.8 mp -106.74 151.02 8.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 174.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.2 p -77.15 173.56 11.71 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.377 -173.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ARG . . . . . 0.582 ' HD3' ' OD2' ' A' ' 170' ' ' ASP . 7.9 tpt180 -39.59 136.18 1.03 Allowed 'General case' 0 CA--C 1.533 0.319 0 O-C-N 123.754 0.659 . . . . 0.0 112.473 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.488 -1.174 . . . . 0.0 111.698 175.263 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.7 mtt . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 120.477 0.18 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.2 mm -104.29 122.87 57.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.7 0.286 . . . . 0.0 110.425 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.1 m -74.04 146.62 43.57 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 175.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.483 ' O ' HG23 ' A' ' 37' ' ' VAL . 20.7 m -70.11 -10.56 13.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.848 0.356 . . . . 0.0 111.744 -176.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -95.39 7.78 45.18 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.34 0.59 . . . . 0.0 109.542 177.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -120.79 87.79 2.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.687 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -136.9 152.84 50.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.217 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -128.19 167.44 16.83 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.809 -176.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.2 m -54.17 -30.24 48.64 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.344 0.592 . . . . 0.0 110.34 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.522 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -140.36 116.74 1.2 Allowed Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 169.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 54.9 tp -150.46 135.35 17.58 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 1.9 p -94.44 122.43 37.0 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.444 0.64 . . . . 0.0 112.192 -176.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.413 HD12 ' C ' ' A' ' 12' ' ' THR . 1.7 mp -119.39 141.92 37.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.53 -176.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.513 ' O ' ' HB3' ' A' ' 61' ' ' GLU . 43.1 t -107.32 107.73 18.79 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.425 HG13 ' CD1' ' A' ' 20' ' ' TRP . 13.1 p -142.2 140.6 29.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -178.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 61.3 32.77 19.2 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.6 -176.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 64.86 23.01 12.6 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.609 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.39 158.55 37.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.796 0.332 . . . . 0.0 110.514 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.6 pt -107.47 123.73 62.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.665 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.435 ' O ' ' HA ' ' A' ' 12' ' ' THR . 54.1 m95 -122.8 160.03 26.85 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.625 -172.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -130.58 115.04 16.21 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.522 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 94.9 t -64.76 119.14 8.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.705 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.4 mm -90.91 -35.96 7.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.718 176.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -160.82 122.09 2.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.067 177.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -104.45 143.28 33.22 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.735 0.302 . . . . 0.0 110.944 -176.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -118.85 99.43 6.75 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.881 0.372 . . . . 0.0 110.337 177.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -78.07 91.88 4.32 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 176.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 p -101.6 135.8 36.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.517 -171.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -109.1 101.76 46.18 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-O 121.309 0.576 . . . . 0.0 110.58 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -58.02 -48.2 17.24 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 123.345 2.696 . . . . 0.0 112.797 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.2 19.43 8.04 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.887 178.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -110.1 -14.31 14.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.681 0.277 . . . . 0.0 111.46 -177.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.05 -42.86 1.24 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.262 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.1 m -102.1 131.22 48.7 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 177.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.13 155.63 19.68 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 174.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.407 ' CE2' ' HB3' ' A' ' 55' ' ' ARG . 34.9 m-85 -129.66 163.38 26.21 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.094 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 4' ' ' VAL . 52.8 t -132.7 102.7 5.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.179 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -80.73 98.96 7.98 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 175.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 53.2 p -100.64 134.2 43.96 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.134 -175.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -95.43 102.68 14.5 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 174.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -138.48 150.96 46.96 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.804 0.335 . . . . 0.0 110.853 -171.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -116.96 144.92 44.01 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.543 -175.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.434 ' HB2' ' CZ3' ' A' ' 20' ' ' TRP . 47.4 t-20 -76.58 115.57 16.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.451 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.8 mt -69.77 -24.75 63.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.194 0.521 . . . . 0.0 110.733 -177.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.6 tpp180 -70.13 -38.8 75.64 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.011 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.3 p -113.48 -15.89 12.51 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -174.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.87 20.82 69.78 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.274 -0.489 . . . . 0.0 112.004 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -96.45 141.65 29.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.856 0.36 . . . . 0.0 111.799 -173.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.2 tp -87.92 137.18 21.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.251 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.488 ' HG3' ' N ' ' A' ' 51' ' ' GLU . 8.7 tp-100 -148.46 175.25 11.29 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -178.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.488 ' N ' ' HG3' ' A' ' 50' ' ' GLN . 10.7 pt-20 -140.17 138.16 34.96 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 170.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -126.51 135.11 50.9 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.686 -175.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.2 p -102.23 102.66 13.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.929 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -85.17 149.32 25.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.026 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.407 ' HB3' ' CE2' ' A' ' 36' ' ' PHE . 5.7 ptm180 -120.18 134.96 55.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.974 0.416 . . . . 0.0 111.385 -175.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.05 132.71 54.68 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.915 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 108.03 -29.88 9.68 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -174.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -102.82 99.67 9.63 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -76.6 137.71 39.68 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.415 0.626 . . . . 0.0 110.831 -175.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.3 t -85.36 150.65 3.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.977 -169.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.513 ' HB3' ' O ' ' A' ' 14' ' ' SER . 34.7 tt0 -85.63 130.98 48.94 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.682 176.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -82.73 156.29 15.83 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.505 2.137 . . . . 0.0 112.895 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -123.61 120.5 32.99 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.431 174.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 67.8 mtt -96.38 108.89 21.48 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.174 0.511 . . . . 0.0 110.799 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -110.2 121.6 63.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.485 177.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.582 ' OE1' ' HD2' ' A' ' 68' ' ' ARG . 40.6 tt0 -95.64 107.76 19.98 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.904 -176.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -84.39 100.77 11.5 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.357 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.582 ' HD2' ' OE1' ' A' ' 66' ' ' GLU . 16.2 mtp180 -106.08 170.24 8.03 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.142 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.56 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 7.7 ptm180 -142.71 120.06 11.6 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.459 0.647 . . . . 0.0 111.141 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.61 ' CB ' ' HB3' ' A' ' 82' ' ' PHE . 1.5 mpt? -115.59 139.94 49.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.926 -174.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -71.75 133.7 45.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.541 174.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -77.31 111.17 12.68 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -174.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -111.21 -179.04 3.61 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 169.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -148.7 159.59 43.98 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.312 0.577 . . . . 0.0 111.82 -175.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.23 -149.55 0.31 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.436 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -66.65 136.69 55.94 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 170.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.01 69.09 2.98 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 118.782 -1.675 . . . . 0.0 113.59 -170.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -127.11 -33.2 2.44 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 158.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -128.73 120.07 25.76 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 113.85 -1.523 . . . . 0.0 108.913 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.576 ' CG ' ' HG ' ' A' ' 98' ' ' LEU . 17.0 m-70 -102.39 132.28 48.49 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 57.1 t -83.58 125.64 40.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.081 -173.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.61 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 61.0 m-85 -123.03 120.54 33.63 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 176.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.56 ' SD ' ' HG2' ' A' ' 90' ' ' GLN . 93.5 mmm -95.19 113.3 24.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.917 -176.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.532 ' HA ' ' HG3' ' A' ' 70' ' ' MET . 20.9 t70 -58.46 117.39 4.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.239 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -76.49 -12.56 60.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.48 -177.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -68.91 -50.27 50.92 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 176.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.1 p -170.99 91.65 0.15 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.103 0.478 . . . . 0.0 112.288 164.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 48.31 26.62 1.14 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 160.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.496 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 45.7 mt-10 -87.59 113.16 23.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 118.666 0.666 . . . . 0.0 110.867 176.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.56 ' HG2' ' SD ' ' A' ' 83' ' ' MET . 73.5 mt-30 -74.47 118.14 17.09 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.343 -178.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.9 m -120.14 121.76 39.51 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.23 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -95.91 127.97 42.39 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.947 0.403 . . . . 0.0 110.483 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.425 HD13 ' CE1' ' A' ' 82' ' ' PHE . 59.6 mt -112.69 140.02 47.81 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.433 178.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.5 t -80.29 158.57 26.11 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.772 -177.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.2 p -58.98 -23.9 62.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.842 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.51 -39.45 87.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.808 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -82.75 -41.07 19.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.597 0.713 . . . . 0.0 109.35 177.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.576 ' HG ' ' CG ' ' A' ' 80' ' ' HIS . 3.3 mm? -67.24 -20.05 65.61 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.445 -171.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -60.94 -31.0 70.55 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.212 0.53 . . . . 0.0 110.096 175.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -82.61 -46.23 13.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.25 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.444 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 0.9 OUTLIER -62.13 -36.61 82.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.467 179.084 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.479 ' O ' ' HB ' ' A' ' 156' ' ' THR . 56.2 mt -67.21 -6.36 17.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.629 0.252 . . . . 0.0 111.608 -178.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -70.53 -41.47 72.5 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 172.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.453 ' HB3' HG12 ' A' ' 129' ' ' VAL . 68.8 m-85 -142.4 115.2 8.66 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.208 177.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 101' ' ' GLU . 0.7 OUTLIER 179.8 171.41 1.07 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 122.95 0.5 . . . . 0.0 110.739 173.004 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.534 ' HD2' ' O ' ' A' ' 130' ' ' GLU . 30.4 mtpp -142.48 144.73 33.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.306 176.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -62.73 113.79 3.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.862 0.363 . . . . 0.0 110.739 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 109.85 -10.28 32.14 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.402 -177.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.536 ' SD ' ' HG3' ' A' ' 126' ' ' PRO . 53.0 ttm -91.11 144.31 25.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.68 0.276 . . . . 0.0 110.465 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.606 ' HA ' ' O ' ' A' ' 70' ' ' MET . 8.4 pt-20 -94.2 138.91 31.68 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.365 0.602 . . . . 0.0 112.075 -177.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 33.9 m -113.57 158.13 14.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.58 175.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.553 ' HA ' ' O ' ' A' ' 68' ' ' ARG . 27.9 mt-30 -96.83 99.94 11.49 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.048 0.452 . . . . 0.0 110.652 -177.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.492 HD12 ' SD ' ' A' ' 70' ' ' MET . 63.7 mt -84.44 127.98 39.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.223 -178.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -100.13 110.34 22.62 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.485 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 43.1 p -107.12 128.7 54.62 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.322 177.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -108.1 110.2 21.82 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 174.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 60.44 29.05 18.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.445 -176.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 98.31 -18.96 56.27 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.984 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.445 ' O ' ' HA ' ' A' ' 115' ' ' THR . 42.5 tt0 -84.64 126.88 33.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.638 0.219 . . . . 0.0 111.364 -176.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 85.5 m -68.21 100.82 1.08 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 175.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 46.7 pt -84.79 -30.77 6.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.064 0.459 . . . . 0.0 110.328 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -170.86 162.38 35.32 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.692 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.4 t -123.81 127.31 73.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 177.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.421 ' HB3' ' HB2' ' A' ' 112' ' ' GLN . 31.0 tt0 -93.74 123.67 37.24 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.007 0.432 . . . . 0.0 109.961 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 125' ' ' LEU . 7.0 mp -78.25 157.62 77.89 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.311 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.536 ' HG3' ' SD ' ' A' ' 109' ' ' MET . 6.9 Cg_endo -48.45 127.81 16.58 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.02 2.48 . . . . 0.0 112.249 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -56.8 -38.29 72.33 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.348 -178.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 29.7 p -133.18 109.27 9.33 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.832 174.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.453 HG12 ' HB3' ' A' ' 104' ' ' TYR . 10.4 p -111.41 140.86 28.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.731 0.3 . . . . 0.0 110.623 -176.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.534 ' O ' ' HD2' ' A' ' 106' ' ' LYS . 7.4 pt-20 -107.06 100.36 9.85 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.402 0.62 . . . . 0.0 110.481 177.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 89.7 mt -106.2 133.47 50.86 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.343 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.4 m -76.12 130.85 38.92 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.098 178.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.5 p -78.88 105.61 8.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.913 0.863 . . . . 0.0 110.652 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 37.0 p -107.53 112.37 25.09 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.427 -178.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 79.06 96.67 0.06 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-O 122.068 0.937 . . . . 0.0 111.036 -177.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.61 ' O ' ' HD3' ' A' ' 138' ' ' PRO . 9.7 t -150.65 153.36 35.49 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.086 -1.415 . . . . 0.0 107.663 174.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -84.29 103.27 2.83 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.61 ' HD3' ' O ' ' A' ' 136' ' ' THR . 68.8 Cg_endo -90.11 172.81 3.56 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.835 2.357 . . . . 0.0 112.356 -175.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.49 21.24 77.54 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.772 176.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 56.5 mt . . . . . 0 C--N 1.325 -0.492 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.552 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 18.0 p . . . . . 0 N--CA 1.448 -0.564 0 CA-C-O 121.195 0.521 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -125.25 148.18 48.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.953 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 42.5 m -73.72 107.17 5.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.089 0.471 . . . . 0.0 110.76 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -107.9 163.5 13.07 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.852 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 21.1 m -118.79 134.52 55.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.047 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.5 m -98.54 175.79 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.506 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -57.31 -28.2 62.86 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 44.1 p -73.94 -11.01 60.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.017 0.436 . . . . 0.0 111.652 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.59 1.85 73.71 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -176.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -81.53 143.27 32.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.915 0.388 . . . . 0.0 110.856 -177.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 23.1 m -100.96 126.91 47.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.399 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.92 155.49 41.64 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -85.79 123.69 31.45 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.36 0.6 . . . . 0.0 111.3 -175.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 27.3 m -116.61 155.06 49.23 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.368 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -56.85 150.51 54.14 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.444 2.096 . . . . 0.0 111.65 175.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 80.7 mt -62.95 -17.3 61.78 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -169.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -88.6 -8.32 54.89 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -176.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 74.5 t -69.24 136.6 25.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.81 0.338 . . . . 0.0 111.249 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -122.68 160.89 24.89 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.479 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -59.4 128.04 35.09 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.887 -177.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 109.42 -15.61 32.42 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.536 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.546 ' OD2' ' HD3' ' A' ' 184' ' ' ARG . 23.7 t70 -67.26 145.35 55.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.8 0.3 . . . . 0.0 110.591 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.411 ' CG1' ' HB2' ' A' ' 130' ' ' GLU . 47.2 t -94.7 109.91 22.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.157 0.503 . . . . 0.0 110.379 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 46.7 mt -90.97 117.33 29.48 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.454 -178.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.426 ' N ' HD13 ' A' ' 173' ' ' ILE . 1.8 mp -91.43 106.45 17.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 57.8 mt -107.67 129.62 61.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.573 -176.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -82.22 96.41 7.85 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.373 175.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 6.5 m -61.68 136.59 58.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.006 -175.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 104.11 -33.74 6.33 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -107.66 -26.73 10.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.026 0.441 . . . . 0.0 110.505 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.36 15.32 76.75 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.206 177.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 5.9 m -68.96 112.65 5.74 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -96.22 111.41 23.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.188 0.518 . . . . 0.0 110.957 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 4.5 mp -107.81 102.35 13.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.124 0.488 . . . . 0.0 110.114 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 48.3 t -80.53 166.74 20.89 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.368 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ARG . . . . . 0.546 ' HD3' ' OD2' ' A' ' 170' ' ' ASP . 25.1 mmt180 72.46 30.22 1.98 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 172.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.137 0 CA-C-O 118.147 -1.363 . . . . 0.0 113.604 174.345 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.9 mtt . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.444 ' HB ' HG22 ' A' ' 60' ' ' VAL . 3.7 mp -81.76 118.86 30.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.242 0.544 . . . . 0.0 110.757 -176.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 m -97.36 151.95 19.42 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.337 171.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.9 m -67.18 -14.68 18.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -167.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -86.06 -0.1 54.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.427 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -133.6 91.31 2.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.242 0.544 . . . . 0.0 111.786 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -126.27 156.7 39.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.589 172.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -126.94 162.11 26.74 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -177.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 p -53.0 -20.36 3.37 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 123.556 0.535 . . . . 0.0 111.63 175.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.607 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -144.49 115.78 0.89 Allowed Glycine 0 N--CA 1.435 -1.376 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 167.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.72 129.22 20.17 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 1.2 m -103.29 118.27 36.4 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.193 0.52 . . . . 0.0 111.055 -178.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.0 mp -117.94 140.31 41.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.321 -176.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.405 ' HB2' ' HB2' ' A' ' 63' ' ' ALA . 22.7 t -102.33 102.02 12.34 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 175.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.5 p -140.34 146.27 24.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.446 -177.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 61.94 28.45 17.32 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.493 -176.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.1 m120 63.86 25.66 14.09 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.445 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.86 163.39 29.61 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.098 177.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 10.1 pt -109.56 126.27 66.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.392 -178.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.546 ' O ' ' HA ' ' A' ' 12' ' ' THR . 64.8 m95 -124.11 146.56 48.55 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.088 -170.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -120.78 104.05 9.58 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.318 -177.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.607 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 78.9 t -63.02 111.91 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.76 177.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.2 mt -92.68 -33.91 5.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.695 176.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -143.12 148.78 37.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.022 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -141.6 131.75 24.8 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.079 0.466 . . . . 0.0 110.905 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -122.37 110.02 15.13 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.373 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -80.06 101.24 8.6 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.5 p -108.5 134.11 51.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.295 0.569 . . . . 0.0 111.331 -172.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.486 ' HZ3' ' HB2' ' A' ' 29' ' ' LYS . 3.9 ttmp? -122.89 100.55 40.2 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.701 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -76.25 -10.49 19.22 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.343 2.029 . . . . 0.0 112.199 177.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.6 25.78 60.17 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.774 -0.648 . . . . 0.0 113.087 175.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -87.56 -12.86 44.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.919 0.39 . . . . 0.0 111.145 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.96 -42.57 1.27 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.685 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.7 p -123.01 132.41 54.12 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 174.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.04 161.65 25.28 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.848 0.356 . . . . 0.0 110.627 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.464 ' HA ' ' O ' ' A' ' 54' ' ' PHE . 86.1 m-85 -128.59 165.46 20.74 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.102 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 53' ' ' THR . 59.5 t -129.67 106.41 13.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 176.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -80.37 99.29 7.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.202 177.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.1 p -111.03 137.15 49.02 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.27 -174.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -95.28 108.85 21.03 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 175.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.428 HD21 ' H ' ' A' ' 41' ' ' LEU . 1.1 pt? -135.94 141.82 44.53 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.764 0.793 . . . . 0.0 111.899 -172.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 33.0 ttt180 -103.77 129.8 51.23 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.86 -1.063 . . . . 0.0 111.49 -173.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -70.12 117.95 12.34 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 172.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.9 mp -64.61 -26.82 68.57 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 121.188 -0.205 . . . . 0.0 111.434 -175.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 45' ' ' ARG . 59.3 mtt180 -76.55 -50.07 14.83 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.825 0.345 . . . . 0.0 111.467 -177.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.4 p -94.54 -17.65 22.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.047 0.451 . . . . 0.0 111.811 -172.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.24 6.57 88.85 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.719 -175.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.439 ' O ' ' HA ' ' A' ' 42' ' ' ARG . . . -68.64 131.04 44.54 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -174.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.7 mm -91.53 98.84 8.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.407 ' HG2' ' N ' ' A' ' 51' ' ' GLU . 34.7 tt0 -112.47 167.34 10.52 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -178.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.407 ' N ' ' HG2' ' A' ' 50' ' ' GLN . 11.0 pt-20 -132.5 125.91 31.7 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.152 0.501 . . . . 0.0 109.949 173.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -115.36 148.19 39.59 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.74 -176.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 10.8 p -112.6 105.06 13.17 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.244 176.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 88.3 m-85 -84.1 144.96 28.7 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.726 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.54 ' HD3' ' OE2' ' A' ' 58' ' ' GLU . 34.5 ttt180 -111.09 136.08 50.66 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.743 0.306 . . . . 0.0 111.549 -173.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.13 129.79 42.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.818 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 106.27 -16.75 41.51 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -175.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.54 ' OE2' ' HD3' ' A' ' 55' ' ' ARG . 81.1 mt-10 -112.71 149.56 32.75 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -127.67 163.41 24.32 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.298 -176.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.444 HG22 ' HB ' ' A' ' 2' ' ' ILE . 5.6 m -134.16 157.63 41.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.37 0.605 . . . . 0.0 111.469 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -83.59 141.56 41.99 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.03 -0.987 . . . . 0.0 110.443 -176.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.27 154.73 41.47 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.538 2.159 . . . . 0.0 112.454 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.405 ' HB2' ' HB2' ' A' ' 14' ' ' SER . . . -122.44 113.07 18.85 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.954 175.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 26.3 mmt -88.64 109.03 19.77 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.99 0.424 . . . . 0.0 110.62 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.545 ' CG1' HG22 ' A' ' 12' ' ' THR . 46.9 mm -99.37 125.4 52.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.049 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.49 ' HG3' ' OG1' ' A' ' 115' ' ' THR . 6.0 pt-20 -117.6 138.02 52.22 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.595 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -112.98 113.86 26.09 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.954 0.406 . . . . 0.0 110.213 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.505 ' HB3' ' OD1' ' A' ' 84' ' ' ASP . 68.6 mtt180 -110.36 117.47 33.71 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.17 -178.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.419 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 9.2 ptm180 -74.05 121.14 20.62 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 174.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.543 ' HG2' ' HA ' ' A' ' 84' ' ' ASP . 28.7 mtt -124.08 147.72 47.66 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.448 -175.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -77.41 136.56 38.41 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.903 177.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -77.14 103.78 7.26 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.413 -176.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.44 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 8.4 mp -104.32 -176.81 3.19 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 170.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -146.79 157.09 43.59 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.621 0.724 . . . . 0.0 112.448 -171.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.424 ' HB2' ' O ' ' A' ' 79' ' ' ASN . . . -150.57 -160.83 1.22 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.308 -1.314 . . . . 0.0 107.713 174.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -72.08 143.15 49.17 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 175.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.5 68.66 2.41 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 118.879 -1.629 . . . . 0.0 113.879 -167.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.568 ' HA ' ' OG ' ' A' ' 95' ' ' SER . 22.8 m-20 -127.93 -30.43 2.48 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 156.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.463 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 92.6 m-20 -137.07 138.65 40.63 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.512 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -121.69 144.56 48.7 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 173.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.44 ' O ' ' HB2' ' A' ' 73' ' ' LEU . 45.9 t -90.41 132.33 35.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.499 -178.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -126.43 125.53 42.3 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 174.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 37.8 mtt -93.7 113.32 25.37 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.454 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.577 ' HB3' ' H ' ' A' ' 89' ' ' GLU . 20.2 t0 -62.15 115.01 3.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.511 -177.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -85.46 -7.13 59.08 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.023 177.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.59 -52.24 27.84 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 173.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.44 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 12.1 p -164.75 90.03 0.52 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 167.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 47.33 28.26 1.03 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 158.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.577 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 49.2 mt-10 -105.89 116.53 32.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 118.981 0.809 . . . . 0.0 112.408 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -75.86 118.68 18.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.277 0.561 . . . . 0.0 110.027 175.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.1 m -120.99 138.26 54.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.547 -175.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -105.87 134.55 48.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.797 0.332 . . . . 0.0 110.817 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' A' ' 79' ' ' ASN . 4.5 mm? -112.88 143.01 44.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.427 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.7 m -79.64 166.93 21.35 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -173.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.568 ' OG ' ' HA ' ' A' ' 78' ' ' ASP . 10.2 m -52.93 -33.38 50.41 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.749 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -52.14 -40.69 61.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.734 -176.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -87.64 -41.03 13.69 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.42 0.628 . . . . 0.0 109.953 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.473 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 4.3 mm? -74.32 -20.88 59.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.314 -171.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -60.58 -32.26 71.37 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.126 0.489 . . . . 0.0 110.204 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -87.44 -39.4 15.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.387 177.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.45 ' O ' HD13 ' A' ' 105' ' ' LEU . 40.7 mt-10 -63.57 -25.62 68.32 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.343 178.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 65.8 mt -71.44 -7.4 47.14 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 122.021 -0.424 . . . . 0.0 110.865 177.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -90.09 -43.8 10.24 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 172.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -130.36 116.24 18.02 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.315 176.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.45 HD13 ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -172.4 164.2 5.68 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.728 0.299 . . . . 0.0 110.627 177.459 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -143.16 138.87 30.07 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -63.7 123.13 18.09 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.638 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.32 1.65 71.75 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.751 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.413 ' SD ' ' HD2' ' A' ' 126' ' ' PRO . 51.9 ttm -62.75 147.62 49.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.106 0.479 . . . . 0.0 111.53 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.41 ' HG2' HH21 ' A' ' 69' ' ' ARG . 4.3 tp10 -89.41 100.32 13.14 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.593 175.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 23.1 m -106.55 155.74 7.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.63 -178.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.495 ' HB2' ' HB3' ' A' ' 124' ' ' GLU . 12.8 mm100 -96.99 99.65 11.18 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 32.8 mm -81.88 116.0 25.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 177.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.404 ' HG2' HD13 ' A' ' 121' ' ' ILE . 27.8 tt0 -91.69 113.16 25.35 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.49 ' OG1' ' HG3' ' A' ' 66' ' ' GLU . 1.7 p -116.11 157.85 24.11 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.705 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -129.64 101.91 6.13 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 176.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 58.55 33.98 23.53 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.225 -173.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 96.49 -22.59 39.27 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.989 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -75.53 131.4 40.03 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.824 -0.221 . . . . 0.0 110.569 -178.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.6 p -75.22 113.24 12.36 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.734 0.302 . . . . 0.0 110.865 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.404 HD13 ' HG2' ' A' ' 114' ' ' GLN . 40.1 pt -105.94 -21.41 5.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.444 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -169.27 163.71 37.35 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.179 -1.01 . . . . 0.0 112.742 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 59.9 t -130.35 129.53 64.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 177.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.495 ' HB3' ' HB2' ' A' ' 112' ' ' GLN . 35.3 tt0 -108.97 101.12 10.24 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.295 0.569 . . . . 0.0 110.669 178.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -77.66 126.22 84.72 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 173.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.413 ' HD2' ' SD ' ' A' ' 109' ' ' MET . 30.5 Cg_exo -37.74 127.5 0.79 Allowed 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.791 2.994 . . . . 0.0 113.359 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 75.5 mmtt -62.49 -26.73 68.69 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.9 -172.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 p -119.08 108.85 15.22 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.072 0.463 . . . . 0.0 109.944 172.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.2 p -110.5 136.41 46.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.428 -177.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -96.45 115.08 26.85 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.847 0.356 . . . . 0.0 110.38 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 80.9 mt -124.38 131.9 53.52 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.584 -177.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.9 m -79.29 134.93 36.63 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.36 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.4 p -85.13 118.28 31.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.621 0.724 . . . . 0.0 110.868 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.544 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 43.2 p -130.97 126.13 35.2 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.496 178.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.544 ' HB2' ' O ' ' A' ' 134' ' ' THR . 48.7 mm-40 79.4 79.07 0.05 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.675 0.75 . . . . 0.0 111.175 -175.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.574 ' O ' ' HD3' ' A' ' 138' ' ' PRO . 11.1 t -150.23 153.58 36.46 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 171.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -102.12 99.65 13.04 Favored Pre-proline 0 C--N 1.321 -0.646 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.348 -178.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.574 ' HD3' ' O ' ' A' ' 136' ' ' THR . 84.6 Cg_endo -91.54 -179.17 1.29 Allowed 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.08 2.52 . . . . 0.0 112.186 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 94.87 13.67 52.28 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.478 178.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.7 mp . . . . . 0 C--N 1.325 -0.476 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.346 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.498 ' HB ' ' HB3' ' A' ' 161' ' ' ASN . 36.9 p . . . . . 0 N--CA 1.45 -0.461 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -131.64 152.48 50.81 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.453 178.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.4 p -72.78 117.56 14.63 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.051 0.453 . . . . 0.0 111.358 -177.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' A' ' 159' ' ' THR . . . -119.66 158.62 26.07 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.954 -178.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.467 ' HB ' ' O ' ' A' ' 134' ' ' THR . 18.4 m -109.73 138.48 46.03 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 174.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.0 m -105.63 178.87 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.496 175.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -54.97 -30.25 58.75 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 79.4 p -76.41 -8.87 58.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.805 0.336 . . . . 0.0 111.839 -177.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 86.13 3.29 85.17 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.582 -175.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -80.79 143.47 32.83 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.851 0.357 . . . . 0.0 110.555 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 152' ' ' ALA . 30.1 m -101.07 120.22 39.89 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.06 177.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.2 161.49 35.6 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.498 ' HB3' ' HB ' ' A' ' 149' ' ' THR . 89.4 m-20 -92.84 112.93 25.06 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.881 0.372 . . . . 0.0 111.53 -173.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 29.2 m -108.32 148.18 37.1 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.393 178.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.38 149.22 30.51 Favored 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.558 2.172 . . . . 0.0 111.964 174.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 59.4 mt -62.38 -11.72 17.24 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -170.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -104.18 10.33 35.81 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -176.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 75.5 t -78.73 142.41 14.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -114.41 145.22 42.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.437 -175.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -62.53 127.06 29.52 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.615 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 112.12 -16.44 25.1 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.356 -176.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -75.49 154.91 36.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.987 0.422 . . . . 0.0 110.631 177.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 88.6 t -105.04 116.63 49.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.747 -177.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.403 HD22 ' N ' ' A' ' 172' ' ' LEU . 2.5 mm? -99.2 138.36 36.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.073 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.559 ' O ' ' HB ' ' A' ' 182' ' ' ILE . 57.0 mt -97.28 115.37 36.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 33.7 mm -109.85 141.31 25.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.427 -178.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.589 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 27.2 t-20 -86.52 103.1 14.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.991 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.0 m -71.77 113.03 8.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.231 176.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 143.43 -47.1 0.81 Allowed Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -177.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -118.81 -22.73 7.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.982 0.42 . . . . 0.0 110.373 175.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 89.48 17.24 55.51 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.109 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 4.2 m -65.04 136.57 56.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.582 0.23 . . . . 0.0 110.605 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -89.84 117.17 28.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.145 0.498 . . . . 0.0 110.927 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.559 ' HB ' ' O ' ' A' ' 173' ' ' ILE . 4.0 mp -96.87 151.42 4.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 169.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 10.7 p -77.11 173.1 12.22 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.829 -0.169 . . . . 0.0 111.018 -173.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 39.0 mtt180 -46.03 144.3 1.93 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.686 0.616 . . . . 0.0 111.885 -176.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.734 -1.037 . . . . 0.0 111.852 177.928 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 120.917 0.389 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 84.5 mt -75.28 134.68 28.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.036 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 m -94.83 143.79 26.17 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 174.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.47 ' HA ' ' CE1' ' A' ' 7' ' ' PHE . 10.8 m -69.11 -1.99 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -172.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -90.09 -2.63 58.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.657 0.265 . . . . 0.0 110.593 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -134.0 89.93 2.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.527 0.679 . . . . 0.0 111.518 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.47 ' CE1' ' HA ' ' A' ' 4' ' ' VAL . 61.6 m-85 -119.58 153.01 36.1 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 171.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -119.57 171.64 8.22 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.477 -176.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.1 p -65.17 -14.57 60.91 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.767 0.794 . . . . 0.0 109.978 174.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.498 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -153.13 115.12 0.66 Allowed Glycine 0 N--CA 1.435 -1.369 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 166.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.6 tp -149.99 132.0 15.26 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.66 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 1.7 m -98.39 122.69 41.89 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.321 0.581 . . . . 0.0 112.092 -172.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.0 mp -117.27 143.73 26.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.279 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.45 ' HB2' ' HB2' ' A' ' 63' ' ' ALA . 35.5 t -104.43 107.43 18.36 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 175.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.9 p -153.93 151.28 11.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -176.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 54.78 45.09 27.39 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 -176.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.7 p30 47.29 31.66 1.87 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.314 1.046 . . . . 0.0 112.222 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.7 166.06 25.69 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.466 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.8 pt -112.13 130.58 65.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.83 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.66 ' O ' ' HA ' ' A' ' 12' ' ' THR . 70.2 m95 -126.6 147.91 49.83 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.885 -168.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.4 ttmm -116.95 104.02 10.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.549 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.498 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 84.1 t -62.81 109.06 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.872 0.368 . . . . 0.0 110.303 177.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 77.0 mt -88.85 -38.15 11.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.512 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -142.47 152.53 42.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.481 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -143.77 136.44 27.2 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.991 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -113.26 99.65 7.97 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.708 176.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -76.05 90.02 3.03 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.0 p -96.5 118.95 43.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.567 0.699 . . . . 0.0 111.519 -171.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.434 ' HB3' ' HZ2' ' A' ' 29' ' ' LYS . 5.2 ttpm? -119.81 96.83 49.66 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.428 176.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.88 -10.77 15.38 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.482 2.121 . . . . 0.0 113.148 -177.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.2 26.65 39.51 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.958 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -95.46 10.67 35.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.796 0.331 . . . . 0.0 111.265 -176.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.48 -42.03 2.03 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.12 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.1 p -133.18 146.58 51.66 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 177.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -96.35 166.13 11.86 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.113 0.482 . . . . 0.0 111.134 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -136.25 167.07 21.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.492 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.9 t -131.88 102.62 5.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.086 0.47 . . . . 0.0 109.733 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -82.47 99.33 9.4 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.5 p -102.76 143.87 31.85 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.916 -173.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -102.52 102.82 13.13 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 174.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.494 HD21 ' H ' ' A' ' 41' ' ' LEU . 1.3 pt? -133.02 150.96 52.11 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.687 0.756 . . . . 0.0 112.36 -169.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 20.3 ttt180 -110.69 129.67 55.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.038 -171.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -69.96 122.52 19.48 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 173.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.9 mp -66.85 -25.67 66.54 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -176.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.1 mtt85 -81.33 -44.83 17.06 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.671 0.272 . . . . 0.0 111.72 -177.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 67.2 p -99.09 -17.07 18.4 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.132 0.492 . . . . 0.0 111.943 -173.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.31 13.64 81.32 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.793 -175.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 42' ' ' ARG . . . -73.53 133.27 43.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.917 0.389 . . . . 0.0 111.672 -175.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 26.4 mm -96.15 99.15 8.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.378 176.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.453 ' O ' HD21 ' A' ' 41' ' ' LEU . 8.9 tt0 -119.75 157.23 29.02 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -177.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -113.9 127.02 55.8 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.291 0.567 . . . . 0.0 110.092 175.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -129.09 146.22 51.1 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.626 -175.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.1 m -107.77 120.66 42.87 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.269 0.557 . . . . 0.0 111.899 -175.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -92.03 155.45 18.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.251 173.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -117.6 132.13 56.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.143 0.497 . . . . 0.0 111.429 -176.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.3 129.66 40.62 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.871 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.19 -16.24 32.63 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -175.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -106.27 137.82 43.55 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -93.4 132.45 37.63 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.122 0.486 . . . . 0.0 110.61 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.5 t -96.03 145.62 8.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.662 -175.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -87.52 125.64 64.68 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.701 0.286 . . . . 0.0 110.493 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -79.12 152.79 24.49 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.563 2.175 . . . . 0.0 112.754 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.45 ' HB2' ' HB2' ' A' ' 14' ' ' SER . . . -117.56 109.39 16.64 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.569 176.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 61.4 mtt -87.25 108.68 19.05 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.168 0.508 . . . . 0.0 110.219 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.44 ' CG1' HG21 ' A' ' 12' ' ' THR . 52.1 mm -90.79 132.67 34.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.073 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -104.72 103.61 13.27 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.955 -177.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -93.99 101.34 13.39 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.938 0.399 . . . . 0.0 110.194 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 41.6 mtm180 -107.05 168.02 9.49 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -134.66 122.11 21.78 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.326 0.584 . . . . 0.0 111.022 -175.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.535 ' HG3' ' HA ' ' A' ' 84' ' ' ASP . 1.9 mpt? -117.39 149.07 41.14 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.348 -173.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -90.87 139.81 30.4 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 174.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -70.74 103.22 2.51 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.773 -174.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -94.49 -175.18 3.54 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 167.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -143.07 142.96 31.68 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 119.764 -0.774 . . . . 0.0 112.511 -167.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.497 ' HB2' ' O ' ' A' ' 79' ' ' ASN . . . -151.85 -172.83 4.34 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.261 -1.336 . . . . 0.0 108.812 175.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -76.61 145.73 38.71 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.13 68.64 2.59 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 118.984 -1.579 . . . . 0.0 114.095 -167.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -126.89 -30.81 2.7 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 156.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.613 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 21.1 p-10 -140.98 132.74 27.37 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 113.608 -1.633 . . . . 0.0 109.68 177.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.498 ' CG ' HD23 ' A' ' 98' ' ' LEU . 54.7 m170 -114.92 146.96 40.59 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 172.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 44.8 t -95.7 125.45 48.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.91 -176.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.53 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 78.8 m-85 -121.68 117.59 27.04 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 89.0 mmm -91.41 114.24 26.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.849 0.357 . . . . 0.0 111.22 -174.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.535 ' HA ' ' HG3' ' A' ' 70' ' ' MET . 22.4 t70 -62.16 116.49 5.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.39 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -77.68 -11.56 59.88 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.439 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -73.3 -50.52 21.73 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 176.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.6 p -169.09 91.59 0.25 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 168.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 48.42 25.32 0.88 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 157.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.465 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 41.6 mt-10 -95.68 116.76 29.34 Favored 'General case' 0 C--N 1.32 -0.702 0 O-C-N 121.453 -0.78 . . . . 0.0 111.172 176.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -85.35 98.26 10.44 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.392 0.615 . . . . 0.0 110.791 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.8 m -89.02 117.04 27.75 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.325 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 80' ' ' HIS . 44.2 mt-10 -95.95 126.15 40.99 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 177.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.613 ' O ' ' HA ' ' A' ' 79' ' ' ASN . 70.9 mt -104.5 146.72 28.47 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.579 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.59 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 28.5 t -86.05 167.34 15.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.66 -175.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.8 p -49.06 -35.69 16.48 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -175.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -53.8 -40.58 66.47 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.903 0.382 . . . . 0.0 111.536 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -80.53 -35.28 34.71 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.291 0.567 . . . . 0.0 109.798 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 94' ' ' SER . 13.3 mt -67.35 -30.37 70.16 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.137 -172.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -63.04 -43.65 98.09 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.949 0.404 . . . . 0.0 110.666 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -65.84 -36.4 83.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.897 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.49 ' O ' HD13 ' A' ' 105' ' ' LEU . 51.1 mt-10 -62.39 -41.31 98.56 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.508 173.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 73.5 mt -63.74 -20.77 66.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.931 0.396 . . . . 0.0 110.617 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -72.02 -50.14 31.05 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 173.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -138.64 116.02 11.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.071 176.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.49 HD13 ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -164.15 150.69 11.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.898 0.38 . . . . 0.0 110.646 178.003 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -145.83 134.96 22.77 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 172.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -64.79 123.42 19.33 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.909 -177.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 101.57 -6.1 54.99 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.565 -178.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 50.4 ttm -69.7 133.45 47.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.806 0.336 . . . . 0.0 110.65 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -95.33 101.86 13.62 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.09 0.471 . . . . 0.0 110.376 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 32.8 m -100.56 166.82 2.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.567 -177.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -108.57 109.18 20.34 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 46.5 mt -89.81 123.75 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-O 121.233 0.54 . . . . 0.0 109.633 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.455 ' HG2' HD11 ' A' ' 121' ' ' ILE . 31.2 tt0 -96.42 107.67 20.09 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.74 -174.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 40.9 p -109.19 159.06 17.23 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 121.44 0.638 . . . . 0.0 111.771 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -137.58 106.31 5.9 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 60.88 32.26 20.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.865 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 98.82 -18.33 57.01 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.052 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -88.36 134.82 33.72 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 122.798 -0.236 . . . . 0.0 110.927 -176.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.0 p -77.93 108.68 11.36 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.733 0.301 . . . . 0.0 110.36 175.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.455 HD11 ' HG2' ' A' ' 114' ' ' GLN . 36.0 pt -92.02 -27.11 4.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.839 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -169.59 167.74 40.75 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.672 177.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 55.7 t -125.35 121.22 59.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -102.78 112.17 24.83 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.015 0.436 . . . . 0.0 110.508 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 66.0 mt -78.7 152.65 77.94 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 175.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.51 144.23 52.34 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.363 2.042 . . . . 0.0 110.635 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.711 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 14.3 mmmm -64.82 -22.35 66.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.705 -173.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 26.3 p -125.55 113.43 17.42 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.862 0.363 . . . . 0.0 111.334 176.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 9.6 p -114.84 140.44 35.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.614 175.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -112.8 124.52 52.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.553 0.692 . . . . 0.0 111.352 177.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 95.7 mt -129.27 145.63 51.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.911 -175.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.3 m -85.52 132.71 34.15 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.128 176.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.8 p -85.81 108.84 17.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.815 0.817 . . . . 0.0 110.769 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.671 ' O ' ' HB ' ' A' ' 153' ' ' THR . 26.9 p -116.48 124.59 50.32 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.621 178.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.539 ' HB2' ' O ' ' A' ' 134' ' ' THR . 1.5 mp0 77.36 86.61 0.08 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.904 0.859 . . . . 0.0 111.18 -176.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.448 ' O ' ' HD3' ' A' ' 138' ' ' PRO . 14.4 t -148.7 156.27 42.14 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 173.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -81.2 109.6 14.57 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -175.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 136' ' ' THR . 98.2 Cg_endo -89.08 166.7 5.62 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.947 2.431 . . . . 0.0 112.944 -176.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.31 -1.3 88.6 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.036 -0.602 . . . . 0.0 113.081 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.402 HD11 ' HD3' ' A' ' 150' ' ' LYS . 58.1 mt . . . . . 0 C--N 1.326 -0.418 0 CA-C-O 121.315 0.579 . . . . 0.0 110.564 -177.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.5 p . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 121.285 0.564 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.402 ' HD3' HD11 ' A' ' 140' ' ' ILE . 37.4 ttpt -127.64 136.28 51.41 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.626 -178.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 35.9 p -72.76 120.19 18.04 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.074 0.464 . . . . 0.0 110.404 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 159' ' ' THR . . . -125.13 160.48 29.02 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.159 -178.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.671 ' HB ' ' O ' ' A' ' 134' ' ' THR . 1.6 m -111.45 136.58 50.41 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.4 m -102.48 177.73 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.175 174.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -55.63 -29.27 58.92 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 80.3 p -75.93 -9.41 58.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.022 0.439 . . . . 0.0 111.529 -177.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 87.56 7.59 75.32 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.091 -0.576 . . . . 0.0 111.898 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -86.14 141.26 29.5 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.666 0.269 . . . . 0.0 110.943 -177.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 152' ' ' ALA . 17.9 m -95.57 115.43 27.42 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.158 176.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.33 161.9 32.39 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -94.52 113.28 25.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.531 0.681 . . . . 0.0 111.54 -174.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 27.3 m -108.59 150.5 40.79 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.971 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.21 150.76 47.12 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.295 1.997 . . . . 0.0 111.481 174.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 54.5 mt -58.28 -23.19 55.42 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -168.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -85.54 -9.36 57.5 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -174.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 94.6 t -70.5 136.18 26.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -122.91 163.45 20.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.868 0.366 . . . . 0.0 110.141 -174.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -60.67 128.05 34.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.733 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 109.43 -16.91 31.59 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.55 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.85 138.74 58.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.952 0.406 . . . . 0.0 111.404 178.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 61.1 t -97.72 104.02 15.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 172.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 184' ' ' ARG . 0.7 OUTLIER -100.31 143.08 30.91 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.71 -176.427 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.505 ' O ' ' HB ' ' A' ' 182' ' ' ILE . 60.7 mt -99.32 136.97 28.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.649 177.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 61.7 mt -127.18 138.21 55.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.711 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 26.6 t-20 -81.0 91.98 6.14 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.011 176.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.9 118.78 18.24 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.115 0.484 . . . . 0.0 110.62 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 129.43 -48.28 0.98 Allowed Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -175.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.421 ' HB2' ' OD1' ' A' ' 175' ' ' ASN . 17.1 m-20 -106.28 -24.92 12.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.03 0.443 . . . . 0.0 110.098 177.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 86.92 15.12 63.57 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.434 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 6.0 m -72.27 127.05 31.36 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -79.42 122.84 26.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.16 0.505 . . . . 0.0 110.386 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.505 ' HB ' ' O ' ' A' ' 173' ' ' ILE . 9.8 mm -100.41 155.2 4.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 14.7 p -75.68 166.8 23.01 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.59 0.709 . . . . 0.0 111.703 -169.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ARG . . . . . 0.445 ' HA ' ' HA ' ' A' ' 172' ' ' LEU . 23.6 ptt180 -85.45 159.37 19.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.549 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.548 -1.14 . . . . 0.0 111.71 175.61 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.415 ' SD ' ' HD3' ' A' ' 59' ' ' LYS . 66.8 mtt . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 120.733 0.301 . . . . 0.0 110.317 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.1 mp -99.41 135.24 35.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.964 0.412 . . . . 0.0 110.136 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.2 m -99.95 156.63 17.04 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.6 m -68.77 -8.66 10.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -170.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -93.48 12.08 26.3 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.648 0.261 . . . . 0.0 110.64 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -140.5 89.36 2.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.282 0.563 . . . . 0.0 111.447 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -122.33 148.55 44.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.531 175.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.429 ' HG3' ' N ' ' A' ' 9' ' ' THR . 20.6 tptm -114.88 161.5 18.16 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.284 -176.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.429 ' N ' ' HG3' ' A' ' 8' ' ' LYS . 8.4 m -49.42 -31.93 10.7 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.2 0.524 . . . . 0.0 111.06 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.542 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -143.38 116.83 1.03 Allowed Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 170.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 66.9 tp -142.07 137.42 31.02 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 2.5 m -100.96 118.97 38.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.011 0.434 . . . . 0.0 110.823 -177.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.8 mp -120.01 137.5 53.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.424 -177.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.6 p -98.48 100.13 11.36 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.7 p -146.81 152.13 13.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.59 -175.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.2 t70 63.9 27.29 14.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.34 0.591 . . . . 0.0 109.682 178.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 63.75 30.53 14.64 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.401 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.94 167.18 24.63 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.095 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 15.5 pt -109.68 123.52 65.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.078 0.466 . . . . 0.0 110.156 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.495 ' O ' ' HA ' ' A' ' 12' ' ' THR . 34.2 m95 -121.16 160.36 23.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.411 -172.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -129.34 107.96 9.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.567 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.542 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 82.7 t -59.95 118.39 3.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.124 0.488 . . . . 0.0 111.009 179.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.1 mm -93.31 -41.89 12.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.758 175.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -158.25 121.56 3.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.21 -177.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -108.58 139.06 43.88 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.044 0.45 . . . . 0.0 111.571 -173.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -116.41 99.89 7.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.442 176.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 -71.75 96.47 1.62 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 175.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.9 p -99.37 134.3 39.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.448 0.642 . . . . 0.0 111.25 -172.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -116.72 87.46 21.64 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.506 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -65.28 -46.72 5.34 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.635 2.223 . . . . 0.0 112.596 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.56 26.79 3.01 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 121.126 -0.559 . . . . 0.0 111.902 -176.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -97.13 10.32 39.7 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.821 0.343 . . . . 0.0 111.104 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.22 -42.32 1.99 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.995 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.413 ' HB3' ' HB3' ' A' ' 56' ' ' ALA . 70.6 m -115.51 138.53 50.94 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 175.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.68 162.6 22.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.058 0.456 . . . . 0.0 110.75 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -132.04 164.9 25.2 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.342 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.4 t -132.33 102.64 5.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 120.956 0.408 . . . . 0.0 110.34 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -79.19 99.03 6.83 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.2 m -106.53 131.15 54.03 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.535 -173.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.9 mttp -84.34 105.4 15.15 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 171.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.43 ' H ' HD22 ' A' ' 41' ' ' LEU . 0.6 OUTLIER -127.97 138.27 52.55 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.718 0.771 . . . . 0.0 110.813 -172.454 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.9 ttt180 -96.97 128.27 43.77 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.989 -177.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -60.84 113.74 2.67 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 172.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.431 HD21 ' OE1' ' A' ' 114' ' ' GLN . 8.9 tt -66.96 -24.11 66.02 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.656 -170.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -85.99 -45.88 11.05 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.691 -177.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 75.1 p -93.81 -21.71 19.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.067 0.461 . . . . 0.0 111.893 -174.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.7 12.27 75.33 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.177 -176.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.91 131.58 38.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.98 0.419 . . . . 0.0 111.685 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.6 mm -89.49 110.93 22.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.606 177.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.451 ' HG2' ' H ' ' A' ' 51' ' ' GLU . 32.7 tt0 -131.79 174.62 9.95 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -177.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.451 ' H ' ' HG2' ' A' ' 50' ' ' GLN . 9.8 pt-20 -137.72 131.83 31.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.178 0.513 . . . . 0.0 110.623 173.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.0 mttp -124.28 154.02 40.86 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.53 -177.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 48.9 m -106.84 112.76 25.87 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.825 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -83.6 151.13 25.5 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 175.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.4 ptp85 -122.91 129.76 52.0 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.354 -171.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.413 ' HB3' ' HB3' ' A' ' 34' ' ' SER . . . -63.53 130.77 45.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.304 177.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.59 -18.4 29.8 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -176.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -104.13 131.56 51.28 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.415 ' HD3' ' SD ' ' A' ' 1' ' ' MET . 18.0 ptpt -77.2 140.05 40.04 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.512 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 65.5 t -98.45 117.02 42.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.208 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -90.19 121.8 68.25 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.388 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.64 151.4 36.66 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.45 2.1 . . . . 0.0 112.403 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -101.81 125.99 48.59 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.131 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 15.8 ptp -85.15 109.58 18.39 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.227 0.537 . . . . 0.0 111.037 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.34 125.23 60.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.038 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -121.82 121.68 37.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.885 0.374 . . . . 0.0 110.468 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -99.63 133.24 44.26 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.487 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -129.91 170.15 14.3 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.431 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 0.0 OUTLIER -129.96 127.93 41.04 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.859 0.361 . . . . 0.0 110.285 177.333 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.604 ' CB ' ' HB3' ' A' ' 82' ' ' PHE . 1.6 mpt? -118.52 147.6 43.5 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.678 -176.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -85.17 142.42 29.48 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 172.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -75.46 109.66 9.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.071 -175.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -103.81 -176.63 3.14 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 167.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -145.67 151.81 38.63 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 119.828 -0.749 . . . . 0.0 112.405 -174.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.7 -163.34 1.75 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.595 177.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -68.28 139.19 55.94 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 175.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.88 70.77 2.68 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 119.174 -1.489 . . . . 0.0 113.673 -168.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -125.62 -31.22 2.99 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 159.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.575 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 27.3 m-80 -141.25 135.11 30.35 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 113.83 -1.532 . . . . 0.0 109.209 175.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.547 ' CG ' HD22 ' A' ' 98' ' ' LEU . 64.2 m170 -104.83 145.88 29.77 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 176.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 40.9 t -91.87 127.32 44.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.733 -176.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.604 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 55.0 m-85 -125.16 126.33 45.1 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.659 0.266 . . . . 0.0 110.417 177.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 50.1 ttm -89.92 112.44 23.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.668 -176.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.575 ' HA ' ' HG3' ' A' ' 70' ' ' MET . 16.0 t0 -70.69 119.19 14.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.024 -176.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -75.42 -16.3 60.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.6 178.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -69.5 -54.01 16.34 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.8 p -167.35 91.87 0.39 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 171.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 48.44 28.5 1.71 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 158.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.429 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 47.2 mt-10 -103.51 120.5 40.98 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 118.661 0.664 . . . . 0.0 111.764 178.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -83.69 89.22 7.11 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 173.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.0 m -77.24 116.26 17.72 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.239 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -90.87 118.85 30.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.228 0.537 . . . . 0.0 110.014 177.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' A' ' 79' ' ' ASN . 57.3 mt -93.61 136.29 34.04 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.852 -177.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.507 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 2.2 m -77.7 172.02 14.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.842 -175.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.9 m -50.97 -40.61 58.17 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -175.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -56.14 -40.16 73.38 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.018 0.437 . . . . 0.0 111.775 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.439 ' HB2' ' HB3' ' A' ' 93' ' ' LEU . 45.4 m-85 -77.71 -32.91 53.2 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.818 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.615 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 14.3 mt -64.25 -30.36 71.41 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.473 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -56.8 -46.41 81.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.428 176.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -62.47 -43.71 98.15 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.061 177.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.536 ' O ' HD11 ' A' ' 105' ' ' LEU . 46.4 mt-10 -60.67 -34.16 73.91 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.015 177.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 55.2 mt -68.58 -6.16 23.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.902 0.382 . . . . 0.0 111.277 -178.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -90.7 -50.02 6.14 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 168.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -136.26 116.79 13.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.312 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.536 HD11 ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -163.65 138.98 6.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.977 0.417 . . . . 0.0 110.837 176.615 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -146.46 147.76 31.55 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 173.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -63.98 130.7 45.11 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.529 0.204 . . . . 0.0 110.537 -176.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.94 -0.6 87.78 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.811 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 56.5 ttp -72.73 142.71 48.17 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.739 -0.271 . . . . 0.0 110.294 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -100.21 119.06 37.78 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.874 0.368 . . . . 0.0 110.448 -177.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 21.1 m -111.88 165.2 7.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.488 -178.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -108.03 105.05 14.63 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 178.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 53.7 mt -92.13 126.68 44.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.181 0.515 . . . . 0.0 109.847 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.431 ' OE1' HD21 ' A' ' 44' ' ' LEU . 24.9 tt0 -99.45 119.13 37.49 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.675 -175.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 64.5 p -116.47 153.54 31.94 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.19 0.519 . . . . 0.0 111.984 -174.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.403 ' HB2' HD11 ' A' ' 121' ' ' ILE . 38.7 t80 -129.67 101.24 5.82 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.276 -0.875 . . . . 0.0 108.962 176.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 61.73 26.93 16.45 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.691 0.758 . . . . 0.0 110.254 -178.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 104.52 -25.8 24.68 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.559 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -79.1 127.45 32.03 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -177.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 43.9 p -69.82 114.16 7.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.761 0.315 . . . . 0.0 110.432 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.403 HD11 ' HB2' ' A' ' 116' ' ' TYR . 22.4 pt -100.52 -26.32 3.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.454 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -164.32 162.43 35.32 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.151 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 86.3 t -135.01 124.48 43.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.921 0.391 . . . . 0.0 110.207 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -106.6 123.57 48.31 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.948 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.404 ' N ' HD21 ' A' ' 125' ' ' LEU . 2.9 mm? -78.69 156.0 78.0 Favored Pre-proline 0 C--N 1.32 -0.675 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 174.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.408 ' HD3' HG13 ' A' ' 111' ' ' VAL . 47.6 Cg_exo -56.1 123.98 15.16 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.423 2.082 . . . . 0.0 111.446 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.58 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 12.8 mptt -54.85 -34.69 63.18 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.22 -176.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 36.3 p -117.45 108.71 15.87 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 171.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.6 p -122.41 135.85 61.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.432 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -96.48 105.8 17.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.463 0.649 . . . . 0.0 111.116 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 58.0 mt -114.3 129.1 56.63 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.981 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.2 m -75.29 130.88 39.82 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.143 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 170' ' ' ASP . 4.2 p -78.32 105.84 8.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.705 0.764 . . . . 0.0 110.618 178.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.424 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 13.8 p -110.81 123.49 50.19 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.17 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 134' ' ' THR . 42.1 mt-10 76.05 97.3 0.07 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.889 0.852 . . . . 0.0 111.422 -177.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 10.3 t -150.34 155.96 40.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.954 174.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.459 ' O ' ' HD3' ' A' ' 150' ' ' LYS . 25.2 mm-40 -80.96 153.72 72.56 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.123 -170.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -68.86 172.11 12.3 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.531 2.154 . . . . 0.0 111.485 174.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 119.44 32.29 1.26 Allowed Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.961 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 24.2 pt . . . . . 0 C--O 1.235 0.299 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 176.272 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.4 p . . . . . 0 N--CA 1.449 -0.507 0 CA-C-O 121.898 0.856 . . . . 0.0 112.666 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.459 ' HD3' ' O ' ' A' ' 137' ' ' GLU . 26.0 ttmt -137.29 143.07 41.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.007 -1.452 . . . . 0.0 108.987 -174.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 25.0 m -73.77 120.72 19.75 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.103 0.477 . . . . 0.0 110.311 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -129.39 162.53 27.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.137 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 21.3 m -127.35 143.82 51.16 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.476 174.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 15.7 m -103.56 173.55 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.786 0.327 . . . . 0.0 110.717 176.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -62.74 -12.54 24.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.65 -174.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.446 HG22 ' O ' ' A' ' 105' ' ' LEU . 68.6 p -87.76 -13.49 42.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.789 0.328 . . . . 0.0 111.469 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 94.49 3.12 63.09 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.763 -174.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -78.14 141.54 38.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.846 0.355 . . . . 0.0 110.416 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 25.0 m -106.61 133.18 51.68 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.381 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -148.68 165.07 32.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.636 0.255 . . . . 0.0 110.48 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -105.53 108.51 20.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.322 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 27.8 m -102.93 157.39 33.83 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.648 -176.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.402 ' HD3' ' CE2' ' A' ' 181' ' ' TYR . 25.5 Cg_exo -62.77 150.52 87.86 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 121.965 1.777 . . . . 0.0 110.828 175.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 52.1 mt -55.78 -24.78 37.7 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -169.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -79.24 -13.32 59.76 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -174.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 91.5 t -68.51 129.8 33.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.123 0.487 . . . . 0.0 110.647 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -121.52 155.01 35.89 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.514 -175.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -57.68 121.39 10.29 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.665 -178.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 114.16 -17.41 19.48 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.496 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.573 ' OD2' ' HD3' ' A' ' 184' ' ' ARG . 22.0 t70 -65.41 144.38 57.1 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 177.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 48.5 t -93.24 108.53 20.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.13 0.49 . . . . 0.0 110.294 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 76.2 mt -92.54 117.92 30.46 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.379 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.401 ' N ' HD13 ' A' ' 173' ' ' ILE . 1.9 mp -90.48 101.97 12.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 175.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 31.9 mm -89.73 124.06 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.421 -175.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.58 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 49.4 t30 -86.44 89.44 7.89 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 174.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.409 HG21 ' HA ' ' A' ' 127' ' ' LYS . 8.9 t -66.74 152.06 46.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.938 0.399 . . . . 0.0 110.463 -176.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 93.42 -45.98 2.38 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.4 -176.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -98.92 -27.73 13.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.107 0.479 . . . . 0.0 110.456 177.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.39 24.06 55.07 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.377 176.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.454 ' HB2' ' HB3' ' A' ' 175' ' ' ASN . 1.3 m -81.76 99.42 8.96 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.402 ' CE2' ' HD3' ' A' ' 163' ' ' PRO . 24.8 p90 -77.17 108.26 10.13 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.15 0.5 . . . . 0.0 110.827 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 36.9 mm -96.37 140.95 16.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 44.6 t -120.73 167.92 11.96 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 110.465 -0.198 . . . . 0.0 110.465 -176.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ARG . . . . . 0.573 ' HD3' ' OD2' ' A' ' 170' ' ' ASP . 25.8 mmt180 72.03 16.84 5.29 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.278 0.631 . . . . 0.0 112.538 173.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.031 0 CA-C-O 118.749 -1.028 . . . . 0.0 112.721 179.814 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 120.452 0.167 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.6 mm -94.74 143.82 11.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.2 m -104.8 157.67 17.04 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.7 m -66.25 -4.24 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.013 -175.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -76.82 -24.5 52.77 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.841 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -112.72 107.51 16.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.306 0.574 . . . . 0.0 111.774 -175.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -140.69 145.85 37.06 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 171.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.2 mtmm -131.11 175.1 9.38 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.231 -174.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 19.6 m -61.78 -22.1 65.13 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.57 0.7 . . . . 0.0 110.237 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -144.91 114.77 0.8 Allowed Glycine 0 N--CA 1.434 -1.495 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 167.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.4 tp -150.36 122.73 8.43 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 175.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 2.1 p -87.03 122.95 31.58 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.461 0.648 . . . . 0.0 111.93 -175.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.7 mm -119.22 141.08 40.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.539 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 43.0 p -107.69 103.82 13.19 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 176.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.3 p -143.9 148.38 18.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 63.75 24.13 13.72 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.206 -175.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 61.95 28.04 17.05 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.193 -176.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.15 164.09 27.08 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.771 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.6 pt -108.52 126.95 65.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.635 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.492 ' CZ3' ' HB2' ' A' ' 43' ' ' ASN . 11.5 m95 -128.36 166.27 18.99 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.719 -174.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -132.63 108.21 8.91 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.767 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 85.6 t -63.91 115.57 2.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.283 177.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' A' ' 9' ' ' THR . 77.1 mt -95.88 -38.9 8.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.584 176.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -140.18 153.73 46.71 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.08 178.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 39' ' ' SER . 16.7 p90 -146.8 128.51 15.23 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.828 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -100.9 99.04 9.48 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.038 177.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -78.14 94.33 4.7 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 175.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.2 p -104.86 126.58 59.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.116 -173.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -117.47 103.86 50.55 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.441 -178.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -57.5 -47.35 22.15 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 123.239 2.626 . . . . 0.0 112.671 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 112.7 5.03 24.41 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.588 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -81.53 -14.46 56.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.097 -0.552 . . . . 0.0 110.812 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.42 -15.1 8.14 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.518 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.4 p -134.41 145.94 49.38 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.418 -0.391 . . . . 0.0 110.097 177.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -125.72 168.31 13.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.692 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -143.8 163.51 33.14 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.516 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.9 t -121.32 105.12 16.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.027 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -81.86 99.37 9.0 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 175.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 25' ' ' PHE . 60.7 p -103.07 146.94 27.61 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.135 0.493 . . . . 0.0 112.099 -171.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -103.2 110.04 21.86 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 174.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.47 HD23 ' H ' ' A' ' 41' ' ' LEU . 0.9 OUTLIER -135.43 144.27 46.39 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.517 0.675 . . . . 0.0 111.778 -171.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 35.8 ttt180 -99.84 127.71 45.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.535 -175.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.492 ' HB2' ' CZ3' ' A' ' 20' ' ' TRP . 53.8 t-20 -71.78 119.8 16.46 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 173.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.8 mp -66.03 -24.6 66.78 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.935 0.397 . . . . 0.0 111.169 -176.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -80.21 -42.88 22.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.67 -176.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.6 p -97.63 -22.3 16.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.203 0.525 . . . . 0.0 111.517 -176.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.31 17.71 79.04 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.662 -176.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 42' ' ' ARG . . . -92.15 143.67 26.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.97 0.414 . . . . 0.0 111.984 -174.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 44.4 mm -92.2 100.99 12.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.774 175.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.444 ' HG2' ' H ' ' A' ' 51' ' ' GLU . 29.6 tt0 -113.56 173.42 6.42 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.444 ' H ' ' HG2' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -122.03 146.91 46.72 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.117 0.484 . . . . 0.0 110.963 173.356 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -134.3 132.11 39.19 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.597 -177.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.2 m -100.24 103.88 15.34 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.065 0.46 . . . . 0.0 111.136 -177.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -87.34 141.45 28.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.892 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 49.7 mtp180 -115.62 133.75 55.72 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.721 0.296 . . . . 0.0 110.784 -176.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.41 133.32 55.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.771 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 107.42 -31.03 8.45 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -176.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -90.19 141.88 28.26 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 177.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -81.53 137.85 35.51 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.285 0.564 . . . . 0.0 111.305 -176.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.5 t -100.14 112.74 33.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.429 176.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -93.61 120.56 66.13 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-O 120.918 0.39 . . . . 0.0 110.787 -177.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -77.33 157.58 33.18 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 123.003 2.469 . . . . 0.0 112.9 -175.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -106.01 115.85 30.93 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.153 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -73.77 108.13 6.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.352 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.452 HG13 HG23 ' A' ' 12' ' ' THR . 37.4 mm -103.41 129.97 54.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.068 0.461 . . . . 0.0 110.453 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.425 ' HB2' ' OG1' ' A' ' 115' ' ' THR . 21.0 mt-10 -109.77 146.45 34.95 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.354 -177.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -136.89 113.93 10.59 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.891 0.377 . . . . 0.0 110.647 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.441 ' HG2' ' HG3' ' A' ' 86' ' ' GLU . 79.1 mtm180 -123.0 156.76 34.14 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.474 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 8.5 ptm180 -114.77 124.59 52.15 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.104 -178.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.617 ' CB ' ' HB3' ' A' ' 82' ' ' PHE . 1.9 mpt? -116.27 142.63 46.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.408 -178.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -82.07 134.78 35.37 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.09 175.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.572 ' CD1' ' HA ' ' A' ' 107' ' ' GLU . 42.8 t80 -71.84 115.67 11.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.317 -173.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 55.8 mt -115.33 -176.47 2.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.781 168.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -146.75 154.63 41.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.178 0.514 . . . . 0.0 111.473 -177.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -140.21 -149.43 0.28 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.229 -0.896 . . . . 0.0 108.584 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -69.46 132.3 46.1 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 171.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -75.86 69.29 2.15 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.104 -1.522 . . . . 0.0 113.719 -167.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -127.19 -29.96 2.71 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 156.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.533 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 19.4 m120 -133.94 142.02 47.54 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.803 178.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.574 ' ND1' ' HG ' ' A' ' 98' ' ' LEU . 53.2 m80 -119.86 144.34 47.42 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.418 177.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 61.1 t -88.69 136.35 23.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.837 -176.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.617 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 63.5 m-85 -131.02 125.62 33.77 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.457 ' O ' ' HA ' ' A' ' 70' ' ' MET . 72.5 mtm -95.86 114.62 26.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.717 0.294 . . . . 0.0 111.533 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.529 ' HA ' ' HG3' ' A' ' 70' ' ' MET . 19.2 t70 -61.97 116.37 4.84 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.77 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -70.52 -20.29 62.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.022 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.456 ' HB2' ' OD2' ' A' ' 84' ' ' ASP . 11.3 mm-40 -64.08 -51.15 65.45 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.477 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 5.0 p -171.15 91.74 0.15 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 168.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 47.99 29.86 1.84 Allowed 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 159.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 87' ' ' SER . 47.2 mt-10 -100.06 117.83 35.14 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 121.768 -0.582 . . . . 0.0 110.937 177.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -84.07 113.86 21.34 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.347 0.594 . . . . 0.0 110.534 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 56.5 m -110.15 128.14 55.3 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.966 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -102.25 141.5 34.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.047 0.451 . . . . 0.0 110.267 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 79' ' ' ASN . 57.3 mt -118.64 144.21 46.31 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.469 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.9 t -83.52 173.24 11.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.583 -174.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.7 t -56.18 -44.24 79.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.935 -173.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.52 -37.22 86.79 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.738 0.304 . . . . 0.0 111.687 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.571 ' O ' ' HG2' ' A' ' 101' ' ' GLU . 97.1 m-85 -67.03 -40.04 87.12 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.574 ' HG ' ' ND1' ' A' ' 80' ' ' HIS . 3.7 mm? -74.6 -11.07 60.1 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.09 178.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -63.75 -44.32 93.84 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.834 0.349 . . . . 0.0 110.589 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.54 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 14.3 tp10 -74.34 -37.0 63.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.122 0.487 . . . . 0.0 109.781 175.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.571 ' HG2' ' O ' ' A' ' 97' ' ' TYR . 9.1 mm-40 -59.38 -43.46 92.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.983 176.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.555 ' O ' ' HB ' ' A' ' 156' ' ' THR . 85.9 mt -71.85 -2.43 17.77 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.006 0.431 . . . . 0.0 111.051 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.54 ' HB3' ' O ' ' A' ' 100' ' ' GLU . 29.3 t30 -80.73 -48.3 12.73 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 171.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.48 ' HB3' HG12 ' A' ' 129' ' ' VAL . 85.5 m-85 -146.99 117.19 7.33 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.523 174.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.483 HD22 ' O ' ' A' ' 101' ' ' GLU . 0.9 OUTLIER -172.94 169.18 4.8 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.588 0.232 . . . . 0.0 110.562 178.476 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.515 ' HD3' ' O ' ' A' ' 130' ' ' GLU . 30.6 mmmt -143.2 149.14 37.57 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 173.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.572 ' HA ' ' CD1' ' A' ' 72' ' ' TYR . 40.4 tt0 -69.57 130.91 43.73 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.071 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.46 -2.29 80.48 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.397 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 58.3 ttm -74.79 140.77 44.24 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -103.19 102.71 12.7 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.121 0.486 . . . . 0.0 110.073 -177.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 19.5 m -99.49 162.8 2.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.152 -174.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.521 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 57.9 mt-30 -104.55 100.36 10.03 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.989 0.423 . . . . 0.0 110.688 -178.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 59.3 mt -74.78 128.18 36.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.94 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.489 ' O ' HG13 ' A' ' 121' ' ' ILE . 7.8 tt0 -105.83 113.91 27.75 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.987 -175.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.425 ' OG1' ' HB2' ' A' ' 66' ' ' GLU . 74.1 p -114.85 155.3 27.06 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.23 -176.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -118.91 99.21 6.6 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 172.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 61.42 41.8 12.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.82 0.819 . . . . 0.0 109.639 -176.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.32 -19.83 37.35 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.506 -0.77 . . . . 0.0 113.192 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -82.02 116.44 21.63 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 24.2 m -65.28 106.01 1.25 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -176.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 114' ' ' GLN . 2.4 pp -100.18 -23.42 4.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.788 -177.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -170.41 175.53 44.28 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.17 -1.014 . . . . 0.0 112.727 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.2 t -135.43 129.76 49.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.849 0.357 . . . . 0.0 110.093 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.521 ' HB2' ' HB2' ' A' ' 112' ' ' GLN . 5.9 mm-40 -98.4 109.69 22.4 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.773 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 77.3 mt -80.6 135.19 53.16 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.784 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.42 131.25 44.63 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.621 2.214 . . . . 0.0 110.641 170.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.585 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 0.7 OUTLIER -60.74 -35.09 75.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.731 -167.036 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 18.0 p -96.76 110.53 22.98 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.029 0.442 . . . . 0.0 111.426 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.48 HG12 ' HB3' ' A' ' 104' ' ' TYR . 6.9 p -129.92 135.67 60.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.285 177.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.515 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 6.7 pt-20 -109.65 121.25 44.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.168 0.509 . . . . 0.0 111.352 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 77.9 mt -122.2 130.28 53.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.294 -178.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.1 m -75.1 134.36 41.34 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.172 178.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.441 HG11 ' O ' ' A' ' 170' ' ' ASP . 4.1 p -83.54 100.23 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-O 121.952 0.882 . . . . 0.0 110.702 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 29.8 p -90.88 103.27 16.0 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.466 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.466 ' HA ' ' OE2' ' A' ' 168' ' ' GLU . 44.1 mt-10 77.77 111.49 0.07 Allowed 'General case' 0 C--O 1.238 0.45 0 O-C-N 124.149 0.906 . . . . 0.0 111.998 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.0 t -150.39 152.81 34.94 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.542 -1.208 . . . . 0.0 108.579 174.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.421 ' O ' ' HD2' ' A' ' 150' ' ' LYS . 4.6 mp0 -82.99 123.5 77.61 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 120.762 0.315 . . . . 0.0 110.448 -176.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -82.38 -179.9 4.97 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.824 2.349 . . . . 0.0 112.114 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 119.45 32.98 1.16 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.22 -0.99 . . . . 0.0 113.162 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.419 HD11 ' HA ' ' A' ' 165' ' ' PHE . 12.2 tt . . . . . 0 CA--C 1.531 0.239 0 CA-C-O 121.401 0.62 . . . . 0.0 111.049 178.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.4 p . . . . . 0 C--O 1.235 0.295 0 CA-C-O 121.147 0.499 . . . . 0.0 111.451 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.421 ' HD2' ' O ' ' A' ' 137' ' ' GLU . 63.3 pttt -138.39 158.42 44.32 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.218 175.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.3 p -73.22 132.39 43.13 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.328 0.585 . . . . 0.0 111.751 -178.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.13 163.38 32.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.599 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 26.0 m -132.01 131.37 42.45 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 174.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.7 m -93.45 175.11 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -59.27 -25.94 64.52 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -176.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.555 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 47.1 p -72.5 -16.74 61.79 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.765 0.317 . . . . 0.0 111.563 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.22 1.81 59.32 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.593 -176.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -84.73 138.22 32.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.488 -0.356 . . . . 0.0 110.661 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 14.8 t -97.23 136.05 38.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.974 176.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -148.65 164.35 34.57 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -176.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -102.23 111.77 24.18 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.204 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 33.9 m -106.47 147.25 34.59 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.96 -176.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.7 154.97 39.73 Favored 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 122.712 2.275 . . . . 0.0 111.679 176.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -67.07 -15.14 63.54 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -168.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.419 ' HA ' HD11 ' A' ' 140' ' ' ILE . 22.1 p90 -80.98 -11.11 59.62 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.861 0.362 . . . . 0.0 111.346 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 92.8 t -76.15 134.07 29.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.147 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -120.14 165.73 14.37 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.466 ' OE2' ' HA ' ' A' ' 135' ' ' GLU . 28.5 tt0 -61.42 152.27 30.24 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.595 -176.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 65.68 6.83 31.63 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 114.354 0.501 . . . . 0.0 114.354 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.441 ' O ' HG11 ' A' ' 133' ' ' VAL . 11.2 m-20 -77.7 147.83 35.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.653 0.727 . . . . 0.0 110.137 171.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 62.3 t -94.48 110.45 23.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.068 0.461 . . . . 0.0 109.898 177.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 67.7 mt -94.08 123.61 37.57 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.73 -176.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.52 ' O ' ' HB ' ' A' ' 182' ' ' ILE . 54.4 mt -90.73 128.38 42.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 174.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 37.1 mm -125.11 139.87 49.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -178.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.585 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 26.3 t-20 -87.32 91.69 8.81 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 174.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 11.1 t -74.07 148.29 42.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.964 0.411 . . . . 0.0 110.175 -177.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 105.65 -40.34 2.52 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 -174.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -109.8 -46.35 3.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.135 0.493 . . . . 0.0 110.001 175.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 107.01 11.15 26.75 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.671 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.423 ' HB2' ' HB3' ' A' ' 175' ' ' ASN . 6.6 m -65.11 132.31 48.84 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -83.14 126.08 32.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.253 0.549 . . . . 0.0 110.468 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.52 ' HB ' ' O ' ' A' ' 173' ' ' ILE . 14.1 mm -106.61 156.71 7.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.4 p -74.45 170.19 16.19 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.258 0.551 . . . . 0.0 111.935 -170.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -70.05 145.27 51.83 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.726 -176.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.946 0 CA-C-O 118.57 -1.128 . . . . 0.0 111.77 178.259 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.8 ttt . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 120.772 0.32 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 46.6 mm -117.64 134.65 60.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 171.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.9 m -88.3 151.14 22.83 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.433 ' O ' HG21 ' A' ' 37' ' ' VAL . 29.7 m -68.5 -1.82 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 121.004 0.43 . . . . 0.0 111.667 -178.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -97.98 0.39 46.28 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.345 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -118.95 89.12 3.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.543 -178.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -134.21 153.29 51.94 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.928 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -129.95 175.94 8.46 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.167 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.2 t -66.33 -9.56 34.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.165 0.507 . . . . 0.0 110.079 175.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.67 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -152.26 115.43 0.69 Allowed Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 110.396 -1.081 . . . . 0.0 110.396 170.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.52 133.09 19.79 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 10.5 p -98.15 123.28 42.12 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.138 0.494 . . . . 0.0 112.023 -177.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.1 mp -125.7 141.93 44.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.14 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.0 t -106.24 105.27 15.22 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 176.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.7 p -147.52 148.36 16.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -176.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 62.68 24.89 14.82 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.199 0.312 . . . . 0.0 110.62 -174.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 63.74 24.16 13.73 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.611 0.72 . . . . 0.0 110.601 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.62 158.77 37.58 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.857 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.7 pt -105.22 125.8 60.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.281 0.563 . . . . 0.0 110.295 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.54 ' O ' ' HA ' ' A' ' 12' ' ' THR . 74.2 m95 -120.84 161.19 21.94 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.448 -170.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -136.7 110.4 8.09 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.163 176.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.67 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 89.3 t -60.52 117.26 2.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.932 177.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.3 mm -92.14 -30.73 4.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.481 175.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -153.89 140.48 18.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.427 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -126.29 138.68 53.62 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.806 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -118.82 100.07 7.16 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.023 176.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -75.58 101.49 4.94 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 177.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.4 p -109.58 126.47 66.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.391 0.615 . . . . 0.0 111.609 -172.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.8 mtmt -113.91 102.73 55.08 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.438 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -55.85 -47.8 23.22 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.509 2.806 . . . . 0.0 112.788 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.8 11.54 10.14 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.137 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -102.46 3.42 37.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.128 0.49 . . . . 0.0 110.694 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.6 -43.0 1.81 Allowed Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.384 178.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.8 p -93.32 126.34 38.39 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.819 0.342 . . . . 0.0 110.296 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.54 162.03 13.26 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.08 0.467 . . . . 0.0 110.813 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -134.84 166.13 23.7 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.815 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.433 HG21 ' O ' ' A' ' 4' ' ' VAL . 49.9 t -131.83 104.09 7.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 175.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -82.3 99.06 9.12 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.3 p -110.56 135.41 51.25 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.076 0.465 . . . . 0.0 111.892 -173.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -91.39 111.94 23.65 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 172.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.441 ' H ' HD22 ' A' ' 41' ' ' LEU . 1.2 pt? -138.71 145.1 39.9 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.175 0.512 . . . . 0.0 110.935 -173.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 9.9 ptt180 -106.96 143.08 35.57 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.865 -174.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -65.23 119.89 11.73 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 171.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.437 HD22 ' OE1' ' A' ' 114' ' ' GLN . 3.9 tt -67.38 -25.57 66.03 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.208 -170.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.4 ' CZ ' HG22 ' A' ' 121' ' ' ILE . 11.9 mtp180 -83.44 -46.42 12.53 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.411 -177.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.2 p -94.97 -20.48 19.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.011 0.434 . . . . 0.0 112.151 -173.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.93 17.85 73.84 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.111 -176.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 42' ' ' ARG . . . -75.0 126.54 31.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.834 0.349 . . . . 0.0 111.803 -177.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.1 mm -87.96 108.86 18.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.107 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -129.67 162.18 28.92 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -122.99 128.06 49.67 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.471 0.653 . . . . 0.0 110.559 174.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -128.12 144.63 51.12 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.559 -176.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.2 m -110.32 118.37 36.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.907 0.384 . . . . 0.0 111.354 -175.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -85.45 155.51 21.21 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.871 176.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.49 ' H ' ' HD2' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -122.19 132.88 54.67 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.043 0.449 . . . . 0.0 111.325 -176.186 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.63 138.06 58.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.089 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 108.22 -28.66 11.4 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.401 -177.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -100.83 141.27 33.95 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 177.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.64 142.68 37.02 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.008 0.432 . . . . 0.0 110.264 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.9 t -93.88 125.84 46.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.316 174.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -89.55 113.31 56.18 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 120.917 0.389 . . . . 0.0 110.21 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.01 159.63 41.11 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.606 2.204 . . . . 0.0 112.719 -176.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.85 109.52 18.28 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.096 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 24.7 ttt -74.19 109.59 7.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.144 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 48.7 mm -96.28 116.83 39.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.835 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.46 ' HB2' ' OG1' ' A' ' 115' ' ' THR . 27.8 mt-10 -96.84 141.51 29.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.506 -176.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -123.08 123.54 41.08 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.723 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.542 ' O ' ' HA ' ' A' ' 112' ' ' GLN . 52.6 mtt180 -124.37 164.33 19.88 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 174.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 10.3 ptm85 -126.72 131.98 51.23 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 176.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.494 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 13.7 mmm -127.01 139.3 53.13 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.265 -170.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -78.44 132.36 37.27 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 175.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -75.37 106.93 7.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.137 -174.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.7 mp -97.38 176.01 6.04 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 166.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -146.95 149.91 34.13 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 119.567 -0.853 . . . . 0.0 113.047 -170.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.96 -169.76 3.47 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 113.976 -1.465 . . . . 0.0 107.211 171.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -63.79 144.14 57.28 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 175.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.3 69.68 2.93 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 118.928 -1.606 . . . . 0.0 113.731 -168.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -126.21 -27.71 3.2 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 158.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.518 HD22 ' HB3' ' A' ' 92' ' ' GLU . 26.7 t-20 -140.76 128.45 21.6 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.308 -1.315 . . . . 0.0 109.897 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.48 ' ND1' HD21 ' A' ' 98' ' ' LEU . 47.6 m170 -122.03 148.28 45.03 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.568 0.223 . . . . 0.0 110.466 175.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 41.8 t -102.24 130.48 52.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.085 -175.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.48 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 79.7 m-85 -125.43 133.49 52.45 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 40.7 mtm -105.64 119.2 38.54 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 121.073 -0.251 . . . . 0.0 110.883 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.478 ' HB3' ' H ' ' A' ' 89' ' ' GLU . 10.6 t70 -61.33 123.9 19.09 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.88 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -72.37 -20.83 61.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.833 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -66.58 -51.55 55.18 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.3 p -172.25 92.46 0.12 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 166.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 48.6 27.46 1.48 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 162.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.478 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 48.5 mt-10 -88.79 110.41 21.0 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 121.756 -0.59 . . . . 0.0 110.276 176.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -78.81 133.72 37.03 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.684 -177.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 90.6 m -131.01 120.85 24.07 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.937 174.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.518 ' HB3' HD22 ' A' ' 79' ' ' ASN . 29.1 mt-10 -99.89 127.56 46.05 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.004 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.43 HD13 ' CE1' ' A' ' 82' ' ' PHE . 52.6 mt -103.83 152.06 22.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.98 -177.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.613 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 13.8 m -96.44 170.64 9.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.316 -172.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.0 m -46.92 -38.13 10.04 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.27 0.628 . . . . 0.0 112.595 -175.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -50.34 -44.74 54.59 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.09 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -81.16 -36.92 29.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.323 0.582 . . . . 0.0 110.437 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 94' ' ' SER . 11.7 mt -64.68 -27.2 68.76 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.261 -171.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -59.87 -47.5 85.49 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.901 0.381 . . . . 0.0 110.561 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.506 ' HA ' ' ND2' ' A' ' 103' ' ' ASN . 41.9 mt-10 -70.1 -33.47 71.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.486 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.571 ' O ' HD12 ' A' ' 105' ' ' LEU . 72.7 mt-10 -59.74 -45.35 92.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.03 171.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 83.1 mt -66.55 -15.27 63.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.885 0.374 . . . . 0.0 111.068 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.506 ' ND2' ' HA ' ' A' ' 100' ' ' GLU . 77.5 m-20 -75.51 -50.55 15.34 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 172.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -145.96 117.2 7.89 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.543 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.571 HD12 ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -165.41 161.74 19.03 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.909 0.385 . . . . 0.0 110.999 176.247 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.477 ' HD3' ' O ' ' A' ' 130' ' ' GLU . 31.3 mmmt -136.0 142.61 44.51 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 172.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -68.52 130.77 43.84 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.72 0.295 . . . . 0.0 110.828 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.13 -4.9 81.43 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.289 -177.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 52.3 ttm -62.25 130.02 43.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.874 0.369 . . . . 0.0 111.121 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 70' ' ' MET . 46.3 mt-10 -95.78 101.12 12.78 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.14 0.495 . . . . 0.0 109.846 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 26.4 m -100.17 164.24 2.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.397 -176.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.542 ' HA ' ' O ' ' A' ' 68' ' ' ARG . 15.2 mt-30 -102.23 108.28 19.61 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.143 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 19.0 mt -84.01 122.79 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.532 ' O ' HG12 ' A' ' 121' ' ' ILE . 16.3 tt0 -99.3 118.77 36.71 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.263 -175.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.46 ' OG1' ' HB2' ' A' ' 66' ' ' GLU . 79.3 p -117.91 155.0 30.94 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.314 0.578 . . . . 0.0 111.854 -174.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -125.75 104.32 8.29 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 173.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 59.37 41.05 20.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.836 0.827 . . . . 0.0 109.852 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 91.16 -23.49 23.91 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.298 -0.865 . . . . 0.0 113.157 178.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -83.36 128.5 34.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.853 0.327 . . . . 0.0 110.946 -175.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.9 t -66.16 120.41 13.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.127 0.489 . . . . 0.0 110.915 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.532 HG12 ' O ' ' A' ' 114' ' ' GLN . 19.9 pt -109.69 -24.68 3.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.437 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -169.44 164.91 38.41 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.372 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 99.3 t -131.62 118.16 37.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.862 0.363 . . . . 0.0 110.195 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.426 ' HB2' ' HB2' ' A' ' 112' ' ' GLN . 42.3 mt-10 -91.13 104.19 16.79 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.867 -176.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 70.3 mt -78.31 138.77 59.79 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 174.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.55 128.65 30.27 Favored 'Trans proline' 0 CA--C 1.515 -0.456 0 C-N-CA 122.771 2.314 . . . . 0.0 111.153 178.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.718 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 95.4 mttt -52.3 -33.7 43.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.479 -169.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.8 p -115.47 109.6 18.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.024 0.44 . . . . 0.0 111.302 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 13.0 p -112.34 143.59 21.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.763 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.477 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 47.3 mt-10 -104.45 124.26 48.93 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 177.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 62.6 mt -126.28 131.41 51.9 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.776 0.322 . . . . 0.0 110.409 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.5 m -74.45 132.84 42.28 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.0 p -89.43 107.22 17.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.41 0.624 . . . . 0.0 110.338 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 13.1 p -105.02 124.53 49.68 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.714 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 70.6 88.87 0.1 Allowed 'General case' 0 C--O 1.237 0.421 0 CA-C-O 122.08 0.943 . . . . 0.0 111.611 -177.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.453 ' O ' ' HD3' ' A' ' 138' ' ' PRO . 15.2 t -151.36 139.85 20.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.512 -1.222 . . . . 0.0 107.839 170.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -82.37 113.0 40.97 Favored Pre-proline 0 C--N 1.322 -0.593 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.293 -170.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 136' ' ' THR . 96.9 Cg_endo -93.75 -179.84 0.87 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.257 2.638 . . . . 0.0 111.858 177.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.19 30.76 24.5 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.819 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.2 tp . . . . . 0 C--N 1.324 -0.533 0 CA-C-O 121.607 0.717 . . . . 0.0 110.195 178.472 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.6 p . . . . . 0 N--CA 1.452 -0.361 0 CA-C-O 120.649 0.261 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -137.22 151.34 48.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.014 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.9 m -73.08 110.62 7.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.216 0.531 . . . . 0.0 111.246 -174.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -116.21 162.06 18.03 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.729 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 22.7 m -125.86 140.68 52.46 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.739 174.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 12.8 m -101.87 173.08 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.805 175.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -56.98 -27.19 61.19 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 80.9 p -73.74 -11.89 60.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.79 0.329 . . . . 0.0 111.487 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 91.82 5.0 66.83 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.932 -0.652 . . . . 0.0 111.844 -177.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -85.04 141.68 30.11 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 27.0 m -99.2 129.67 45.45 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.648 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.4 mp -132.61 155.93 47.83 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 120.729 0.299 . . . . 0.0 110.238 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -93.7 99.35 11.78 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 34.6 m -97.34 150.71 37.1 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.082 -174.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -56.48 152.25 41.21 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.535 2.157 . . . . 0.0 111.277 174.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 59.1 mt -64.93 -14.85 61.11 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.612 -169.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -86.65 -7.42 58.34 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 88.0 t -75.6 131.13 35.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.861 0.362 . . . . 0.0 110.831 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -120.64 144.73 48.0 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.33 -175.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -69.56 132.97 47.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.138 0.494 . . . . 0.0 110.987 -176.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 109.78 -16.51 30.95 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.418 -174.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.428 ' OD1' ' HB2' ' A' ' 184' ' ' ARG . 10.7 t70 -84.93 156.71 21.09 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 74.7 t -104.02 116.13 47.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.87 0.367 . . . . 0.0 110.563 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 80.1 mt -94.68 145.65 24.7 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.587 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.626 ' O ' ' HB ' ' A' ' 182' ' ' ILE . 26.6 mt -98.66 134.82 35.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 175.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 67.2 mt -135.2 137.6 49.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 O-C-N 122.039 -0.413 . . . . 0.0 110.46 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.718 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 27.0 t-20 -83.68 98.01 9.41 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 175.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 8.9 t -85.37 157.92 20.39 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.855 0.36 . . . . 0.0 110.071 -177.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 94.45 -48.71 2.11 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -173.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.536 ' HB3' ' OD1' ' A' ' 175' ' ' ASN . 33.1 t70 -98.52 -42.3 7.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.001 0.429 . . . . 0.0 110.08 176.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 105.97 5.3 38.39 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.827 -0.701 . . . . 0.0 113.427 173.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 64.0 m -68.61 133.67 48.83 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.957 0.408 . . . . 0.0 111.038 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -86.64 134.41 33.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.1 0.476 . . . . 0.0 110.851 -177.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.626 ' HB ' ' O ' ' A' ' 173' ' ' ILE . 56.0 mt -116.04 155.0 17.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.3 p -75.88 172.7 12.26 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.419 0.152 . . . . 0.0 110.729 -176.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ARG . . . . . 0.428 ' HB2' ' OD1' ' A' ' 170' ' ' ASP . 8.3 ptp180 -57.99 159.15 5.9 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.174 0.511 . . . . 0.0 111.575 -173.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.791 -1.005 . . . . 0.0 111.471 178.722 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.9 mtp . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 120.578 0.228 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 53.7 mt -115.73 137.95 47.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-O 121.209 0.528 . . . . 0.0 111.382 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.0 t -116.97 166.07 12.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.03 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.401 ' O ' HG22 ' A' ' 37' ' ' VAL . 21.2 m -67.96 -7.9 7.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -170.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -86.92 -2.39 58.57 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.637 -176.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -137.62 95.45 3.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.284 0.564 . . . . 0.0 112.198 -178.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -121.1 160.37 23.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.231 173.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -139.94 169.17 18.19 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.585 -0.154 . . . . 0.0 110.585 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.1 t -61.81 -13.1 20.95 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 123.632 0.583 . . . . 0.0 111.828 -173.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.34 113.14 0.66 Allowed Glycine 0 N--CA 1.434 -1.475 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 165.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 62.9 tp -150.93 129.35 12.08 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 2.7 p -98.48 129.4 45.07 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.24 0.543 . . . . 0.0 111.677 -177.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 mp -128.37 138.58 54.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.996 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.7 p -94.66 110.45 22.29 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.042 175.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.7 p -150.67 147.78 15.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -178.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 62.11 30.93 17.92 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.312 0.383 . . . . 0.0 110.864 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 63.3 24.43 14.26 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.94 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -137.83 168.59 19.38 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.255 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 11.1 pt -116.73 127.31 74.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.257 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.545 ' O ' ' HA ' ' A' ' 12' ' ' THR . 15.4 m95 -127.67 157.87 39.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.044 -172.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 44.5 tttm -123.23 119.51 30.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.317 175.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 90.9 t -62.34 117.95 4.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.402 0.62 . . . . 0.0 110.65 175.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 86.8 mt -90.0 -39.07 11.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.4 173.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -152.3 148.0 27.02 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.027 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -135.98 140.67 44.11 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.107 0.48 . . . . 0.0 111.032 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 7.3 tp-100 -117.93 99.89 7.21 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.053 175.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -78.0 89.25 4.15 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.0 p -97.04 131.06 44.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.058 -173.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.404 ' HD3' ' N ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -122.93 105.11 35.18 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.442 179.542 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.46 -10.63 27.21 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.689 2.259 . . . . 0.0 112.793 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.69 22.89 63.3 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.775 176.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -104.18 0.59 29.7 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.991 0.424 . . . . 0.0 110.79 -178.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 130.81 -42.07 1.45 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.765 175.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.4 m -118.83 146.42 44.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.768 0.318 . . . . 0.0 110.692 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.82 160.92 14.06 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.142 0.496 . . . . 0.0 110.945 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -132.49 161.8 32.82 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 53' ' ' THR . 48.1 t -132.24 102.6 5.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 120.842 0.353 . . . . 0.0 110.601 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -79.71 99.09 7.25 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 174.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.1 p -112.5 139.5 48.03 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.129 0.49 . . . . 0.0 112.17 -174.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -89.76 121.22 31.7 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 171.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -141.23 142.42 33.96 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.491 0.662 . . . . 0.0 111.697 -174.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.1 ttp180 -104.67 129.73 52.79 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.483 -174.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -69.09 118.22 11.72 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 173.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.3 mp -66.65 -28.93 68.86 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -175.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.579 ' HA ' ' O ' ' A' ' 121' ' ' ILE . 68.0 mtt85 -73.07 -44.57 60.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.958 0.409 . . . . 0.0 111.65 -176.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.4 p -102.85 -11.61 18.16 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.018 0.437 . . . . 0.0 112.029 -173.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.92 21.82 78.25 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -176.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.8 133.41 34.34 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -172.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.3 mm -89.74 110.05 21.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.926 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -132.25 172.69 12.1 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.28 147.12 51.96 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.022 0.439 . . . . 0.0 110.864 175.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -142.75 148.04 36.57 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.908 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 43.7 m -111.44 117.53 33.29 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.006 0.432 . . . . 0.0 110.342 178.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -84.6 140.71 31.18 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.82 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 47.8 mtm105 -107.17 138.44 43.35 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.585 -177.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.53 130.65 46.08 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.795 0.331 . . . . 0.0 110.258 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.67 -29.97 8.92 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -174.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.11 119.83 24.53 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 175.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -71.32 131.8 43.96 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.369 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.9 t -91.34 107.99 19.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.156 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -87.64 113.25 53.51 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.419 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.94 155.5 53.0 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.503 2.136 . . . . 0.0 112.702 -178.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.31 115.58 27.6 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.328 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 46.1 ttm -76.92 108.47 9.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.781 -178.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.436 HG13 HG21 ' A' ' 12' ' ' THR . 43.2 mm -100.94 139.02 23.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.396 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' A' ' 114' ' ' GLN . 39.0 mt-10 -105.09 116.73 32.44 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 175.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -99.71 99.08 9.86 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 173.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -111.87 124.73 52.98 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.015 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.569 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 12.8 ptp180 -86.84 120.18 27.84 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.329 0.585 . . . . 0.0 109.485 177.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.812 ' SD ' ' HA ' ' A' ' 84' ' ' ASP . 8.5 mmt -107.32 145.58 32.64 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.724 -178.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -79.58 136.12 36.77 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 172.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.438 ' CZ ' HD23 ' A' ' 105' ' ' LEU . 47.4 t80 -77.13 108.38 10.19 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.807 -176.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 3.3 mm? -99.51 177.33 5.2 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 167.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -146.94 150.73 35.76 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.67 -175.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.05 -162.92 1.65 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.735 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -62.74 137.76 58.35 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 174.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.43 70.19 2.46 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 119.209 -1.472 . . . . 0.0 113.151 -171.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -125.87 -32.56 2.8 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 161.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.497 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 78.6 m-20 -141.29 135.19 30.35 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 114.065 -1.425 . . . . 0.0 109.293 175.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.514 ' ND1' HD23 ' A' ' 98' ' ' LEU . 58.6 m170 -107.66 144.1 35.22 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 175.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.416 ' O ' ' HB2' ' A' ' 73' ' ' LEU . 49.5 t -94.3 121.91 45.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.794 -175.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.534 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 76.8 m-85 -117.85 126.04 51.65 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 176.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 14.7 tmm? -97.48 117.26 31.33 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.021 -175.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.812 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 17.6 t70 -62.42 114.65 3.63 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.418 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -76.94 -5.11 47.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.414 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -76.9 -50.94 12.17 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 173.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.7 p -170.94 93.95 0.18 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 168.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 50.09 28.83 3.19 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 157.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.48 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 34.1 mt-10 -101.14 115.25 30.04 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 121.466 -0.771 . . . . 0.0 111.287 175.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -82.38 108.98 16.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.316 0.579 . . . . 0.0 110.962 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 54.8 m -101.81 123.21 45.38 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.801 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -99.58 125.25 45.34 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.852 0.358 . . . . 0.0 110.334 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 79' ' ' ASN . 42.6 mt -97.85 138.77 34.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.349 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.514 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 29.5 t -79.95 169.23 18.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.716 -174.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.2 p -50.48 -39.41 48.18 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.963 0.505 . . . . 0.0 112.312 -175.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -59.31 -36.09 74.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.648 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -76.07 -35.47 59.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.305 0.574 . . . . 0.0 109.504 177.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.617 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 14.2 mt -64.32 -30.09 71.15 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.238 -176.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -62.6 -32.69 73.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.935 176.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -73.27 -40.52 64.53 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.55 ' O ' HD12 ' A' ' 105' ' ' LEU . 47.8 mt-10 -62.05 -36.76 82.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.732 175.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 79.9 mt -73.52 0.57 12.12 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.078 0.466 . . . . 0.0 110.824 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.429 ' O ' ' HB2' ' A' ' 158' ' ' TYR . 57.5 t30 -93.95 -43.26 8.63 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 170.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -148.34 117.09 6.66 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.26 172.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.55 HD12 ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -160.21 153.39 21.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.926 0.393 . . . . 0.0 110.649 172.255 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.7 mtpt -144.03 146.85 33.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.791 172.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -71.13 132.11 44.57 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.344 -174.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.67 0.68 90.25 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.771 177.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.42 ' SD ' ' HG3' ' A' ' 126' ' ' PRO . 57.5 ttm -82.65 141.74 32.26 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.809 0.338 . . . . 0.0 111.438 -177.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.524 ' HA ' ' O ' ' A' ' 70' ' ' MET . 54.2 mp0 -84.19 123.47 30.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.084 175.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 34.7 m -121.79 158.9 24.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.329 177.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.519 ' HB2' ' HB3' ' A' ' 124' ' ' GLU . 15.8 mm-40 -91.34 101.55 14.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.755 0.312 . . . . 0.0 110.194 -175.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 48.8 mm -94.01 122.03 45.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 178.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.501 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 87.2 mt-30 -98.47 117.34 32.68 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.742 0.306 . . . . 0.0 110.539 -178.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.401 ' OG1' ' HB2' ' A' ' 66' ' ' GLU . 35.2 p -112.36 151.22 30.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.915 176.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -135.56 103.12 5.34 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 60.06 31.77 20.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.528 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 104.44 -30.27 10.42 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 121.102 -0.571 . . . . 0.0 113.019 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -76.72 131.21 38.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.561 0.219 . . . . 0.0 111.276 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 17.6 p -73.43 106.6 5.3 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 172.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.579 ' O ' ' HA ' ' A' ' 45' ' ' ARG . 45.2 pt -94.25 -31.2 4.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -174.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -162.38 164.38 35.55 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 119.641 -1.266 . . . . 0.0 113.135 -177.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 59.9 t -133.38 127.57 54.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.519 ' HB3' ' HB2' ' A' ' 112' ' ' GLN . 35.1 tt0 -118.69 122.99 43.81 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.041 0.448 . . . . 0.0 110.337 178.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.402 ' N ' HD22 ' A' ' 125' ' ' LEU . 3.0 mm? -86.54 155.67 56.55 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.42 ' HG3' ' SD ' ' A' ' 109' ' ' MET . 10.5 Cg_endo -53.5 132.76 50.4 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.58 2.187 . . . . 0.0 110.982 176.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 95.7 mttt -54.85 -34.77 63.28 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.518 -174.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 19.7 p -122.92 109.08 13.69 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.045 176.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.5 p -106.25 136.81 39.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.499 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -94.3 108.53 20.42 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 177.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.439 HD13 HD13 ' A' ' 174' ' ' ILE . 98.7 mt -117.92 134.4 54.98 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.253 0.549 . . . . 0.0 110.744 -176.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.0 m -81.45 131.25 35.27 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.752 177.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.0 p -81.05 119.36 30.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.685 0.755 . . . . 0.0 111.084 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.471 ' O ' ' HB ' ' A' ' 153' ' ' THR . 41.6 p -125.27 128.9 48.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.555 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 75.94 86.02 0.09 Allowed 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.898 0.856 . . . . 0.0 110.69 -175.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.45 ' O ' ' HD3' ' A' ' 138' ' ' PRO . 13.3 t -150.96 155.02 38.22 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.462 173.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -82.5 110.7 23.35 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 120.424 0.154 . . . . 0.0 110.699 -176.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 136' ' ' THR . 96.6 Cg_endo -91.11 162.7 3.83 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.056 2.504 . . . . 0.0 112.709 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 98.15 -2.62 59.71 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.547 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 9.6 tt . . . . . 0 C--N 1.323 -0.576 0 CA-C-O 121.308 0.575 . . . . 0.0 110.356 -178.827 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 27.6 p . . . . . 0 N--CA 1.449 -0.51 0 CA-C-O 121.267 0.556 . . . . 0.0 112.004 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.404 ' HE3' ' OG1' ' A' ' 136' ' ' THR . 54.0 pttt -130.75 147.46 52.41 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.225 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 17.2 t -73.84 99.76 3.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.343 0.592 . . . . 0.0 110.303 -178.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -106.98 170.07 8.17 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.61 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.471 ' HB ' ' O ' ' A' ' 134' ' ' THR . 3.5 m -122.75 147.37 46.57 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 175.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.446 HG23 HG22 ' A' ' 156' ' ' THR . 2.6 m -109.68 170.95 2.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.23 173.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -53.24 -33.24 52.11 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -176.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.446 HG22 HG23 ' A' ' 154' ' ' VAL . 15.1 t -74.46 -8.25 55.68 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -176.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 95.91 -4.71 65.84 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.476 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.429 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 90.9 t80 -76.31 137.19 39.72 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.808 0.337 . . . . 0.0 110.719 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.55 130.87 44.57 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.522 177.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.99 148.07 36.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.937 0.398 . . . . 0.0 111.357 -175.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -85.55 102.41 13.5 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.775 176.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 26.8 m -102.18 149.78 36.91 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.503 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -51.81 145.38 31.78 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.514 2.143 . . . . 0.0 111.39 175.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 72.4 mt -59.07 -24.61 63.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.622 -169.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -85.89 7.49 23.92 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -175.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.417 HG22 ' HD2' ' A' ' 184' ' ' ARG . 91.1 t -82.91 137.79 20.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 176.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -123.38 156.52 35.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.671 -0.241 . . . . 0.0 110.68 -176.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -59.15 116.7 4.03 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.502 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 121.24 -16.6 9.2 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.535 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -64.57 139.51 58.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.812 0.339 . . . . 0.0 110.989 176.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 55.4 t -100.43 103.73 15.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.89 150.01 34.28 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.808 -176.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.434 ' O ' ' HB ' ' A' ' 182' ' ' ILE . 55.1 mt -103.03 134.66 43.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.827 -173.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.439 HD13 HD13 ' A' ' 131' ' ' LEU . 4.0 mp -121.68 141.12 43.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.754 0.312 . . . . 0.0 110.325 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 28.0 t-20 -84.61 105.58 15.52 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 175.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 37.6 p -64.82 158.6 24.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.151 -173.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 77.78 -55.3 3.81 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.415 178.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -84.8 -43.13 14.49 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.737 0.303 . . . . 0.0 110.737 -177.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 101.88 4.15 51.68 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.513 173.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 34.9 m -63.78 142.92 58.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.958 0.409 . . . . 0.0 110.951 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -98.44 124.37 43.11 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.2 0.524 . . . . 0.0 111.177 -175.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.434 ' HB ' ' O ' ' A' ' 173' ' ' ILE . 2.6 mp -95.11 152.87 3.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 173.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 17.4 m -74.85 169.42 17.96 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.234 0.54 . . . . 0.0 111.609 -170.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ARG . . . . . 0.417 ' HD2' HG22 ' A' ' 166' ' ' VAL . 58.6 mtp180 -63.08 147.58 50.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.358 -175.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.097 -1.39 . . . . 0.0 110.904 175.858 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.8 mtt . . . . . 0 N--CA 1.482 1.166 0 CA-C-O 120.776 0.322 . . . . 0.0 110.643 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 61.0 mt -93.97 131.77 39.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.446 -174.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 p -88.91 158.14 18.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.954 174.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.419 ' O ' HG21 ' A' ' 37' ' ' VAL . 15.8 m -71.28 -3.27 3.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -173.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -99.68 6.57 45.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.459 0.647 . . . . 0.0 109.895 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -124.31 88.94 2.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.244 0.545 . . . . 0.0 111.177 -177.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -142.06 156.3 45.4 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.026 177.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -139.95 165.77 26.44 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.7 t -57.19 -15.24 5.32 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.087 0.47 . . . . 0.0 111.169 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.42 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -147.95 113.72 0.65 Allowed Glycine 0 N--CA 1.435 -1.368 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 165.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 55.4 tp -151.63 134.61 15.77 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.595 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 1.1 p -98.46 124.44 43.17 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.356 0.598 . . . . 0.0 112.262 -176.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.0 mp -127.49 138.99 53.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.983 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.7 p -100.24 110.32 22.56 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.164 0.507 . . . . 0.0 110.301 176.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.5 p -155.03 156.83 4.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -177.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 61.16 24.59 14.69 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.712 0.291 . . . . 0.0 110.887 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 16.0 m120 65.45 30.18 10.95 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.211 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -145.05 163.98 32.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.306 178.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 13.8 pt -105.97 125.77 61.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.199 0.523 . . . . 0.0 109.886 176.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.595 ' O ' ' HA ' ' A' ' 12' ' ' THR . 82.1 m95 -117.77 161.44 19.69 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.803 -169.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -132.02 101.63 5.5 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.606 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.42 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 89.9 t -62.74 116.55 2.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.901 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.4 mm -88.95 -36.14 8.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.242 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -162.71 113.78 1.51 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.788 -177.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 39' ' ' SER . 19.8 p90 -102.87 146.37 28.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.0 0.429 . . . . 0.0 111.014 -176.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -123.47 104.58 9.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.408 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -77.49 96.26 4.68 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 175.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.4 p -104.1 136.18 38.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.614 -171.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -117.94 89.75 34.97 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.456 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.36 -11.31 31.08 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.736 2.291 . . . . 0.0 113.121 -175.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.46 26.23 25.95 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.446 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -92.93 -11.84 32.37 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.33 0.586 . . . . 0.0 110.354 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.04 -19.85 17.52 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 -176.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.5 m -129.28 140.49 51.41 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.77 152.56 20.09 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.204 0.525 . . . . 0.0 110.824 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -131.64 167.1 20.02 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.929 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.419 HG21 ' O ' ' A' ' 4' ' ' VAL . 46.1 t -132.4 102.47 5.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 120.725 0.297 . . . . 0.0 110.428 178.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -77.45 99.26 5.57 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 25' ' ' PHE . 18.2 m -103.4 126.03 50.32 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.547 -175.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.5 tppt? -84.68 110.22 18.59 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 173.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.01 144.06 40.9 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.893 0.854 . . . . 0.0 112.121 -172.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 42' ' ' ARG . 18.6 ttt180 -100.19 130.15 46.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.519 -175.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -64.48 112.29 3.07 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 173.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.6 tt -71.34 -14.08 62.08 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.209 0.528 . . . . 0.0 110.635 -171.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 -86.82 -45.28 11.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.497 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.4 p -101.24 -20.52 15.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.059 0.457 . . . . 0.0 111.868 -173.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.15 10.15 75.34 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.86 -176.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.71 145.4 38.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.116 0.484 . . . . 0.0 111.961 -175.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.6 mm -100.09 113.43 35.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.428 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.502 ' HG2' ' H ' ' A' ' 51' ' ' GLU . 31.8 tt0 -133.32 176.38 8.57 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.502 ' H ' ' HG2' ' A' ' 50' ' ' GLN . 9.6 pt-20 -138.26 142.35 39.87 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.937 0.398 . . . . 0.0 110.24 173.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -130.41 134.08 46.85 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.363 -177.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.4 p -98.19 110.34 22.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.048 0.451 . . . . 0.0 110.857 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -84.64 147.98 26.67 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.917 178.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.63 ' HD3' ' OE2' ' A' ' 58' ' ' GLU . 44.4 ttt180 -112.92 128.96 56.61 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.93 -174.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.3 125.76 24.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.605 178.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.43 -15.88 32.23 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.928 -178.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.63 ' OE2' ' HD3' ' A' ' 55' ' ' ARG . 42.8 mt-10 -119.26 99.71 6.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.899 0.38 . . . . 0.0 110.19 177.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -76.84 153.38 34.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.955 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.0 m -120.4 162.8 18.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.073 0.464 . . . . 0.0 111.446 -176.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -84.07 132.87 46.75 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.425 -177.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -79.07 151.75 23.97 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.688 2.259 . . . . 0.0 112.334 176.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -118.99 114.52 22.67 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.387 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 64.8 mtt -94.15 118.12 31.09 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 48.9 mm -89.35 127.57 41.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.582 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -103.23 118.0 35.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.522 -174.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -102.42 125.72 49.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.787 0.327 . . . . 0.0 110.408 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 71.0 mtt-85 -126.18 115.03 19.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.964 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 69' ' ' ARG . 13.3 ptm180 -85.49 117.82 24.64 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.369 0.604 . . . . 0.0 109.683 175.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.61 ' SD ' HD13 ' A' ' 113' ' ' ILE . 31.1 mtt -120.75 143.68 48.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.697 -174.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -77.3 132.72 38.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.777 176.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -73.37 104.26 4.32 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.23 -174.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 60.8 mt -99.06 -175.66 3.1 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 172.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -144.04 149.65 36.99 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.644 0.735 . . . . 0.0 112.518 -170.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' A' ' 79' ' ' ASN . . . -151.27 -154.23 0.53 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.661 178.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -79.86 152.06 29.88 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -82.27 66.65 3.84 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 117.858 -2.115 . . . . 0.0 112.787 -174.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -129.14 -31.79 2.08 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 156.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.567 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 81.9 m-20 -141.04 130.34 23.63 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.653 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.406 ' O ' ' HA ' ' A' ' 92' ' ' GLU . 30.1 m170 -110.69 141.52 43.83 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 175.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.412 ' O ' ' HB2' ' A' ' 73' ' ' LEU . 41.5 t -87.52 130.52 37.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.922 -177.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.438 ' CE1' HD11 ' A' ' 93' ' ' LEU . 83.0 m-85 -124.26 128.39 49.09 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 174.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 25.8 ttt -94.34 112.0 23.77 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.46 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.509 ' HB3' ' H ' ' A' ' 89' ' ' GLU . 25.0 t70 -58.59 110.05 0.91 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.168 177.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -80.59 -4.51 54.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.7 -177.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -70.19 -50.7 37.55 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 173.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.6 p -171.85 93.56 0.15 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 165.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 49.79 29.37 3.2 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 159.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.509 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 42.9 mt-10 -100.12 105.97 17.65 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 121.584 -0.697 . . . . 0.0 111.346 176.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -70.08 125.02 25.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.919 0.39 . . . . 0.0 110.22 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 46.6 m -128.16 125.33 38.88 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.161 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 80' ' ' HIS . 32.3 mt-10 -104.58 131.74 51.64 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.8 0.333 . . . . 0.0 110.769 -177.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.567 ' O ' ' HA ' ' A' ' 79' ' ' ASN . 42.3 mt -100.28 146.56 26.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.575 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.624 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 8.3 t -88.08 166.31 14.52 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.924 -172.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.7 t -51.1 -42.8 60.88 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -171.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -55.1 -45.89 75.5 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -178.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -71.8 -39.89 69.57 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.25 0.548 . . . . 0.0 109.562 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.624 ' HG ' ' O ' ' A' ' 94' ' ' SER . 56.8 mt -60.2 -28.16 67.75 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.851 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -57.82 -43.95 86.08 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.914 0.388 . . . . 0.0 110.913 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -80.17 -43.33 21.76 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.692 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.94 -27.57 69.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.99 177.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 22.3 mt -75.07 -14.44 60.58 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 122.308 -0.245 . . . . 0.0 111.096 177.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -74.6 -43.92 53.24 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.401 ' HB3' HG13 ' A' ' 129' ' ' VAL . 40.9 m-85 -138.18 116.74 12.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.431 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.448 HD21 ' C ' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -170.78 157.99 5.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.302 0.572 . . . . 0.0 111.113 176.141 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.454 ' HD3' ' O ' ' A' ' 130' ' ' GLU . 31.5 mmmt -130.1 139.29 50.95 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.775 172.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -73.21 127.35 32.36 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.28 -0.36 71.64 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.079 -175.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.429 ' SD ' ' HG3' ' A' ' 126' ' ' PRO . 42.1 ttm -87.47 144.18 26.86 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.679 0.276 . . . . 0.0 111.145 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 70' ' ' MET . 45.3 mt-10 -85.51 122.63 29.91 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.963 177.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 24.9 m -112.34 156.34 13.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -101.31 99.27 9.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.086 0.47 . . . . 0.0 110.176 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.61 HD13 ' SD ' ' A' ' 70' ' ' MET . 54.6 mt -83.24 127.11 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.49 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.508 ' O ' HG12 ' A' ' 121' ' ' ILE . 17.6 tt0 -100.31 112.34 24.67 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.392 -174.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 25.7 p -116.16 155.75 27.69 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.857 -176.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -132.69 109.46 9.72 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 172.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 60.46 31.48 20.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.029 0.442 . . . . 0.0 110.853 -175.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.68 -12.95 65.51 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.715 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -86.18 126.94 34.61 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 25.5 m -67.67 117.05 9.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.637 0.256 . . . . 0.0 110.658 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 114' ' ' GLN . 12.9 pt -105.64 -23.35 4.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.813 0.34 . . . . 0.0 111.047 178.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -170.65 166.41 39.6 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.013 176.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 61.1 t -133.19 126.11 52.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -107.4 113.38 26.69 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.936 0.398 . . . . 0.0 110.962 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.403 ' N ' HD22 ' A' ' 125' ' ' LEU . 3.0 mm? -81.02 149.95 67.67 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 173.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.429 ' HG3' ' SD ' ' A' ' 109' ' ' MET . 9.8 Cg_endo -53.38 137.67 64.78 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.559 2.173 . . . . 0.0 111.417 176.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.597 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 31.8 mmtp -61.28 -27.93 68.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.715 -172.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.5 p -124.61 107.46 11.04 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.194 0.521 . . . . 0.0 110.394 174.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.401 HG13 ' HB3' ' A' ' 104' ' ' TYR . 7.1 p -107.27 144.96 15.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.457 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.454 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 35.7 mt-10 -110.36 113.36 25.96 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.906 0.384 . . . . 0.0 110.381 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 73.6 mt -120.5 129.41 53.83 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.406 -176.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.6 m -72.42 131.21 42.28 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.143 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 170' ' ' ASP . 9.6 p -84.16 112.96 22.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.749 0.785 . . . . 0.0 110.515 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.439 ' O ' ' HB ' ' A' ' 153' ' ' THR . 31.9 p -115.81 119.53 36.31 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.184 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 77.37 87.81 0.07 Allowed 'General case' 0 C--O 1.237 0.413 0 O-C-N 123.991 0.807 . . . . 0.0 110.904 -177.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 12.8 t -151.03 152.88 34.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.81 172.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -114.02 109.74 49.36 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 120.73 0.3 . . . . 0.0 111.393 -177.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 164' ' ' LEU . 12.4 Cg_exo -70.87 -176.39 1.78 Allowed 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 123.66 2.907 . . . . 0.0 111.601 172.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 122.99 35.54 0.72 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.059 -1.067 . . . . 0.0 113.246 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.1 tp -48.0 118.27 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 121.258 0.552 . . . . 0.0 109.994 173.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -87.76 56.22 3.81 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -166.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 82.69 -32.01 2.95 Favored Glycine 0 CA--C 1.518 0.224 0 CA-C-N 115.923 -0.581 . . . . 0.0 114.093 171.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -80.43 153.28 28.34 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 117.184 0.492 . . . . 0.0 110.361 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 2.7 m -110.29 45.3 1.13 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.374 0.607 . . . . 0.0 110.057 -178.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.19 128.24 34.92 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.399 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 16.8 p -70.44 -19.44 62.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.394 -177.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -100.12 19.26 53.73 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.152 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.437 ' O ' ' HG ' ' A' ' 164' ' ' LEU . . . -80.66 82.73 6.59 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 177.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 29.6 p -123.43 158.22 31.66 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.746 -175.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.8 ttpp -132.58 161.06 34.82 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 176.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 34.9 p -72.49 107.69 5.16 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.159 0.504 . . . . 0.0 110.513 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -107.32 164.08 12.49 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.386 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.439 ' HB ' ' O ' ' A' ' 134' ' ' THR . 22.4 m -119.19 136.03 54.39 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.857 175.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 12.4 m -100.77 174.29 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.0 175.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -56.16 -29.01 60.22 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 59.3 p -72.71 -19.31 61.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.986 0.422 . . . . 0.0 111.484 -177.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 100.22 -3.12 56.67 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -174.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -75.63 144.57 41.65 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.871 0.367 . . . . 0.0 110.688 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 18.9 m -106.07 122.71 46.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.3 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.85 158.58 43.85 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -177.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -88.85 108.86 19.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.069 -174.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 32.7 m -102.72 147.36 33.94 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.586 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 148' ' ' ALA . 51.0 Cg_exo -54.15 144.83 56.93 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.289 1.993 . . . . 0.0 111.51 172.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' A' ' 138' ' ' PRO . 77.2 mt -63.0 -7.78 5.99 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -172.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -100.55 10.5 41.1 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 93.9 t -87.78 131.87 34.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.532 0.206 . . . . 0.0 110.55 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -110.73 154.2 24.22 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.996 0.427 . . . . 0.0 110.934 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -59.83 127.13 30.41 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.731 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 112.26 -20.9 20.7 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.429 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.445 ' O ' HG12 ' A' ' 133' ' ' VAL . 2.2 m-20 -64.13 143.39 57.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.851 0.358 . . . . 0.0 110.761 177.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 61.8 t -95.09 110.32 23.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.315 0.579 . . . . 0.0 109.843 177.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 47.8 mt -87.35 129.33 35.06 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.5 -176.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.551 ' O ' ' HB ' ' A' ' 182' ' ' ILE . 40.8 mt -94.43 127.96 46.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 59.8 mt -126.39 138.33 54.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.78 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.597 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 0.2 OUTLIER -80.98 91.39 6.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.655 177.557 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.64 133.52 49.51 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.627 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 120.46 -40.33 2.2 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -115.07 -28.87 6.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.24 0.543 . . . . 0.0 110.254 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 88.45 19.34 52.69 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.111 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 19.3 t -79.31 130.83 35.84 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.8 0.333 . . . . 0.0 110.111 -177.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -76.67 127.42 32.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.322 0.582 . . . . 0.0 111.163 -177.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.551 ' HB ' ' O ' ' A' ' 173' ' ' ILE . 59.7 mt -105.8 153.68 7.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 173.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 16.2 p -74.69 146.34 42.4 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.252 0.548 . . . . 0.0 111.113 -168.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -55.93 142.16 36.67 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.077 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.648 -1.085 . . . . 0.0 112.238 -179.005 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ttt . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 121.073 0.463 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.6 mp -111.88 130.7 65.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.0 t -111.78 174.0 6.09 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 22.9 m -72.33 0.91 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -172.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -93.13 -1.57 56.25 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.017 0.437 . . . . 0.0 110.225 176.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -111.06 88.92 2.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.104 -176.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -141.47 147.56 38.06 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 175.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -130.11 174.96 9.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.729 -0.214 . . . . 0.0 110.496 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.4 t -57.84 -24.48 57.62 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 121.343 0.592 . . . . 0.0 110.234 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.622 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -147.13 116.33 0.84 Allowed Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 169.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 57.8 tp -145.94 130.99 18.29 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 1.7 p -92.87 127.21 38.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.925 0.393 . . . . 0.0 111.957 -177.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mp -127.19 139.69 51.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.247 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.8 t -99.74 107.89 20.08 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.5 p -151.22 150.18 13.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -176.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.8 23.95 14.27 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.803 0.335 . . . . 0.0 110.474 -176.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.7 m120 62.12 33.4 16.99 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.878 -178.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -140.97 162.28 35.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.029 176.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 11.8 pt -104.92 121.0 56.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.344 0.592 . . . . 0.0 110.292 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.561 ' O ' ' HA ' ' A' ' 12' ' ' THR . 70.9 m95 -115.77 164.38 14.46 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.838 -172.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -140.42 109.27 6.01 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 120.935 0.397 . . . . 0.0 110.209 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.622 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 94.2 t -58.66 122.03 7.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.128 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 81.4 mt -87.58 -38.5 12.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.517 174.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -163.2 144.44 9.56 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.24 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -125.24 138.54 54.11 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.095 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -109.52 98.68 8.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.144 175.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 21.5 t-160 -81.08 98.13 7.86 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.9 131.34 48.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.401 0.62 . . . . 0.0 111.458 -174.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.435 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -111.86 101.54 51.68 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.292 -177.818 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -65.87 -46.81 4.4 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.776 2.317 . . . . 0.0 112.47 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.02 17.55 6.28 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.92 -177.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -105.66 10.42 32.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.997 0.427 . . . . 0.0 110.271 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.57 -43.21 3.22 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 -176.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.2 m -89.3 98.33 11.71 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.851 0.358 . . . . 0.0 110.098 176.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -86.73 171.5 10.88 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.504 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -142.13 164.25 30.66 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.355 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 48.0 t -127.95 107.05 15.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.594 -176.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -80.5 98.17 7.46 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 173.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.6 p -104.97 135.81 45.62 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.99 0.424 . . . . 0.0 111.489 -175.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -95.95 109.87 22.17 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 175.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.439 ' H ' HD22 ' A' ' 41' ' ' LEU . 1.4 pt? -132.5 145.61 51.3 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.405 0.621 . . . . 0.0 111.369 -172.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 22.0 ttp180 -106.39 132.1 52.81 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.657 -175.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -62.03 119.32 8.66 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 172.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.2 tt -64.86 -28.05 69.29 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.795 -171.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 52.9 mtt-85 -85.11 -43.65 13.68 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -176.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.6 p -102.05 -9.68 20.37 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -172.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.22 18.94 75.39 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.41 -178.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.472 ' O ' ' HA ' ' A' ' 42' ' ' ARG . . . -77.01 131.31 38.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.745 0.307 . . . . 0.0 111.553 -177.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.3 mm -89.89 102.14 12.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.062 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.444 ' HG2' ' N ' ' A' ' 51' ' ' GLU . 36.0 tt0 -116.13 169.2 9.45 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.444 ' N ' ' HG2' ' A' ' 50' ' ' GLN . 6.6 pt-20 -136.59 130.05 31.74 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.346 0.593 . . . . 0.0 110.541 172.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -123.22 146.49 47.78 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.306 -176.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 55.3 m -107.55 111.03 23.1 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.979 0.418 . . . . 0.0 110.862 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -85.37 142.43 29.3 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.802 177.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 55' ' ' ARG . 36.7 mtp-105 -113.38 135.15 54.17 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.083 -173.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.11 129.34 40.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.478 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.73 -18.37 29.48 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.353 -175.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -99.81 134.81 42.17 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -87.34 133.83 33.65 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.354 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.2 t -94.13 134.99 29.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.331 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -101.47 112.93 65.79 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.885 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.0 163.64 34.93 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.58 2.186 . . . . 0.0 112.606 -177.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -121.89 109.57 14.81 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.701 177.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 64.2 mtt -84.65 109.35 17.93 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.039 0.447 . . . . 0.0 110.903 -177.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.474 HD11 ' CD1' ' A' ' 121' ' ' ILE . 34.6 mm -90.38 120.94 40.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.928 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -94.9 109.27 21.29 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -89.09 131.04 35.43 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.903 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 52.2 mtt180 -130.44 170.39 14.26 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -130.18 125.37 34.81 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.02 0.438 . . . . 0.0 110.07 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.5 ' CB ' ' HB3' ' A' ' 82' ' ' PHE . 2.0 mpt? -117.49 143.22 46.27 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.347 -176.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -84.78 139.46 31.93 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.74 173.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.53 ' CD1' ' HA ' ' A' ' 107' ' ' GLU . 32.7 t80 -71.63 110.15 6.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.861 -176.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.8 mp -100.69 -174.66 2.69 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 169.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -143.02 147.82 35.74 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.437 0.637 . . . . 0.0 111.759 -169.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.5 -165.95 2.38 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.805 176.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -72.51 146.17 46.99 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 174.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.66 68.45 3.0 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 118.683 -1.722 . . . . 0.0 112.857 -171.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -128.13 -33.05 2.21 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 161.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.414 ' OD1' ' HB3' ' A' ' 92' ' ' GLU . 28.3 t30 -143.26 136.82 28.41 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 113.359 -1.746 . . . . 0.0 109.267 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.44 ' ND1' HD21 ' A' ' 98' ' ' LEU . 55.7 m170 -117.58 148.41 41.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.771 0.32 . . . . 0.0 110.539 178.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 45.7 t -100.17 132.23 46.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.079 -176.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.5 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 71.6 m-85 -130.19 124.72 33.25 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 176.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 90.6 mmm -99.7 117.73 34.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.724 0.297 . . . . 0.0 111.52 -175.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.513 ' OD2' ' HB3' ' A' ' 86' ' ' GLU . 11.5 t70 -67.63 127.67 33.61 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.496 -178.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -79.64 -16.59 55.5 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.202 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.513 ' HB3' ' OD2' ' A' ' 84' ' ' ASP . 11.6 tp10 -66.92 -52.69 40.06 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 56.0 p -171.43 91.71 0.14 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 167.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 47.41 28.05 1.04 Allowed 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 162.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.453 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 28.0 mm-40 -83.42 101.31 11.28 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 118.392 0.542 . . . . 0.0 110.083 176.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -73.65 96.47 2.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.856 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.9 m -95.6 129.32 42.83 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.476 -175.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.414 ' HB3' ' OD1' ' A' ' 79' ' ' ASN . 35.5 mt-10 -106.68 137.67 44.27 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.931 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.474 HD11 ' CE1' ' A' ' 82' ' ' PHE . 64.7 mt -119.72 133.57 55.57 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.027 0.441 . . . . 0.0 111.189 -178.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.603 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 49.8 m -90.81 179.72 5.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.023 -176.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.0 p -47.73 -41.14 22.32 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -174.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -55.23 -38.14 68.09 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.038 0.446 . . . . 0.0 111.621 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -85.68 -34.96 21.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.041 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 94' ' ' SER . 20.8 mt -63.63 -22.51 66.94 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.288 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -59.77 -42.77 94.03 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.477 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -66.74 -38.38 86.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.621 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.579 ' O ' HD12 ' A' ' 105' ' ' LEU . 53.5 mt-10 -63.1 -36.4 83.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.097 175.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 82.3 mt -62.42 -21.23 65.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.917 0.389 . . . . 0.0 110.34 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -80.96 -50.99 9.03 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 171.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -142.79 118.53 10.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.546 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.579 HD12 ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -154.17 144.74 22.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.996 0.427 . . . . 0.0 110.312 172.415 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.43 ' HB2' ' HE1' ' A' ' 109' ' ' MET . 27.9 mmmt -144.42 139.86 28.64 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 175.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.53 ' HA ' ' CD1' ' A' ' 72' ' ' TYR . 29.0 tt0 -74.44 129.72 38.29 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.091 -177.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.54 1.24 71.64 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.49 -177.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.43 ' HE1' ' HB2' ' A' ' 106' ' ' LYS . 50.0 ttm -67.74 144.05 55.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.06 0.457 . . . . 0.0 111.501 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -92.59 104.28 16.59 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.822 174.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 26.3 m -105.49 158.76 5.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.704 0.288 . . . . 0.0 110.75 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -111.72 103.39 11.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.834 0.35 . . . . 0.0 110.098 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 60.4 mt -96.52 127.35 48.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.958 0.409 . . . . 0.0 110.394 -177.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.472 ' O ' HG12 ' A' ' 121' ' ' ILE . 76.5 mt-30 -91.04 120.02 31.68 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.928 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 62.4 p -116.32 145.72 42.97 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.319 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -124.98 98.89 5.88 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 60.38 41.8 15.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.691 -173.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 88.93 -18.69 42.55 Favored Glycine 0 CA--C 1.516 0.151 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.874 178.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -82.43 123.68 29.36 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.658 0.266 . . . . 0.0 110.767 -177.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 42.5 p -69.57 107.88 3.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.883 0.373 . . . . 0.0 110.455 178.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.474 ' CD1' HD11 ' A' ' 65' ' ' ILE . 21.6 pt -93.94 -28.35 4.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.022 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -164.19 155.05 26.23 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.325 178.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.6 t -120.68 123.27 69.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -106.14 123.27 47.76 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 120.956 0.408 . . . . 0.0 110.351 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 75.2 mt -97.08 148.54 34.54 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.725 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.23 135.46 64.92 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.034 2.489 . . . . 0.0 112.123 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 62.5 mttm -67.5 -16.03 63.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.894 -173.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 18.6 p -127.06 109.83 12.3 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.945 0.402 . . . . 0.0 110.671 175.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 12.3 p -120.69 141.79 39.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.513 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -104.02 104.47 14.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.35 0.595 . . . . 0.0 110.784 -178.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 78.0 mt -119.41 129.65 54.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.479 -177.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 3.1 m -75.04 134.09 41.47 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.49 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.7 p -79.35 109.1 13.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.683 0.754 . . . . 0.0 109.944 174.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.434 ' O ' ' HB3' ' A' ' 135' ' ' GLU . 36.3 p -114.5 115.36 27.12 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.552 -177.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.434 ' HB3' ' O ' ' A' ' 134' ' ' THR . 15.9 tp10 77.52 101.65 0.07 Allowed 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.928 0.871 . . . . 0.0 110.841 -177.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 14.6 t -150.75 153.74 36.08 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.616 -1.175 . . . . 0.0 108.343 175.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -82.39 147.01 55.41 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-O 120.889 0.376 . . . . 0.0 110.903 -174.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.11 -179.76 2.83 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 123.101 2.534 . . . . 0.0 112.162 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 119.35 32.53 1.23 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.005 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.9 tt -62.09 108.92 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.467 0.651 . . . . 0.0 110.636 176.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -84.52 -56.97 3.34 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.44 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 85.6 -31.41 3.9 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.224 174.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -102.23 -74.51 0.63 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.833 0.349 . . . . 0.0 110.791 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 23.9 m -82.18 76.86 9.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.432 0.634 . . . . 0.0 110.773 -177.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -129.6 -75.41 0.55 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.868 176.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 33.9 p 46.23 58.15 4.73 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.135 0.574 . . . . 0.0 112.443 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 106.26 10.77 29.0 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.347 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -89.35 129.42 35.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.819 0.342 . . . . 0.0 110.208 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 24.1 p -132.24 161.76 32.64 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.112 0.482 . . . . 0.0 111.462 -175.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -129.78 150.1 51.23 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.926 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 18.5 m -73.8 99.83 3.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.092 0.472 . . . . 0.0 111.447 -175.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -104.94 164.94 11.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.782 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 25.9 m -125.75 130.32 51.25 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.004 175.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 14.6 m -86.99 175.01 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.599 -0.441 . . . . 0.0 110.811 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -57.03 -30.0 63.86 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 64.9 p -72.72 -20.18 61.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.766 0.317 . . . . 0.0 111.477 -177.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 102.78 -1.11 48.59 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.617 -175.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -74.49 129.98 38.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.88 0.372 . . . . 0.0 110.856 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.8 p -91.82 131.94 36.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.709 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -148.71 153.59 38.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.913 0.387 . . . . 0.0 110.321 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -87.83 101.18 13.46 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.205 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 31.7 m -95.86 144.93 28.67 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.635 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.86 150.02 24.14 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 122.478 2.119 . . . . 0.0 111.433 175.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 65.0 mt -61.71 -22.01 64.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.714 -169.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -79.21 -17.15 55.39 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 63.4 t -65.5 131.21 31.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.63 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -119.53 159.02 25.13 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.414 -176.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -57.15 123.58 15.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.666 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 109.95 -12.62 31.95 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.774 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.567 ' OD1' ' HD3' ' A' ' 184' ' ' ARG . 26.2 t70 -68.03 141.02 56.33 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.741 0.305 . . . . 0.0 110.64 178.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 3.7 p -86.1 108.21 17.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.716 0.77 . . . . 0.0 110.425 177.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 85.3 mt -91.59 119.12 31.21 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.256 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.573 ' O ' ' HB ' ' A' ' 182' ' ' ILE . 56.0 mt -90.57 104.47 15.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 173.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 37.1 mt -95.75 130.92 43.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 C-N-CA 120.414 -0.514 . . . . 0.0 109.854 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.553 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 23.3 t-20 -80.07 89.55 5.39 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.976 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 4.7 m -61.43 129.55 41.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.658 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 115.55 -41.98 2.02 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -177.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -106.94 -33.66 7.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.199 0.523 . . . . 0.0 110.086 176.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 95.01 10.78 57.18 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.487 177.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.81 131.18 47.96 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -178.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -100.0 112.41 24.69 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.227 0.537 . . . . 0.0 110.839 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.573 ' HB ' ' O ' ' A' ' 173' ' ' ILE . 4.0 mp -107.63 134.93 47.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 43.0 t -113.43 165.63 12.28 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.477 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . 0.567 ' HD3' ' OD1' ' A' ' 170' ' ' ASP . 30.1 mmt180 69.82 25.7 4.97 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 123.69 0.618 . . . . 0.0 112.095 174.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.626 -1.097 . . . . 0.0 113.009 177.987 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mmt . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 120.947 0.403 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 60' ' ' VAL . 44.4 mm -109.29 145.06 16.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.673 178.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.6 t -94.23 156.28 16.62 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 176.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.9 m -71.69 1.36 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.269 0.557 . . . . 0.0 110.827 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -107.22 11.29 29.47 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.447 176.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -126.92 88.5 2.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.026 0.441 . . . . 0.0 111.041 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -139.86 152.34 46.39 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.372 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.473 ' HG2' ' HG ' ' A' ' 11' ' ' LEU . 19.3 ptpt -143.6 178.19 7.96 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.6 p -56.11 -12.97 1.71 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.514 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -160.19 115.56 0.67 Allowed Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.04 172.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.473 ' HG ' ' HG2' ' A' ' 8' ' ' LYS . 8.9 mt -148.66 138.91 22.44 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 122.541 0.336 . . . . 0.0 110.293 174.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 2.9 m -95.28 115.49 27.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.189 0.519 . . . . 0.0 110.743 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.432 HG23 ' O ' ' A' ' 61' ' ' GLU . 1.9 mp -120.95 140.7 44.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.209 -176.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.7 t -98.91 118.0 34.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.953 0.406 . . . . 0.0 110.336 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.7 p -153.09 144.89 15.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 62.45 28.54 16.85 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 122.627 0.371 . . . . 0.0 110.661 -176.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.6 m120 62.52 25.22 15.02 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.396 -177.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.99 159.2 39.44 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 176.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 10.5 pt -106.46 122.96 60.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.233 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.518 ' O ' ' HA ' ' A' ' 12' ' ' THR . 33.3 m95 -119.63 165.52 14.36 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.772 -172.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -128.03 104.88 8.03 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.713 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.514 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 77.3 t -62.8 106.15 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.554 178.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.0 mm -85.0 -33.43 8.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.713 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -152.52 147.08 25.79 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.328 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -136.03 141.87 44.37 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.636 -177.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -124.52 106.35 10.09 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.078 177.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 16.1 t60 -74.07 89.61 1.97 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 176.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.5 p -92.83 128.15 44.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.894 -172.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.3 pttt -126.11 102.57 27.44 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.765 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -57.26 -47.2 23.47 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.357 2.704 . . . . 0.0 112.469 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.72 4.02 17.6 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.763 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -84.8 -12.42 53.66 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.075 0.464 . . . . 0.0 110.183 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.35 -42.25 1.29 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.659 176.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.0 m -99.84 134.34 42.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.868 0.366 . . . . 0.0 110.952 -177.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.55 153.97 18.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.173 0.511 . . . . 0.0 110.887 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -133.76 168.77 18.11 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.264 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 48.2 t -130.32 103.86 8.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 120.992 0.425 . . . . 0.0 110.083 176.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -82.37 98.82 9.04 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.7 p -110.03 139.0 45.63 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.817 -173.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -95.53 114.97 26.78 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 174.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.403 HD21 ' H ' ' A' ' 41' ' ' LEU . 0.9 OUTLIER -136.91 141.88 42.72 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.727 0.775 . . . . 0.0 111.316 -171.335 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -98.73 130.04 45.19 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.621 -176.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -64.24 114.14 4.04 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 171.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.417 HD22 ' OE1' ' A' ' 114' ' ' GLN . 7.8 tt -70.24 -22.16 62.93 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.726 -170.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -83.01 -46.45 12.84 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.4 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.7 p -97.24 -14.27 21.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.196 0.522 . . . . 0.0 111.908 -174.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.9 24.79 71.0 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.952 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.35 133.46 33.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.861 0.363 . . . . 0.0 111.784 -175.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.6 mm -93.36 109.85 22.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.107 178.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -136.78 177.41 7.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.841 0.353 . . . . 0.0 110.44 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -137.98 146.81 43.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.111 0.481 . . . . 0.0 110.517 173.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -135.07 171.41 14.47 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.309 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.8 t -127.77 118.31 23.52 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.416 0.626 . . . . 0.0 110.828 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -85.23 151.79 23.81 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.497 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -123.78 130.38 52.53 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.326 0.584 . . . . 0.0 111.795 -173.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.94 138.48 58.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.112 176.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.92 -19.21 28.17 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 111.341 -0.703 . . . . 0.0 111.341 -174.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -126.25 150.77 48.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.024 0.44 . . . . 0.0 110.415 176.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 20.1 pttm -89.33 152.13 21.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.29 -175.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.413 ' HB ' ' HB ' ' A' ' 2' ' ' ILE . 64.4 t -102.53 136.44 34.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.348 -178.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.432 ' O ' HG23 ' A' ' 13' ' ' ILE . 7.1 tp10 -88.52 121.2 70.29 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.738 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.27 151.64 20.53 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.244 1.963 . . . . 0.0 112.048 175.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.68 116.8 30.01 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.402 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 61.8 mtt -96.73 110.25 22.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.472 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 54.8 mt -109.85 138.93 35.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.839 0.352 . . . . 0.0 111.07 -176.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -112.85 139.51 48.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.441 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -117.09 127.01 53.73 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 177.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.509 ' HG2' ' OE2' ' A' ' 86' ' ' GLU . 40.6 mtm180 -135.82 165.39 25.72 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -127.84 125.65 40.15 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.18 0.514 . . . . 0.0 111.262 -176.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.543 ' HG3' ' HA ' ' A' ' 84' ' ' ASP . 1.9 mpt? -119.92 141.02 49.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.557 -176.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -79.31 140.47 37.54 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.102 177.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -74.58 111.59 9.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.745 -174.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -104.86 -179.64 4.0 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 167.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -145.5 142.14 28.95 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.487 -171.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.72 -170.74 3.53 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.664 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -60.67 131.19 49.94 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.68 68.84 2.44 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 119.153 -1.499 . . . . 0.0 114.322 -165.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -126.76 -30.42 2.77 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 154.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.449 ' OD1' ' HB3' ' A' ' 92' ' ' GLU . 55.7 t30 -133.53 132.38 40.87 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 113.59 -1.641 . . . . 0.0 109.477 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.616 ' CD2' ' HG ' ' A' ' 98' ' ' LEU . 14.5 m-70 -124.23 143.65 50.41 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 55.7 t -92.56 134.17 31.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.026 -175.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.504 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 74.4 m-85 -128.9 126.12 39.04 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 174.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.0 mmt -99.15 117.92 34.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.777 0.323 . . . . 0.0 111.332 -175.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.543 ' HA ' ' HG3' ' A' ' 70' ' ' MET . 23.0 t70 -60.23 115.39 3.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.088 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -72.56 -18.75 61.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.315 -176.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.509 ' OE2' ' HG2' ' A' ' 68' ' ' ARG . 46.3 mt-10 -71.76 -45.78 60.56 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 120.669 -0.412 . . . . 0.0 109.949 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.4 p -169.42 91.3 0.23 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 168.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 47.51 28.19 1.12 Allowed 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 156.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.505 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 37.2 tt0 -93.79 118.14 31.03 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 118.711 0.687 . . . . 0.0 110.809 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -77.61 112.63 14.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.264 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 43.0 m -110.21 119.28 38.77 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.37 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.449 ' HB3' ' OD1' ' A' ' 79' ' ' ASN . 36.3 mt-10 -99.19 127.77 45.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.314 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 39.9 mt -118.89 148.9 42.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.018 0.437 . . . . 0.0 111.004 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.2 m -89.99 166.57 13.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.089 -174.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.8 t -55.52 -31.54 62.15 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.462 -177.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -50.35 -49.24 54.65 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.605 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -77.98 -40.67 38.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.362 0.601 . . . . 0.0 109.74 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.616 ' HG ' ' CD2' ' A' ' 80' ' ' HIS . 4.3 mm? -66.09 -13.82 60.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.88 -174.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -57.77 -39.03 76.48 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.915 0.388 . . . . 0.0 110.106 172.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.566 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 8.4 tp10 -78.09 -43.43 29.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.746 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.462 ' O ' HD12 ' A' ' 105' ' ' LEU . 1.2 mp0 -57.47 -46.21 83.93 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.654 175.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 82.4 mt -67.92 -9.07 42.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.98 0.419 . . . . 0.0 111.116 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.566 ' HB3' ' O ' ' A' ' 100' ' ' GLU . 23.1 t30 -78.73 -50.2 11.78 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 173.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -141.1 116.7 10.24 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.293 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.462 HD12 ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -171.64 167.46 6.53 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.251 0.548 . . . . 0.0 111.818 178.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -141.67 143.67 33.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.842 168.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.5 mp0 -65.09 123.29 19.11 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 175.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.34 -13.43 47.89 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.039 -175.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.421 ' SD ' ' HG2' ' A' ' 126' ' ' PRO . 44.2 ttm -76.67 136.67 39.13 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -98.89 126.54 44.59 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.229 0.538 . . . . 0.0 111.142 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 31.4 m -106.71 160.05 6.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.905 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -100.14 100.86 11.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.065 0.46 . . . . 0.0 110.263 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.42 HD11 ' SD ' ' A' ' 70' ' ' MET . 65.1 mt -83.17 129.01 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.581 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.462 ' HG2' HD13 ' A' ' 121' ' ' ILE . 35.3 tt0 -106.8 117.36 33.84 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.925 -176.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 16.5 p -116.19 153.18 32.31 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.088 -174.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -130.03 99.39 5.06 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.935 176.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 61.97 31.79 17.96 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.374 0.607 . . . . 0.0 110.312 -174.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 93.78 -16.69 60.25 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.399 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -80.86 114.86 20.04 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 29.6 m -63.57 112.37 2.77 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.782 0.325 . . . . 0.0 110.604 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.462 HD13 ' HG2' ' A' ' 114' ' ' GLN . 38.7 pt -97.65 -23.97 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.04 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -170.47 163.46 36.68 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.016 -1.087 . . . . 0.0 112.848 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.3 t -127.63 126.63 67.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -106.59 120.6 42.38 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.76 -176.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.423 ' N ' HD21 ' A' ' 125' ' ' LEU . 1.9 mm? -86.18 150.21 51.67 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.421 ' HG2' ' SD ' ' A' ' 109' ' ' MET . 71.9 Cg_exo -51.42 130.89 34.59 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.697 2.265 . . . . 0.0 111.602 174.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 34.8 mmtp -62.37 -27.25 68.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.329 -170.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 34.9 p -121.32 112.73 18.95 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.97 176.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.1 p -114.8 137.03 49.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.164 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -109.32 99.03 8.34 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.226 0.536 . . . . 0.0 110.703 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.2 mt -106.9 142.05 37.14 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.056 0.455 . . . . 0.0 111.272 -173.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.4 m -84.14 133.7 34.61 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.037 176.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.6 p -87.34 112.37 23.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.629 0.728 . . . . 0.0 111.029 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 27.5 p -111.15 119.66 39.71 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.316 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 75.11 108.27 0.07 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.873 0.844 . . . . 0.0 111.041 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 8.9 t -150.55 153.44 35.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.673 178.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.443 ' O ' ' HD2' ' A' ' 150' ' ' LYS . 52.5 mt-10 -84.2 150.43 57.86 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.245 -176.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.29 179.9 6.07 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.51 2.14 . . . . 0.0 111.863 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 119.81 27.92 2.0 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.431 -177.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.9 tt -66.46 117.09 6.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.277 0.56 . . . . 0.0 110.447 176.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -71.95 -34.42 68.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.454 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 119.54 -26.41 7.31 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.108 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -102.68 170.9 7.73 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.169 0.509 . . . . 0.0 110.805 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.8 t -125.5 21.17 7.87 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.629 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -93.99 -29.48 15.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.185 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.9 t -62.47 144.48 55.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.838 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -96.14 15.35 63.1 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.173 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -86.61 154.32 21.12 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.741 0.305 . . . . 0.0 110.815 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 23.0 p -136.8 174.54 10.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.507 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.443 ' HD2' ' O ' ' A' ' 137' ' ' GLU . 59.6 pttt -133.41 145.86 50.68 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.524 177.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 9.1 t -73.18 118.66 16.4 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.109 0.481 . . . . 0.0 110.338 -176.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -124.02 164.22 19.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.013 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 33.4 m -120.54 135.98 54.92 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 9.7 m -98.73 173.94 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.284 177.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -52.81 -31.23 37.69 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 68.5 p -74.42 -12.6 60.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.712 0.291 . . . . 0.0 111.721 -176.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 95.48 -4.72 66.93 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.015 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -75.53 144.91 41.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.992 0.425 . . . . 0.0 110.603 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 23.3 m -107.24 122.44 46.55 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.178 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.07 161.62 37.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.696 0.284 . . . . 0.0 110.302 -177.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -92.1 111.49 23.06 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.083 -175.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 27.4 m -101.14 155.81 35.89 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.228 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -58.2 152.09 55.12 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.357 2.038 . . . . 0.0 111.4 174.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 72.6 mt -64.08 -18.33 64.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.468 -169.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -91.28 -1.94 57.54 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -176.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 85.8 t -73.11 135.6 27.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.957 0.408 . . . . 0.0 110.694 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -113.98 151.51 32.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.193 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -63.33 125.7 25.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.115 0.483 . . . . 0.0 110.683 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 109.54 -10.5 32.93 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.19 -176.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.582 ' OD2' ' HD3' ' A' ' 184' ' ' ARG . 19.1 t70 -73.39 148.19 43.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.597 0.237 . . . . 0.0 110.676 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.467 ' O ' ' HD2' ' A' ' 184' ' ' ARG . 60.7 t -105.33 99.97 9.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.197 0.522 . . . . 0.0 110.51 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.486 HD22 ' H ' ' A' ' 172' ' ' LEU . 0.7 OUTLIER -96.01 141.17 29.73 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.603 -177.718 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 59.2 mt -99.22 130.54 48.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.344 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 43.9 mm -117.87 141.43 36.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.579 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 23.6 t-20 -87.85 98.81 11.68 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 177.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.21 127.06 31.23 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.518 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 111.02 -37.25 3.81 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.652 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -104.78 -23.84 12.99 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.099 0.476 . . . . 0.0 110.359 176.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 73.88 17.53 79.36 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.201 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 9.6 p -84.42 152.37 24.06 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.873 0.368 . . . . 0.0 110.633 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -97.33 124.79 41.58 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.19 0.519 . . . . 0.0 110.671 -175.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.454 ' N ' HD12 ' A' ' 182' ' ' ILE . 2.8 mp -106.74 151.02 8.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 174.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.2 p -77.15 173.56 11.71 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.377 -173.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . 0.582 ' HD3' ' OD2' ' A' ' 170' ' ' ASP . 7.9 tpt180 -39.59 136.18 1.03 Allowed 'General case' 0 CA--C 1.533 0.319 0 O-C-N 123.754 0.659 . . . . 0.0 112.473 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.488 -1.174 . . . . 0.0 111.698 175.263 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.7 mtt . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 120.477 0.18 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.2 mm -104.29 122.87 57.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.7 0.286 . . . . 0.0 110.425 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.1 m -74.04 146.62 43.57 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 175.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.483 ' O ' HG23 ' A' ' 37' ' ' VAL . 20.7 m -70.11 -10.56 13.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.848 0.356 . . . . 0.0 111.744 -176.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -95.39 7.78 45.18 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.34 0.59 . . . . 0.0 109.542 177.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -120.79 87.79 2.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.687 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -136.9 152.84 50.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.217 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -128.19 167.44 16.83 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.809 -176.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.2 m -54.17 -30.24 48.64 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.344 0.592 . . . . 0.0 110.34 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.522 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -140.36 116.74 1.2 Allowed Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 169.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 54.9 tp -150.46 135.35 17.58 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 1.9 p -94.44 122.43 37.0 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.444 0.64 . . . . 0.0 112.192 -176.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.413 HD12 ' C ' ' A' ' 12' ' ' THR . 1.7 mp -119.39 141.92 37.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.53 -176.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.513 ' O ' ' HB3' ' A' ' 61' ' ' GLU . 43.1 t -107.32 107.73 18.79 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.425 HG13 ' CD1' ' A' ' 20' ' ' TRP . 13.1 p -142.2 140.6 29.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -178.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 61.3 32.77 19.2 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.6 -176.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 64.86 23.01 12.6 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.609 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.39 158.55 37.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.796 0.332 . . . . 0.0 110.514 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.6 pt -107.47 123.73 62.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.665 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.435 ' O ' ' HA ' ' A' ' 12' ' ' THR . 54.1 m95 -122.8 160.03 26.85 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.625 -172.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -130.58 115.04 16.21 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.522 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 94.9 t -64.76 119.14 8.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.705 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.4 mm -90.91 -35.96 7.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.718 176.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -160.82 122.09 2.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.067 177.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -104.45 143.28 33.22 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.735 0.302 . . . . 0.0 110.944 -176.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -118.85 99.43 6.75 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.881 0.372 . . . . 0.0 110.337 177.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -78.07 91.88 4.32 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 176.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 p -101.6 135.8 36.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.517 -171.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -109.1 101.76 46.18 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-O 121.309 0.576 . . . . 0.0 110.58 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -58.02 -48.2 17.24 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 123.345 2.696 . . . . 0.0 112.797 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.2 19.43 8.04 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.887 178.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -110.1 -14.31 14.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.681 0.277 . . . . 0.0 111.46 -177.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.05 -42.86 1.24 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.262 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.1 m -102.1 131.22 48.7 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 177.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.13 155.63 19.68 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 174.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.407 ' CE2' ' HB3' ' A' ' 55' ' ' ARG . 34.9 m-85 -129.66 163.38 26.21 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.094 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 4' ' ' VAL . 52.8 t -132.7 102.7 5.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.179 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -80.73 98.96 7.98 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 175.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 53.2 p -100.64 134.2 43.96 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.134 -175.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -95.43 102.68 14.5 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 174.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -138.48 150.96 46.96 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.804 0.335 . . . . 0.0 110.853 -171.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -116.96 144.92 44.01 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.543 -175.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.434 ' HB2' ' CZ3' ' A' ' 20' ' ' TRP . 47.4 t-20 -76.58 115.57 16.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.451 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.8 mt -69.77 -24.75 63.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.194 0.521 . . . . 0.0 110.733 -177.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.6 tpp180 -70.13 -38.8 75.64 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.011 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.3 p -113.48 -15.89 12.51 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -174.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.87 20.82 69.78 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.274 -0.489 . . . . 0.0 112.004 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -96.45 141.65 29.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.856 0.36 . . . . 0.0 111.799 -173.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.2 tp -87.92 137.18 21.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.251 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.488 ' HG3' ' N ' ' A' ' 51' ' ' GLU . 8.7 tp-100 -148.46 175.25 11.29 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -178.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.488 ' N ' ' HG3' ' A' ' 50' ' ' GLN . 10.7 pt-20 -140.17 138.16 34.96 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 170.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -126.51 135.11 50.9 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.686 -175.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.2 p -102.23 102.66 13.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.929 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -85.17 149.32 25.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.026 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.407 ' HB3' ' CE2' ' A' ' 36' ' ' PHE . 5.7 ptm180 -120.18 134.96 55.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.974 0.416 . . . . 0.0 111.385 -175.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.05 132.71 54.68 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.915 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 108.03 -29.88 9.68 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -174.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -102.82 99.67 9.63 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -76.6 137.71 39.68 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.415 0.626 . . . . 0.0 110.831 -175.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.3 t -85.36 150.65 3.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.977 -169.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.513 ' HB3' ' O ' ' A' ' 14' ' ' SER . 34.7 tt0 -85.63 130.98 48.94 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.682 176.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -82.73 156.29 15.83 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.505 2.137 . . . . 0.0 112.895 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -123.61 120.5 32.99 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.431 174.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 67.8 mtt -96.38 108.89 21.48 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.174 0.511 . . . . 0.0 110.799 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -110.2 121.6 63.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.485 177.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.582 ' OE1' ' HD2' ' A' ' 68' ' ' ARG . 40.6 tt0 -95.64 107.76 19.98 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.904 -176.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -84.39 100.77 11.5 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.357 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.582 ' HD2' ' OE1' ' A' ' 66' ' ' GLU . 16.2 mtp180 -106.08 170.24 8.03 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.142 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.56 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 7.7 ptm180 -142.71 120.06 11.6 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.459 0.647 . . . . 0.0 111.141 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.61 ' CB ' ' HB3' ' A' ' 82' ' ' PHE . 1.5 mpt? -115.59 139.94 49.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.926 -174.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -71.75 133.7 45.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.541 174.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -77.31 111.17 12.68 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -174.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -111.21 -179.04 3.61 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 169.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -148.7 159.59 43.98 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.312 0.577 . . . . 0.0 111.82 -175.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.23 -149.55 0.31 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.436 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -66.65 136.69 55.94 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 170.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.01 69.09 2.98 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 118.782 -1.675 . . . . 0.0 113.59 -170.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -127.11 -33.2 2.44 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 158.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -128.73 120.07 25.76 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 113.85 -1.523 . . . . 0.0 108.913 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.576 ' CG ' ' HG ' ' A' ' 98' ' ' LEU . 17.0 m-70 -102.39 132.28 48.49 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 57.1 t -83.58 125.64 40.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.081 -173.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.61 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 61.0 m-85 -123.03 120.54 33.63 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 176.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.56 ' SD ' ' HG2' ' A' ' 90' ' ' GLN . 93.5 mmm -95.19 113.3 24.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.917 -176.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.532 ' HA ' ' HG3' ' A' ' 70' ' ' MET . 20.9 t70 -58.46 117.39 4.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.239 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -76.49 -12.56 60.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.48 -177.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -68.91 -50.27 50.92 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 176.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.1 p -170.99 91.65 0.15 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.103 0.478 . . . . 0.0 112.288 164.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 48.31 26.62 1.14 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 160.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.496 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 45.7 mt-10 -87.59 113.16 23.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 118.666 0.666 . . . . 0.0 110.867 176.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.56 ' HG2' ' SD ' ' A' ' 83' ' ' MET . 73.5 mt-30 -74.47 118.14 17.09 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.343 -178.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.9 m -120.14 121.76 39.51 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.23 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -95.91 127.97 42.39 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.947 0.403 . . . . 0.0 110.483 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.425 HD13 ' CE1' ' A' ' 82' ' ' PHE . 59.6 mt -112.69 140.02 47.81 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.433 178.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.5 t -80.29 158.57 26.11 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.772 -177.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.2 p -58.98 -23.9 62.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.842 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.51 -39.45 87.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.808 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -82.75 -41.07 19.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.597 0.713 . . . . 0.0 109.35 177.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.576 ' HG ' ' CG ' ' A' ' 80' ' ' HIS . 3.3 mm? -67.24 -20.05 65.61 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.445 -171.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -60.94 -31.0 70.55 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.212 0.53 . . . . 0.0 110.096 175.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -82.61 -46.23 13.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.25 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.444 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 0.9 OUTLIER -62.13 -36.61 82.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.467 179.084 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.479 ' O ' ' HB ' ' A' ' 156' ' ' THR . 56.2 mt -67.21 -6.36 17.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.629 0.252 . . . . 0.0 111.608 -178.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -70.53 -41.47 72.5 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 172.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.453 ' HB3' HG12 ' A' ' 129' ' ' VAL . 68.8 m-85 -142.4 115.2 8.66 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.208 177.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 101' ' ' GLU . 0.7 OUTLIER 179.8 171.41 1.07 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 122.95 0.5 . . . . 0.0 110.739 173.004 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.534 ' HD2' ' O ' ' A' ' 130' ' ' GLU . 30.4 mtpp -142.48 144.73 33.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.306 176.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -62.73 113.79 3.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.862 0.363 . . . . 0.0 110.739 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 109.85 -10.28 32.14 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.402 -177.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.536 ' SD ' ' HG3' ' A' ' 126' ' ' PRO . 53.0 ttm -91.11 144.31 25.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.68 0.276 . . . . 0.0 110.465 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.606 ' HA ' ' O ' ' A' ' 70' ' ' MET . 8.4 pt-20 -94.2 138.91 31.68 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.365 0.602 . . . . 0.0 112.075 -177.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 33.9 m -113.57 158.13 14.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.58 175.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.553 ' HA ' ' O ' ' A' ' 68' ' ' ARG . 27.9 mt-30 -96.83 99.94 11.49 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.048 0.452 . . . . 0.0 110.652 -177.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.492 HD12 ' SD ' ' A' ' 70' ' ' MET . 63.7 mt -84.44 127.98 39.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.223 -178.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -100.13 110.34 22.62 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.485 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 43.1 p -107.12 128.7 54.62 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.322 177.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -108.1 110.2 21.82 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 174.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 60.44 29.05 18.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.445 -176.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 98.31 -18.96 56.27 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.984 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.445 ' O ' ' HA ' ' A' ' 115' ' ' THR . 42.5 tt0 -84.64 126.88 33.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.638 0.219 . . . . 0.0 111.364 -176.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 85.5 m -68.21 100.82 1.08 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 175.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 46.7 pt -84.79 -30.77 6.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.064 0.459 . . . . 0.0 110.328 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -170.86 162.38 35.32 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.692 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.4 t -123.81 127.31 73.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 177.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.421 ' HB3' ' HB2' ' A' ' 112' ' ' GLN . 31.0 tt0 -93.74 123.67 37.24 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.007 0.432 . . . . 0.0 109.961 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 125' ' ' LEU . 7.0 mp -78.25 157.62 77.89 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.311 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.536 ' HG3' ' SD ' ' A' ' 109' ' ' MET . 6.9 Cg_endo -48.45 127.81 16.58 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.02 2.48 . . . . 0.0 112.249 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -56.8 -38.29 72.33 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.348 -178.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 29.7 p -133.18 109.27 9.33 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.832 174.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.453 HG12 ' HB3' ' A' ' 104' ' ' TYR . 10.4 p -111.41 140.86 28.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.731 0.3 . . . . 0.0 110.623 -176.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.534 ' O ' ' HD2' ' A' ' 106' ' ' LYS . 7.4 pt-20 -107.06 100.36 9.85 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.402 0.62 . . . . 0.0 110.481 177.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 89.7 mt -106.2 133.47 50.86 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.343 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.4 m -76.12 130.85 38.92 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.098 178.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.5 p -78.88 105.61 8.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.913 0.863 . . . . 0.0 110.652 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 37.0 p -107.53 112.37 25.09 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.427 -178.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 79.06 96.67 0.06 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-O 122.068 0.937 . . . . 0.0 111.036 -177.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.61 ' O ' ' HD3' ' A' ' 138' ' ' PRO . 9.7 t -150.65 153.36 35.49 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.086 -1.415 . . . . 0.0 107.663 174.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -84.29 103.27 2.83 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.61 ' HD3' ' O ' ' A' ' 136' ' ' THR . 68.8 Cg_endo -90.11 172.81 3.56 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.835 2.357 . . . . 0.0 112.356 -175.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.49 21.24 77.54 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.772 176.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 56.5 mt -88.11 122.64 39.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -92.3 172.52 8.35 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.174 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 119.91 -2.39 13.3 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.731 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 62.93 -173.18 0.16 Allowed 'General case' 0 N--CA 1.463 0.197 0 O-C-N 124.067 0.51 . . . . 0.0 111.081 176.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 55.2 m -153.69 87.66 1.24 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.955 0.407 . . . . 0.0 109.933 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -130.54 3.01 4.58 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -176.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.3 m -150.21 36.38 0.67 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.528 0.68 . . . . 0.0 110.654 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 85.07 21.13 56.17 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.596 -0.812 . . . . 0.0 113.855 174.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.28 93.61 3.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.371 0.585 . . . . 0.0 109.894 174.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 18.0 p -122.79 164.83 17.64 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.146 -176.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -125.25 148.18 48.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.953 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 42.5 m -73.72 107.17 5.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.089 0.471 . . . . 0.0 110.76 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -107.9 163.5 13.07 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.852 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 21.1 m -118.79 134.52 55.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.047 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.5 m -98.54 175.79 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.506 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -57.31 -28.2 62.86 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 44.1 p -73.94 -11.01 60.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.017 0.436 . . . . 0.0 111.652 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.59 1.85 73.71 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -176.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -81.53 143.27 32.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.915 0.388 . . . . 0.0 110.856 -177.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 23.1 m -100.96 126.91 47.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.399 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.92 155.49 41.64 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -85.79 123.69 31.45 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.36 0.6 . . . . 0.0 111.3 -175.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 27.3 m -116.61 155.06 49.23 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.368 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -56.85 150.51 54.14 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.444 2.096 . . . . 0.0 111.65 175.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 80.7 mt -62.95 -17.3 61.78 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -169.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -88.6 -8.32 54.89 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -176.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 74.5 t -69.24 136.6 25.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.81 0.338 . . . . 0.0 111.249 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -122.68 160.89 24.89 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.479 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -59.4 128.04 35.09 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.887 -177.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 109.42 -15.61 32.42 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.536 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.546 ' OD2' ' HD3' ' A' ' 184' ' ' ARG . 23.7 t70 -67.26 145.35 55.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.8 0.3 . . . . 0.0 110.591 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.411 ' CG1' ' HB2' ' A' ' 130' ' ' GLU . 47.2 t -94.7 109.91 22.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.157 0.503 . . . . 0.0 110.379 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 46.7 mt -90.97 117.33 29.48 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.454 -178.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.426 ' N ' HD13 ' A' ' 173' ' ' ILE . 1.8 mp -91.43 106.45 17.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 57.8 mt -107.67 129.62 61.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.573 -176.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -82.22 96.41 7.85 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.373 175.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 6.5 m -61.68 136.59 58.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.006 -175.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 104.11 -33.74 6.33 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -107.66 -26.73 10.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.026 0.441 . . . . 0.0 110.505 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.36 15.32 76.75 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.206 177.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 5.9 m -68.96 112.65 5.74 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -96.22 111.41 23.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.188 0.518 . . . . 0.0 110.957 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 4.5 mp -107.81 102.35 13.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.124 0.488 . . . . 0.0 110.114 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 48.3 t -80.53 166.74 20.89 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.368 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . 0.546 ' HD3' ' OD2' ' A' ' 170' ' ' ASP . 25.1 mmt180 72.46 30.22 1.98 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 172.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.137 0 CA-C-O 118.147 -1.363 . . . . 0.0 113.604 174.345 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.9 mtt . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.444 ' HB ' HG22 ' A' ' 60' ' ' VAL . 3.7 mp -81.76 118.86 30.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.242 0.544 . . . . 0.0 110.757 -176.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 m -97.36 151.95 19.42 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.337 171.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.9 m -67.18 -14.68 18.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -167.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -86.06 -0.1 54.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.427 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -133.6 91.31 2.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.242 0.544 . . . . 0.0 111.786 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -126.27 156.7 39.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.589 172.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -126.94 162.11 26.74 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -177.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 p -53.0 -20.36 3.37 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 123.556 0.535 . . . . 0.0 111.63 175.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.607 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -144.49 115.78 0.89 Allowed Glycine 0 N--CA 1.435 -1.376 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 167.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.72 129.22 20.17 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 1.2 m -103.29 118.27 36.4 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.193 0.52 . . . . 0.0 111.055 -178.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.0 mp -117.94 140.31 41.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.321 -176.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.405 ' HB2' ' HB2' ' A' ' 63' ' ' ALA . 22.7 t -102.33 102.02 12.34 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 175.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.5 p -140.34 146.27 24.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.446 -177.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 61.94 28.45 17.32 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.493 -176.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.1 m120 63.86 25.66 14.09 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.445 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.86 163.39 29.61 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.098 177.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 10.1 pt -109.56 126.27 66.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.392 -178.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.546 ' O ' ' HA ' ' A' ' 12' ' ' THR . 64.8 m95 -124.11 146.56 48.55 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.088 -170.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -120.78 104.05 9.58 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.318 -177.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.607 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 78.9 t -63.02 111.91 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.76 177.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.2 mt -92.68 -33.91 5.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.695 176.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -143.12 148.78 37.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.022 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -141.6 131.75 24.8 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.079 0.466 . . . . 0.0 110.905 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -122.37 110.02 15.13 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.373 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -80.06 101.24 8.6 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.5 p -108.5 134.11 51.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.295 0.569 . . . . 0.0 111.331 -172.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.486 ' HZ3' ' HB2' ' A' ' 29' ' ' LYS . 3.9 ttmp? -122.89 100.55 40.2 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.701 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -76.25 -10.49 19.22 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.343 2.029 . . . . 0.0 112.199 177.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.6 25.78 60.17 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.774 -0.648 . . . . 0.0 113.087 175.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -87.56 -12.86 44.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.919 0.39 . . . . 0.0 111.145 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.96 -42.57 1.27 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.685 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.7 p -123.01 132.41 54.12 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 174.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.04 161.65 25.28 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.848 0.356 . . . . 0.0 110.627 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.464 ' HA ' ' O ' ' A' ' 54' ' ' PHE . 86.1 m-85 -128.59 165.46 20.74 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.102 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 53' ' ' THR . 59.5 t -129.67 106.41 13.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 176.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -80.37 99.29 7.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.202 177.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.1 p -111.03 137.15 49.02 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.27 -174.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -95.28 108.85 21.03 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 175.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.428 HD21 ' H ' ' A' ' 41' ' ' LEU . 1.1 pt? -135.94 141.82 44.53 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.764 0.793 . . . . 0.0 111.899 -172.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 33.0 ttt180 -103.77 129.8 51.23 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.86 -1.063 . . . . 0.0 111.49 -173.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -70.12 117.95 12.34 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 172.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.9 mp -64.61 -26.82 68.57 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 121.188 -0.205 . . . . 0.0 111.434 -175.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 45' ' ' ARG . 59.3 mtt180 -76.55 -50.07 14.83 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.825 0.345 . . . . 0.0 111.467 -177.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.4 p -94.54 -17.65 22.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.047 0.451 . . . . 0.0 111.811 -172.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.24 6.57 88.85 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.719 -175.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.439 ' O ' ' HA ' ' A' ' 42' ' ' ARG . . . -68.64 131.04 44.54 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -174.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.7 mm -91.53 98.84 8.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.407 ' HG2' ' N ' ' A' ' 51' ' ' GLU . 34.7 tt0 -112.47 167.34 10.52 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -178.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.407 ' N ' ' HG2' ' A' ' 50' ' ' GLN . 11.0 pt-20 -132.5 125.91 31.7 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.152 0.501 . . . . 0.0 109.949 173.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -115.36 148.19 39.59 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.74 -176.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 10.8 p -112.6 105.06 13.17 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.244 176.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 88.3 m-85 -84.1 144.96 28.7 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.726 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.54 ' HD3' ' OE2' ' A' ' 58' ' ' GLU . 34.5 ttt180 -111.09 136.08 50.66 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.743 0.306 . . . . 0.0 111.549 -173.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.13 129.79 42.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.818 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 106.27 -16.75 41.51 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -175.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.54 ' OE2' ' HD3' ' A' ' 55' ' ' ARG . 81.1 mt-10 -112.71 149.56 32.75 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -127.67 163.41 24.32 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.298 -176.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.444 HG22 ' HB ' ' A' ' 2' ' ' ILE . 5.6 m -134.16 157.63 41.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.37 0.605 . . . . 0.0 111.469 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -83.59 141.56 41.99 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.03 -0.987 . . . . 0.0 110.443 -176.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.27 154.73 41.47 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.538 2.159 . . . . 0.0 112.454 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.405 ' HB2' ' HB2' ' A' ' 14' ' ' SER . . . -122.44 113.07 18.85 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.954 175.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 26.3 mmt -88.64 109.03 19.77 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.99 0.424 . . . . 0.0 110.62 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.545 ' CG1' HG22 ' A' ' 12' ' ' THR . 46.9 mm -99.37 125.4 52.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.049 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.49 ' HG3' ' OG1' ' A' ' 115' ' ' THR . 6.0 pt-20 -117.6 138.02 52.22 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.595 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -112.98 113.86 26.09 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.954 0.406 . . . . 0.0 110.213 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.505 ' HB3' ' OD1' ' A' ' 84' ' ' ASP . 68.6 mtt180 -110.36 117.47 33.71 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.17 -178.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.419 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 9.2 ptm180 -74.05 121.14 20.62 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 174.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.543 ' HG2' ' HA ' ' A' ' 84' ' ' ASP . 28.7 mtt -124.08 147.72 47.66 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.448 -175.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -77.41 136.56 38.41 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.903 177.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -77.14 103.78 7.26 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.413 -176.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.44 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 8.4 mp -104.32 -176.81 3.19 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 170.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -146.79 157.09 43.59 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.621 0.724 . . . . 0.0 112.448 -171.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.424 ' HB2' ' O ' ' A' ' 79' ' ' ASN . . . -150.57 -160.83 1.22 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.308 -1.314 . . . . 0.0 107.713 174.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -72.08 143.15 49.17 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 175.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.5 68.66 2.41 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 118.879 -1.629 . . . . 0.0 113.879 -167.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.568 ' HA ' ' OG ' ' A' ' 95' ' ' SER . 22.8 m-20 -127.93 -30.43 2.48 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 156.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.463 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 92.6 m-20 -137.07 138.65 40.63 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.512 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -121.69 144.56 48.7 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 173.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.44 ' O ' ' HB2' ' A' ' 73' ' ' LEU . 45.9 t -90.41 132.33 35.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.499 -178.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -126.43 125.53 42.3 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 174.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 37.8 mtt -93.7 113.32 25.37 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.454 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.577 ' HB3' ' H ' ' A' ' 89' ' ' GLU . 20.2 t0 -62.15 115.01 3.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.511 -177.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -85.46 -7.13 59.08 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.023 177.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.59 -52.24 27.84 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 173.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.44 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 12.1 p -164.75 90.03 0.52 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 167.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 47.33 28.26 1.03 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 158.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.577 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 49.2 mt-10 -105.89 116.53 32.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 118.981 0.809 . . . . 0.0 112.408 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -75.86 118.68 18.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.277 0.561 . . . . 0.0 110.027 175.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.1 m -120.99 138.26 54.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.547 -175.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -105.87 134.55 48.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.797 0.332 . . . . 0.0 110.817 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' A' ' 79' ' ' ASN . 4.5 mm? -112.88 143.01 44.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.427 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.7 m -79.64 166.93 21.35 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -173.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.568 ' OG ' ' HA ' ' A' ' 78' ' ' ASP . 10.2 m -52.93 -33.38 50.41 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.749 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -52.14 -40.69 61.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.734 -176.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -87.64 -41.03 13.69 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.42 0.628 . . . . 0.0 109.953 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.473 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 4.3 mm? -74.32 -20.88 59.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.314 -171.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -60.58 -32.26 71.37 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.126 0.489 . . . . 0.0 110.204 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -87.44 -39.4 15.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.387 177.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.45 ' O ' HD13 ' A' ' 105' ' ' LEU . 40.7 mt-10 -63.57 -25.62 68.32 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.343 178.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 65.8 mt -71.44 -7.4 47.14 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 122.021 -0.424 . . . . 0.0 110.865 177.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -90.09 -43.8 10.24 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 172.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -130.36 116.24 18.02 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.315 176.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.45 HD13 ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -172.4 164.2 5.68 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.728 0.299 . . . . 0.0 110.627 177.459 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -143.16 138.87 30.07 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -63.7 123.13 18.09 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.638 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.32 1.65 71.75 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.751 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.413 ' SD ' ' HD2' ' A' ' 126' ' ' PRO . 51.9 ttm -62.75 147.62 49.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.106 0.479 . . . . 0.0 111.53 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.41 ' HG2' HH21 ' A' ' 69' ' ' ARG . 4.3 tp10 -89.41 100.32 13.14 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.593 175.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 23.1 m -106.55 155.74 7.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.63 -178.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.495 ' HB2' ' HB3' ' A' ' 124' ' ' GLU . 12.8 mm100 -96.99 99.65 11.18 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 32.8 mm -81.88 116.0 25.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 177.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.404 ' HG2' HD13 ' A' ' 121' ' ' ILE . 27.8 tt0 -91.69 113.16 25.35 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.49 ' OG1' ' HG3' ' A' ' 66' ' ' GLU . 1.7 p -116.11 157.85 24.11 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.705 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -129.64 101.91 6.13 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 176.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 58.55 33.98 23.53 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.225 -173.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 96.49 -22.59 39.27 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.989 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -75.53 131.4 40.03 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.824 -0.221 . . . . 0.0 110.569 -178.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.6 p -75.22 113.24 12.36 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.734 0.302 . . . . 0.0 110.865 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.404 HD13 ' HG2' ' A' ' 114' ' ' GLN . 40.1 pt -105.94 -21.41 5.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.444 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -169.27 163.71 37.35 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.179 -1.01 . . . . 0.0 112.742 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 59.9 t -130.35 129.53 64.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 177.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.495 ' HB3' ' HB2' ' A' ' 112' ' ' GLN . 35.3 tt0 -108.97 101.12 10.24 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.295 0.569 . . . . 0.0 110.669 178.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -77.66 126.22 84.72 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 173.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.413 ' HD2' ' SD ' ' A' ' 109' ' ' MET . 30.5 Cg_exo -37.74 127.5 0.79 Allowed 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.791 2.994 . . . . 0.0 113.359 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 75.5 mmtt -62.49 -26.73 68.69 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.9 -172.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 p -119.08 108.85 15.22 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.072 0.463 . . . . 0.0 109.944 172.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.2 p -110.5 136.41 46.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.428 -177.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -96.45 115.08 26.85 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.847 0.356 . . . . 0.0 110.38 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 80.9 mt -124.38 131.9 53.52 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.584 -177.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.9 m -79.29 134.93 36.63 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.36 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.4 p -85.13 118.28 31.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.621 0.724 . . . . 0.0 110.868 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.544 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 43.2 p -130.97 126.13 35.2 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.496 178.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.544 ' HB2' ' O ' ' A' ' 134' ' ' THR . 48.7 mm-40 79.4 79.07 0.05 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.675 0.75 . . . . 0.0 111.175 -175.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.574 ' O ' ' HD3' ' A' ' 138' ' ' PRO . 11.1 t -150.23 153.58 36.46 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 171.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -102.12 99.65 13.04 Favored Pre-proline 0 C--N 1.321 -0.646 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.348 -178.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.574 ' HD3' ' O ' ' A' ' 136' ' ' THR . 84.6 Cg_endo -91.54 -179.17 1.29 Allowed 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.08 2.52 . . . . 0.0 112.186 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 94.87 13.67 52.28 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.478 178.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.7 mp -105.76 126.37 61.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -93.09 -33.84 13.91 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.087 0.47 . . . . 0.0 109.966 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.73 -11.83 70.56 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.814 175.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 66.24 -41.1 0.36 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.809 1.244 . . . . 0.0 113.041 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.8 p -94.01 -59.96 1.85 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.93 0.395 . . . . 0.0 111.047 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -139.49 116.75 11.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.698 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.1 t -79.13 -14.07 59.35 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.446 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -74.63 -7.12 79.1 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.137 177.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.533 ' O ' ' HG ' ' A' ' 164' ' ' LEU . . . -62.19 161.26 11.46 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 175.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.498 ' HB ' ' HB3' ' A' ' 161' ' ' ASN . 36.9 p -114.3 155.47 26.16 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -171.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -131.64 152.48 50.81 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.453 178.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.4 p -72.78 117.56 14.63 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.051 0.453 . . . . 0.0 111.358 -177.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' A' ' 159' ' ' THR . . . -119.66 158.62 26.07 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.954 -178.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.467 ' HB ' ' O ' ' A' ' 134' ' ' THR . 18.4 m -109.73 138.48 46.03 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 174.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.0 m -105.63 178.87 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.496 175.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -54.97 -30.25 58.75 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 79.4 p -76.41 -8.87 58.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.805 0.336 . . . . 0.0 111.839 -177.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 86.13 3.29 85.17 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.582 -175.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -80.79 143.47 32.83 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.851 0.357 . . . . 0.0 110.555 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 152' ' ' ALA . 30.1 m -101.07 120.22 39.89 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.06 177.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.2 161.49 35.6 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.498 ' HB3' ' HB ' ' A' ' 149' ' ' THR . 89.4 m-20 -92.84 112.93 25.06 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.881 0.372 . . . . 0.0 111.53 -173.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 29.2 m -108.32 148.18 37.1 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.393 178.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.38 149.22 30.51 Favored 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.558 2.172 . . . . 0.0 111.964 174.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 148' ' ' ALA . 59.4 mt -62.38 -11.72 17.24 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -170.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -104.18 10.33 35.81 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -176.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 75.5 t -78.73 142.41 14.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -114.41 145.22 42.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.437 -175.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -62.53 127.06 29.52 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.615 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 112.12 -16.44 25.1 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.356 -176.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -75.49 154.91 36.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.987 0.422 . . . . 0.0 110.631 177.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 88.6 t -105.04 116.63 49.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.747 -177.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.403 HD22 ' N ' ' A' ' 172' ' ' LEU . 2.5 mm? -99.2 138.36 36.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.073 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.559 ' O ' ' HB ' ' A' ' 182' ' ' ILE . 57.0 mt -97.28 115.37 36.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 33.7 mm -109.85 141.31 25.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.427 -178.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.589 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 27.2 t-20 -86.52 103.1 14.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.991 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.0 m -71.77 113.03 8.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.231 176.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 143.43 -47.1 0.81 Allowed Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -177.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -118.81 -22.73 7.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.982 0.42 . . . . 0.0 110.373 175.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 89.48 17.24 55.51 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.109 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 4.2 m -65.04 136.57 56.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.582 0.23 . . . . 0.0 110.605 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -89.84 117.17 28.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.145 0.498 . . . . 0.0 110.927 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.559 ' HB ' ' O ' ' A' ' 173' ' ' ILE . 4.0 mp -96.87 151.42 4.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 169.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 10.7 p -77.11 173.1 12.22 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.829 -0.169 . . . . 0.0 111.018 -173.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 39.0 mtt180 -46.03 144.3 1.93 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.686 0.616 . . . . 0.0 111.885 -176.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.734 -1.037 . . . . 0.0 111.852 177.928 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 120.917 0.389 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 84.5 mt -75.28 134.68 28.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.036 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 m -94.83 143.79 26.17 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 174.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.47 ' HA ' ' CE1' ' A' ' 7' ' ' PHE . 10.8 m -69.11 -1.99 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -172.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -90.09 -2.63 58.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.657 0.265 . . . . 0.0 110.593 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -134.0 89.93 2.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.527 0.679 . . . . 0.0 111.518 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.47 ' CE1' ' HA ' ' A' ' 4' ' ' VAL . 61.6 m-85 -119.58 153.01 36.1 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 171.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -119.57 171.64 8.22 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.477 -176.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.1 p -65.17 -14.57 60.91 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.767 0.794 . . . . 0.0 109.978 174.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.498 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -153.13 115.12 0.66 Allowed Glycine 0 N--CA 1.435 -1.369 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 166.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.6 tp -149.99 132.0 15.26 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.66 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 1.7 m -98.39 122.69 41.89 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.321 0.581 . . . . 0.0 112.092 -172.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.0 mp -117.27 143.73 26.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.279 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.45 ' HB2' ' HB2' ' A' ' 63' ' ' ALA . 35.5 t -104.43 107.43 18.36 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 175.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.9 p -153.93 151.28 11.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -176.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 54.78 45.09 27.39 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 -176.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.7 p30 47.29 31.66 1.87 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.314 1.046 . . . . 0.0 112.222 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.7 166.06 25.69 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.466 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.8 pt -112.13 130.58 65.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.83 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.66 ' O ' ' HA ' ' A' ' 12' ' ' THR . 70.2 m95 -126.6 147.91 49.83 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.885 -168.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.4 ttmm -116.95 104.02 10.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.549 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.498 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 84.1 t -62.81 109.06 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.872 0.368 . . . . 0.0 110.303 177.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 77.0 mt -88.85 -38.15 11.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.512 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -142.47 152.53 42.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.481 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -143.77 136.44 27.2 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.991 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -113.26 99.65 7.97 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.708 176.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -76.05 90.02 3.03 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.0 p -96.5 118.95 43.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.567 0.699 . . . . 0.0 111.519 -171.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.434 ' HB3' ' HZ2' ' A' ' 29' ' ' LYS . 5.2 ttpm? -119.81 96.83 49.66 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.428 176.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.88 -10.77 15.38 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.482 2.121 . . . . 0.0 113.148 -177.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.2 26.65 39.51 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.958 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -95.46 10.67 35.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.796 0.331 . . . . 0.0 111.265 -176.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.48 -42.03 2.03 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.12 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.1 p -133.18 146.58 51.66 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 177.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -96.35 166.13 11.86 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.113 0.482 . . . . 0.0 111.134 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -136.25 167.07 21.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.492 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.9 t -131.88 102.62 5.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.086 0.47 . . . . 0.0 109.733 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -82.47 99.33 9.4 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.5 p -102.76 143.87 31.85 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.916 -173.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -102.52 102.82 13.13 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 174.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.494 HD21 ' H ' ' A' ' 41' ' ' LEU . 1.3 pt? -133.02 150.96 52.11 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.687 0.756 . . . . 0.0 112.36 -169.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 20.3 ttt180 -110.69 129.67 55.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.038 -171.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -69.96 122.52 19.48 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 173.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.9 mp -66.85 -25.67 66.54 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -176.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.1 mtt85 -81.33 -44.83 17.06 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.671 0.272 . . . . 0.0 111.72 -177.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 67.2 p -99.09 -17.07 18.4 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.132 0.492 . . . . 0.0 111.943 -173.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.31 13.64 81.32 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.793 -175.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 42' ' ' ARG . . . -73.53 133.27 43.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.917 0.389 . . . . 0.0 111.672 -175.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 26.4 mm -96.15 99.15 8.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.378 176.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.453 ' O ' HD21 ' A' ' 41' ' ' LEU . 8.9 tt0 -119.75 157.23 29.02 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -177.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -113.9 127.02 55.8 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.291 0.567 . . . . 0.0 110.092 175.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -129.09 146.22 51.1 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.626 -175.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.1 m -107.77 120.66 42.87 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.269 0.557 . . . . 0.0 111.899 -175.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -92.03 155.45 18.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.251 173.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -117.6 132.13 56.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.143 0.497 . . . . 0.0 111.429 -176.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.3 129.66 40.62 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.871 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.19 -16.24 32.63 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -175.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -106.27 137.82 43.55 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -93.4 132.45 37.63 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.122 0.486 . . . . 0.0 110.61 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.5 t -96.03 145.62 8.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.662 -175.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -87.52 125.64 64.68 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.701 0.286 . . . . 0.0 110.493 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -79.12 152.79 24.49 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.563 2.175 . . . . 0.0 112.754 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.45 ' HB2' ' HB2' ' A' ' 14' ' ' SER . . . -117.56 109.39 16.64 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.569 176.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 61.4 mtt -87.25 108.68 19.05 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.168 0.508 . . . . 0.0 110.219 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.44 ' CG1' HG21 ' A' ' 12' ' ' THR . 52.1 mm -90.79 132.67 34.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.073 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -104.72 103.61 13.27 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.955 -177.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -93.99 101.34 13.39 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.938 0.399 . . . . 0.0 110.194 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 41.6 mtm180 -107.05 168.02 9.49 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -134.66 122.11 21.78 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.326 0.584 . . . . 0.0 111.022 -175.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.535 ' HG3' ' HA ' ' A' ' 84' ' ' ASP . 1.9 mpt? -117.39 149.07 41.14 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.348 -173.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -90.87 139.81 30.4 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 174.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -70.74 103.22 2.51 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.773 -174.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -94.49 -175.18 3.54 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 167.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -143.07 142.96 31.68 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 119.764 -0.774 . . . . 0.0 112.511 -167.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.497 ' HB2' ' O ' ' A' ' 79' ' ' ASN . . . -151.85 -172.83 4.34 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.261 -1.336 . . . . 0.0 108.812 175.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -76.61 145.73 38.71 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.13 68.64 2.59 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 118.984 -1.579 . . . . 0.0 114.095 -167.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -126.89 -30.81 2.7 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 156.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.613 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 21.1 p-10 -140.98 132.74 27.37 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 113.608 -1.633 . . . . 0.0 109.68 177.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.498 ' CG ' HD23 ' A' ' 98' ' ' LEU . 54.7 m170 -114.92 146.96 40.59 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 172.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 44.8 t -95.7 125.45 48.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.91 -176.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.53 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 78.8 m-85 -121.68 117.59 27.04 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 89.0 mmm -91.41 114.24 26.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.849 0.357 . . . . 0.0 111.22 -174.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.535 ' HA ' ' HG3' ' A' ' 70' ' ' MET . 22.4 t70 -62.16 116.49 5.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.39 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -77.68 -11.56 59.88 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.439 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -73.3 -50.52 21.73 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 176.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.6 p -169.09 91.59 0.25 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 168.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 48.42 25.32 0.88 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 157.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.465 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 41.6 mt-10 -95.68 116.76 29.34 Favored 'General case' 0 C--N 1.32 -0.702 0 O-C-N 121.453 -0.78 . . . . 0.0 111.172 176.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -85.35 98.26 10.44 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.392 0.615 . . . . 0.0 110.791 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.8 m -89.02 117.04 27.75 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.325 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 80' ' ' HIS . 44.2 mt-10 -95.95 126.15 40.99 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 177.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.613 ' O ' ' HA ' ' A' ' 79' ' ' ASN . 70.9 mt -104.5 146.72 28.47 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.579 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.59 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 28.5 t -86.05 167.34 15.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.66 -175.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.8 p -49.06 -35.69 16.48 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -175.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -53.8 -40.58 66.47 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.903 0.382 . . . . 0.0 111.536 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -80.53 -35.28 34.71 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.291 0.567 . . . . 0.0 109.798 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 94' ' ' SER . 13.3 mt -67.35 -30.37 70.16 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.137 -172.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -63.04 -43.65 98.09 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.949 0.404 . . . . 0.0 110.666 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -65.84 -36.4 83.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.897 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.49 ' O ' HD13 ' A' ' 105' ' ' LEU . 51.1 mt-10 -62.39 -41.31 98.56 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.508 173.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 73.5 mt -63.74 -20.77 66.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.931 0.396 . . . . 0.0 110.617 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -72.02 -50.14 31.05 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 173.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -138.64 116.02 11.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.071 176.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.49 HD13 ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -164.15 150.69 11.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.898 0.38 . . . . 0.0 110.646 178.003 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -145.83 134.96 22.77 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 172.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -64.79 123.42 19.33 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.909 -177.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 101.57 -6.1 54.99 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.565 -178.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 50.4 ttm -69.7 133.45 47.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.806 0.336 . . . . 0.0 110.65 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -95.33 101.86 13.62 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.09 0.471 . . . . 0.0 110.376 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 32.8 m -100.56 166.82 2.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.567 -177.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -108.57 109.18 20.34 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 46.5 mt -89.81 123.75 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-O 121.233 0.54 . . . . 0.0 109.633 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.455 ' HG2' HD11 ' A' ' 121' ' ' ILE . 31.2 tt0 -96.42 107.67 20.09 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.74 -174.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 40.9 p -109.19 159.06 17.23 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 121.44 0.638 . . . . 0.0 111.771 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -137.58 106.31 5.9 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 60.88 32.26 20.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.865 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 98.82 -18.33 57.01 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.052 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -88.36 134.82 33.72 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 122.798 -0.236 . . . . 0.0 110.927 -176.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.0 p -77.93 108.68 11.36 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.733 0.301 . . . . 0.0 110.36 175.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.455 HD11 ' HG2' ' A' ' 114' ' ' GLN . 36.0 pt -92.02 -27.11 4.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.839 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -169.59 167.74 40.75 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.672 177.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 55.7 t -125.35 121.22 59.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -102.78 112.17 24.83 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.015 0.436 . . . . 0.0 110.508 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 66.0 mt -78.7 152.65 77.94 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 175.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.51 144.23 52.34 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.363 2.042 . . . . 0.0 110.635 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.711 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 14.3 mmmm -64.82 -22.35 66.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.705 -173.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 26.3 p -125.55 113.43 17.42 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.862 0.363 . . . . 0.0 111.334 176.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 9.6 p -114.84 140.44 35.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.614 175.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -112.8 124.52 52.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.553 0.692 . . . . 0.0 111.352 177.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 95.7 mt -129.27 145.63 51.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.911 -175.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.3 m -85.52 132.71 34.15 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.128 176.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.8 p -85.81 108.84 17.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.815 0.817 . . . . 0.0 110.769 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.671 ' O ' ' HB ' ' A' ' 153' ' ' THR . 26.9 p -116.48 124.59 50.32 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.621 178.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.539 ' HB2' ' O ' ' A' ' 134' ' ' THR . 1.5 mp0 77.36 86.61 0.08 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.904 0.859 . . . . 0.0 111.18 -176.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.448 ' O ' ' HD3' ' A' ' 138' ' ' PRO . 14.4 t -148.7 156.27 42.14 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 173.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -81.2 109.6 14.57 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -175.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 136' ' ' THR . 98.2 Cg_endo -89.08 166.7 5.62 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.947 2.431 . . . . 0.0 112.944 -176.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.31 -1.3 88.6 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.036 -0.602 . . . . 0.0 113.081 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.402 HD11 ' HD3' ' A' ' 150' ' ' LYS . 58.1 mt -78.4 100.69 3.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.315 0.579 . . . . 0.0 110.564 -177.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -75.51 -33.26 60.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.515 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 118.51 -14.16 11.92 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.148 -176.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -66.36 122.54 17.75 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 54.0 p 51.17 36.16 15.05 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 123.807 0.692 . . . . 0.0 111.242 -174.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -165.78 34.01 0.05 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.435 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.4 m -75.93 80.16 2.81 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.236 -174.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -102.85 165.8 16.43 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 175.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.55 -46.61 82.1 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.959 0.379 . . . . 0.0 110.915 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.5 p -146.75 176.05 10.15 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.285 0.564 . . . . 0.0 111.073 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.402 ' HD3' HD11 ' A' ' 140' ' ' ILE . 37.4 ttpt -127.64 136.28 51.41 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.626 -178.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 35.9 p -72.76 120.19 18.04 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.074 0.464 . . . . 0.0 110.404 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 159' ' ' THR . . . -125.13 160.48 29.02 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.159 -178.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.671 ' HB ' ' O ' ' A' ' 134' ' ' THR . 1.6 m -111.45 136.58 50.41 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.4 m -102.48 177.73 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.175 174.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -55.63 -29.27 58.92 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 80.3 p -75.93 -9.41 58.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.022 0.439 . . . . 0.0 111.529 -177.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 87.56 7.59 75.32 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.091 -0.576 . . . . 0.0 111.898 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -86.14 141.26 29.5 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.666 0.269 . . . . 0.0 110.943 -177.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 152' ' ' ALA . 17.9 m -95.57 115.43 27.42 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.158 176.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.33 161.9 32.39 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -94.52 113.28 25.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.531 0.681 . . . . 0.0 111.54 -174.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 27.3 m -108.59 150.5 40.79 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.971 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.21 150.76 47.12 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.295 1.997 . . . . 0.0 111.481 174.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 54.5 mt -58.28 -23.19 55.42 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -168.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -85.54 -9.36 57.5 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -174.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 94.6 t -70.5 136.18 26.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -122.91 163.45 20.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.868 0.366 . . . . 0.0 110.141 -174.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -60.67 128.05 34.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.733 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 109.43 -16.91 31.59 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.55 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.85 138.74 58.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.952 0.406 . . . . 0.0 111.404 178.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 61.1 t -97.72 104.02 15.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 172.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 184' ' ' ARG . 0.7 OUTLIER -100.31 143.08 30.91 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.71 -176.427 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.505 ' O ' ' HB ' ' A' ' 182' ' ' ILE . 60.7 mt -99.32 136.97 28.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.649 177.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 61.7 mt -127.18 138.21 55.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.711 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 26.6 t-20 -81.0 91.98 6.14 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.011 176.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.9 118.78 18.24 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.115 0.484 . . . . 0.0 110.62 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 129.43 -48.28 0.98 Allowed Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -175.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.421 ' HB2' ' OD1' ' A' ' 175' ' ' ASN . 17.1 m-20 -106.28 -24.92 12.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.03 0.443 . . . . 0.0 110.098 177.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 86.92 15.12 63.57 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.434 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 6.0 m -72.27 127.05 31.36 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -79.42 122.84 26.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.16 0.505 . . . . 0.0 110.386 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.505 ' HB ' ' O ' ' A' ' 173' ' ' ILE . 9.8 mm -100.41 155.2 4.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 14.7 p -75.68 166.8 23.01 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.59 0.709 . . . . 0.0 111.703 -169.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . 0.445 ' HA ' ' HA ' ' A' ' 172' ' ' LEU . 23.6 ptt180 -85.45 159.37 19.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.549 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.548 -1.14 . . . . 0.0 111.71 175.61 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.415 ' SD ' ' HD3' ' A' ' 59' ' ' LYS . 66.8 mtt . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 120.733 0.301 . . . . 0.0 110.317 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.1 mp -99.41 135.24 35.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.964 0.412 . . . . 0.0 110.136 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.2 m -99.95 156.63 17.04 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.6 m -68.77 -8.66 10.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -170.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -93.48 12.08 26.3 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.648 0.261 . . . . 0.0 110.64 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -140.5 89.36 2.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.282 0.563 . . . . 0.0 111.447 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -122.33 148.55 44.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.531 175.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.429 ' HG3' ' N ' ' A' ' 9' ' ' THR . 20.6 tptm -114.88 161.5 18.16 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.284 -176.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.429 ' N ' ' HG3' ' A' ' 8' ' ' LYS . 8.4 m -49.42 -31.93 10.7 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.2 0.524 . . . . 0.0 111.06 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.542 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -143.38 116.83 1.03 Allowed Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 170.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 66.9 tp -142.07 137.42 31.02 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 2.5 m -100.96 118.97 38.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.011 0.434 . . . . 0.0 110.823 -177.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.8 mp -120.01 137.5 53.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.424 -177.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.6 p -98.48 100.13 11.36 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.7 p -146.81 152.13 13.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.59 -175.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.2 t70 63.9 27.29 14.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.34 0.591 . . . . 0.0 109.682 178.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 63.75 30.53 14.64 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.401 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.94 167.18 24.63 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.095 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 15.5 pt -109.68 123.52 65.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.078 0.466 . . . . 0.0 110.156 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.495 ' O ' ' HA ' ' A' ' 12' ' ' THR . 34.2 m95 -121.16 160.36 23.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.411 -172.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -129.34 107.96 9.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.567 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.542 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 82.7 t -59.95 118.39 3.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.124 0.488 . . . . 0.0 111.009 179.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.1 mm -93.31 -41.89 12.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.758 175.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -158.25 121.56 3.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.21 -177.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -108.58 139.06 43.88 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.044 0.45 . . . . 0.0 111.571 -173.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -116.41 99.89 7.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.442 176.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 -71.75 96.47 1.62 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 175.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.9 p -99.37 134.3 39.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.448 0.642 . . . . 0.0 111.25 -172.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -116.72 87.46 21.64 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.506 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -65.28 -46.72 5.34 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.635 2.223 . . . . 0.0 112.596 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.56 26.79 3.01 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 121.126 -0.559 . . . . 0.0 111.902 -176.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -97.13 10.32 39.7 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.821 0.343 . . . . 0.0 111.104 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.22 -42.32 1.99 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.995 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.413 ' HB3' ' HB3' ' A' ' 56' ' ' ALA . 70.6 m -115.51 138.53 50.94 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 175.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.68 162.6 22.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.058 0.456 . . . . 0.0 110.75 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -132.04 164.9 25.2 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.342 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.4 t -132.33 102.64 5.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 120.956 0.408 . . . . 0.0 110.34 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -79.19 99.03 6.83 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.2 m -106.53 131.15 54.03 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.535 -173.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.9 mttp -84.34 105.4 15.15 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 171.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.43 ' H ' HD22 ' A' ' 41' ' ' LEU . 0.6 OUTLIER -127.97 138.27 52.55 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.718 0.771 . . . . 0.0 110.813 -172.454 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.9 ttt180 -96.97 128.27 43.77 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.989 -177.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -60.84 113.74 2.67 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 172.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.431 HD21 ' OE1' ' A' ' 114' ' ' GLN . 8.9 tt -66.96 -24.11 66.02 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.656 -170.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -85.99 -45.88 11.05 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.691 -177.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 75.1 p -93.81 -21.71 19.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.067 0.461 . . . . 0.0 111.893 -174.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.7 12.27 75.33 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.177 -176.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.91 131.58 38.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.98 0.419 . . . . 0.0 111.685 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.6 mm -89.49 110.93 22.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.606 177.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.451 ' HG2' ' H ' ' A' ' 51' ' ' GLU . 32.7 tt0 -131.79 174.62 9.95 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -177.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.451 ' H ' ' HG2' ' A' ' 50' ' ' GLN . 9.8 pt-20 -137.72 131.83 31.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.178 0.513 . . . . 0.0 110.623 173.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.0 mttp -124.28 154.02 40.86 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.53 -177.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 48.9 m -106.84 112.76 25.87 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.825 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -83.6 151.13 25.5 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 175.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.4 ptp85 -122.91 129.76 52.0 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.354 -171.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.413 ' HB3' ' HB3' ' A' ' 34' ' ' SER . . . -63.53 130.77 45.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.304 177.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.59 -18.4 29.8 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -176.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -104.13 131.56 51.28 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.415 ' HD3' ' SD ' ' A' ' 1' ' ' MET . 18.0 ptpt -77.2 140.05 40.04 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.512 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 65.5 t -98.45 117.02 42.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.208 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -90.19 121.8 68.25 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.388 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.64 151.4 36.66 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.45 2.1 . . . . 0.0 112.403 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -101.81 125.99 48.59 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.131 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 15.8 ptp -85.15 109.58 18.39 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.227 0.537 . . . . 0.0 111.037 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.34 125.23 60.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.038 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -121.82 121.68 37.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.885 0.374 . . . . 0.0 110.468 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -99.63 133.24 44.26 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.487 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -129.91 170.15 14.3 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.431 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 0.0 OUTLIER -129.96 127.93 41.04 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.859 0.361 . . . . 0.0 110.285 177.333 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.604 ' CB ' ' HB3' ' A' ' 82' ' ' PHE . 1.6 mpt? -118.52 147.6 43.5 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.678 -176.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -85.17 142.42 29.48 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 172.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -75.46 109.66 9.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.071 -175.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -103.81 -176.63 3.14 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 167.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -145.67 151.81 38.63 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 119.828 -0.749 . . . . 0.0 112.405 -174.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.7 -163.34 1.75 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.595 177.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -68.28 139.19 55.94 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 175.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.88 70.77 2.68 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 119.174 -1.489 . . . . 0.0 113.673 -168.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -125.62 -31.22 2.99 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 159.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.575 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 27.3 m-80 -141.25 135.11 30.35 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 113.83 -1.532 . . . . 0.0 109.209 175.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.547 ' CG ' HD22 ' A' ' 98' ' ' LEU . 64.2 m170 -104.83 145.88 29.77 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 176.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 40.9 t -91.87 127.32 44.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.733 -176.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.604 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 55.0 m-85 -125.16 126.33 45.1 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.659 0.266 . . . . 0.0 110.417 177.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 50.1 ttm -89.92 112.44 23.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.668 -176.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.575 ' HA ' ' HG3' ' A' ' 70' ' ' MET . 16.0 t0 -70.69 119.19 14.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.024 -176.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -75.42 -16.3 60.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.6 178.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -69.5 -54.01 16.34 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.8 p -167.35 91.87 0.39 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 171.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 48.44 28.5 1.71 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 158.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.429 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 47.2 mt-10 -103.51 120.5 40.98 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 118.661 0.664 . . . . 0.0 111.764 178.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -83.69 89.22 7.11 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 173.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.0 m -77.24 116.26 17.72 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.239 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -90.87 118.85 30.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.228 0.537 . . . . 0.0 110.014 177.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' A' ' 79' ' ' ASN . 57.3 mt -93.61 136.29 34.04 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.852 -177.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.507 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 2.2 m -77.7 172.02 14.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.842 -175.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.9 m -50.97 -40.61 58.17 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -175.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -56.14 -40.16 73.38 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.018 0.437 . . . . 0.0 111.775 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.439 ' HB2' ' HB3' ' A' ' 93' ' ' LEU . 45.4 m-85 -77.71 -32.91 53.2 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.818 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.615 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 14.3 mt -64.25 -30.36 71.41 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.473 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -56.8 -46.41 81.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.428 176.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -62.47 -43.71 98.15 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.061 177.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.536 ' O ' HD11 ' A' ' 105' ' ' LEU . 46.4 mt-10 -60.67 -34.16 73.91 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.015 177.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 55.2 mt -68.58 -6.16 23.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.902 0.382 . . . . 0.0 111.277 -178.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -90.7 -50.02 6.14 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 168.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -136.26 116.79 13.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.312 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.536 HD11 ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -163.65 138.98 6.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.977 0.417 . . . . 0.0 110.837 176.615 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -146.46 147.76 31.55 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 173.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -63.98 130.7 45.11 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.529 0.204 . . . . 0.0 110.537 -176.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.94 -0.6 87.78 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.811 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 56.5 ttp -72.73 142.71 48.17 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.739 -0.271 . . . . 0.0 110.294 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -100.21 119.06 37.78 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.874 0.368 . . . . 0.0 110.448 -177.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 21.1 m -111.88 165.2 7.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.488 -178.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -108.03 105.05 14.63 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 178.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 53.7 mt -92.13 126.68 44.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.181 0.515 . . . . 0.0 109.847 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.431 ' OE1' HD21 ' A' ' 44' ' ' LEU . 24.9 tt0 -99.45 119.13 37.49 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.675 -175.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 64.5 p -116.47 153.54 31.94 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.19 0.519 . . . . 0.0 111.984 -174.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.403 ' HB2' HD11 ' A' ' 121' ' ' ILE . 38.7 t80 -129.67 101.24 5.82 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.276 -0.875 . . . . 0.0 108.962 176.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 61.73 26.93 16.45 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.691 0.758 . . . . 0.0 110.254 -178.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 104.52 -25.8 24.68 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.559 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -79.1 127.45 32.03 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -177.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 43.9 p -69.82 114.16 7.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.761 0.315 . . . . 0.0 110.432 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.403 HD11 ' HB2' ' A' ' 116' ' ' TYR . 22.4 pt -100.52 -26.32 3.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.454 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -164.32 162.43 35.32 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.151 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 86.3 t -135.01 124.48 43.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.921 0.391 . . . . 0.0 110.207 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -106.6 123.57 48.31 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.948 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.404 ' N ' HD21 ' A' ' 125' ' ' LEU . 2.9 mm? -78.69 156.0 78.0 Favored Pre-proline 0 C--N 1.32 -0.675 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 174.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.408 ' HD3' HG13 ' A' ' 111' ' ' VAL . 47.6 Cg_exo -56.1 123.98 15.16 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.423 2.082 . . . . 0.0 111.446 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.58 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 12.8 mptt -54.85 -34.69 63.18 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.22 -176.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 36.3 p -117.45 108.71 15.87 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 171.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.6 p -122.41 135.85 61.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.432 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -96.48 105.8 17.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.463 0.649 . . . . 0.0 111.116 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 58.0 mt -114.3 129.1 56.63 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.981 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.2 m -75.29 130.88 39.82 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.143 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 170' ' ' ASP . 4.2 p -78.32 105.84 8.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.705 0.764 . . . . 0.0 110.618 178.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.424 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 13.8 p -110.81 123.49 50.19 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.17 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 134' ' ' THR . 42.1 mt-10 76.05 97.3 0.07 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.889 0.852 . . . . 0.0 111.422 -177.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 10.3 t -150.34 155.96 40.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.954 174.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.459 ' O ' ' HD3' ' A' ' 150' ' ' LYS . 25.2 mm-40 -80.96 153.72 72.56 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.123 -170.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -68.86 172.11 12.3 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.531 2.154 . . . . 0.0 111.485 174.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 119.44 32.29 1.26 Allowed Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.961 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 24.2 pt -65.16 143.12 16.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 176.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -144.39 121.44 11.42 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.814 0.34 . . . . 0.0 110.922 -174.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 82.87 -18.98 12.98 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.996 -0.547 . . . . 0.0 113.417 174.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 67.39 -67.99 0.16 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.415 0.686 . . . . 0.0 111.323 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.0 t -84.01 -23.14 31.09 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.962 0.41 . . . . 0.0 110.21 177.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.43 111.71 2.43 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.286 -177.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.9 m -95.21 85.24 4.24 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.407 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.01 140.54 8.69 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.822 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 68.06 153.17 0.09 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.348 0.659 . . . . 0.0 111.526 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.4 p -121.31 163.81 18.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.898 0.856 . . . . 0.0 112.666 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.459 ' HD3' ' O ' ' A' ' 137' ' ' GLU . 26.0 ttmt -137.29 143.07 41.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.007 -1.452 . . . . 0.0 108.987 -174.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 25.0 m -73.77 120.72 19.75 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.103 0.477 . . . . 0.0 110.311 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -129.39 162.53 27.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.137 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 21.3 m -127.35 143.82 51.16 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.476 174.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 15.7 m -103.56 173.55 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.786 0.327 . . . . 0.0 110.717 176.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -62.74 -12.54 24.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.65 -174.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.446 HG22 ' O ' ' A' ' 105' ' ' LEU . 68.6 p -87.76 -13.49 42.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.789 0.328 . . . . 0.0 111.469 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 94.49 3.12 63.09 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.763 -174.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -78.14 141.54 38.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.846 0.355 . . . . 0.0 110.416 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 25.0 m -106.61 133.18 51.68 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.381 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -148.68 165.07 32.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.636 0.255 . . . . 0.0 110.48 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -105.53 108.51 20.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.322 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 27.8 m -102.93 157.39 33.83 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.648 -176.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.402 ' HD3' ' CE2' ' A' ' 181' ' ' TYR . 25.5 Cg_exo -62.77 150.52 87.86 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 121.965 1.777 . . . . 0.0 110.828 175.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 52.1 mt -55.78 -24.78 37.7 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -169.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -79.24 -13.32 59.76 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -174.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 91.5 t -68.51 129.8 33.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.123 0.487 . . . . 0.0 110.647 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -121.52 155.01 35.89 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.514 -175.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -57.68 121.39 10.29 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.665 -178.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 114.16 -17.41 19.48 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.496 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.573 ' OD2' ' HD3' ' A' ' 184' ' ' ARG . 22.0 t70 -65.41 144.38 57.1 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 177.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 48.5 t -93.24 108.53 20.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.13 0.49 . . . . 0.0 110.294 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 76.2 mt -92.54 117.92 30.46 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.379 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.401 ' N ' HD13 ' A' ' 173' ' ' ILE . 1.9 mp -90.48 101.97 12.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 175.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 31.9 mm -89.73 124.06 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.421 -175.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.58 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 49.4 t30 -86.44 89.44 7.89 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 174.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.409 HG21 ' HA ' ' A' ' 127' ' ' LYS . 8.9 t -66.74 152.06 46.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.938 0.399 . . . . 0.0 110.463 -176.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 93.42 -45.98 2.38 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.4 -176.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -98.92 -27.73 13.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.107 0.479 . . . . 0.0 110.456 177.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.39 24.06 55.07 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.377 176.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.454 ' HB2' ' HB3' ' A' ' 175' ' ' ASN . 1.3 m -81.76 99.42 8.96 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.402 ' CE2' ' HD3' ' A' ' 163' ' ' PRO . 24.8 p90 -77.17 108.26 10.13 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.15 0.5 . . . . 0.0 110.827 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 36.9 mm -96.37 140.95 16.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 44.6 t -120.73 167.92 11.96 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 110.465 -0.198 . . . . 0.0 110.465 -176.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . 0.573 ' HD3' ' OD2' ' A' ' 170' ' ' ASP . 25.8 mmt180 72.03 16.84 5.29 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.278 0.631 . . . . 0.0 112.538 173.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.031 0 CA-C-O 118.749 -1.028 . . . . 0.0 112.721 179.814 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 120.452 0.167 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.6 mm -94.74 143.82 11.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.2 m -104.8 157.67 17.04 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.7 m -66.25 -4.24 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.013 -175.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -76.82 -24.5 52.77 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.841 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -112.72 107.51 16.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.306 0.574 . . . . 0.0 111.774 -175.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -140.69 145.85 37.06 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 171.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.2 mtmm -131.11 175.1 9.38 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.231 -174.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 19.6 m -61.78 -22.1 65.13 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.57 0.7 . . . . 0.0 110.237 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -144.91 114.77 0.8 Allowed Glycine 0 N--CA 1.434 -1.495 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 167.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.4 tp -150.36 122.73 8.43 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 175.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 2.1 p -87.03 122.95 31.58 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.461 0.648 . . . . 0.0 111.93 -175.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.7 mm -119.22 141.08 40.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.539 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 43.0 p -107.69 103.82 13.19 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 176.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.3 p -143.9 148.38 18.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 63.75 24.13 13.72 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.206 -175.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 61.95 28.04 17.05 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.193 -176.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.15 164.09 27.08 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.771 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.6 pt -108.52 126.95 65.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.635 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.492 ' CZ3' ' HB2' ' A' ' 43' ' ' ASN . 11.5 m95 -128.36 166.27 18.99 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.719 -174.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -132.63 108.21 8.91 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.767 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 85.6 t -63.91 115.57 2.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.283 177.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' A' ' 9' ' ' THR . 77.1 mt -95.88 -38.9 8.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.584 176.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -140.18 153.73 46.71 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.08 178.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 39' ' ' SER . 16.7 p90 -146.8 128.51 15.23 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.828 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -100.9 99.04 9.48 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.038 177.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -78.14 94.33 4.7 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 175.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.2 p -104.86 126.58 59.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.116 -173.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -117.47 103.86 50.55 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.441 -178.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -57.5 -47.35 22.15 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 123.239 2.626 . . . . 0.0 112.671 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 112.7 5.03 24.41 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.588 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -81.53 -14.46 56.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.097 -0.552 . . . . 0.0 110.812 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.42 -15.1 8.14 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.518 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.4 p -134.41 145.94 49.38 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.418 -0.391 . . . . 0.0 110.097 177.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -125.72 168.31 13.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.692 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -143.8 163.51 33.14 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.516 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.9 t -121.32 105.12 16.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.027 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -81.86 99.37 9.0 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 175.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 25' ' ' PHE . 60.7 p -103.07 146.94 27.61 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.135 0.493 . . . . 0.0 112.099 -171.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -103.2 110.04 21.86 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 174.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.47 HD23 ' H ' ' A' ' 41' ' ' LEU . 0.9 OUTLIER -135.43 144.27 46.39 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.517 0.675 . . . . 0.0 111.778 -171.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 35.8 ttt180 -99.84 127.71 45.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.535 -175.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.492 ' HB2' ' CZ3' ' A' ' 20' ' ' TRP . 53.8 t-20 -71.78 119.8 16.46 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 173.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.8 mp -66.03 -24.6 66.78 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.935 0.397 . . . . 0.0 111.169 -176.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -80.21 -42.88 22.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.67 -176.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.6 p -97.63 -22.3 16.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.203 0.525 . . . . 0.0 111.517 -176.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.31 17.71 79.04 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.662 -176.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 42' ' ' ARG . . . -92.15 143.67 26.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.97 0.414 . . . . 0.0 111.984 -174.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 44.4 mm -92.2 100.99 12.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.774 175.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.444 ' HG2' ' H ' ' A' ' 51' ' ' GLU . 29.6 tt0 -113.56 173.42 6.42 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.444 ' H ' ' HG2' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -122.03 146.91 46.72 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.117 0.484 . . . . 0.0 110.963 173.356 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -134.3 132.11 39.19 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.597 -177.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.2 m -100.24 103.88 15.34 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.065 0.46 . . . . 0.0 111.136 -177.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -87.34 141.45 28.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.892 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 49.7 mtp180 -115.62 133.75 55.72 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.721 0.296 . . . . 0.0 110.784 -176.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.41 133.32 55.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.771 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 107.42 -31.03 8.45 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -176.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -90.19 141.88 28.26 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 177.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -81.53 137.85 35.51 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.285 0.564 . . . . 0.0 111.305 -176.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.5 t -100.14 112.74 33.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.429 176.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -93.61 120.56 66.13 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-O 120.918 0.39 . . . . 0.0 110.787 -177.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -77.33 157.58 33.18 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 123.003 2.469 . . . . 0.0 112.9 -175.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -106.01 115.85 30.93 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.153 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -73.77 108.13 6.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.352 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.452 HG13 HG23 ' A' ' 12' ' ' THR . 37.4 mm -103.41 129.97 54.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.068 0.461 . . . . 0.0 110.453 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.425 ' HB2' ' OG1' ' A' ' 115' ' ' THR . 21.0 mt-10 -109.77 146.45 34.95 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.354 -177.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -136.89 113.93 10.59 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.891 0.377 . . . . 0.0 110.647 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.441 ' HG2' ' HG3' ' A' ' 86' ' ' GLU . 79.1 mtm180 -123.0 156.76 34.14 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.474 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 8.5 ptm180 -114.77 124.59 52.15 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.104 -178.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.617 ' CB ' ' HB3' ' A' ' 82' ' ' PHE . 1.9 mpt? -116.27 142.63 46.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.408 -178.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -82.07 134.78 35.37 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.09 175.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.572 ' CD1' ' HA ' ' A' ' 107' ' ' GLU . 42.8 t80 -71.84 115.67 11.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.317 -173.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 55.8 mt -115.33 -176.47 2.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.781 168.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -146.75 154.63 41.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.178 0.514 . . . . 0.0 111.473 -177.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -140.21 -149.43 0.28 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.229 -0.896 . . . . 0.0 108.584 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -69.46 132.3 46.1 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 171.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -75.86 69.29 2.15 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.104 -1.522 . . . . 0.0 113.719 -167.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -127.19 -29.96 2.71 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 156.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.533 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 19.4 m120 -133.94 142.02 47.54 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.803 178.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.574 ' ND1' ' HG ' ' A' ' 98' ' ' LEU . 53.2 m80 -119.86 144.34 47.42 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.418 177.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 61.1 t -88.69 136.35 23.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.837 -176.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.617 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 63.5 m-85 -131.02 125.62 33.77 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.457 ' O ' ' HA ' ' A' ' 70' ' ' MET . 72.5 mtm -95.86 114.62 26.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.717 0.294 . . . . 0.0 111.533 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.529 ' HA ' ' HG3' ' A' ' 70' ' ' MET . 19.2 t70 -61.97 116.37 4.84 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.77 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -70.52 -20.29 62.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.022 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.456 ' HB2' ' OD2' ' A' ' 84' ' ' ASP . 11.3 mm-40 -64.08 -51.15 65.45 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.477 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 5.0 p -171.15 91.74 0.15 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 168.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 47.99 29.86 1.84 Allowed 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 159.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 87' ' ' SER . 47.2 mt-10 -100.06 117.83 35.14 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 121.768 -0.582 . . . . 0.0 110.937 177.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -84.07 113.86 21.34 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.347 0.594 . . . . 0.0 110.534 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 56.5 m -110.15 128.14 55.3 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.966 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -102.25 141.5 34.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.047 0.451 . . . . 0.0 110.267 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 79' ' ' ASN . 57.3 mt -118.64 144.21 46.31 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.469 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.9 t -83.52 173.24 11.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.583 -174.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.7 t -56.18 -44.24 79.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.935 -173.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.52 -37.22 86.79 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.738 0.304 . . . . 0.0 111.687 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.571 ' O ' ' HG2' ' A' ' 101' ' ' GLU . 97.1 m-85 -67.03 -40.04 87.12 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.574 ' HG ' ' ND1' ' A' ' 80' ' ' HIS . 3.7 mm? -74.6 -11.07 60.1 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.09 178.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -63.75 -44.32 93.84 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.834 0.349 . . . . 0.0 110.589 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.54 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 14.3 tp10 -74.34 -37.0 63.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.122 0.487 . . . . 0.0 109.781 175.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.571 ' HG2' ' O ' ' A' ' 97' ' ' TYR . 9.1 mm-40 -59.38 -43.46 92.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.983 176.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.555 ' O ' ' HB ' ' A' ' 156' ' ' THR . 85.9 mt -71.85 -2.43 17.77 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.006 0.431 . . . . 0.0 111.051 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.54 ' HB3' ' O ' ' A' ' 100' ' ' GLU . 29.3 t30 -80.73 -48.3 12.73 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 171.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.48 ' HB3' HG12 ' A' ' 129' ' ' VAL . 85.5 m-85 -146.99 117.19 7.33 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.523 174.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.483 HD22 ' O ' ' A' ' 101' ' ' GLU . 0.9 OUTLIER -172.94 169.18 4.8 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.588 0.232 . . . . 0.0 110.562 178.476 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.515 ' HD3' ' O ' ' A' ' 130' ' ' GLU . 30.6 mmmt -143.2 149.14 37.57 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 173.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.572 ' HA ' ' CD1' ' A' ' 72' ' ' TYR . 40.4 tt0 -69.57 130.91 43.73 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.071 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.46 -2.29 80.48 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.397 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 58.3 ttm -74.79 140.77 44.24 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -103.19 102.71 12.7 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.121 0.486 . . . . 0.0 110.073 -177.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 19.5 m -99.49 162.8 2.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.152 -174.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.521 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 57.9 mt-30 -104.55 100.36 10.03 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.989 0.423 . . . . 0.0 110.688 -178.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 59.3 mt -74.78 128.18 36.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.94 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.489 ' O ' HG13 ' A' ' 121' ' ' ILE . 7.8 tt0 -105.83 113.91 27.75 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.987 -175.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.425 ' OG1' ' HB2' ' A' ' 66' ' ' GLU . 74.1 p -114.85 155.3 27.06 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.23 -176.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -118.91 99.21 6.6 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 172.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 61.42 41.8 12.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.82 0.819 . . . . 0.0 109.639 -176.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.32 -19.83 37.35 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.506 -0.77 . . . . 0.0 113.192 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -82.02 116.44 21.63 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 24.2 m -65.28 106.01 1.25 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -176.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 114' ' ' GLN . 2.4 pp -100.18 -23.42 4.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.788 -177.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -170.41 175.53 44.28 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.17 -1.014 . . . . 0.0 112.727 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.2 t -135.43 129.76 49.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.849 0.357 . . . . 0.0 110.093 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.521 ' HB2' ' HB2' ' A' ' 112' ' ' GLN . 5.9 mm-40 -98.4 109.69 22.4 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.773 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 77.3 mt -80.6 135.19 53.16 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.784 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.42 131.25 44.63 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.621 2.214 . . . . 0.0 110.641 170.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.585 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 0.7 OUTLIER -60.74 -35.09 75.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.731 -167.036 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 18.0 p -96.76 110.53 22.98 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.029 0.442 . . . . 0.0 111.426 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.48 HG12 ' HB3' ' A' ' 104' ' ' TYR . 6.9 p -129.92 135.67 60.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.285 177.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.515 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 6.7 pt-20 -109.65 121.25 44.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.168 0.509 . . . . 0.0 111.352 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 77.9 mt -122.2 130.28 53.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.294 -178.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.1 m -75.1 134.36 41.34 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.172 178.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.441 HG11 ' O ' ' A' ' 170' ' ' ASP . 4.1 p -83.54 100.23 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-O 121.952 0.882 . . . . 0.0 110.702 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 29.8 p -90.88 103.27 16.0 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.466 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.466 ' HA ' ' OE2' ' A' ' 168' ' ' GLU . 44.1 mt-10 77.77 111.49 0.07 Allowed 'General case' 0 C--O 1.238 0.45 0 O-C-N 124.149 0.906 . . . . 0.0 111.998 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.0 t -150.39 152.81 34.94 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.542 -1.208 . . . . 0.0 108.579 174.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.421 ' O ' ' HD2' ' A' ' 150' ' ' LYS . 4.6 mp0 -82.99 123.5 77.61 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 120.762 0.315 . . . . 0.0 110.448 -176.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -82.38 -179.9 4.97 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.824 2.349 . . . . 0.0 112.114 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 119.45 32.98 1.16 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.22 -0.99 . . . . 0.0 113.162 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.482 HG12 ' H ' ' A' ' 142' ' ' GLY . 12.2 tt -51.48 127.3 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-O 121.401 0.62 . . . . 0.0 111.049 178.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -74.28 -10.79 59.94 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.99 -172.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.482 ' H ' HG12 ' A' ' 140' ' ' ILE . . . 82.14 -30.7 2.95 Favored Glycine 0 C--O 1.231 -0.08 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.216 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -63.85 149.03 47.91 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 122.654 0.382 . . . . 0.0 110.404 176.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 4.0 t -67.75 87.0 0.22 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.912 0.863 . . . . 0.0 110.868 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -117.66 57.62 0.81 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.586 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.8 p -73.36 -9.95 59.23 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.39 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -98.74 -1.72 57.46 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.871 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -108.65 158.84 17.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.658 0.266 . . . . 0.0 110.387 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.4 p -140.26 173.67 11.28 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.147 0.499 . . . . 0.0 111.451 -177.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.421 ' HD2' ' O ' ' A' ' 137' ' ' GLU . 63.3 pttt -138.39 158.42 44.32 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.218 175.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.3 p -73.22 132.39 43.13 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.328 0.585 . . . . 0.0 111.751 -178.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.13 163.38 32.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.599 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 26.0 m -132.01 131.37 42.45 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 174.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.7 m -93.45 175.11 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -59.27 -25.94 64.52 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -176.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.555 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 47.1 p -72.5 -16.74 61.79 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.765 0.317 . . . . 0.0 111.563 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.22 1.81 59.32 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.593 -176.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -84.73 138.22 32.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.488 -0.356 . . . . 0.0 110.661 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 14.8 t -97.23 136.05 38.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.974 176.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -148.65 164.35 34.57 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -176.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -102.23 111.77 24.18 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.204 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 33.9 m -106.47 147.25 34.59 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.96 -176.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.7 154.97 39.73 Favored 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 122.712 2.275 . . . . 0.0 111.679 176.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -67.07 -15.14 63.54 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -168.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.419 ' HA ' HD11 ' A' ' 140' ' ' ILE . 22.1 p90 -80.98 -11.11 59.62 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.861 0.362 . . . . 0.0 111.346 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 92.8 t -76.15 134.07 29.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.147 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -120.14 165.73 14.37 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.466 ' OE2' ' HA ' ' A' ' 135' ' ' GLU . 28.5 tt0 -61.42 152.27 30.24 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.595 -176.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 65.68 6.83 31.63 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 114.354 0.501 . . . . 0.0 114.354 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.441 ' O ' HG11 ' A' ' 133' ' ' VAL . 11.2 m-20 -77.7 147.83 35.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.653 0.727 . . . . 0.0 110.137 171.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 62.3 t -94.48 110.45 23.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.068 0.461 . . . . 0.0 109.898 177.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 67.7 mt -94.08 123.61 37.57 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.73 -176.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.52 ' O ' ' HB ' ' A' ' 182' ' ' ILE . 54.4 mt -90.73 128.38 42.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 174.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 37.1 mm -125.11 139.87 49.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -178.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.585 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 26.3 t-20 -87.32 91.69 8.81 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 174.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 11.1 t -74.07 148.29 42.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.964 0.411 . . . . 0.0 110.175 -177.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 105.65 -40.34 2.52 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 -174.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -109.8 -46.35 3.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.135 0.493 . . . . 0.0 110.001 175.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 107.01 11.15 26.75 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.671 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.423 ' HB2' ' HB3' ' A' ' 175' ' ' ASN . 6.6 m -65.11 132.31 48.84 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -83.14 126.08 32.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.253 0.549 . . . . 0.0 110.468 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.52 ' HB ' ' O ' ' A' ' 173' ' ' ILE . 14.1 mm -106.61 156.71 7.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.4 p -74.45 170.19 16.19 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.258 0.551 . . . . 0.0 111.935 -170.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -70.05 145.27 51.83 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.726 -176.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.946 0 CA-C-O 118.57 -1.128 . . . . 0.0 111.77 178.259 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.8 ttt . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 120.772 0.32 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 46.6 mm -117.64 134.65 60.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 171.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.9 m -88.3 151.14 22.83 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.433 ' O ' HG21 ' A' ' 37' ' ' VAL . 29.7 m -68.5 -1.82 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 121.004 0.43 . . . . 0.0 111.667 -178.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -97.98 0.39 46.28 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.345 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -118.95 89.12 3.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.543 -178.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -134.21 153.29 51.94 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.928 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -129.95 175.94 8.46 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.167 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.2 t -66.33 -9.56 34.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.165 0.507 . . . . 0.0 110.079 175.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.67 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -152.26 115.43 0.69 Allowed Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 110.396 -1.081 . . . . 0.0 110.396 170.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.52 133.09 19.79 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 10.5 p -98.15 123.28 42.12 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.138 0.494 . . . . 0.0 112.023 -177.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.1 mp -125.7 141.93 44.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.14 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.0 t -106.24 105.27 15.22 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 176.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.7 p -147.52 148.36 16.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -176.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 62.68 24.89 14.82 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.199 0.312 . . . . 0.0 110.62 -174.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 63.74 24.16 13.73 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.611 0.72 . . . . 0.0 110.601 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.62 158.77 37.58 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.857 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.7 pt -105.22 125.8 60.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.281 0.563 . . . . 0.0 110.295 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.54 ' O ' ' HA ' ' A' ' 12' ' ' THR . 74.2 m95 -120.84 161.19 21.94 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.448 -170.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -136.7 110.4 8.09 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.163 176.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.67 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 89.3 t -60.52 117.26 2.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.932 177.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.3 mm -92.14 -30.73 4.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.481 175.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -153.89 140.48 18.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.427 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -126.29 138.68 53.62 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.806 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -118.82 100.07 7.16 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.023 176.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -75.58 101.49 4.94 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 177.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.4 p -109.58 126.47 66.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.391 0.615 . . . . 0.0 111.609 -172.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.8 mtmt -113.91 102.73 55.08 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.438 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -55.85 -47.8 23.22 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.509 2.806 . . . . 0.0 112.788 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.8 11.54 10.14 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.137 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -102.46 3.42 37.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.128 0.49 . . . . 0.0 110.694 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.6 -43.0 1.81 Allowed Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.384 178.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.8 p -93.32 126.34 38.39 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.819 0.342 . . . . 0.0 110.296 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.54 162.03 13.26 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.08 0.467 . . . . 0.0 110.813 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -134.84 166.13 23.7 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.815 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.433 HG21 ' O ' ' A' ' 4' ' ' VAL . 49.9 t -131.83 104.09 7.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 175.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -82.3 99.06 9.12 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.3 p -110.56 135.41 51.25 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.076 0.465 . . . . 0.0 111.892 -173.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -91.39 111.94 23.65 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 172.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.441 ' H ' HD22 ' A' ' 41' ' ' LEU . 1.2 pt? -138.71 145.1 39.9 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.175 0.512 . . . . 0.0 110.935 -173.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 9.9 ptt180 -106.96 143.08 35.57 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.865 -174.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -65.23 119.89 11.73 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 171.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.437 HD22 ' OE1' ' A' ' 114' ' ' GLN . 3.9 tt -67.38 -25.57 66.03 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.208 -170.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.4 ' CZ ' HG22 ' A' ' 121' ' ' ILE . 11.9 mtp180 -83.44 -46.42 12.53 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.411 -177.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.2 p -94.97 -20.48 19.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.011 0.434 . . . . 0.0 112.151 -173.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.93 17.85 73.84 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.111 -176.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 42' ' ' ARG . . . -75.0 126.54 31.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.834 0.349 . . . . 0.0 111.803 -177.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.1 mm -87.96 108.86 18.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.107 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -129.67 162.18 28.92 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -122.99 128.06 49.67 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.471 0.653 . . . . 0.0 110.559 174.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -128.12 144.63 51.12 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.559 -176.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.2 m -110.32 118.37 36.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.907 0.384 . . . . 0.0 111.354 -175.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -85.45 155.51 21.21 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.871 176.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.49 ' H ' ' HD2' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -122.19 132.88 54.67 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.043 0.449 . . . . 0.0 111.325 -176.186 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.63 138.06 58.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.089 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 108.22 -28.66 11.4 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.401 -177.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -100.83 141.27 33.95 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 177.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.64 142.68 37.02 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.008 0.432 . . . . 0.0 110.264 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.9 t -93.88 125.84 46.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.316 174.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -89.55 113.31 56.18 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 120.917 0.389 . . . . 0.0 110.21 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.01 159.63 41.11 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.606 2.204 . . . . 0.0 112.719 -176.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.85 109.52 18.28 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.096 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 24.7 ttt -74.19 109.59 7.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.144 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 48.7 mm -96.28 116.83 39.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.835 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.46 ' HB2' ' OG1' ' A' ' 115' ' ' THR . 27.8 mt-10 -96.84 141.51 29.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.506 -176.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -123.08 123.54 41.08 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.723 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.542 ' O ' ' HA ' ' A' ' 112' ' ' GLN . 52.6 mtt180 -124.37 164.33 19.88 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 174.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 10.3 ptm85 -126.72 131.98 51.23 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 176.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.494 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 13.7 mmm -127.01 139.3 53.13 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.265 -170.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -78.44 132.36 37.27 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 175.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -75.37 106.93 7.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.137 -174.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.7 mp -97.38 176.01 6.04 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 166.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -146.95 149.91 34.13 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 119.567 -0.853 . . . . 0.0 113.047 -170.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.96 -169.76 3.47 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 113.976 -1.465 . . . . 0.0 107.211 171.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -63.79 144.14 57.28 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 175.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.3 69.68 2.93 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 118.928 -1.606 . . . . 0.0 113.731 -168.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -126.21 -27.71 3.2 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 158.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.518 HD22 ' HB3' ' A' ' 92' ' ' GLU . 26.7 t-20 -140.76 128.45 21.6 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.308 -1.315 . . . . 0.0 109.897 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.48 ' ND1' HD21 ' A' ' 98' ' ' LEU . 47.6 m170 -122.03 148.28 45.03 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.568 0.223 . . . . 0.0 110.466 175.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 41.8 t -102.24 130.48 52.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.085 -175.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.48 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 79.7 m-85 -125.43 133.49 52.45 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 40.7 mtm -105.64 119.2 38.54 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 121.073 -0.251 . . . . 0.0 110.883 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.478 ' HB3' ' H ' ' A' ' 89' ' ' GLU . 10.6 t70 -61.33 123.9 19.09 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.88 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -72.37 -20.83 61.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.833 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -66.58 -51.55 55.18 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.3 p -172.25 92.46 0.12 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 166.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 48.6 27.46 1.48 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 162.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.478 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 48.5 mt-10 -88.79 110.41 21.0 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 121.756 -0.59 . . . . 0.0 110.276 176.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -78.81 133.72 37.03 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.684 -177.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 90.6 m -131.01 120.85 24.07 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.937 174.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.518 ' HB3' HD22 ' A' ' 79' ' ' ASN . 29.1 mt-10 -99.89 127.56 46.05 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.004 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.43 HD13 ' CE1' ' A' ' 82' ' ' PHE . 52.6 mt -103.83 152.06 22.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.98 -177.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.613 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 13.8 m -96.44 170.64 9.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.316 -172.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.0 m -46.92 -38.13 10.04 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.27 0.628 . . . . 0.0 112.595 -175.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -50.34 -44.74 54.59 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.09 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -81.16 -36.92 29.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.323 0.582 . . . . 0.0 110.437 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 94' ' ' SER . 11.7 mt -64.68 -27.2 68.76 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.261 -171.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -59.87 -47.5 85.49 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.901 0.381 . . . . 0.0 110.561 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.506 ' HA ' ' ND2' ' A' ' 103' ' ' ASN . 41.9 mt-10 -70.1 -33.47 71.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.486 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.571 ' O ' HD12 ' A' ' 105' ' ' LEU . 72.7 mt-10 -59.74 -45.35 92.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.03 171.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 83.1 mt -66.55 -15.27 63.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.885 0.374 . . . . 0.0 111.068 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.506 ' ND2' ' HA ' ' A' ' 100' ' ' GLU . 77.5 m-20 -75.51 -50.55 15.34 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 172.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -145.96 117.2 7.89 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.543 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.571 HD12 ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -165.41 161.74 19.03 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.909 0.385 . . . . 0.0 110.999 176.247 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.477 ' HD3' ' O ' ' A' ' 130' ' ' GLU . 31.3 mmmt -136.0 142.61 44.51 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 172.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -68.52 130.77 43.84 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.72 0.295 . . . . 0.0 110.828 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.13 -4.9 81.43 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.289 -177.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 52.3 ttm -62.25 130.02 43.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.874 0.369 . . . . 0.0 111.121 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 70' ' ' MET . 46.3 mt-10 -95.78 101.12 12.78 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.14 0.495 . . . . 0.0 109.846 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 26.4 m -100.17 164.24 2.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.397 -176.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.542 ' HA ' ' O ' ' A' ' 68' ' ' ARG . 15.2 mt-30 -102.23 108.28 19.61 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.143 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 19.0 mt -84.01 122.79 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.532 ' O ' HG12 ' A' ' 121' ' ' ILE . 16.3 tt0 -99.3 118.77 36.71 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.263 -175.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.46 ' OG1' ' HB2' ' A' ' 66' ' ' GLU . 79.3 p -117.91 155.0 30.94 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.314 0.578 . . . . 0.0 111.854 -174.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -125.75 104.32 8.29 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 173.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 59.37 41.05 20.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.836 0.827 . . . . 0.0 109.852 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 91.16 -23.49 23.91 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.298 -0.865 . . . . 0.0 113.157 178.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -83.36 128.5 34.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.853 0.327 . . . . 0.0 110.946 -175.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.9 t -66.16 120.41 13.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.127 0.489 . . . . 0.0 110.915 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.532 HG12 ' O ' ' A' ' 114' ' ' GLN . 19.9 pt -109.69 -24.68 3.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.437 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -169.44 164.91 38.41 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.372 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 99.3 t -131.62 118.16 37.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.862 0.363 . . . . 0.0 110.195 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.426 ' HB2' ' HB2' ' A' ' 112' ' ' GLN . 42.3 mt-10 -91.13 104.19 16.79 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.867 -176.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 70.3 mt -78.31 138.77 59.79 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 174.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.55 128.65 30.27 Favored 'Trans proline' 0 CA--C 1.515 -0.456 0 C-N-CA 122.771 2.314 . . . . 0.0 111.153 178.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.718 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 95.4 mttt -52.3 -33.7 43.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.479 -169.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.8 p -115.47 109.6 18.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.024 0.44 . . . . 0.0 111.302 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 13.0 p -112.34 143.59 21.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.763 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.477 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 47.3 mt-10 -104.45 124.26 48.93 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 177.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 62.6 mt -126.28 131.41 51.9 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.776 0.322 . . . . 0.0 110.409 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.5 m -74.45 132.84 42.28 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.0 p -89.43 107.22 17.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.41 0.624 . . . . 0.0 110.338 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 13.1 p -105.02 124.53 49.68 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.714 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 70.6 88.87 0.1 Allowed 'General case' 0 C--O 1.237 0.421 0 CA-C-O 122.08 0.943 . . . . 0.0 111.611 -177.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.453 ' O ' ' HD3' ' A' ' 138' ' ' PRO . 15.2 t -151.36 139.85 20.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.512 -1.222 . . . . 0.0 107.839 170.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -82.37 113.0 40.97 Favored Pre-proline 0 C--N 1.322 -0.593 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.293 -170.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 136' ' ' THR . 96.9 Cg_endo -93.75 -179.84 0.87 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.257 2.638 . . . . 0.0 111.858 177.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.19 30.76 24.5 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.819 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.2 tp -128.29 99.44 5.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.607 0.717 . . . . 0.0 110.195 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -156.46 164.12 38.62 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.476 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 120.16 -28.69 6.24 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.391 177.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -103.14 153.9 19.85 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 26.0 m -71.24 88.73 0.85 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.245 0.545 . . . . 0.0 111.037 -177.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -80.0 72.67 6.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.52 178.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.4 t -68.81 -25.7 64.81 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.004 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -159.87 28.74 0.36 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.342 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -92.09 133.11 36.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.68 0.276 . . . . 0.0 110.664 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.6 p -131.91 168.42 17.9 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.794 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -137.22 151.34 48.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.014 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.9 m -73.08 110.62 7.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.216 0.531 . . . . 0.0 111.246 -174.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -116.21 162.06 18.03 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.729 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 22.7 m -125.86 140.68 52.46 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.739 174.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 12.8 m -101.87 173.08 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.805 175.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -56.98 -27.19 61.19 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 80.9 p -73.74 -11.89 60.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.79 0.329 . . . . 0.0 111.487 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 91.82 5.0 66.83 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.932 -0.652 . . . . 0.0 111.844 -177.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -85.04 141.68 30.11 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 27.0 m -99.2 129.67 45.45 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.648 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.4 mp -132.61 155.93 47.83 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 120.729 0.299 . . . . 0.0 110.238 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -93.7 99.35 11.78 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 34.6 m -97.34 150.71 37.1 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.082 -174.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -56.48 152.25 41.21 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.535 2.157 . . . . 0.0 111.277 174.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 59.1 mt -64.93 -14.85 61.11 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.612 -169.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -86.65 -7.42 58.34 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 88.0 t -75.6 131.13 35.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.861 0.362 . . . . 0.0 110.831 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -120.64 144.73 48.0 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.33 -175.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -69.56 132.97 47.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.138 0.494 . . . . 0.0 110.987 -176.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 109.78 -16.51 30.95 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.418 -174.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.428 ' OD1' ' HB2' ' A' ' 184' ' ' ARG . 10.7 t70 -84.93 156.71 21.09 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 74.7 t -104.02 116.13 47.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.87 0.367 . . . . 0.0 110.563 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 80.1 mt -94.68 145.65 24.7 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.587 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.626 ' O ' ' HB ' ' A' ' 182' ' ' ILE . 26.6 mt -98.66 134.82 35.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 175.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 67.2 mt -135.2 137.6 49.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 O-C-N 122.039 -0.413 . . . . 0.0 110.46 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.718 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 27.0 t-20 -83.68 98.01 9.41 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 175.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 8.9 t -85.37 157.92 20.39 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.855 0.36 . . . . 0.0 110.071 -177.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 94.45 -48.71 2.11 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -173.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.536 ' HB3' ' OD1' ' A' ' 175' ' ' ASN . 33.1 t70 -98.52 -42.3 7.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.001 0.429 . . . . 0.0 110.08 176.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 105.97 5.3 38.39 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.827 -0.701 . . . . 0.0 113.427 173.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 64.0 m -68.61 133.67 48.83 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.957 0.408 . . . . 0.0 111.038 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -86.64 134.41 33.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.1 0.476 . . . . 0.0 110.851 -177.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.626 ' HB ' ' O ' ' A' ' 173' ' ' ILE . 56.0 mt -116.04 155.0 17.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.3 p -75.88 172.7 12.26 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.419 0.152 . . . . 0.0 110.729 -176.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . 0.428 ' HB2' ' OD1' ' A' ' 170' ' ' ASP . 8.3 ptp180 -57.99 159.15 5.9 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.174 0.511 . . . . 0.0 111.575 -173.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.791 -1.005 . . . . 0.0 111.471 178.722 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.9 mtp . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 120.578 0.228 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 53.7 mt -115.73 137.95 47.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-O 121.209 0.528 . . . . 0.0 111.382 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.0 t -116.97 166.07 12.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.03 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.401 ' O ' HG22 ' A' ' 37' ' ' VAL . 21.2 m -67.96 -7.9 7.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -170.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -86.92 -2.39 58.57 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.637 -176.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -137.62 95.45 3.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.284 0.564 . . . . 0.0 112.198 -178.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -121.1 160.37 23.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.231 173.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -139.94 169.17 18.19 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.585 -0.154 . . . . 0.0 110.585 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.1 t -61.81 -13.1 20.95 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 123.632 0.583 . . . . 0.0 111.828 -173.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.34 113.14 0.66 Allowed Glycine 0 N--CA 1.434 -1.475 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 165.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 62.9 tp -150.93 129.35 12.08 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 2.7 p -98.48 129.4 45.07 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.24 0.543 . . . . 0.0 111.677 -177.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 mp -128.37 138.58 54.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.996 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.7 p -94.66 110.45 22.29 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.042 175.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.7 p -150.67 147.78 15.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -178.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 62.11 30.93 17.92 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.312 0.383 . . . . 0.0 110.864 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 63.3 24.43 14.26 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.94 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -137.83 168.59 19.38 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.255 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 11.1 pt -116.73 127.31 74.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.257 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.545 ' O ' ' HA ' ' A' ' 12' ' ' THR . 15.4 m95 -127.67 157.87 39.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.044 -172.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 44.5 tttm -123.23 119.51 30.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.317 175.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 90.9 t -62.34 117.95 4.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.402 0.62 . . . . 0.0 110.65 175.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 86.8 mt -90.0 -39.07 11.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.4 173.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -152.3 148.0 27.02 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.027 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -135.98 140.67 44.11 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.107 0.48 . . . . 0.0 111.032 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 7.3 tp-100 -117.93 99.89 7.21 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.053 175.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -78.0 89.25 4.15 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.0 p -97.04 131.06 44.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.058 -173.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.404 ' HD3' ' N ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -122.93 105.11 35.18 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.442 179.542 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.46 -10.63 27.21 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.689 2.259 . . . . 0.0 112.793 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.69 22.89 63.3 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.775 176.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -104.18 0.59 29.7 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.991 0.424 . . . . 0.0 110.79 -178.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 130.81 -42.07 1.45 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.765 175.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.4 m -118.83 146.42 44.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.768 0.318 . . . . 0.0 110.692 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.82 160.92 14.06 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.142 0.496 . . . . 0.0 110.945 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -132.49 161.8 32.82 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 53' ' ' THR . 48.1 t -132.24 102.6 5.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 120.842 0.353 . . . . 0.0 110.601 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -79.71 99.09 7.25 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 174.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.1 p -112.5 139.5 48.03 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.129 0.49 . . . . 0.0 112.17 -174.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -89.76 121.22 31.7 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 171.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -141.23 142.42 33.96 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.491 0.662 . . . . 0.0 111.697 -174.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.1 ttp180 -104.67 129.73 52.79 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.483 -174.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -69.09 118.22 11.72 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 173.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.3 mp -66.65 -28.93 68.86 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -175.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.579 ' HA ' ' O ' ' A' ' 121' ' ' ILE . 68.0 mtt85 -73.07 -44.57 60.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.958 0.409 . . . . 0.0 111.65 -176.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.4 p -102.85 -11.61 18.16 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.018 0.437 . . . . 0.0 112.029 -173.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.92 21.82 78.25 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -176.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.8 133.41 34.34 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -172.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.3 mm -89.74 110.05 21.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.926 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -132.25 172.69 12.1 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.28 147.12 51.96 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.022 0.439 . . . . 0.0 110.864 175.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -142.75 148.04 36.57 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.908 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 43.7 m -111.44 117.53 33.29 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.006 0.432 . . . . 0.0 110.342 178.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -84.6 140.71 31.18 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.82 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 47.8 mtm105 -107.17 138.44 43.35 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.585 -177.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.53 130.65 46.08 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.795 0.331 . . . . 0.0 110.258 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.67 -29.97 8.92 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -174.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.11 119.83 24.53 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 175.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -71.32 131.8 43.96 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.369 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.9 t -91.34 107.99 19.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.156 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -87.64 113.25 53.51 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.419 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.94 155.5 53.0 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.503 2.136 . . . . 0.0 112.702 -178.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.31 115.58 27.6 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.328 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 46.1 ttm -76.92 108.47 9.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.781 -178.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.436 HG13 HG21 ' A' ' 12' ' ' THR . 43.2 mm -100.94 139.02 23.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.396 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' A' ' 114' ' ' GLN . 39.0 mt-10 -105.09 116.73 32.44 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 175.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -99.71 99.08 9.86 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 173.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -111.87 124.73 52.98 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.015 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.569 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 12.8 ptp180 -86.84 120.18 27.84 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.329 0.585 . . . . 0.0 109.485 177.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.812 ' SD ' ' HA ' ' A' ' 84' ' ' ASP . 8.5 mmt -107.32 145.58 32.64 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.724 -178.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -79.58 136.12 36.77 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 172.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.438 ' CZ ' HD23 ' A' ' 105' ' ' LEU . 47.4 t80 -77.13 108.38 10.19 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.807 -176.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 3.3 mm? -99.51 177.33 5.2 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 167.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -146.94 150.73 35.76 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.67 -175.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.05 -162.92 1.65 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.735 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -62.74 137.76 58.35 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 174.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.43 70.19 2.46 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 119.209 -1.472 . . . . 0.0 113.151 -171.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -125.87 -32.56 2.8 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 161.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.497 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 78.6 m-20 -141.29 135.19 30.35 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 114.065 -1.425 . . . . 0.0 109.293 175.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.514 ' ND1' HD23 ' A' ' 98' ' ' LEU . 58.6 m170 -107.66 144.1 35.22 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 175.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.416 ' O ' ' HB2' ' A' ' 73' ' ' LEU . 49.5 t -94.3 121.91 45.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.794 -175.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.534 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 76.8 m-85 -117.85 126.04 51.65 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 176.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 14.7 tmm? -97.48 117.26 31.33 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.021 -175.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.812 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 17.6 t70 -62.42 114.65 3.63 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.418 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -76.94 -5.11 47.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.414 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -76.9 -50.94 12.17 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 173.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.7 p -170.94 93.95 0.18 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 168.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 50.09 28.83 3.19 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 157.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.48 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 34.1 mt-10 -101.14 115.25 30.04 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 121.466 -0.771 . . . . 0.0 111.287 175.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -82.38 108.98 16.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.316 0.579 . . . . 0.0 110.962 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 54.8 m -101.81 123.21 45.38 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.801 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -99.58 125.25 45.34 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.852 0.358 . . . . 0.0 110.334 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 79' ' ' ASN . 42.6 mt -97.85 138.77 34.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.349 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.514 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 29.5 t -79.95 169.23 18.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.716 -174.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.2 p -50.48 -39.41 48.18 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.963 0.505 . . . . 0.0 112.312 -175.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -59.31 -36.09 74.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.648 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -76.07 -35.47 59.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.305 0.574 . . . . 0.0 109.504 177.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.617 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 14.2 mt -64.32 -30.09 71.15 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.238 -176.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -62.6 -32.69 73.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.935 176.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -73.27 -40.52 64.53 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.55 ' O ' HD12 ' A' ' 105' ' ' LEU . 47.8 mt-10 -62.05 -36.76 82.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.732 175.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 79.9 mt -73.52 0.57 12.12 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.078 0.466 . . . . 0.0 110.824 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.429 ' O ' ' HB2' ' A' ' 158' ' ' TYR . 57.5 t30 -93.95 -43.26 8.63 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 170.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -148.34 117.09 6.66 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.26 172.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.55 HD12 ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -160.21 153.39 21.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.926 0.393 . . . . 0.0 110.649 172.255 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.7 mtpt -144.03 146.85 33.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.791 172.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -71.13 132.11 44.57 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.344 -174.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.67 0.68 90.25 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.771 177.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.42 ' SD ' ' HG3' ' A' ' 126' ' ' PRO . 57.5 ttm -82.65 141.74 32.26 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.809 0.338 . . . . 0.0 111.438 -177.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.524 ' HA ' ' O ' ' A' ' 70' ' ' MET . 54.2 mp0 -84.19 123.47 30.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.084 175.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 34.7 m -121.79 158.9 24.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.329 177.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.519 ' HB2' ' HB3' ' A' ' 124' ' ' GLU . 15.8 mm-40 -91.34 101.55 14.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.755 0.312 . . . . 0.0 110.194 -175.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 48.8 mm -94.01 122.03 45.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 178.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.501 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 87.2 mt-30 -98.47 117.34 32.68 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.742 0.306 . . . . 0.0 110.539 -178.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.401 ' OG1' ' HB2' ' A' ' 66' ' ' GLU . 35.2 p -112.36 151.22 30.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.915 176.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -135.56 103.12 5.34 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 60.06 31.77 20.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.528 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 104.44 -30.27 10.42 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 121.102 -0.571 . . . . 0.0 113.019 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -76.72 131.21 38.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.561 0.219 . . . . 0.0 111.276 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 17.6 p -73.43 106.6 5.3 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 172.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.579 ' O ' ' HA ' ' A' ' 45' ' ' ARG . 45.2 pt -94.25 -31.2 4.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -174.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -162.38 164.38 35.55 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 119.641 -1.266 . . . . 0.0 113.135 -177.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 59.9 t -133.38 127.57 54.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.519 ' HB3' ' HB2' ' A' ' 112' ' ' GLN . 35.1 tt0 -118.69 122.99 43.81 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.041 0.448 . . . . 0.0 110.337 178.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.402 ' N ' HD22 ' A' ' 125' ' ' LEU . 3.0 mm? -86.54 155.67 56.55 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.42 ' HG3' ' SD ' ' A' ' 109' ' ' MET . 10.5 Cg_endo -53.5 132.76 50.4 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.58 2.187 . . . . 0.0 110.982 176.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 95.7 mttt -54.85 -34.77 63.28 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.518 -174.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 19.7 p -122.92 109.08 13.69 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.045 176.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.5 p -106.25 136.81 39.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.499 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -94.3 108.53 20.42 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 177.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.439 HD13 HD13 ' A' ' 174' ' ' ILE . 98.7 mt -117.92 134.4 54.98 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.253 0.549 . . . . 0.0 110.744 -176.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.0 m -81.45 131.25 35.27 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.752 177.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.0 p -81.05 119.36 30.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.685 0.755 . . . . 0.0 111.084 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.471 ' O ' ' HB ' ' A' ' 153' ' ' THR . 41.6 p -125.27 128.9 48.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.555 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 75.94 86.02 0.09 Allowed 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.898 0.856 . . . . 0.0 110.69 -175.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.45 ' O ' ' HD3' ' A' ' 138' ' ' PRO . 13.3 t -150.96 155.02 38.22 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.462 173.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -82.5 110.7 23.35 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 120.424 0.154 . . . . 0.0 110.699 -176.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 136' ' ' THR . 96.6 Cg_endo -91.11 162.7 3.83 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.056 2.504 . . . . 0.0 112.709 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 98.15 -2.62 59.71 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.547 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 9.6 tt -107.37 105.24 18.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.308 0.575 . . . . 0.0 110.356 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -155.15 163.54 40.08 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.058 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.92 -30.4 10.31 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -95.21 86.96 4.7 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 27.6 m -82.76 -50.28 8.85 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.495 -176.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.405 ' O ' ' HB ' ' A' ' 146' ' ' THR . . . 47.63 57.54 5.83 Favored 'General case' 0 N--CA 1.462 0.164 0 O-C-N 123.727 0.642 . . . . 0.0 111.458 177.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' A' ' 145' ' ' ALA . 98.8 m 71.49 -56.56 0.63 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.31 -177.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -176.51 51.78 0.11 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.161 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.81 135.79 57.59 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.681 0.277 . . . . 0.0 110.297 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 27.6 p -126.93 163.31 23.96 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.267 0.556 . . . . 0.0 112.004 -173.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.404 ' HE3' ' OG1' ' A' ' 136' ' ' THR . 54.0 pttt -130.75 147.46 52.41 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.225 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 17.2 t -73.84 99.76 3.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.343 0.592 . . . . 0.0 110.303 -178.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -106.98 170.07 8.17 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.61 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.471 ' HB ' ' O ' ' A' ' 134' ' ' THR . 3.5 m -122.75 147.37 46.57 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 175.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.446 HG23 HG22 ' A' ' 156' ' ' THR . 2.6 m -109.68 170.95 2.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.23 173.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -53.24 -33.24 52.11 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -176.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.446 HG22 HG23 ' A' ' 154' ' ' VAL . 15.1 t -74.46 -8.25 55.68 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -176.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 95.91 -4.71 65.84 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.476 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.429 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 90.9 t80 -76.31 137.19 39.72 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.808 0.337 . . . . 0.0 110.719 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.55 130.87 44.57 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.522 177.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.99 148.07 36.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.937 0.398 . . . . 0.0 111.357 -175.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -85.55 102.41 13.5 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.775 176.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 26.8 m -102.18 149.78 36.91 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.503 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -51.81 145.38 31.78 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.514 2.143 . . . . 0.0 111.39 175.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 72.4 mt -59.07 -24.61 63.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.622 -169.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -85.89 7.49 23.92 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -175.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.417 HG22 ' HD2' ' A' ' 184' ' ' ARG . 91.1 t -82.91 137.79 20.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 176.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -123.38 156.52 35.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.671 -0.241 . . . . 0.0 110.68 -176.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -59.15 116.7 4.03 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.502 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 121.24 -16.6 9.2 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.535 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -64.57 139.51 58.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.812 0.339 . . . . 0.0 110.989 176.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 55.4 t -100.43 103.73 15.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.89 150.01 34.28 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.808 -176.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.434 ' O ' ' HB ' ' A' ' 182' ' ' ILE . 55.1 mt -103.03 134.66 43.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.827 -173.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.439 HD13 HD13 ' A' ' 131' ' ' LEU . 4.0 mp -121.68 141.12 43.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.754 0.312 . . . . 0.0 110.325 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 28.0 t-20 -84.61 105.58 15.52 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 175.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 37.6 p -64.82 158.6 24.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.151 -173.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 77.78 -55.3 3.81 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.415 178.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -84.8 -43.13 14.49 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.737 0.303 . . . . 0.0 110.737 -177.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 101.88 4.15 51.68 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.513 173.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 34.9 m -63.78 142.92 58.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.958 0.409 . . . . 0.0 110.951 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -98.44 124.37 43.11 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.2 0.524 . . . . 0.0 111.177 -175.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.434 ' HB ' ' O ' ' A' ' 173' ' ' ILE . 2.6 mp -95.11 152.87 3.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 173.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 17.4 m -74.85 169.42 17.96 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.234 0.54 . . . . 0.0 111.609 -170.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . 0.417 ' HD2' HG22 ' A' ' 166' ' ' VAL . 58.6 mtp180 -63.08 147.58 50.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.358 -175.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.097 -1.39 . . . . 0.0 110.904 175.858 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.8 mtt . . . . . 0 N--CA 1.482 1.166 0 CA-C-O 120.776 0.322 . . . . 0.0 110.643 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.434 HD12 HG13 ' A' ' 13' ' ' ILE . 61.0 mt -93.97 131.77 39.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.446 -174.131 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 p -88.91 158.14 18.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.954 174.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.425 ' O ' HG21 ' A' ' 37' ' ' VAL . 15.8 m -71.28 -3.27 3.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -173.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -99.68 6.57 45.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.459 0.647 . . . . 0.0 109.895 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -124.31 88.94 2.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.244 0.545 . . . . 0.0 111.177 -177.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -142.06 156.3 45.4 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.026 177.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -139.95 165.77 26.44 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.7 t -57.19 -15.24 5.32 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.087 0.47 . . . . 0.0 111.169 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -147.95 113.72 0.65 Allowed Glycine 0 N--CA 1.435 -1.368 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 165.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 55.4 tp -151.63 134.61 15.77 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 1.1 p -98.46 124.44 43.17 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.356 0.598 . . . . 0.0 112.262 -176.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.434 HG13 HD12 ' A' ' 2' ' ' ILE . 4.0 mp -127.49 138.99 53.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.983 -178.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.7 p -100.24 110.32 22.56 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.164 0.507 . . . . 0.0 110.301 176.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.5 p -155.03 156.83 4.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -177.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 61.16 24.59 14.69 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.712 0.291 . . . . 0.0 110.887 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 16.0 m120 65.45 30.18 10.95 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.211 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -145.05 163.98 32.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.306 178.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 13.8 pt -105.97 125.77 61.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.199 0.523 . . . . 0.0 109.886 176.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.601 ' O ' ' HA ' ' A' ' 12' ' ' THR . 82.1 m95 -117.77 161.44 19.69 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.803 -169.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -132.02 101.63 5.5 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.606 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.414 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 89.9 t -62.74 116.55 2.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.901 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.4 mm -88.95 -36.14 8.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.242 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -162.71 113.78 1.51 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.788 -177.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 39' ' ' SER . 19.8 p90 -102.87 146.37 28.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.0 0.429 . . . . 0.0 111.014 -176.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -123.47 104.58 9.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.408 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -77.49 96.26 4.68 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 175.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.4 p -104.1 136.18 38.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.614 -171.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -117.94 89.75 34.97 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.456 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.36 -11.31 31.08 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.736 2.291 . . . . 0.0 113.121 -175.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.46 26.23 25.95 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.446 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -92.93 -11.84 32.37 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.33 0.586 . . . . 0.0 110.354 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.04 -19.85 17.52 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 -176.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.5 m -129.28 140.49 51.41 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.77 152.56 20.09 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.204 0.525 . . . . 0.0 110.824 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -131.64 167.1 20.02 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.929 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.425 HG21 ' O ' ' A' ' 4' ' ' VAL . 46.1 t -132.4 102.47 5.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 120.725 0.297 . . . . 0.0 110.428 178.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -77.45 99.26 5.57 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.461 ' HA ' ' HA ' ' A' ' 25' ' ' PHE . 18.2 m -103.4 126.03 50.32 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.547 -175.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.5 tppt? -84.68 110.22 18.59 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 173.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.453 HD23 ' H ' ' A' ' 41' ' ' LEU . 0.8 OUTLIER -138.01 144.06 40.9 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.893 0.854 . . . . 0.0 112.121 -172.881 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 42' ' ' ARG . 18.6 ttt180 -100.19 130.15 46.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.519 -175.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -64.48 112.29 3.07 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 173.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.6 tt -71.34 -14.08 62.08 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.209 0.528 . . . . 0.0 110.635 -171.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 45' ' ' ARG . 11.7 mtp180 -86.82 -45.28 11.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.497 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.4 p -101.24 -20.52 15.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.059 0.457 . . . . 0.0 111.868 -173.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.15 10.15 75.34 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.86 -176.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.71 145.4 38.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.116 0.484 . . . . 0.0 111.961 -175.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.6 mm -100.09 113.43 35.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.428 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.511 ' HG2' ' H ' ' A' ' 51' ' ' GLU . 31.8 tt0 -133.32 176.38 8.57 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.511 ' H ' ' HG2' ' A' ' 50' ' ' GLN . 9.6 pt-20 -138.26 142.35 39.87 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.937 0.398 . . . . 0.0 110.24 173.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -130.41 134.08 46.85 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.363 -177.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.4 p -98.19 110.34 22.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.048 0.451 . . . . 0.0 110.857 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -84.64 147.98 26.67 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.917 178.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.643 ' HD3' ' OE2' ' A' ' 58' ' ' GLU . 44.4 ttt180 -112.92 128.96 56.61 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.93 -174.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.3 125.76 24.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.605 178.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.43 -15.88 32.23 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.928 -178.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.643 ' OE2' ' HD3' ' A' ' 55' ' ' ARG . 42.8 mt-10 -119.26 99.71 6.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.899 0.38 . . . . 0.0 110.19 177.038 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -76.84 153.38 34.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.955 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.0 m -120.4 162.8 18.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.073 0.464 . . . . 0.0 111.446 -176.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -84.07 132.87 46.75 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.425 -177.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.418 ' HB3' HD11 ' A' ' 2' ' ' ILE . 82.2 Cg_endo -79.07 151.75 23.97 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.688 2.259 . . . . 0.0 112.334 176.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -118.99 114.52 22.67 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.387 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 64.8 mtt -94.15 118.12 31.09 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 48.9 mm -89.35 127.57 41.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.582 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -103.23 118.0 35.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.522 -174.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -102.42 125.72 49.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.787 0.327 . . . . 0.0 110.408 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 71.0 mtt-85 -126.18 115.03 19.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.964 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' A' ' 69' ' ' ARG . 13.3 ptm180 -85.49 117.82 24.64 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.369 0.604 . . . . 0.0 109.683 175.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.618 ' SD ' HD12 ' A' ' 113' ' ' ILE . 31.1 mtt -120.75 143.68 48.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.697 -174.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -77.3 132.72 38.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.777 176.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -73.37 104.26 4.32 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.23 -174.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.407 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 60.8 mt -99.06 -175.66 3.1 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 172.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -144.04 149.65 36.99 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.644 0.735 . . . . 0.0 112.518 -170.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.27 -154.23 0.53 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.661 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -79.86 152.06 29.88 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -82.27 66.65 3.84 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 117.858 -2.115 . . . . 0.0 112.787 -174.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -129.14 -31.79 2.08 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 156.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.572 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 81.9 m-20 -141.04 130.34 23.63 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.653 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.428 ' O ' ' HA ' ' A' ' 92' ' ' GLU . 30.1 m170 -110.69 141.52 43.83 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 175.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.407 ' O ' ' HB2' ' A' ' 73' ' ' LEU . 41.5 t -87.52 130.52 37.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.922 -177.084 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.424 ' CE1' HD12 ' A' ' 93' ' ' LEU . 83.0 m-85 -124.26 128.39 49.09 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 174.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 25.8 ttt -94.34 112.0 23.77 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.46 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.604 ' HB3' ' H ' ' A' ' 89' ' ' GLU . 25.0 t70 -58.59 110.05 0.91 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.168 177.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -80.59 -4.51 54.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.7 -177.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -70.19 -50.7 37.55 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 173.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.6 p -171.85 93.56 0.15 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 165.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 49.79 29.37 3.2 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 159.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.604 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 42.9 mt-10 -100.12 105.97 17.65 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 121.584 -0.697 . . . . 0.0 111.346 176.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -70.08 125.02 25.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.919 0.39 . . . . 0.0 110.22 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 46.6 m -128.16 125.33 38.88 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.161 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.428 ' HA ' ' O ' ' A' ' 80' ' ' HIS . 32.3 mt-10 -104.58 131.74 51.64 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.8 0.333 . . . . 0.0 110.769 -177.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 79' ' ' ASN . 42.3 mt -100.28 146.56 26.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.575 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.634 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 8.3 t -88.08 166.31 14.52 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.924 -172.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.7 t -51.1 -42.8 60.88 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -171.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -55.1 -45.89 75.5 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -178.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -71.8 -39.89 69.57 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.25 0.548 . . . . 0.0 109.562 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 94' ' ' SER . 56.8 mt -60.2 -28.16 67.75 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.851 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -57.82 -43.95 86.08 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.914 0.388 . . . . 0.0 110.913 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -80.17 -43.33 21.76 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.692 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.486 ' HG3' HD11 ' A' ' 125' ' ' LEU . 0.6 OUTLIER -62.94 -27.57 69.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.99 177.626 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 22.3 mt -75.07 -14.44 60.58 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 122.308 -0.245 . . . . 0.0 111.096 177.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -74.6 -43.92 53.24 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.428 ' HB3' HG11 ' A' ' 129' ' ' VAL . 40.9 m-85 -138.18 116.74 12.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.431 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.454 HD22 ' C ' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -170.78 157.99 5.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.302 0.572 . . . . 0.0 111.113 176.141 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.447 ' HD3' ' O ' ' A' ' 130' ' ' GLU . 31.5 mmmt -130.1 139.29 50.95 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.775 172.039 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -73.21 127.35 32.36 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.28 -0.36 71.64 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.079 -175.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.459 ' SD ' ' HG3' ' A' ' 126' ' ' PRO . 42.1 ttm -87.47 144.18 26.86 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.679 0.276 . . . . 0.0 111.145 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 70' ' ' MET . 45.3 mt-10 -85.51 122.63 29.91 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.963 177.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 24.9 m -112.34 156.34 13.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -101.31 99.27 9.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.086 0.47 . . . . 0.0 110.176 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.618 HD12 ' SD ' ' A' ' 70' ' ' MET . 54.6 mt -83.24 127.11 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.49 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.531 ' O ' HG12 ' A' ' 121' ' ' ILE . 17.6 tt0 -100.31 112.34 24.67 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.392 -174.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 25.7 p -116.16 155.75 27.69 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.857 -176.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.416 ' HB2' HD13 ' A' ' 121' ' ' ILE . 78.6 t80 -132.69 109.46 9.72 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 172.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 60.46 31.48 20.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.029 0.442 . . . . 0.0 110.853 -175.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.68 -12.95 65.51 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.715 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -86.18 126.94 34.61 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 25.5 m -67.67 117.05 9.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.637 0.256 . . . . 0.0 110.658 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 114' ' ' GLN . 12.9 pt -105.64 -23.35 4.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.813 0.34 . . . . 0.0 111.047 178.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -170.65 166.41 39.6 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.013 176.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 61.1 t -133.19 126.11 52.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -107.4 113.38 26.69 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.936 0.398 . . . . 0.0 110.962 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.486 HD11 ' HG3' ' A' ' 101' ' ' GLU . 3.0 mm? -81.02 149.95 67.67 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 173.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.459 ' HG3' ' SD ' ' A' ' 109' ' ' MET . 9.8 Cg_endo -53.38 137.67 64.78 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.559 2.173 . . . . 0.0 111.417 176.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.605 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 31.8 mmtp -61.28 -27.93 68.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.715 -172.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.5 p -124.61 107.46 11.04 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.194 0.521 . . . . 0.0 110.394 174.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.428 HG11 ' HB3' ' A' ' 104' ' ' TYR . 7.1 p -107.27 144.96 15.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.457 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.447 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 35.7 mt-10 -110.36 113.36 25.96 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.906 0.384 . . . . 0.0 110.381 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 73.6 mt -120.5 129.41 53.83 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.406 -176.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.6 m -72.42 131.21 42.28 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.143 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 170' ' ' ASP . 9.6 p -84.16 112.96 22.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.749 0.785 . . . . 0.0 110.515 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.45 ' O ' ' HB ' ' A' ' 153' ' ' THR . 31.9 p -115.81 119.53 36.31 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.184 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 77.37 87.81 0.07 Allowed 'General case' 0 C--O 1.237 0.413 0 O-C-N 123.991 0.807 . . . . 0.0 110.904 -177.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 12.8 t -151.03 152.88 34.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.81 172.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -114.02 109.74 49.36 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 120.73 0.3 . . . . 0.0 111.393 -177.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 164' ' ' LEU . 12.4 Cg_exo -70.87 -176.39 1.78 Allowed 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 123.66 2.907 . . . . 0.0 111.601 172.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 122.99 35.54 0.72 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.059 -1.067 . . . . 0.0 113.246 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.1 tp . . . . . 0 CA--C 1.538 0.518 0 CA-C-O 121.258 0.552 . . . . 0.0 109.994 173.287 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 29.6 p . . . . . 0 N--CA 1.45 -0.458 0 CA-C-O 120.945 0.403 . . . . 0.0 111.746 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.8 ttpp -132.58 161.06 34.82 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 176.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 34.9 p -72.49 107.69 5.16 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.159 0.504 . . . . 0.0 110.513 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.468 ' HB2' HG22 ' A' ' 162' ' ' VAL . . . -107.32 164.08 12.49 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.386 178.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' A' ' 134' ' ' THR . 22.4 m -119.19 136.03 54.39 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.857 175.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 12.4 m -100.77 174.29 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.0 175.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -56.16 -29.01 60.22 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 59.3 p -72.71 -19.31 61.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.986 0.422 . . . . 0.0 111.484 -177.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 100.22 -3.12 56.67 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -174.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -75.63 144.57 41.65 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.871 0.367 . . . . 0.0 110.688 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 18.9 m -106.07 122.71 46.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.3 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.85 158.58 43.85 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -177.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -88.85 108.86 19.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.069 -174.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.468 HG22 ' HB2' ' A' ' 152' ' ' ALA . 32.7 m -102.72 147.36 33.94 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.586 178.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.15 144.83 56.93 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.289 1.993 . . . . 0.0 111.51 172.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 138' ' ' PRO . 77.2 mt -63.0 -7.78 5.99 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -172.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -100.55 10.5 41.1 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 93.9 t -87.78 131.87 34.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.532 0.206 . . . . 0.0 110.55 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -110.73 154.2 24.22 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.996 0.427 . . . . 0.0 110.934 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -59.83 127.13 30.41 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.731 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 112.26 -20.9 20.7 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.429 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.454 ' O ' HG12 ' A' ' 133' ' ' VAL . 2.2 m-20 -64.13 143.39 57.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.851 0.358 . . . . 0.0 110.761 177.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 61.8 t -95.09 110.32 23.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.315 0.579 . . . . 0.0 109.843 177.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.42 HD11 ' HB ' ' A' ' 133' ' ' VAL . 47.8 mt -87.35 129.33 35.06 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.5 -176.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.555 ' O ' ' HB ' ' A' ' 182' ' ' ILE . 40.8 mt -94.43 127.96 46.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 59.8 mt -126.39 138.33 54.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.78 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.605 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 40.7 t-20 -80.98 91.39 6.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.655 177.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.64 133.52 49.51 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.627 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 120.46 -40.33 2.2 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -115.07 -28.87 6.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.24 0.543 . . . . 0.0 110.254 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 88.45 19.34 52.69 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.111 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 19.3 t -79.31 130.83 35.84 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.8 0.333 . . . . 0.0 110.111 -177.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -76.67 127.42 32.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.322 0.582 . . . . 0.0 111.163 -177.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.555 ' HB ' ' O ' ' A' ' 173' ' ' ILE . 59.7 mt -105.8 153.68 7.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 173.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 16.2 p -74.69 146.34 42.4 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.252 0.548 . . . . 0.0 111.113 -168.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -55.93 142.16 36.67 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.077 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.648 -1.085 . . . . 0.0 112.238 -179.005 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ttt . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 121.073 0.463 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.6 mp -111.88 130.7 65.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.0 t -111.78 174.0 6.09 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 22.9 m -72.33 0.91 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -172.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -93.13 -1.57 56.25 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.017 0.437 . . . . 0.0 110.225 176.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -111.06 88.92 2.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.104 -176.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -141.47 147.56 38.06 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 175.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -130.11 174.96 9.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.729 -0.214 . . . . 0.0 110.496 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.4 t -57.84 -24.48 57.62 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 121.343 0.592 . . . . 0.0 110.234 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.624 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -147.13 116.33 0.84 Allowed Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 169.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 57.8 tp -145.94 130.99 18.29 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.567 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 1.7 p -92.87 127.21 38.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.925 0.393 . . . . 0.0 111.957 -177.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mp -127.19 139.69 51.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.247 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.8 t -99.74 107.89 20.08 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.5 p -151.22 150.18 13.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -176.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.8 23.95 14.27 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.803 0.335 . . . . 0.0 110.474 -176.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.7 m120 62.12 33.4 16.99 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.878 -178.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -140.97 162.28 35.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.029 176.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 11.8 pt -104.92 121.0 56.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.344 0.592 . . . . 0.0 110.292 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.567 ' O ' ' HA ' ' A' ' 12' ' ' THR . 70.9 m95 -115.77 164.38 14.46 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.838 -172.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -140.42 109.27 6.01 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 120.935 0.397 . . . . 0.0 110.209 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.624 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 94.2 t -58.66 122.03 7.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.128 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.441 HD11 ' HB2' ' A' ' 42' ' ' ARG . 81.4 mt -87.58 -38.5 12.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.517 174.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -163.2 144.44 9.56 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.24 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -125.24 138.54 54.11 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.095 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -109.52 98.68 8.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.144 175.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 21.5 t-160 -81.08 98.13 7.86 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.9 131.34 48.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.401 0.62 . . . . 0.0 111.458 -174.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.44 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -111.86 101.54 51.68 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.292 -177.818 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -65.87 -46.81 4.4 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.776 2.317 . . . . 0.0 112.47 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.02 17.55 6.28 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.92 -177.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -105.66 10.42 32.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.997 0.427 . . . . 0.0 110.271 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.57 -43.21 3.22 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 -176.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.2 m -89.3 98.33 11.71 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.851 0.358 . . . . 0.0 110.098 176.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -86.73 171.5 10.88 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.504 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -142.13 164.25 30.66 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.355 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 53' ' ' THR . 48.0 t -127.95 107.05 15.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.594 -176.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -80.5 98.17 7.46 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 173.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.6 p -104.97 135.81 45.62 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.99 0.424 . . . . 0.0 111.489 -175.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -95.95 109.87 22.17 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 175.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.555 HD23 ' H ' ' A' ' 41' ' ' LEU . 1.4 pt? -132.5 145.61 51.3 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.405 0.621 . . . . 0.0 111.369 -172.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 22.0 ttp180 -106.39 132.1 52.81 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.657 -175.079 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -62.03 119.32 8.66 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 172.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.452 HD22 HD12 ' A' ' 121' ' ' ILE . 4.2 tt -64.86 -28.05 69.29 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.795 -171.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 45' ' ' ARG . 52.9 mtt-85 -85.11 -43.65 13.68 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -176.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.6 p -102.05 -9.68 20.37 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -172.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.22 18.94 75.39 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.41 -178.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 42' ' ' ARG . . . -77.01 131.31 38.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.745 0.307 . . . . 0.0 111.553 -177.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.3 mm -89.89 102.14 12.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.062 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.457 ' HG2' ' N ' ' A' ' 51' ' ' GLU . 36.0 tt0 -116.13 169.2 9.45 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.457 ' N ' ' HG2' ' A' ' 50' ' ' GLN . 6.6 pt-20 -136.59 130.05 31.74 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.346 0.593 . . . . 0.0 110.541 172.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -123.22 146.49 47.78 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.306 -176.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 55.3 m -107.55 111.03 23.1 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.979 0.418 . . . . 0.0 110.862 177.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -85.37 142.43 29.3 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.802 177.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 55' ' ' ARG . 36.7 mtp-105 -113.38 135.15 54.17 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.083 -173.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.11 129.34 40.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.478 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.73 -18.37 29.48 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.353 -175.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -99.81 134.81 42.17 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -87.34 133.83 33.65 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.354 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.2 t -94.13 134.99 29.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.331 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -101.47 112.93 65.79 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.885 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.0 163.64 34.93 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.58 2.186 . . . . 0.0 112.606 -177.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -121.89 109.57 14.81 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.701 177.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 64.2 mtt -84.65 109.35 17.93 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.039 0.447 . . . . 0.0 110.903 -177.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.484 HD12 ' CD1' ' A' ' 121' ' ' ILE . 34.6 mm -90.38 120.94 40.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.928 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -94.9 109.27 21.29 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -89.09 131.04 35.43 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.903 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 52.2 mtt180 -130.44 170.39 14.26 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 69' ' ' ARG . 13.7 ptm180 -130.18 125.37 34.81 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.02 0.438 . . . . 0.0 110.07 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.515 ' CB ' ' HB3' ' A' ' 82' ' ' PHE . 2.0 mpt? -117.49 143.22 46.27 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.347 -176.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -84.78 139.46 31.93 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.74 173.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.539 ' CD1' ' HA ' ' A' ' 107' ' ' GLU . 32.7 t80 -71.63 110.15 6.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.861 -176.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.8 mp -100.69 -174.66 2.69 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 169.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -143.02 147.82 35.74 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.437 0.637 . . . . 0.0 111.759 -169.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.5 -165.95 2.38 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.805 176.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -72.51 146.17 46.99 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 174.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.66 68.45 3.0 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 118.683 -1.722 . . . . 0.0 112.857 -171.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -128.13 -33.05 2.21 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 161.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.425 ' OD1' ' HB3' ' A' ' 92' ' ' GLU . 28.3 t30 -143.26 136.82 28.41 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 113.359 -1.746 . . . . 0.0 109.267 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.462 ' ND1' HD22 ' A' ' 98' ' ' LEU . 55.7 m170 -117.58 148.41 41.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.771 0.32 . . . . 0.0 110.539 178.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 45.7 t -100.17 132.23 46.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.079 -176.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.515 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 71.6 m-85 -130.19 124.72 33.25 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 176.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 90.6 mmm -99.7 117.73 34.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.724 0.297 . . . . 0.0 111.52 -175.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.542 ' HB3' ' H ' ' A' ' 89' ' ' GLU . 11.5 t70 -67.63 127.67 33.61 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.496 -178.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -79.64 -16.59 55.5 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.202 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.522 ' HB3' ' OD2' ' A' ' 84' ' ' ASP . 11.6 tp10 -66.92 -52.69 40.06 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 56.0 p -171.43 91.71 0.14 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 167.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 47.41 28.05 1.04 Allowed 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 162.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.542 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 28.0 mm-40 -83.42 101.31 11.28 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 118.392 0.542 . . . . 0.0 110.083 176.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -73.65 96.47 2.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.856 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.9 m -95.6 129.32 42.83 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.476 -175.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.425 ' HB3' ' OD1' ' A' ' 79' ' ' ASN . 35.5 mt-10 -106.68 137.67 44.27 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.931 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.471 HD12 ' CE1' ' A' ' 82' ' ' PHE . 64.7 mt -119.72 133.57 55.57 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.027 0.441 . . . . 0.0 111.189 -178.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.614 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 49.8 m -90.81 179.72 5.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.023 -176.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.0 p -47.73 -41.14 22.32 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -174.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -55.23 -38.14 68.09 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.038 0.446 . . . . 0.0 111.621 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.421 ' HB2' ' HB3' ' A' ' 93' ' ' LEU . 66.0 m-85 -85.68 -34.96 21.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.041 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.614 ' HG ' ' O ' ' A' ' 94' ' ' SER . 20.8 mt -63.63 -22.51 66.94 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.288 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -59.77 -42.77 94.03 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.477 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -66.74 -38.38 86.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.621 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.594 ' O ' HD12 ' A' ' 105' ' ' LEU . 53.5 mt-10 -63.1 -36.4 83.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.097 175.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 82.3 mt -62.42 -21.23 65.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.917 0.389 . . . . 0.0 110.34 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -80.96 -50.99 9.03 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 171.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -142.79 118.53 10.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.546 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.594 HD12 ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -154.17 144.74 22.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.996 0.427 . . . . 0.0 110.312 172.415 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -144.42 139.86 28.64 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 175.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.539 ' HA ' ' CD1' ' A' ' 72' ' ' TYR . 29.0 tt0 -74.44 129.72 38.29 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.091 -177.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.54 1.24 71.64 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.49 -177.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 50.0 ttm -67.74 144.05 55.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.06 0.457 . . . . 0.0 111.501 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -92.59 104.28 16.59 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.822 174.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 26.3 m -105.49 158.76 5.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.704 0.288 . . . . 0.0 110.75 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -111.72 103.39 11.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.834 0.35 . . . . 0.0 110.098 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 60.4 mt -96.52 127.35 48.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.958 0.409 . . . . 0.0 110.394 -177.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.494 ' O ' HG12 ' A' ' 121' ' ' ILE . 76.5 mt-30 -91.04 120.02 31.68 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.928 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 62.4 p -116.32 145.72 42.97 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.319 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -124.98 98.89 5.88 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 60.38 41.8 15.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.691 -173.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 88.93 -18.69 42.55 Favored Glycine 0 CA--C 1.516 0.151 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.874 178.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -82.43 123.68 29.36 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.658 0.266 . . . . 0.0 110.767 -177.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 42.5 p -69.57 107.88 3.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.883 0.373 . . . . 0.0 110.455 178.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.494 HG12 ' O ' ' A' ' 114' ' ' GLN . 21.6 pt -93.94 -28.35 4.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.022 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -164.19 155.05 26.23 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.325 178.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.6 t -120.68 123.27 69.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -106.14 123.27 47.76 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 120.956 0.408 . . . . 0.0 110.351 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.469 ' HB2' HG21 ' A' ' 176' ' ' THR . 75.2 mt -97.08 148.54 34.54 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.725 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.23 135.46 64.92 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.034 2.489 . . . . 0.0 112.123 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 62.5 mttm -67.5 -16.03 63.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.894 -173.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 18.6 p -127.06 109.83 12.3 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.945 0.402 . . . . 0.0 110.671 175.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 12.3 p -120.69 141.79 39.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.513 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -104.02 104.47 14.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.35 0.595 . . . . 0.0 110.784 -178.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 78.0 mt -119.41 129.65 54.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.479 -177.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 3.1 m -75.04 134.09 41.47 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.49 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.468 ' HB ' HD11 ' A' ' 172' ' ' LEU . 3.7 p -79.35 109.1 13.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.683 0.754 . . . . 0.0 109.944 174.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.444 ' O ' ' HB3' ' A' ' 135' ' ' GLU . 36.3 p -114.5 115.36 27.12 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.552 -177.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.444 ' HB3' ' O ' ' A' ' 134' ' ' THR . 15.9 tp10 77.52 101.65 0.07 Allowed 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.928 0.871 . . . . 0.0 110.841 -177.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 14.6 t -150.75 153.74 36.08 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.616 -1.175 . . . . 0.0 108.343 175.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -82.39 147.01 55.41 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-O 120.889 0.376 . . . . 0.0 110.903 -174.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.11 -179.76 2.83 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 123.101 2.534 . . . . 0.0 112.162 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 119.35 32.53 1.23 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.005 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.9 tt . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 121.467 0.651 . . . . 0.0 110.636 176.914 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 24.1 p . . . . . 0 N--CA 1.448 -0.548 0 CA-C-O 121.112 0.482 . . . . 0.0 111.462 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -129.78 150.1 51.23 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.926 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 18.5 m -73.8 99.83 3.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.092 0.472 . . . . 0.0 111.447 -175.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -104.94 164.94 11.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.782 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 25.9 m -125.75 130.32 51.25 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.004 175.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 14.6 m -86.99 175.01 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.599 -0.441 . . . . 0.0 110.811 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -57.03 -30.0 63.86 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.469 HG22 HD13 ' A' ' 105' ' ' LEU . 64.9 p -72.72 -20.18 61.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.766 0.317 . . . . 0.0 111.477 -177.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 102.78 -1.11 48.59 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.617 -175.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -74.49 129.98 38.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.88 0.372 . . . . 0.0 110.856 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.8 p -91.82 131.94 36.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.709 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -148.71 153.59 38.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.913 0.387 . . . . 0.0 110.321 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -87.83 101.18 13.46 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.205 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 31.7 m -95.86 144.93 28.67 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.635 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.86 150.02 24.14 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 122.478 2.119 . . . . 0.0 111.433 175.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 65.0 mt -61.71 -22.01 64.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.714 -169.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -79.21 -17.15 55.39 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 63.4 t -65.5 131.21 31.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.63 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -119.53 159.02 25.13 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.414 -176.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -57.15 123.58 15.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.666 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 109.95 -12.62 31.95 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.774 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.584 ' OD1' ' HD3' ' A' ' 184' ' ' ARG . 26.2 t70 -68.03 141.02 56.33 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.741 0.305 . . . . 0.0 110.64 178.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 3.7 p -86.1 108.21 17.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.716 0.77 . . . . 0.0 110.425 177.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.468 HD11 ' HB ' ' A' ' 133' ' ' VAL . 85.3 mt -91.59 119.12 31.21 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.256 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.596 ' O ' ' HB ' ' A' ' 182' ' ' ILE . 56.0 mt -90.57 104.47 15.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 173.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 37.1 mt -95.75 130.92 43.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 C-N-CA 120.414 -0.514 . . . . 0.0 109.854 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.563 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 23.3 t-20 -80.07 89.55 5.39 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.976 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.469 HG21 ' HB2' ' A' ' 125' ' ' LEU . 4.7 m -61.43 129.55 41.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.658 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 115.55 -41.98 2.02 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -177.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -106.94 -33.66 7.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.199 0.523 . . . . 0.0 110.086 176.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 95.01 10.78 57.18 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.487 177.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.81 131.18 47.96 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -178.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -100.0 112.41 24.69 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.227 0.537 . . . . 0.0 110.839 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.596 ' HB ' ' O ' ' A' ' 173' ' ' ILE . 4.0 mp -107.63 134.93 47.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 43.0 t -113.43 165.63 12.28 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.477 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ARG . . . . . 0.584 ' HD3' ' OD1' ' A' ' 170' ' ' ASP . 30.1 mmt180 69.82 25.7 4.97 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 123.69 0.618 . . . . 0.0 112.095 174.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.626 -1.097 . . . . 0.0 113.009 177.987 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mmt . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 120.947 0.403 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.437 ' HB ' ' HB ' ' A' ' 60' ' ' VAL . 44.4 mm -109.29 145.06 16.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.673 178.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.6 t -94.23 156.28 16.62 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 176.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.9 m -71.69 1.36 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.269 0.557 . . . . 0.0 110.827 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -107.22 11.29 29.47 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.447 176.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -126.92 88.5 2.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.026 0.441 . . . . 0.0 111.041 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -139.86 152.34 46.39 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.372 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.501 ' HG2' ' HG ' ' A' ' 11' ' ' LEU . 19.3 ptpt -143.6 178.19 7.96 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.6 p -56.11 -12.97 1.71 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -160.19 115.56 0.67 Allowed Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.04 172.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.501 ' HG ' ' HG2' ' A' ' 8' ' ' LYS . 8.9 mt -148.66 138.91 22.44 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 122.541 0.336 . . . . 0.0 110.293 174.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 2.9 m -95.28 115.49 27.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.189 0.519 . . . . 0.0 110.743 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.438 HG23 ' O ' ' A' ' 61' ' ' GLU . 1.9 mp -120.95 140.7 44.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.209 -176.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.7 t -98.91 118.0 34.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.953 0.406 . . . . 0.0 110.336 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.7 p -153.09 144.89 15.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 62.45 28.54 16.85 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 122.627 0.371 . . . . 0.0 110.661 -176.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.6 m120 62.52 25.22 15.02 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.396 -177.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.99 159.2 39.44 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 176.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 10.5 pt -106.46 122.96 60.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.233 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.527 ' O ' ' HA ' ' A' ' 12' ' ' THR . 33.3 m95 -119.63 165.52 14.36 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.772 -172.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -128.03 104.88 8.03 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.713 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.507 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 77.3 t -62.8 106.15 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.554 178.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.0 mm -85.0 -33.43 8.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.713 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -152.52 147.08 25.79 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.328 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -136.03 141.87 44.37 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.636 -177.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -124.52 106.35 10.09 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.078 177.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -74.07 89.61 1.97 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 176.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.5 p -92.83 128.15 44.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.894 -172.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.3 pttt -126.11 102.57 27.44 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.765 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -57.26 -47.2 23.47 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.357 2.704 . . . . 0.0 112.469 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.72 4.02 17.6 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.763 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -84.8 -12.42 53.66 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.075 0.464 . . . . 0.0 110.183 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.35 -42.25 1.29 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.659 176.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.0 m -99.84 134.34 42.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.868 0.366 . . . . 0.0 110.952 -177.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.55 153.97 18.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.173 0.511 . . . . 0.0 110.887 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -133.76 168.77 18.11 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.264 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 48.2 t -130.32 103.86 8.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 120.992 0.425 . . . . 0.0 110.083 176.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -82.37 98.82 9.04 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.7 p -110.03 139.0 45.63 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.817 -173.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -95.53 114.97 26.78 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 174.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.544 HD23 ' H ' ' A' ' 41' ' ' LEU . 0.9 OUTLIER -136.91 141.88 42.72 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.727 0.775 . . . . 0.0 111.316 -171.335 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -98.73 130.04 45.19 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.621 -176.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -64.24 114.14 4.04 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 171.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.424 HD21 ' OE1' ' A' ' 114' ' ' GLN . 7.8 tt -70.24 -22.16 62.93 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.726 -170.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -83.01 -46.45 12.84 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.4 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.7 p -97.24 -14.27 21.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.196 0.522 . . . . 0.0 111.908 -174.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.9 24.79 71.0 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.952 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.35 133.46 33.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.861 0.363 . . . . 0.0 111.784 -175.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.6 mm -93.36 109.85 22.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.107 178.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -136.78 177.41 7.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.841 0.353 . . . . 0.0 110.44 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -137.98 146.81 43.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.111 0.481 . . . . 0.0 110.517 173.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -135.07 171.41 14.47 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.309 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.8 t -127.77 118.31 23.52 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.416 0.626 . . . . 0.0 110.828 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -85.23 151.79 23.81 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.497 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -123.78 130.38 52.53 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.326 0.584 . . . . 0.0 111.795 -173.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.94 138.48 58.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.112 176.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.92 -19.21 28.17 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 111.341 -0.703 . . . . 0.0 111.341 -174.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -126.25 150.77 48.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.024 0.44 . . . . 0.0 110.415 176.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 20.1 pttm -89.33 152.13 21.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.29 -175.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.437 ' HB ' ' HB ' ' A' ' 2' ' ' ILE . 64.4 t -102.53 136.44 34.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.348 -178.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.438 ' O ' HG23 ' A' ' 13' ' ' ILE . 7.1 tp10 -88.52 121.2 70.29 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.738 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.27 151.64 20.53 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.244 1.963 . . . . 0.0 112.048 175.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.452 ' HB3' HG22 ' A' ' 12' ' ' THR . . . -113.68 116.8 30.01 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.402 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 61.8 mtt -96.73 110.25 22.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.472 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 54.8 mt -109.85 138.93 35.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.839 0.352 . . . . 0.0 111.07 -176.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -112.85 139.51 48.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.441 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -117.09 127.01 53.73 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 177.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.51 ' HG2' ' OE2' ' A' ' 86' ' ' GLU . 40.6 mtm180 -135.82 165.39 25.72 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.402 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 16.5 ptp180 -127.84 125.65 40.15 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.18 0.514 . . . . 0.0 111.262 -176.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.546 ' HG3' ' HA ' ' A' ' 84' ' ' ASP . 1.9 mpt? -119.92 141.02 49.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.557 -176.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -79.31 140.47 37.54 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.102 177.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -74.58 111.59 9.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.745 -174.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -104.86 -179.64 4.0 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 167.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -145.5 142.14 28.95 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.487 -171.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.72 -170.74 3.53 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.664 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -60.67 131.19 49.94 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.68 68.84 2.44 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 119.153 -1.499 . . . . 0.0 114.322 -165.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -126.76 -30.42 2.77 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 154.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.458 ' OD1' ' HB3' ' A' ' 92' ' ' GLU . 55.7 t30 -133.53 132.38 40.87 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 113.59 -1.641 . . . . 0.0 109.477 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.627 ' CD2' ' HG ' ' A' ' 98' ' ' LEU . 14.5 m-70 -124.23 143.65 50.41 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 55.7 t -92.56 134.17 31.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.026 -175.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.519 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 74.4 m-85 -128.9 126.12 39.04 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 174.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.0 mmt -99.15 117.92 34.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.777 0.323 . . . . 0.0 111.332 -175.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.597 ' HB3' ' H ' ' A' ' 89' ' ' GLU . 23.0 t70 -60.23 115.39 3.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.088 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -72.56 -18.75 61.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.315 -176.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.51 ' OE2' ' HG2' ' A' ' 68' ' ' ARG . 46.3 mt-10 -71.76 -45.78 60.56 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 120.669 -0.412 . . . . 0.0 109.949 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.4 p -169.42 91.3 0.23 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 168.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 47.51 28.19 1.12 Allowed 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 156.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.597 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 37.2 tt0 -93.79 118.14 31.03 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 118.711 0.687 . . . . 0.0 110.809 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -77.61 112.63 14.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.264 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 43.0 m -110.21 119.28 38.77 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.37 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.458 ' HB3' ' OD1' ' A' ' 79' ' ' ASN . 36.3 mt-10 -99.19 127.77 45.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.314 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 39.9 mt -118.89 148.9 42.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.018 0.437 . . . . 0.0 111.004 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.2 m -89.99 166.57 13.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.089 -174.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.8 t -55.52 -31.54 62.15 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.462 -177.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -50.35 -49.24 54.65 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.605 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -77.98 -40.67 38.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.362 0.601 . . . . 0.0 109.74 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.627 ' HG ' ' CD2' ' A' ' 80' ' ' HIS . 4.3 mm? -66.09 -13.82 60.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.88 -174.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -57.77 -39.03 76.48 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.915 0.388 . . . . 0.0 110.106 172.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.58 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 8.4 tp10 -78.09 -43.43 29.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.746 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.468 ' O ' HD12 ' A' ' 105' ' ' LEU . 1.2 mp0 -57.47 -46.21 83.93 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.654 175.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 82.4 mt -67.92 -9.07 42.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.98 0.419 . . . . 0.0 111.116 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.58 ' HB3' ' O ' ' A' ' 100' ' ' GLU . 23.1 t30 -78.73 -50.2 11.78 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 173.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -141.1 116.7 10.24 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.293 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.468 HD12 ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -171.64 167.46 6.53 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.251 0.548 . . . . 0.0 111.818 178.89 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.401 ' N ' HD22 ' A' ' 105' ' ' LEU . 66.1 mttm -141.67 143.67 33.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.842 168.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.5 mp0 -65.09 123.29 19.11 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 175.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.34 -13.43 47.89 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.039 -175.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.414 ' SD ' ' HG2' ' A' ' 126' ' ' PRO . 44.2 ttm -76.67 136.67 39.13 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 70' ' ' MET . 11.7 pt-20 -98.89 126.54 44.59 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.229 0.538 . . . . 0.0 111.142 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 31.4 m -106.71 160.05 6.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.905 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -100.14 100.86 11.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.065 0.46 . . . . 0.0 110.263 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.422 HD12 ' SD ' ' A' ' 70' ' ' MET . 65.1 mt -83.17 129.01 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.581 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.496 ' HG2' HD11 ' A' ' 121' ' ' ILE . 35.3 tt0 -106.8 117.36 33.84 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.925 -176.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 16.5 p -116.19 153.18 32.31 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.088 -174.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -130.03 99.39 5.06 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.935 176.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 61.97 31.79 17.96 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.374 0.607 . . . . 0.0 110.312 -174.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 93.78 -16.69 60.25 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.399 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -80.86 114.86 20.04 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 29.6 m -63.57 112.37 2.77 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.782 0.325 . . . . 0.0 110.604 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.496 HD11 ' HG2' ' A' ' 114' ' ' GLN . 38.7 pt -97.65 -23.97 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.04 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -170.47 163.46 36.68 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.016 -1.087 . . . . 0.0 112.848 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.3 t -127.63 126.63 67.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -106.59 120.6 42.38 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.76 -176.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.441 HD22 ' N ' ' A' ' 125' ' ' LEU . 1.9 mm? -86.18 150.21 51.67 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.414 ' HG2' ' SD ' ' A' ' 109' ' ' MET . 71.9 Cg_exo -51.42 130.89 34.59 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.697 2.265 . . . . 0.0 111.602 174.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.58 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 34.8 mmtp -62.37 -27.25 68.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.329 -170.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 34.9 p -121.32 112.73 18.95 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.97 176.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.1 p -114.8 137.03 49.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.164 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -109.32 99.03 8.34 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.226 0.536 . . . . 0.0 110.703 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.2 mt -106.9 142.05 37.14 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.056 0.455 . . . . 0.0 111.272 -173.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.4 m -84.14 133.7 34.61 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.037 176.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.6 p -87.34 112.37 23.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.629 0.728 . . . . 0.0 111.029 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 27.5 p -111.15 119.66 39.71 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.316 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 75.11 108.27 0.07 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.873 0.844 . . . . 0.0 111.041 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 8.9 t -150.55 153.44 35.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.673 178.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.452 ' O ' ' HD2' ' A' ' 150' ' ' LYS . 52.5 mt-10 -84.2 150.43 57.86 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.245 -176.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.29 179.9 6.07 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.51 2.14 . . . . 0.0 111.863 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 119.81 27.92 2.0 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.431 -177.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.9 tt . . . . . 0 C--N 1.33 -0.266 0 CA-C-O 121.277 0.56 . . . . 0.0 110.447 176.614 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 23.0 p . . . . . 0 N--CA 1.453 -0.279 0 CA-C-O 120.892 0.377 . . . . 0.0 110.507 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.452 ' HD2' ' O ' ' A' ' 137' ' ' GLU . 59.6 pttt -133.41 145.86 50.68 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.524 177.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 9.1 t -73.18 118.66 16.4 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.109 0.481 . . . . 0.0 110.338 -176.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -124.02 164.22 19.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.013 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 33.4 m -120.54 135.98 54.92 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 9.7 m -98.73 173.94 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.284 177.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -52.81 -31.23 37.69 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 68.5 p -74.42 -12.6 60.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.712 0.291 . . . . 0.0 111.721 -176.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 95.48 -4.72 66.93 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.015 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -75.53 144.91 41.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.992 0.425 . . . . 0.0 110.603 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 23.3 m -107.24 122.44 46.55 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.178 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.07 161.62 37.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.696 0.284 . . . . 0.0 110.302 -177.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -92.1 111.49 23.06 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.083 -175.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 27.4 m -101.14 155.81 35.89 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.228 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -58.2 152.09 55.12 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.357 2.038 . . . . 0.0 111.4 174.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 72.6 mt -64.08 -18.33 64.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.468 -169.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -91.28 -1.94 57.54 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -176.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 85.8 t -73.11 135.6 27.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.957 0.408 . . . . 0.0 110.694 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -113.98 151.51 32.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.193 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -63.33 125.7 25.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.115 0.483 . . . . 0.0 110.683 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 109.54 -10.5 32.93 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.19 -176.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.592 ' OD2' ' HD3' ' A' ' 184' ' ' ARG . 19.1 t70 -73.39 148.19 43.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.597 0.237 . . . . 0.0 110.676 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.477 ' O ' ' HD2' ' A' ' 184' ' ' ARG . 60.7 t -105.33 99.97 9.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.197 0.522 . . . . 0.0 110.51 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.558 ' H ' HD23 ' A' ' 172' ' ' LEU . 0.7 OUTLIER -96.01 141.17 29.73 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.603 -177.718 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.421 ' O ' ' HB ' ' A' ' 182' ' ' ILE . 59.2 mt -99.22 130.54 48.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.344 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 43.9 mm -117.87 141.43 36.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.58 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 23.6 t-20 -87.85 98.81 11.68 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 177.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.21 127.06 31.23 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.518 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 111.02 -37.25 3.81 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.652 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -104.78 -23.84 12.99 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.099 0.476 . . . . 0.0 110.359 176.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 73.88 17.53 79.36 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.201 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 9.6 p -84.42 152.37 24.06 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.873 0.368 . . . . 0.0 110.633 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -97.33 124.79 41.58 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.19 0.519 . . . . 0.0 110.671 -175.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' A' ' 173' ' ' ILE . 2.8 mp -106.74 151.02 8.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 174.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.2 p -77.15 173.56 11.71 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.377 -173.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ARG . . . . . 0.592 ' HD3' ' OD2' ' A' ' 170' ' ' ASP . 7.9 tpt180 -39.59 136.18 1.03 Allowed 'General case' 0 CA--C 1.533 0.319 0 O-C-N 123.754 0.659 . . . . 0.0 112.473 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.488 -1.174 . . . . 0.0 111.698 175.263 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.7 mtt . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 120.477 0.18 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.2 mm -104.29 122.87 57.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.7 0.286 . . . . 0.0 110.425 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.1 m -74.04 146.62 43.57 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 175.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.49 ' O ' HG21 ' A' ' 37' ' ' VAL . 20.7 m -70.11 -10.56 13.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.848 0.356 . . . . 0.0 111.744 -176.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -95.39 7.78 45.18 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.34 0.59 . . . . 0.0 109.542 177.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -120.79 87.79 2.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.687 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -136.9 152.84 50.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.217 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -128.19 167.44 16.83 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.809 -176.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.2 m -54.17 -30.24 48.64 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.344 0.592 . . . . 0.0 110.34 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.524 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -140.36 116.74 1.2 Allowed Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 169.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 54.9 tp -150.46 135.35 17.58 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 1.9 p -94.44 122.43 37.0 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.444 0.64 . . . . 0.0 112.192 -176.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.401 HD12 ' C ' ' A' ' 12' ' ' THR . 1.7 mp -119.39 141.92 37.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.53 -176.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.514 ' O ' ' HB3' ' A' ' 61' ' ' GLU . 43.1 t -107.32 107.73 18.79 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.433 HG12 ' CD1' ' A' ' 20' ' ' TRP . 13.1 p -142.2 140.6 29.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -178.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 61.3 32.77 19.2 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.6 -176.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 64.86 23.01 12.6 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.609 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.39 158.55 37.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.796 0.332 . . . . 0.0 110.514 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.6 pt -107.47 123.73 62.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.665 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.442 ' O ' ' HA ' ' A' ' 12' ' ' THR . 54.1 m95 -122.8 160.03 26.85 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.625 -172.1 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -130.58 115.04 16.21 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.524 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 94.9 t -64.76 119.14 8.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.705 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.4 mm -90.91 -35.96 7.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.718 176.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -160.82 122.09 2.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.067 177.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -104.45 143.28 33.22 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.735 0.302 . . . . 0.0 110.944 -176.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -118.85 99.43 6.75 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.881 0.372 . . . . 0.0 110.337 177.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -78.07 91.88 4.32 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 176.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 p -101.6 135.8 36.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.517 -171.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -109.1 101.76 46.18 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-O 121.309 0.576 . . . . 0.0 110.58 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -58.02 -48.2 17.24 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 123.345 2.696 . . . . 0.0 112.797 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.2 19.43 8.04 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.887 178.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -110.1 -14.31 14.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.681 0.277 . . . . 0.0 111.46 -177.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.05 -42.86 1.24 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.262 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.1 m -102.1 131.22 48.7 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 177.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.13 155.63 19.68 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 174.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 55' ' ' ARG . 34.9 m-85 -129.66 163.38 26.21 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.094 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.49 HG21 ' O ' ' A' ' 4' ' ' VAL . 52.8 t -132.7 102.7 5.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.179 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -80.73 98.96 7.98 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 175.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 53.2 p -100.64 134.2 43.96 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.134 -175.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -95.43 102.68 14.5 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 174.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.519 HD23 ' H ' ' A' ' 41' ' ' LEU . 1.3 pt? -138.48 150.96 46.96 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.804 0.335 . . . . 0.0 110.853 -171.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -116.96 144.92 44.01 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.543 -175.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.44 ' HB2' ' CZ3' ' A' ' 20' ' ' TRP . 47.4 t-20 -76.58 115.57 16.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.451 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.8 mt -69.77 -24.75 63.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.194 0.521 . . . . 0.0 110.733 -177.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.6 tpp180 -70.13 -38.8 75.64 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.011 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.3 p -113.48 -15.89 12.51 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -174.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.87 20.82 69.78 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.274 -0.489 . . . . 0.0 112.004 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -96.45 141.65 29.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.856 0.36 . . . . 0.0 111.799 -173.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.2 tp -87.92 137.18 21.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.251 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.481 ' HG3' ' N ' ' A' ' 51' ' ' GLU . 58.4 tp60 -148.46 175.25 11.29 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -178.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.481 ' N ' ' HG3' ' A' ' 50' ' ' GLN . 10.7 pt-20 -140.17 138.16 34.96 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 170.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -126.51 135.11 50.9 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.686 -175.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.2 p -102.23 102.66 13.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.929 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -85.17 149.32 25.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.026 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.426 ' HB3' ' CE2' ' A' ' 36' ' ' PHE . 5.7 ptm180 -120.18 134.96 55.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.974 0.416 . . . . 0.0 111.385 -175.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.05 132.71 54.68 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.915 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 108.03 -29.88 9.68 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -174.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -102.82 99.67 9.63 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -76.6 137.71 39.68 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.415 0.626 . . . . 0.0 110.831 -175.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.3 t -85.36 150.65 3.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.977 -169.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.514 ' HB3' ' O ' ' A' ' 14' ' ' SER . 34.7 tt0 -85.63 130.98 48.94 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.682 176.127 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -82.73 156.29 15.83 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.505 2.137 . . . . 0.0 112.895 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.441 ' HB2' ' HB2' ' A' ' 14' ' ' SER . . . -123.61 120.5 32.99 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.431 174.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 67.8 mtt -96.38 108.89 21.48 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.174 0.511 . . . . 0.0 110.799 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -110.2 121.6 63.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.485 177.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.583 ' OE1' ' HD2' ' A' ' 68' ' ' ARG . 40.6 tt0 -95.64 107.76 19.98 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.904 -176.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -84.39 100.77 11.5 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.357 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.583 ' HD2' ' OE1' ' A' ' 66' ' ' GLU . 16.2 mtp180 -106.08 170.24 8.03 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.142 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.585 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 7.7 ptm180 -142.71 120.06 11.6 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.459 0.647 . . . . 0.0 111.141 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.623 ' CB ' ' HB3' ' A' ' 82' ' ' PHE . 1.5 mpt? -115.59 139.94 49.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.926 -174.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -71.75 133.7 45.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.541 174.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -77.31 111.17 12.68 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -174.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -111.21 -179.04 3.61 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 169.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -148.7 159.59 43.98 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.312 0.577 . . . . 0.0 111.82 -175.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.23 -149.55 0.31 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.436 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -66.65 136.69 55.94 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 170.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.01 69.09 2.98 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 118.782 -1.675 . . . . 0.0 113.59 -170.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -127.11 -33.2 2.44 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 158.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -128.73 120.07 25.76 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 113.85 -1.523 . . . . 0.0 108.913 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.579 ' CG ' ' HG ' ' A' ' 98' ' ' LEU . 17.0 m-70 -102.39 132.28 48.49 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 57.1 t -83.58 125.64 40.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.081 -173.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.623 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 61.0 m-85 -123.03 120.54 33.63 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 176.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.575 ' SD ' ' HG2' ' A' ' 90' ' ' GLN . 93.5 mmm -95.19 113.3 24.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.917 -176.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.584 ' HB3' ' H ' ' A' ' 89' ' ' GLU . 20.9 t70 -58.46 117.39 4.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.239 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -76.49 -12.56 60.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.48 -177.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -68.91 -50.27 50.92 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 176.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.1 p -170.99 91.65 0.15 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.103 0.478 . . . . 0.0 112.288 164.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 48.31 26.62 1.14 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 160.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.584 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 45.7 mt-10 -87.59 113.16 23.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 118.666 0.666 . . . . 0.0 110.867 176.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.575 ' HG2' ' SD ' ' A' ' 83' ' ' MET . 73.5 mt-30 -74.47 118.14 17.09 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.343 -178.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.9 m -120.14 121.76 39.51 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.23 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -95.91 127.97 42.39 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.947 0.403 . . . . 0.0 110.483 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.434 HD12 ' CE1' ' A' ' 82' ' ' PHE . 59.6 mt -112.69 140.02 47.81 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.433 178.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.5 t -80.29 158.57 26.11 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.772 -177.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.2 p -58.98 -23.9 62.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.842 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.51 -39.45 87.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.808 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -82.75 -41.07 19.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.597 0.713 . . . . 0.0 109.35 177.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.579 ' HG ' ' CG ' ' A' ' 80' ' ' HIS . 3.3 mm? -67.24 -20.05 65.61 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.445 -171.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -60.94 -31.0 70.55 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.212 0.53 . . . . 0.0 110.096 175.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -82.61 -46.23 13.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.25 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.467 ' HA ' HD21 ' A' ' 125' ' ' LEU . 0.9 OUTLIER -62.13 -36.61 82.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.467 179.084 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.486 ' O ' ' HB ' ' A' ' 156' ' ' THR . 56.2 mt -67.21 -6.36 17.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.629 0.252 . . . . 0.0 111.608 -178.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -70.53 -41.47 72.5 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 172.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.504 ' HB3' HG11 ' A' ' 129' ' ' VAL . 68.8 m-85 -142.4 115.2 8.66 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.208 177.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 101' ' ' GLU . 0.7 OUTLIER 179.8 171.41 1.07 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 122.95 0.5 . . . . 0.0 110.739 173.004 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.542 ' HD2' ' O ' ' A' ' 130' ' ' GLU . 30.4 mtpp -142.48 144.73 33.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.306 176.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -62.73 113.79 3.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.862 0.363 . . . . 0.0 110.739 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 109.85 -10.28 32.14 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.402 -177.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.536 ' SD ' ' HG3' ' A' ' 126' ' ' PRO . 53.0 ttm -91.11 144.31 25.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.68 0.276 . . . . 0.0 110.465 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.62 ' HA ' ' O ' ' A' ' 70' ' ' MET . 8.4 pt-20 -94.2 138.91 31.68 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.365 0.602 . . . . 0.0 112.075 -177.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 33.9 m -113.57 158.13 14.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.58 175.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.566 ' HA ' ' O ' ' A' ' 68' ' ' ARG . 80.0 mt-30 -96.83 99.94 11.49 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.048 0.452 . . . . 0.0 110.652 -177.1 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.497 HD12 ' SD ' ' A' ' 70' ' ' MET . 63.7 mt -84.44 127.98 39.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.223 -178.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.405 ' O ' HG12 ' A' ' 121' ' ' ILE . 91.5 mt-30 -100.13 110.34 22.62 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.485 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 43.1 p -107.12 128.7 54.62 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.322 177.08 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -108.1 110.2 21.82 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 174.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 60.44 29.05 18.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.445 -176.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 98.31 -18.96 56.27 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.984 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 115' ' ' THR . 42.5 tt0 -84.64 126.88 33.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.638 0.219 . . . . 0.0 111.364 -176.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 85.5 m -68.21 100.82 1.08 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 175.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 114' ' ' GLN . 46.7 pt -84.79 -30.77 6.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.064 0.459 . . . . 0.0 110.328 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -170.86 162.38 35.32 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.692 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.4 t -123.81 127.31 73.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 177.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.456 ' HB3' ' HB2' ' A' ' 112' ' ' GLN . 31.0 tt0 -93.74 123.67 37.24 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.007 0.432 . . . . 0.0 109.961 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.477 HD23 ' HB2' ' A' ' 104' ' ' TYR . 7.0 mp -78.25 157.62 77.89 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.311 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.536 ' HG3' ' SD ' ' A' ' 109' ' ' MET . 6.9 Cg_endo -48.45 127.81 16.58 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.02 2.48 . . . . 0.0 112.249 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -56.8 -38.29 72.33 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.348 -178.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 29.7 p -133.18 109.27 9.33 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.832 174.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.504 HG11 ' HB3' ' A' ' 104' ' ' TYR . 10.4 p -111.41 140.86 28.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.731 0.3 . . . . 0.0 110.623 -176.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.542 ' O ' ' HD2' ' A' ' 106' ' ' LYS . 7.4 pt-20 -107.06 100.36 9.85 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.402 0.62 . . . . 0.0 110.481 177.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 89.7 mt -106.2 133.47 50.86 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.343 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.4 m -76.12 130.85 38.92 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.098 178.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.431 ' HB ' HD11 ' A' ' 172' ' ' LEU . 7.5 p -78.88 105.61 8.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.913 0.863 . . . . 0.0 110.652 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 37.0 p -107.53 112.37 25.09 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.427 -178.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 79.06 96.67 0.06 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-O 122.068 0.937 . . . . 0.0 111.036 -177.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.608 ' O ' ' HD3' ' A' ' 138' ' ' PRO . 9.7 t -150.65 153.36 35.49 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.086 -1.415 . . . . 0.0 107.663 174.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -84.29 103.27 2.83 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.608 ' HD3' ' O ' ' A' ' 136' ' ' THR . 68.8 Cg_endo -90.11 172.81 3.56 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.835 2.357 . . . . 0.0 112.356 -175.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.49 21.24 77.54 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.772 176.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 56.5 mt . . . . . 0 C--N 1.325 -0.492 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.552 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 18.0 p . . . . . 0 N--CA 1.448 -0.564 0 CA-C-O 121.195 0.521 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -125.25 148.18 48.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.953 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 42.5 m -73.72 107.17 5.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.089 0.471 . . . . 0.0 110.76 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -107.9 163.5 13.07 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.852 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 21.1 m -118.79 134.52 55.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.047 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.5 m -98.54 175.79 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.506 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -57.31 -28.2 62.86 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.486 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 44.1 p -73.94 -11.01 60.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.017 0.436 . . . . 0.0 111.652 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.59 1.85 73.71 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -176.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -81.53 143.27 32.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.915 0.388 . . . . 0.0 110.856 -177.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 23.1 m -100.96 126.91 47.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.399 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.92 155.49 41.64 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -85.79 123.69 31.45 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.36 0.6 . . . . 0.0 111.3 -175.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.401 ' HB ' HG21 ' A' ' 166' ' ' VAL . 27.3 m -116.61 155.06 49.23 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.368 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -56.85 150.51 54.14 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.444 2.096 . . . . 0.0 111.65 175.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 80.7 mt -62.95 -17.3 61.78 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -169.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -88.6 -8.32 54.89 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -176.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.401 HG21 ' HB ' ' A' ' 162' ' ' VAL . 74.5 t -69.24 136.6 25.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.81 0.338 . . . . 0.0 111.249 -177.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -122.68 160.89 24.89 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.479 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -59.4 128.04 35.09 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.887 -177.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 109.42 -15.61 32.42 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.536 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.563 ' OD2' ' HD3' ' A' ' 184' ' ' ARG . 23.7 t70 -67.26 145.35 55.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.8 0.3 . . . . 0.0 110.591 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.427 ' CG1' ' HB2' ' A' ' 130' ' ' GLU . 47.2 t -94.7 109.91 22.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.157 0.503 . . . . 0.0 110.379 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.431 HD11 ' HB ' ' A' ' 133' ' ' VAL . 46.7 mt -90.97 117.33 29.48 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.454 -178.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.404 HD12 ' N ' ' A' ' 173' ' ' ILE . 1.8 mp -91.43 106.45 17.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 57.8 mt -107.67 129.62 61.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.573 -176.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -82.22 96.41 7.85 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.373 175.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.458 HG21 ' HB2' ' A' ' 125' ' ' LEU . 6.5 m -61.68 136.59 58.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.006 -175.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 104.11 -33.74 6.33 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -107.66 -26.73 10.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.026 0.441 . . . . 0.0 110.505 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.36 15.32 76.75 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.206 177.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 5.9 m -68.96 112.65 5.74 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -96.22 111.41 23.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.188 0.518 . . . . 0.0 110.957 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 4.5 mp -107.81 102.35 13.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.124 0.488 . . . . 0.0 110.114 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 48.3 t -80.53 166.74 20.89 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.368 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ARG . . . . . 0.563 ' HD3' ' OD2' ' A' ' 170' ' ' ASP . 25.1 mmt180 72.46 30.22 1.98 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 172.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.137 0 CA-C-O 118.147 -1.363 . . . . 0.0 113.604 174.345 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.9 mtt . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.507 ' HB ' HG23 ' A' ' 60' ' ' VAL . 3.7 mp -81.76 118.86 30.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.242 0.544 . . . . 0.0 110.757 -176.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 m -97.36 151.95 19.42 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.337 171.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.9 m -67.18 -14.68 18.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -167.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -86.06 -0.1 54.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.427 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -133.6 91.31 2.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.242 0.544 . . . . 0.0 111.786 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -126.27 156.7 39.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.589 172.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -126.94 162.11 26.74 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -177.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 p -53.0 -20.36 3.37 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 123.556 0.535 . . . . 0.0 111.63 175.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.603 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -144.49 115.78 0.89 Allowed Glycine 0 N--CA 1.435 -1.376 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 167.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.72 129.22 20.17 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.56 HG21 ' CG1' ' A' ' 65' ' ' ILE . 1.2 m -103.29 118.27 36.4 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.193 0.52 . . . . 0.0 111.055 -178.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.0 mp -117.94 140.31 41.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.321 -176.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.7 t -102.33 102.02 12.34 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 175.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.5 p -140.34 146.27 24.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.446 -177.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 61.94 28.45 17.32 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.493 -176.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.1 m120 63.86 25.66 14.09 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.445 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.86 163.39 29.61 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.098 177.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 10.1 pt -109.56 126.27 66.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.392 -178.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.553 ' O ' ' HA ' ' A' ' 12' ' ' THR . 64.8 m95 -124.11 146.56 48.55 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.088 -170.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -120.78 104.05 9.58 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.318 -177.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.603 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 78.9 t -63.02 111.91 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.76 177.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.2 mt -92.68 -33.91 5.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.695 176.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.405 ' HB2' ' HD3' ' A' ' 40' ' ' LYS . 33.0 m-20 -143.12 148.78 37.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.022 177.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -141.6 131.75 24.8 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.079 0.466 . . . . 0.0 110.905 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -122.37 110.02 15.13 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.373 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -80.06 101.24 8.6 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.5 p -108.5 134.11 51.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.295 0.569 . . . . 0.0 111.331 -172.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -122.89 100.55 40.2 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.701 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -76.25 -10.49 19.22 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.343 2.029 . . . . 0.0 112.199 177.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.6 25.78 60.17 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.774 -0.648 . . . . 0.0 113.087 175.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -87.56 -12.86 44.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.919 0.39 . . . . 0.0 111.145 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.96 -42.57 1.27 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.685 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.7 p -123.01 132.41 54.12 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 174.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.04 161.65 25.28 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.848 0.356 . . . . 0.0 110.627 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.479 ' HA ' ' O ' ' A' ' 54' ' ' PHE . 86.1 m-85 -128.59 165.46 20.74 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.102 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 53' ' ' THR . 59.5 t -129.67 106.41 13.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 176.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -80.37 99.29 7.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.202 177.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 16.1 p -111.03 137.15 49.02 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.27 -174.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.405 ' HD3' ' HB2' ' A' ' 24' ' ' ASP . 45.9 mtpt -95.28 108.85 21.03 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 175.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.529 HD23 ' H ' ' A' ' 41' ' ' LEU . 1.1 pt? -135.94 141.82 44.53 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.764 0.793 . . . . 0.0 111.899 -172.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 33.0 ttt180 -103.77 129.8 51.23 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.86 -1.063 . . . . 0.0 111.49 -173.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -70.12 117.95 12.34 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 172.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.422 ' H ' HD12 ' A' ' 44' ' ' LEU . 5.9 mp -64.61 -26.82 68.57 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 121.188 -0.205 . . . . 0.0 111.434 -175.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.443 HH11 ' HD2' ' A' ' 45' ' ' ARG . 59.3 mtt180 -76.55 -50.07 14.83 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.825 0.345 . . . . 0.0 111.467 -177.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.4 p -94.54 -17.65 22.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.047 0.451 . . . . 0.0 111.811 -172.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.24 6.57 88.85 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.719 -175.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 42' ' ' ARG . . . -68.64 131.04 44.54 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -174.09 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.7 mm -91.53 98.84 8.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.416 ' HG2' ' N ' ' A' ' 51' ' ' GLU . 34.7 tt0 -112.47 167.34 10.52 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -178.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.416 ' N ' ' HG2' ' A' ' 50' ' ' GLN . 11.0 pt-20 -132.5 125.91 31.7 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.152 0.501 . . . . 0.0 109.949 173.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.445 ' HD2' HD11 ' A' ' 41' ' ' LEU . 56.3 mttm -115.36 148.19 39.59 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.74 -176.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 10.8 p -112.6 105.06 13.17 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.244 176.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.479 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 88.3 m-85 -84.1 144.96 28.7 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.726 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.554 ' HD3' ' OE2' ' A' ' 58' ' ' GLU . 34.5 ttt180 -111.09 136.08 50.66 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.743 0.306 . . . . 0.0 111.549 -173.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.13 129.79 42.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.818 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 106.27 -16.75 41.51 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -175.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.554 ' OE2' ' HD3' ' A' ' 55' ' ' ARG . 81.1 mt-10 -112.71 149.56 32.75 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -127.67 163.41 24.32 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.298 -176.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.507 HG23 ' HB ' ' A' ' 2' ' ' ILE . 5.6 m -134.16 157.63 41.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.37 0.605 . . . . 0.0 111.469 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -83.59 141.56 41.99 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.03 -0.987 . . . . 0.0 110.443 -176.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.27 154.73 41.47 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.538 2.159 . . . . 0.0 112.454 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.44 113.07 18.85 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.954 175.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 26.3 mmt -88.64 109.03 19.77 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.99 0.424 . . . . 0.0 110.62 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.56 ' CG1' HG21 ' A' ' 12' ' ' THR . 46.9 mm -99.37 125.4 52.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.049 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.498 ' HG3' ' OG1' ' A' ' 115' ' ' THR . 6.0 pt-20 -117.6 138.02 52.22 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.595 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -112.98 113.86 26.09 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.954 0.406 . . . . 0.0 110.213 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.515 ' HB3' ' OD1' ' A' ' 84' ' ' ASP . 68.6 mtt180 -110.36 117.47 33.71 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.17 -178.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 9.2 ptm180 -74.05 121.14 20.62 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 174.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.559 ' HG2' ' HA ' ' A' ' 84' ' ' ASP . 28.7 mtt -124.08 147.72 47.66 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.448 -175.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -77.41 136.56 38.41 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.903 177.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -77.14 103.78 7.26 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.413 -176.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 8.4 mp -104.32 -176.81 3.19 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 170.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -146.79 157.09 43.59 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.621 0.724 . . . . 0.0 112.448 -171.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 79' ' ' ASN . . . -150.57 -160.83 1.22 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.308 -1.314 . . . . 0.0 107.713 174.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -72.08 143.15 49.17 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 175.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.5 68.66 2.41 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 118.879 -1.629 . . . . 0.0 113.879 -167.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.579 ' HA ' ' OG ' ' A' ' 95' ' ' SER . 22.8 m-20 -127.93 -30.43 2.48 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 156.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.47 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 92.6 m-20 -137.07 138.65 40.63 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.512 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -121.69 144.56 48.7 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 173.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.444 ' O ' ' HB2' ' A' ' 73' ' ' LEU . 45.9 t -90.41 132.33 35.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.499 -178.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -126.43 125.53 42.3 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 174.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 37.8 mtt -93.7 113.32 25.37 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.454 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.677 ' HB3' ' H ' ' A' ' 89' ' ' GLU . 20.2 t0 -62.15 115.01 3.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.511 -177.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -85.46 -7.13 59.08 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.023 177.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.59 -52.24 27.84 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 173.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.44 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 12.1 p -164.75 90.03 0.52 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 167.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 47.33 28.26 1.03 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 158.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.677 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 49.2 mt-10 -105.89 116.53 32.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 118.981 0.809 . . . . 0.0 112.408 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -75.86 118.68 18.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.277 0.561 . . . . 0.0 110.027 175.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.1 m -120.99 138.26 54.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.547 -175.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -105.87 134.55 48.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.797 0.332 . . . . 0.0 110.817 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 79' ' ' ASN . 4.5 mm? -112.88 143.01 44.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.427 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.7 m -79.64 166.93 21.35 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -173.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.579 ' OG ' ' HA ' ' A' ' 78' ' ' ASP . 10.2 m -52.93 -33.38 50.41 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.749 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -52.14 -40.69 61.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.734 -176.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -87.64 -41.03 13.69 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.42 0.628 . . . . 0.0 109.953 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.487 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 4.3 mm? -74.32 -20.88 59.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.314 -171.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -60.58 -32.26 71.37 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.126 0.489 . . . . 0.0 110.204 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -87.44 -39.4 15.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.387 177.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.455 ' O ' HD12 ' A' ' 105' ' ' LEU . 40.7 mt-10 -63.57 -25.62 68.32 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.343 178.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 65.8 mt -71.44 -7.4 47.14 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 122.021 -0.424 . . . . 0.0 110.865 177.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -90.09 -43.8 10.24 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 172.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -130.36 116.24 18.02 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.315 176.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.455 HD12 ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -172.4 164.2 5.68 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.728 0.299 . . . . 0.0 110.627 177.459 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -143.16 138.87 30.07 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -63.7 123.13 18.09 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.638 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.32 1.65 71.75 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.751 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.41 ' SD ' ' HD2' ' A' ' 126' ' ' PRO . 51.9 ttm -62.75 147.62 49.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.106 0.479 . . . . 0.0 111.53 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.43 ' HG2' HH21 ' A' ' 69' ' ' ARG . 4.3 tp10 -89.41 100.32 13.14 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.593 175.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 23.1 m -106.55 155.74 7.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.63 -178.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.53 ' HB2' ' HB3' ' A' ' 124' ' ' GLU . 12.8 mm100 -96.99 99.65 11.18 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.447 HD13 HG13 ' A' ' 123' ' ' VAL . 32.8 mm -81.88 116.0 25.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 177.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.419 ' HG2' HD11 ' A' ' 121' ' ' ILE . 17.7 tt0 -91.69 113.16 25.35 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.498 ' OG1' ' HG3' ' A' ' 66' ' ' GLU . 1.7 p -116.11 157.85 24.11 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.705 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -129.64 101.91 6.13 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 176.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 58.55 33.98 23.53 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.225 -173.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 96.49 -22.59 39.27 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.989 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -75.53 131.4 40.03 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.824 -0.221 . . . . 0.0 110.569 -178.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.6 p -75.22 113.24 12.36 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.734 0.302 . . . . 0.0 110.865 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.419 HD11 ' HG2' ' A' ' 114' ' ' GLN . 40.1 pt -105.94 -21.41 5.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.444 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -169.27 163.71 37.35 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.179 -1.01 . . . . 0.0 112.742 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.447 HG13 HD13 ' A' ' 113' ' ' ILE . 59.9 t -130.35 129.53 64.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 177.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.53 ' HB3' ' HB2' ' A' ' 112' ' ' GLN . 35.3 tt0 -108.97 101.12 10.24 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.295 0.569 . . . . 0.0 110.669 178.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -77.66 126.22 84.72 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 173.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.41 ' HD2' ' SD ' ' A' ' 109' ' ' MET . 30.5 Cg_exo -37.74 127.5 0.79 Allowed 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.791 2.994 . . . . 0.0 113.359 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.595 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 75.5 mmtt -62.49 -26.73 68.69 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.9 -172.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 p -119.08 108.85 15.22 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.072 0.463 . . . . 0.0 109.944 172.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.2 p -110.5 136.41 46.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.428 -177.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -96.45 115.08 26.85 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.847 0.356 . . . . 0.0 110.38 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 80.9 mt -124.38 131.9 53.52 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.584 -177.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.9 m -79.29 134.93 36.63 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.36 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.416 HG13 ' HA ' ' A' ' 168' ' ' GLU . 7.4 p -85.13 118.28 31.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.621 0.724 . . . . 0.0 110.868 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.539 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 43.2 p -130.97 126.13 35.2 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.496 178.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.539 ' HB2' ' O ' ' A' ' 134' ' ' THR . 48.7 mm-40 79.4 79.07 0.05 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.675 0.75 . . . . 0.0 111.175 -175.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.587 ' O ' ' HD3' ' A' ' 138' ' ' PRO . 11.1 t -150.23 153.58 36.46 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 171.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -102.12 99.65 13.04 Favored Pre-proline 0 C--N 1.321 -0.646 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.348 -178.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.587 ' HD3' ' O ' ' A' ' 136' ' ' THR . 84.6 Cg_endo -91.54 -179.17 1.29 Allowed 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.08 2.52 . . . . 0.0 112.186 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 94.87 13.67 52.28 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.478 178.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.7 mp . . . . . 0 C--N 1.325 -0.476 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.346 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.514 ' HB ' ' HB3' ' A' ' 161' ' ' ASN . 36.9 p . . . . . 0 N--CA 1.45 -0.461 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -131.64 152.48 50.81 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.453 178.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.4 p -72.78 117.56 14.63 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.051 0.453 . . . . 0.0 111.358 -177.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 159' ' ' THR . . . -119.66 158.62 26.07 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.954 -178.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 134' ' ' THR . 18.4 m -109.73 138.48 46.03 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 174.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.0 m -105.63 178.87 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.496 175.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -54.97 -30.25 58.75 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 79.4 p -76.41 -8.87 58.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.805 0.336 . . . . 0.0 111.839 -177.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 86.13 3.29 85.17 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.582 -175.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -80.79 143.47 32.83 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.851 0.357 . . . . 0.0 110.555 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 152' ' ' ALA . 30.1 m -101.07 120.22 39.89 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.06 177.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.2 161.49 35.6 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.514 ' HB3' ' HB ' ' A' ' 149' ' ' THR . 89.4 m-20 -92.84 112.93 25.06 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.881 0.372 . . . . 0.0 111.53 -173.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.42 ' HB ' HG21 ' A' ' 166' ' ' VAL . 29.2 m -108.32 148.18 37.1 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.393 178.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.38 149.22 30.51 Favored 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.558 2.172 . . . . 0.0 111.964 174.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 59.4 mt -62.38 -11.72 17.24 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -170.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -104.18 10.33 35.81 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -176.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.42 HG21 ' HB ' ' A' ' 162' ' ' VAL . 75.5 t -78.73 142.41 14.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 178.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -114.41 145.22 42.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.437 -175.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.446 ' HG2' HG22 ' A' ' 136' ' ' THR . 48.7 mt-10 -62.53 127.06 29.52 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.615 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 112.12 -16.44 25.1 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.356 -176.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -75.49 154.91 36.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.987 0.422 . . . . 0.0 110.631 177.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 88.6 t -105.04 116.63 49.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.747 -177.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.42 HD22 ' N ' ' A' ' 172' ' ' LEU . 2.5 mm? -99.2 138.36 36.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.073 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.58 ' O ' ' HB ' ' A' ' 182' ' ' ILE . 57.0 mt -97.28 115.37 36.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 33.7 mm -109.85 141.31 25.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.427 -178.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.595 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 27.2 t-20 -86.52 103.1 14.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.991 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.0 m -71.77 113.03 8.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.231 176.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 143.43 -47.1 0.81 Allowed Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -177.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -118.81 -22.73 7.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.982 0.42 . . . . 0.0 110.373 175.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 89.48 17.24 55.51 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.109 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 4.2 m -65.04 136.57 56.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.582 0.23 . . . . 0.0 110.605 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -89.84 117.17 28.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.145 0.498 . . . . 0.0 110.927 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.58 ' HB ' ' O ' ' A' ' 173' ' ' ILE . 4.0 mp -96.87 151.42 4.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 169.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 10.7 p -77.11 173.1 12.22 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.829 -0.169 . . . . 0.0 111.018 -173.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 39.0 mtt180 -46.03 144.3 1.93 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.686 0.616 . . . . 0.0 111.885 -176.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.734 -1.037 . . . . 0.0 111.852 177.928 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 120.917 0.389 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 84.5 mt -75.28 134.68 28.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.036 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 m -94.83 143.79 26.17 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 174.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.525 HG21 ' HA ' ' A' ' 56' ' ' ALA . 10.8 m -69.11 -1.99 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -172.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -90.09 -2.63 58.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.657 0.265 . . . . 0.0 110.593 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -134.0 89.93 2.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.527 0.679 . . . . 0.0 111.518 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.456 ' CE1' ' HA ' ' A' ' 4' ' ' VAL . 61.6 m-85 -119.58 153.01 36.1 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 171.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -119.57 171.64 8.22 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.477 -176.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.1 p -65.17 -14.57 60.91 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.767 0.794 . . . . 0.0 109.978 174.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.49 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -153.13 115.12 0.66 Allowed Glycine 0 N--CA 1.435 -1.369 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 166.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.6 tp -149.99 132.0 15.26 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.671 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 1.7 m -98.39 122.69 41.89 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.321 0.581 . . . . 0.0 112.092 -172.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.0 mp -117.27 143.73 26.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.279 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.462 ' HB2' ' HB2' ' A' ' 63' ' ' ALA . 35.5 t -104.43 107.43 18.36 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 175.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.9 p -153.93 151.28 11.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -176.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 54.78 45.09 27.39 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 -176.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.7 p30 47.29 31.66 1.87 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.314 1.046 . . . . 0.0 112.222 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.7 166.06 25.69 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.466 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.8 pt -112.13 130.58 65.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.83 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.671 ' O ' ' HA ' ' A' ' 12' ' ' THR . 70.2 m95 -126.6 147.91 49.83 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.885 -168.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.4 ttmm -116.95 104.02 10.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.549 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.49 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 84.1 t -62.81 109.06 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.872 0.368 . . . . 0.0 110.303 177.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 77.0 mt -88.85 -38.15 11.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.512 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -142.47 152.53 42.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.481 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -143.77 136.44 27.2 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.991 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 50.0 tp60 -113.26 99.65 7.97 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.708 176.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 62.4 t-80 -76.05 90.02 3.03 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.0 p -96.5 118.95 43.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.567 0.699 . . . . 0.0 111.519 -171.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -119.81 96.83 49.66 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.428 176.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.88 -10.77 15.38 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.482 2.121 . . . . 0.0 113.148 -177.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.2 26.65 39.51 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.958 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -95.46 10.67 35.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.796 0.331 . . . . 0.0 111.265 -176.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.48 -42.03 2.03 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.12 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.1 p -133.18 146.58 51.66 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 177.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -96.35 166.13 11.86 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.113 0.482 . . . . 0.0 111.134 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -136.25 167.07 21.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.492 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.9 t -131.88 102.62 5.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.086 0.47 . . . . 0.0 109.733 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -82.47 99.33 9.4 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 40.5 p -102.76 143.87 31.85 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.916 -173.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -102.52 102.82 13.13 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 174.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.611 HD23 ' H ' ' A' ' 41' ' ' LEU . 1.3 pt? -133.02 150.96 52.11 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.687 0.756 . . . . 0.0 112.36 -169.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 20.3 ttt180 -110.69 129.67 55.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.038 -171.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -69.96 122.52 19.48 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 173.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.9 mp -66.85 -25.67 66.54 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -176.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.1 mtt85 -81.33 -44.83 17.06 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.671 0.272 . . . . 0.0 111.72 -177.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 67.2 p -99.09 -17.07 18.4 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.132 0.492 . . . . 0.0 111.943 -173.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.31 13.64 81.32 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.793 -175.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 42' ' ' ARG . . . -73.53 133.27 43.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.917 0.389 . . . . 0.0 111.672 -175.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 26.4 mm -96.15 99.15 8.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.378 176.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.456 ' O ' HD23 ' A' ' 41' ' ' LEU . 52.6 tt0 -119.75 157.23 29.02 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -177.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 39' ' ' SER . 15.1 pt-20 -113.9 127.02 55.8 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.291 0.567 . . . . 0.0 110.092 175.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -129.09 146.22 51.1 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.626 -175.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.1 m -107.77 120.66 42.87 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.269 0.557 . . . . 0.0 111.899 -175.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -92.03 155.45 18.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.251 173.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -117.6 132.13 56.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.143 0.497 . . . . 0.0 111.429 -176.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.525 ' HA ' HG21 ' A' ' 4' ' ' VAL . . . -67.3 129.66 40.62 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.871 -178.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.19 -16.24 32.63 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -175.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -106.27 137.82 43.55 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -93.4 132.45 37.63 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.122 0.486 . . . . 0.0 110.61 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.5 t -96.03 145.62 8.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.662 -175.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -87.52 125.64 64.68 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.701 0.286 . . . . 0.0 110.493 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -79.12 152.79 24.49 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.563 2.175 . . . . 0.0 112.754 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.462 ' HB2' ' HB2' ' A' ' 14' ' ' SER . . . -117.56 109.39 16.64 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.569 176.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 61.4 mtt -87.25 108.68 19.05 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.168 0.508 . . . . 0.0 110.219 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.462 ' CG1' HG21 ' A' ' 12' ' ' THR . 52.1 mm -90.79 132.67 34.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.073 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -104.72 103.61 13.27 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.955 -177.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -93.99 101.34 13.39 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.938 0.399 . . . . 0.0 110.194 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 41.6 mtm180 -107.05 168.02 9.49 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -134.66 122.11 21.78 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.326 0.584 . . . . 0.0 111.022 -175.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.544 ' CB ' ' HB3' ' A' ' 82' ' ' PHE . 1.9 mpt? -117.39 149.07 41.14 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.348 -173.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -90.87 139.81 30.4 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 174.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -70.74 103.22 2.51 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.773 -174.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -94.49 -175.18 3.54 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 167.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -143.07 142.96 31.68 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 119.764 -0.774 . . . . 0.0 112.511 -167.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 79' ' ' ASN . . . -151.85 -172.83 4.34 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.261 -1.336 . . . . 0.0 108.812 175.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -76.61 145.73 38.71 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.13 68.64 2.59 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 118.984 -1.579 . . . . 0.0 114.095 -167.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -126.89 -30.81 2.7 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 156.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.617 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 21.1 p-10 -140.98 132.74 27.37 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 113.608 -1.633 . . . . 0.0 109.68 177.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.531 ' CG ' HD22 ' A' ' 98' ' ' LEU . 54.7 m170 -114.92 146.96 40.59 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 172.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 44.8 t -95.7 125.45 48.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.91 -176.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.544 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 78.8 m-85 -121.68 117.59 27.04 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 89.0 mmm -91.41 114.24 26.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.849 0.357 . . . . 0.0 111.22 -174.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.562 ' HB3' ' H ' ' A' ' 89' ' ' GLU . 22.4 t70 -62.16 116.49 5.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.39 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -77.68 -11.56 59.88 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.439 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -73.3 -50.52 21.73 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 176.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.6 p -169.09 91.59 0.25 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 168.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 48.42 25.32 0.88 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 157.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.562 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 41.6 mt-10 -95.68 116.76 29.34 Favored 'General case' 0 C--N 1.32 -0.702 0 O-C-N 121.453 -0.78 . . . . 0.0 111.172 176.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -85.35 98.26 10.44 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.392 0.615 . . . . 0.0 110.791 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.8 m -89.02 117.04 27.75 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.325 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 80' ' ' HIS . 44.2 mt-10 -95.95 126.15 40.99 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 177.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.617 ' O ' ' HA ' ' A' ' 79' ' ' ASN . 70.9 mt -104.5 146.72 28.47 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.579 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.605 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 28.5 t -86.05 167.34 15.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.66 -175.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.8 p -49.06 -35.69 16.48 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -175.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -53.8 -40.58 66.47 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.903 0.382 . . . . 0.0 111.536 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -80.53 -35.28 34.71 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.291 0.567 . . . . 0.0 109.798 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 94' ' ' SER . 13.3 mt -67.35 -30.37 70.16 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.137 -172.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -63.04 -43.65 98.09 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.949 0.404 . . . . 0.0 110.666 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -65.84 -36.4 83.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.897 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.489 ' O ' HD12 ' A' ' 105' ' ' LEU . 51.1 mt-10 -62.39 -41.31 98.56 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.508 173.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 73.5 mt -63.74 -20.77 66.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.931 0.396 . . . . 0.0 110.617 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -72.02 -50.14 31.05 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 173.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -138.64 116.02 11.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.071 176.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.489 HD12 ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -164.15 150.69 11.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.898 0.38 . . . . 0.0 110.646 178.003 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -145.83 134.96 22.77 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 172.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -64.79 123.42 19.33 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.909 -177.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 101.57 -6.1 54.99 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.565 -178.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 50.4 ttm -69.7 133.45 47.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.806 0.336 . . . . 0.0 110.65 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -95.33 101.86 13.62 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.09 0.471 . . . . 0.0 110.376 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 32.8 m -100.56 166.82 2.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.567 -177.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -108.57 109.18 20.34 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 46.5 mt -89.81 123.75 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-O 121.233 0.54 . . . . 0.0 109.633 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.492 ' HG2' HD11 ' A' ' 121' ' ' ILE . 31.2 tt0 -96.42 107.67 20.09 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.74 -174.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 40.9 p -109.19 159.06 17.23 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 121.44 0.638 . . . . 0.0 111.771 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -137.58 106.31 5.9 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 60.88 32.26 20.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.865 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 98.82 -18.33 57.01 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.052 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -88.36 134.82 33.72 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 122.798 -0.236 . . . . 0.0 110.927 -176.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.0 p -77.93 108.68 11.36 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.733 0.301 . . . . 0.0 110.36 175.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.492 HD11 ' HG2' ' A' ' 114' ' ' GLN . 36.0 pt -92.02 -27.11 4.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.839 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -169.59 167.74 40.75 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.672 177.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 55.7 t -125.35 121.22 59.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -102.78 112.17 24.83 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.015 0.436 . . . . 0.0 110.508 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 66.0 mt -78.7 152.65 77.94 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 175.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.51 144.23 52.34 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.363 2.042 . . . . 0.0 110.635 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.719 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 14.3 mmmm -64.82 -22.35 66.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.705 -173.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 26.3 p -125.55 113.43 17.42 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.862 0.363 . . . . 0.0 111.334 176.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 9.6 p -114.84 140.44 35.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.614 175.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -112.8 124.52 52.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.553 0.692 . . . . 0.0 111.352 177.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 95.7 mt -129.27 145.63 51.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.911 -175.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.3 m -85.52 132.71 34.15 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.128 176.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 170' ' ' ASP . 5.8 p -85.81 108.84 17.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.815 0.817 . . . . 0.0 110.769 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.679 ' O ' ' HB ' ' A' ' 153' ' ' THR . 26.9 p -116.48 124.59 50.32 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.621 178.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.541 ' HB2' ' O ' ' A' ' 134' ' ' THR . 1.5 mp0 77.36 86.61 0.08 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.904 0.859 . . . . 0.0 111.18 -176.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.448 ' O ' ' HD3' ' A' ' 138' ' ' PRO . 14.4 t -148.7 156.27 42.14 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 173.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -81.2 109.6 14.57 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -175.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 136' ' ' THR . 98.2 Cg_endo -89.08 166.7 5.62 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.947 2.431 . . . . 0.0 112.944 -176.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.31 -1.3 88.6 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.036 -0.602 . . . . 0.0 113.081 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.449 HD12 ' HD3' ' A' ' 150' ' ' LYS . 58.1 mt . . . . . 0 C--N 1.326 -0.418 0 CA-C-O 121.315 0.579 . . . . 0.0 110.564 -177.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.5 p . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 121.285 0.564 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.449 ' HD3' HD12 ' A' ' 140' ' ' ILE . 37.4 ttpt -127.64 136.28 51.41 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.626 -178.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 35.9 p -72.76 120.19 18.04 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.074 0.464 . . . . 0.0 110.404 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 159' ' ' THR . . . -125.13 160.48 29.02 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.159 -178.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.679 ' HB ' ' O ' ' A' ' 134' ' ' THR . 1.6 m -111.45 136.58 50.41 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.4 m -102.48 177.73 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.175 174.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -55.63 -29.27 58.92 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.407 HG22 HD13 ' A' ' 105' ' ' LEU . 80.3 p -75.93 -9.41 58.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.022 0.439 . . . . 0.0 111.529 -177.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 87.56 7.59 75.32 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.091 -0.576 . . . . 0.0 111.898 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -86.14 141.26 29.5 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.666 0.269 . . . . 0.0 110.943 -177.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 152' ' ' ALA . 17.9 m -95.57 115.43 27.42 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.158 176.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.33 161.9 32.39 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -94.52 113.28 25.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.531 0.681 . . . . 0.0 111.54 -174.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 27.3 m -108.59 150.5 40.79 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.971 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.21 150.76 47.12 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.295 1.997 . . . . 0.0 111.481 174.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 54.5 mt -58.28 -23.19 55.42 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -168.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -85.54 -9.36 57.5 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -174.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 94.6 t -70.5 136.18 26.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -122.91 163.45 20.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.868 0.366 . . . . 0.0 110.141 -174.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -60.67 128.05 34.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.733 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 109.43 -16.91 31.59 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.55 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.408 ' OD1' ' HD2' ' A' ' 184' ' ' ARG . 7.1 m-20 -64.85 138.74 58.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.952 0.406 . . . . 0.0 111.404 178.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 61.1 t -97.72 104.02 15.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 172.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.484 ' H ' HD23 ' A' ' 172' ' ' LEU . 0.7 OUTLIER -100.31 143.08 30.91 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.71 -176.427 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.523 ' O ' ' HB ' ' A' ' 182' ' ' ILE . 60.7 mt -99.32 136.97 28.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.649 177.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 61.7 mt -127.18 138.21 55.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.719 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 26.6 t-20 -81.0 91.98 6.14 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.011 176.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.9 118.78 18.24 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.115 0.484 . . . . 0.0 110.62 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 129.43 -48.28 0.98 Allowed Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -175.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ASP . . . . . 0.42 ' HB2' ' OD1' ' A' ' 175' ' ' ASN . 17.1 m-20 -106.28 -24.92 12.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.03 0.443 . . . . 0.0 110.098 177.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 86.92 15.12 63.57 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.434 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 6.0 m -72.27 127.05 31.36 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -79.42 122.84 26.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.16 0.505 . . . . 0.0 110.386 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.523 ' HB ' ' O ' ' A' ' 173' ' ' ILE . 9.8 mm -100.41 155.2 4.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.119 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 14.7 p -75.68 166.8 23.01 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.59 0.709 . . . . 0.0 111.703 -169.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 172' ' ' LEU . 23.6 ptt180 -85.45 159.37 19.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.549 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.548 -1.14 . . . . 0.0 111.71 175.61 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.425 ' SD ' ' HD3' ' A' ' 59' ' ' LYS . 66.8 mtt . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 120.733 0.301 . . . . 0.0 110.317 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.1 mp -99.41 135.24 35.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.964 0.412 . . . . 0.0 110.136 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.2 m -99.95 156.63 17.04 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.6 m -68.77 -8.66 10.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -170.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -93.48 12.08 26.3 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.648 0.261 . . . . 0.0 110.64 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -140.5 89.36 2.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.282 0.563 . . . . 0.0 111.447 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -122.33 148.55 44.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.531 175.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.413 ' HG3' ' N ' ' A' ' 9' ' ' THR . 20.6 tptm -114.88 161.5 18.16 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.284 -176.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.413 ' N ' ' HG3' ' A' ' 8' ' ' LYS . 8.4 m -49.42 -31.93 10.7 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.2 0.524 . . . . 0.0 111.06 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.548 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -143.38 116.83 1.03 Allowed Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 170.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 66.9 tp -142.07 137.42 31.02 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 2.5 m -100.96 118.97 38.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.011 0.434 . . . . 0.0 110.823 -177.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.8 mp -120.01 137.5 53.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.424 -177.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.6 p -98.48 100.13 11.36 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.7 p -146.81 152.13 13.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.59 -175.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.405 ' CB ' ' HE2' ' A' ' 52' ' ' LYS . 24.2 t70 63.9 27.29 14.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.34 0.591 . . . . 0.0 109.682 178.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 63.75 30.53 14.64 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.401 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.94 167.18 24.63 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.095 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 15.5 pt -109.68 123.52 65.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.078 0.466 . . . . 0.0 110.156 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.501 ' O ' ' HA ' ' A' ' 12' ' ' THR . 34.2 m95 -121.16 160.36 23.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.411 -172.327 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -129.34 107.96 9.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.567 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.548 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 82.7 t -59.95 118.39 3.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.124 0.488 . . . . 0.0 111.009 179.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.1 mm -93.31 -41.89 12.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.758 175.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -158.25 121.56 3.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.21 -177.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -108.58 139.06 43.88 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.044 0.45 . . . . 0.0 111.571 -173.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -116.41 99.89 7.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.442 176.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 -71.75 96.47 1.62 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 175.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.9 p -99.37 134.3 39.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.448 0.642 . . . . 0.0 111.25 -172.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -116.72 87.46 21.64 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.506 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -65.28 -46.72 5.34 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.635 2.223 . . . . 0.0 112.596 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.56 26.79 3.01 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 121.126 -0.559 . . . . 0.0 111.902 -176.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -97.13 10.32 39.7 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.821 0.343 . . . . 0.0 111.104 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.22 -42.32 1.99 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.995 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.425 ' HB3' ' HB3' ' A' ' 56' ' ' ALA . 70.6 m -115.51 138.53 50.94 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 175.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.68 162.6 22.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.058 0.456 . . . . 0.0 110.75 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -132.04 164.9 25.2 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.342 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.4 t -132.33 102.64 5.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 120.956 0.408 . . . . 0.0 110.34 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -79.19 99.03 6.83 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.2 m -106.53 131.15 54.03 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.535 -173.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.9 mttp -84.34 105.4 15.15 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 171.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.563 HD23 ' H ' ' A' ' 41' ' ' LEU . 0.6 OUTLIER -127.97 138.27 52.55 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.718 0.771 . . . . 0.0 110.813 -172.454 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.9 ttt180 -96.97 128.27 43.77 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.989 -177.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -60.84 113.74 2.67 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 172.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.432 HD21 ' OE1' ' A' ' 114' ' ' GLN . 8.9 tt -66.96 -24.11 66.02 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.656 -170.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -85.99 -45.88 11.05 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.691 -177.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 75.1 p -93.81 -21.71 19.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.067 0.461 . . . . 0.0 111.893 -174.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.7 12.27 75.33 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.177 -176.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.91 131.58 38.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.98 0.419 . . . . 0.0 111.685 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.6 mm -89.49 110.93 22.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.606 177.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.466 ' HG2' ' H ' ' A' ' 51' ' ' GLU . 32.7 tt0 -131.79 174.62 9.95 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -177.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.466 ' H ' ' HG2' ' A' ' 50' ' ' GLN . 9.8 pt-20 -137.72 131.83 31.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.178 0.513 . . . . 0.0 110.623 173.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.405 ' HE2' ' CB ' ' A' ' 16' ' ' ASP . 33.0 mttp -124.28 154.02 40.86 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.53 -177.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 48.9 m -106.84 112.76 25.87 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.825 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -83.6 151.13 25.5 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 175.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.4 ptp85 -122.91 129.76 52.0 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.354 -171.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.425 ' HB3' ' HB3' ' A' ' 34' ' ' SER . . . -63.53 130.77 45.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.304 177.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.59 -18.4 29.8 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -176.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -104.13 131.56 51.28 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.425 ' HD3' ' SD ' ' A' ' 1' ' ' MET . 18.0 ptpt -77.2 140.05 40.04 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.512 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 65.5 t -98.45 117.02 42.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.208 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -90.19 121.8 68.25 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.388 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.64 151.4 36.66 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.45 2.1 . . . . 0.0 112.403 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.483 ' HB3' HG22 ' A' ' 12' ' ' THR . . . -101.81 125.99 48.59 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.131 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 15.8 ptp -85.15 109.58 18.39 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.227 0.537 . . . . 0.0 111.037 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.34 125.23 60.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.038 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -121.82 121.68 37.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.885 0.374 . . . . 0.0 110.468 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -99.63 133.24 44.26 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.487 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -129.91 170.15 14.3 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 0.0 OUTLIER -129.96 127.93 41.04 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.859 0.361 . . . . 0.0 110.285 177.333 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.618 ' CB ' ' HB3' ' A' ' 82' ' ' PHE . 1.6 mpt? -118.52 147.6 43.5 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.678 -176.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -85.17 142.42 29.48 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 172.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -75.46 109.66 9.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.071 -175.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -103.81 -176.63 3.14 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 167.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -145.67 151.81 38.63 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 119.828 -0.749 . . . . 0.0 112.405 -174.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.7 -163.34 1.75 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.595 177.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -68.28 139.19 55.94 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 175.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.88 70.77 2.68 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 119.174 -1.489 . . . . 0.0 113.673 -168.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -125.62 -31.22 2.99 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 159.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.587 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 27.3 m-80 -141.25 135.11 30.35 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 113.83 -1.532 . . . . 0.0 109.209 175.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.557 ' CG ' HD22 ' A' ' 98' ' ' LEU . 64.2 m170 -104.83 145.88 29.77 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 176.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 40.9 t -91.87 127.32 44.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.733 -176.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.618 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 55.0 m-85 -125.16 126.33 45.1 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.659 0.266 . . . . 0.0 110.417 177.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 50.1 ttm -89.92 112.44 23.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.668 -176.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.594 ' HA ' ' HG3' ' A' ' 70' ' ' MET . 16.0 t0 -70.69 119.19 14.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.024 -176.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -75.42 -16.3 60.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.6 178.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -69.5 -54.01 16.34 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.8 p -167.35 91.87 0.39 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 171.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 48.44 28.5 1.71 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 158.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.522 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 47.2 mt-10 -103.51 120.5 40.98 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 118.661 0.664 . . . . 0.0 111.764 178.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -83.69 89.22 7.11 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 173.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.0 m -77.24 116.26 17.72 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.239 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -90.87 118.85 30.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.228 0.537 . . . . 0.0 110.014 177.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.587 ' O ' ' HA ' ' A' ' 79' ' ' ASN . 57.3 mt -93.61 136.29 34.04 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.852 -177.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.522 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 2.2 m -77.7 172.02 14.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.842 -175.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.9 m -50.97 -40.61 58.17 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -175.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -56.14 -40.16 73.38 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.018 0.437 . . . . 0.0 111.775 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.469 ' HB2' ' HB3' ' A' ' 93' ' ' LEU . 45.4 m-85 -77.71 -32.91 53.2 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.818 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.626 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 14.3 mt -64.25 -30.36 71.41 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.473 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -56.8 -46.41 81.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.428 176.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -62.47 -43.71 98.15 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.061 177.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.542 ' O ' HD12 ' A' ' 105' ' ' LEU . 46.4 mt-10 -60.67 -34.16 73.91 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.015 177.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.626 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 55.2 mt -68.58 -6.16 23.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.902 0.382 . . . . 0.0 111.277 -178.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -90.7 -50.02 6.14 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 168.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -136.26 116.79 13.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.312 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.542 HD12 ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -163.65 138.98 6.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.977 0.417 . . . . 0.0 110.837 176.615 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -146.46 147.76 31.55 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 173.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -63.98 130.7 45.11 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.529 0.204 . . . . 0.0 110.537 -176.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.94 -0.6 87.78 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.811 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 56.5 ttp -72.73 142.71 48.17 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.739 -0.271 . . . . 0.0 110.294 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -100.21 119.06 37.78 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.874 0.368 . . . . 0.0 110.448 -177.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 21.1 m -111.88 165.2 7.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.488 -178.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -108.03 105.05 14.63 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 178.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 53.7 mt -92.13 126.68 44.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.181 0.515 . . . . 0.0 109.847 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.432 ' OE1' HD21 ' A' ' 44' ' ' LEU . 24.9 tt0 -99.45 119.13 37.49 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.675 -175.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 64.5 p -116.47 153.54 31.94 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.19 0.519 . . . . 0.0 111.984 -174.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.458 ' HB2' HD13 ' A' ' 121' ' ' ILE . 38.7 t80 -129.67 101.24 5.82 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.276 -0.875 . . . . 0.0 108.962 176.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 61.73 26.93 16.45 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.691 0.758 . . . . 0.0 110.254 -178.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 104.52 -25.8 24.68 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.559 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -79.1 127.45 32.03 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -177.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 43.9 p -69.82 114.16 7.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.761 0.315 . . . . 0.0 110.432 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.458 HD13 ' HB2' ' A' ' 116' ' ' TYR . 22.4 pt -100.52 -26.32 3.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.454 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -164.32 162.43 35.32 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.151 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.482 HG21 HD13 ' A' ' 93' ' ' LEU . 86.3 t -135.01 124.48 43.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.921 0.391 . . . . 0.0 110.207 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -106.6 123.57 48.31 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.948 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.402 HD22 ' N ' ' A' ' 125' ' ' LEU . 2.9 mm? -78.69 156.0 78.0 Favored Pre-proline 0 C--N 1.32 -0.675 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 174.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.434 ' HD3' HG12 ' A' ' 111' ' ' VAL . 47.6 Cg_exo -56.1 123.98 15.16 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.423 2.082 . . . . 0.0 111.446 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.582 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 12.8 mptt -54.85 -34.69 63.18 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.22 -176.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 36.3 p -117.45 108.71 15.87 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 171.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.6 p -122.41 135.85 61.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.432 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -96.48 105.8 17.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.463 0.649 . . . . 0.0 111.116 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 58.0 mt -114.3 129.1 56.63 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.981 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.2 m -75.29 130.88 39.82 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.143 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 170' ' ' ASP . 4.2 p -78.32 105.84 8.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.705 0.764 . . . . 0.0 110.618 178.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.418 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 13.8 p -110.81 123.49 50.19 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.17 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 134' ' ' THR . 42.1 mt-10 76.05 97.3 0.07 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.889 0.852 . . . . 0.0 111.422 -177.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.415 HG22 ' CG ' ' A' ' 168' ' ' GLU . 10.3 t -150.34 155.96 40.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.954 174.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.462 ' O ' ' HD3' ' A' ' 150' ' ' LYS . 25.2 mm-40 -80.96 153.72 72.56 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.123 -170.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -68.86 172.11 12.3 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.531 2.154 . . . . 0.0 111.485 174.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 119.44 32.29 1.26 Allowed Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.961 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 164' ' ' LEU . 24.2 pt . . . . . 0 C--O 1.235 0.299 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 176.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.4 p . . . . . 0 N--CA 1.449 -0.507 0 CA-C-O 121.898 0.856 . . . . 0.0 112.666 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.462 ' HD3' ' O ' ' A' ' 137' ' ' GLU . 26.0 ttmt -137.29 143.07 41.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.007 -1.452 . . . . 0.0 108.987 -174.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 25.0 m -73.77 120.72 19.75 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.103 0.477 . . . . 0.0 110.311 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -129.39 162.53 27.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.137 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 21.3 m -127.35 143.82 51.16 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.476 174.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 15.7 m -103.56 173.55 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.786 0.327 . . . . 0.0 110.717 176.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -62.74 -12.54 24.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.65 -174.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.438 HG22 ' O ' ' A' ' 105' ' ' LEU . 68.6 p -87.76 -13.49 42.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.789 0.328 . . . . 0.0 111.469 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 94.49 3.12 63.09 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.763 -174.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -78.14 141.54 38.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.846 0.355 . . . . 0.0 110.416 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 25.0 m -106.61 133.18 51.68 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.381 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -148.68 165.07 32.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.636 0.255 . . . . 0.0 110.48 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -105.53 108.51 20.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.322 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.429 ' HB ' HG21 ' A' ' 166' ' ' VAL . 27.8 m -102.93 157.39 33.83 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.648 -176.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -62.77 150.52 87.86 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 121.965 1.777 . . . . 0.0 110.828 175.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 140' ' ' ILE . 52.1 mt -55.78 -24.78 37.7 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -169.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -79.24 -13.32 59.76 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -174.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.429 HG21 ' HB ' ' A' ' 162' ' ' VAL . 91.5 t -68.51 129.8 33.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.123 0.487 . . . . 0.0 110.647 -178.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -121.52 155.01 35.89 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.514 -175.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.415 ' CG ' HG22 ' A' ' 136' ' ' THR . 75.5 mt-10 -57.68 121.39 10.29 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.665 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 114.16 -17.41 19.48 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.496 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.588 ' OD2' ' HD3' ' A' ' 184' ' ' ARG . 22.0 t70 -65.41 144.38 57.1 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 177.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 48.5 t -93.24 108.53 20.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.13 0.49 . . . . 0.0 110.294 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 76.2 mt -92.54 117.92 30.46 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.379 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 1.9 mp -90.48 101.97 12.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 175.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 31.9 mm -89.73 124.06 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.421 -175.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.582 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 49.4 t30 -86.44 89.44 7.89 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 174.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.457 HG22 ' HA ' ' A' ' 127' ' ' LYS . 8.9 t -66.74 152.06 46.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.938 0.399 . . . . 0.0 110.463 -176.101 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 93.42 -45.98 2.38 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.4 -176.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -98.92 -27.73 13.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.107 0.479 . . . . 0.0 110.456 177.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.39 24.06 55.07 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.377 176.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.471 ' HB2' ' HB3' ' A' ' 175' ' ' ASN . 1.3 m -81.76 99.42 8.96 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -77.17 108.26 10.13 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.15 0.5 . . . . 0.0 110.827 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 36.9 mm -96.37 140.95 16.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 44.6 t -120.73 167.92 11.96 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 110.465 -0.198 . . . . 0.0 110.465 -176.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ARG . . . . . 0.588 ' HD3' ' OD2' ' A' ' 170' ' ' ASP . 25.8 mmt180 72.03 16.84 5.29 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.278 0.631 . . . . 0.0 112.538 173.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.031 0 CA-C-O 118.749 -1.028 . . . . 0.0 112.721 179.814 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 120.452 0.167 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.403 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 50.6 mm -94.74 143.82 11.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.2 m -104.8 157.67 17.04 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.7 m -66.25 -4.24 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.013 -175.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -76.82 -24.5 52.77 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.841 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -112.72 107.51 16.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.306 0.574 . . . . 0.0 111.774 -175.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -140.69 145.85 37.06 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 171.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.2 mtmm -131.11 175.1 9.38 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.231 -174.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 19.6 m -61.78 -22.1 65.13 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.57 0.7 . . . . 0.0 110.237 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -144.91 114.77 0.8 Allowed Glycine 0 N--CA 1.434 -1.495 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 167.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.4 tp -150.36 122.73 8.43 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 175.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.543 HG21 HG13 ' A' ' 65' ' ' ILE . 2.1 p -87.03 122.95 31.58 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.461 0.648 . . . . 0.0 111.93 -175.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.7 mm -119.22 141.08 40.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.539 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.452 ' HB3' ' HB2' ' A' ' 63' ' ' ALA . 43.0 p -107.69 103.82 13.19 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 176.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.3 p -143.9 148.38 18.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 63.75 24.13 13.72 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.206 -175.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 61.95 28.04 17.05 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.193 -176.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.15 164.09 27.08 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.771 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.6 pt -108.52 126.95 65.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.635 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.498 ' CZ3' ' HB2' ' A' ' 43' ' ' ASN . 11.5 m95 -128.36 166.27 18.99 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.719 -174.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -132.63 108.21 8.91 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.767 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 85.6 t -63.91 115.57 2.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.283 177.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 9' ' ' THR . 77.1 mt -95.88 -38.9 8.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.584 176.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -140.18 153.73 46.71 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.08 178.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 39' ' ' SER . 16.7 p90 -146.8 128.51 15.23 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.828 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -100.9 99.04 9.48 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.038 177.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -78.14 94.33 4.7 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 175.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.2 p -104.86 126.58 59.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.116 -173.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -117.47 103.86 50.55 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.441 -178.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -57.5 -47.35 22.15 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 123.239 2.626 . . . . 0.0 112.671 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 112.7 5.03 24.41 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.588 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -81.53 -14.46 56.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.097 -0.552 . . . . 0.0 110.812 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.42 -15.1 8.14 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.518 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.4 p -134.41 145.94 49.38 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.418 -0.391 . . . . 0.0 110.097 177.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -125.72 168.31 13.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.692 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -143.8 163.51 33.14 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.516 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.9 t -121.32 105.12 16.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.027 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -81.86 99.37 9.0 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 175.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 25' ' ' PHE . 60.7 p -103.07 146.94 27.61 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.135 0.493 . . . . 0.0 112.099 -171.008 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -103.2 110.04 21.86 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 174.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.543 HD23 ' H ' ' A' ' 41' ' ' LEU . 0.9 OUTLIER -135.43 144.27 46.39 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.517 0.675 . . . . 0.0 111.778 -171.922 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 35.8 ttt180 -99.84 127.71 45.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.535 -175.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.498 ' HB2' ' CZ3' ' A' ' 20' ' ' TRP . 53.8 t-20 -71.78 119.8 16.46 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 173.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.8 mp -66.03 -24.6 66.78 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.935 0.397 . . . . 0.0 111.169 -176.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -80.21 -42.88 22.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.67 -176.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.6 p -97.63 -22.3 16.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.203 0.525 . . . . 0.0 111.517 -176.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.31 17.71 79.04 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.662 -176.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' A' ' 42' ' ' ARG . . . -92.15 143.67 26.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.97 0.414 . . . . 0.0 111.984 -174.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 44.4 mm -92.2 100.99 12.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.774 175.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.442 ' HG2' ' H ' ' A' ' 51' ' ' GLU . 29.6 tt0 -113.56 173.42 6.42 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.442 ' H ' ' HG2' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -122.03 146.91 46.72 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.117 0.484 . . . . 0.0 110.963 173.356 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.405 ' HB2' HD21 ' A' ' 41' ' ' LEU . 14.3 tppt? -134.3 132.11 39.19 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.597 -177.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.2 m -100.24 103.88 15.34 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.065 0.46 . . . . 0.0 111.136 -177.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -87.34 141.45 28.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.892 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 49.7 mtp180 -115.62 133.75 55.72 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.721 0.296 . . . . 0.0 110.784 -176.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.41 133.32 55.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.771 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 107.42 -31.03 8.45 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -176.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -90.19 141.88 28.26 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 177.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -81.53 137.85 35.51 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.285 0.564 . . . . 0.0 111.305 -176.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.403 ' O ' ' HB ' ' A' ' 2' ' ' ILE . 61.5 t -100.14 112.74 33.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.429 176.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -93.61 120.56 66.13 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-O 120.918 0.39 . . . . 0.0 110.787 -177.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -77.33 157.58 33.18 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 123.003 2.469 . . . . 0.0 112.9 -175.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.452 ' HB2' ' HB3' ' A' ' 14' ' ' SER . . . -106.01 115.85 30.93 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.153 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -73.77 108.13 6.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.352 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.543 HG13 HG21 ' A' ' 12' ' ' THR . 37.4 mm -103.41 129.97 54.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.068 0.461 . . . . 0.0 110.453 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.433 ' HB2' ' OG1' ' A' ' 115' ' ' THR . 21.0 mt-10 -109.77 146.45 34.95 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.354 -177.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -136.89 113.93 10.59 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.891 0.377 . . . . 0.0 110.647 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.452 ' HG2' ' HG3' ' A' ' 86' ' ' GLU . 79.1 mtm180 -123.0 156.76 34.14 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.502 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 8.5 ptm180 -114.77 124.59 52.15 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.104 -178.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.629 ' CB ' ' HB3' ' A' ' 82' ' ' PHE . 1.9 mpt? -116.27 142.63 46.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.408 -178.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -82.07 134.78 35.37 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.09 175.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.588 ' CD1' ' HA ' ' A' ' 107' ' ' GLU . 42.8 t80 -71.84 115.67 11.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.317 -173.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 55.8 mt -115.33 -176.47 2.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.781 168.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -146.75 154.63 41.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.178 0.514 . . . . 0.0 111.473 -177.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -140.21 -149.43 0.28 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.229 -0.896 . . . . 0.0 108.584 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -69.46 132.3 46.1 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 171.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -75.86 69.29 2.15 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.104 -1.522 . . . . 0.0 113.719 -167.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -127.19 -29.96 2.71 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 156.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.542 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 19.4 m120 -133.94 142.02 47.54 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.803 178.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.58 ' ND1' ' HG ' ' A' ' 98' ' ' LEU . 53.2 m80 -119.86 144.34 47.42 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.418 177.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 61.1 t -88.69 136.35 23.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.837 -176.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.629 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 63.5 m-85 -131.02 125.62 33.77 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.452 ' O ' ' HA ' ' A' ' 70' ' ' MET . 72.5 mtm -95.86 114.62 26.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.717 0.294 . . . . 0.0 111.533 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.542 ' HA ' ' HG3' ' A' ' 70' ' ' MET . 19.2 t70 -61.97 116.37 4.84 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.77 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -70.52 -20.29 62.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.022 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.465 ' HB2' ' OD2' ' A' ' 84' ' ' ASP . 11.3 mm-40 -64.08 -51.15 65.45 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.478 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 5.0 p -171.15 91.74 0.15 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 168.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 47.99 29.86 1.84 Allowed 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 159.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.488 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 47.2 mt-10 -100.06 117.83 35.14 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 121.768 -0.582 . . . . 0.0 110.937 177.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -84.07 113.86 21.34 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.347 0.594 . . . . 0.0 110.534 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 56.5 m -110.15 128.14 55.3 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.966 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -102.25 141.5 34.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.047 0.451 . . . . 0.0 110.267 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' A' ' 79' ' ' ASN . 57.3 mt -118.64 144.21 46.31 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.469 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.9 t -83.52 173.24 11.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.583 -174.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.7 t -56.18 -44.24 79.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.935 -173.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.52 -37.22 86.79 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.738 0.304 . . . . 0.0 111.687 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.587 ' O ' ' HG2' ' A' ' 101' ' ' GLU . 97.1 m-85 -67.03 -40.04 87.12 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.58 ' HG ' ' ND1' ' A' ' 80' ' ' HIS . 3.7 mm? -74.6 -11.07 60.1 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.09 178.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -63.75 -44.32 93.84 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.834 0.349 . . . . 0.0 110.589 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.555 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 14.3 tp10 -74.34 -37.0 63.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.122 0.487 . . . . 0.0 109.781 175.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.587 ' HG2' ' O ' ' A' ' 97' ' ' TYR . 9.1 mm-40 -59.38 -43.46 92.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.983 176.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.558 ' O ' ' HB ' ' A' ' 156' ' ' THR . 85.9 mt -71.85 -2.43 17.77 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.006 0.431 . . . . 0.0 111.051 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.555 ' HB3' ' O ' ' A' ' 100' ' ' GLU . 29.3 t30 -80.73 -48.3 12.73 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 171.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.514 ' HB3' HG11 ' A' ' 129' ' ' VAL . 85.5 m-85 -146.99 117.19 7.33 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.523 174.011 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.476 HD22 ' O ' ' A' ' 101' ' ' GLU . 0.9 OUTLIER -172.94 169.18 4.8 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.588 0.232 . . . . 0.0 110.562 178.476 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.509 ' HD3' ' O ' ' A' ' 130' ' ' GLU . 30.6 mmmt -143.2 149.14 37.57 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 173.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.588 ' HA ' ' CD1' ' A' ' 72' ' ' TYR . 40.4 tt0 -69.57 130.91 43.73 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.071 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.46 -2.29 80.48 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.397 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 58.3 ttm -74.79 140.77 44.24 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 70' ' ' MET . 48.6 mt-10 -103.19 102.71 12.7 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.121 0.486 . . . . 0.0 110.073 -177.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.502 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 19.5 m -99.49 162.8 2.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.152 -174.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.565 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 57.9 mt-30 -104.55 100.36 10.03 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.989 0.423 . . . . 0.0 110.688 -178.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 59.3 mt -74.78 128.18 36.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.94 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.498 ' O ' HG13 ' A' ' 121' ' ' ILE . 7.8 tt0 -105.83 113.91 27.75 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.987 -175.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.433 ' OG1' ' HB2' ' A' ' 66' ' ' GLU . 74.1 p -114.85 155.3 27.06 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.23 -176.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -118.91 99.21 6.6 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 172.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 61.42 41.8 12.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.82 0.819 . . . . 0.0 109.639 -176.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.32 -19.83 37.35 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.506 -0.77 . . . . 0.0 113.192 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -82.02 116.44 21.63 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 24.2 m -65.28 106.01 1.25 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -176.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 114' ' ' GLN . 2.4 pp -100.18 -23.42 4.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.788 -177.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -170.41 175.53 44.28 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.17 -1.014 . . . . 0.0 112.727 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.2 t -135.43 129.76 49.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.849 0.357 . . . . 0.0 110.093 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.565 ' HB2' ' HB2' ' A' ' 112' ' ' GLN . 5.9 mm-40 -98.4 109.69 22.4 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.773 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 77.3 mt -80.6 135.19 53.16 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.784 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.42 131.25 44.63 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.621 2.214 . . . . 0.0 110.641 170.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 0.7 OUTLIER -60.74 -35.09 75.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.731 -167.036 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 18.0 p -96.76 110.53 22.98 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.029 0.442 . . . . 0.0 111.426 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.514 HG11 ' HB3' ' A' ' 104' ' ' TYR . 6.9 p -129.92 135.67 60.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.285 177.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.509 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 6.7 pt-20 -109.65 121.25 44.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.168 0.509 . . . . 0.0 111.352 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 77.9 mt -122.2 130.28 53.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.294 -178.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.1 m -75.1 134.36 41.34 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.172 178.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.446 HG12 ' O ' ' A' ' 170' ' ' ASP . 4.1 p -83.54 100.23 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-O 121.952 0.882 . . . . 0.0 110.702 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 29.8 p -90.88 103.27 16.0 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.466 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.474 ' HA ' ' OE2' ' A' ' 168' ' ' GLU . 44.1 mt-10 77.77 111.49 0.07 Allowed 'General case' 0 C--O 1.238 0.45 0 O-C-N 124.149 0.906 . . . . 0.0 111.998 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.0 t -150.39 152.81 34.94 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.542 -1.208 . . . . 0.0 108.579 174.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.43 ' O ' ' HD2' ' A' ' 150' ' ' LYS . 4.6 mp0 -82.99 123.5 77.61 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 120.762 0.315 . . . . 0.0 110.448 -176.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -82.38 -179.9 4.97 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.824 2.349 . . . . 0.0 112.114 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 119.45 32.98 1.16 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.22 -0.99 . . . . 0.0 113.162 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.442 HD12 ' HA ' ' A' ' 165' ' ' PHE . 12.2 tt . . . . . 0 CA--C 1.531 0.239 0 CA-C-O 121.401 0.62 . . . . 0.0 111.049 178.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.4 p . . . . . 0 C--O 1.235 0.295 0 CA-C-O 121.147 0.499 . . . . 0.0 111.451 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.43 ' HD2' ' O ' ' A' ' 137' ' ' GLU . 63.3 pttt -138.39 158.42 44.32 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.218 175.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.3 p -73.22 132.39 43.13 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.328 0.585 . . . . 0.0 111.751 -178.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.13 163.38 32.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.599 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 26.0 m -132.01 131.37 42.45 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 174.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.7 m -93.45 175.11 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -59.27 -25.94 64.52 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -176.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.558 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 47.1 p -72.5 -16.74 61.79 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.765 0.317 . . . . 0.0 111.563 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.22 1.81 59.32 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.593 -176.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -84.73 138.22 32.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.488 -0.356 . . . . 0.0 110.661 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 14.8 t -97.23 136.05 38.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.974 176.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -148.65 164.35 34.57 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -176.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -102.23 111.77 24.18 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.204 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 33.9 m -106.47 147.25 34.59 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.96 -176.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.7 154.97 39.73 Favored 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 122.712 2.275 . . . . 0.0 111.679 176.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.494 ' H ' HD22 ' A' ' 164' ' ' LEU . 1.8 mm? -67.07 -15.14 63.54 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -168.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.442 ' HA ' HD12 ' A' ' 140' ' ' ILE . 22.1 p90 -80.98 -11.11 59.62 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.861 0.362 . . . . 0.0 111.346 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.405 HG13 HD21 ' A' ' 172' ' ' LEU . 92.8 t -76.15 134.07 29.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.147 177.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -120.14 165.73 14.37 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.474 ' OE2' ' HA ' ' A' ' 135' ' ' GLU . 28.5 tt0 -61.42 152.27 30.24 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.595 -176.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 65.68 6.83 31.63 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 114.354 0.501 . . . . 0.0 114.354 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.446 ' O ' HG12 ' A' ' 133' ' ' VAL . 11.2 m-20 -77.7 147.83 35.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.653 0.727 . . . . 0.0 110.137 171.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 62.3 t -94.48 110.45 23.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.068 0.461 . . . . 0.0 109.898 177.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.406 HD23 ' HG2' ' A' ' 184' ' ' ARG . 67.7 mt -94.08 123.61 37.57 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.73 -176.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.535 ' O ' ' HB ' ' A' ' 182' ' ' ILE . 54.4 mt -90.73 128.38 42.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 174.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 37.1 mm -125.11 139.87 49.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -178.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.589 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 26.3 t-20 -87.32 91.69 8.81 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 174.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 11.1 t -74.07 148.29 42.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.964 0.411 . . . . 0.0 110.175 -177.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 105.65 -40.34 2.52 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 -174.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -109.8 -46.35 3.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.135 0.493 . . . . 0.0 110.001 175.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 107.01 11.15 26.75 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.671 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 175' ' ' ASN . 6.6 m -65.11 132.31 48.84 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -83.14 126.08 32.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.253 0.549 . . . . 0.0 110.468 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.535 ' HB ' ' O ' ' A' ' 173' ' ' ILE . 14.1 mm -106.61 156.71 7.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.4 p -74.45 170.19 16.19 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.258 0.551 . . . . 0.0 111.935 -170.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ARG . . . . . 0.406 ' HG2' HD23 ' A' ' 172' ' ' LEU . 84.0 mtm180 -70.05 145.27 51.83 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.726 -176.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.946 0 CA-C-O 118.57 -1.128 . . . . 0.0 111.77 178.259 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.8 ttt . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 120.772 0.32 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 46.6 mm -117.64 134.65 60.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 171.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.9 m -88.3 151.14 22.83 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.44 ' O ' HG21 ' A' ' 37' ' ' VAL . 29.7 m -68.5 -1.82 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 121.004 0.43 . . . . 0.0 111.667 -178.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -97.98 0.39 46.28 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.345 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -118.95 89.12 3.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.543 -178.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -134.21 153.29 51.94 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.928 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -129.95 175.94 8.46 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.167 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.2 t -66.33 -9.56 34.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.165 0.507 . . . . 0.0 110.079 175.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.669 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -152.26 115.43 0.69 Allowed Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 110.396 -1.081 . . . . 0.0 110.396 170.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.52 133.09 19.79 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 10.5 p -98.15 123.28 42.12 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.138 0.494 . . . . 0.0 112.023 -177.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.1 mp -125.7 141.93 44.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.14 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.412 ' HB2' ' HB2' ' A' ' 63' ' ' ALA . 23.0 t -106.24 105.27 15.22 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 176.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.7 p -147.52 148.36 16.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -176.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 62.68 24.89 14.82 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.199 0.312 . . . . 0.0 110.62 -174.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 64.3 t30 63.74 24.16 13.73 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.611 0.72 . . . . 0.0 110.601 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.62 158.77 37.58 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.857 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.7 pt -105.22 125.8 60.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.281 0.563 . . . . 0.0 110.295 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.538 ' O ' ' HA ' ' A' ' 12' ' ' THR . 74.2 m95 -120.84 161.19 21.94 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.448 -170.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -136.7 110.4 8.09 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.163 176.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.669 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 89.3 t -60.52 117.26 2.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.932 177.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.3 mm -92.14 -30.73 4.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.481 175.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -153.89 140.48 18.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.427 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -126.29 138.68 53.62 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.806 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -118.82 100.07 7.16 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.023 176.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -75.58 101.49 4.94 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 177.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.4 p -109.58 126.47 66.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.391 0.615 . . . . 0.0 111.609 -172.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.8 mtmt -113.91 102.73 55.08 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.438 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -55.85 -47.8 23.22 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.509 2.806 . . . . 0.0 112.788 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.8 11.54 10.14 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.137 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -102.46 3.42 37.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.128 0.49 . . . . 0.0 110.694 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.6 -43.0 1.81 Allowed Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.384 178.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.8 p -93.32 126.34 38.39 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.819 0.342 . . . . 0.0 110.296 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.54 162.03 13.26 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.08 0.467 . . . . 0.0 110.813 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -134.84 166.13 23.7 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.815 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.44 HG21 ' O ' ' A' ' 4' ' ' VAL . 49.9 t -131.83 104.09 7.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 175.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -82.3 99.06 9.12 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.3 p -110.56 135.41 51.25 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.076 0.465 . . . . 0.0 111.892 -173.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -91.39 111.94 23.65 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 172.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.534 HD23 ' H ' ' A' ' 41' ' ' LEU . 1.2 pt? -138.71 145.1 39.9 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.175 0.512 . . . . 0.0 110.935 -173.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 9.9 ptt180 -106.96 143.08 35.57 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.865 -174.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -65.23 119.89 11.73 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 171.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.526 HD22 HD12 ' A' ' 121' ' ' ILE . 3.9 tt -67.38 -25.57 66.03 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.208 -170.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.406 ' CZ ' HG22 ' A' ' 121' ' ' ILE . 11.9 mtp180 -83.44 -46.42 12.53 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.411 -177.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.2 p -94.97 -20.48 19.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.011 0.434 . . . . 0.0 112.151 -173.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.93 17.85 73.84 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.111 -176.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 42' ' ' ARG . . . -75.0 126.54 31.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.834 0.349 . . . . 0.0 111.803 -177.208 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.1 mm -87.96 108.86 18.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.107 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -129.67 162.18 28.92 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -122.99 128.06 49.67 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.471 0.653 . . . . 0.0 110.559 174.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -128.12 144.63 51.12 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.559 -176.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.2 m -110.32 118.37 36.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.907 0.384 . . . . 0.0 111.354 -175.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -85.45 155.51 21.21 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.871 176.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.563 ' H ' ' HD2' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -122.19 132.88 54.67 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.043 0.449 . . . . 0.0 111.325 -176.186 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.63 138.06 58.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.089 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 108.22 -28.66 11.4 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.401 -177.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -100.83 141.27 33.95 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 177.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.64 142.68 37.02 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.008 0.432 . . . . 0.0 110.264 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.9 t -93.88 125.84 46.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.316 174.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -89.55 113.31 56.18 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 120.917 0.389 . . . . 0.0 110.21 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.01 159.63 41.11 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.606 2.204 . . . . 0.0 112.719 -176.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.412 ' HB2' ' HB2' ' A' ' 14' ' ' SER . . . -114.85 109.52 18.28 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.096 177.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 24.7 ttt -74.19 109.59 7.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.144 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.495 HG13 HG21 ' A' ' 12' ' ' THR . 48.7 mm -96.28 116.83 39.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.835 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.473 ' HB2' ' OG1' ' A' ' 115' ' ' THR . 27.8 mt-10 -96.84 141.51 29.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.506 -176.051 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -123.08 123.54 41.08 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.723 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.55 ' O ' ' HA ' ' A' ' 112' ' ' GLN . 52.6 mtt180 -124.37 164.33 19.88 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 174.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 10.3 ptm85 -126.72 131.98 51.23 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 176.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.522 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 13.7 mmm -127.01 139.3 53.13 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.265 -170.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -78.44 132.36 37.27 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 175.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.419 ' HB2' ' O ' ' A' ' 109' ' ' MET . 38.6 t80 -75.37 106.93 7.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.137 -174.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.7 mp -97.38 176.01 6.04 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 166.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -146.95 149.91 34.13 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 119.567 -0.853 . . . . 0.0 113.047 -170.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.96 -169.76 3.47 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 113.976 -1.465 . . . . 0.0 107.211 171.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -63.79 144.14 57.28 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 175.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.3 69.68 2.93 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 118.928 -1.606 . . . . 0.0 113.731 -168.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -126.21 -27.71 3.2 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 158.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -140.76 128.45 21.6 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.308 -1.315 . . . . 0.0 109.897 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.495 ' ND1' HD22 ' A' ' 98' ' ' LEU . 47.6 m170 -122.03 148.28 45.03 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.568 0.223 . . . . 0.0 110.466 175.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 41.8 t -102.24 130.48 52.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.085 -175.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.485 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 79.7 m-85 -125.43 133.49 52.45 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.404 ' O ' ' HA ' ' A' ' 70' ' ' MET . 40.7 mtm -105.64 119.2 38.54 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 121.073 -0.251 . . . . 0.0 110.883 -178.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.559 ' HB3' ' H ' ' A' ' 89' ' ' GLU . 10.6 t70 -61.33 123.9 19.09 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.88 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -72.37 -20.83 61.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.833 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -66.58 -51.55 55.18 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.3 p -172.25 92.46 0.12 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 166.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 48.6 27.46 1.48 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 162.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.559 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 48.5 mt-10 -88.79 110.41 21.0 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 121.756 -0.59 . . . . 0.0 110.276 176.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -78.81 133.72 37.03 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.684 -177.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 90.6 m -131.01 120.85 24.07 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.937 174.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 80' ' ' HIS . 29.1 mt-10 -99.89 127.56 46.05 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.004 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.433 HD12 ' CE1' ' A' ' 82' ' ' PHE . 52.6 mt -103.83 152.06 22.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.98 -177.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.624 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 13.8 m -96.44 170.64 9.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.316 -172.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.0 m -46.92 -38.13 10.04 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.27 0.628 . . . . 0.0 112.595 -175.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -50.34 -44.74 54.59 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.09 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -81.16 -36.92 29.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.323 0.582 . . . . 0.0 110.437 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.624 ' HG ' ' O ' ' A' ' 94' ' ' SER . 11.7 mt -64.68 -27.2 68.76 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.261 -171.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -59.87 -47.5 85.49 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.901 0.381 . . . . 0.0 110.561 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.51 ' HA ' ' ND2' ' A' ' 103' ' ' ASN . 41.9 mt-10 -70.1 -33.47 71.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.486 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.577 ' O ' HD12 ' A' ' 105' ' ' LEU . 72.7 mt-10 -59.74 -45.35 92.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.03 171.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 83.1 mt -66.55 -15.27 63.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.885 0.374 . . . . 0.0 111.068 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.51 ' ND2' ' HA ' ' A' ' 100' ' ' GLU . 77.5 m-20 -75.51 -50.55 15.34 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 172.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -145.96 117.2 7.89 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.543 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.577 HD12 ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -165.41 161.74 19.03 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.909 0.385 . . . . 0.0 110.999 176.247 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.471 ' HD3' ' O ' ' A' ' 130' ' ' GLU . 31.3 mmmt -136.0 142.61 44.51 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 172.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -68.52 130.77 43.84 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.72 0.295 . . . . 0.0 110.828 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.13 -4.9 81.43 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.289 -177.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.419 ' O ' ' HB2' ' A' ' 72' ' ' TYR . 52.3 ttm -62.25 130.02 43.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.874 0.369 . . . . 0.0 111.121 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.522 ' HA ' ' O ' ' A' ' 70' ' ' MET . 46.3 mt-10 -95.78 101.12 12.78 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.14 0.495 . . . . 0.0 109.846 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 26.4 m -100.17 164.24 2.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.397 -176.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.55 ' HA ' ' O ' ' A' ' 68' ' ' ARG . 15.2 mt-30 -102.23 108.28 19.61 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.143 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.464 HD12 ' HG3' ' A' ' 70' ' ' MET . 19.0 mt -84.01 122.79 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.554 ' O ' HG12 ' A' ' 121' ' ' ILE . 16.3 tt0 -99.3 118.77 36.71 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.263 -175.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.473 ' OG1' ' HB2' ' A' ' 66' ' ' GLU . 79.3 p -117.91 155.0 30.94 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.314 0.578 . . . . 0.0 111.854 -174.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -125.75 104.32 8.29 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 173.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 59.37 41.05 20.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.836 0.827 . . . . 0.0 109.852 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 91.16 -23.49 23.91 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.298 -0.865 . . . . 0.0 113.157 178.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -83.36 128.5 34.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.853 0.327 . . . . 0.0 110.946 -175.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.9 t -66.16 120.41 13.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.127 0.489 . . . . 0.0 110.915 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.554 HG12 ' O ' ' A' ' 114' ' ' GLN . 19.9 pt -109.69 -24.68 3.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.437 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -169.44 164.91 38.41 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.372 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 99.3 t -131.62 118.16 37.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.862 0.363 . . . . 0.0 110.195 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 112' ' ' GLN . 42.3 mt-10 -91.13 104.19 16.79 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.867 -176.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 70.3 mt -78.31 138.77 59.79 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 174.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.55 128.65 30.27 Favored 'Trans proline' 0 CA--C 1.515 -0.456 0 C-N-CA 122.771 2.314 . . . . 0.0 111.153 178.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.732 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 95.4 mttt -52.3 -33.7 43.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.479 -169.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.8 p -115.47 109.6 18.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.024 0.44 . . . . 0.0 111.302 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 13.0 p -112.34 143.59 21.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.763 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.471 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 47.3 mt-10 -104.45 124.26 48.93 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 177.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 62.6 mt -126.28 131.41 51.9 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.776 0.322 . . . . 0.0 110.409 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.5 m -74.45 132.84 42.28 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 170' ' ' ASP . 5.0 p -89.43 107.22 17.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.41 0.624 . . . . 0.0 110.338 178.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 13.1 p -105.02 124.53 49.68 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.714 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 70.6 88.87 0.1 Allowed 'General case' 0 C--O 1.237 0.421 0 CA-C-O 122.08 0.943 . . . . 0.0 111.611 -177.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.453 ' O ' ' HD3' ' A' ' 138' ' ' PRO . 15.2 t -151.36 139.85 20.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.512 -1.222 . . . . 0.0 107.839 170.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -82.37 113.0 40.97 Favored Pre-proline 0 C--N 1.322 -0.593 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.293 -170.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 136' ' ' THR . 96.9 Cg_endo -93.75 -179.84 0.87 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.257 2.638 . . . . 0.0 111.858 177.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.19 30.76 24.5 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.819 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.424 HG23 ' HB3' ' A' ' 164' ' ' LEU . 4.2 tp . . . . . 0 C--N 1.324 -0.533 0 CA-C-O 121.607 0.717 . . . . 0.0 110.195 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.6 p . . . . . 0 N--CA 1.452 -0.361 0 CA-C-O 120.649 0.261 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -137.22 151.34 48.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.014 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.9 m -73.08 110.62 7.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.216 0.531 . . . . 0.0 111.246 -174.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -116.21 162.06 18.03 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.729 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 22.7 m -125.86 140.68 52.46 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.739 174.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 12.8 m -101.87 173.08 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.805 175.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -56.98 -27.19 61.19 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.413 HG22 HD13 ' A' ' 105' ' ' LEU . 80.9 p -73.74 -11.89 60.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.79 0.329 . . . . 0.0 111.487 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 91.82 5.0 66.83 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.932 -0.652 . . . . 0.0 111.844 -177.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -85.04 141.68 30.11 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 27.0 m -99.2 129.67 45.45 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.648 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.4 mp -132.61 155.93 47.83 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 120.729 0.299 . . . . 0.0 110.238 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -93.7 99.35 11.78 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 34.6 m -97.34 150.71 37.1 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.082 -174.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -56.48 152.25 41.21 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.535 2.157 . . . . 0.0 111.277 174.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.424 ' HB3' HG23 ' A' ' 140' ' ' ILE . 59.1 mt -64.93 -14.85 61.11 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.612 -169.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -86.65 -7.42 58.34 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 88.0 t -75.6 131.13 35.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.861 0.362 . . . . 0.0 110.831 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -120.64 144.73 48.0 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.33 -175.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.419 ' HB3' HG22 ' A' ' 136' ' ' THR . 9.2 pt-20 -69.56 132.97 47.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.138 0.494 . . . . 0.0 110.987 -176.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 109.78 -16.51 30.95 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.418 -174.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.441 ' OD1' ' HB2' ' A' ' 184' ' ' ARG . 10.7 t70 -84.93 156.71 21.09 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 74.7 t -104.02 116.13 47.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.87 0.367 . . . . 0.0 110.563 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 184' ' ' ARG . 80.1 mt -94.68 145.65 24.7 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.587 -178.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.635 ' O ' ' HB ' ' A' ' 182' ' ' ILE . 26.6 mt -98.66 134.82 35.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 175.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 67.2 mt -135.2 137.6 49.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 O-C-N 122.039 -0.413 . . . . 0.0 110.46 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.732 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 27.0 t-20 -83.68 98.01 9.41 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 175.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 8.9 t -85.37 157.92 20.39 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.855 0.36 . . . . 0.0 110.071 -177.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 94.45 -48.71 2.11 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -173.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ASP . . . . . 0.551 ' HB3' ' OD1' ' A' ' 175' ' ' ASN . 33.1 t70 -98.52 -42.3 7.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.001 0.429 . . . . 0.0 110.08 176.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 105.97 5.3 38.39 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.827 -0.701 . . . . 0.0 113.427 173.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 64.0 m -68.61 133.67 48.83 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.957 0.408 . . . . 0.0 111.038 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -86.64 134.41 33.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.1 0.476 . . . . 0.0 110.851 -177.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.635 ' HB ' ' O ' ' A' ' 173' ' ' ILE . 56.0 mt -116.04 155.0 17.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.3 p -75.88 172.7 12.26 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.419 0.152 . . . . 0.0 110.729 -176.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ARG . . . . . 0.441 ' HB2' ' OD1' ' A' ' 170' ' ' ASP . 8.3 ptp180 -57.99 159.15 5.9 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.174 0.511 . . . . 0.0 111.575 -173.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.791 -1.005 . . . . 0.0 111.471 178.722 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.9 mtp . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 120.578 0.228 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.416 HD12 ' HB3' ' A' ' 62' ' ' PRO . 53.7 mt -115.73 137.95 47.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-O 121.209 0.528 . . . . 0.0 111.382 -177.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.0 t -116.97 166.07 12.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.03 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.407 ' O ' HG21 ' A' ' 37' ' ' VAL . 21.2 m -67.96 -7.9 7.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -170.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -86.92 -2.39 58.57 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.637 -176.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -137.62 95.45 3.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.284 0.564 . . . . 0.0 112.198 -178.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -121.1 160.37 23.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.231 173.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -139.94 169.17 18.19 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.585 -0.154 . . . . 0.0 110.585 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.1 t -61.81 -13.1 20.95 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 123.632 0.583 . . . . 0.0 111.828 -173.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.34 113.14 0.66 Allowed Glycine 0 N--CA 1.434 -1.475 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 165.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 62.9 tp -150.93 129.35 12.08 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 2.7 p -98.48 129.4 45.07 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.24 0.543 . . . . 0.0 111.677 -177.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 mp -128.37 138.58 54.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.996 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.7 p -94.66 110.45 22.29 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.042 175.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.7 p -150.67 147.78 15.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -178.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 62.11 30.93 17.92 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.312 0.383 . . . . 0.0 110.864 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 63.3 24.43 14.26 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.94 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -137.83 168.59 19.38 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.255 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 11.1 pt -116.73 127.31 74.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.257 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.551 ' O ' ' HA ' ' A' ' 12' ' ' THR . 15.4 m95 -127.67 157.87 39.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.044 -172.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 44.5 tttm -123.23 119.51 30.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.317 175.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 90.9 t -62.34 117.95 4.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.402 0.62 . . . . 0.0 110.65 175.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 86.8 mt -90.0 -39.07 11.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.4 173.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -152.3 148.0 27.02 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.027 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -135.98 140.67 44.11 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.107 0.48 . . . . 0.0 111.032 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 54.5 tp60 -117.93 99.89 7.21 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.053 175.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -78.0 89.25 4.15 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.0 p -97.04 131.06 44.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.058 -173.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.403 ' HD3' ' N ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -122.93 105.11 35.18 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.442 179.542 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.46 -10.63 27.21 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.689 2.259 . . . . 0.0 112.793 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.69 22.89 63.3 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.775 176.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -104.18 0.59 29.7 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.991 0.424 . . . . 0.0 110.79 -178.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 130.81 -42.07 1.45 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.765 175.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.4 m -118.83 146.42 44.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.768 0.318 . . . . 0.0 110.692 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.82 160.92 14.06 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.142 0.496 . . . . 0.0 110.945 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -132.49 161.8 32.82 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 53' ' ' THR . 48.1 t -132.24 102.6 5.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 120.842 0.353 . . . . 0.0 110.601 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -79.71 99.09 7.25 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 174.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.1 p -112.5 139.5 48.03 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.129 0.49 . . . . 0.0 112.17 -174.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -89.76 121.22 31.7 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 171.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.473 HD23 ' H ' ' A' ' 41' ' ' LEU . 0.8 OUTLIER -141.23 142.42 33.96 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.491 0.662 . . . . 0.0 111.697 -174.513 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.1 ttp180 -104.67 129.73 52.79 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.483 -174.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -69.09 118.22 11.72 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 173.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.3 mp -66.65 -28.93 68.86 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -175.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.588 ' HA ' ' O ' ' A' ' 121' ' ' ILE . 68.0 mtt85 -73.07 -44.57 60.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.958 0.409 . . . . 0.0 111.65 -176.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.4 p -102.85 -11.61 18.16 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.018 0.437 . . . . 0.0 112.029 -173.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.92 21.82 78.25 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -176.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.8 133.41 34.34 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -172.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.3 mm -89.74 110.05 21.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.926 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.4 ' HG2' ' N ' ' A' ' 51' ' ' GLU . 50.8 tt0 -132.25 172.69 12.1 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.4 ' N ' ' HG2' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -130.28 147.12 51.96 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.022 0.439 . . . . 0.0 110.864 175.836 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.425 ' HD2' HD11 ' A' ' 41' ' ' LEU . 67.8 mttm -142.75 148.04 36.57 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.908 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 43.7 m -111.44 117.53 33.29 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.006 0.432 . . . . 0.0 110.342 178.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -84.6 140.71 31.18 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.82 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 47.8 mtm105 -107.17 138.44 43.35 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.585 -177.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.53 130.65 46.08 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.795 0.331 . . . . 0.0 110.258 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.67 -29.97 8.92 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -174.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.11 119.83 24.53 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 175.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -71.32 131.8 43.96 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.369 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.9 t -91.34 107.99 19.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.156 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -87.64 113.25 53.51 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.419 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.416 ' HB3' HD12 ' A' ' 2' ' ' ILE . 58.3 Cg_endo -72.94 155.5 53.0 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.503 2.136 . . . . 0.0 112.702 -178.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.31 115.58 27.6 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.328 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 46.1 ttm -76.92 108.47 9.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.781 -178.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.488 HG13 HG21 ' A' ' 12' ' ' THR . 43.2 mm -100.94 139.02 23.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.396 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 114' ' ' GLN . 39.0 mt-10 -105.09 116.73 32.44 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 175.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -99.71 99.08 9.86 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 173.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -111.87 124.73 52.98 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.015 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.589 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 12.8 ptp180 -86.84 120.18 27.84 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.329 0.585 . . . . 0.0 109.485 177.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.817 ' SD ' ' HA ' ' A' ' 84' ' ' ASP . 8.5 mmt -107.32 145.58 32.64 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.724 -178.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -79.58 136.12 36.77 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 172.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.451 ' CZ ' HD23 ' A' ' 105' ' ' LEU . 47.4 t80 -77.13 108.38 10.19 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.807 -176.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 3.3 mm? -99.51 177.33 5.2 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 167.07 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -146.94 150.73 35.76 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.67 -175.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.05 -162.92 1.65 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.735 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -62.74 137.76 58.35 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 174.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.43 70.19 2.46 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 119.209 -1.472 . . . . 0.0 113.151 -171.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -125.87 -32.56 2.8 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 161.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.501 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 78.6 m-20 -141.29 135.19 30.35 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 114.065 -1.425 . . . . 0.0 109.293 175.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.527 ' CG ' HD22 ' A' ' 98' ' ' LEU . 58.6 m170 -107.66 144.1 35.22 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 175.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 73' ' ' LEU . 49.5 t -94.3 121.91 45.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.794 -175.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.542 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 76.8 m-85 -117.85 126.04 51.65 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 176.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 14.7 tmm? -97.48 117.26 31.33 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.021 -175.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.817 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 17.6 t70 -62.42 114.65 3.63 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.418 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -76.94 -5.11 47.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.414 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -76.9 -50.94 12.17 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 173.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.7 p -170.94 93.95 0.18 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 168.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 50.09 28.83 3.19 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 157.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.57 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 34.1 mt-10 -101.14 115.25 30.04 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 121.466 -0.771 . . . . 0.0 111.287 175.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -82.38 108.98 16.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.316 0.579 . . . . 0.0 110.962 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 54.8 m -101.81 123.21 45.38 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.801 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -99.58 125.25 45.34 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.852 0.358 . . . . 0.0 110.334 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.501 ' O ' ' HA ' ' A' ' 79' ' ' ASN . 42.6 mt -97.85 138.77 34.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.349 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.526 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 29.5 t -79.95 169.23 18.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.716 -174.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.2 p -50.48 -39.41 48.18 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.963 0.505 . . . . 0.0 112.312 -175.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -59.31 -36.09 74.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.648 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -76.07 -35.47 59.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.305 0.574 . . . . 0.0 109.504 177.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.634 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 14.2 mt -64.32 -30.09 71.15 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.238 -176.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -62.6 -32.69 73.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.935 176.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -73.27 -40.52 64.53 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.552 ' O ' HD12 ' A' ' 105' ' ' LEU . 47.8 mt-10 -62.05 -36.76 82.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.732 175.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 79.9 mt -73.52 0.57 12.12 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.078 0.466 . . . . 0.0 110.824 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' A' ' 158' ' ' TYR . 57.5 t30 -93.95 -43.26 8.63 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 170.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -148.34 117.09 6.66 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.26 172.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.552 HD12 ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -160.21 153.39 21.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.926 0.393 . . . . 0.0 110.649 172.255 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.7 mtpt -144.03 146.85 33.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.791 172.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -71.13 132.11 44.57 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.344 -174.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.67 0.68 90.25 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.771 177.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.446 ' SD ' ' HG3' ' A' ' 126' ' ' PRO . 57.5 ttm -82.65 141.74 32.26 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.809 0.338 . . . . 0.0 111.438 -177.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' A' ' 70' ' ' MET . 54.2 mp0 -84.19 123.47 30.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.084 175.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 34.7 m -121.79 158.9 24.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.329 177.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.55 ' HB2' ' HB3' ' A' ' 124' ' ' GLU . 15.8 mm-40 -91.34 101.55 14.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.755 0.312 . . . . 0.0 110.194 -175.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 48.8 mm -94.01 122.03 45.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 178.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 87.2 mt-30 -98.47 117.34 32.68 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.742 0.306 . . . . 0.0 110.539 -178.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.413 ' OG1' ' HB2' ' A' ' 66' ' ' GLU . 35.2 p -112.36 151.22 30.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.915 176.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -135.56 103.12 5.34 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 60.06 31.77 20.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.528 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 104.44 -30.27 10.42 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 121.102 -0.571 . . . . 0.0 113.019 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -76.72 131.21 38.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.561 0.219 . . . . 0.0 111.276 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 17.6 p -73.43 106.6 5.3 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 172.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' A' ' 45' ' ' ARG . 45.2 pt -94.25 -31.2 4.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -174.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -162.38 164.38 35.55 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 119.641 -1.266 . . . . 0.0 113.135 -177.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 59.9 t -133.38 127.57 54.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.55 ' HB3' ' HB2' ' A' ' 112' ' ' GLN . 35.1 tt0 -118.69 122.99 43.81 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.041 0.448 . . . . 0.0 110.337 178.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -86.54 155.67 56.55 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.446 ' HG3' ' SD ' ' A' ' 109' ' ' MET . 10.5 Cg_endo -53.5 132.76 50.4 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.58 2.187 . . . . 0.0 110.982 176.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 95.7 mttt -54.85 -34.77 63.28 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.518 -174.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 19.7 p -122.92 109.08 13.69 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.045 176.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.5 p -106.25 136.81 39.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.499 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -94.3 108.53 20.42 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 177.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.524 HD12 HD13 ' A' ' 174' ' ' ILE . 98.7 mt -117.92 134.4 54.98 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.253 0.549 . . . . 0.0 110.744 -176.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.0 m -81.45 131.25 35.27 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.752 177.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.0 p -81.05 119.36 30.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.685 0.755 . . . . 0.0 111.084 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.482 ' O ' ' HB ' ' A' ' 153' ' ' THR . 41.6 p -125.27 128.9 48.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.555 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 75.94 86.02 0.09 Allowed 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.898 0.856 . . . . 0.0 110.69 -175.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.449 ' O ' ' HD3' ' A' ' 138' ' ' PRO . 13.3 t -150.96 155.02 38.22 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.462 173.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -82.5 110.7 23.35 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 120.424 0.154 . . . . 0.0 110.699 -176.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 136' ' ' THR . 96.6 Cg_endo -91.11 162.7 3.83 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.056 2.504 . . . . 0.0 112.709 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 98.15 -2.62 59.71 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.547 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 9.6 tt . . . . . 0 C--N 1.323 -0.576 0 CA-C-O 121.308 0.575 . . . . 0.0 110.356 -178.827 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 27.6 p . . . . . 0 N--CA 1.449 -0.51 0 CA-C-O 121.267 0.556 . . . . 0.0 112.004 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.402 ' HE3' ' OG1' ' A' ' 136' ' ' THR . 54.0 pttt -130.75 147.46 52.41 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.225 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 17.2 t -73.84 99.76 3.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.343 0.592 . . . . 0.0 110.303 -178.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -106.98 170.07 8.17 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.61 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 134' ' ' THR . 3.5 m -122.75 147.37 46.57 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 175.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.582 HG23 HG22 ' A' ' 156' ' ' THR . 2.6 m -109.68 170.95 2.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.23 173.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -53.24 -33.24 52.11 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -176.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.582 HG22 HG23 ' A' ' 154' ' ' VAL . 15.1 t -74.46 -8.25 55.68 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -176.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 95.91 -4.71 65.84 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.476 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.462 ' H ' HG23 ' A' ' 156' ' ' THR . 90.9 t80 -76.31 137.19 39.72 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.808 0.337 . . . . 0.0 110.719 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.55 130.87 44.57 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.522 177.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.475 HD11 HG13 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -142.99 148.07 36.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.937 0.398 . . . . 0.0 111.357 -175.244 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -85.55 102.41 13.5 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.775 176.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.468 HG13 HD13 ' A' ' 160' ' ' LEU . 26.8 m -102.18 149.78 36.91 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.503 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -51.81 145.38 31.78 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.514 2.143 . . . . 0.0 111.39 175.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 72.4 mt -59.07 -24.61 63.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.622 -169.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -85.89 7.49 23.92 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -175.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.429 HG22 ' HD2' ' A' ' 184' ' ' ARG . 91.1 t -82.91 137.79 20.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 176.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -123.38 156.52 35.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.671 -0.241 . . . . 0.0 110.68 -176.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -59.15 116.7 4.03 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.502 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 121.24 -16.6 9.2 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.535 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -64.57 139.51 58.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.812 0.339 . . . . 0.0 110.989 176.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 55.4 t -100.43 103.73 15.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.414 ' CD1' HD11 ' A' ' 174' ' ' ILE . 0.9 OUTLIER -113.89 150.01 34.28 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.808 -176.898 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.457 ' O ' ' HB ' ' A' ' 182' ' ' ILE . 55.1 mt -103.03 134.66 43.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.827 -173.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.524 HD13 HD12 ' A' ' 131' ' ' LEU . 4.0 mp -121.68 141.12 43.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.754 0.312 . . . . 0.0 110.325 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.508 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 28.0 t-20 -84.61 105.58 15.52 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 175.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 37.6 p -64.82 158.6 24.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.151 -173.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 77.78 -55.3 3.81 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.415 178.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -84.8 -43.13 14.49 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.737 0.303 . . . . 0.0 110.737 -177.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 101.88 4.15 51.68 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.513 173.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 34.9 m -63.78 142.92 58.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.958 0.409 . . . . 0.0 110.951 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -98.44 124.37 43.11 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.2 0.524 . . . . 0.0 111.177 -175.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.457 ' HB ' ' O ' ' A' ' 173' ' ' ILE . 2.6 mp -95.11 152.87 3.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 173.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 17.4 m -74.85 169.42 17.96 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.234 0.54 . . . . 0.0 111.609 -170.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ARG . . . . . 0.429 ' HD2' HG22 ' A' ' 166' ' ' VAL . 58.6 mtp180 -63.08 147.58 50.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.358 -175.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.097 -1.39 . . . . 0.0 110.904 175.858 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.8 mtt . . . . . 0 N--CA 1.482 1.166 0 CA-C-O 120.776 0.322 . . . . 0.0 110.643 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.434 HD12 HG13 ' A' ' 13' ' ' ILE . 61.0 mt -93.97 131.77 39.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.446 -174.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 p -88.91 158.14 18.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.954 174.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.425 ' O ' HG21 ' A' ' 37' ' ' VAL . 15.8 m -71.28 -3.27 3.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -173.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -99.68 6.57 45.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.459 0.647 . . . . 0.0 109.895 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -124.31 88.94 2.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.244 0.545 . . . . 0.0 111.177 -177.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -142.06 156.3 45.4 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.026 177.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -139.95 165.77 26.44 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.7 t -57.19 -15.24 5.32 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.087 0.47 . . . . 0.0 111.169 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -147.95 113.72 0.65 Allowed Glycine 0 N--CA 1.435 -1.368 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 165.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 55.4 tp -151.63 134.61 15.77 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 1.1 p -98.46 124.44 43.17 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.356 0.598 . . . . 0.0 112.262 -176.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.434 HG13 HD12 ' A' ' 2' ' ' ILE . 4.0 mp -127.49 138.99 53.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.983 -178.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.7 p -100.24 110.32 22.56 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.164 0.507 . . . . 0.0 110.301 176.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.5 p -155.03 156.83 4.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -177.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 61.16 24.59 14.69 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.712 0.291 . . . . 0.0 110.887 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 16.0 m120 65.45 30.18 10.95 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.211 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -145.05 163.98 32.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.306 178.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 13.8 pt -105.97 125.77 61.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.199 0.523 . . . . 0.0 109.886 176.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.601 ' O ' ' HA ' ' A' ' 12' ' ' THR . 82.1 m95 -117.77 161.44 19.69 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.803 -169.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -132.02 101.63 5.5 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.606 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.414 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 89.9 t -62.74 116.55 2.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.901 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.4 mm -88.95 -36.14 8.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.242 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -162.71 113.78 1.51 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.788 -177.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 39' ' ' SER . 19.8 p90 -102.87 146.37 28.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.0 0.429 . . . . 0.0 111.014 -176.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -123.47 104.58 9.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.408 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -77.49 96.26 4.68 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 175.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.4 p -104.1 136.18 38.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.614 -171.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -117.94 89.75 34.97 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.456 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.36 -11.31 31.08 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.736 2.291 . . . . 0.0 113.121 -175.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.46 26.23 25.95 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.446 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -92.93 -11.84 32.37 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.33 0.586 . . . . 0.0 110.354 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.04 -19.85 17.52 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 -176.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.5 m -129.28 140.49 51.41 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.77 152.56 20.09 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.204 0.525 . . . . 0.0 110.824 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -131.64 167.1 20.02 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.929 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.425 HG21 ' O ' ' A' ' 4' ' ' VAL . 46.1 t -132.4 102.47 5.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 120.725 0.297 . . . . 0.0 110.428 178.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -77.45 99.26 5.57 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.461 ' HA ' ' HA ' ' A' ' 25' ' ' PHE . 18.2 m -103.4 126.03 50.32 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.547 -175.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.5 tppt? -84.68 110.22 18.59 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 173.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.453 HD23 ' H ' ' A' ' 41' ' ' LEU . 0.8 OUTLIER -138.01 144.06 40.9 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.893 0.854 . . . . 0.0 112.121 -172.881 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 42' ' ' ARG . 18.6 ttt180 -100.19 130.15 46.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.519 -175.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -64.48 112.29 3.07 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 173.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.6 tt -71.34 -14.08 62.08 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.209 0.528 . . . . 0.0 110.635 -171.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 45' ' ' ARG . 11.7 mtp180 -86.82 -45.28 11.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.497 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.4 p -101.24 -20.52 15.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.059 0.457 . . . . 0.0 111.868 -173.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.15 10.15 75.34 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.86 -176.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.71 145.4 38.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.116 0.484 . . . . 0.0 111.961 -175.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.6 mm -100.09 113.43 35.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.428 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.511 ' HG2' ' H ' ' A' ' 51' ' ' GLU . 31.8 tt0 -133.32 176.38 8.57 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.511 ' H ' ' HG2' ' A' ' 50' ' ' GLN . 9.6 pt-20 -138.26 142.35 39.87 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.937 0.398 . . . . 0.0 110.24 173.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -130.41 134.08 46.85 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.363 -177.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.4 p -98.19 110.34 22.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.048 0.451 . . . . 0.0 110.857 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -84.64 147.98 26.67 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.917 178.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.643 ' HD3' ' OE2' ' A' ' 58' ' ' GLU . 44.4 ttt180 -112.92 128.96 56.61 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.93 -174.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.3 125.76 24.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.605 178.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.43 -15.88 32.23 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.928 -178.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.643 ' OE2' ' HD3' ' A' ' 55' ' ' ARG . 42.8 mt-10 -119.26 99.71 6.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.899 0.38 . . . . 0.0 110.19 177.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -76.84 153.38 34.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.955 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.0 m -120.4 162.8 18.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.073 0.464 . . . . 0.0 111.446 -176.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -84.07 132.87 46.75 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.425 -177.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.418 ' HB3' HD11 ' A' ' 2' ' ' ILE . 82.2 Cg_endo -79.07 151.75 23.97 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.688 2.259 . . . . 0.0 112.334 176.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -118.99 114.52 22.67 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.387 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 64.8 mtt -94.15 118.12 31.09 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 48.9 mm -89.35 127.57 41.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.582 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -103.23 118.0 35.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.522 -174.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -102.42 125.72 49.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.787 0.327 . . . . 0.0 110.408 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 71.0 mtt-85 -126.18 115.03 19.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.964 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' A' ' 69' ' ' ARG . 13.3 ptm180 -85.49 117.82 24.64 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.369 0.604 . . . . 0.0 109.683 175.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.618 ' SD ' HD12 ' A' ' 113' ' ' ILE . 31.1 mtt -120.75 143.68 48.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.697 -174.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -77.3 132.72 38.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.777 176.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -73.37 104.26 4.32 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.23 -174.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.407 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 60.8 mt -99.06 -175.66 3.1 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 172.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -144.04 149.65 36.99 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.644 0.735 . . . . 0.0 112.518 -170.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.27 -154.23 0.53 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.661 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -79.86 152.06 29.88 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -82.27 66.65 3.84 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 117.858 -2.115 . . . . 0.0 112.787 -174.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -129.14 -31.79 2.08 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 156.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.572 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 81.9 m-20 -141.04 130.34 23.63 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.653 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.428 ' O ' ' HA ' ' A' ' 92' ' ' GLU . 30.1 m170 -110.69 141.52 43.83 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 175.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.407 ' O ' ' HB2' ' A' ' 73' ' ' LEU . 41.5 t -87.52 130.52 37.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.922 -177.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.424 ' CE1' HD12 ' A' ' 93' ' ' LEU . 83.0 m-85 -124.26 128.39 49.09 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 174.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 25.8 ttt -94.34 112.0 23.77 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.46 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.604 ' HB3' ' H ' ' A' ' 89' ' ' GLU . 25.0 t70 -58.59 110.05 0.91 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.168 177.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -80.59 -4.51 54.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.7 -177.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -70.19 -50.7 37.55 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 173.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.6 p -171.85 93.56 0.15 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 165.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 49.79 29.37 3.2 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 159.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.604 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 42.9 mt-10 -100.12 105.97 17.65 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 121.584 -0.697 . . . . 0.0 111.346 176.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -70.08 125.02 25.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.919 0.39 . . . . 0.0 110.22 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 46.6 m -128.16 125.33 38.88 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.161 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.428 ' HA ' ' O ' ' A' ' 80' ' ' HIS . 32.3 mt-10 -104.58 131.74 51.64 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.8 0.333 . . . . 0.0 110.769 -177.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 79' ' ' ASN . 42.3 mt -100.28 146.56 26.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.575 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.634 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 8.3 t -88.08 166.31 14.52 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.924 -172.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.7 t -51.1 -42.8 60.88 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -171.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -55.1 -45.89 75.5 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -178.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -71.8 -39.89 69.57 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.25 0.548 . . . . 0.0 109.562 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 94' ' ' SER . 56.8 mt -60.2 -28.16 67.75 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.851 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -57.82 -43.95 86.08 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.914 0.388 . . . . 0.0 110.913 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -80.17 -43.33 21.76 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.692 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.486 ' HG3' HD11 ' A' ' 125' ' ' LEU . 0.6 OUTLIER -62.94 -27.57 69.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.99 177.626 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 22.3 mt -75.07 -14.44 60.58 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 122.308 -0.245 . . . . 0.0 111.096 177.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -74.6 -43.92 53.24 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.428 ' HB3' HG11 ' A' ' 129' ' ' VAL . 40.9 m-85 -138.18 116.74 12.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.431 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.454 HD22 ' C ' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -170.78 157.99 5.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.302 0.572 . . . . 0.0 111.113 176.141 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.447 ' HD3' ' O ' ' A' ' 130' ' ' GLU . 31.5 mmmt -130.1 139.29 50.95 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.775 172.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -73.21 127.35 32.36 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.28 -0.36 71.64 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.079 -175.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.459 ' SD ' ' HG3' ' A' ' 126' ' ' PRO . 42.1 ttm -87.47 144.18 26.86 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.679 0.276 . . . . 0.0 111.145 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 70' ' ' MET . 45.3 mt-10 -85.51 122.63 29.91 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.963 177.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 24.9 m -112.34 156.34 13.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -101.31 99.27 9.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.086 0.47 . . . . 0.0 110.176 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.618 HD12 ' SD ' ' A' ' 70' ' ' MET . 54.6 mt -83.24 127.11 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.49 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.531 ' O ' HG12 ' A' ' 121' ' ' ILE . 17.6 tt0 -100.31 112.34 24.67 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.392 -174.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 25.7 p -116.16 155.75 27.69 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.857 -176.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.416 ' HB2' HD13 ' A' ' 121' ' ' ILE . 78.6 t80 -132.69 109.46 9.72 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 172.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 60.46 31.48 20.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.029 0.442 . . . . 0.0 110.853 -175.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.68 -12.95 65.51 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.715 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -86.18 126.94 34.61 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 25.5 m -67.67 117.05 9.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.637 0.256 . . . . 0.0 110.658 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 114' ' ' GLN . 12.9 pt -105.64 -23.35 4.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.813 0.34 . . . . 0.0 111.047 178.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -170.65 166.41 39.6 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.013 176.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 61.1 t -133.19 126.11 52.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -107.4 113.38 26.69 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.936 0.398 . . . . 0.0 110.962 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.486 HD11 ' HG3' ' A' ' 101' ' ' GLU . 3.0 mm? -81.02 149.95 67.67 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 173.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.459 ' HG3' ' SD ' ' A' ' 109' ' ' MET . 9.8 Cg_endo -53.38 137.67 64.78 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.559 2.173 . . . . 0.0 111.417 176.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.605 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 31.8 mmtp -61.28 -27.93 68.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.715 -172.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.5 p -124.61 107.46 11.04 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.194 0.521 . . . . 0.0 110.394 174.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.428 HG11 ' HB3' ' A' ' 104' ' ' TYR . 7.1 p -107.27 144.96 15.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.457 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.447 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 35.7 mt-10 -110.36 113.36 25.96 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.906 0.384 . . . . 0.0 110.381 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 73.6 mt -120.5 129.41 53.83 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.406 -176.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.6 m -72.42 131.21 42.28 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.143 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 170' ' ' ASP . 9.6 p -84.16 112.96 22.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.749 0.785 . . . . 0.0 110.515 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.45 ' O ' ' HB ' ' A' ' 153' ' ' THR . 31.9 p -115.81 119.53 36.31 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.184 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 77.37 87.81 0.07 Allowed 'General case' 0 C--O 1.237 0.413 0 O-C-N 123.991 0.807 . . . . 0.0 110.904 -177.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 12.8 t -151.03 152.88 34.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.81 172.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -114.02 109.74 49.36 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 120.73 0.3 . . . . 0.0 111.393 -177.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 164' ' ' LEU . 12.4 Cg_exo -70.87 -176.39 1.78 Allowed 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 123.66 2.907 . . . . 0.0 111.601 172.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 122.99 35.54 0.72 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.059 -1.067 . . . . 0.0 113.246 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.1 tp -48.0 118.27 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 121.258 0.552 . . . . 0.0 109.994 173.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -87.76 56.22 3.81 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -166.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 82.69 -32.01 2.95 Favored Glycine 0 CA--C 1.518 0.224 0 CA-C-N 115.923 -0.581 . . . . 0.0 114.093 171.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -80.43 153.28 28.34 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 117.184 0.492 . . . . 0.0 110.361 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 2.7 m -110.29 45.3 1.13 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.374 0.607 . . . . 0.0 110.057 -178.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.19 128.24 34.92 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.399 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 16.8 p -70.44 -19.44 62.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.394 -177.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -100.12 19.26 53.73 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.152 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.449 ' O ' ' HG ' ' A' ' 164' ' ' LEU . . . -80.66 82.73 6.59 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 177.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 29.6 p -123.43 158.22 31.66 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.746 -175.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.8 ttpp -132.58 161.06 34.82 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 176.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 34.9 p -72.49 107.69 5.16 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.159 0.504 . . . . 0.0 110.513 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.468 ' HB2' HG22 ' A' ' 162' ' ' VAL . . . -107.32 164.08 12.49 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.386 178.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' A' ' 134' ' ' THR . 22.4 m -119.19 136.03 54.39 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.857 175.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 12.4 m -100.77 174.29 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.0 175.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -56.16 -29.01 60.22 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 59.3 p -72.71 -19.31 61.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.986 0.422 . . . . 0.0 111.484 -177.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 100.22 -3.12 56.67 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -174.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -75.63 144.57 41.65 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.871 0.367 . . . . 0.0 110.688 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 18.9 m -106.07 122.71 46.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.3 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.85 158.58 43.85 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -177.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -88.85 108.86 19.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.069 -174.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.468 HG22 ' HB2' ' A' ' 152' ' ' ALA . 32.7 m -102.72 147.36 33.94 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.586 178.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' A' ' 148' ' ' ALA . 51.0 Cg_exo -54.15 144.83 56.93 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.289 1.993 . . . . 0.0 111.51 172.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 138' ' ' PRO . 77.2 mt -63.0 -7.78 5.99 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -172.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -100.55 10.5 41.1 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 93.9 t -87.78 131.87 34.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.532 0.206 . . . . 0.0 110.55 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -110.73 154.2 24.22 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.996 0.427 . . . . 0.0 110.934 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -59.83 127.13 30.41 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.731 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 112.26 -20.9 20.7 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.429 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.454 ' O ' HG12 ' A' ' 133' ' ' VAL . 2.2 m-20 -64.13 143.39 57.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.851 0.358 . . . . 0.0 110.761 177.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 61.8 t -95.09 110.32 23.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.315 0.579 . . . . 0.0 109.843 177.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.42 HD11 ' HB ' ' A' ' 133' ' ' VAL . 47.8 mt -87.35 129.33 35.06 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.5 -176.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.555 ' O ' ' HB ' ' A' ' 182' ' ' ILE . 40.8 mt -94.43 127.96 46.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 59.8 mt -126.39 138.33 54.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.78 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.605 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 40.7 t-20 -80.98 91.39 6.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.655 177.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.64 133.52 49.51 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.627 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 120.46 -40.33 2.2 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -115.07 -28.87 6.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.24 0.543 . . . . 0.0 110.254 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 88.45 19.34 52.69 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.111 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 19.3 t -79.31 130.83 35.84 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.8 0.333 . . . . 0.0 110.111 -177.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -76.67 127.42 32.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.322 0.582 . . . . 0.0 111.163 -177.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.555 ' HB ' ' O ' ' A' ' 173' ' ' ILE . 59.7 mt -105.8 153.68 7.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 173.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 16.2 p -74.69 146.34 42.4 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.252 0.548 . . . . 0.0 111.113 -168.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -55.93 142.16 36.67 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.077 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.648 -1.085 . . . . 0.0 112.238 -179.005 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ttt . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 121.073 0.463 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.6 mp -111.88 130.7 65.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.0 t -111.78 174.0 6.09 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 22.9 m -72.33 0.91 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -172.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -93.13 -1.57 56.25 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.017 0.437 . . . . 0.0 110.225 176.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -111.06 88.92 2.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.104 -176.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -141.47 147.56 38.06 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 175.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -130.11 174.96 9.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.729 -0.214 . . . . 0.0 110.496 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.4 t -57.84 -24.48 57.62 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 121.343 0.592 . . . . 0.0 110.234 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.624 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -147.13 116.33 0.84 Allowed Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 169.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 57.8 tp -145.94 130.99 18.29 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.567 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 1.7 p -92.87 127.21 38.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.925 0.393 . . . . 0.0 111.957 -177.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mp -127.19 139.69 51.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.247 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.8 t -99.74 107.89 20.08 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.5 p -151.22 150.18 13.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -176.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.8 23.95 14.27 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.803 0.335 . . . . 0.0 110.474 -176.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.7 m120 62.12 33.4 16.99 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.878 -178.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -140.97 162.28 35.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.029 176.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 11.8 pt -104.92 121.0 56.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.344 0.592 . . . . 0.0 110.292 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.567 ' O ' ' HA ' ' A' ' 12' ' ' THR . 70.9 m95 -115.77 164.38 14.46 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.838 -172.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -140.42 109.27 6.01 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 120.935 0.397 . . . . 0.0 110.209 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.624 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 94.2 t -58.66 122.03 7.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.128 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.441 HD11 ' HB2' ' A' ' 42' ' ' ARG . 81.4 mt -87.58 -38.5 12.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.517 174.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -163.2 144.44 9.56 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.24 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -125.24 138.54 54.11 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.095 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -109.52 98.68 8.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.144 175.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 21.5 t-160 -81.08 98.13 7.86 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.9 131.34 48.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.401 0.62 . . . . 0.0 111.458 -174.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.44 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -111.86 101.54 51.68 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.292 -177.818 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -65.87 -46.81 4.4 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.776 2.317 . . . . 0.0 112.47 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.02 17.55 6.28 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.92 -177.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -105.66 10.42 32.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.997 0.427 . . . . 0.0 110.271 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.57 -43.21 3.22 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 -176.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.2 m -89.3 98.33 11.71 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.851 0.358 . . . . 0.0 110.098 176.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -86.73 171.5 10.88 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.504 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -142.13 164.25 30.66 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.355 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 53' ' ' THR . 48.0 t -127.95 107.05 15.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.594 -176.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -80.5 98.17 7.46 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 173.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.6 p -104.97 135.81 45.62 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.99 0.424 . . . . 0.0 111.489 -175.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -95.95 109.87 22.17 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 175.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.555 HD23 ' H ' ' A' ' 41' ' ' LEU . 1.4 pt? -132.5 145.61 51.3 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.405 0.621 . . . . 0.0 111.369 -172.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 22.0 ttp180 -106.39 132.1 52.81 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.657 -175.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -62.03 119.32 8.66 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 172.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.452 HD22 HD12 ' A' ' 121' ' ' ILE . 4.2 tt -64.86 -28.05 69.29 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.795 -171.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 45' ' ' ARG . 52.9 mtt-85 -85.11 -43.65 13.68 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -176.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.6 p -102.05 -9.68 20.37 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -172.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.22 18.94 75.39 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.41 -178.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 42' ' ' ARG . . . -77.01 131.31 38.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.745 0.307 . . . . 0.0 111.553 -177.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.3 mm -89.89 102.14 12.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.062 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.457 ' HG2' ' N ' ' A' ' 51' ' ' GLU . 36.0 tt0 -116.13 169.2 9.45 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.457 ' N ' ' HG2' ' A' ' 50' ' ' GLN . 6.6 pt-20 -136.59 130.05 31.74 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.346 0.593 . . . . 0.0 110.541 172.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -123.22 146.49 47.78 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.306 -176.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 55.3 m -107.55 111.03 23.1 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.979 0.418 . . . . 0.0 110.862 177.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -85.37 142.43 29.3 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.802 177.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 55' ' ' ARG . 36.7 mtp-105 -113.38 135.15 54.17 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.083 -173.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.11 129.34 40.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.478 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.73 -18.37 29.48 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.353 -175.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -99.81 134.81 42.17 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -87.34 133.83 33.65 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.354 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.2 t -94.13 134.99 29.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.331 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -101.47 112.93 65.79 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.885 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.0 163.64 34.93 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.58 2.186 . . . . 0.0 112.606 -177.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -121.89 109.57 14.81 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.701 177.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 64.2 mtt -84.65 109.35 17.93 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.039 0.447 . . . . 0.0 110.903 -177.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.484 HD12 ' CD1' ' A' ' 121' ' ' ILE . 34.6 mm -90.38 120.94 40.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.928 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -94.9 109.27 21.29 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -89.09 131.04 35.43 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.903 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 52.2 mtt180 -130.44 170.39 14.26 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 69' ' ' ARG . 13.7 ptm180 -130.18 125.37 34.81 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.02 0.438 . . . . 0.0 110.07 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.515 ' CB ' ' HB3' ' A' ' 82' ' ' PHE . 2.0 mpt? -117.49 143.22 46.27 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.347 -176.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -84.78 139.46 31.93 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.74 173.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.539 ' CD1' ' HA ' ' A' ' 107' ' ' GLU . 32.7 t80 -71.63 110.15 6.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.861 -176.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.8 mp -100.69 -174.66 2.69 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 169.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -143.02 147.82 35.74 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.437 0.637 . . . . 0.0 111.759 -169.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.5 -165.95 2.38 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.805 176.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -72.51 146.17 46.99 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 174.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.66 68.45 3.0 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 118.683 -1.722 . . . . 0.0 112.857 -171.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -128.13 -33.05 2.21 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 161.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.425 ' OD1' ' HB3' ' A' ' 92' ' ' GLU . 28.3 t30 -143.26 136.82 28.41 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 113.359 -1.746 . . . . 0.0 109.267 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.462 ' ND1' HD22 ' A' ' 98' ' ' LEU . 55.7 m170 -117.58 148.41 41.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.771 0.32 . . . . 0.0 110.539 178.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 45.7 t -100.17 132.23 46.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.079 -176.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.515 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 71.6 m-85 -130.19 124.72 33.25 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 176.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 90.6 mmm -99.7 117.73 34.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.724 0.297 . . . . 0.0 111.52 -175.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.542 ' HB3' ' H ' ' A' ' 89' ' ' GLU . 11.5 t70 -67.63 127.67 33.61 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.496 -178.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -79.64 -16.59 55.5 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.202 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.522 ' HB3' ' OD2' ' A' ' 84' ' ' ASP . 11.6 tp10 -66.92 -52.69 40.06 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 56.0 p -171.43 91.71 0.14 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 167.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 47.41 28.05 1.04 Allowed 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 162.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.542 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 28.0 mm-40 -83.42 101.31 11.28 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 118.392 0.542 . . . . 0.0 110.083 176.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -73.65 96.47 2.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.856 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.9 m -95.6 129.32 42.83 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.476 -175.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.425 ' HB3' ' OD1' ' A' ' 79' ' ' ASN . 35.5 mt-10 -106.68 137.67 44.27 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.931 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.471 HD12 ' CE1' ' A' ' 82' ' ' PHE . 64.7 mt -119.72 133.57 55.57 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.027 0.441 . . . . 0.0 111.189 -178.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.614 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 49.8 m -90.81 179.72 5.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.023 -176.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.0 p -47.73 -41.14 22.32 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -174.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -55.23 -38.14 68.09 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.038 0.446 . . . . 0.0 111.621 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.421 ' HB2' ' HB3' ' A' ' 93' ' ' LEU . 66.0 m-85 -85.68 -34.96 21.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.041 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.614 ' HG ' ' O ' ' A' ' 94' ' ' SER . 20.8 mt -63.63 -22.51 66.94 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.288 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -59.77 -42.77 94.03 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.477 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -66.74 -38.38 86.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.621 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.594 ' O ' HD12 ' A' ' 105' ' ' LEU . 53.5 mt-10 -63.1 -36.4 83.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.097 175.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 82.3 mt -62.42 -21.23 65.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.917 0.389 . . . . 0.0 110.34 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -80.96 -50.99 9.03 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 171.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -142.79 118.53 10.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.546 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.594 HD12 ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -154.17 144.74 22.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.996 0.427 . . . . 0.0 110.312 172.415 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -144.42 139.86 28.64 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 175.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.539 ' HA ' ' CD1' ' A' ' 72' ' ' TYR . 29.0 tt0 -74.44 129.72 38.29 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.091 -177.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.54 1.24 71.64 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.49 -177.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 50.0 ttm -67.74 144.05 55.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.06 0.457 . . . . 0.0 111.501 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -92.59 104.28 16.59 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.822 174.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 26.3 m -105.49 158.76 5.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.704 0.288 . . . . 0.0 110.75 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -111.72 103.39 11.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.834 0.35 . . . . 0.0 110.098 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 60.4 mt -96.52 127.35 48.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.958 0.409 . . . . 0.0 110.394 -177.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.494 ' O ' HG12 ' A' ' 121' ' ' ILE . 76.5 mt-30 -91.04 120.02 31.68 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.928 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 62.4 p -116.32 145.72 42.97 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.319 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -124.98 98.89 5.88 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 60.38 41.8 15.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.691 -173.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 88.93 -18.69 42.55 Favored Glycine 0 CA--C 1.516 0.151 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.874 178.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -82.43 123.68 29.36 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.658 0.266 . . . . 0.0 110.767 -177.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 42.5 p -69.57 107.88 3.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.883 0.373 . . . . 0.0 110.455 178.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.494 HG12 ' O ' ' A' ' 114' ' ' GLN . 21.6 pt -93.94 -28.35 4.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.022 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -164.19 155.05 26.23 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.325 178.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.6 t -120.68 123.27 69.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -106.14 123.27 47.76 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 120.956 0.408 . . . . 0.0 110.351 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.469 ' HB2' HG21 ' A' ' 176' ' ' THR . 75.2 mt -97.08 148.54 34.54 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.725 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.23 135.46 64.92 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.034 2.489 . . . . 0.0 112.123 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 62.5 mttm -67.5 -16.03 63.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.894 -173.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 18.6 p -127.06 109.83 12.3 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.945 0.402 . . . . 0.0 110.671 175.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 12.3 p -120.69 141.79 39.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.513 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -104.02 104.47 14.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.35 0.595 . . . . 0.0 110.784 -178.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 78.0 mt -119.41 129.65 54.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.479 -177.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 3.1 m -75.04 134.09 41.47 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.49 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.468 ' HB ' HD11 ' A' ' 172' ' ' LEU . 3.7 p -79.35 109.1 13.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.683 0.754 . . . . 0.0 109.944 174.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.444 ' O ' ' HB3' ' A' ' 135' ' ' GLU . 36.3 p -114.5 115.36 27.12 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.552 -177.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.444 ' HB3' ' O ' ' A' ' 134' ' ' THR . 15.9 tp10 77.52 101.65 0.07 Allowed 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.928 0.871 . . . . 0.0 110.841 -177.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 14.6 t -150.75 153.74 36.08 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.616 -1.175 . . . . 0.0 108.343 175.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -82.39 147.01 55.41 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-O 120.889 0.376 . . . . 0.0 110.903 -174.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.11 -179.76 2.83 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 123.101 2.534 . . . . 0.0 112.162 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 119.35 32.53 1.23 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.005 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.9 tt -62.09 108.92 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.467 0.651 . . . . 0.0 110.636 176.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -84.52 -56.97 3.34 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.44 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 85.6 -31.41 3.9 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.224 174.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -102.23 -74.51 0.63 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.833 0.349 . . . . 0.0 110.791 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 23.9 m -82.18 76.86 9.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.432 0.634 . . . . 0.0 110.773 -177.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -129.6 -75.41 0.55 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.868 176.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 33.9 p 46.23 58.15 4.73 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.135 0.574 . . . . 0.0 112.443 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 106.26 10.77 29.0 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.347 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -89.35 129.42 35.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.819 0.342 . . . . 0.0 110.208 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 24.1 p -132.24 161.76 32.64 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.112 0.482 . . . . 0.0 111.462 -175.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -129.78 150.1 51.23 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.926 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 18.5 m -73.8 99.83 3.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.092 0.472 . . . . 0.0 111.447 -175.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -104.94 164.94 11.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.782 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 25.9 m -125.75 130.32 51.25 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.004 175.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 14.6 m -86.99 175.01 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.599 -0.441 . . . . 0.0 110.811 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -57.03 -30.0 63.86 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.469 HG22 HD13 ' A' ' 105' ' ' LEU . 64.9 p -72.72 -20.18 61.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.766 0.317 . . . . 0.0 111.477 -177.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 102.78 -1.11 48.59 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.617 -175.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -74.49 129.98 38.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.88 0.372 . . . . 0.0 110.856 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.8 p -91.82 131.94 36.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.709 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -148.71 153.59 38.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.913 0.387 . . . . 0.0 110.321 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -87.83 101.18 13.46 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.205 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 31.7 m -95.86 144.93 28.67 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.635 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.86 150.02 24.14 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 122.478 2.119 . . . . 0.0 111.433 175.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 65.0 mt -61.71 -22.01 64.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.714 -169.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -79.21 -17.15 55.39 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 63.4 t -65.5 131.21 31.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.63 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -119.53 159.02 25.13 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.414 -176.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -57.15 123.58 15.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.666 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 109.95 -12.62 31.95 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.774 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.584 ' OD1' ' HD3' ' A' ' 184' ' ' ARG . 26.2 t70 -68.03 141.02 56.33 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.741 0.305 . . . . 0.0 110.64 178.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 3.7 p -86.1 108.21 17.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.716 0.77 . . . . 0.0 110.425 177.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.468 HD11 ' HB ' ' A' ' 133' ' ' VAL . 85.3 mt -91.59 119.12 31.21 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.256 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.596 ' O ' ' HB ' ' A' ' 182' ' ' ILE . 56.0 mt -90.57 104.47 15.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 173.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 37.1 mt -95.75 130.92 43.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 C-N-CA 120.414 -0.514 . . . . 0.0 109.854 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.563 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 23.3 t-20 -80.07 89.55 5.39 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.976 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.469 HG21 ' HB2' ' A' ' 125' ' ' LEU . 4.7 m -61.43 129.55 41.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.658 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 115.55 -41.98 2.02 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -177.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -106.94 -33.66 7.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.199 0.523 . . . . 0.0 110.086 176.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 95.01 10.78 57.18 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.487 177.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.81 131.18 47.96 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -178.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -100.0 112.41 24.69 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.227 0.537 . . . . 0.0 110.839 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.596 ' HB ' ' O ' ' A' ' 173' ' ' ILE . 4.0 mp -107.63 134.93 47.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 43.0 t -113.43 165.63 12.28 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.477 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.584 ' HD3' ' OD1' ' A' ' 170' ' ' ASP . 30.1 mmt180 69.82 25.7 4.97 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 123.69 0.618 . . . . 0.0 112.095 174.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.626 -1.097 . . . . 0.0 113.009 177.987 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mmt . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 120.947 0.403 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.437 ' HB ' ' HB ' ' A' ' 60' ' ' VAL . 44.4 mm -109.29 145.06 16.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.673 178.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.6 t -94.23 156.28 16.62 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 176.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.9 m -71.69 1.36 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.269 0.557 . . . . 0.0 110.827 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -107.22 11.29 29.47 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.447 176.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -126.92 88.5 2.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.026 0.441 . . . . 0.0 111.041 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -139.86 152.34 46.39 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.372 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.501 ' HG2' ' HG ' ' A' ' 11' ' ' LEU . 19.3 ptpt -143.6 178.19 7.96 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.6 p -56.11 -12.97 1.71 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -160.19 115.56 0.67 Allowed Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.04 172.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.501 ' HG ' ' HG2' ' A' ' 8' ' ' LYS . 8.9 mt -148.66 138.91 22.44 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 122.541 0.336 . . . . 0.0 110.293 174.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 2.9 m -95.28 115.49 27.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.189 0.519 . . . . 0.0 110.743 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.438 HG23 ' O ' ' A' ' 61' ' ' GLU . 1.9 mp -120.95 140.7 44.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.209 -176.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.7 t -98.91 118.0 34.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.953 0.406 . . . . 0.0 110.336 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.7 p -153.09 144.89 15.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 62.45 28.54 16.85 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 122.627 0.371 . . . . 0.0 110.661 -176.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.6 m120 62.52 25.22 15.02 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.396 -177.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.99 159.2 39.44 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 176.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 10.5 pt -106.46 122.96 60.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.233 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.527 ' O ' ' HA ' ' A' ' 12' ' ' THR . 33.3 m95 -119.63 165.52 14.36 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.772 -172.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -128.03 104.88 8.03 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.713 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.507 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 77.3 t -62.8 106.15 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.554 178.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.0 mm -85.0 -33.43 8.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.713 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -152.52 147.08 25.79 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.328 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -136.03 141.87 44.37 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.636 -177.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -124.52 106.35 10.09 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.078 177.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -74.07 89.61 1.97 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 176.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.5 p -92.83 128.15 44.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.894 -172.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.3 pttt -126.11 102.57 27.44 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.765 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -57.26 -47.2 23.47 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.357 2.704 . . . . 0.0 112.469 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.72 4.02 17.6 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.763 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -84.8 -12.42 53.66 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.075 0.464 . . . . 0.0 110.183 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.35 -42.25 1.29 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.659 176.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.0 m -99.84 134.34 42.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.868 0.366 . . . . 0.0 110.952 -177.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.55 153.97 18.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.173 0.511 . . . . 0.0 110.887 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -133.76 168.77 18.11 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.264 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 48.2 t -130.32 103.86 8.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 120.992 0.425 . . . . 0.0 110.083 176.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -82.37 98.82 9.04 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.7 p -110.03 139.0 45.63 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.817 -173.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -95.53 114.97 26.78 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 174.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.544 HD23 ' H ' ' A' ' 41' ' ' LEU . 0.9 OUTLIER -136.91 141.88 42.72 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.727 0.775 . . . . 0.0 111.316 -171.335 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -98.73 130.04 45.19 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.621 -176.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -64.24 114.14 4.04 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 171.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.424 HD21 ' OE1' ' A' ' 114' ' ' GLN . 7.8 tt -70.24 -22.16 62.93 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.726 -170.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -83.01 -46.45 12.84 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.4 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.7 p -97.24 -14.27 21.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.196 0.522 . . . . 0.0 111.908 -174.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.9 24.79 71.0 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.952 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.35 133.46 33.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.861 0.363 . . . . 0.0 111.784 -175.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.6 mm -93.36 109.85 22.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.107 178.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -136.78 177.41 7.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.841 0.353 . . . . 0.0 110.44 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -137.98 146.81 43.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.111 0.481 . . . . 0.0 110.517 173.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -135.07 171.41 14.47 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.309 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.8 t -127.77 118.31 23.52 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.416 0.626 . . . . 0.0 110.828 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -85.23 151.79 23.81 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.497 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -123.78 130.38 52.53 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.326 0.584 . . . . 0.0 111.795 -173.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.94 138.48 58.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.112 176.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.92 -19.21 28.17 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 111.341 -0.703 . . . . 0.0 111.341 -174.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -126.25 150.77 48.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.024 0.44 . . . . 0.0 110.415 176.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 20.1 pttm -89.33 152.13 21.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.29 -175.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.437 ' HB ' ' HB ' ' A' ' 2' ' ' ILE . 64.4 t -102.53 136.44 34.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.348 -178.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.438 ' O ' HG23 ' A' ' 13' ' ' ILE . 7.1 tp10 -88.52 121.2 70.29 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.738 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.27 151.64 20.53 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.244 1.963 . . . . 0.0 112.048 175.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.452 ' HB3' HG22 ' A' ' 12' ' ' THR . . . -113.68 116.8 30.01 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.402 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 61.8 mtt -96.73 110.25 22.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.472 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 54.8 mt -109.85 138.93 35.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.839 0.352 . . . . 0.0 111.07 -176.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -112.85 139.51 48.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.441 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -117.09 127.01 53.73 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 177.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.51 ' HG2' ' OE2' ' A' ' 86' ' ' GLU . 40.6 mtm180 -135.82 165.39 25.72 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.402 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 16.5 ptp180 -127.84 125.65 40.15 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.18 0.514 . . . . 0.0 111.262 -176.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.546 ' HG3' ' HA ' ' A' ' 84' ' ' ASP . 1.9 mpt? -119.92 141.02 49.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.557 -176.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -79.31 140.47 37.54 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.102 177.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -74.58 111.59 9.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.745 -174.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -104.86 -179.64 4.0 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 167.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -145.5 142.14 28.95 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.487 -171.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.72 -170.74 3.53 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.664 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -60.67 131.19 49.94 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.68 68.84 2.44 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 119.153 -1.499 . . . . 0.0 114.322 -165.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -126.76 -30.42 2.77 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 154.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.458 ' OD1' ' HB3' ' A' ' 92' ' ' GLU . 55.7 t30 -133.53 132.38 40.87 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 113.59 -1.641 . . . . 0.0 109.477 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.627 ' CD2' ' HG ' ' A' ' 98' ' ' LEU . 14.5 m-70 -124.23 143.65 50.41 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 55.7 t -92.56 134.17 31.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.026 -175.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.519 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 74.4 m-85 -128.9 126.12 39.04 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 174.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.0 mmt -99.15 117.92 34.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.777 0.323 . . . . 0.0 111.332 -175.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.597 ' HB3' ' H ' ' A' ' 89' ' ' GLU . 23.0 t70 -60.23 115.39 3.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.088 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -72.56 -18.75 61.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.315 -176.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.51 ' OE2' ' HG2' ' A' ' 68' ' ' ARG . 46.3 mt-10 -71.76 -45.78 60.56 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 120.669 -0.412 . . . . 0.0 109.949 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.4 p -169.42 91.3 0.23 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 168.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 47.51 28.19 1.12 Allowed 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 156.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.597 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 37.2 tt0 -93.79 118.14 31.03 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 118.711 0.687 . . . . 0.0 110.809 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -77.61 112.63 14.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.264 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 43.0 m -110.21 119.28 38.77 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.37 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.458 ' HB3' ' OD1' ' A' ' 79' ' ' ASN . 36.3 mt-10 -99.19 127.77 45.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.314 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 39.9 mt -118.89 148.9 42.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.018 0.437 . . . . 0.0 111.004 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.2 m -89.99 166.57 13.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.089 -174.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.8 t -55.52 -31.54 62.15 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.462 -177.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -50.35 -49.24 54.65 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.605 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -77.98 -40.67 38.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.362 0.601 . . . . 0.0 109.74 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.627 ' HG ' ' CD2' ' A' ' 80' ' ' HIS . 4.3 mm? -66.09 -13.82 60.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.88 -174.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -57.77 -39.03 76.48 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.915 0.388 . . . . 0.0 110.106 172.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.58 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 8.4 tp10 -78.09 -43.43 29.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.746 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.468 ' O ' HD12 ' A' ' 105' ' ' LEU . 1.2 mp0 -57.47 -46.21 83.93 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.654 175.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 82.4 mt -67.92 -9.07 42.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.98 0.419 . . . . 0.0 111.116 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.58 ' HB3' ' O ' ' A' ' 100' ' ' GLU . 23.1 t30 -78.73 -50.2 11.78 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 173.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -141.1 116.7 10.24 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.293 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.468 HD12 ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -171.64 167.46 6.53 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.251 0.548 . . . . 0.0 111.818 178.89 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.401 ' N ' HD22 ' A' ' 105' ' ' LEU . 66.1 mttm -141.67 143.67 33.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.842 168.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.5 mp0 -65.09 123.29 19.11 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 175.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.34 -13.43 47.89 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.039 -175.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.414 ' SD ' ' HG2' ' A' ' 126' ' ' PRO . 44.2 ttm -76.67 136.67 39.13 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 70' ' ' MET . 11.7 pt-20 -98.89 126.54 44.59 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.229 0.538 . . . . 0.0 111.142 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 31.4 m -106.71 160.05 6.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.905 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -100.14 100.86 11.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.065 0.46 . . . . 0.0 110.263 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.422 HD12 ' SD ' ' A' ' 70' ' ' MET . 65.1 mt -83.17 129.01 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.581 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.496 ' HG2' HD11 ' A' ' 121' ' ' ILE . 35.3 tt0 -106.8 117.36 33.84 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.925 -176.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 16.5 p -116.19 153.18 32.31 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.088 -174.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -130.03 99.39 5.06 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.935 176.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 61.97 31.79 17.96 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.374 0.607 . . . . 0.0 110.312 -174.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 93.78 -16.69 60.25 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.399 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -80.86 114.86 20.04 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 29.6 m -63.57 112.37 2.77 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.782 0.325 . . . . 0.0 110.604 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.496 HD11 ' HG2' ' A' ' 114' ' ' GLN . 38.7 pt -97.65 -23.97 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.04 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -170.47 163.46 36.68 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.016 -1.087 . . . . 0.0 112.848 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.3 t -127.63 126.63 67.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -106.59 120.6 42.38 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.76 -176.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.441 HD22 ' N ' ' A' ' 125' ' ' LEU . 1.9 mm? -86.18 150.21 51.67 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.414 ' HG2' ' SD ' ' A' ' 109' ' ' MET . 71.9 Cg_exo -51.42 130.89 34.59 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.697 2.265 . . . . 0.0 111.602 174.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.58 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 34.8 mmtp -62.37 -27.25 68.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.329 -170.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 34.9 p -121.32 112.73 18.95 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.97 176.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.1 p -114.8 137.03 49.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.164 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -109.32 99.03 8.34 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.226 0.536 . . . . 0.0 110.703 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.2 mt -106.9 142.05 37.14 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.056 0.455 . . . . 0.0 111.272 -173.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.4 m -84.14 133.7 34.61 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.037 176.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.6 p -87.34 112.37 23.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.629 0.728 . . . . 0.0 111.029 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 27.5 p -111.15 119.66 39.71 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.316 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 75.11 108.27 0.07 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.873 0.844 . . . . 0.0 111.041 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 8.9 t -150.55 153.44 35.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.673 178.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.452 ' O ' ' HD2' ' A' ' 150' ' ' LYS . 52.5 mt-10 -84.2 150.43 57.86 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.245 -176.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.29 179.9 6.07 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.51 2.14 . . . . 0.0 111.863 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 119.81 27.92 2.0 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.431 -177.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.9 tt -66.46 117.09 6.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.277 0.56 . . . . 0.0 110.447 176.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -71.95 -34.42 68.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.454 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 119.54 -26.41 7.31 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.108 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -102.68 170.9 7.73 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.169 0.509 . . . . 0.0 110.805 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.8 t -125.5 21.17 7.87 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.629 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -93.99 -29.48 15.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.185 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.9 t -62.47 144.48 55.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.838 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -96.14 15.35 63.1 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.173 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -86.61 154.32 21.12 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.741 0.305 . . . . 0.0 110.815 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 23.0 p -136.8 174.54 10.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.507 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.452 ' HD2' ' O ' ' A' ' 137' ' ' GLU . 59.6 pttt -133.41 145.86 50.68 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.524 177.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 9.1 t -73.18 118.66 16.4 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.109 0.481 . . . . 0.0 110.338 -176.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -124.02 164.22 19.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.013 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 33.4 m -120.54 135.98 54.92 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 9.7 m -98.73 173.94 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.284 177.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -52.81 -31.23 37.69 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 68.5 p -74.42 -12.6 60.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.712 0.291 . . . . 0.0 111.721 -176.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 95.48 -4.72 66.93 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.015 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -75.53 144.91 41.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.992 0.425 . . . . 0.0 110.603 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 23.3 m -107.24 122.44 46.55 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.178 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.07 161.62 37.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.696 0.284 . . . . 0.0 110.302 -177.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -92.1 111.49 23.06 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.083 -175.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 27.4 m -101.14 155.81 35.89 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.228 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -58.2 152.09 55.12 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.357 2.038 . . . . 0.0 111.4 174.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 72.6 mt -64.08 -18.33 64.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.468 -169.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -91.28 -1.94 57.54 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -176.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 85.8 t -73.11 135.6 27.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.957 0.408 . . . . 0.0 110.694 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -113.98 151.51 32.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.193 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -63.33 125.7 25.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.115 0.483 . . . . 0.0 110.683 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 109.54 -10.5 32.93 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.19 -176.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.592 ' OD2' ' HD3' ' A' ' 184' ' ' ARG . 19.1 t70 -73.39 148.19 43.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.597 0.237 . . . . 0.0 110.676 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.477 ' O ' ' HD2' ' A' ' 184' ' ' ARG . 60.7 t -105.33 99.97 9.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.197 0.522 . . . . 0.0 110.51 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.558 ' H ' HD23 ' A' ' 172' ' ' LEU . 0.7 OUTLIER -96.01 141.17 29.73 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.603 -177.718 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.421 ' O ' ' HB ' ' A' ' 182' ' ' ILE . 59.2 mt -99.22 130.54 48.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.344 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 43.9 mm -117.87 141.43 36.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.58 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 23.6 t-20 -87.85 98.81 11.68 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 177.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.21 127.06 31.23 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.518 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 111.02 -37.25 3.81 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.652 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -104.78 -23.84 12.99 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.099 0.476 . . . . 0.0 110.359 176.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 73.88 17.53 79.36 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.201 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 9.6 p -84.42 152.37 24.06 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.873 0.368 . . . . 0.0 110.633 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -97.33 124.79 41.58 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.19 0.519 . . . . 0.0 110.671 -175.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' A' ' 173' ' ' ILE . 2.8 mp -106.74 151.02 8.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 174.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.2 p -77.15 173.56 11.71 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.377 -173.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.592 ' HD3' ' OD2' ' A' ' 170' ' ' ASP . 7.9 tpt180 -39.59 136.18 1.03 Allowed 'General case' 0 CA--C 1.533 0.319 0 O-C-N 123.754 0.659 . . . . 0.0 112.473 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.488 -1.174 . . . . 0.0 111.698 175.263 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.7 mtt . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 120.477 0.18 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.2 mm -104.29 122.87 57.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.7 0.286 . . . . 0.0 110.425 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.1 m -74.04 146.62 43.57 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 175.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.49 ' O ' HG21 ' A' ' 37' ' ' VAL . 20.7 m -70.11 -10.56 13.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.848 0.356 . . . . 0.0 111.744 -176.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -95.39 7.78 45.18 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.34 0.59 . . . . 0.0 109.542 177.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -120.79 87.79 2.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.687 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -136.9 152.84 50.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.217 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -128.19 167.44 16.83 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.809 -176.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.2 m -54.17 -30.24 48.64 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.344 0.592 . . . . 0.0 110.34 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.524 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -140.36 116.74 1.2 Allowed Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 169.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 54.9 tp -150.46 135.35 17.58 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 1.9 p -94.44 122.43 37.0 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.444 0.64 . . . . 0.0 112.192 -176.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.401 HD12 ' C ' ' A' ' 12' ' ' THR . 1.7 mp -119.39 141.92 37.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.53 -176.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.514 ' O ' ' HB3' ' A' ' 61' ' ' GLU . 43.1 t -107.32 107.73 18.79 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.433 HG12 ' CD1' ' A' ' 20' ' ' TRP . 13.1 p -142.2 140.6 29.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -178.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 61.3 32.77 19.2 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.6 -176.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 64.86 23.01 12.6 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.609 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.39 158.55 37.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.796 0.332 . . . . 0.0 110.514 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.6 pt -107.47 123.73 62.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.665 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.442 ' O ' ' HA ' ' A' ' 12' ' ' THR . 54.1 m95 -122.8 160.03 26.85 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.625 -172.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -130.58 115.04 16.21 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.524 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 94.9 t -64.76 119.14 8.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.705 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.4 mm -90.91 -35.96 7.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.718 176.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -160.82 122.09 2.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.067 177.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -104.45 143.28 33.22 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.735 0.302 . . . . 0.0 110.944 -176.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -118.85 99.43 6.75 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.881 0.372 . . . . 0.0 110.337 177.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -78.07 91.88 4.32 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 176.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 p -101.6 135.8 36.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.517 -171.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -109.1 101.76 46.18 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-O 121.309 0.576 . . . . 0.0 110.58 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -58.02 -48.2 17.24 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 123.345 2.696 . . . . 0.0 112.797 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.2 19.43 8.04 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.887 178.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -110.1 -14.31 14.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.681 0.277 . . . . 0.0 111.46 -177.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.05 -42.86 1.24 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.262 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.1 m -102.1 131.22 48.7 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 177.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.13 155.63 19.68 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 174.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 55' ' ' ARG . 34.9 m-85 -129.66 163.38 26.21 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.094 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.49 HG21 ' O ' ' A' ' 4' ' ' VAL . 52.8 t -132.7 102.7 5.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.179 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -80.73 98.96 7.98 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 175.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 53.2 p -100.64 134.2 43.96 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.134 -175.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -95.43 102.68 14.5 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 174.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.519 HD23 ' H ' ' A' ' 41' ' ' LEU . 1.3 pt? -138.48 150.96 46.96 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.804 0.335 . . . . 0.0 110.853 -171.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -116.96 144.92 44.01 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.543 -175.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.44 ' HB2' ' CZ3' ' A' ' 20' ' ' TRP . 47.4 t-20 -76.58 115.57 16.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.451 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.8 mt -69.77 -24.75 63.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.194 0.521 . . . . 0.0 110.733 -177.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.6 tpp180 -70.13 -38.8 75.64 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.011 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.3 p -113.48 -15.89 12.51 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -174.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.87 20.82 69.78 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.274 -0.489 . . . . 0.0 112.004 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -96.45 141.65 29.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.856 0.36 . . . . 0.0 111.799 -173.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.2 tp -87.92 137.18 21.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.251 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.481 ' HG3' ' N ' ' A' ' 51' ' ' GLU . 58.4 tp60 -148.46 175.25 11.29 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -178.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.481 ' N ' ' HG3' ' A' ' 50' ' ' GLN . 10.7 pt-20 -140.17 138.16 34.96 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 170.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -126.51 135.11 50.9 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.686 -175.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.2 p -102.23 102.66 13.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.929 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -85.17 149.32 25.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.026 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.426 ' HB3' ' CE2' ' A' ' 36' ' ' PHE . 5.7 ptm180 -120.18 134.96 55.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.974 0.416 . . . . 0.0 111.385 -175.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.05 132.71 54.68 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.915 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 108.03 -29.88 9.68 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -174.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -102.82 99.67 9.63 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -76.6 137.71 39.68 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.415 0.626 . . . . 0.0 110.831 -175.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.3 t -85.36 150.65 3.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.977 -169.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.514 ' HB3' ' O ' ' A' ' 14' ' ' SER . 34.7 tt0 -85.63 130.98 48.94 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.682 176.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -82.73 156.29 15.83 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.505 2.137 . . . . 0.0 112.895 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.441 ' HB2' ' HB2' ' A' ' 14' ' ' SER . . . -123.61 120.5 32.99 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.431 174.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 67.8 mtt -96.38 108.89 21.48 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.174 0.511 . . . . 0.0 110.799 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -110.2 121.6 63.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.485 177.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.583 ' OE1' ' HD2' ' A' ' 68' ' ' ARG . 40.6 tt0 -95.64 107.76 19.98 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.904 -176.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -84.39 100.77 11.5 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.357 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.583 ' HD2' ' OE1' ' A' ' 66' ' ' GLU . 16.2 mtp180 -106.08 170.24 8.03 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.142 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.585 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 7.7 ptm180 -142.71 120.06 11.6 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.459 0.647 . . . . 0.0 111.141 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.623 ' CB ' ' HB3' ' A' ' 82' ' ' PHE . 1.5 mpt? -115.59 139.94 49.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.926 -174.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -71.75 133.7 45.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.541 174.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -77.31 111.17 12.68 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -174.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -111.21 -179.04 3.61 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 169.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -148.7 159.59 43.98 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.312 0.577 . . . . 0.0 111.82 -175.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.23 -149.55 0.31 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.436 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -66.65 136.69 55.94 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 170.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.01 69.09 2.98 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 118.782 -1.675 . . . . 0.0 113.59 -170.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -127.11 -33.2 2.44 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 158.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -128.73 120.07 25.76 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 113.85 -1.523 . . . . 0.0 108.913 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.579 ' CG ' ' HG ' ' A' ' 98' ' ' LEU . 17.0 m-70 -102.39 132.28 48.49 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 57.1 t -83.58 125.64 40.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.081 -173.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.623 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 61.0 m-85 -123.03 120.54 33.63 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 176.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.575 ' SD ' ' HG2' ' A' ' 90' ' ' GLN . 93.5 mmm -95.19 113.3 24.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.917 -176.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.584 ' HB3' ' H ' ' A' ' 89' ' ' GLU . 20.9 t70 -58.46 117.39 4.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.239 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -76.49 -12.56 60.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.48 -177.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -68.91 -50.27 50.92 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 176.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.1 p -170.99 91.65 0.15 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.103 0.478 . . . . 0.0 112.288 164.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 48.31 26.62 1.14 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 160.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.584 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 45.7 mt-10 -87.59 113.16 23.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 118.666 0.666 . . . . 0.0 110.867 176.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.575 ' HG2' ' SD ' ' A' ' 83' ' ' MET . 73.5 mt-30 -74.47 118.14 17.09 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.343 -178.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.9 m -120.14 121.76 39.51 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.23 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -95.91 127.97 42.39 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.947 0.403 . . . . 0.0 110.483 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.434 HD12 ' CE1' ' A' ' 82' ' ' PHE . 59.6 mt -112.69 140.02 47.81 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.433 178.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.5 t -80.29 158.57 26.11 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.772 -177.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.2 p -58.98 -23.9 62.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.842 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.51 -39.45 87.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.808 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -82.75 -41.07 19.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.597 0.713 . . . . 0.0 109.35 177.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.579 ' HG ' ' CG ' ' A' ' 80' ' ' HIS . 3.3 mm? -67.24 -20.05 65.61 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.445 -171.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -60.94 -31.0 70.55 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.212 0.53 . . . . 0.0 110.096 175.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -82.61 -46.23 13.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.25 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.467 ' HA ' HD21 ' A' ' 125' ' ' LEU . 0.9 OUTLIER -62.13 -36.61 82.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.467 179.084 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.486 ' O ' ' HB ' ' A' ' 156' ' ' THR . 56.2 mt -67.21 -6.36 17.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.629 0.252 . . . . 0.0 111.608 -178.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -70.53 -41.47 72.5 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 172.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.504 ' HB3' HG11 ' A' ' 129' ' ' VAL . 68.8 m-85 -142.4 115.2 8.66 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.208 177.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 101' ' ' GLU . 0.7 OUTLIER 179.8 171.41 1.07 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 122.95 0.5 . . . . 0.0 110.739 173.004 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.542 ' HD2' ' O ' ' A' ' 130' ' ' GLU . 30.4 mtpp -142.48 144.73 33.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.306 176.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -62.73 113.79 3.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.862 0.363 . . . . 0.0 110.739 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 109.85 -10.28 32.14 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.402 -177.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.536 ' SD ' ' HG3' ' A' ' 126' ' ' PRO . 53.0 ttm -91.11 144.31 25.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.68 0.276 . . . . 0.0 110.465 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.62 ' HA ' ' O ' ' A' ' 70' ' ' MET . 8.4 pt-20 -94.2 138.91 31.68 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.365 0.602 . . . . 0.0 112.075 -177.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 33.9 m -113.57 158.13 14.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.58 175.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.566 ' HA ' ' O ' ' A' ' 68' ' ' ARG . 80.0 mt-30 -96.83 99.94 11.49 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.048 0.452 . . . . 0.0 110.652 -177.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.497 HD12 ' SD ' ' A' ' 70' ' ' MET . 63.7 mt -84.44 127.98 39.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.223 -178.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.405 ' O ' HG12 ' A' ' 121' ' ' ILE . 91.5 mt-30 -100.13 110.34 22.62 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.485 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 43.1 p -107.12 128.7 54.62 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.322 177.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -108.1 110.2 21.82 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 174.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 60.44 29.05 18.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.445 -176.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 98.31 -18.96 56.27 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.984 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 115' ' ' THR . 42.5 tt0 -84.64 126.88 33.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.638 0.219 . . . . 0.0 111.364 -176.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 85.5 m -68.21 100.82 1.08 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 175.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 114' ' ' GLN . 46.7 pt -84.79 -30.77 6.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.064 0.459 . . . . 0.0 110.328 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -170.86 162.38 35.32 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.692 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.4 t -123.81 127.31 73.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 177.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.456 ' HB3' ' HB2' ' A' ' 112' ' ' GLN . 31.0 tt0 -93.74 123.67 37.24 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.007 0.432 . . . . 0.0 109.961 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.477 HD23 ' HB2' ' A' ' 104' ' ' TYR . 7.0 mp -78.25 157.62 77.89 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.311 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.536 ' HG3' ' SD ' ' A' ' 109' ' ' MET . 6.9 Cg_endo -48.45 127.81 16.58 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.02 2.48 . . . . 0.0 112.249 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -56.8 -38.29 72.33 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.348 -178.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 29.7 p -133.18 109.27 9.33 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.832 174.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.504 HG11 ' HB3' ' A' ' 104' ' ' TYR . 10.4 p -111.41 140.86 28.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.731 0.3 . . . . 0.0 110.623 -176.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.542 ' O ' ' HD2' ' A' ' 106' ' ' LYS . 7.4 pt-20 -107.06 100.36 9.85 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.402 0.62 . . . . 0.0 110.481 177.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 89.7 mt -106.2 133.47 50.86 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.343 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.4 m -76.12 130.85 38.92 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.098 178.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.431 ' HB ' HD11 ' A' ' 172' ' ' LEU . 7.5 p -78.88 105.61 8.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.913 0.863 . . . . 0.0 110.652 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 37.0 p -107.53 112.37 25.09 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.427 -178.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 79.06 96.67 0.06 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-O 122.068 0.937 . . . . 0.0 111.036 -177.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.608 ' O ' ' HD3' ' A' ' 138' ' ' PRO . 9.7 t -150.65 153.36 35.49 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.086 -1.415 . . . . 0.0 107.663 174.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -84.29 103.27 2.83 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.608 ' HD3' ' O ' ' A' ' 136' ' ' THR . 68.8 Cg_endo -90.11 172.81 3.56 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.835 2.357 . . . . 0.0 112.356 -175.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.49 21.24 77.54 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.772 176.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 56.5 mt -88.11 122.64 39.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.409 ' HD2' ' N ' ' A' ' 141' ' ' LYS . 11.8 mptt -92.3 172.52 8.35 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.174 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 119.91 -2.39 13.3 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.731 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 62.93 -173.18 0.16 Allowed 'General case' 0 N--CA 1.463 0.197 0 O-C-N 124.067 0.51 . . . . 0.0 111.081 176.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 55.2 m -153.69 87.66 1.24 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.955 0.407 . . . . 0.0 109.933 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -130.54 3.01 4.58 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -176.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.3 m -150.21 36.38 0.67 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.528 0.68 . . . . 0.0 110.654 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 85.07 21.13 56.17 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.596 -0.812 . . . . 0.0 113.855 174.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.28 93.61 3.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.371 0.585 . . . . 0.0 109.894 174.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 18.0 p -122.79 164.83 17.64 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.146 -176.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -125.25 148.18 48.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.953 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 42.5 m -73.72 107.17 5.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.089 0.471 . . . . 0.0 110.76 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -107.9 163.5 13.07 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.852 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 21.1 m -118.79 134.52 55.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.047 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.5 m -98.54 175.79 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.506 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -57.31 -28.2 62.86 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.486 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 44.1 p -73.94 -11.01 60.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.017 0.436 . . . . 0.0 111.652 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.59 1.85 73.71 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -176.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -81.53 143.27 32.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.915 0.388 . . . . 0.0 110.856 -177.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 23.1 m -100.96 126.91 47.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.399 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.92 155.49 41.64 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -85.79 123.69 31.45 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.36 0.6 . . . . 0.0 111.3 -175.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.401 ' HB ' HG21 ' A' ' 166' ' ' VAL . 27.3 m -116.61 155.06 49.23 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.368 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -56.85 150.51 54.14 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.444 2.096 . . . . 0.0 111.65 175.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 80.7 mt -62.95 -17.3 61.78 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -169.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -88.6 -8.32 54.89 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -176.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.401 HG21 ' HB ' ' A' ' 162' ' ' VAL . 74.5 t -69.24 136.6 25.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.81 0.338 . . . . 0.0 111.249 -177.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -122.68 160.89 24.89 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.479 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -59.4 128.04 35.09 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.887 -177.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 109.42 -15.61 32.42 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.536 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.563 ' OD2' ' HD3' ' A' ' 184' ' ' ARG . 23.7 t70 -67.26 145.35 55.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.8 0.3 . . . . 0.0 110.591 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.427 ' CG1' ' HB2' ' A' ' 130' ' ' GLU . 47.2 t -94.7 109.91 22.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.157 0.503 . . . . 0.0 110.379 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.431 HD11 ' HB ' ' A' ' 133' ' ' VAL . 46.7 mt -90.97 117.33 29.48 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.454 -178.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.404 HD12 ' N ' ' A' ' 173' ' ' ILE . 1.8 mp -91.43 106.45 17.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 57.8 mt -107.67 129.62 61.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.573 -176.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -82.22 96.41 7.85 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.373 175.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.458 HG21 ' HB2' ' A' ' 125' ' ' LEU . 6.5 m -61.68 136.59 58.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.006 -175.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 104.11 -33.74 6.33 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -107.66 -26.73 10.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.026 0.441 . . . . 0.0 110.505 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.36 15.32 76.75 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.206 177.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 5.9 m -68.96 112.65 5.74 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -96.22 111.41 23.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.188 0.518 . . . . 0.0 110.957 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 4.5 mp -107.81 102.35 13.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.124 0.488 . . . . 0.0 110.114 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 48.3 t -80.53 166.74 20.89 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.368 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.563 ' HD3' ' OD2' ' A' ' 170' ' ' ASP . 25.1 mmt180 72.46 30.22 1.98 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 172.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.137 0 CA-C-O 118.147 -1.363 . . . . 0.0 113.604 174.345 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.9 mtt . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.507 ' HB ' HG23 ' A' ' 60' ' ' VAL . 3.7 mp -81.76 118.86 30.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.242 0.544 . . . . 0.0 110.757 -176.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 m -97.36 151.95 19.42 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.337 171.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.9 m -67.18 -14.68 18.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -167.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -86.06 -0.1 54.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.427 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -133.6 91.31 2.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.242 0.544 . . . . 0.0 111.786 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -126.27 156.7 39.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.589 172.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -126.94 162.11 26.74 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -177.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 p -53.0 -20.36 3.37 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 123.556 0.535 . . . . 0.0 111.63 175.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.603 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -144.49 115.78 0.89 Allowed Glycine 0 N--CA 1.435 -1.376 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 167.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.72 129.22 20.17 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.56 HG21 ' CG1' ' A' ' 65' ' ' ILE . 1.2 m -103.29 118.27 36.4 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.193 0.52 . . . . 0.0 111.055 -178.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.0 mp -117.94 140.31 41.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.321 -176.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.7 t -102.33 102.02 12.34 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 175.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.5 p -140.34 146.27 24.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.446 -177.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 61.94 28.45 17.32 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.493 -176.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.1 m120 63.86 25.66 14.09 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.445 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.86 163.39 29.61 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.098 177.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 10.1 pt -109.56 126.27 66.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.392 -178.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.553 ' O ' ' HA ' ' A' ' 12' ' ' THR . 64.8 m95 -124.11 146.56 48.55 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.088 -170.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -120.78 104.05 9.58 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.318 -177.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.603 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 78.9 t -63.02 111.91 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.76 177.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.2 mt -92.68 -33.91 5.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.695 176.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.405 ' HB2' ' HD3' ' A' ' 40' ' ' LYS . 33.0 m-20 -143.12 148.78 37.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.022 177.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -141.6 131.75 24.8 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.079 0.466 . . . . 0.0 110.905 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -122.37 110.02 15.13 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.373 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -80.06 101.24 8.6 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.5 p -108.5 134.11 51.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.295 0.569 . . . . 0.0 111.331 -172.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -122.89 100.55 40.2 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.701 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -76.25 -10.49 19.22 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.343 2.029 . . . . 0.0 112.199 177.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.6 25.78 60.17 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.774 -0.648 . . . . 0.0 113.087 175.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -87.56 -12.86 44.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.919 0.39 . . . . 0.0 111.145 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.96 -42.57 1.27 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.685 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.7 p -123.01 132.41 54.12 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 174.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.04 161.65 25.28 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.848 0.356 . . . . 0.0 110.627 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.479 ' HA ' ' O ' ' A' ' 54' ' ' PHE . 86.1 m-85 -128.59 165.46 20.74 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.102 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 53' ' ' THR . 59.5 t -129.67 106.41 13.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 176.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -80.37 99.29 7.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.202 177.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 16.1 p -111.03 137.15 49.02 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.27 -174.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.405 ' HD3' ' HB2' ' A' ' 24' ' ' ASP . 45.9 mtpt -95.28 108.85 21.03 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 175.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.529 HD23 ' H ' ' A' ' 41' ' ' LEU . 1.1 pt? -135.94 141.82 44.53 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.764 0.793 . . . . 0.0 111.899 -172.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 33.0 ttt180 -103.77 129.8 51.23 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.86 -1.063 . . . . 0.0 111.49 -173.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -70.12 117.95 12.34 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 172.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.422 ' H ' HD12 ' A' ' 44' ' ' LEU . 5.9 mp -64.61 -26.82 68.57 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 121.188 -0.205 . . . . 0.0 111.434 -175.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.443 HH11 ' HD2' ' A' ' 45' ' ' ARG . 59.3 mtt180 -76.55 -50.07 14.83 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.825 0.345 . . . . 0.0 111.467 -177.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.4 p -94.54 -17.65 22.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.047 0.451 . . . . 0.0 111.811 -172.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.24 6.57 88.85 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.719 -175.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 42' ' ' ARG . . . -68.64 131.04 44.54 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -174.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.7 mm -91.53 98.84 8.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.416 ' HG2' ' N ' ' A' ' 51' ' ' GLU . 34.7 tt0 -112.47 167.34 10.52 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -178.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.416 ' N ' ' HG2' ' A' ' 50' ' ' GLN . 11.0 pt-20 -132.5 125.91 31.7 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.152 0.501 . . . . 0.0 109.949 173.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.445 ' HD2' HD11 ' A' ' 41' ' ' LEU . 56.3 mttm -115.36 148.19 39.59 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.74 -176.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 10.8 p -112.6 105.06 13.17 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.244 176.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.479 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 88.3 m-85 -84.1 144.96 28.7 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.726 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.554 ' HD3' ' OE2' ' A' ' 58' ' ' GLU . 34.5 ttt180 -111.09 136.08 50.66 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.743 0.306 . . . . 0.0 111.549 -173.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.13 129.79 42.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.818 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 106.27 -16.75 41.51 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -175.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.554 ' OE2' ' HD3' ' A' ' 55' ' ' ARG . 81.1 mt-10 -112.71 149.56 32.75 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -127.67 163.41 24.32 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.298 -176.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.507 HG23 ' HB ' ' A' ' 2' ' ' ILE . 5.6 m -134.16 157.63 41.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.37 0.605 . . . . 0.0 111.469 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -83.59 141.56 41.99 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.03 -0.987 . . . . 0.0 110.443 -176.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.27 154.73 41.47 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.538 2.159 . . . . 0.0 112.454 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.44 113.07 18.85 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.954 175.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 26.3 mmt -88.64 109.03 19.77 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.99 0.424 . . . . 0.0 110.62 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.56 ' CG1' HG21 ' A' ' 12' ' ' THR . 46.9 mm -99.37 125.4 52.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.049 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.498 ' HG3' ' OG1' ' A' ' 115' ' ' THR . 6.0 pt-20 -117.6 138.02 52.22 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.595 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -112.98 113.86 26.09 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.954 0.406 . . . . 0.0 110.213 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.515 ' HB3' ' OD1' ' A' ' 84' ' ' ASP . 68.6 mtt180 -110.36 117.47 33.71 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.17 -178.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 9.2 ptm180 -74.05 121.14 20.62 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 174.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.559 ' HG2' ' HA ' ' A' ' 84' ' ' ASP . 28.7 mtt -124.08 147.72 47.66 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.448 -175.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -77.41 136.56 38.41 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.903 177.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -77.14 103.78 7.26 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.413 -176.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 8.4 mp -104.32 -176.81 3.19 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 170.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -146.79 157.09 43.59 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.621 0.724 . . . . 0.0 112.448 -171.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 79' ' ' ASN . . . -150.57 -160.83 1.22 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.308 -1.314 . . . . 0.0 107.713 174.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -72.08 143.15 49.17 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 175.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.5 68.66 2.41 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 118.879 -1.629 . . . . 0.0 113.879 -167.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.579 ' HA ' ' OG ' ' A' ' 95' ' ' SER . 22.8 m-20 -127.93 -30.43 2.48 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 156.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.47 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 92.6 m-20 -137.07 138.65 40.63 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.512 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -121.69 144.56 48.7 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 173.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.444 ' O ' ' HB2' ' A' ' 73' ' ' LEU . 45.9 t -90.41 132.33 35.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.499 -178.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -126.43 125.53 42.3 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 174.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 37.8 mtt -93.7 113.32 25.37 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.454 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.677 ' HB3' ' H ' ' A' ' 89' ' ' GLU . 20.2 t0 -62.15 115.01 3.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.511 -177.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -85.46 -7.13 59.08 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.023 177.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.59 -52.24 27.84 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 173.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.44 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 12.1 p -164.75 90.03 0.52 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 167.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 47.33 28.26 1.03 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 158.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.677 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 49.2 mt-10 -105.89 116.53 32.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 118.981 0.809 . . . . 0.0 112.408 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -75.86 118.68 18.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.277 0.561 . . . . 0.0 110.027 175.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.1 m -120.99 138.26 54.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.547 -175.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -105.87 134.55 48.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.797 0.332 . . . . 0.0 110.817 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 79' ' ' ASN . 4.5 mm? -112.88 143.01 44.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.427 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.7 m -79.64 166.93 21.35 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -173.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.579 ' OG ' ' HA ' ' A' ' 78' ' ' ASP . 10.2 m -52.93 -33.38 50.41 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.749 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -52.14 -40.69 61.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.734 -176.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -87.64 -41.03 13.69 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.42 0.628 . . . . 0.0 109.953 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.487 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 4.3 mm? -74.32 -20.88 59.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.314 -171.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -60.58 -32.26 71.37 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.126 0.489 . . . . 0.0 110.204 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -87.44 -39.4 15.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.387 177.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.455 ' O ' HD12 ' A' ' 105' ' ' LEU . 40.7 mt-10 -63.57 -25.62 68.32 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.343 178.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 65.8 mt -71.44 -7.4 47.14 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 122.021 -0.424 . . . . 0.0 110.865 177.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -90.09 -43.8 10.24 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 172.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -130.36 116.24 18.02 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.315 176.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.455 HD12 ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -172.4 164.2 5.68 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.728 0.299 . . . . 0.0 110.627 177.459 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -143.16 138.87 30.07 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -63.7 123.13 18.09 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.638 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.32 1.65 71.75 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.751 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.41 ' SD ' ' HD2' ' A' ' 126' ' ' PRO . 51.9 ttm -62.75 147.62 49.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.106 0.479 . . . . 0.0 111.53 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.43 ' HG2' HH21 ' A' ' 69' ' ' ARG . 4.3 tp10 -89.41 100.32 13.14 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.593 175.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 23.1 m -106.55 155.74 7.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.63 -178.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.53 ' HB2' ' HB3' ' A' ' 124' ' ' GLU . 12.8 mm100 -96.99 99.65 11.18 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.447 HD13 HG13 ' A' ' 123' ' ' VAL . 32.8 mm -81.88 116.0 25.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 177.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.419 ' HG2' HD11 ' A' ' 121' ' ' ILE . 17.7 tt0 -91.69 113.16 25.35 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.498 ' OG1' ' HG3' ' A' ' 66' ' ' GLU . 1.7 p -116.11 157.85 24.11 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.705 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -129.64 101.91 6.13 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 176.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 58.55 33.98 23.53 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.225 -173.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 96.49 -22.59 39.27 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.989 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -75.53 131.4 40.03 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.824 -0.221 . . . . 0.0 110.569 -178.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.6 p -75.22 113.24 12.36 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.734 0.302 . . . . 0.0 110.865 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.419 HD11 ' HG2' ' A' ' 114' ' ' GLN . 40.1 pt -105.94 -21.41 5.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.444 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -169.27 163.71 37.35 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.179 -1.01 . . . . 0.0 112.742 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.447 HG13 HD13 ' A' ' 113' ' ' ILE . 59.9 t -130.35 129.53 64.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 177.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.53 ' HB3' ' HB2' ' A' ' 112' ' ' GLN . 35.3 tt0 -108.97 101.12 10.24 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.295 0.569 . . . . 0.0 110.669 178.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -77.66 126.22 84.72 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 173.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.41 ' HD2' ' SD ' ' A' ' 109' ' ' MET . 30.5 Cg_exo -37.74 127.5 0.79 Allowed 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.791 2.994 . . . . 0.0 113.359 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.595 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 75.5 mmtt -62.49 -26.73 68.69 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.9 -172.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 p -119.08 108.85 15.22 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.072 0.463 . . . . 0.0 109.944 172.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.2 p -110.5 136.41 46.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.428 -177.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -96.45 115.08 26.85 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.847 0.356 . . . . 0.0 110.38 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 80.9 mt -124.38 131.9 53.52 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.584 -177.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.9 m -79.29 134.93 36.63 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.36 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.416 HG13 ' HA ' ' A' ' 168' ' ' GLU . 7.4 p -85.13 118.28 31.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.621 0.724 . . . . 0.0 110.868 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.539 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 43.2 p -130.97 126.13 35.2 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.496 178.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.539 ' HB2' ' O ' ' A' ' 134' ' ' THR . 48.7 mm-40 79.4 79.07 0.05 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.675 0.75 . . . . 0.0 111.175 -175.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.587 ' O ' ' HD3' ' A' ' 138' ' ' PRO . 11.1 t -150.23 153.58 36.46 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 171.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -102.12 99.65 13.04 Favored Pre-proline 0 C--N 1.321 -0.646 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.348 -178.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.587 ' HD3' ' O ' ' A' ' 136' ' ' THR . 84.6 Cg_endo -91.54 -179.17 1.29 Allowed 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.08 2.52 . . . . 0.0 112.186 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 94.87 13.67 52.28 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.478 178.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.7 mp -105.76 126.37 61.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -93.09 -33.84 13.91 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.087 0.47 . . . . 0.0 109.966 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.73 -11.83 70.56 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.814 175.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 66.24 -41.1 0.36 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.809 1.244 . . . . 0.0 113.041 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.8 p -94.01 -59.96 1.85 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.93 0.395 . . . . 0.0 111.047 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -139.49 116.75 11.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.698 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.1 t -79.13 -14.07 59.35 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.446 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -74.63 -7.12 79.1 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.137 177.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.544 ' O ' ' HG ' ' A' ' 164' ' ' LEU . . . -62.19 161.26 11.46 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 175.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.514 ' HB ' ' HB3' ' A' ' 161' ' ' ASN . 36.9 p -114.3 155.47 26.16 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -171.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -131.64 152.48 50.81 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.453 178.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.4 p -72.78 117.56 14.63 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.051 0.453 . . . . 0.0 111.358 -177.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 159' ' ' THR . . . -119.66 158.62 26.07 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.954 -178.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 134' ' ' THR . 18.4 m -109.73 138.48 46.03 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 174.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.0 m -105.63 178.87 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.496 175.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -54.97 -30.25 58.75 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 79.4 p -76.41 -8.87 58.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.805 0.336 . . . . 0.0 111.839 -177.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 86.13 3.29 85.17 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.582 -175.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -80.79 143.47 32.83 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.851 0.357 . . . . 0.0 110.555 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 152' ' ' ALA . 30.1 m -101.07 120.22 39.89 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.06 177.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.2 161.49 35.6 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.514 ' HB3' ' HB ' ' A' ' 149' ' ' THR . 89.4 m-20 -92.84 112.93 25.06 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.881 0.372 . . . . 0.0 111.53 -173.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.42 ' HB ' HG21 ' A' ' 166' ' ' VAL . 29.2 m -108.32 148.18 37.1 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.393 178.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 148' ' ' ALA . 53.0 Cg_exo -53.38 149.22 30.51 Favored 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.558 2.172 . . . . 0.0 111.964 174.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 148' ' ' ALA . 59.4 mt -62.38 -11.72 17.24 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -170.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -104.18 10.33 35.81 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -176.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.42 HG21 ' HB ' ' A' ' 162' ' ' VAL . 75.5 t -78.73 142.41 14.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 178.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -114.41 145.22 42.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.437 -175.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.446 ' HG2' HG22 ' A' ' 136' ' ' THR . 48.7 mt-10 -62.53 127.06 29.52 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.615 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 112.12 -16.44 25.1 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.356 -176.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -75.49 154.91 36.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.987 0.422 . . . . 0.0 110.631 177.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 88.6 t -105.04 116.63 49.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.747 -177.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.42 HD22 ' N ' ' A' ' 172' ' ' LEU . 2.5 mm? -99.2 138.36 36.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.073 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.58 ' O ' ' HB ' ' A' ' 182' ' ' ILE . 57.0 mt -97.28 115.37 36.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 33.7 mm -109.85 141.31 25.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.427 -178.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.595 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 27.2 t-20 -86.52 103.1 14.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.991 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.0 m -71.77 113.03 8.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.231 176.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 143.43 -47.1 0.81 Allowed Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -177.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -118.81 -22.73 7.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.982 0.42 . . . . 0.0 110.373 175.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 89.48 17.24 55.51 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.109 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 4.2 m -65.04 136.57 56.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.582 0.23 . . . . 0.0 110.605 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -89.84 117.17 28.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.145 0.498 . . . . 0.0 110.927 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.58 ' HB ' ' O ' ' A' ' 173' ' ' ILE . 4.0 mp -96.87 151.42 4.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 169.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 10.7 p -77.11 173.1 12.22 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.829 -0.169 . . . . 0.0 111.018 -173.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 39.0 mtt180 -46.03 144.3 1.93 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.686 0.616 . . . . 0.0 111.885 -176.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.734 -1.037 . . . . 0.0 111.852 177.928 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 120.917 0.389 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 84.5 mt -75.28 134.68 28.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.036 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 m -94.83 143.79 26.17 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 174.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.525 HG21 ' HA ' ' A' ' 56' ' ' ALA . 10.8 m -69.11 -1.99 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -172.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -90.09 -2.63 58.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.657 0.265 . . . . 0.0 110.593 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -134.0 89.93 2.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.527 0.679 . . . . 0.0 111.518 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.456 ' CE1' ' HA ' ' A' ' 4' ' ' VAL . 61.6 m-85 -119.58 153.01 36.1 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 171.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -119.57 171.64 8.22 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.477 -176.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.1 p -65.17 -14.57 60.91 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.767 0.794 . . . . 0.0 109.978 174.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.49 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -153.13 115.12 0.66 Allowed Glycine 0 N--CA 1.435 -1.369 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 166.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.6 tp -149.99 132.0 15.26 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.671 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 1.7 m -98.39 122.69 41.89 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.321 0.581 . . . . 0.0 112.092 -172.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.0 mp -117.27 143.73 26.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.279 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.462 ' HB2' ' HB2' ' A' ' 63' ' ' ALA . 35.5 t -104.43 107.43 18.36 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 175.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.9 p -153.93 151.28 11.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -176.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 54.78 45.09 27.39 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 -176.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.7 p30 47.29 31.66 1.87 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.314 1.046 . . . . 0.0 112.222 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.7 166.06 25.69 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.466 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.8 pt -112.13 130.58 65.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.83 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.671 ' O ' ' HA ' ' A' ' 12' ' ' THR . 70.2 m95 -126.6 147.91 49.83 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.885 -168.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.4 ttmm -116.95 104.02 10.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.549 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.49 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 84.1 t -62.81 109.06 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.872 0.368 . . . . 0.0 110.303 177.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 77.0 mt -88.85 -38.15 11.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.512 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -142.47 152.53 42.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.481 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -143.77 136.44 27.2 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.991 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 50.0 tp60 -113.26 99.65 7.97 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.708 176.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 62.4 t-80 -76.05 90.02 3.03 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.0 p -96.5 118.95 43.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.567 0.699 . . . . 0.0 111.519 -171.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -119.81 96.83 49.66 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.428 176.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.88 -10.77 15.38 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.482 2.121 . . . . 0.0 113.148 -177.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.2 26.65 39.51 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.958 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -95.46 10.67 35.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.796 0.331 . . . . 0.0 111.265 -176.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.48 -42.03 2.03 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.12 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.1 p -133.18 146.58 51.66 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 177.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -96.35 166.13 11.86 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.113 0.482 . . . . 0.0 111.134 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -136.25 167.07 21.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.492 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.9 t -131.88 102.62 5.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.086 0.47 . . . . 0.0 109.733 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -82.47 99.33 9.4 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 40.5 p -102.76 143.87 31.85 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.916 -173.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -102.52 102.82 13.13 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 174.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.611 HD23 ' H ' ' A' ' 41' ' ' LEU . 1.3 pt? -133.02 150.96 52.11 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.687 0.756 . . . . 0.0 112.36 -169.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 20.3 ttt180 -110.69 129.67 55.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.038 -171.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -69.96 122.52 19.48 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 173.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.9 mp -66.85 -25.67 66.54 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -176.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.1 mtt85 -81.33 -44.83 17.06 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.671 0.272 . . . . 0.0 111.72 -177.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 67.2 p -99.09 -17.07 18.4 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.132 0.492 . . . . 0.0 111.943 -173.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.31 13.64 81.32 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.793 -175.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 42' ' ' ARG . . . -73.53 133.27 43.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.917 0.389 . . . . 0.0 111.672 -175.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 26.4 mm -96.15 99.15 8.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.378 176.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.456 ' O ' HD23 ' A' ' 41' ' ' LEU . 52.6 tt0 -119.75 157.23 29.02 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -177.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 39' ' ' SER . 15.1 pt-20 -113.9 127.02 55.8 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.291 0.567 . . . . 0.0 110.092 175.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -129.09 146.22 51.1 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.626 -175.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.1 m -107.77 120.66 42.87 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.269 0.557 . . . . 0.0 111.899 -175.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -92.03 155.45 18.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.251 173.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -117.6 132.13 56.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.143 0.497 . . . . 0.0 111.429 -176.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.525 ' HA ' HG21 ' A' ' 4' ' ' VAL . . . -67.3 129.66 40.62 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.871 -178.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.19 -16.24 32.63 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -175.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -106.27 137.82 43.55 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -93.4 132.45 37.63 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.122 0.486 . . . . 0.0 110.61 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.5 t -96.03 145.62 8.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.662 -175.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -87.52 125.64 64.68 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.701 0.286 . . . . 0.0 110.493 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -79.12 152.79 24.49 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.563 2.175 . . . . 0.0 112.754 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.462 ' HB2' ' HB2' ' A' ' 14' ' ' SER . . . -117.56 109.39 16.64 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.569 176.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 61.4 mtt -87.25 108.68 19.05 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.168 0.508 . . . . 0.0 110.219 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.462 ' CG1' HG21 ' A' ' 12' ' ' THR . 52.1 mm -90.79 132.67 34.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.073 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -104.72 103.61 13.27 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.955 -177.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -93.99 101.34 13.39 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.938 0.399 . . . . 0.0 110.194 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 41.6 mtm180 -107.05 168.02 9.49 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -134.66 122.11 21.78 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.326 0.584 . . . . 0.0 111.022 -175.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.544 ' CB ' ' HB3' ' A' ' 82' ' ' PHE . 1.9 mpt? -117.39 149.07 41.14 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.348 -173.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -90.87 139.81 30.4 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 174.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -70.74 103.22 2.51 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.773 -174.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -94.49 -175.18 3.54 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 167.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -143.07 142.96 31.68 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 119.764 -0.774 . . . . 0.0 112.511 -167.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 79' ' ' ASN . . . -151.85 -172.83 4.34 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.261 -1.336 . . . . 0.0 108.812 175.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -76.61 145.73 38.71 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.13 68.64 2.59 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 118.984 -1.579 . . . . 0.0 114.095 -167.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -126.89 -30.81 2.7 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 156.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.617 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 21.1 p-10 -140.98 132.74 27.37 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 113.608 -1.633 . . . . 0.0 109.68 177.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.531 ' CG ' HD22 ' A' ' 98' ' ' LEU . 54.7 m170 -114.92 146.96 40.59 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 172.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 44.8 t -95.7 125.45 48.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.91 -176.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.544 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 78.8 m-85 -121.68 117.59 27.04 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 89.0 mmm -91.41 114.24 26.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.849 0.357 . . . . 0.0 111.22 -174.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.562 ' HB3' ' H ' ' A' ' 89' ' ' GLU . 22.4 t70 -62.16 116.49 5.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.39 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -77.68 -11.56 59.88 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.439 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -73.3 -50.52 21.73 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 176.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.6 p -169.09 91.59 0.25 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 168.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 48.42 25.32 0.88 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 157.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.562 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 41.6 mt-10 -95.68 116.76 29.34 Favored 'General case' 0 C--N 1.32 -0.702 0 O-C-N 121.453 -0.78 . . . . 0.0 111.172 176.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -85.35 98.26 10.44 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.392 0.615 . . . . 0.0 110.791 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.8 m -89.02 117.04 27.75 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.325 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 80' ' ' HIS . 44.2 mt-10 -95.95 126.15 40.99 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 177.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.617 ' O ' ' HA ' ' A' ' 79' ' ' ASN . 70.9 mt -104.5 146.72 28.47 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.579 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.605 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 28.5 t -86.05 167.34 15.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.66 -175.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.8 p -49.06 -35.69 16.48 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -175.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -53.8 -40.58 66.47 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.903 0.382 . . . . 0.0 111.536 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -80.53 -35.28 34.71 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.291 0.567 . . . . 0.0 109.798 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 94' ' ' SER . 13.3 mt -67.35 -30.37 70.16 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.137 -172.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -63.04 -43.65 98.09 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.949 0.404 . . . . 0.0 110.666 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -65.84 -36.4 83.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.897 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.489 ' O ' HD12 ' A' ' 105' ' ' LEU . 51.1 mt-10 -62.39 -41.31 98.56 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.508 173.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 73.5 mt -63.74 -20.77 66.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.931 0.396 . . . . 0.0 110.617 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -72.02 -50.14 31.05 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 173.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -138.64 116.02 11.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.071 176.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.489 HD12 ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -164.15 150.69 11.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.898 0.38 . . . . 0.0 110.646 178.003 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -145.83 134.96 22.77 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 172.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -64.79 123.42 19.33 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.909 -177.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 101.57 -6.1 54.99 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.565 -178.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 50.4 ttm -69.7 133.45 47.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.806 0.336 . . . . 0.0 110.65 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -95.33 101.86 13.62 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.09 0.471 . . . . 0.0 110.376 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 32.8 m -100.56 166.82 2.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.567 -177.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -108.57 109.18 20.34 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 46.5 mt -89.81 123.75 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-O 121.233 0.54 . . . . 0.0 109.633 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.492 ' HG2' HD11 ' A' ' 121' ' ' ILE . 31.2 tt0 -96.42 107.67 20.09 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.74 -174.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 40.9 p -109.19 159.06 17.23 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 121.44 0.638 . . . . 0.0 111.771 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -137.58 106.31 5.9 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 60.88 32.26 20.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.865 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 98.82 -18.33 57.01 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.052 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -88.36 134.82 33.72 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 122.798 -0.236 . . . . 0.0 110.927 -176.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.0 p -77.93 108.68 11.36 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.733 0.301 . . . . 0.0 110.36 175.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.492 HD11 ' HG2' ' A' ' 114' ' ' GLN . 36.0 pt -92.02 -27.11 4.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.839 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -169.59 167.74 40.75 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.672 177.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 55.7 t -125.35 121.22 59.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -102.78 112.17 24.83 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.015 0.436 . . . . 0.0 110.508 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 66.0 mt -78.7 152.65 77.94 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 175.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.51 144.23 52.34 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.363 2.042 . . . . 0.0 110.635 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.719 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 14.3 mmmm -64.82 -22.35 66.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.705 -173.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 26.3 p -125.55 113.43 17.42 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.862 0.363 . . . . 0.0 111.334 176.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 9.6 p -114.84 140.44 35.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.614 175.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -112.8 124.52 52.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.553 0.692 . . . . 0.0 111.352 177.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 95.7 mt -129.27 145.63 51.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.911 -175.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.3 m -85.52 132.71 34.15 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.128 176.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 170' ' ' ASP . 5.8 p -85.81 108.84 17.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.815 0.817 . . . . 0.0 110.769 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.679 ' O ' ' HB ' ' A' ' 153' ' ' THR . 26.9 p -116.48 124.59 50.32 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.621 178.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.541 ' HB2' ' O ' ' A' ' 134' ' ' THR . 1.5 mp0 77.36 86.61 0.08 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.904 0.859 . . . . 0.0 111.18 -176.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.448 ' O ' ' HD3' ' A' ' 138' ' ' PRO . 14.4 t -148.7 156.27 42.14 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 173.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -81.2 109.6 14.57 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -175.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 136' ' ' THR . 98.2 Cg_endo -89.08 166.7 5.62 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.947 2.431 . . . . 0.0 112.944 -176.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.31 -1.3 88.6 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.036 -0.602 . . . . 0.0 113.081 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.449 HD12 ' HD3' ' A' ' 150' ' ' LYS . 58.1 mt -78.4 100.69 3.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.315 0.579 . . . . 0.0 110.564 -177.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -75.51 -33.26 60.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.515 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 118.51 -14.16 11.92 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.148 -176.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -66.36 122.54 17.75 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 54.0 p 51.17 36.16 15.05 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 123.807 0.692 . . . . 0.0 111.242 -174.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -165.78 34.01 0.05 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.435 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.4 m -75.93 80.16 2.81 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.236 -174.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -102.85 165.8 16.43 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 175.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.55 -46.61 82.1 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.959 0.379 . . . . 0.0 110.915 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.5 p -146.75 176.05 10.15 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.285 0.564 . . . . 0.0 111.073 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.449 ' HD3' HD12 ' A' ' 140' ' ' ILE . 37.4 ttpt -127.64 136.28 51.41 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.626 -178.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 35.9 p -72.76 120.19 18.04 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.074 0.464 . . . . 0.0 110.404 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 159' ' ' THR . . . -125.13 160.48 29.02 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.159 -178.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.679 ' HB ' ' O ' ' A' ' 134' ' ' THR . 1.6 m -111.45 136.58 50.41 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.4 m -102.48 177.73 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.175 174.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -55.63 -29.27 58.92 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.407 HG22 HD13 ' A' ' 105' ' ' LEU . 80.3 p -75.93 -9.41 58.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.022 0.439 . . . . 0.0 111.529 -177.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 87.56 7.59 75.32 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.091 -0.576 . . . . 0.0 111.898 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -86.14 141.26 29.5 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.666 0.269 . . . . 0.0 110.943 -177.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 152' ' ' ALA . 17.9 m -95.57 115.43 27.42 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.158 176.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.33 161.9 32.39 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -94.52 113.28 25.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.531 0.681 . . . . 0.0 111.54 -174.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 27.3 m -108.59 150.5 40.79 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.971 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.21 150.76 47.12 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.295 1.997 . . . . 0.0 111.481 174.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 54.5 mt -58.28 -23.19 55.42 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -168.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -85.54 -9.36 57.5 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -174.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 94.6 t -70.5 136.18 26.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -122.91 163.45 20.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.868 0.366 . . . . 0.0 110.141 -174.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -60.67 128.05 34.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.733 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 109.43 -16.91 31.59 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.55 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.408 ' OD1' ' HD2' ' A' ' 184' ' ' ARG . 7.1 m-20 -64.85 138.74 58.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.952 0.406 . . . . 0.0 111.404 178.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 61.1 t -97.72 104.02 15.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 172.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.484 ' H ' HD23 ' A' ' 172' ' ' LEU . 0.7 OUTLIER -100.31 143.08 30.91 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.71 -176.427 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.523 ' O ' ' HB ' ' A' ' 182' ' ' ILE . 60.7 mt -99.32 136.97 28.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.649 177.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 61.7 mt -127.18 138.21 55.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.719 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 26.6 t-20 -81.0 91.98 6.14 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.011 176.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.9 118.78 18.24 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.115 0.484 . . . . 0.0 110.62 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 129.43 -48.28 0.98 Allowed Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -175.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.42 ' HB2' ' OD1' ' A' ' 175' ' ' ASN . 17.1 m-20 -106.28 -24.92 12.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.03 0.443 . . . . 0.0 110.098 177.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 86.92 15.12 63.57 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.434 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 6.0 m -72.27 127.05 31.36 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -79.42 122.84 26.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.16 0.505 . . . . 0.0 110.386 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.523 ' HB ' ' O ' ' A' ' 173' ' ' ILE . 9.8 mm -100.41 155.2 4.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 14.7 p -75.68 166.8 23.01 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.59 0.709 . . . . 0.0 111.703 -169.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 172' ' ' LEU . 23.6 ptt180 -85.45 159.37 19.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.549 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.548 -1.14 . . . . 0.0 111.71 175.61 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.425 ' SD ' ' HD3' ' A' ' 59' ' ' LYS . 66.8 mtt . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 120.733 0.301 . . . . 0.0 110.317 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.1 mp -99.41 135.24 35.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.964 0.412 . . . . 0.0 110.136 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.2 m -99.95 156.63 17.04 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.6 m -68.77 -8.66 10.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -170.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -93.48 12.08 26.3 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.648 0.261 . . . . 0.0 110.64 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -140.5 89.36 2.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.282 0.563 . . . . 0.0 111.447 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -122.33 148.55 44.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.531 175.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.413 ' HG3' ' N ' ' A' ' 9' ' ' THR . 20.6 tptm -114.88 161.5 18.16 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.284 -176.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.413 ' N ' ' HG3' ' A' ' 8' ' ' LYS . 8.4 m -49.42 -31.93 10.7 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.2 0.524 . . . . 0.0 111.06 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.548 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -143.38 116.83 1.03 Allowed Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 170.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 66.9 tp -142.07 137.42 31.02 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 2.5 m -100.96 118.97 38.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.011 0.434 . . . . 0.0 110.823 -177.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.8 mp -120.01 137.5 53.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.424 -177.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.6 p -98.48 100.13 11.36 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.7 p -146.81 152.13 13.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.59 -175.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.405 ' CB ' ' HE2' ' A' ' 52' ' ' LYS . 24.2 t70 63.9 27.29 14.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.34 0.591 . . . . 0.0 109.682 178.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 63.75 30.53 14.64 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.401 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.94 167.18 24.63 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.095 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 15.5 pt -109.68 123.52 65.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.078 0.466 . . . . 0.0 110.156 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.501 ' O ' ' HA ' ' A' ' 12' ' ' THR . 34.2 m95 -121.16 160.36 23.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.411 -172.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -129.34 107.96 9.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.567 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.548 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 82.7 t -59.95 118.39 3.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.124 0.488 . . . . 0.0 111.009 179.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.1 mm -93.31 -41.89 12.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.758 175.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -158.25 121.56 3.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.21 -177.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -108.58 139.06 43.88 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.044 0.45 . . . . 0.0 111.571 -173.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -116.41 99.89 7.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.442 176.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 -71.75 96.47 1.62 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 175.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.9 p -99.37 134.3 39.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.448 0.642 . . . . 0.0 111.25 -172.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -116.72 87.46 21.64 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.506 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -65.28 -46.72 5.34 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.635 2.223 . . . . 0.0 112.596 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.56 26.79 3.01 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 121.126 -0.559 . . . . 0.0 111.902 -176.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -97.13 10.32 39.7 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.821 0.343 . . . . 0.0 111.104 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.22 -42.32 1.99 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.995 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.425 ' HB3' ' HB3' ' A' ' 56' ' ' ALA . 70.6 m -115.51 138.53 50.94 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 175.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.68 162.6 22.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.058 0.456 . . . . 0.0 110.75 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -132.04 164.9 25.2 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.342 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.4 t -132.33 102.64 5.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 120.956 0.408 . . . . 0.0 110.34 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -79.19 99.03 6.83 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.2 m -106.53 131.15 54.03 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.535 -173.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.9 mttp -84.34 105.4 15.15 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 171.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.563 HD23 ' H ' ' A' ' 41' ' ' LEU . 0.6 OUTLIER -127.97 138.27 52.55 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.718 0.771 . . . . 0.0 110.813 -172.454 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.9 ttt180 -96.97 128.27 43.77 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.989 -177.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -60.84 113.74 2.67 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 172.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.432 HD21 ' OE1' ' A' ' 114' ' ' GLN . 8.9 tt -66.96 -24.11 66.02 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.656 -170.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -85.99 -45.88 11.05 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.691 -177.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 75.1 p -93.81 -21.71 19.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.067 0.461 . . . . 0.0 111.893 -174.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.7 12.27 75.33 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.177 -176.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.91 131.58 38.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.98 0.419 . . . . 0.0 111.685 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.6 mm -89.49 110.93 22.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.606 177.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.466 ' HG2' ' H ' ' A' ' 51' ' ' GLU . 32.7 tt0 -131.79 174.62 9.95 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -177.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.466 ' H ' ' HG2' ' A' ' 50' ' ' GLN . 9.8 pt-20 -137.72 131.83 31.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.178 0.513 . . . . 0.0 110.623 173.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.405 ' HE2' ' CB ' ' A' ' 16' ' ' ASP . 33.0 mttp -124.28 154.02 40.86 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.53 -177.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 48.9 m -106.84 112.76 25.87 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.825 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -83.6 151.13 25.5 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 175.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.4 ptp85 -122.91 129.76 52.0 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.354 -171.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.425 ' HB3' ' HB3' ' A' ' 34' ' ' SER . . . -63.53 130.77 45.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.304 177.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.59 -18.4 29.8 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -176.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -104.13 131.56 51.28 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.425 ' HD3' ' SD ' ' A' ' 1' ' ' MET . 18.0 ptpt -77.2 140.05 40.04 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.512 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 65.5 t -98.45 117.02 42.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.208 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -90.19 121.8 68.25 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.388 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.64 151.4 36.66 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.45 2.1 . . . . 0.0 112.403 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.483 ' HB3' HG22 ' A' ' 12' ' ' THR . . . -101.81 125.99 48.59 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.131 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 15.8 ptp -85.15 109.58 18.39 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.227 0.537 . . . . 0.0 111.037 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.34 125.23 60.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.038 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -121.82 121.68 37.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.885 0.374 . . . . 0.0 110.468 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -99.63 133.24 44.26 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.487 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -129.91 170.15 14.3 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 0.0 OUTLIER -129.96 127.93 41.04 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.859 0.361 . . . . 0.0 110.285 177.333 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.618 ' CB ' ' HB3' ' A' ' 82' ' ' PHE . 1.6 mpt? -118.52 147.6 43.5 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.678 -176.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -85.17 142.42 29.48 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 172.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -75.46 109.66 9.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.071 -175.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -103.81 -176.63 3.14 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 167.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -145.67 151.81 38.63 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 119.828 -0.749 . . . . 0.0 112.405 -174.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.7 -163.34 1.75 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.595 177.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -68.28 139.19 55.94 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 175.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.88 70.77 2.68 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 119.174 -1.489 . . . . 0.0 113.673 -168.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -125.62 -31.22 2.99 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 159.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.587 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 27.3 m-80 -141.25 135.11 30.35 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 113.83 -1.532 . . . . 0.0 109.209 175.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.557 ' CG ' HD22 ' A' ' 98' ' ' LEU . 64.2 m170 -104.83 145.88 29.77 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 176.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 40.9 t -91.87 127.32 44.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.733 -176.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.618 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 55.0 m-85 -125.16 126.33 45.1 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.659 0.266 . . . . 0.0 110.417 177.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 50.1 ttm -89.92 112.44 23.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.668 -176.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.594 ' HA ' ' HG3' ' A' ' 70' ' ' MET . 16.0 t0 -70.69 119.19 14.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.024 -176.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -75.42 -16.3 60.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.6 178.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -69.5 -54.01 16.34 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.8 p -167.35 91.87 0.39 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 171.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 48.44 28.5 1.71 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 158.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.522 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 47.2 mt-10 -103.51 120.5 40.98 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 118.661 0.664 . . . . 0.0 111.764 178.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -83.69 89.22 7.11 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 173.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.0 m -77.24 116.26 17.72 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.239 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -90.87 118.85 30.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.228 0.537 . . . . 0.0 110.014 177.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.587 ' O ' ' HA ' ' A' ' 79' ' ' ASN . 57.3 mt -93.61 136.29 34.04 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.852 -177.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.522 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 2.2 m -77.7 172.02 14.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.842 -175.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.9 m -50.97 -40.61 58.17 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -175.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -56.14 -40.16 73.38 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.018 0.437 . . . . 0.0 111.775 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.469 ' HB2' ' HB3' ' A' ' 93' ' ' LEU . 45.4 m-85 -77.71 -32.91 53.2 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.818 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.626 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 14.3 mt -64.25 -30.36 71.41 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.473 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -56.8 -46.41 81.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.428 176.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -62.47 -43.71 98.15 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.061 177.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.542 ' O ' HD12 ' A' ' 105' ' ' LEU . 46.4 mt-10 -60.67 -34.16 73.91 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.015 177.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.626 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 55.2 mt -68.58 -6.16 23.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.902 0.382 . . . . 0.0 111.277 -178.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -90.7 -50.02 6.14 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 168.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -136.26 116.79 13.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.312 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.542 HD12 ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -163.65 138.98 6.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.977 0.417 . . . . 0.0 110.837 176.615 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -146.46 147.76 31.55 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 173.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -63.98 130.7 45.11 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.529 0.204 . . . . 0.0 110.537 -176.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.94 -0.6 87.78 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.811 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 56.5 ttp -72.73 142.71 48.17 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.739 -0.271 . . . . 0.0 110.294 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -100.21 119.06 37.78 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.874 0.368 . . . . 0.0 110.448 -177.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 21.1 m -111.88 165.2 7.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.488 -178.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -108.03 105.05 14.63 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 178.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 53.7 mt -92.13 126.68 44.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.181 0.515 . . . . 0.0 109.847 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.432 ' OE1' HD21 ' A' ' 44' ' ' LEU . 24.9 tt0 -99.45 119.13 37.49 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.675 -175.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 64.5 p -116.47 153.54 31.94 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.19 0.519 . . . . 0.0 111.984 -174.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.458 ' HB2' HD13 ' A' ' 121' ' ' ILE . 38.7 t80 -129.67 101.24 5.82 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.276 -0.875 . . . . 0.0 108.962 176.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 61.73 26.93 16.45 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.691 0.758 . . . . 0.0 110.254 -178.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 104.52 -25.8 24.68 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.559 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -79.1 127.45 32.03 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -177.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 43.9 p -69.82 114.16 7.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.761 0.315 . . . . 0.0 110.432 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.458 HD13 ' HB2' ' A' ' 116' ' ' TYR . 22.4 pt -100.52 -26.32 3.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.454 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -164.32 162.43 35.32 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.151 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.482 HG21 HD13 ' A' ' 93' ' ' LEU . 86.3 t -135.01 124.48 43.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.921 0.391 . . . . 0.0 110.207 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -106.6 123.57 48.31 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.948 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.402 HD22 ' N ' ' A' ' 125' ' ' LEU . 2.9 mm? -78.69 156.0 78.0 Favored Pre-proline 0 C--N 1.32 -0.675 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 174.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.434 ' HD3' HG12 ' A' ' 111' ' ' VAL . 47.6 Cg_exo -56.1 123.98 15.16 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.423 2.082 . . . . 0.0 111.446 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.582 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 12.8 mptt -54.85 -34.69 63.18 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.22 -176.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 36.3 p -117.45 108.71 15.87 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 171.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.6 p -122.41 135.85 61.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.432 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -96.48 105.8 17.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.463 0.649 . . . . 0.0 111.116 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 58.0 mt -114.3 129.1 56.63 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.981 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.2 m -75.29 130.88 39.82 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.143 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 170' ' ' ASP . 4.2 p -78.32 105.84 8.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.705 0.764 . . . . 0.0 110.618 178.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.418 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 13.8 p -110.81 123.49 50.19 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.17 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 134' ' ' THR . 42.1 mt-10 76.05 97.3 0.07 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.889 0.852 . . . . 0.0 111.422 -177.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.415 HG22 ' CG ' ' A' ' 168' ' ' GLU . 10.3 t -150.34 155.96 40.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.954 174.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.462 ' O ' ' HD3' ' A' ' 150' ' ' LYS . 25.2 mm-40 -80.96 153.72 72.56 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.123 -170.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -68.86 172.11 12.3 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.531 2.154 . . . . 0.0 111.485 174.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 119.44 32.29 1.26 Allowed Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.961 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 164' ' ' LEU . 24.2 pt -65.16 143.12 16.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 176.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -144.39 121.44 11.42 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.814 0.34 . . . . 0.0 110.922 -174.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.401 ' HA3' ' HB3' ' A' ' 145' ' ' ALA . . . 82.87 -18.98 12.98 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.996 -0.547 . . . . 0.0 113.417 174.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 67.39 -67.99 0.16 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.415 0.686 . . . . 0.0 111.323 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.0 t -84.01 -23.14 31.09 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.962 0.41 . . . . 0.0 110.21 177.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.401 ' HB3' ' HA3' ' A' ' 142' ' ' GLY . . . -63.43 111.71 2.43 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.286 -177.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.9 m -95.21 85.24 4.24 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.407 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.01 140.54 8.69 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.822 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 68.06 153.17 0.09 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.348 0.659 . . . . 0.0 111.526 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.4 p -121.31 163.81 18.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.898 0.856 . . . . 0.0 112.666 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.462 ' HD3' ' O ' ' A' ' 137' ' ' GLU . 26.0 ttmt -137.29 143.07 41.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.007 -1.452 . . . . 0.0 108.987 -174.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 25.0 m -73.77 120.72 19.75 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.103 0.477 . . . . 0.0 110.311 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -129.39 162.53 27.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.137 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 21.3 m -127.35 143.82 51.16 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.476 174.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 15.7 m -103.56 173.55 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.786 0.327 . . . . 0.0 110.717 176.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -62.74 -12.54 24.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.65 -174.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.438 HG22 ' O ' ' A' ' 105' ' ' LEU . 68.6 p -87.76 -13.49 42.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.789 0.328 . . . . 0.0 111.469 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 94.49 3.12 63.09 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.763 -174.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -78.14 141.54 38.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.846 0.355 . . . . 0.0 110.416 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 25.0 m -106.61 133.18 51.68 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.381 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -148.68 165.07 32.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.636 0.255 . . . . 0.0 110.48 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -105.53 108.51 20.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.322 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.429 ' HB ' HG21 ' A' ' 166' ' ' VAL . 27.8 m -102.93 157.39 33.83 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.648 -176.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -62.77 150.52 87.86 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 121.965 1.777 . . . . 0.0 110.828 175.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 140' ' ' ILE . 52.1 mt -55.78 -24.78 37.7 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -169.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -79.24 -13.32 59.76 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -174.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.429 HG21 ' HB ' ' A' ' 162' ' ' VAL . 91.5 t -68.51 129.8 33.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.123 0.487 . . . . 0.0 110.647 -178.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -121.52 155.01 35.89 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.514 -175.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.415 ' CG ' HG22 ' A' ' 136' ' ' THR . 75.5 mt-10 -57.68 121.39 10.29 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.665 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 114.16 -17.41 19.48 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.496 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.588 ' OD2' ' HD3' ' A' ' 184' ' ' ARG . 22.0 t70 -65.41 144.38 57.1 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 177.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 48.5 t -93.24 108.53 20.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.13 0.49 . . . . 0.0 110.294 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 76.2 mt -92.54 117.92 30.46 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.379 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 1.9 mp -90.48 101.97 12.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 175.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 31.9 mm -89.73 124.06 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.421 -175.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.582 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 49.4 t30 -86.44 89.44 7.89 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 174.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.457 HG22 ' HA ' ' A' ' 127' ' ' LYS . 8.9 t -66.74 152.06 46.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.938 0.399 . . . . 0.0 110.463 -176.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 93.42 -45.98 2.38 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.4 -176.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -98.92 -27.73 13.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.107 0.479 . . . . 0.0 110.456 177.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.39 24.06 55.07 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.377 176.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.471 ' HB2' ' HB3' ' A' ' 175' ' ' ASN . 1.3 m -81.76 99.42 8.96 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -77.17 108.26 10.13 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.15 0.5 . . . . 0.0 110.827 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 36.9 mm -96.37 140.95 16.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 44.6 t -120.73 167.92 11.96 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 110.465 -0.198 . . . . 0.0 110.465 -176.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.588 ' HD3' ' OD2' ' A' ' 170' ' ' ASP . 25.8 mmt180 72.03 16.84 5.29 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.278 0.631 . . . . 0.0 112.538 173.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.031 0 CA-C-O 118.749 -1.028 . . . . 0.0 112.721 179.814 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 120.452 0.167 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.403 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 50.6 mm -94.74 143.82 11.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.2 m -104.8 157.67 17.04 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.7 m -66.25 -4.24 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.013 -175.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -76.82 -24.5 52.77 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.841 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -112.72 107.51 16.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.306 0.574 . . . . 0.0 111.774 -175.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -140.69 145.85 37.06 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 171.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.2 mtmm -131.11 175.1 9.38 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.231 -174.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 19.6 m -61.78 -22.1 65.13 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.57 0.7 . . . . 0.0 110.237 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -144.91 114.77 0.8 Allowed Glycine 0 N--CA 1.434 -1.495 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 167.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.4 tp -150.36 122.73 8.43 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 175.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.543 HG21 HG13 ' A' ' 65' ' ' ILE . 2.1 p -87.03 122.95 31.58 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.461 0.648 . . . . 0.0 111.93 -175.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.7 mm -119.22 141.08 40.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.539 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.452 ' HB3' ' HB2' ' A' ' 63' ' ' ALA . 43.0 p -107.69 103.82 13.19 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 176.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.3 p -143.9 148.38 18.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 63.75 24.13 13.72 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.206 -175.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 61.95 28.04 17.05 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.193 -176.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.15 164.09 27.08 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.771 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.6 pt -108.52 126.95 65.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.635 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.498 ' CZ3' ' HB2' ' A' ' 43' ' ' ASN . 11.5 m95 -128.36 166.27 18.99 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.719 -174.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -132.63 108.21 8.91 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.767 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 85.6 t -63.91 115.57 2.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.283 177.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 9' ' ' THR . 77.1 mt -95.88 -38.9 8.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.584 176.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -140.18 153.73 46.71 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.08 178.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 39' ' ' SER . 16.7 p90 -146.8 128.51 15.23 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.828 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -100.9 99.04 9.48 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.038 177.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -78.14 94.33 4.7 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 175.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.2 p -104.86 126.58 59.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.116 -173.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -117.47 103.86 50.55 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.441 -178.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -57.5 -47.35 22.15 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 123.239 2.626 . . . . 0.0 112.671 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 112.7 5.03 24.41 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.588 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -81.53 -14.46 56.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.097 -0.552 . . . . 0.0 110.812 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.42 -15.1 8.14 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.518 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.4 p -134.41 145.94 49.38 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.418 -0.391 . . . . 0.0 110.097 177.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -125.72 168.31 13.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.692 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -143.8 163.51 33.14 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.516 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.9 t -121.32 105.12 16.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.027 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -81.86 99.37 9.0 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 175.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 25' ' ' PHE . 60.7 p -103.07 146.94 27.61 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.135 0.493 . . . . 0.0 112.099 -171.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -103.2 110.04 21.86 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 174.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.543 HD23 ' H ' ' A' ' 41' ' ' LEU . 0.9 OUTLIER -135.43 144.27 46.39 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.517 0.675 . . . . 0.0 111.778 -171.922 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 35.8 ttt180 -99.84 127.71 45.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.535 -175.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.498 ' HB2' ' CZ3' ' A' ' 20' ' ' TRP . 53.8 t-20 -71.78 119.8 16.46 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 173.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.8 mp -66.03 -24.6 66.78 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.935 0.397 . . . . 0.0 111.169 -176.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -80.21 -42.88 22.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.67 -176.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.6 p -97.63 -22.3 16.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.203 0.525 . . . . 0.0 111.517 -176.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.31 17.71 79.04 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.662 -176.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' A' ' 42' ' ' ARG . . . -92.15 143.67 26.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.97 0.414 . . . . 0.0 111.984 -174.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 44.4 mm -92.2 100.99 12.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.774 175.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.442 ' HG2' ' H ' ' A' ' 51' ' ' GLU . 29.6 tt0 -113.56 173.42 6.42 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.442 ' H ' ' HG2' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -122.03 146.91 46.72 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.117 0.484 . . . . 0.0 110.963 173.356 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.405 ' HB2' HD21 ' A' ' 41' ' ' LEU . 14.3 tppt? -134.3 132.11 39.19 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.597 -177.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.2 m -100.24 103.88 15.34 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.065 0.46 . . . . 0.0 111.136 -177.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -87.34 141.45 28.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.892 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 49.7 mtp180 -115.62 133.75 55.72 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.721 0.296 . . . . 0.0 110.784 -176.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.41 133.32 55.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.771 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 107.42 -31.03 8.45 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -176.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -90.19 141.88 28.26 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 177.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -81.53 137.85 35.51 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.285 0.564 . . . . 0.0 111.305 -176.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.403 ' O ' ' HB ' ' A' ' 2' ' ' ILE . 61.5 t -100.14 112.74 33.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.429 176.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -93.61 120.56 66.13 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-O 120.918 0.39 . . . . 0.0 110.787 -177.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -77.33 157.58 33.18 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 123.003 2.469 . . . . 0.0 112.9 -175.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.452 ' HB2' ' HB3' ' A' ' 14' ' ' SER . . . -106.01 115.85 30.93 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.153 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -73.77 108.13 6.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.352 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.543 HG13 HG21 ' A' ' 12' ' ' THR . 37.4 mm -103.41 129.97 54.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.068 0.461 . . . . 0.0 110.453 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.433 ' HB2' ' OG1' ' A' ' 115' ' ' THR . 21.0 mt-10 -109.77 146.45 34.95 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.354 -177.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -136.89 113.93 10.59 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.891 0.377 . . . . 0.0 110.647 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.452 ' HG2' ' HG3' ' A' ' 86' ' ' GLU . 79.1 mtm180 -123.0 156.76 34.14 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.502 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 8.5 ptm180 -114.77 124.59 52.15 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.104 -178.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.629 ' CB ' ' HB3' ' A' ' 82' ' ' PHE . 1.9 mpt? -116.27 142.63 46.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.408 -178.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -82.07 134.78 35.37 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.09 175.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.588 ' CD1' ' HA ' ' A' ' 107' ' ' GLU . 42.8 t80 -71.84 115.67 11.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.317 -173.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 55.8 mt -115.33 -176.47 2.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.781 168.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -146.75 154.63 41.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.178 0.514 . . . . 0.0 111.473 -177.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -140.21 -149.43 0.28 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.229 -0.896 . . . . 0.0 108.584 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -69.46 132.3 46.1 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 171.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -75.86 69.29 2.15 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.104 -1.522 . . . . 0.0 113.719 -167.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -127.19 -29.96 2.71 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 156.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.542 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 19.4 m120 -133.94 142.02 47.54 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.803 178.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.58 ' ND1' ' HG ' ' A' ' 98' ' ' LEU . 53.2 m80 -119.86 144.34 47.42 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.418 177.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 61.1 t -88.69 136.35 23.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.837 -176.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.629 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 63.5 m-85 -131.02 125.62 33.77 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.452 ' O ' ' HA ' ' A' ' 70' ' ' MET . 72.5 mtm -95.86 114.62 26.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.717 0.294 . . . . 0.0 111.533 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.542 ' HA ' ' HG3' ' A' ' 70' ' ' MET . 19.2 t70 -61.97 116.37 4.84 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.77 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -70.52 -20.29 62.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.022 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.465 ' HB2' ' OD2' ' A' ' 84' ' ' ASP . 11.3 mm-40 -64.08 -51.15 65.45 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.478 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 5.0 p -171.15 91.74 0.15 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 168.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 47.99 29.86 1.84 Allowed 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 159.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.488 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 47.2 mt-10 -100.06 117.83 35.14 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 121.768 -0.582 . . . . 0.0 110.937 177.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -84.07 113.86 21.34 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.347 0.594 . . . . 0.0 110.534 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 56.5 m -110.15 128.14 55.3 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.966 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -102.25 141.5 34.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.047 0.451 . . . . 0.0 110.267 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' A' ' 79' ' ' ASN . 57.3 mt -118.64 144.21 46.31 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.469 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.9 t -83.52 173.24 11.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.583 -174.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.7 t -56.18 -44.24 79.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.935 -173.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.52 -37.22 86.79 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.738 0.304 . . . . 0.0 111.687 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.587 ' O ' ' HG2' ' A' ' 101' ' ' GLU . 97.1 m-85 -67.03 -40.04 87.12 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.58 ' HG ' ' ND1' ' A' ' 80' ' ' HIS . 3.7 mm? -74.6 -11.07 60.1 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.09 178.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -63.75 -44.32 93.84 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.834 0.349 . . . . 0.0 110.589 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.555 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 14.3 tp10 -74.34 -37.0 63.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.122 0.487 . . . . 0.0 109.781 175.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.587 ' HG2' ' O ' ' A' ' 97' ' ' TYR . 9.1 mm-40 -59.38 -43.46 92.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.983 176.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.558 ' O ' ' HB ' ' A' ' 156' ' ' THR . 85.9 mt -71.85 -2.43 17.77 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.006 0.431 . . . . 0.0 111.051 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.555 ' HB3' ' O ' ' A' ' 100' ' ' GLU . 29.3 t30 -80.73 -48.3 12.73 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 171.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.514 ' HB3' HG11 ' A' ' 129' ' ' VAL . 85.5 m-85 -146.99 117.19 7.33 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.523 174.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.476 HD22 ' O ' ' A' ' 101' ' ' GLU . 0.9 OUTLIER -172.94 169.18 4.8 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.588 0.232 . . . . 0.0 110.562 178.476 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.509 ' HD3' ' O ' ' A' ' 130' ' ' GLU . 30.6 mmmt -143.2 149.14 37.57 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 173.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.588 ' HA ' ' CD1' ' A' ' 72' ' ' TYR . 40.4 tt0 -69.57 130.91 43.73 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.071 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.46 -2.29 80.48 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.397 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 58.3 ttm -74.79 140.77 44.24 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 70' ' ' MET . 48.6 mt-10 -103.19 102.71 12.7 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.121 0.486 . . . . 0.0 110.073 -177.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.502 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 19.5 m -99.49 162.8 2.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.152 -174.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.565 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 57.9 mt-30 -104.55 100.36 10.03 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.989 0.423 . . . . 0.0 110.688 -178.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 59.3 mt -74.78 128.18 36.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.94 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.498 ' O ' HG13 ' A' ' 121' ' ' ILE . 7.8 tt0 -105.83 113.91 27.75 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.987 -175.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.433 ' OG1' ' HB2' ' A' ' 66' ' ' GLU . 74.1 p -114.85 155.3 27.06 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.23 -176.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -118.91 99.21 6.6 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 172.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 61.42 41.8 12.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.82 0.819 . . . . 0.0 109.639 -176.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.32 -19.83 37.35 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.506 -0.77 . . . . 0.0 113.192 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -82.02 116.44 21.63 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 24.2 m -65.28 106.01 1.25 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -176.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 114' ' ' GLN . 2.4 pp -100.18 -23.42 4.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.788 -177.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -170.41 175.53 44.28 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.17 -1.014 . . . . 0.0 112.727 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.2 t -135.43 129.76 49.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.849 0.357 . . . . 0.0 110.093 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.565 ' HB2' ' HB2' ' A' ' 112' ' ' GLN . 5.9 mm-40 -98.4 109.69 22.4 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.773 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 77.3 mt -80.6 135.19 53.16 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.784 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.42 131.25 44.63 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.621 2.214 . . . . 0.0 110.641 170.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 0.7 OUTLIER -60.74 -35.09 75.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.731 -167.036 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 18.0 p -96.76 110.53 22.98 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.029 0.442 . . . . 0.0 111.426 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.514 HG11 ' HB3' ' A' ' 104' ' ' TYR . 6.9 p -129.92 135.67 60.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.285 177.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.509 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 6.7 pt-20 -109.65 121.25 44.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.168 0.509 . . . . 0.0 111.352 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 77.9 mt -122.2 130.28 53.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.294 -178.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.1 m -75.1 134.36 41.34 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.172 178.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.446 HG12 ' O ' ' A' ' 170' ' ' ASP . 4.1 p -83.54 100.23 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-O 121.952 0.882 . . . . 0.0 110.702 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 29.8 p -90.88 103.27 16.0 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.466 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.474 ' HA ' ' OE2' ' A' ' 168' ' ' GLU . 44.1 mt-10 77.77 111.49 0.07 Allowed 'General case' 0 C--O 1.238 0.45 0 O-C-N 124.149 0.906 . . . . 0.0 111.998 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.0 t -150.39 152.81 34.94 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.542 -1.208 . . . . 0.0 108.579 174.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.43 ' O ' ' HD2' ' A' ' 150' ' ' LYS . 4.6 mp0 -82.99 123.5 77.61 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 120.762 0.315 . . . . 0.0 110.448 -176.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -82.38 -179.9 4.97 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.824 2.349 . . . . 0.0 112.114 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 119.45 32.98 1.16 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.22 -0.99 . . . . 0.0 113.162 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.573 HG12 ' H ' ' A' ' 142' ' ' GLY . 12.2 tt -51.48 127.3 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-O 121.401 0.62 . . . . 0.0 111.049 178.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -74.28 -10.79 59.94 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.99 -172.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.573 ' H ' HG12 ' A' ' 140' ' ' ILE . . . 82.14 -30.7 2.95 Favored Glycine 0 C--O 1.231 -0.08 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.216 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -63.85 149.03 47.91 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 122.654 0.382 . . . . 0.0 110.404 176.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 4.0 t -67.75 87.0 0.22 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.912 0.863 . . . . 0.0 110.868 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -117.66 57.62 0.81 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.586 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.8 p -73.36 -9.95 59.23 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.39 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -98.74 -1.72 57.46 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.871 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -108.65 158.84 17.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.658 0.266 . . . . 0.0 110.387 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.4 p -140.26 173.67 11.28 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.147 0.499 . . . . 0.0 111.451 -177.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.43 ' HD2' ' O ' ' A' ' 137' ' ' GLU . 63.3 pttt -138.39 158.42 44.32 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.218 175.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.3 p -73.22 132.39 43.13 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.328 0.585 . . . . 0.0 111.751 -178.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.13 163.38 32.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.599 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 26.0 m -132.01 131.37 42.45 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 174.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.7 m -93.45 175.11 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -59.27 -25.94 64.52 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -176.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.558 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 47.1 p -72.5 -16.74 61.79 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.765 0.317 . . . . 0.0 111.563 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.22 1.81 59.32 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.593 -176.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -84.73 138.22 32.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.488 -0.356 . . . . 0.0 110.661 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 14.8 t -97.23 136.05 38.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.974 176.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -148.65 164.35 34.57 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -176.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -102.23 111.77 24.18 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.204 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 33.9 m -106.47 147.25 34.59 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.96 -176.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.7 154.97 39.73 Favored 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 122.712 2.275 . . . . 0.0 111.679 176.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.494 ' H ' HD22 ' A' ' 164' ' ' LEU . 1.8 mm? -67.07 -15.14 63.54 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -168.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.442 ' HA ' HD12 ' A' ' 140' ' ' ILE . 22.1 p90 -80.98 -11.11 59.62 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.861 0.362 . . . . 0.0 111.346 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.405 HG13 HD21 ' A' ' 172' ' ' LEU . 92.8 t -76.15 134.07 29.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.147 177.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -120.14 165.73 14.37 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.474 ' OE2' ' HA ' ' A' ' 135' ' ' GLU . 28.5 tt0 -61.42 152.27 30.24 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.595 -176.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 65.68 6.83 31.63 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 114.354 0.501 . . . . 0.0 114.354 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.446 ' O ' HG12 ' A' ' 133' ' ' VAL . 11.2 m-20 -77.7 147.83 35.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.653 0.727 . . . . 0.0 110.137 171.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 62.3 t -94.48 110.45 23.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.068 0.461 . . . . 0.0 109.898 177.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.406 HD23 ' HG2' ' A' ' 184' ' ' ARG . 67.7 mt -94.08 123.61 37.57 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.73 -176.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.535 ' O ' ' HB ' ' A' ' 182' ' ' ILE . 54.4 mt -90.73 128.38 42.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 174.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 37.1 mm -125.11 139.87 49.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -178.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.589 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 26.3 t-20 -87.32 91.69 8.81 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 174.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 11.1 t -74.07 148.29 42.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.964 0.411 . . . . 0.0 110.175 -177.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 105.65 -40.34 2.52 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 -174.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -109.8 -46.35 3.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.135 0.493 . . . . 0.0 110.001 175.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 107.01 11.15 26.75 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.671 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 175' ' ' ASN . 6.6 m -65.11 132.31 48.84 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -83.14 126.08 32.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.253 0.549 . . . . 0.0 110.468 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.535 ' HB ' ' O ' ' A' ' 173' ' ' ILE . 14.1 mm -106.61 156.71 7.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.4 p -74.45 170.19 16.19 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.258 0.551 . . . . 0.0 111.935 -170.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.406 ' HG2' HD23 ' A' ' 172' ' ' LEU . 84.0 mtm180 -70.05 145.27 51.83 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.726 -176.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.946 0 CA-C-O 118.57 -1.128 . . . . 0.0 111.77 178.259 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.8 ttt . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 120.772 0.32 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 46.6 mm -117.64 134.65 60.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 171.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.9 m -88.3 151.14 22.83 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.44 ' O ' HG21 ' A' ' 37' ' ' VAL . 29.7 m -68.5 -1.82 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 121.004 0.43 . . . . 0.0 111.667 -178.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -97.98 0.39 46.28 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.345 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -118.95 89.12 3.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.543 -178.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -134.21 153.29 51.94 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.928 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -129.95 175.94 8.46 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.167 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.2 t -66.33 -9.56 34.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.165 0.507 . . . . 0.0 110.079 175.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.669 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -152.26 115.43 0.69 Allowed Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 110.396 -1.081 . . . . 0.0 110.396 170.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.52 133.09 19.79 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 10.5 p -98.15 123.28 42.12 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.138 0.494 . . . . 0.0 112.023 -177.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.1 mp -125.7 141.93 44.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.14 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.412 ' HB2' ' HB2' ' A' ' 63' ' ' ALA . 23.0 t -106.24 105.27 15.22 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 176.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.7 p -147.52 148.36 16.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -176.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 62.68 24.89 14.82 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.199 0.312 . . . . 0.0 110.62 -174.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 64.3 t30 63.74 24.16 13.73 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.611 0.72 . . . . 0.0 110.601 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.62 158.77 37.58 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.857 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.7 pt -105.22 125.8 60.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.281 0.563 . . . . 0.0 110.295 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.538 ' O ' ' HA ' ' A' ' 12' ' ' THR . 74.2 m95 -120.84 161.19 21.94 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.448 -170.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -136.7 110.4 8.09 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.163 176.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.669 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 89.3 t -60.52 117.26 2.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.932 177.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.3 mm -92.14 -30.73 4.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.481 175.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -153.89 140.48 18.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.427 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -126.29 138.68 53.62 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.806 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -118.82 100.07 7.16 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.023 176.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -75.58 101.49 4.94 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 177.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.4 p -109.58 126.47 66.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.391 0.615 . . . . 0.0 111.609 -172.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.8 mtmt -113.91 102.73 55.08 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.438 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -55.85 -47.8 23.22 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.509 2.806 . . . . 0.0 112.788 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.8 11.54 10.14 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.137 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -102.46 3.42 37.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.128 0.49 . . . . 0.0 110.694 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.6 -43.0 1.81 Allowed Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.384 178.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.8 p -93.32 126.34 38.39 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.819 0.342 . . . . 0.0 110.296 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.54 162.03 13.26 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.08 0.467 . . . . 0.0 110.813 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -134.84 166.13 23.7 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.815 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.44 HG21 ' O ' ' A' ' 4' ' ' VAL . 49.9 t -131.83 104.09 7.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 175.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -82.3 99.06 9.12 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.3 p -110.56 135.41 51.25 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.076 0.465 . . . . 0.0 111.892 -173.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -91.39 111.94 23.65 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 172.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.534 HD23 ' H ' ' A' ' 41' ' ' LEU . 1.2 pt? -138.71 145.1 39.9 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.175 0.512 . . . . 0.0 110.935 -173.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 9.9 ptt180 -106.96 143.08 35.57 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.865 -174.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -65.23 119.89 11.73 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 171.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.526 HD22 HD12 ' A' ' 121' ' ' ILE . 3.9 tt -67.38 -25.57 66.03 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.208 -170.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.406 ' CZ ' HG22 ' A' ' 121' ' ' ILE . 11.9 mtp180 -83.44 -46.42 12.53 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.411 -177.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.2 p -94.97 -20.48 19.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.011 0.434 . . . . 0.0 112.151 -173.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.93 17.85 73.84 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.111 -176.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 42' ' ' ARG . . . -75.0 126.54 31.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.834 0.349 . . . . 0.0 111.803 -177.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.1 mm -87.96 108.86 18.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.107 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -129.67 162.18 28.92 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -122.99 128.06 49.67 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.471 0.653 . . . . 0.0 110.559 174.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -128.12 144.63 51.12 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.559 -176.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.2 m -110.32 118.37 36.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.907 0.384 . . . . 0.0 111.354 -175.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -85.45 155.51 21.21 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.871 176.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.563 ' H ' ' HD2' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -122.19 132.88 54.67 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.043 0.449 . . . . 0.0 111.325 -176.186 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.63 138.06 58.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.089 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 108.22 -28.66 11.4 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.401 -177.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -100.83 141.27 33.95 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 177.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.64 142.68 37.02 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.008 0.432 . . . . 0.0 110.264 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.9 t -93.88 125.84 46.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.316 174.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -89.55 113.31 56.18 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 120.917 0.389 . . . . 0.0 110.21 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.01 159.63 41.11 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.606 2.204 . . . . 0.0 112.719 -176.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.412 ' HB2' ' HB2' ' A' ' 14' ' ' SER . . . -114.85 109.52 18.28 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.096 177.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 24.7 ttt -74.19 109.59 7.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.144 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.495 HG13 HG21 ' A' ' 12' ' ' THR . 48.7 mm -96.28 116.83 39.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.835 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.473 ' HB2' ' OG1' ' A' ' 115' ' ' THR . 27.8 mt-10 -96.84 141.51 29.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.506 -176.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -123.08 123.54 41.08 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.723 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.55 ' O ' ' HA ' ' A' ' 112' ' ' GLN . 52.6 mtt180 -124.37 164.33 19.88 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 174.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 10.3 ptm85 -126.72 131.98 51.23 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 176.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.522 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 13.7 mmm -127.01 139.3 53.13 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.265 -170.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -78.44 132.36 37.27 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 175.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.419 ' HB2' ' O ' ' A' ' 109' ' ' MET . 38.6 t80 -75.37 106.93 7.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.137 -174.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.7 mp -97.38 176.01 6.04 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 166.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -146.95 149.91 34.13 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 119.567 -0.853 . . . . 0.0 113.047 -170.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.96 -169.76 3.47 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 113.976 -1.465 . . . . 0.0 107.211 171.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -63.79 144.14 57.28 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 175.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.3 69.68 2.93 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 118.928 -1.606 . . . . 0.0 113.731 -168.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -126.21 -27.71 3.2 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 158.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -140.76 128.45 21.6 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.308 -1.315 . . . . 0.0 109.897 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.495 ' ND1' HD22 ' A' ' 98' ' ' LEU . 47.6 m170 -122.03 148.28 45.03 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.568 0.223 . . . . 0.0 110.466 175.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 41.8 t -102.24 130.48 52.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.085 -175.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.485 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 79.7 m-85 -125.43 133.49 52.45 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.404 ' O ' ' HA ' ' A' ' 70' ' ' MET . 40.7 mtm -105.64 119.2 38.54 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 121.073 -0.251 . . . . 0.0 110.883 -178.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.559 ' HB3' ' H ' ' A' ' 89' ' ' GLU . 10.6 t70 -61.33 123.9 19.09 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.88 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -72.37 -20.83 61.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.833 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -66.58 -51.55 55.18 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.3 p -172.25 92.46 0.12 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 166.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 48.6 27.46 1.48 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 162.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.559 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 48.5 mt-10 -88.79 110.41 21.0 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 121.756 -0.59 . . . . 0.0 110.276 176.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -78.81 133.72 37.03 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.684 -177.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 90.6 m -131.01 120.85 24.07 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.937 174.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 80' ' ' HIS . 29.1 mt-10 -99.89 127.56 46.05 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.004 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.433 HD12 ' CE1' ' A' ' 82' ' ' PHE . 52.6 mt -103.83 152.06 22.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.98 -177.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.624 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 13.8 m -96.44 170.64 9.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.316 -172.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.0 m -46.92 -38.13 10.04 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.27 0.628 . . . . 0.0 112.595 -175.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -50.34 -44.74 54.59 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.09 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -81.16 -36.92 29.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.323 0.582 . . . . 0.0 110.437 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.624 ' HG ' ' O ' ' A' ' 94' ' ' SER . 11.7 mt -64.68 -27.2 68.76 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.261 -171.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -59.87 -47.5 85.49 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.901 0.381 . . . . 0.0 110.561 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.51 ' HA ' ' ND2' ' A' ' 103' ' ' ASN . 41.9 mt-10 -70.1 -33.47 71.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.486 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.577 ' O ' HD12 ' A' ' 105' ' ' LEU . 72.7 mt-10 -59.74 -45.35 92.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.03 171.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 83.1 mt -66.55 -15.27 63.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.885 0.374 . . . . 0.0 111.068 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.51 ' ND2' ' HA ' ' A' ' 100' ' ' GLU . 77.5 m-20 -75.51 -50.55 15.34 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 172.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -145.96 117.2 7.89 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.543 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.577 HD12 ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -165.41 161.74 19.03 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.909 0.385 . . . . 0.0 110.999 176.247 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.471 ' HD3' ' O ' ' A' ' 130' ' ' GLU . 31.3 mmmt -136.0 142.61 44.51 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 172.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -68.52 130.77 43.84 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.72 0.295 . . . . 0.0 110.828 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.13 -4.9 81.43 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.289 -177.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.419 ' O ' ' HB2' ' A' ' 72' ' ' TYR . 52.3 ttm -62.25 130.02 43.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.874 0.369 . . . . 0.0 111.121 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.522 ' HA ' ' O ' ' A' ' 70' ' ' MET . 46.3 mt-10 -95.78 101.12 12.78 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.14 0.495 . . . . 0.0 109.846 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 26.4 m -100.17 164.24 2.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.397 -176.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.55 ' HA ' ' O ' ' A' ' 68' ' ' ARG . 15.2 mt-30 -102.23 108.28 19.61 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.143 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.464 HD12 ' HG3' ' A' ' 70' ' ' MET . 19.0 mt -84.01 122.79 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.554 ' O ' HG12 ' A' ' 121' ' ' ILE . 16.3 tt0 -99.3 118.77 36.71 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.263 -175.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.473 ' OG1' ' HB2' ' A' ' 66' ' ' GLU . 79.3 p -117.91 155.0 30.94 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.314 0.578 . . . . 0.0 111.854 -174.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -125.75 104.32 8.29 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 173.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 59.37 41.05 20.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.836 0.827 . . . . 0.0 109.852 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 91.16 -23.49 23.91 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.298 -0.865 . . . . 0.0 113.157 178.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -83.36 128.5 34.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.853 0.327 . . . . 0.0 110.946 -175.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.9 t -66.16 120.41 13.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.127 0.489 . . . . 0.0 110.915 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.554 HG12 ' O ' ' A' ' 114' ' ' GLN . 19.9 pt -109.69 -24.68 3.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.437 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -169.44 164.91 38.41 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.372 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 99.3 t -131.62 118.16 37.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.862 0.363 . . . . 0.0 110.195 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 112' ' ' GLN . 42.3 mt-10 -91.13 104.19 16.79 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.867 -176.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 70.3 mt -78.31 138.77 59.79 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 174.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.55 128.65 30.27 Favored 'Trans proline' 0 CA--C 1.515 -0.456 0 C-N-CA 122.771 2.314 . . . . 0.0 111.153 178.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.732 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 95.4 mttt -52.3 -33.7 43.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.479 -169.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.8 p -115.47 109.6 18.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.024 0.44 . . . . 0.0 111.302 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 13.0 p -112.34 143.59 21.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.763 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.471 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 47.3 mt-10 -104.45 124.26 48.93 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 177.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 62.6 mt -126.28 131.41 51.9 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.776 0.322 . . . . 0.0 110.409 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.5 m -74.45 132.84 42.28 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 170' ' ' ASP . 5.0 p -89.43 107.22 17.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.41 0.624 . . . . 0.0 110.338 178.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 13.1 p -105.02 124.53 49.68 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.714 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 70.6 88.87 0.1 Allowed 'General case' 0 C--O 1.237 0.421 0 CA-C-O 122.08 0.943 . . . . 0.0 111.611 -177.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.453 ' O ' ' HD3' ' A' ' 138' ' ' PRO . 15.2 t -151.36 139.85 20.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.512 -1.222 . . . . 0.0 107.839 170.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -82.37 113.0 40.97 Favored Pre-proline 0 C--N 1.322 -0.593 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.293 -170.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 136' ' ' THR . 96.9 Cg_endo -93.75 -179.84 0.87 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.257 2.638 . . . . 0.0 111.858 177.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.19 30.76 24.5 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.819 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.424 HG23 ' HB3' ' A' ' 164' ' ' LEU . 4.2 tp -128.29 99.44 5.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.607 0.717 . . . . 0.0 110.195 178.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -156.46 164.12 38.62 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.476 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 120.16 -28.69 6.24 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.391 177.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -103.14 153.9 19.85 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 26.0 m -71.24 88.73 0.85 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.245 0.545 . . . . 0.0 111.037 -177.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -80.0 72.67 6.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.52 178.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.4 t -68.81 -25.7 64.81 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.004 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -159.87 28.74 0.36 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.342 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -92.09 133.11 36.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.68 0.276 . . . . 0.0 110.664 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.6 p -131.91 168.42 17.9 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.794 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -137.22 151.34 48.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.014 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.9 m -73.08 110.62 7.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.216 0.531 . . . . 0.0 111.246 -174.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -116.21 162.06 18.03 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.729 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 22.7 m -125.86 140.68 52.46 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.739 174.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 12.8 m -101.87 173.08 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.805 175.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -56.98 -27.19 61.19 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.413 HG22 HD13 ' A' ' 105' ' ' LEU . 80.9 p -73.74 -11.89 60.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.79 0.329 . . . . 0.0 111.487 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 91.82 5.0 66.83 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.932 -0.652 . . . . 0.0 111.844 -177.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -85.04 141.68 30.11 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 27.0 m -99.2 129.67 45.45 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.648 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.4 mp -132.61 155.93 47.83 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 120.729 0.299 . . . . 0.0 110.238 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -93.7 99.35 11.78 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 34.6 m -97.34 150.71 37.1 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.082 -174.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -56.48 152.25 41.21 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.535 2.157 . . . . 0.0 111.277 174.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.424 ' HB3' HG23 ' A' ' 140' ' ' ILE . 59.1 mt -64.93 -14.85 61.11 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.612 -169.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -86.65 -7.42 58.34 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 88.0 t -75.6 131.13 35.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.861 0.362 . . . . 0.0 110.831 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -120.64 144.73 48.0 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.33 -175.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.419 ' HB3' HG22 ' A' ' 136' ' ' THR . 9.2 pt-20 -69.56 132.97 47.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.138 0.494 . . . . 0.0 110.987 -176.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 109.78 -16.51 30.95 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.418 -174.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.441 ' OD1' ' HB2' ' A' ' 184' ' ' ARG . 10.7 t70 -84.93 156.71 21.09 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 74.7 t -104.02 116.13 47.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.87 0.367 . . . . 0.0 110.563 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 184' ' ' ARG . 80.1 mt -94.68 145.65 24.7 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.587 -178.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.635 ' O ' ' HB ' ' A' ' 182' ' ' ILE . 26.6 mt -98.66 134.82 35.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 175.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 67.2 mt -135.2 137.6 49.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 O-C-N 122.039 -0.413 . . . . 0.0 110.46 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.732 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 27.0 t-20 -83.68 98.01 9.41 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 175.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 8.9 t -85.37 157.92 20.39 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.855 0.36 . . . . 0.0 110.071 -177.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 94.45 -48.71 2.11 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -173.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.551 ' HB3' ' OD1' ' A' ' 175' ' ' ASN . 33.1 t70 -98.52 -42.3 7.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.001 0.429 . . . . 0.0 110.08 176.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 105.97 5.3 38.39 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.827 -0.701 . . . . 0.0 113.427 173.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 64.0 m -68.61 133.67 48.83 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.957 0.408 . . . . 0.0 111.038 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -86.64 134.41 33.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.1 0.476 . . . . 0.0 110.851 -177.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.635 ' HB ' ' O ' ' A' ' 173' ' ' ILE . 56.0 mt -116.04 155.0 17.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.3 p -75.88 172.7 12.26 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.419 0.152 . . . . 0.0 110.729 -176.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.441 ' HB2' ' OD1' ' A' ' 170' ' ' ASP . 8.3 ptp180 -57.99 159.15 5.9 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.174 0.511 . . . . 0.0 111.575 -173.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.791 -1.005 . . . . 0.0 111.471 178.722 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.9 mtp . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 120.578 0.228 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.416 HD12 ' HB3' ' A' ' 62' ' ' PRO . 53.7 mt -115.73 137.95 47.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-O 121.209 0.528 . . . . 0.0 111.382 -177.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.0 t -116.97 166.07 12.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.03 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.407 ' O ' HG21 ' A' ' 37' ' ' VAL . 21.2 m -67.96 -7.9 7.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -170.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -86.92 -2.39 58.57 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.637 -176.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -137.62 95.45 3.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.284 0.564 . . . . 0.0 112.198 -178.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -121.1 160.37 23.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.231 173.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -139.94 169.17 18.19 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.585 -0.154 . . . . 0.0 110.585 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.1 t -61.81 -13.1 20.95 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 123.632 0.583 . . . . 0.0 111.828 -173.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.34 113.14 0.66 Allowed Glycine 0 N--CA 1.434 -1.475 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 165.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 62.9 tp -150.93 129.35 12.08 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 2.7 p -98.48 129.4 45.07 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.24 0.543 . . . . 0.0 111.677 -177.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 mp -128.37 138.58 54.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.996 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.7 p -94.66 110.45 22.29 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.042 175.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.7 p -150.67 147.78 15.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -178.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 62.11 30.93 17.92 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.312 0.383 . . . . 0.0 110.864 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 63.3 24.43 14.26 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.94 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -137.83 168.59 19.38 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.255 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 11.1 pt -116.73 127.31 74.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.257 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.551 ' O ' ' HA ' ' A' ' 12' ' ' THR . 15.4 m95 -127.67 157.87 39.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.044 -172.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 44.5 tttm -123.23 119.51 30.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.317 175.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 90.9 t -62.34 117.95 4.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.402 0.62 . . . . 0.0 110.65 175.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 86.8 mt -90.0 -39.07 11.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.4 173.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -152.3 148.0 27.02 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.027 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -135.98 140.67 44.11 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.107 0.48 . . . . 0.0 111.032 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 54.5 tp60 -117.93 99.89 7.21 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.053 175.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -78.0 89.25 4.15 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.0 p -97.04 131.06 44.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.058 -173.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.403 ' HD3' ' N ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -122.93 105.11 35.18 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.442 179.542 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.46 -10.63 27.21 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.689 2.259 . . . . 0.0 112.793 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.69 22.89 63.3 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.775 176.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -104.18 0.59 29.7 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.991 0.424 . . . . 0.0 110.79 -178.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 130.81 -42.07 1.45 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.765 175.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.4 m -118.83 146.42 44.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.768 0.318 . . . . 0.0 110.692 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.82 160.92 14.06 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.142 0.496 . . . . 0.0 110.945 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -132.49 161.8 32.82 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 53' ' ' THR . 48.1 t -132.24 102.6 5.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 120.842 0.353 . . . . 0.0 110.601 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -79.71 99.09 7.25 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 174.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.1 p -112.5 139.5 48.03 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.129 0.49 . . . . 0.0 112.17 -174.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -89.76 121.22 31.7 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 171.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.473 HD23 ' H ' ' A' ' 41' ' ' LEU . 0.8 OUTLIER -141.23 142.42 33.96 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.491 0.662 . . . . 0.0 111.697 -174.513 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.1 ttp180 -104.67 129.73 52.79 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.483 -174.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -69.09 118.22 11.72 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 173.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.3 mp -66.65 -28.93 68.86 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -175.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.588 ' HA ' ' O ' ' A' ' 121' ' ' ILE . 68.0 mtt85 -73.07 -44.57 60.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.958 0.409 . . . . 0.0 111.65 -176.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.4 p -102.85 -11.61 18.16 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.018 0.437 . . . . 0.0 112.029 -173.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.92 21.82 78.25 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -176.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.8 133.41 34.34 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -172.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.3 mm -89.74 110.05 21.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.926 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.4 ' HG2' ' N ' ' A' ' 51' ' ' GLU . 50.8 tt0 -132.25 172.69 12.1 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.4 ' N ' ' HG2' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -130.28 147.12 51.96 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.022 0.439 . . . . 0.0 110.864 175.836 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.425 ' HD2' HD11 ' A' ' 41' ' ' LEU . 67.8 mttm -142.75 148.04 36.57 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.908 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 43.7 m -111.44 117.53 33.29 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.006 0.432 . . . . 0.0 110.342 178.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -84.6 140.71 31.18 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.82 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 47.8 mtm105 -107.17 138.44 43.35 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.585 -177.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.53 130.65 46.08 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.795 0.331 . . . . 0.0 110.258 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.67 -29.97 8.92 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -174.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.11 119.83 24.53 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 175.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -71.32 131.8 43.96 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.369 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.9 t -91.34 107.99 19.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.156 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -87.64 113.25 53.51 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.419 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.416 ' HB3' HD12 ' A' ' 2' ' ' ILE . 58.3 Cg_endo -72.94 155.5 53.0 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.503 2.136 . . . . 0.0 112.702 -178.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.31 115.58 27.6 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.328 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 46.1 ttm -76.92 108.47 9.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.781 -178.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.488 HG13 HG21 ' A' ' 12' ' ' THR . 43.2 mm -100.94 139.02 23.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.396 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 114' ' ' GLN . 39.0 mt-10 -105.09 116.73 32.44 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 175.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -99.71 99.08 9.86 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 173.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -111.87 124.73 52.98 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.015 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.589 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 12.8 ptp180 -86.84 120.18 27.84 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.329 0.585 . . . . 0.0 109.485 177.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.817 ' SD ' ' HA ' ' A' ' 84' ' ' ASP . 8.5 mmt -107.32 145.58 32.64 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.724 -178.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -79.58 136.12 36.77 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 172.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.451 ' CZ ' HD23 ' A' ' 105' ' ' LEU . 47.4 t80 -77.13 108.38 10.19 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.807 -176.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 3.3 mm? -99.51 177.33 5.2 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 167.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -146.94 150.73 35.76 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.67 -175.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.05 -162.92 1.65 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.735 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -62.74 137.76 58.35 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 174.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.43 70.19 2.46 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 119.209 -1.472 . . . . 0.0 113.151 -171.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -125.87 -32.56 2.8 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 161.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.501 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 78.6 m-20 -141.29 135.19 30.35 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 114.065 -1.425 . . . . 0.0 109.293 175.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.527 ' CG ' HD22 ' A' ' 98' ' ' LEU . 58.6 m170 -107.66 144.1 35.22 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 175.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 73' ' ' LEU . 49.5 t -94.3 121.91 45.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.794 -175.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.542 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 76.8 m-85 -117.85 126.04 51.65 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 176.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 14.7 tmm? -97.48 117.26 31.33 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.021 -175.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.817 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 17.6 t70 -62.42 114.65 3.63 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.418 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -76.94 -5.11 47.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.414 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -76.9 -50.94 12.17 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 173.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.7 p -170.94 93.95 0.18 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 168.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 50.09 28.83 3.19 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 157.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.57 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 34.1 mt-10 -101.14 115.25 30.04 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 121.466 -0.771 . . . . 0.0 111.287 175.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -82.38 108.98 16.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.316 0.579 . . . . 0.0 110.962 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 54.8 m -101.81 123.21 45.38 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.801 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -99.58 125.25 45.34 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.852 0.358 . . . . 0.0 110.334 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.501 ' O ' ' HA ' ' A' ' 79' ' ' ASN . 42.6 mt -97.85 138.77 34.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.349 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.526 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 29.5 t -79.95 169.23 18.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.716 -174.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.2 p -50.48 -39.41 48.18 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.963 0.505 . . . . 0.0 112.312 -175.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -59.31 -36.09 74.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.648 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -76.07 -35.47 59.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.305 0.574 . . . . 0.0 109.504 177.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.634 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 14.2 mt -64.32 -30.09 71.15 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.238 -176.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -62.6 -32.69 73.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.935 176.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -73.27 -40.52 64.53 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.552 ' O ' HD12 ' A' ' 105' ' ' LEU . 47.8 mt-10 -62.05 -36.76 82.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.732 175.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 79.9 mt -73.52 0.57 12.12 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.078 0.466 . . . . 0.0 110.824 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' A' ' 158' ' ' TYR . 57.5 t30 -93.95 -43.26 8.63 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 170.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -148.34 117.09 6.66 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.26 172.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.552 HD12 ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -160.21 153.39 21.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.926 0.393 . . . . 0.0 110.649 172.255 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.7 mtpt -144.03 146.85 33.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.791 172.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -71.13 132.11 44.57 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.344 -174.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.67 0.68 90.25 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.771 177.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.446 ' SD ' ' HG3' ' A' ' 126' ' ' PRO . 57.5 ttm -82.65 141.74 32.26 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.809 0.338 . . . . 0.0 111.438 -177.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' A' ' 70' ' ' MET . 54.2 mp0 -84.19 123.47 30.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.084 175.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 34.7 m -121.79 158.9 24.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.329 177.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.55 ' HB2' ' HB3' ' A' ' 124' ' ' GLU . 15.8 mm-40 -91.34 101.55 14.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.755 0.312 . . . . 0.0 110.194 -175.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 48.8 mm -94.01 122.03 45.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 178.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 87.2 mt-30 -98.47 117.34 32.68 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.742 0.306 . . . . 0.0 110.539 -178.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.413 ' OG1' ' HB2' ' A' ' 66' ' ' GLU . 35.2 p -112.36 151.22 30.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.915 176.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -135.56 103.12 5.34 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 60.06 31.77 20.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.528 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 104.44 -30.27 10.42 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 121.102 -0.571 . . . . 0.0 113.019 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -76.72 131.21 38.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.561 0.219 . . . . 0.0 111.276 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 17.6 p -73.43 106.6 5.3 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 172.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' A' ' 45' ' ' ARG . 45.2 pt -94.25 -31.2 4.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -174.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -162.38 164.38 35.55 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 119.641 -1.266 . . . . 0.0 113.135 -177.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 59.9 t -133.38 127.57 54.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.55 ' HB3' ' HB2' ' A' ' 112' ' ' GLN . 35.1 tt0 -118.69 122.99 43.81 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.041 0.448 . . . . 0.0 110.337 178.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -86.54 155.67 56.55 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.446 ' HG3' ' SD ' ' A' ' 109' ' ' MET . 10.5 Cg_endo -53.5 132.76 50.4 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.58 2.187 . . . . 0.0 110.982 176.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 95.7 mttt -54.85 -34.77 63.28 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.518 -174.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 19.7 p -122.92 109.08 13.69 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.045 176.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.5 p -106.25 136.81 39.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.499 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -94.3 108.53 20.42 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 177.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.524 HD12 HD13 ' A' ' 174' ' ' ILE . 98.7 mt -117.92 134.4 54.98 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.253 0.549 . . . . 0.0 110.744 -176.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.0 m -81.45 131.25 35.27 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.752 177.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.0 p -81.05 119.36 30.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.685 0.755 . . . . 0.0 111.084 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.482 ' O ' ' HB ' ' A' ' 153' ' ' THR . 41.6 p -125.27 128.9 48.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.555 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 75.94 86.02 0.09 Allowed 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.898 0.856 . . . . 0.0 110.69 -175.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.449 ' O ' ' HD3' ' A' ' 138' ' ' PRO . 13.3 t -150.96 155.02 38.22 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.462 173.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -82.5 110.7 23.35 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 120.424 0.154 . . . . 0.0 110.699 -176.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 136' ' ' THR . 96.6 Cg_endo -91.11 162.7 3.83 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.056 2.504 . . . . 0.0 112.709 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 98.15 -2.62 59.71 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.547 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 9.6 tt -107.37 105.24 18.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.308 0.575 . . . . 0.0 110.356 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -155.15 163.54 40.08 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.058 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.92 -30.4 10.31 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -95.21 86.96 4.7 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 27.6 m -82.76 -50.28 8.85 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.495 -176.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.41 ' O ' ' HB ' ' A' ' 146' ' ' THR . . . 47.63 57.54 5.83 Favored 'General case' 0 N--CA 1.462 0.164 0 O-C-N 123.727 0.642 . . . . 0.0 111.458 177.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 145' ' ' ALA . 98.8 m 71.49 -56.56 0.63 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.31 -177.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -176.51 51.78 0.11 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.161 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.81 135.79 57.59 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.681 0.277 . . . . 0.0 110.297 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 27.6 p -126.93 163.31 23.96 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.267 0.556 . . . . 0.0 112.004 -173.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.402 ' HE3' ' OG1' ' A' ' 136' ' ' THR . 54.0 pttt -130.75 147.46 52.41 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.225 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 17.2 t -73.84 99.76 3.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.343 0.592 . . . . 0.0 110.303 -178.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -106.98 170.07 8.17 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.61 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 134' ' ' THR . 3.5 m -122.75 147.37 46.57 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 175.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.582 HG23 HG22 ' A' ' 156' ' ' THR . 2.6 m -109.68 170.95 2.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.23 173.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -53.24 -33.24 52.11 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -176.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.582 HG22 HG23 ' A' ' 154' ' ' VAL . 15.1 t -74.46 -8.25 55.68 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -176.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 95.91 -4.71 65.84 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.476 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.462 ' H ' HG23 ' A' ' 156' ' ' THR . 90.9 t80 -76.31 137.19 39.72 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.808 0.337 . . . . 0.0 110.719 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.55 130.87 44.57 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.522 177.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.475 HD11 HG13 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -142.99 148.07 36.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.937 0.398 . . . . 0.0 111.357 -175.244 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -85.55 102.41 13.5 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.775 176.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.468 HG13 HD13 ' A' ' 160' ' ' LEU . 26.8 m -102.18 149.78 36.91 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.503 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -51.81 145.38 31.78 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.514 2.143 . . . . 0.0 111.39 175.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 72.4 mt -59.07 -24.61 63.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.622 -169.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -85.89 7.49 23.92 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -175.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.429 HG22 ' HD2' ' A' ' 184' ' ' ARG . 91.1 t -82.91 137.79 20.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 176.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -123.38 156.52 35.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.671 -0.241 . . . . 0.0 110.68 -176.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -59.15 116.7 4.03 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.502 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 121.24 -16.6 9.2 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.535 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -64.57 139.51 58.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.812 0.339 . . . . 0.0 110.989 176.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 55.4 t -100.43 103.73 15.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.414 ' CD1' HD11 ' A' ' 174' ' ' ILE . 0.9 OUTLIER -113.89 150.01 34.28 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.808 -176.898 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.457 ' O ' ' HB ' ' A' ' 182' ' ' ILE . 55.1 mt -103.03 134.66 43.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.827 -173.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.524 HD13 HD12 ' A' ' 131' ' ' LEU . 4.0 mp -121.68 141.12 43.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.754 0.312 . . . . 0.0 110.325 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.508 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 28.0 t-20 -84.61 105.58 15.52 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 175.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 37.6 p -64.82 158.6 24.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.151 -173.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 77.78 -55.3 3.81 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.415 178.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -84.8 -43.13 14.49 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.737 0.303 . . . . 0.0 110.737 -177.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 101.88 4.15 51.68 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.513 173.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 34.9 m -63.78 142.92 58.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.958 0.409 . . . . 0.0 110.951 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -98.44 124.37 43.11 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.2 0.524 . . . . 0.0 111.177 -175.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.457 ' HB ' ' O ' ' A' ' 173' ' ' ILE . 2.6 mp -95.11 152.87 3.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 173.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 17.4 m -74.85 169.42 17.96 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.234 0.54 . . . . 0.0 111.609 -170.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.429 ' HD2' HG22 ' A' ' 166' ' ' VAL . 58.6 mtp180 -63.08 147.58 50.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.358 -175.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.097 -1.39 . . . . 0.0 110.904 175.858 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.8 mtt . . . . . 0 N--CA 1.482 1.166 0 CA-C-O 120.776 0.322 . . . . 0.0 110.643 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.434 HD12 HG13 ' A' ' 13' ' ' ILE . 61.0 mt -93.97 131.77 39.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.446 -174.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 p -88.91 158.14 18.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.954 174.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.425 ' O ' HG21 ' A' ' 37' ' ' VAL . 15.8 m -71.28 -3.27 3.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -173.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -99.68 6.57 45.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.459 0.647 . . . . 0.0 109.895 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -124.31 88.94 2.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.244 0.545 . . . . 0.0 111.177 -177.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -142.06 156.3 45.4 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.026 177.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -139.95 165.77 26.44 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.7 t -57.19 -15.24 5.32 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.087 0.47 . . . . 0.0 111.169 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -147.95 113.72 0.65 Allowed Glycine 0 N--CA 1.435 -1.368 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 165.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 55.4 tp -151.63 134.61 15.77 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 1.1 p -98.46 124.44 43.17 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.356 0.598 . . . . 0.0 112.262 -176.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.434 HG13 HD12 ' A' ' 2' ' ' ILE . 4.0 mp -127.49 138.99 53.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.983 -178.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.7 p -100.24 110.32 22.56 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.164 0.507 . . . . 0.0 110.301 176.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.5 p -155.03 156.83 4.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -177.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 61.16 24.59 14.69 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.712 0.291 . . . . 0.0 110.887 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 16.0 m120 65.45 30.18 10.95 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.211 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -145.05 163.98 32.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.306 178.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 13.8 pt -105.97 125.77 61.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.199 0.523 . . . . 0.0 109.886 176.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.601 ' O ' ' HA ' ' A' ' 12' ' ' THR . 82.1 m95 -117.77 161.44 19.69 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.803 -169.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -132.02 101.63 5.5 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.606 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.414 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 89.9 t -62.74 116.55 2.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.901 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.4 mm -88.95 -36.14 8.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.242 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -162.71 113.78 1.51 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.788 -177.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 39' ' ' SER . 19.8 p90 -102.87 146.37 28.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.0 0.429 . . . . 0.0 111.014 -176.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -123.47 104.58 9.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.408 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -77.49 96.26 4.68 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 175.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.4 p -104.1 136.18 38.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.614 -171.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -117.94 89.75 34.97 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.456 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.36 -11.31 31.08 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.736 2.291 . . . . 0.0 113.121 -175.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.46 26.23 25.95 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.446 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -92.93 -11.84 32.37 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.33 0.586 . . . . 0.0 110.354 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.04 -19.85 17.52 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 -176.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.5 m -129.28 140.49 51.41 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.77 152.56 20.09 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.204 0.525 . . . . 0.0 110.824 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -131.64 167.1 20.02 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.929 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.425 HG21 ' O ' ' A' ' 4' ' ' VAL . 46.1 t -132.4 102.47 5.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 120.725 0.297 . . . . 0.0 110.428 178.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -77.45 99.26 5.57 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.461 ' HA ' ' HA ' ' A' ' 25' ' ' PHE . 18.2 m -103.4 126.03 50.32 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.547 -175.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.5 tppt? -84.68 110.22 18.59 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 173.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.453 HD23 ' H ' ' A' ' 41' ' ' LEU . 0.8 OUTLIER -138.01 144.06 40.9 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.893 0.854 . . . . 0.0 112.121 -172.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 42' ' ' ARG . 18.6 ttt180 -100.19 130.15 46.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.519 -175.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -64.48 112.29 3.07 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 173.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.6 tt -71.34 -14.08 62.08 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.209 0.528 . . . . 0.0 110.635 -171.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 45' ' ' ARG . 11.7 mtp180 -86.82 -45.28 11.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.497 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.4 p -101.24 -20.52 15.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.059 0.457 . . . . 0.0 111.868 -173.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.15 10.15 75.34 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.86 -176.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.71 145.4 38.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.116 0.484 . . . . 0.0 111.961 -175.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.6 mm -100.09 113.43 35.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.428 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.511 ' HG2' ' H ' ' A' ' 51' ' ' GLU . 31.8 tt0 -133.32 176.38 8.57 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.511 ' H ' ' HG2' ' A' ' 50' ' ' GLN . 9.6 pt-20 -138.26 142.35 39.87 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.937 0.398 . . . . 0.0 110.24 173.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -130.41 134.08 46.85 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.363 -177.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.4 p -98.19 110.34 22.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.048 0.451 . . . . 0.0 110.857 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -84.64 147.98 26.67 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.917 178.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.643 ' HD3' ' OE2' ' A' ' 58' ' ' GLU . 44.4 ttt180 -112.92 128.96 56.61 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.93 -174.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.3 125.76 24.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.605 178.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.43 -15.88 32.23 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.928 -178.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.643 ' OE2' ' HD3' ' A' ' 55' ' ' ARG . 42.8 mt-10 -119.26 99.71 6.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.899 0.38 . . . . 0.0 110.19 177.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -76.84 153.38 34.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.955 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.0 m -120.4 162.8 18.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.073 0.464 . . . . 0.0 111.446 -176.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -84.07 132.87 46.75 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.425 -177.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.418 ' HB3' HD11 ' A' ' 2' ' ' ILE . 82.2 Cg_endo -79.07 151.75 23.97 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.688 2.259 . . . . 0.0 112.334 176.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -118.99 114.52 22.67 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.387 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 64.8 mtt -94.15 118.12 31.09 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 48.9 mm -89.35 127.57 41.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.582 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -103.23 118.0 35.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.522 -174.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -102.42 125.72 49.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.787 0.327 . . . . 0.0 110.408 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 71.0 mtt-85 -126.18 115.03 19.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.964 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' A' ' 69' ' ' ARG . 13.3 ptm180 -85.49 117.82 24.64 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.369 0.604 . . . . 0.0 109.683 175.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.618 ' SD ' HD12 ' A' ' 113' ' ' ILE . 31.1 mtt -120.75 143.68 48.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.697 -174.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -77.3 132.72 38.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.777 176.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -73.37 104.26 4.32 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.23 -174.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.407 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 60.8 mt -99.06 -175.66 3.1 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 172.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -144.04 149.65 36.99 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.644 0.735 . . . . 0.0 112.518 -170.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.27 -154.23 0.53 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.661 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -79.86 152.06 29.88 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -82.27 66.65 3.84 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 117.858 -2.115 . . . . 0.0 112.787 -174.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -129.14 -31.79 2.08 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 156.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.572 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 81.9 m-20 -141.04 130.34 23.63 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.653 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.428 ' O ' ' HA ' ' A' ' 92' ' ' GLU . 30.1 m170 -110.69 141.52 43.83 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 175.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.407 ' O ' ' HB2' ' A' ' 73' ' ' LEU . 41.5 t -87.52 130.52 37.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.922 -177.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.424 ' CE1' HD12 ' A' ' 93' ' ' LEU . 83.0 m-85 -124.26 128.39 49.09 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 174.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 25.8 ttt -94.34 112.0 23.77 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.46 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.604 ' HB3' ' H ' ' A' ' 89' ' ' GLU . 25.0 t70 -58.59 110.05 0.91 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.168 177.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -80.59 -4.51 54.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.7 -177.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -70.19 -50.7 37.55 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 173.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.6 p -171.85 93.56 0.15 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 165.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 49.79 29.37 3.2 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 159.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.604 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 42.9 mt-10 -100.12 105.97 17.65 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 121.584 -0.697 . . . . 0.0 111.346 176.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -70.08 125.02 25.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.919 0.39 . . . . 0.0 110.22 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 46.6 m -128.16 125.33 38.88 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.161 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.428 ' HA ' ' O ' ' A' ' 80' ' ' HIS . 32.3 mt-10 -104.58 131.74 51.64 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.8 0.333 . . . . 0.0 110.769 -177.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 79' ' ' ASN . 42.3 mt -100.28 146.56 26.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.575 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.634 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 8.3 t -88.08 166.31 14.52 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.924 -172.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.7 t -51.1 -42.8 60.88 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -171.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -55.1 -45.89 75.5 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -178.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -71.8 -39.89 69.57 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.25 0.548 . . . . 0.0 109.562 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 94' ' ' SER . 56.8 mt -60.2 -28.16 67.75 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.851 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -57.82 -43.95 86.08 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.914 0.388 . . . . 0.0 110.913 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -80.17 -43.33 21.76 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.692 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.486 ' HG3' HD11 ' A' ' 125' ' ' LEU . 0.6 OUTLIER -62.94 -27.57 69.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.99 177.626 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 22.3 mt -75.07 -14.44 60.58 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 122.308 -0.245 . . . . 0.0 111.096 177.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -74.6 -43.92 53.24 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.428 ' HB3' HG11 ' A' ' 129' ' ' VAL . 40.9 m-85 -138.18 116.74 12.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.431 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.454 HD22 ' C ' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -170.78 157.99 5.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.302 0.572 . . . . 0.0 111.113 176.141 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.447 ' HD3' ' O ' ' A' ' 130' ' ' GLU . 31.5 mmmt -130.1 139.29 50.95 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.775 172.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -73.21 127.35 32.36 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.28 -0.36 71.64 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.079 -175.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.459 ' SD ' ' HG3' ' A' ' 126' ' ' PRO . 42.1 ttm -87.47 144.18 26.86 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.679 0.276 . . . . 0.0 111.145 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 70' ' ' MET . 45.3 mt-10 -85.51 122.63 29.91 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.963 177.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 24.9 m -112.34 156.34 13.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -101.31 99.27 9.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.086 0.47 . . . . 0.0 110.176 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.618 HD12 ' SD ' ' A' ' 70' ' ' MET . 54.6 mt -83.24 127.11 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.49 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.531 ' O ' HG12 ' A' ' 121' ' ' ILE . 17.6 tt0 -100.31 112.34 24.67 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.392 -174.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 25.7 p -116.16 155.75 27.69 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.857 -176.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.416 ' HB2' HD13 ' A' ' 121' ' ' ILE . 78.6 t80 -132.69 109.46 9.72 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 172.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 60.46 31.48 20.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.029 0.442 . . . . 0.0 110.853 -175.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.68 -12.95 65.51 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.715 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -86.18 126.94 34.61 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 25.5 m -67.67 117.05 9.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.637 0.256 . . . . 0.0 110.658 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 114' ' ' GLN . 12.9 pt -105.64 -23.35 4.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.813 0.34 . . . . 0.0 111.047 178.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -170.65 166.41 39.6 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.013 176.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 61.1 t -133.19 126.11 52.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -107.4 113.38 26.69 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.936 0.398 . . . . 0.0 110.962 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.486 HD11 ' HG3' ' A' ' 101' ' ' GLU . 3.0 mm? -81.02 149.95 67.67 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 173.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.459 ' HG3' ' SD ' ' A' ' 109' ' ' MET . 9.8 Cg_endo -53.38 137.67 64.78 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.559 2.173 . . . . 0.0 111.417 176.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.605 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 31.8 mmtp -61.28 -27.93 68.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.715 -172.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.5 p -124.61 107.46 11.04 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.194 0.521 . . . . 0.0 110.394 174.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.428 HG11 ' HB3' ' A' ' 104' ' ' TYR . 7.1 p -107.27 144.96 15.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.457 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.447 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 35.7 mt-10 -110.36 113.36 25.96 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.906 0.384 . . . . 0.0 110.381 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 73.6 mt -120.5 129.41 53.83 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.406 -176.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.6 m -72.42 131.21 42.28 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.143 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 170' ' ' ASP . 9.6 p -84.16 112.96 22.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.749 0.785 . . . . 0.0 110.515 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.45 ' O ' ' HB ' ' A' ' 153' ' ' THR . 31.9 p -115.81 119.53 36.31 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.184 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 77.37 87.81 0.07 Allowed 'General case' 0 C--O 1.237 0.413 0 O-C-N 123.991 0.807 . . . . 0.0 110.904 -177.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 12.8 t -151.03 152.88 34.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.81 172.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -114.02 109.74 49.36 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 120.73 0.3 . . . . 0.0 111.393 -177.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 164' ' ' LEU . 12.4 Cg_exo -70.87 -176.39 1.78 Allowed 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 123.66 2.907 . . . . 0.0 111.601 172.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 122.99 35.54 0.72 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.059 -1.067 . . . . 0.0 113.246 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.1 tp . . . . . 0 CA--C 1.538 0.518 0 CA-C-O 121.258 0.552 . . . . 0.0 109.994 173.287 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 29.6 p . . . . . 0 N--CA 1.45 -0.458 0 CA-C-O 120.945 0.403 . . . . 0.0 111.746 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.8 ttpp -132.58 161.06 34.82 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 176.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 34.9 p -72.49 107.69 5.16 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.159 0.504 . . . . 0.0 110.513 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.468 ' HB2' HG22 ' A' ' 162' ' ' VAL . . . -107.32 164.08 12.49 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.386 178.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' A' ' 134' ' ' THR . 22.4 m -119.19 136.03 54.39 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.857 175.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 12.4 m -100.77 174.29 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.0 175.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -56.16 -29.01 60.22 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 59.3 p -72.71 -19.31 61.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.986 0.422 . . . . 0.0 111.484 -177.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 100.22 -3.12 56.67 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -174.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -75.63 144.57 41.65 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.871 0.367 . . . . 0.0 110.688 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 18.9 m -106.07 122.71 46.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.3 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.85 158.58 43.85 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -177.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -88.85 108.86 19.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.069 -174.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.468 HG22 ' HB2' ' A' ' 152' ' ' ALA . 32.7 m -102.72 147.36 33.94 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.586 178.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.15 144.83 56.93 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.289 1.993 . . . . 0.0 111.51 172.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 138' ' ' PRO . 77.2 mt -63.0 -7.78 5.99 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -172.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -100.55 10.5 41.1 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 93.9 t -87.78 131.87 34.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.532 0.206 . . . . 0.0 110.55 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -110.73 154.2 24.22 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.996 0.427 . . . . 0.0 110.934 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -59.83 127.13 30.41 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.731 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 112.26 -20.9 20.7 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.429 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.454 ' O ' HG12 ' A' ' 133' ' ' VAL . 2.2 m-20 -64.13 143.39 57.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.851 0.358 . . . . 0.0 110.761 177.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 61.8 t -95.09 110.32 23.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.315 0.579 . . . . 0.0 109.843 177.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.42 HD11 ' HB ' ' A' ' 133' ' ' VAL . 47.8 mt -87.35 129.33 35.06 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.5 -176.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.555 ' O ' ' HB ' ' A' ' 182' ' ' ILE . 40.8 mt -94.43 127.96 46.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 59.8 mt -126.39 138.33 54.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.78 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.605 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 0.2 OUTLIER -80.98 91.39 6.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.655 177.557 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.64 133.52 49.51 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.627 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 120.46 -40.33 2.2 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -115.07 -28.87 6.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.24 0.543 . . . . 0.0 110.254 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 88.45 19.34 52.69 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.111 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 19.3 t -79.31 130.83 35.84 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.8 0.333 . . . . 0.0 110.111 -177.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -76.67 127.42 32.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.322 0.582 . . . . 0.0 111.163 -177.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.555 ' HB ' ' O ' ' A' ' 173' ' ' ILE . 59.7 mt -105.8 153.68 7.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 173.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 16.2 p -74.69 146.34 42.4 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.252 0.548 . . . . 0.0 111.113 -168.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -55.93 142.16 36.67 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.077 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.648 -1.085 . . . . 0.0 112.238 -179.005 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ttt . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 121.073 0.463 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.6 mp -111.88 130.7 65.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.0 t -111.78 174.0 6.09 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 22.9 m -72.33 0.91 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -172.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -93.13 -1.57 56.25 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.017 0.437 . . . . 0.0 110.225 176.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -111.06 88.92 2.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.104 -176.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -141.47 147.56 38.06 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 175.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -130.11 174.96 9.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.729 -0.214 . . . . 0.0 110.496 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.4 t -57.84 -24.48 57.62 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 121.343 0.592 . . . . 0.0 110.234 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.624 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -147.13 116.33 0.84 Allowed Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 169.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 57.8 tp -145.94 130.99 18.29 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.567 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 1.7 p -92.87 127.21 38.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.925 0.393 . . . . 0.0 111.957 -177.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mp -127.19 139.69 51.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.247 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.8 t -99.74 107.89 20.08 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.5 p -151.22 150.18 13.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -176.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.8 23.95 14.27 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.803 0.335 . . . . 0.0 110.474 -176.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.7 m120 62.12 33.4 16.99 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.878 -178.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -140.97 162.28 35.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.029 176.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 11.8 pt -104.92 121.0 56.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.344 0.592 . . . . 0.0 110.292 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.567 ' O ' ' HA ' ' A' ' 12' ' ' THR . 70.9 m95 -115.77 164.38 14.46 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.838 -172.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -140.42 109.27 6.01 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 120.935 0.397 . . . . 0.0 110.209 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.624 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 94.2 t -58.66 122.03 7.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.128 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.441 HD11 ' HB2' ' A' ' 42' ' ' ARG . 81.4 mt -87.58 -38.5 12.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.517 174.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -163.2 144.44 9.56 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.24 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -125.24 138.54 54.11 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.095 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -109.52 98.68 8.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.144 175.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 21.5 t-160 -81.08 98.13 7.86 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.9 131.34 48.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.401 0.62 . . . . 0.0 111.458 -174.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.44 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -111.86 101.54 51.68 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.292 -177.818 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -65.87 -46.81 4.4 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.776 2.317 . . . . 0.0 112.47 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.02 17.55 6.28 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.92 -177.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -105.66 10.42 32.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.997 0.427 . . . . 0.0 110.271 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.57 -43.21 3.22 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 -176.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.2 m -89.3 98.33 11.71 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.851 0.358 . . . . 0.0 110.098 176.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -86.73 171.5 10.88 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.504 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -142.13 164.25 30.66 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.355 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 53' ' ' THR . 48.0 t -127.95 107.05 15.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.594 -176.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -80.5 98.17 7.46 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 173.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.6 p -104.97 135.81 45.62 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.99 0.424 . . . . 0.0 111.489 -175.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -95.95 109.87 22.17 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 175.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.555 HD23 ' H ' ' A' ' 41' ' ' LEU . 1.4 pt? -132.5 145.61 51.3 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.405 0.621 . . . . 0.0 111.369 -172.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 22.0 ttp180 -106.39 132.1 52.81 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.657 -175.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -62.03 119.32 8.66 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 172.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.452 HD22 HD12 ' A' ' 121' ' ' ILE . 4.2 tt -64.86 -28.05 69.29 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.795 -171.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 45' ' ' ARG . 52.9 mtt-85 -85.11 -43.65 13.68 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -176.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.6 p -102.05 -9.68 20.37 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -172.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.22 18.94 75.39 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.41 -178.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 42' ' ' ARG . . . -77.01 131.31 38.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.745 0.307 . . . . 0.0 111.553 -177.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.3 mm -89.89 102.14 12.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.062 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.457 ' HG2' ' N ' ' A' ' 51' ' ' GLU . 36.0 tt0 -116.13 169.2 9.45 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.457 ' N ' ' HG2' ' A' ' 50' ' ' GLN . 6.6 pt-20 -136.59 130.05 31.74 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.346 0.593 . . . . 0.0 110.541 172.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -123.22 146.49 47.78 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.306 -176.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 55.3 m -107.55 111.03 23.1 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.979 0.418 . . . . 0.0 110.862 177.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -85.37 142.43 29.3 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.802 177.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 55' ' ' ARG . 36.7 mtp-105 -113.38 135.15 54.17 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.083 -173.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.11 129.34 40.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.478 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.73 -18.37 29.48 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.353 -175.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -99.81 134.81 42.17 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -87.34 133.83 33.65 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.354 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.2 t -94.13 134.99 29.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.331 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -101.47 112.93 65.79 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.885 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.0 163.64 34.93 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.58 2.186 . . . . 0.0 112.606 -177.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -121.89 109.57 14.81 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.701 177.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 64.2 mtt -84.65 109.35 17.93 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.039 0.447 . . . . 0.0 110.903 -177.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.484 HD12 ' CD1' ' A' ' 121' ' ' ILE . 34.6 mm -90.38 120.94 40.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.928 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -94.9 109.27 21.29 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -89.09 131.04 35.43 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.903 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 52.2 mtt180 -130.44 170.39 14.26 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 69' ' ' ARG . 13.7 ptm180 -130.18 125.37 34.81 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.02 0.438 . . . . 0.0 110.07 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.515 ' CB ' ' HB3' ' A' ' 82' ' ' PHE . 2.0 mpt? -117.49 143.22 46.27 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.347 -176.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -84.78 139.46 31.93 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.74 173.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.539 ' CD1' ' HA ' ' A' ' 107' ' ' GLU . 32.7 t80 -71.63 110.15 6.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.861 -176.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.8 mp -100.69 -174.66 2.69 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 169.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -143.02 147.82 35.74 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.437 0.637 . . . . 0.0 111.759 -169.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.5 -165.95 2.38 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.805 176.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -72.51 146.17 46.99 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 174.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.66 68.45 3.0 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 118.683 -1.722 . . . . 0.0 112.857 -171.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -128.13 -33.05 2.21 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 161.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.425 ' OD1' ' HB3' ' A' ' 92' ' ' GLU . 28.3 t30 -143.26 136.82 28.41 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 113.359 -1.746 . . . . 0.0 109.267 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.462 ' ND1' HD22 ' A' ' 98' ' ' LEU . 55.7 m170 -117.58 148.41 41.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.771 0.32 . . . . 0.0 110.539 178.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 45.7 t -100.17 132.23 46.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.079 -176.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.515 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 71.6 m-85 -130.19 124.72 33.25 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 176.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 90.6 mmm -99.7 117.73 34.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.724 0.297 . . . . 0.0 111.52 -175.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.542 ' HB3' ' H ' ' A' ' 89' ' ' GLU . 11.5 t70 -67.63 127.67 33.61 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.496 -178.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -79.64 -16.59 55.5 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.202 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.522 ' HB3' ' OD2' ' A' ' 84' ' ' ASP . 11.6 tp10 -66.92 -52.69 40.06 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 56.0 p -171.43 91.71 0.14 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 167.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 47.41 28.05 1.04 Allowed 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 162.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.542 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 28.0 mm-40 -83.42 101.31 11.28 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 118.392 0.542 . . . . 0.0 110.083 176.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -73.65 96.47 2.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.856 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.9 m -95.6 129.32 42.83 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.476 -175.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.425 ' HB3' ' OD1' ' A' ' 79' ' ' ASN . 35.5 mt-10 -106.68 137.67 44.27 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.931 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.471 HD12 ' CE1' ' A' ' 82' ' ' PHE . 64.7 mt -119.72 133.57 55.57 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.027 0.441 . . . . 0.0 111.189 -178.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.614 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 49.8 m -90.81 179.72 5.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.023 -176.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.0 p -47.73 -41.14 22.32 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -174.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -55.23 -38.14 68.09 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.038 0.446 . . . . 0.0 111.621 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.421 ' HB2' ' HB3' ' A' ' 93' ' ' LEU . 66.0 m-85 -85.68 -34.96 21.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.041 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.614 ' HG ' ' O ' ' A' ' 94' ' ' SER . 20.8 mt -63.63 -22.51 66.94 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.288 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -59.77 -42.77 94.03 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.477 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -66.74 -38.38 86.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.621 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.594 ' O ' HD12 ' A' ' 105' ' ' LEU . 53.5 mt-10 -63.1 -36.4 83.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.097 175.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 82.3 mt -62.42 -21.23 65.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.917 0.389 . . . . 0.0 110.34 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -80.96 -50.99 9.03 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 171.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -142.79 118.53 10.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.546 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.594 HD12 ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -154.17 144.74 22.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.996 0.427 . . . . 0.0 110.312 172.415 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -144.42 139.86 28.64 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 175.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.539 ' HA ' ' CD1' ' A' ' 72' ' ' TYR . 29.0 tt0 -74.44 129.72 38.29 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.091 -177.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.54 1.24 71.64 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.49 -177.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 50.0 ttm -67.74 144.05 55.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.06 0.457 . . . . 0.0 111.501 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -92.59 104.28 16.59 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.822 174.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 26.3 m -105.49 158.76 5.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.704 0.288 . . . . 0.0 110.75 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -111.72 103.39 11.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.834 0.35 . . . . 0.0 110.098 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 60.4 mt -96.52 127.35 48.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.958 0.409 . . . . 0.0 110.394 -177.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.494 ' O ' HG12 ' A' ' 121' ' ' ILE . 76.5 mt-30 -91.04 120.02 31.68 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.928 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 62.4 p -116.32 145.72 42.97 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.319 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -124.98 98.89 5.88 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 60.38 41.8 15.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.691 -173.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 88.93 -18.69 42.55 Favored Glycine 0 CA--C 1.516 0.151 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.874 178.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -82.43 123.68 29.36 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.658 0.266 . . . . 0.0 110.767 -177.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 42.5 p -69.57 107.88 3.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.883 0.373 . . . . 0.0 110.455 178.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.494 HG12 ' O ' ' A' ' 114' ' ' GLN . 21.6 pt -93.94 -28.35 4.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.022 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -164.19 155.05 26.23 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.325 178.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.6 t -120.68 123.27 69.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -106.14 123.27 47.76 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 120.956 0.408 . . . . 0.0 110.351 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.469 ' HB2' HG21 ' A' ' 176' ' ' THR . 75.2 mt -97.08 148.54 34.54 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.725 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.23 135.46 64.92 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.034 2.489 . . . . 0.0 112.123 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 62.5 mttm -67.5 -16.03 63.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.894 -173.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 18.6 p -127.06 109.83 12.3 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.945 0.402 . . . . 0.0 110.671 175.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 12.3 p -120.69 141.79 39.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.513 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -104.02 104.47 14.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.35 0.595 . . . . 0.0 110.784 -178.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 78.0 mt -119.41 129.65 54.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.479 -177.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 3.1 m -75.04 134.09 41.47 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.49 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.468 ' HB ' HD11 ' A' ' 172' ' ' LEU . 3.7 p -79.35 109.1 13.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.683 0.754 . . . . 0.0 109.944 174.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.444 ' O ' ' HB3' ' A' ' 135' ' ' GLU . 36.3 p -114.5 115.36 27.12 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.552 -177.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.444 ' HB3' ' O ' ' A' ' 134' ' ' THR . 15.9 tp10 77.52 101.65 0.07 Allowed 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.928 0.871 . . . . 0.0 110.841 -177.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 14.6 t -150.75 153.74 36.08 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.616 -1.175 . . . . 0.0 108.343 175.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -82.39 147.01 55.41 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-O 120.889 0.376 . . . . 0.0 110.903 -174.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.11 -179.76 2.83 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 123.101 2.534 . . . . 0.0 112.162 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 119.35 32.53 1.23 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.005 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.9 tt . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 121.467 0.651 . . . . 0.0 110.636 176.914 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 24.1 p . . . . . 0 N--CA 1.448 -0.548 0 CA-C-O 121.112 0.482 . . . . 0.0 111.462 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -129.78 150.1 51.23 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.926 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 18.5 m -73.8 99.83 3.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.092 0.472 . . . . 0.0 111.447 -175.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -104.94 164.94 11.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.782 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 25.9 m -125.75 130.32 51.25 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.004 175.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 14.6 m -86.99 175.01 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.599 -0.441 . . . . 0.0 110.811 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -57.03 -30.0 63.86 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.469 HG22 HD13 ' A' ' 105' ' ' LEU . 64.9 p -72.72 -20.18 61.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.766 0.317 . . . . 0.0 111.477 -177.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 102.78 -1.11 48.59 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.617 -175.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -74.49 129.98 38.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.88 0.372 . . . . 0.0 110.856 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.8 p -91.82 131.94 36.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.709 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -148.71 153.59 38.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.913 0.387 . . . . 0.0 110.321 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -87.83 101.18 13.46 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.205 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 31.7 m -95.86 144.93 28.67 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.635 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.86 150.02 24.14 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 122.478 2.119 . . . . 0.0 111.433 175.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 65.0 mt -61.71 -22.01 64.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.714 -169.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -79.21 -17.15 55.39 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 63.4 t -65.5 131.21 31.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.63 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -119.53 159.02 25.13 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.414 -176.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -57.15 123.58 15.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.666 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 109.95 -12.62 31.95 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.774 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.584 ' OD1' ' HD3' ' A' ' 184' ' ' ARG . 26.2 t70 -68.03 141.02 56.33 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.741 0.305 . . . . 0.0 110.64 178.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 3.7 p -86.1 108.21 17.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.716 0.77 . . . . 0.0 110.425 177.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.468 HD11 ' HB ' ' A' ' 133' ' ' VAL . 85.3 mt -91.59 119.12 31.21 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.256 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.596 ' O ' ' HB ' ' A' ' 182' ' ' ILE . 56.0 mt -90.57 104.47 15.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 173.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 37.1 mt -95.75 130.92 43.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 C-N-CA 120.414 -0.514 . . . . 0.0 109.854 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.563 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 23.3 t-20 -80.07 89.55 5.39 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.976 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.469 HG21 ' HB2' ' A' ' 125' ' ' LEU . 4.7 m -61.43 129.55 41.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.658 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 115.55 -41.98 2.02 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -177.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -106.94 -33.66 7.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.199 0.523 . . . . 0.0 110.086 176.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 95.01 10.78 57.18 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.487 177.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.81 131.18 47.96 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -178.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -100.0 112.41 24.69 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.227 0.537 . . . . 0.0 110.839 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.596 ' HB ' ' O ' ' A' ' 173' ' ' ILE . 4.0 mp -107.63 134.93 47.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 43.0 t -113.43 165.63 12.28 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.477 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ARG . . . . . 0.584 ' HD3' ' OD1' ' A' ' 170' ' ' ASP . 30.1 mmt180 69.82 25.7 4.97 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 123.69 0.618 . . . . 0.0 112.095 174.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.626 -1.097 . . . . 0.0 113.009 177.987 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mmt . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 120.947 0.403 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.437 ' HB ' ' HB ' ' A' ' 60' ' ' VAL . 44.4 mm -109.29 145.06 16.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.673 178.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.6 t -94.23 156.28 16.62 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 176.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.9 m -71.69 1.36 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.269 0.557 . . . . 0.0 110.827 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -107.22 11.29 29.47 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.447 176.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -126.92 88.5 2.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.026 0.441 . . . . 0.0 111.041 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -139.86 152.34 46.39 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.372 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.501 ' HG2' ' HG ' ' A' ' 11' ' ' LEU . 19.3 ptpt -143.6 178.19 7.96 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.6 p -56.11 -12.97 1.71 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -160.19 115.56 0.67 Allowed Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.04 172.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.501 ' HG ' ' HG2' ' A' ' 8' ' ' LYS . 8.9 mt -148.66 138.91 22.44 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 122.541 0.336 . . . . 0.0 110.293 174.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 2.9 m -95.28 115.49 27.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.189 0.519 . . . . 0.0 110.743 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.438 HG23 ' O ' ' A' ' 61' ' ' GLU . 1.9 mp -120.95 140.7 44.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.209 -176.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.7 t -98.91 118.0 34.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.953 0.406 . . . . 0.0 110.336 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.7 p -153.09 144.89 15.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 62.45 28.54 16.85 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 122.627 0.371 . . . . 0.0 110.661 -176.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.6 m120 62.52 25.22 15.02 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.396 -177.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.99 159.2 39.44 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 176.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 10.5 pt -106.46 122.96 60.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.233 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.527 ' O ' ' HA ' ' A' ' 12' ' ' THR . 33.3 m95 -119.63 165.52 14.36 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.772 -172.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -128.03 104.88 8.03 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.713 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.507 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 77.3 t -62.8 106.15 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.554 178.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.0 mm -85.0 -33.43 8.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.713 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -152.52 147.08 25.79 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.328 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -136.03 141.87 44.37 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.636 -177.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -124.52 106.35 10.09 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.078 177.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 16.1 t60 -74.07 89.61 1.97 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 176.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.5 p -92.83 128.15 44.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.894 -172.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.3 pttt -126.11 102.57 27.44 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.765 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -57.26 -47.2 23.47 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.357 2.704 . . . . 0.0 112.469 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.72 4.02 17.6 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.763 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -84.8 -12.42 53.66 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.075 0.464 . . . . 0.0 110.183 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.35 -42.25 1.29 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.659 176.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.0 m -99.84 134.34 42.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.868 0.366 . . . . 0.0 110.952 -177.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.55 153.97 18.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.173 0.511 . . . . 0.0 110.887 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -133.76 168.77 18.11 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.264 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 48.2 t -130.32 103.86 8.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 120.992 0.425 . . . . 0.0 110.083 176.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -82.37 98.82 9.04 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.7 p -110.03 139.0 45.63 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.817 -173.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -95.53 114.97 26.78 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 174.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.544 HD23 ' H ' ' A' ' 41' ' ' LEU . 0.9 OUTLIER -136.91 141.88 42.72 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.727 0.775 . . . . 0.0 111.316 -171.335 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -98.73 130.04 45.19 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.621 -176.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -64.24 114.14 4.04 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 171.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.424 HD21 ' OE1' ' A' ' 114' ' ' GLN . 7.8 tt -70.24 -22.16 62.93 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.726 -170.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -83.01 -46.45 12.84 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.4 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.7 p -97.24 -14.27 21.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.196 0.522 . . . . 0.0 111.908 -174.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.9 24.79 71.0 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.952 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.35 133.46 33.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.861 0.363 . . . . 0.0 111.784 -175.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.6 mm -93.36 109.85 22.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.107 178.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -136.78 177.41 7.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.841 0.353 . . . . 0.0 110.44 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -137.98 146.81 43.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.111 0.481 . . . . 0.0 110.517 173.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -135.07 171.41 14.47 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.309 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.8 t -127.77 118.31 23.52 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.416 0.626 . . . . 0.0 110.828 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -85.23 151.79 23.81 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.497 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -123.78 130.38 52.53 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.326 0.584 . . . . 0.0 111.795 -173.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.94 138.48 58.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.112 176.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.92 -19.21 28.17 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 111.341 -0.703 . . . . 0.0 111.341 -174.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -126.25 150.77 48.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.024 0.44 . . . . 0.0 110.415 176.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 20.1 pttm -89.33 152.13 21.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.29 -175.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.437 ' HB ' ' HB ' ' A' ' 2' ' ' ILE . 64.4 t -102.53 136.44 34.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.348 -178.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.438 ' O ' HG23 ' A' ' 13' ' ' ILE . 7.1 tp10 -88.52 121.2 70.29 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.738 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.27 151.64 20.53 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.244 1.963 . . . . 0.0 112.048 175.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.452 ' HB3' HG22 ' A' ' 12' ' ' THR . . . -113.68 116.8 30.01 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.402 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 61.8 mtt -96.73 110.25 22.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.472 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 54.8 mt -109.85 138.93 35.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.839 0.352 . . . . 0.0 111.07 -176.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -112.85 139.51 48.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.441 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -117.09 127.01 53.73 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 177.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.51 ' HG2' ' OE2' ' A' ' 86' ' ' GLU . 40.6 mtm180 -135.82 165.39 25.72 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.402 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 16.5 ptp180 -127.84 125.65 40.15 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.18 0.514 . . . . 0.0 111.262 -176.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.546 ' HG3' ' HA ' ' A' ' 84' ' ' ASP . 1.9 mpt? -119.92 141.02 49.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.557 -176.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -79.31 140.47 37.54 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.102 177.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -74.58 111.59 9.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.745 -174.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -104.86 -179.64 4.0 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 167.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -145.5 142.14 28.95 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.487 -171.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.72 -170.74 3.53 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.664 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -60.67 131.19 49.94 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.68 68.84 2.44 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 119.153 -1.499 . . . . 0.0 114.322 -165.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -126.76 -30.42 2.77 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 154.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.458 ' OD1' ' HB3' ' A' ' 92' ' ' GLU . 55.7 t30 -133.53 132.38 40.87 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 113.59 -1.641 . . . . 0.0 109.477 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.627 ' CD2' ' HG ' ' A' ' 98' ' ' LEU . 14.5 m-70 -124.23 143.65 50.41 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 55.7 t -92.56 134.17 31.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.026 -175.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.519 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 74.4 m-85 -128.9 126.12 39.04 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 174.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.0 mmt -99.15 117.92 34.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.777 0.323 . . . . 0.0 111.332 -175.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.597 ' HB3' ' H ' ' A' ' 89' ' ' GLU . 23.0 t70 -60.23 115.39 3.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.088 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -72.56 -18.75 61.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.315 -176.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.51 ' OE2' ' HG2' ' A' ' 68' ' ' ARG . 46.3 mt-10 -71.76 -45.78 60.56 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 120.669 -0.412 . . . . 0.0 109.949 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.4 p -169.42 91.3 0.23 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 168.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 47.51 28.19 1.12 Allowed 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 156.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.597 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 37.2 tt0 -93.79 118.14 31.03 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 118.711 0.687 . . . . 0.0 110.809 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -77.61 112.63 14.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.264 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 43.0 m -110.21 119.28 38.77 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.37 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.458 ' HB3' ' OD1' ' A' ' 79' ' ' ASN . 36.3 mt-10 -99.19 127.77 45.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.314 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 39.9 mt -118.89 148.9 42.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.018 0.437 . . . . 0.0 111.004 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.2 m -89.99 166.57 13.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.089 -174.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.8 t -55.52 -31.54 62.15 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.462 -177.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -50.35 -49.24 54.65 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.605 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -77.98 -40.67 38.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.362 0.601 . . . . 0.0 109.74 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.627 ' HG ' ' CD2' ' A' ' 80' ' ' HIS . 4.3 mm? -66.09 -13.82 60.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.88 -174.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -57.77 -39.03 76.48 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.915 0.388 . . . . 0.0 110.106 172.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.58 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 8.4 tp10 -78.09 -43.43 29.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.746 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.468 ' O ' HD12 ' A' ' 105' ' ' LEU . 1.2 mp0 -57.47 -46.21 83.93 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.654 175.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 82.4 mt -67.92 -9.07 42.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.98 0.419 . . . . 0.0 111.116 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.58 ' HB3' ' O ' ' A' ' 100' ' ' GLU . 23.1 t30 -78.73 -50.2 11.78 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 173.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -141.1 116.7 10.24 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.293 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.468 HD12 ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -171.64 167.46 6.53 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.251 0.548 . . . . 0.0 111.818 178.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.401 ' N ' HD22 ' A' ' 105' ' ' LEU . 66.1 mttm -141.67 143.67 33.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.842 168.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.5 mp0 -65.09 123.29 19.11 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 175.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.34 -13.43 47.89 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.039 -175.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.414 ' SD ' ' HG2' ' A' ' 126' ' ' PRO . 44.2 ttm -76.67 136.67 39.13 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 70' ' ' MET . 11.7 pt-20 -98.89 126.54 44.59 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.229 0.538 . . . . 0.0 111.142 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 31.4 m -106.71 160.05 6.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.905 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -100.14 100.86 11.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.065 0.46 . . . . 0.0 110.263 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.422 HD12 ' SD ' ' A' ' 70' ' ' MET . 65.1 mt -83.17 129.01 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.581 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.496 ' HG2' HD11 ' A' ' 121' ' ' ILE . 35.3 tt0 -106.8 117.36 33.84 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.925 -176.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 16.5 p -116.19 153.18 32.31 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.088 -174.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -130.03 99.39 5.06 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.935 176.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 61.97 31.79 17.96 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.374 0.607 . . . . 0.0 110.312 -174.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 93.78 -16.69 60.25 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.399 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -80.86 114.86 20.04 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 29.6 m -63.57 112.37 2.77 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.782 0.325 . . . . 0.0 110.604 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.496 HD11 ' HG2' ' A' ' 114' ' ' GLN . 38.7 pt -97.65 -23.97 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.04 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -170.47 163.46 36.68 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.016 -1.087 . . . . 0.0 112.848 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.3 t -127.63 126.63 67.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -106.59 120.6 42.38 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.76 -176.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.441 HD22 ' N ' ' A' ' 125' ' ' LEU . 1.9 mm? -86.18 150.21 51.67 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.414 ' HG2' ' SD ' ' A' ' 109' ' ' MET . 71.9 Cg_exo -51.42 130.89 34.59 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.697 2.265 . . . . 0.0 111.602 174.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.58 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 34.8 mmtp -62.37 -27.25 68.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.329 -170.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 34.9 p -121.32 112.73 18.95 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.97 176.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.1 p -114.8 137.03 49.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.164 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -109.32 99.03 8.34 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.226 0.536 . . . . 0.0 110.703 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.2 mt -106.9 142.05 37.14 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.056 0.455 . . . . 0.0 111.272 -173.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.4 m -84.14 133.7 34.61 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.037 176.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.6 p -87.34 112.37 23.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.629 0.728 . . . . 0.0 111.029 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 27.5 p -111.15 119.66 39.71 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.316 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 75.11 108.27 0.07 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.873 0.844 . . . . 0.0 111.041 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 8.9 t -150.55 153.44 35.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.673 178.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.452 ' O ' ' HD2' ' A' ' 150' ' ' LYS . 52.5 mt-10 -84.2 150.43 57.86 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.245 -176.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.29 179.9 6.07 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.51 2.14 . . . . 0.0 111.863 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 119.81 27.92 2.0 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.431 -177.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.9 tt . . . . . 0 C--N 1.33 -0.266 0 CA-C-O 121.277 0.56 . . . . 0.0 110.447 176.614 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 23.0 p . . . . . 0 N--CA 1.453 -0.279 0 CA-C-O 120.892 0.377 . . . . 0.0 110.507 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.452 ' HD2' ' O ' ' A' ' 137' ' ' GLU . 59.6 pttt -133.41 145.86 50.68 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.524 177.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 9.1 t -73.18 118.66 16.4 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.109 0.481 . . . . 0.0 110.338 -176.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -124.02 164.22 19.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.013 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 33.4 m -120.54 135.98 54.92 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 9.7 m -98.73 173.94 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.284 177.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -52.81 -31.23 37.69 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 68.5 p -74.42 -12.6 60.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.712 0.291 . . . . 0.0 111.721 -176.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 95.48 -4.72 66.93 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.015 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -75.53 144.91 41.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.992 0.425 . . . . 0.0 110.603 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 23.3 m -107.24 122.44 46.55 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.178 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.07 161.62 37.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.696 0.284 . . . . 0.0 110.302 -177.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -92.1 111.49 23.06 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.083 -175.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 27.4 m -101.14 155.81 35.89 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.228 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -58.2 152.09 55.12 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.357 2.038 . . . . 0.0 111.4 174.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 72.6 mt -64.08 -18.33 64.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.468 -169.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -91.28 -1.94 57.54 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -176.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 85.8 t -73.11 135.6 27.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.957 0.408 . . . . 0.0 110.694 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -113.98 151.51 32.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.193 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -63.33 125.7 25.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.115 0.483 . . . . 0.0 110.683 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 109.54 -10.5 32.93 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.19 -176.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.592 ' OD2' ' HD3' ' A' ' 184' ' ' ARG . 19.1 t70 -73.39 148.19 43.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.597 0.237 . . . . 0.0 110.676 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.477 ' O ' ' HD2' ' A' ' 184' ' ' ARG . 60.7 t -105.33 99.97 9.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.197 0.522 . . . . 0.0 110.51 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.558 ' H ' HD23 ' A' ' 172' ' ' LEU . 0.7 OUTLIER -96.01 141.17 29.73 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.603 -177.718 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.421 ' O ' ' HB ' ' A' ' 182' ' ' ILE . 59.2 mt -99.22 130.54 48.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.344 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 43.9 mm -117.87 141.43 36.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.58 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 23.6 t-20 -87.85 98.81 11.68 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 177.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.21 127.06 31.23 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.518 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 111.02 -37.25 3.81 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.652 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -104.78 -23.84 12.99 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.099 0.476 . . . . 0.0 110.359 176.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 73.88 17.53 79.36 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.201 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 9.6 p -84.42 152.37 24.06 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.873 0.368 . . . . 0.0 110.633 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -97.33 124.79 41.58 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.19 0.519 . . . . 0.0 110.671 -175.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' A' ' 173' ' ' ILE . 2.8 mp -106.74 151.02 8.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 174.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.2 p -77.15 173.56 11.71 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.377 -173.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ARG . . . . . 0.592 ' HD3' ' OD2' ' A' ' 170' ' ' ASP . 7.9 tpt180 -39.59 136.18 1.03 Allowed 'General case' 0 CA--C 1.533 0.319 0 O-C-N 123.754 0.659 . . . . 0.0 112.473 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.488 -1.174 . . . . 0.0 111.698 175.263 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.7 mtt . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 120.477 0.18 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.2 mm -104.29 122.87 57.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.7 0.286 . . . . 0.0 110.425 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.1 m -74.04 146.62 43.57 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 175.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.49 ' O ' HG21 ' A' ' 37' ' ' VAL . 20.7 m -70.11 -10.56 13.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.848 0.356 . . . . 0.0 111.744 -176.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -95.39 7.78 45.18 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.34 0.59 . . . . 0.0 109.542 177.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -120.79 87.79 2.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.687 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -136.9 152.84 50.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.217 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -128.19 167.44 16.83 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.809 -176.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.2 m -54.17 -30.24 48.64 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.344 0.592 . . . . 0.0 110.34 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.524 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -140.36 116.74 1.2 Allowed Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 169.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 54.9 tp -150.46 135.35 17.58 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 1.9 p -94.44 122.43 37.0 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.444 0.64 . . . . 0.0 112.192 -176.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.401 HD12 ' C ' ' A' ' 12' ' ' THR . 1.7 mp -119.39 141.92 37.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.53 -176.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.514 ' O ' ' HB3' ' A' ' 61' ' ' GLU . 43.1 t -107.32 107.73 18.79 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.433 HG12 ' CD1' ' A' ' 20' ' ' TRP . 13.1 p -142.2 140.6 29.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -178.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 61.3 32.77 19.2 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.6 -176.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 64.86 23.01 12.6 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.609 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.39 158.55 37.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.796 0.332 . . . . 0.0 110.514 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.6 pt -107.47 123.73 62.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.665 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.442 ' O ' ' HA ' ' A' ' 12' ' ' THR . 54.1 m95 -122.8 160.03 26.85 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.625 -172.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -130.58 115.04 16.21 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.524 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 94.9 t -64.76 119.14 8.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.705 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.4 mm -90.91 -35.96 7.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.718 176.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -160.82 122.09 2.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.067 177.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -104.45 143.28 33.22 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.735 0.302 . . . . 0.0 110.944 -176.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -118.85 99.43 6.75 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.881 0.372 . . . . 0.0 110.337 177.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -78.07 91.88 4.32 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 176.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 p -101.6 135.8 36.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.517 -171.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -109.1 101.76 46.18 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-O 121.309 0.576 . . . . 0.0 110.58 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -58.02 -48.2 17.24 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 123.345 2.696 . . . . 0.0 112.797 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.2 19.43 8.04 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.887 178.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -110.1 -14.31 14.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.681 0.277 . . . . 0.0 111.46 -177.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.05 -42.86 1.24 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.262 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.1 m -102.1 131.22 48.7 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 177.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.13 155.63 19.68 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 174.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 55' ' ' ARG . 34.9 m-85 -129.66 163.38 26.21 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.094 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.49 HG21 ' O ' ' A' ' 4' ' ' VAL . 52.8 t -132.7 102.7 5.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.179 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -80.73 98.96 7.98 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 175.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 53.2 p -100.64 134.2 43.96 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.134 -175.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -95.43 102.68 14.5 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 174.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.519 HD23 ' H ' ' A' ' 41' ' ' LEU . 1.3 pt? -138.48 150.96 46.96 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.804 0.335 . . . . 0.0 110.853 -171.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -116.96 144.92 44.01 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.543 -175.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.44 ' HB2' ' CZ3' ' A' ' 20' ' ' TRP . 47.4 t-20 -76.58 115.57 16.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.451 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.8 mt -69.77 -24.75 63.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.194 0.521 . . . . 0.0 110.733 -177.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.6 tpp180 -70.13 -38.8 75.64 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.011 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.3 p -113.48 -15.89 12.51 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -174.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.87 20.82 69.78 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.274 -0.489 . . . . 0.0 112.004 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -96.45 141.65 29.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.856 0.36 . . . . 0.0 111.799 -173.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.2 tp -87.92 137.18 21.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.251 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.481 ' HG3' ' N ' ' A' ' 51' ' ' GLU . 8.7 tp-100 -148.46 175.25 11.29 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -178.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.481 ' N ' ' HG3' ' A' ' 50' ' ' GLN . 10.7 pt-20 -140.17 138.16 34.96 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 170.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -126.51 135.11 50.9 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.686 -175.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.2 p -102.23 102.66 13.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.929 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -85.17 149.32 25.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.026 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.426 ' HB3' ' CE2' ' A' ' 36' ' ' PHE . 5.7 ptm180 -120.18 134.96 55.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.974 0.416 . . . . 0.0 111.385 -175.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.05 132.71 54.68 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.915 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 108.03 -29.88 9.68 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -174.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -102.82 99.67 9.63 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -76.6 137.71 39.68 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.415 0.626 . . . . 0.0 110.831 -175.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.3 t -85.36 150.65 3.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.977 -169.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.514 ' HB3' ' O ' ' A' ' 14' ' ' SER . 34.7 tt0 -85.63 130.98 48.94 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.682 176.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -82.73 156.29 15.83 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.505 2.137 . . . . 0.0 112.895 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.441 ' HB2' ' HB2' ' A' ' 14' ' ' SER . . . -123.61 120.5 32.99 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.431 174.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 67.8 mtt -96.38 108.89 21.48 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.174 0.511 . . . . 0.0 110.799 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -110.2 121.6 63.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.485 177.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.583 ' OE1' ' HD2' ' A' ' 68' ' ' ARG . 40.6 tt0 -95.64 107.76 19.98 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.904 -176.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -84.39 100.77 11.5 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.357 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.583 ' HD2' ' OE1' ' A' ' 66' ' ' GLU . 16.2 mtp180 -106.08 170.24 8.03 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.142 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.585 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 7.7 ptm180 -142.71 120.06 11.6 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.459 0.647 . . . . 0.0 111.141 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.623 ' CB ' ' HB3' ' A' ' 82' ' ' PHE . 1.5 mpt? -115.59 139.94 49.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.926 -174.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -71.75 133.7 45.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.541 174.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -77.31 111.17 12.68 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -174.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -111.21 -179.04 3.61 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 169.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -148.7 159.59 43.98 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.312 0.577 . . . . 0.0 111.82 -175.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.23 -149.55 0.31 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.436 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -66.65 136.69 55.94 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 170.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.01 69.09 2.98 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 118.782 -1.675 . . . . 0.0 113.59 -170.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -127.11 -33.2 2.44 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 158.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -128.73 120.07 25.76 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 113.85 -1.523 . . . . 0.0 108.913 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.579 ' CG ' ' HG ' ' A' ' 98' ' ' LEU . 17.0 m-70 -102.39 132.28 48.49 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 57.1 t -83.58 125.64 40.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.081 -173.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.623 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 61.0 m-85 -123.03 120.54 33.63 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 176.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.575 ' SD ' ' HG2' ' A' ' 90' ' ' GLN . 93.5 mmm -95.19 113.3 24.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.917 -176.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.584 ' HB3' ' H ' ' A' ' 89' ' ' GLU . 20.9 t70 -58.46 117.39 4.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.239 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -76.49 -12.56 60.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.48 -177.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -68.91 -50.27 50.92 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 176.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.1 p -170.99 91.65 0.15 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.103 0.478 . . . . 0.0 112.288 164.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 48.31 26.62 1.14 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 160.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.584 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 45.7 mt-10 -87.59 113.16 23.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 118.666 0.666 . . . . 0.0 110.867 176.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.575 ' HG2' ' SD ' ' A' ' 83' ' ' MET . 73.5 mt-30 -74.47 118.14 17.09 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.343 -178.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.9 m -120.14 121.76 39.51 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.23 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -95.91 127.97 42.39 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.947 0.403 . . . . 0.0 110.483 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.434 HD12 ' CE1' ' A' ' 82' ' ' PHE . 59.6 mt -112.69 140.02 47.81 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.433 178.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.5 t -80.29 158.57 26.11 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.772 -177.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.2 p -58.98 -23.9 62.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.842 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.51 -39.45 87.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.808 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -82.75 -41.07 19.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.597 0.713 . . . . 0.0 109.35 177.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.579 ' HG ' ' CG ' ' A' ' 80' ' ' HIS . 3.3 mm? -67.24 -20.05 65.61 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.445 -171.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -60.94 -31.0 70.55 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.212 0.53 . . . . 0.0 110.096 175.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -82.61 -46.23 13.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.25 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.467 ' HA ' HD21 ' A' ' 125' ' ' LEU . 0.9 OUTLIER -62.13 -36.61 82.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.467 179.084 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.486 ' O ' ' HB ' ' A' ' 156' ' ' THR . 56.2 mt -67.21 -6.36 17.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.629 0.252 . . . . 0.0 111.608 -178.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -70.53 -41.47 72.5 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 172.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.504 ' HB3' HG11 ' A' ' 129' ' ' VAL . 68.8 m-85 -142.4 115.2 8.66 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.208 177.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 101' ' ' GLU . 0.7 OUTLIER 179.8 171.41 1.07 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 122.95 0.5 . . . . 0.0 110.739 173.004 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.542 ' HD2' ' O ' ' A' ' 130' ' ' GLU . 30.4 mtpp -142.48 144.73 33.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.306 176.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -62.73 113.79 3.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.862 0.363 . . . . 0.0 110.739 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 109.85 -10.28 32.14 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.402 -177.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.536 ' SD ' ' HG3' ' A' ' 126' ' ' PRO . 53.0 ttm -91.11 144.31 25.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.68 0.276 . . . . 0.0 110.465 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.62 ' HA ' ' O ' ' A' ' 70' ' ' MET . 8.4 pt-20 -94.2 138.91 31.68 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.365 0.602 . . . . 0.0 112.075 -177.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 33.9 m -113.57 158.13 14.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.58 175.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.566 ' HA ' ' O ' ' A' ' 68' ' ' ARG . 27.9 mt-30 -96.83 99.94 11.49 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.048 0.452 . . . . 0.0 110.652 -177.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.497 HD12 ' SD ' ' A' ' 70' ' ' MET . 63.7 mt -84.44 127.98 39.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.223 -178.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.405 ' O ' HG12 ' A' ' 121' ' ' ILE . 91.5 mt-30 -100.13 110.34 22.62 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.485 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 43.1 p -107.12 128.7 54.62 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.322 177.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -108.1 110.2 21.82 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 174.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 60.44 29.05 18.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.445 -176.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 98.31 -18.96 56.27 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.984 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 115' ' ' THR . 42.5 tt0 -84.64 126.88 33.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.638 0.219 . . . . 0.0 111.364 -176.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 85.5 m -68.21 100.82 1.08 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 175.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 114' ' ' GLN . 46.7 pt -84.79 -30.77 6.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.064 0.459 . . . . 0.0 110.328 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -170.86 162.38 35.32 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.692 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.4 t -123.81 127.31 73.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 177.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.456 ' HB3' ' HB2' ' A' ' 112' ' ' GLN . 31.0 tt0 -93.74 123.67 37.24 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.007 0.432 . . . . 0.0 109.961 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.477 HD23 ' HB2' ' A' ' 104' ' ' TYR . 7.0 mp -78.25 157.62 77.89 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.311 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.536 ' HG3' ' SD ' ' A' ' 109' ' ' MET . 6.9 Cg_endo -48.45 127.81 16.58 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.02 2.48 . . . . 0.0 112.249 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -56.8 -38.29 72.33 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.348 -178.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 29.7 p -133.18 109.27 9.33 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.832 174.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.504 HG11 ' HB3' ' A' ' 104' ' ' TYR . 10.4 p -111.41 140.86 28.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.731 0.3 . . . . 0.0 110.623 -176.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.542 ' O ' ' HD2' ' A' ' 106' ' ' LYS . 7.4 pt-20 -107.06 100.36 9.85 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.402 0.62 . . . . 0.0 110.481 177.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 89.7 mt -106.2 133.47 50.86 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.343 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.4 m -76.12 130.85 38.92 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.098 178.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.431 ' HB ' HD11 ' A' ' 172' ' ' LEU . 7.5 p -78.88 105.61 8.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.913 0.863 . . . . 0.0 110.652 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 37.0 p -107.53 112.37 25.09 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.427 -178.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 79.06 96.67 0.06 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-O 122.068 0.937 . . . . 0.0 111.036 -177.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.608 ' O ' ' HD3' ' A' ' 138' ' ' PRO . 9.7 t -150.65 153.36 35.49 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.086 -1.415 . . . . 0.0 107.663 174.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -84.29 103.27 2.83 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.608 ' HD3' ' O ' ' A' ' 136' ' ' THR . 68.8 Cg_endo -90.11 172.81 3.56 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.835 2.357 . . . . 0.0 112.356 -175.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.49 21.24 77.54 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.772 176.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 56.5 mt . . . . . 0 C--N 1.325 -0.492 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.552 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 18.0 p . . . . . 0 N--CA 1.448 -0.564 0 CA-C-O 121.195 0.521 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -125.25 148.18 48.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.953 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 42.5 m -73.72 107.17 5.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.089 0.471 . . . . 0.0 110.76 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -107.9 163.5 13.07 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.852 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 21.1 m -118.79 134.52 55.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.047 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.5 m -98.54 175.79 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.506 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -57.31 -28.2 62.86 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.486 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 44.1 p -73.94 -11.01 60.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.017 0.436 . . . . 0.0 111.652 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.59 1.85 73.71 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -176.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -81.53 143.27 32.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.915 0.388 . . . . 0.0 110.856 -177.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 23.1 m -100.96 126.91 47.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.399 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.92 155.49 41.64 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -85.79 123.69 31.45 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.36 0.6 . . . . 0.0 111.3 -175.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.401 ' HB ' HG21 ' A' ' 166' ' ' VAL . 27.3 m -116.61 155.06 49.23 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.368 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -56.85 150.51 54.14 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.444 2.096 . . . . 0.0 111.65 175.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 80.7 mt -62.95 -17.3 61.78 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -169.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -88.6 -8.32 54.89 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -176.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.401 HG21 ' HB ' ' A' ' 162' ' ' VAL . 74.5 t -69.24 136.6 25.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.81 0.338 . . . . 0.0 111.249 -177.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -122.68 160.89 24.89 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.479 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -59.4 128.04 35.09 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.887 -177.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 109.42 -15.61 32.42 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.536 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.563 ' OD2' ' HD3' ' A' ' 184' ' ' ARG . 23.7 t70 -67.26 145.35 55.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.8 0.3 . . . . 0.0 110.591 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.427 ' CG1' ' HB2' ' A' ' 130' ' ' GLU . 47.2 t -94.7 109.91 22.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.157 0.503 . . . . 0.0 110.379 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.431 HD11 ' HB ' ' A' ' 133' ' ' VAL . 46.7 mt -90.97 117.33 29.48 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.454 -178.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.404 HD12 ' N ' ' A' ' 173' ' ' ILE . 1.8 mp -91.43 106.45 17.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 57.8 mt -107.67 129.62 61.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.573 -176.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -82.22 96.41 7.85 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.373 175.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.458 HG21 ' HB2' ' A' ' 125' ' ' LEU . 6.5 m -61.68 136.59 58.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.006 -175.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 104.11 -33.74 6.33 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -107.66 -26.73 10.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.026 0.441 . . . . 0.0 110.505 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.36 15.32 76.75 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.206 177.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 5.9 m -68.96 112.65 5.74 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -96.22 111.41 23.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.188 0.518 . . . . 0.0 110.957 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 4.5 mp -107.81 102.35 13.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.124 0.488 . . . . 0.0 110.114 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 48.3 t -80.53 166.74 20.89 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.368 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ARG . . . . . 0.563 ' HD3' ' OD2' ' A' ' 170' ' ' ASP . 25.1 mmt180 72.46 30.22 1.98 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 172.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.137 0 CA-C-O 118.147 -1.363 . . . . 0.0 113.604 174.345 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.9 mtt . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.507 ' HB ' HG23 ' A' ' 60' ' ' VAL . 3.7 mp -81.76 118.86 30.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.242 0.544 . . . . 0.0 110.757 -176.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 m -97.36 151.95 19.42 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.337 171.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.9 m -67.18 -14.68 18.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -167.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -86.06 -0.1 54.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.427 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -133.6 91.31 2.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.242 0.544 . . . . 0.0 111.786 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -126.27 156.7 39.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.589 172.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -126.94 162.11 26.74 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -177.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 p -53.0 -20.36 3.37 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 123.556 0.535 . . . . 0.0 111.63 175.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.603 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -144.49 115.78 0.89 Allowed Glycine 0 N--CA 1.435 -1.376 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 167.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.72 129.22 20.17 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.56 HG21 ' CG1' ' A' ' 65' ' ' ILE . 1.2 m -103.29 118.27 36.4 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.193 0.52 . . . . 0.0 111.055 -178.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.0 mp -117.94 140.31 41.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.321 -176.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.7 t -102.33 102.02 12.34 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 175.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.5 p -140.34 146.27 24.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.446 -177.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 61.94 28.45 17.32 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.493 -176.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.1 m120 63.86 25.66 14.09 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.445 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.86 163.39 29.61 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.098 177.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 10.1 pt -109.56 126.27 66.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.392 -178.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.553 ' O ' ' HA ' ' A' ' 12' ' ' THR . 64.8 m95 -124.11 146.56 48.55 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.088 -170.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -120.78 104.05 9.58 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.318 -177.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.603 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 78.9 t -63.02 111.91 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.76 177.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.2 mt -92.68 -33.91 5.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.695 176.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.405 ' HB2' ' HD3' ' A' ' 40' ' ' LYS . 33.0 m-20 -143.12 148.78 37.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.022 177.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -141.6 131.75 24.8 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.079 0.466 . . . . 0.0 110.905 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -122.37 110.02 15.13 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.373 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -80.06 101.24 8.6 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.5 p -108.5 134.11 51.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.295 0.569 . . . . 0.0 111.331 -172.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -122.89 100.55 40.2 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.701 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -76.25 -10.49 19.22 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.343 2.029 . . . . 0.0 112.199 177.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.6 25.78 60.17 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.774 -0.648 . . . . 0.0 113.087 175.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -87.56 -12.86 44.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.919 0.39 . . . . 0.0 111.145 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.96 -42.57 1.27 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.685 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.7 p -123.01 132.41 54.12 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 174.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.04 161.65 25.28 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.848 0.356 . . . . 0.0 110.627 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.479 ' HA ' ' O ' ' A' ' 54' ' ' PHE . 86.1 m-85 -128.59 165.46 20.74 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.102 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 53' ' ' THR . 59.5 t -129.67 106.41 13.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 176.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -80.37 99.29 7.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.202 177.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 16.1 p -111.03 137.15 49.02 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.27 -174.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.405 ' HD3' ' HB2' ' A' ' 24' ' ' ASP . 45.9 mtpt -95.28 108.85 21.03 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 175.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.529 HD23 ' H ' ' A' ' 41' ' ' LEU . 1.1 pt? -135.94 141.82 44.53 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.764 0.793 . . . . 0.0 111.899 -172.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 33.0 ttt180 -103.77 129.8 51.23 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.86 -1.063 . . . . 0.0 111.49 -173.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -70.12 117.95 12.34 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 172.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.422 ' H ' HD12 ' A' ' 44' ' ' LEU . 5.9 mp -64.61 -26.82 68.57 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 121.188 -0.205 . . . . 0.0 111.434 -175.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.443 HH11 ' HD2' ' A' ' 45' ' ' ARG . 59.3 mtt180 -76.55 -50.07 14.83 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.825 0.345 . . . . 0.0 111.467 -177.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.4 p -94.54 -17.65 22.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.047 0.451 . . . . 0.0 111.811 -172.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.24 6.57 88.85 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.719 -175.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 42' ' ' ARG . . . -68.64 131.04 44.54 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -174.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.7 mm -91.53 98.84 8.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.416 ' HG2' ' N ' ' A' ' 51' ' ' GLU . 34.7 tt0 -112.47 167.34 10.52 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -178.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.416 ' N ' ' HG2' ' A' ' 50' ' ' GLN . 11.0 pt-20 -132.5 125.91 31.7 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.152 0.501 . . . . 0.0 109.949 173.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.445 ' HD2' HD11 ' A' ' 41' ' ' LEU . 56.3 mttm -115.36 148.19 39.59 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.74 -176.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 10.8 p -112.6 105.06 13.17 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.244 176.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.479 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 88.3 m-85 -84.1 144.96 28.7 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.726 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.554 ' HD3' ' OE2' ' A' ' 58' ' ' GLU . 34.5 ttt180 -111.09 136.08 50.66 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.743 0.306 . . . . 0.0 111.549 -173.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.13 129.79 42.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.818 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 106.27 -16.75 41.51 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -175.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.554 ' OE2' ' HD3' ' A' ' 55' ' ' ARG . 81.1 mt-10 -112.71 149.56 32.75 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -127.67 163.41 24.32 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.298 -176.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.507 HG23 ' HB ' ' A' ' 2' ' ' ILE . 5.6 m -134.16 157.63 41.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.37 0.605 . . . . 0.0 111.469 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -83.59 141.56 41.99 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.03 -0.987 . . . . 0.0 110.443 -176.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.27 154.73 41.47 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.538 2.159 . . . . 0.0 112.454 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.44 113.07 18.85 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.954 175.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 26.3 mmt -88.64 109.03 19.77 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.99 0.424 . . . . 0.0 110.62 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.56 ' CG1' HG21 ' A' ' 12' ' ' THR . 46.9 mm -99.37 125.4 52.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.049 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.498 ' HG3' ' OG1' ' A' ' 115' ' ' THR . 6.0 pt-20 -117.6 138.02 52.22 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.595 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.403 HD22 ' C ' ' A' ' 66' ' ' GLU . 1.0 OUTLIER -112.98 113.86 26.09 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.954 0.406 . . . . 0.0 110.213 178.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.515 ' HB3' ' OD1' ' A' ' 84' ' ' ASP . 68.6 mtt180 -110.36 117.47 33.71 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.17 -178.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 9.2 ptm180 -74.05 121.14 20.62 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 174.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.559 ' HG2' ' HA ' ' A' ' 84' ' ' ASP . 28.7 mtt -124.08 147.72 47.66 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.448 -175.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -77.41 136.56 38.41 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.903 177.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -77.14 103.78 7.26 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.413 -176.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 8.4 mp -104.32 -176.81 3.19 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 170.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -146.79 157.09 43.59 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.621 0.724 . . . . 0.0 112.448 -171.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 79' ' ' ASN . . . -150.57 -160.83 1.22 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.308 -1.314 . . . . 0.0 107.713 174.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -72.08 143.15 49.17 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 175.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.5 68.66 2.41 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 118.879 -1.629 . . . . 0.0 113.879 -167.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.579 ' HA ' ' OG ' ' A' ' 95' ' ' SER . 22.8 m-20 -127.93 -30.43 2.48 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 156.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.47 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 92.6 m-20 -137.07 138.65 40.63 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.512 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -121.69 144.56 48.7 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 173.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.444 ' O ' ' HB2' ' A' ' 73' ' ' LEU . 45.9 t -90.41 132.33 35.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.499 -178.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -126.43 125.53 42.3 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 174.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 37.8 mtt -93.7 113.32 25.37 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.454 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.677 ' HB3' ' H ' ' A' ' 89' ' ' GLU . 20.2 t0 -62.15 115.01 3.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.511 -177.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -85.46 -7.13 59.08 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.023 177.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.59 -52.24 27.84 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 173.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.44 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 12.1 p -164.75 90.03 0.52 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 167.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 47.33 28.26 1.03 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 158.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.677 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 49.2 mt-10 -105.89 116.53 32.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 118.981 0.809 . . . . 0.0 112.408 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -75.86 118.68 18.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.277 0.561 . . . . 0.0 110.027 175.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.1 m -120.99 138.26 54.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.547 -175.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -105.87 134.55 48.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.797 0.332 . . . . 0.0 110.817 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 79' ' ' ASN . 4.5 mm? -112.88 143.01 44.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.427 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.7 m -79.64 166.93 21.35 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -173.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.579 ' OG ' ' HA ' ' A' ' 78' ' ' ASP . 10.2 m -52.93 -33.38 50.41 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.749 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -52.14 -40.69 61.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.734 -176.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -87.64 -41.03 13.69 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.42 0.628 . . . . 0.0 109.953 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.487 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 4.3 mm? -74.32 -20.88 59.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.314 -171.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -60.58 -32.26 71.37 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.126 0.489 . . . . 0.0 110.204 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -87.44 -39.4 15.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.387 177.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.455 ' O ' HD12 ' A' ' 105' ' ' LEU . 40.7 mt-10 -63.57 -25.62 68.32 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.343 178.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 65.8 mt -71.44 -7.4 47.14 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 122.021 -0.424 . . . . 0.0 110.865 177.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -90.09 -43.8 10.24 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 172.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -130.36 116.24 18.02 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.315 176.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.455 HD12 ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -172.4 164.2 5.68 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.728 0.299 . . . . 0.0 110.627 177.459 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -143.16 138.87 30.07 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -63.7 123.13 18.09 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.638 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.32 1.65 71.75 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.751 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.41 ' SD ' ' HD2' ' A' ' 126' ' ' PRO . 51.9 ttm -62.75 147.62 49.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.106 0.479 . . . . 0.0 111.53 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.43 ' HG2' HH21 ' A' ' 69' ' ' ARG . 4.3 tp10 -89.41 100.32 13.14 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.593 175.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 23.1 m -106.55 155.74 7.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.63 -178.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.53 ' HB2' ' HB3' ' A' ' 124' ' ' GLU . 12.8 mm100 -96.99 99.65 11.18 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.447 HD13 HG13 ' A' ' 123' ' ' VAL . 32.8 mm -81.88 116.0 25.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 177.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.419 ' HG2' HD11 ' A' ' 121' ' ' ILE . 27.8 tt0 -91.69 113.16 25.35 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.498 ' OG1' ' HG3' ' A' ' 66' ' ' GLU . 1.7 p -116.11 157.85 24.11 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.705 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -129.64 101.91 6.13 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 176.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 58.55 33.98 23.53 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.225 -173.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 96.49 -22.59 39.27 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.989 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -75.53 131.4 40.03 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.824 -0.221 . . . . 0.0 110.569 -178.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.6 p -75.22 113.24 12.36 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.734 0.302 . . . . 0.0 110.865 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.419 HD11 ' HG2' ' A' ' 114' ' ' GLN . 40.1 pt -105.94 -21.41 5.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.444 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -169.27 163.71 37.35 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.179 -1.01 . . . . 0.0 112.742 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.447 HG13 HD13 ' A' ' 113' ' ' ILE . 59.9 t -130.35 129.53 64.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 177.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.53 ' HB3' ' HB2' ' A' ' 112' ' ' GLN . 35.3 tt0 -108.97 101.12 10.24 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.295 0.569 . . . . 0.0 110.669 178.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -77.66 126.22 84.72 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 173.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.41 ' HD2' ' SD ' ' A' ' 109' ' ' MET . 30.5 Cg_exo -37.74 127.5 0.79 Allowed 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.791 2.994 . . . . 0.0 113.359 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.595 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 75.5 mmtt -62.49 -26.73 68.69 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.9 -172.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 p -119.08 108.85 15.22 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.072 0.463 . . . . 0.0 109.944 172.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.2 p -110.5 136.41 46.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.428 -177.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -96.45 115.08 26.85 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.847 0.356 . . . . 0.0 110.38 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 80.9 mt -124.38 131.9 53.52 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.584 -177.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.9 m -79.29 134.93 36.63 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.36 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.416 HG13 ' HA ' ' A' ' 168' ' ' GLU . 7.4 p -85.13 118.28 31.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.621 0.724 . . . . 0.0 110.868 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.539 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 43.2 p -130.97 126.13 35.2 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.496 178.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.539 ' HB2' ' O ' ' A' ' 134' ' ' THR . 48.7 mm-40 79.4 79.07 0.05 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.675 0.75 . . . . 0.0 111.175 -175.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.587 ' O ' ' HD3' ' A' ' 138' ' ' PRO . 11.1 t -150.23 153.58 36.46 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 171.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -102.12 99.65 13.04 Favored Pre-proline 0 C--N 1.321 -0.646 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.348 -178.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.587 ' HD3' ' O ' ' A' ' 136' ' ' THR . 84.6 Cg_endo -91.54 -179.17 1.29 Allowed 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.08 2.52 . . . . 0.0 112.186 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 94.87 13.67 52.28 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.478 178.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.7 mp . . . . . 0 C--N 1.325 -0.476 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.346 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.514 ' HB ' ' HB3' ' A' ' 161' ' ' ASN . 36.9 p . . . . . 0 N--CA 1.45 -0.461 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -131.64 152.48 50.81 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.453 178.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.4 p -72.78 117.56 14.63 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.051 0.453 . . . . 0.0 111.358 -177.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 159' ' ' THR . . . -119.66 158.62 26.07 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.954 -178.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 134' ' ' THR . 18.4 m -109.73 138.48 46.03 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 174.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.0 m -105.63 178.87 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.496 175.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -54.97 -30.25 58.75 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 79.4 p -76.41 -8.87 58.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.805 0.336 . . . . 0.0 111.839 -177.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 86.13 3.29 85.17 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.582 -175.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -80.79 143.47 32.83 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.851 0.357 . . . . 0.0 110.555 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 152' ' ' ALA . 30.1 m -101.07 120.22 39.89 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.06 177.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.2 161.49 35.6 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.514 ' HB3' ' HB ' ' A' ' 149' ' ' THR . 89.4 m-20 -92.84 112.93 25.06 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.881 0.372 . . . . 0.0 111.53 -173.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.42 ' HB ' HG21 ' A' ' 166' ' ' VAL . 29.2 m -108.32 148.18 37.1 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.393 178.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.38 149.22 30.51 Favored 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.558 2.172 . . . . 0.0 111.964 174.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 59.4 mt -62.38 -11.72 17.24 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -170.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -104.18 10.33 35.81 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -176.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.42 HG21 ' HB ' ' A' ' 162' ' ' VAL . 75.5 t -78.73 142.41 14.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 178.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -114.41 145.22 42.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.437 -175.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.446 ' HG2' HG22 ' A' ' 136' ' ' THR . 48.7 mt-10 -62.53 127.06 29.52 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.615 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 112.12 -16.44 25.1 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.356 -176.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -75.49 154.91 36.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.987 0.422 . . . . 0.0 110.631 177.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 88.6 t -105.04 116.63 49.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.747 -177.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.42 HD22 ' N ' ' A' ' 172' ' ' LEU . 2.5 mm? -99.2 138.36 36.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.073 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.58 ' O ' ' HB ' ' A' ' 182' ' ' ILE . 57.0 mt -97.28 115.37 36.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 33.7 mm -109.85 141.31 25.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.427 -178.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.595 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 27.2 t-20 -86.52 103.1 14.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.991 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.0 m -71.77 113.03 8.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.231 176.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 143.43 -47.1 0.81 Allowed Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -177.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -118.81 -22.73 7.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.982 0.42 . . . . 0.0 110.373 175.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 89.48 17.24 55.51 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.109 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 4.2 m -65.04 136.57 56.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.582 0.23 . . . . 0.0 110.605 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -89.84 117.17 28.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.145 0.498 . . . . 0.0 110.927 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.58 ' HB ' ' O ' ' A' ' 173' ' ' ILE . 4.0 mp -96.87 151.42 4.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 169.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 10.7 p -77.11 173.1 12.22 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.829 -0.169 . . . . 0.0 111.018 -173.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 39.0 mtt180 -46.03 144.3 1.93 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.686 0.616 . . . . 0.0 111.885 -176.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.734 -1.037 . . . . 0.0 111.852 177.928 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 120.917 0.389 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 84.5 mt -75.28 134.68 28.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.036 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 m -94.83 143.79 26.17 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 174.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.525 HG21 ' HA ' ' A' ' 56' ' ' ALA . 10.8 m -69.11 -1.99 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -172.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -90.09 -2.63 58.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.657 0.265 . . . . 0.0 110.593 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -134.0 89.93 2.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.527 0.679 . . . . 0.0 111.518 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.456 ' CE1' ' HA ' ' A' ' 4' ' ' VAL . 61.6 m-85 -119.58 153.01 36.1 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 171.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -119.57 171.64 8.22 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.477 -176.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.1 p -65.17 -14.57 60.91 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.767 0.794 . . . . 0.0 109.978 174.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.49 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -153.13 115.12 0.66 Allowed Glycine 0 N--CA 1.435 -1.369 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 166.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.6 tp -149.99 132.0 15.26 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.671 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 1.7 m -98.39 122.69 41.89 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.321 0.581 . . . . 0.0 112.092 -172.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.0 mp -117.27 143.73 26.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.279 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.462 ' HB2' ' HB2' ' A' ' 63' ' ' ALA . 35.5 t -104.43 107.43 18.36 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 175.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.9 p -153.93 151.28 11.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -176.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 54.78 45.09 27.39 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 -176.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.7 p30 47.29 31.66 1.87 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.314 1.046 . . . . 0.0 112.222 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.7 166.06 25.69 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.466 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.8 pt -112.13 130.58 65.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.83 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.671 ' O ' ' HA ' ' A' ' 12' ' ' THR . 70.2 m95 -126.6 147.91 49.83 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.885 -168.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.4 ttmm -116.95 104.02 10.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.549 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.49 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 84.1 t -62.81 109.06 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.872 0.368 . . . . 0.0 110.303 177.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 77.0 mt -88.85 -38.15 11.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.512 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -142.47 152.53 42.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.481 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -143.77 136.44 27.2 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.991 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -113.26 99.65 7.97 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.708 176.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -76.05 90.02 3.03 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.0 p -96.5 118.95 43.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.567 0.699 . . . . 0.0 111.519 -171.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -119.81 96.83 49.66 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.428 176.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.88 -10.77 15.38 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.482 2.121 . . . . 0.0 113.148 -177.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.2 26.65 39.51 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.958 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -95.46 10.67 35.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.796 0.331 . . . . 0.0 111.265 -176.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.48 -42.03 2.03 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.12 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.1 p -133.18 146.58 51.66 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 177.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -96.35 166.13 11.86 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.113 0.482 . . . . 0.0 111.134 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -136.25 167.07 21.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.492 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.9 t -131.88 102.62 5.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.086 0.47 . . . . 0.0 109.733 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -82.47 99.33 9.4 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 40.5 p -102.76 143.87 31.85 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.916 -173.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -102.52 102.82 13.13 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 174.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.611 HD23 ' H ' ' A' ' 41' ' ' LEU . 1.3 pt? -133.02 150.96 52.11 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.687 0.756 . . . . 0.0 112.36 -169.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 20.3 ttt180 -110.69 129.67 55.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.038 -171.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -69.96 122.52 19.48 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 173.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.9 mp -66.85 -25.67 66.54 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -176.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.1 mtt85 -81.33 -44.83 17.06 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.671 0.272 . . . . 0.0 111.72 -177.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 67.2 p -99.09 -17.07 18.4 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.132 0.492 . . . . 0.0 111.943 -173.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.31 13.64 81.32 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.793 -175.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 42' ' ' ARG . . . -73.53 133.27 43.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.917 0.389 . . . . 0.0 111.672 -175.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 26.4 mm -96.15 99.15 8.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.378 176.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.456 ' O ' HD23 ' A' ' 41' ' ' LEU . 8.9 tt0 -119.75 157.23 29.02 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -177.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 39' ' ' SER . 15.1 pt-20 -113.9 127.02 55.8 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.291 0.567 . . . . 0.0 110.092 175.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -129.09 146.22 51.1 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.626 -175.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.1 m -107.77 120.66 42.87 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.269 0.557 . . . . 0.0 111.899 -175.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -92.03 155.45 18.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.251 173.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -117.6 132.13 56.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.143 0.497 . . . . 0.0 111.429 -176.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.525 ' HA ' HG21 ' A' ' 4' ' ' VAL . . . -67.3 129.66 40.62 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.871 -178.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.19 -16.24 32.63 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -175.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -106.27 137.82 43.55 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -93.4 132.45 37.63 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.122 0.486 . . . . 0.0 110.61 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.5 t -96.03 145.62 8.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.662 -175.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -87.52 125.64 64.68 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.701 0.286 . . . . 0.0 110.493 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -79.12 152.79 24.49 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.563 2.175 . . . . 0.0 112.754 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.462 ' HB2' ' HB2' ' A' ' 14' ' ' SER . . . -117.56 109.39 16.64 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.569 176.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 61.4 mtt -87.25 108.68 19.05 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.168 0.508 . . . . 0.0 110.219 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.462 ' CG1' HG21 ' A' ' 12' ' ' THR . 52.1 mm -90.79 132.67 34.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.073 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -104.72 103.61 13.27 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.955 -177.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -93.99 101.34 13.39 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.938 0.399 . . . . 0.0 110.194 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 41.6 mtm180 -107.05 168.02 9.49 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -134.66 122.11 21.78 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.326 0.584 . . . . 0.0 111.022 -175.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.544 ' CB ' ' HB3' ' A' ' 82' ' ' PHE . 1.9 mpt? -117.39 149.07 41.14 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.348 -173.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -90.87 139.81 30.4 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 174.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -70.74 103.22 2.51 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.773 -174.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -94.49 -175.18 3.54 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 167.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -143.07 142.96 31.68 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 119.764 -0.774 . . . . 0.0 112.511 -167.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 79' ' ' ASN . . . -151.85 -172.83 4.34 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.261 -1.336 . . . . 0.0 108.812 175.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -76.61 145.73 38.71 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.13 68.64 2.59 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 118.984 -1.579 . . . . 0.0 114.095 -167.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -126.89 -30.81 2.7 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 156.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.617 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 21.1 p-10 -140.98 132.74 27.37 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 113.608 -1.633 . . . . 0.0 109.68 177.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.531 ' CG ' HD22 ' A' ' 98' ' ' LEU . 54.7 m170 -114.92 146.96 40.59 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 172.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 44.8 t -95.7 125.45 48.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.91 -176.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.544 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 78.8 m-85 -121.68 117.59 27.04 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 89.0 mmm -91.41 114.24 26.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.849 0.357 . . . . 0.0 111.22 -174.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.562 ' HB3' ' H ' ' A' ' 89' ' ' GLU . 22.4 t70 -62.16 116.49 5.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.39 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -77.68 -11.56 59.88 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.439 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -73.3 -50.52 21.73 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 176.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.6 p -169.09 91.59 0.25 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 168.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 48.42 25.32 0.88 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 157.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.562 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 41.6 mt-10 -95.68 116.76 29.34 Favored 'General case' 0 C--N 1.32 -0.702 0 O-C-N 121.453 -0.78 . . . . 0.0 111.172 176.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -85.35 98.26 10.44 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.392 0.615 . . . . 0.0 110.791 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.8 m -89.02 117.04 27.75 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.325 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 80' ' ' HIS . 44.2 mt-10 -95.95 126.15 40.99 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 177.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.617 ' O ' ' HA ' ' A' ' 79' ' ' ASN . 70.9 mt -104.5 146.72 28.47 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.579 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.605 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 28.5 t -86.05 167.34 15.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.66 -175.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.8 p -49.06 -35.69 16.48 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -175.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -53.8 -40.58 66.47 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.903 0.382 . . . . 0.0 111.536 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -80.53 -35.28 34.71 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.291 0.567 . . . . 0.0 109.798 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 94' ' ' SER . 13.3 mt -67.35 -30.37 70.16 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.137 -172.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -63.04 -43.65 98.09 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.949 0.404 . . . . 0.0 110.666 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -65.84 -36.4 83.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.897 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.489 ' O ' HD12 ' A' ' 105' ' ' LEU . 51.1 mt-10 -62.39 -41.31 98.56 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.508 173.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 73.5 mt -63.74 -20.77 66.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.931 0.396 . . . . 0.0 110.617 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -72.02 -50.14 31.05 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 173.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -138.64 116.02 11.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.071 176.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.489 HD12 ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -164.15 150.69 11.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.898 0.38 . . . . 0.0 110.646 178.003 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -145.83 134.96 22.77 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 172.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -64.79 123.42 19.33 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.909 -177.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 101.57 -6.1 54.99 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.565 -178.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 50.4 ttm -69.7 133.45 47.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.806 0.336 . . . . 0.0 110.65 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -95.33 101.86 13.62 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.09 0.471 . . . . 0.0 110.376 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 32.8 m -100.56 166.82 2.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.567 -177.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -108.57 109.18 20.34 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 46.5 mt -89.81 123.75 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-O 121.233 0.54 . . . . 0.0 109.633 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.492 ' HG2' HD11 ' A' ' 121' ' ' ILE . 31.2 tt0 -96.42 107.67 20.09 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.74 -174.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 40.9 p -109.19 159.06 17.23 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 121.44 0.638 . . . . 0.0 111.771 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -137.58 106.31 5.9 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 60.88 32.26 20.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.865 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 98.82 -18.33 57.01 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.052 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -88.36 134.82 33.72 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 122.798 -0.236 . . . . 0.0 110.927 -176.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.0 p -77.93 108.68 11.36 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.733 0.301 . . . . 0.0 110.36 175.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.492 HD11 ' HG2' ' A' ' 114' ' ' GLN . 36.0 pt -92.02 -27.11 4.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.839 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -169.59 167.74 40.75 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.672 177.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 55.7 t -125.35 121.22 59.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -102.78 112.17 24.83 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.015 0.436 . . . . 0.0 110.508 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 66.0 mt -78.7 152.65 77.94 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 175.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.51 144.23 52.34 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.363 2.042 . . . . 0.0 110.635 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.719 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 14.3 mmmm -64.82 -22.35 66.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.705 -173.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 26.3 p -125.55 113.43 17.42 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.862 0.363 . . . . 0.0 111.334 176.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 9.6 p -114.84 140.44 35.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.614 175.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -112.8 124.52 52.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.553 0.692 . . . . 0.0 111.352 177.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 95.7 mt -129.27 145.63 51.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.911 -175.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.3 m -85.52 132.71 34.15 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.128 176.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 170' ' ' ASP . 5.8 p -85.81 108.84 17.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.815 0.817 . . . . 0.0 110.769 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.679 ' O ' ' HB ' ' A' ' 153' ' ' THR . 26.9 p -116.48 124.59 50.32 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.621 178.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.541 ' HB2' ' O ' ' A' ' 134' ' ' THR . 1.5 mp0 77.36 86.61 0.08 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.904 0.859 . . . . 0.0 111.18 -176.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.448 ' O ' ' HD3' ' A' ' 138' ' ' PRO . 14.4 t -148.7 156.27 42.14 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 173.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -81.2 109.6 14.57 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -175.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 136' ' ' THR . 98.2 Cg_endo -89.08 166.7 5.62 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.947 2.431 . . . . 0.0 112.944 -176.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.31 -1.3 88.6 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.036 -0.602 . . . . 0.0 113.081 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.449 HD12 ' HD3' ' A' ' 150' ' ' LYS . 58.1 mt . . . . . 0 C--N 1.326 -0.418 0 CA-C-O 121.315 0.579 . . . . 0.0 110.564 -177.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.5 p . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 121.285 0.564 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.449 ' HD3' HD12 ' A' ' 140' ' ' ILE . 37.4 ttpt -127.64 136.28 51.41 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.626 -178.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 35.9 p -72.76 120.19 18.04 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.074 0.464 . . . . 0.0 110.404 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 159' ' ' THR . . . -125.13 160.48 29.02 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.159 -178.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.679 ' HB ' ' O ' ' A' ' 134' ' ' THR . 1.6 m -111.45 136.58 50.41 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.4 m -102.48 177.73 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.175 174.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -55.63 -29.27 58.92 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.407 HG22 HD13 ' A' ' 105' ' ' LEU . 80.3 p -75.93 -9.41 58.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.022 0.439 . . . . 0.0 111.529 -177.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 87.56 7.59 75.32 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.091 -0.576 . . . . 0.0 111.898 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -86.14 141.26 29.5 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.666 0.269 . . . . 0.0 110.943 -177.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 152' ' ' ALA . 17.9 m -95.57 115.43 27.42 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.158 176.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.33 161.9 32.39 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -94.52 113.28 25.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.531 0.681 . . . . 0.0 111.54 -174.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 27.3 m -108.59 150.5 40.79 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.971 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.21 150.76 47.12 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.295 1.997 . . . . 0.0 111.481 174.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 54.5 mt -58.28 -23.19 55.42 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -168.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -85.54 -9.36 57.5 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -174.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 94.6 t -70.5 136.18 26.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -122.91 163.45 20.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.868 0.366 . . . . 0.0 110.141 -174.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -60.67 128.05 34.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.733 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 109.43 -16.91 31.59 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.55 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.408 ' OD1' ' HD2' ' A' ' 184' ' ' ARG . 7.1 m-20 -64.85 138.74 58.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.952 0.406 . . . . 0.0 111.404 178.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 61.1 t -97.72 104.02 15.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 172.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.484 ' H ' HD23 ' A' ' 172' ' ' LEU . 0.7 OUTLIER -100.31 143.08 30.91 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.71 -176.427 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.523 ' O ' ' HB ' ' A' ' 182' ' ' ILE . 60.7 mt -99.32 136.97 28.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.649 177.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 61.7 mt -127.18 138.21 55.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.719 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 26.6 t-20 -81.0 91.98 6.14 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.011 176.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.9 118.78 18.24 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.115 0.484 . . . . 0.0 110.62 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 129.43 -48.28 0.98 Allowed Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -175.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . 0.42 ' HB2' ' OD1' ' A' ' 175' ' ' ASN . 17.1 m-20 -106.28 -24.92 12.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.03 0.443 . . . . 0.0 110.098 177.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 86.92 15.12 63.57 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.434 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 6.0 m -72.27 127.05 31.36 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -79.42 122.84 26.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.16 0.505 . . . . 0.0 110.386 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.523 ' HB ' ' O ' ' A' ' 173' ' ' ILE . 9.8 mm -100.41 155.2 4.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 14.7 p -75.68 166.8 23.01 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.59 0.709 . . . . 0.0 111.703 -169.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 172' ' ' LEU . 23.6 ptt180 -85.45 159.37 19.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.549 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.548 -1.14 . . . . 0.0 111.71 175.61 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.425 ' SD ' ' HD3' ' A' ' 59' ' ' LYS . 66.8 mtt . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 120.733 0.301 . . . . 0.0 110.317 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.1 mp -99.41 135.24 35.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.964 0.412 . . . . 0.0 110.136 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.2 m -99.95 156.63 17.04 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.6 m -68.77 -8.66 10.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -170.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -93.48 12.08 26.3 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.648 0.261 . . . . 0.0 110.64 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -140.5 89.36 2.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.282 0.563 . . . . 0.0 111.447 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -122.33 148.55 44.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.531 175.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.413 ' HG3' ' N ' ' A' ' 9' ' ' THR . 20.6 tptm -114.88 161.5 18.16 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.284 -176.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.413 ' N ' ' HG3' ' A' ' 8' ' ' LYS . 8.4 m -49.42 -31.93 10.7 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.2 0.524 . . . . 0.0 111.06 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.548 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -143.38 116.83 1.03 Allowed Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 170.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 66.9 tp -142.07 137.42 31.02 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 2.5 m -100.96 118.97 38.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.011 0.434 . . . . 0.0 110.823 -177.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.8 mp -120.01 137.5 53.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.424 -177.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.6 p -98.48 100.13 11.36 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.7 p -146.81 152.13 13.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.59 -175.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.405 ' CB ' ' HE2' ' A' ' 52' ' ' LYS . 24.2 t70 63.9 27.29 14.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.34 0.591 . . . . 0.0 109.682 178.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 63.75 30.53 14.64 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.401 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.94 167.18 24.63 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.095 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 15.5 pt -109.68 123.52 65.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.078 0.466 . . . . 0.0 110.156 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.501 ' O ' ' HA ' ' A' ' 12' ' ' THR . 34.2 m95 -121.16 160.36 23.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.411 -172.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -129.34 107.96 9.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.567 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.548 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 82.7 t -59.95 118.39 3.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.124 0.488 . . . . 0.0 111.009 179.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.1 mm -93.31 -41.89 12.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.758 175.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -158.25 121.56 3.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.21 -177.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -108.58 139.06 43.88 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.044 0.45 . . . . 0.0 111.571 -173.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -116.41 99.89 7.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.442 176.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 -71.75 96.47 1.62 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 175.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.9 p -99.37 134.3 39.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.448 0.642 . . . . 0.0 111.25 -172.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -116.72 87.46 21.64 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.506 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -65.28 -46.72 5.34 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.635 2.223 . . . . 0.0 112.596 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.56 26.79 3.01 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 121.126 -0.559 . . . . 0.0 111.902 -176.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -97.13 10.32 39.7 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.821 0.343 . . . . 0.0 111.104 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.22 -42.32 1.99 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.995 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.425 ' HB3' ' HB3' ' A' ' 56' ' ' ALA . 70.6 m -115.51 138.53 50.94 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 175.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.68 162.6 22.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.058 0.456 . . . . 0.0 110.75 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -132.04 164.9 25.2 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.342 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.4 t -132.33 102.64 5.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 120.956 0.408 . . . . 0.0 110.34 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -79.19 99.03 6.83 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.2 m -106.53 131.15 54.03 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.535 -173.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.9 mttp -84.34 105.4 15.15 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 171.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.563 HD23 ' H ' ' A' ' 41' ' ' LEU . 0.6 OUTLIER -127.97 138.27 52.55 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.718 0.771 . . . . 0.0 110.813 -172.454 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.9 ttt180 -96.97 128.27 43.77 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.989 -177.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -60.84 113.74 2.67 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 172.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.432 HD21 ' OE1' ' A' ' 114' ' ' GLN . 8.9 tt -66.96 -24.11 66.02 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.656 -170.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -85.99 -45.88 11.05 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.691 -177.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 75.1 p -93.81 -21.71 19.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.067 0.461 . . . . 0.0 111.893 -174.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.7 12.27 75.33 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.177 -176.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.91 131.58 38.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.98 0.419 . . . . 0.0 111.685 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.6 mm -89.49 110.93 22.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.606 177.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.466 ' HG2' ' H ' ' A' ' 51' ' ' GLU . 32.7 tt0 -131.79 174.62 9.95 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -177.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.466 ' H ' ' HG2' ' A' ' 50' ' ' GLN . 9.8 pt-20 -137.72 131.83 31.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.178 0.513 . . . . 0.0 110.623 173.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.405 ' HE2' ' CB ' ' A' ' 16' ' ' ASP . 33.0 mttp -124.28 154.02 40.86 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.53 -177.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 48.9 m -106.84 112.76 25.87 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.825 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -83.6 151.13 25.5 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 175.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.4 ptp85 -122.91 129.76 52.0 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.354 -171.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.425 ' HB3' ' HB3' ' A' ' 34' ' ' SER . . . -63.53 130.77 45.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.304 177.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.59 -18.4 29.8 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -176.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -104.13 131.56 51.28 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.425 ' HD3' ' SD ' ' A' ' 1' ' ' MET . 18.0 ptpt -77.2 140.05 40.04 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.512 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 65.5 t -98.45 117.02 42.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.208 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -90.19 121.8 68.25 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.388 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.64 151.4 36.66 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.45 2.1 . . . . 0.0 112.403 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.483 ' HB3' HG22 ' A' ' 12' ' ' THR . . . -101.81 125.99 48.59 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.131 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 15.8 ptp -85.15 109.58 18.39 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.227 0.537 . . . . 0.0 111.037 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.34 125.23 60.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.038 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -121.82 121.68 37.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.885 0.374 . . . . 0.0 110.468 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -99.63 133.24 44.26 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.487 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -129.91 170.15 14.3 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 0.0 OUTLIER -129.96 127.93 41.04 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.859 0.361 . . . . 0.0 110.285 177.333 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.618 ' CB ' ' HB3' ' A' ' 82' ' ' PHE . 1.6 mpt? -118.52 147.6 43.5 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.678 -176.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -85.17 142.42 29.48 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 172.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -75.46 109.66 9.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.071 -175.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -103.81 -176.63 3.14 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 167.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -145.67 151.81 38.63 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 119.828 -0.749 . . . . 0.0 112.405 -174.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.7 -163.34 1.75 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.595 177.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -68.28 139.19 55.94 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 175.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.88 70.77 2.68 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 119.174 -1.489 . . . . 0.0 113.673 -168.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -125.62 -31.22 2.99 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 159.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.587 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 27.3 m-80 -141.25 135.11 30.35 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 113.83 -1.532 . . . . 0.0 109.209 175.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.557 ' CG ' HD22 ' A' ' 98' ' ' LEU . 64.2 m170 -104.83 145.88 29.77 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 176.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 40.9 t -91.87 127.32 44.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.733 -176.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.618 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 55.0 m-85 -125.16 126.33 45.1 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.659 0.266 . . . . 0.0 110.417 177.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 50.1 ttm -89.92 112.44 23.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.668 -176.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.594 ' HA ' ' HG3' ' A' ' 70' ' ' MET . 16.0 t0 -70.69 119.19 14.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.024 -176.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -75.42 -16.3 60.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.6 178.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -69.5 -54.01 16.34 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.8 p -167.35 91.87 0.39 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 171.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 48.44 28.5 1.71 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 158.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.522 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 47.2 mt-10 -103.51 120.5 40.98 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 118.661 0.664 . . . . 0.0 111.764 178.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -83.69 89.22 7.11 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 173.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.0 m -77.24 116.26 17.72 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.239 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -90.87 118.85 30.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.228 0.537 . . . . 0.0 110.014 177.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.587 ' O ' ' HA ' ' A' ' 79' ' ' ASN . 57.3 mt -93.61 136.29 34.04 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.852 -177.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.522 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 2.2 m -77.7 172.02 14.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.842 -175.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.9 m -50.97 -40.61 58.17 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -175.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -56.14 -40.16 73.38 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.018 0.437 . . . . 0.0 111.775 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.469 ' HB2' ' HB3' ' A' ' 93' ' ' LEU . 45.4 m-85 -77.71 -32.91 53.2 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.818 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.626 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 14.3 mt -64.25 -30.36 71.41 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.473 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -56.8 -46.41 81.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.428 176.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -62.47 -43.71 98.15 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.061 177.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.542 ' O ' HD12 ' A' ' 105' ' ' LEU . 46.4 mt-10 -60.67 -34.16 73.91 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.015 177.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.626 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 55.2 mt -68.58 -6.16 23.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.902 0.382 . . . . 0.0 111.277 -178.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -90.7 -50.02 6.14 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 168.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -136.26 116.79 13.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.312 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.542 HD12 ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -163.65 138.98 6.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.977 0.417 . . . . 0.0 110.837 176.615 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -146.46 147.76 31.55 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 173.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -63.98 130.7 45.11 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.529 0.204 . . . . 0.0 110.537 -176.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.94 -0.6 87.78 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.811 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 56.5 ttp -72.73 142.71 48.17 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.739 -0.271 . . . . 0.0 110.294 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -100.21 119.06 37.78 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.874 0.368 . . . . 0.0 110.448 -177.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 21.1 m -111.88 165.2 7.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.488 -178.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -108.03 105.05 14.63 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 178.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 53.7 mt -92.13 126.68 44.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.181 0.515 . . . . 0.0 109.847 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.432 ' OE1' HD21 ' A' ' 44' ' ' LEU . 24.9 tt0 -99.45 119.13 37.49 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.675 -175.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 64.5 p -116.47 153.54 31.94 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.19 0.519 . . . . 0.0 111.984 -174.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.458 ' HB2' HD13 ' A' ' 121' ' ' ILE . 38.7 t80 -129.67 101.24 5.82 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.276 -0.875 . . . . 0.0 108.962 176.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 61.73 26.93 16.45 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.691 0.758 . . . . 0.0 110.254 -178.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 104.52 -25.8 24.68 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.559 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -79.1 127.45 32.03 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -177.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 43.9 p -69.82 114.16 7.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.761 0.315 . . . . 0.0 110.432 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.458 HD13 ' HB2' ' A' ' 116' ' ' TYR . 22.4 pt -100.52 -26.32 3.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.454 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -164.32 162.43 35.32 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.151 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.482 HG21 HD13 ' A' ' 93' ' ' LEU . 86.3 t -135.01 124.48 43.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.921 0.391 . . . . 0.0 110.207 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -106.6 123.57 48.31 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.948 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.402 HD22 ' N ' ' A' ' 125' ' ' LEU . 2.9 mm? -78.69 156.0 78.0 Favored Pre-proline 0 C--N 1.32 -0.675 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 174.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.434 ' HD3' HG12 ' A' ' 111' ' ' VAL . 47.6 Cg_exo -56.1 123.98 15.16 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.423 2.082 . . . . 0.0 111.446 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.582 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 12.8 mptt -54.85 -34.69 63.18 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.22 -176.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 36.3 p -117.45 108.71 15.87 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 171.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.6 p -122.41 135.85 61.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.432 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -96.48 105.8 17.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.463 0.649 . . . . 0.0 111.116 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 58.0 mt -114.3 129.1 56.63 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.981 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.2 m -75.29 130.88 39.82 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.143 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 170' ' ' ASP . 4.2 p -78.32 105.84 8.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.705 0.764 . . . . 0.0 110.618 178.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.418 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 13.8 p -110.81 123.49 50.19 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.17 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 134' ' ' THR . 42.1 mt-10 76.05 97.3 0.07 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.889 0.852 . . . . 0.0 111.422 -177.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.415 HG22 ' CG ' ' A' ' 168' ' ' GLU . 10.3 t -150.34 155.96 40.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.954 174.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.462 ' O ' ' HD3' ' A' ' 150' ' ' LYS . 25.2 mm-40 -80.96 153.72 72.56 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.123 -170.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -68.86 172.11 12.3 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.531 2.154 . . . . 0.0 111.485 174.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 119.44 32.29 1.26 Allowed Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.961 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 164' ' ' LEU . 24.2 pt . . . . . 0 C--O 1.235 0.299 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 176.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.4 p . . . . . 0 N--CA 1.449 -0.507 0 CA-C-O 121.898 0.856 . . . . 0.0 112.666 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.462 ' HD3' ' O ' ' A' ' 137' ' ' GLU . 26.0 ttmt -137.29 143.07 41.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.007 -1.452 . . . . 0.0 108.987 -174.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 25.0 m -73.77 120.72 19.75 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.103 0.477 . . . . 0.0 110.311 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -129.39 162.53 27.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.137 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 21.3 m -127.35 143.82 51.16 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.476 174.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 15.7 m -103.56 173.55 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.786 0.327 . . . . 0.0 110.717 176.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -62.74 -12.54 24.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.65 -174.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.438 HG22 ' O ' ' A' ' 105' ' ' LEU . 68.6 p -87.76 -13.49 42.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.789 0.328 . . . . 0.0 111.469 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 94.49 3.12 63.09 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.763 -174.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -78.14 141.54 38.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.846 0.355 . . . . 0.0 110.416 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 25.0 m -106.61 133.18 51.68 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.381 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -148.68 165.07 32.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.636 0.255 . . . . 0.0 110.48 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -105.53 108.51 20.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.322 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.429 ' HB ' HG21 ' A' ' 166' ' ' VAL . 27.8 m -102.93 157.39 33.83 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.648 -176.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -62.77 150.52 87.86 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 121.965 1.777 . . . . 0.0 110.828 175.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 140' ' ' ILE . 52.1 mt -55.78 -24.78 37.7 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -169.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -79.24 -13.32 59.76 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -174.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.429 HG21 ' HB ' ' A' ' 162' ' ' VAL . 91.5 t -68.51 129.8 33.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.123 0.487 . . . . 0.0 110.647 -178.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -121.52 155.01 35.89 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.514 -175.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.415 ' CG ' HG22 ' A' ' 136' ' ' THR . 75.5 mt-10 -57.68 121.39 10.29 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.665 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 114.16 -17.41 19.48 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.496 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.588 ' OD2' ' HD3' ' A' ' 184' ' ' ARG . 22.0 t70 -65.41 144.38 57.1 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 177.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 48.5 t -93.24 108.53 20.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.13 0.49 . . . . 0.0 110.294 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 76.2 mt -92.54 117.92 30.46 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.379 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 1.9 mp -90.48 101.97 12.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 175.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 31.9 mm -89.73 124.06 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.421 -175.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.582 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 49.4 t30 -86.44 89.44 7.89 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 174.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.457 HG22 ' HA ' ' A' ' 127' ' ' LYS . 8.9 t -66.74 152.06 46.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.938 0.399 . . . . 0.0 110.463 -176.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 93.42 -45.98 2.38 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.4 -176.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -98.92 -27.73 13.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.107 0.479 . . . . 0.0 110.456 177.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.39 24.06 55.07 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.377 176.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.471 ' HB2' ' HB3' ' A' ' 175' ' ' ASN . 1.3 m -81.76 99.42 8.96 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -77.17 108.26 10.13 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.15 0.5 . . . . 0.0 110.827 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 36.9 mm -96.37 140.95 16.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 44.6 t -120.73 167.92 11.96 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 110.465 -0.198 . . . . 0.0 110.465 -176.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ARG . . . . . 0.588 ' HD3' ' OD2' ' A' ' 170' ' ' ASP . 25.8 mmt180 72.03 16.84 5.29 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.278 0.631 . . . . 0.0 112.538 173.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.031 0 CA-C-O 118.749 -1.028 . . . . 0.0 112.721 179.814 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 120.452 0.167 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.403 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 50.6 mm -94.74 143.82 11.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.2 m -104.8 157.67 17.04 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.7 m -66.25 -4.24 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.013 -175.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -76.82 -24.5 52.77 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.841 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -112.72 107.51 16.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.306 0.574 . . . . 0.0 111.774 -175.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -140.69 145.85 37.06 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 171.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.2 mtmm -131.11 175.1 9.38 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.231 -174.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 19.6 m -61.78 -22.1 65.13 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.57 0.7 . . . . 0.0 110.237 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -144.91 114.77 0.8 Allowed Glycine 0 N--CA 1.434 -1.495 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 167.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.4 tp -150.36 122.73 8.43 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 175.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.543 HG21 HG13 ' A' ' 65' ' ' ILE . 2.1 p -87.03 122.95 31.58 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.461 0.648 . . . . 0.0 111.93 -175.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.7 mm -119.22 141.08 40.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.539 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.452 ' HB3' ' HB2' ' A' ' 63' ' ' ALA . 43.0 p -107.69 103.82 13.19 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 176.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.3 p -143.9 148.38 18.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 63.75 24.13 13.72 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.206 -175.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 61.95 28.04 17.05 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.193 -176.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.15 164.09 27.08 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.771 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.6 pt -108.52 126.95 65.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.635 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.498 ' CZ3' ' HB2' ' A' ' 43' ' ' ASN . 11.5 m95 -128.36 166.27 18.99 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.719 -174.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -132.63 108.21 8.91 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.767 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 85.6 t -63.91 115.57 2.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.283 177.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 9' ' ' THR . 77.1 mt -95.88 -38.9 8.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.584 176.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -140.18 153.73 46.71 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.08 178.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 39' ' ' SER . 16.7 p90 -146.8 128.51 15.23 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.828 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -100.9 99.04 9.48 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.038 177.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -78.14 94.33 4.7 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 175.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.2 p -104.86 126.58 59.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.116 -173.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -117.47 103.86 50.55 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.441 -178.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -57.5 -47.35 22.15 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 123.239 2.626 . . . . 0.0 112.671 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 112.7 5.03 24.41 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.588 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -81.53 -14.46 56.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.097 -0.552 . . . . 0.0 110.812 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.42 -15.1 8.14 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.518 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.4 p -134.41 145.94 49.38 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.418 -0.391 . . . . 0.0 110.097 177.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -125.72 168.31 13.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.692 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -143.8 163.51 33.14 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.516 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.9 t -121.32 105.12 16.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.027 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -81.86 99.37 9.0 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 175.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 25' ' ' PHE . 60.7 p -103.07 146.94 27.61 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.135 0.493 . . . . 0.0 112.099 -171.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -103.2 110.04 21.86 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 174.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.543 HD23 ' H ' ' A' ' 41' ' ' LEU . 0.9 OUTLIER -135.43 144.27 46.39 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.517 0.675 . . . . 0.0 111.778 -171.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 35.8 ttt180 -99.84 127.71 45.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.535 -175.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.498 ' HB2' ' CZ3' ' A' ' 20' ' ' TRP . 53.8 t-20 -71.78 119.8 16.46 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 173.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.8 mp -66.03 -24.6 66.78 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.935 0.397 . . . . 0.0 111.169 -176.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -80.21 -42.88 22.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.67 -176.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.6 p -97.63 -22.3 16.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.203 0.525 . . . . 0.0 111.517 -176.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.31 17.71 79.04 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.662 -176.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' A' ' 42' ' ' ARG . . . -92.15 143.67 26.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.97 0.414 . . . . 0.0 111.984 -174.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 44.4 mm -92.2 100.99 12.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.774 175.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.442 ' HG2' ' H ' ' A' ' 51' ' ' GLU . 29.6 tt0 -113.56 173.42 6.42 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.442 ' H ' ' HG2' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -122.03 146.91 46.72 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.117 0.484 . . . . 0.0 110.963 173.356 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.405 ' HB2' HD21 ' A' ' 41' ' ' LEU . 14.3 tppt? -134.3 132.11 39.19 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.597 -177.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.2 m -100.24 103.88 15.34 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.065 0.46 . . . . 0.0 111.136 -177.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -87.34 141.45 28.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.892 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 49.7 mtp180 -115.62 133.75 55.72 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.721 0.296 . . . . 0.0 110.784 -176.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.41 133.32 55.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.771 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 107.42 -31.03 8.45 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -176.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -90.19 141.88 28.26 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 177.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -81.53 137.85 35.51 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.285 0.564 . . . . 0.0 111.305 -176.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.403 ' O ' ' HB ' ' A' ' 2' ' ' ILE . 61.5 t -100.14 112.74 33.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.429 176.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -93.61 120.56 66.13 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-O 120.918 0.39 . . . . 0.0 110.787 -177.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -77.33 157.58 33.18 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 123.003 2.469 . . . . 0.0 112.9 -175.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.452 ' HB2' ' HB3' ' A' ' 14' ' ' SER . . . -106.01 115.85 30.93 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.153 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -73.77 108.13 6.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.352 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.543 HG13 HG21 ' A' ' 12' ' ' THR . 37.4 mm -103.41 129.97 54.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.068 0.461 . . . . 0.0 110.453 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.433 ' HB2' ' OG1' ' A' ' 115' ' ' THR . 21.0 mt-10 -109.77 146.45 34.95 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.354 -177.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -136.89 113.93 10.59 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.891 0.377 . . . . 0.0 110.647 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.452 ' HG2' ' HG3' ' A' ' 86' ' ' GLU . 79.1 mtm180 -123.0 156.76 34.14 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.502 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 8.5 ptm180 -114.77 124.59 52.15 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.104 -178.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.629 ' CB ' ' HB3' ' A' ' 82' ' ' PHE . 1.9 mpt? -116.27 142.63 46.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.408 -178.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -82.07 134.78 35.37 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.09 175.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.588 ' CD1' ' HA ' ' A' ' 107' ' ' GLU . 42.8 t80 -71.84 115.67 11.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.317 -173.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 55.8 mt -115.33 -176.47 2.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.781 168.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -146.75 154.63 41.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.178 0.514 . . . . 0.0 111.473 -177.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -140.21 -149.43 0.28 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.229 -0.896 . . . . 0.0 108.584 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -69.46 132.3 46.1 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 171.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -75.86 69.29 2.15 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.104 -1.522 . . . . 0.0 113.719 -167.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -127.19 -29.96 2.71 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 156.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.542 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 19.4 m120 -133.94 142.02 47.54 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.803 178.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.58 ' ND1' ' HG ' ' A' ' 98' ' ' LEU . 53.2 m80 -119.86 144.34 47.42 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.418 177.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 61.1 t -88.69 136.35 23.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.837 -176.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.629 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 63.5 m-85 -131.02 125.62 33.77 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.452 ' O ' ' HA ' ' A' ' 70' ' ' MET . 72.5 mtm -95.86 114.62 26.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.717 0.294 . . . . 0.0 111.533 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.542 ' HA ' ' HG3' ' A' ' 70' ' ' MET . 19.2 t70 -61.97 116.37 4.84 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.77 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -70.52 -20.29 62.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.022 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.465 ' HB2' ' OD2' ' A' ' 84' ' ' ASP . 11.3 mm-40 -64.08 -51.15 65.45 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.478 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 5.0 p -171.15 91.74 0.15 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 168.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 47.99 29.86 1.84 Allowed 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 159.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.488 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 47.2 mt-10 -100.06 117.83 35.14 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 121.768 -0.582 . . . . 0.0 110.937 177.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -84.07 113.86 21.34 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.347 0.594 . . . . 0.0 110.534 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 56.5 m -110.15 128.14 55.3 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.966 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -102.25 141.5 34.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.047 0.451 . . . . 0.0 110.267 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' A' ' 79' ' ' ASN . 57.3 mt -118.64 144.21 46.31 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.469 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.9 t -83.52 173.24 11.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.583 -174.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.7 t -56.18 -44.24 79.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.935 -173.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.52 -37.22 86.79 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.738 0.304 . . . . 0.0 111.687 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.587 ' O ' ' HG2' ' A' ' 101' ' ' GLU . 97.1 m-85 -67.03 -40.04 87.12 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.58 ' HG ' ' ND1' ' A' ' 80' ' ' HIS . 3.7 mm? -74.6 -11.07 60.1 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.09 178.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -63.75 -44.32 93.84 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.834 0.349 . . . . 0.0 110.589 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.555 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 14.3 tp10 -74.34 -37.0 63.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.122 0.487 . . . . 0.0 109.781 175.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.587 ' HG2' ' O ' ' A' ' 97' ' ' TYR . 9.1 mm-40 -59.38 -43.46 92.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.983 176.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.558 ' O ' ' HB ' ' A' ' 156' ' ' THR . 85.9 mt -71.85 -2.43 17.77 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.006 0.431 . . . . 0.0 111.051 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.555 ' HB3' ' O ' ' A' ' 100' ' ' GLU . 29.3 t30 -80.73 -48.3 12.73 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 171.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.514 ' HB3' HG11 ' A' ' 129' ' ' VAL . 85.5 m-85 -146.99 117.19 7.33 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.523 174.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.476 HD22 ' O ' ' A' ' 101' ' ' GLU . 0.9 OUTLIER -172.94 169.18 4.8 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.588 0.232 . . . . 0.0 110.562 178.476 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.509 ' HD3' ' O ' ' A' ' 130' ' ' GLU . 30.6 mmmt -143.2 149.14 37.57 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 173.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.588 ' HA ' ' CD1' ' A' ' 72' ' ' TYR . 40.4 tt0 -69.57 130.91 43.73 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.071 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.46 -2.29 80.48 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.397 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 58.3 ttm -74.79 140.77 44.24 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 70' ' ' MET . 48.6 mt-10 -103.19 102.71 12.7 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.121 0.486 . . . . 0.0 110.073 -177.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.502 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 19.5 m -99.49 162.8 2.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.152 -174.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.565 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 57.9 mt-30 -104.55 100.36 10.03 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.989 0.423 . . . . 0.0 110.688 -178.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 59.3 mt -74.78 128.18 36.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.94 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.498 ' O ' HG13 ' A' ' 121' ' ' ILE . 7.8 tt0 -105.83 113.91 27.75 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.987 -175.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.433 ' OG1' ' HB2' ' A' ' 66' ' ' GLU . 74.1 p -114.85 155.3 27.06 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.23 -176.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -118.91 99.21 6.6 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 172.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 61.42 41.8 12.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.82 0.819 . . . . 0.0 109.639 -176.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.32 -19.83 37.35 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.506 -0.77 . . . . 0.0 113.192 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -82.02 116.44 21.63 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 24.2 m -65.28 106.01 1.25 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -176.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 114' ' ' GLN . 2.4 pp -100.18 -23.42 4.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.788 -177.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -170.41 175.53 44.28 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.17 -1.014 . . . . 0.0 112.727 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.2 t -135.43 129.76 49.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.849 0.357 . . . . 0.0 110.093 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.565 ' HB2' ' HB2' ' A' ' 112' ' ' GLN . 5.9 mm-40 -98.4 109.69 22.4 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.773 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 77.3 mt -80.6 135.19 53.16 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.784 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.42 131.25 44.63 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.621 2.214 . . . . 0.0 110.641 170.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 0.7 OUTLIER -60.74 -35.09 75.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.731 -167.036 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 18.0 p -96.76 110.53 22.98 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.029 0.442 . . . . 0.0 111.426 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.514 HG11 ' HB3' ' A' ' 104' ' ' TYR . 6.9 p -129.92 135.67 60.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.285 177.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.509 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 6.7 pt-20 -109.65 121.25 44.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.168 0.509 . . . . 0.0 111.352 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 77.9 mt -122.2 130.28 53.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.294 -178.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.1 m -75.1 134.36 41.34 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.172 178.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.446 HG12 ' O ' ' A' ' 170' ' ' ASP . 4.1 p -83.54 100.23 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-O 121.952 0.882 . . . . 0.0 110.702 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 29.8 p -90.88 103.27 16.0 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.466 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.474 ' HA ' ' OE2' ' A' ' 168' ' ' GLU . 44.1 mt-10 77.77 111.49 0.07 Allowed 'General case' 0 C--O 1.238 0.45 0 O-C-N 124.149 0.906 . . . . 0.0 111.998 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.0 t -150.39 152.81 34.94 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.542 -1.208 . . . . 0.0 108.579 174.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.43 ' O ' ' HD2' ' A' ' 150' ' ' LYS . 4.6 mp0 -82.99 123.5 77.61 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 120.762 0.315 . . . . 0.0 110.448 -176.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -82.38 -179.9 4.97 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.824 2.349 . . . . 0.0 112.114 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 119.45 32.98 1.16 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.22 -0.99 . . . . 0.0 113.162 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.442 HD12 ' HA ' ' A' ' 165' ' ' PHE . 12.2 tt . . . . . 0 CA--C 1.531 0.239 0 CA-C-O 121.401 0.62 . . . . 0.0 111.049 178.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.4 p . . . . . 0 C--O 1.235 0.295 0 CA-C-O 121.147 0.499 . . . . 0.0 111.451 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.43 ' HD2' ' O ' ' A' ' 137' ' ' GLU . 63.3 pttt -138.39 158.42 44.32 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.218 175.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.3 p -73.22 132.39 43.13 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.328 0.585 . . . . 0.0 111.751 -178.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.13 163.38 32.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.599 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 26.0 m -132.01 131.37 42.45 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 174.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.7 m -93.45 175.11 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -59.27 -25.94 64.52 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -176.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.558 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 47.1 p -72.5 -16.74 61.79 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.765 0.317 . . . . 0.0 111.563 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.22 1.81 59.32 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.593 -176.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -84.73 138.22 32.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.488 -0.356 . . . . 0.0 110.661 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 14.8 t -97.23 136.05 38.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.974 176.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -148.65 164.35 34.57 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -176.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -102.23 111.77 24.18 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.204 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 33.9 m -106.47 147.25 34.59 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.96 -176.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.7 154.97 39.73 Favored 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 122.712 2.275 . . . . 0.0 111.679 176.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.494 ' H ' HD22 ' A' ' 164' ' ' LEU . 1.8 mm? -67.07 -15.14 63.54 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -168.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.442 ' HA ' HD12 ' A' ' 140' ' ' ILE . 22.1 p90 -80.98 -11.11 59.62 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.861 0.362 . . . . 0.0 111.346 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.405 HG13 HD21 ' A' ' 172' ' ' LEU . 92.8 t -76.15 134.07 29.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.147 177.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -120.14 165.73 14.37 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.474 ' OE2' ' HA ' ' A' ' 135' ' ' GLU . 28.5 tt0 -61.42 152.27 30.24 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.595 -176.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 65.68 6.83 31.63 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 114.354 0.501 . . . . 0.0 114.354 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.446 ' O ' HG12 ' A' ' 133' ' ' VAL . 11.2 m-20 -77.7 147.83 35.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.653 0.727 . . . . 0.0 110.137 171.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 62.3 t -94.48 110.45 23.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.068 0.461 . . . . 0.0 109.898 177.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.406 HD23 ' HG2' ' A' ' 184' ' ' ARG . 67.7 mt -94.08 123.61 37.57 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.73 -176.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.535 ' O ' ' HB ' ' A' ' 182' ' ' ILE . 54.4 mt -90.73 128.38 42.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 174.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 37.1 mm -125.11 139.87 49.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -178.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.589 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 26.3 t-20 -87.32 91.69 8.81 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 174.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 11.1 t -74.07 148.29 42.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.964 0.411 . . . . 0.0 110.175 -177.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 105.65 -40.34 2.52 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 -174.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -109.8 -46.35 3.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.135 0.493 . . . . 0.0 110.001 175.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 107.01 11.15 26.75 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.671 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 175' ' ' ASN . 6.6 m -65.11 132.31 48.84 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -83.14 126.08 32.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.253 0.549 . . . . 0.0 110.468 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.535 ' HB ' ' O ' ' A' ' 173' ' ' ILE . 14.1 mm -106.61 156.71 7.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.4 p -74.45 170.19 16.19 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.258 0.551 . . . . 0.0 111.935 -170.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ARG . . . . . 0.406 ' HG2' HD23 ' A' ' 172' ' ' LEU . 84.0 mtm180 -70.05 145.27 51.83 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.726 -176.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.946 0 CA-C-O 118.57 -1.128 . . . . 0.0 111.77 178.259 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.8 ttt . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 120.772 0.32 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 46.6 mm -117.64 134.65 60.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 171.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.9 m -88.3 151.14 22.83 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.44 ' O ' HG21 ' A' ' 37' ' ' VAL . 29.7 m -68.5 -1.82 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 121.004 0.43 . . . . 0.0 111.667 -178.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -97.98 0.39 46.28 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.345 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -118.95 89.12 3.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.543 -178.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -134.21 153.29 51.94 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.928 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -129.95 175.94 8.46 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.167 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.2 t -66.33 -9.56 34.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.165 0.507 . . . . 0.0 110.079 175.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.669 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -152.26 115.43 0.69 Allowed Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 110.396 -1.081 . . . . 0.0 110.396 170.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.52 133.09 19.79 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 10.5 p -98.15 123.28 42.12 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.138 0.494 . . . . 0.0 112.023 -177.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.1 mp -125.7 141.93 44.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.14 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.412 ' HB2' ' HB2' ' A' ' 63' ' ' ALA . 23.0 t -106.24 105.27 15.22 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 176.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.7 p -147.52 148.36 16.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -176.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 62.68 24.89 14.82 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.199 0.312 . . . . 0.0 110.62 -174.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 63.74 24.16 13.73 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.611 0.72 . . . . 0.0 110.601 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.62 158.77 37.58 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.857 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.7 pt -105.22 125.8 60.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.281 0.563 . . . . 0.0 110.295 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.538 ' O ' ' HA ' ' A' ' 12' ' ' THR . 74.2 m95 -120.84 161.19 21.94 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.448 -170.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -136.7 110.4 8.09 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.163 176.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.669 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 89.3 t -60.52 117.26 2.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.932 177.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.3 mm -92.14 -30.73 4.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.481 175.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -153.89 140.48 18.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.427 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -126.29 138.68 53.62 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.806 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -118.82 100.07 7.16 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.023 176.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -75.58 101.49 4.94 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 177.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.4 p -109.58 126.47 66.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.391 0.615 . . . . 0.0 111.609 -172.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.8 mtmt -113.91 102.73 55.08 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.438 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -55.85 -47.8 23.22 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.509 2.806 . . . . 0.0 112.788 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.8 11.54 10.14 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.137 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -102.46 3.42 37.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.128 0.49 . . . . 0.0 110.694 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.6 -43.0 1.81 Allowed Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.384 178.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.8 p -93.32 126.34 38.39 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.819 0.342 . . . . 0.0 110.296 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.54 162.03 13.26 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.08 0.467 . . . . 0.0 110.813 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -134.84 166.13 23.7 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.815 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.44 HG21 ' O ' ' A' ' 4' ' ' VAL . 49.9 t -131.83 104.09 7.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 175.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -82.3 99.06 9.12 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.3 p -110.56 135.41 51.25 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.076 0.465 . . . . 0.0 111.892 -173.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -91.39 111.94 23.65 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 172.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.534 HD23 ' H ' ' A' ' 41' ' ' LEU . 1.2 pt? -138.71 145.1 39.9 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.175 0.512 . . . . 0.0 110.935 -173.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 9.9 ptt180 -106.96 143.08 35.57 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.865 -174.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -65.23 119.89 11.73 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 171.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.526 HD22 HD12 ' A' ' 121' ' ' ILE . 3.9 tt -67.38 -25.57 66.03 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.208 -170.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.406 ' CZ ' HG22 ' A' ' 121' ' ' ILE . 11.9 mtp180 -83.44 -46.42 12.53 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.411 -177.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.2 p -94.97 -20.48 19.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.011 0.434 . . . . 0.0 112.151 -173.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.93 17.85 73.84 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.111 -176.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 42' ' ' ARG . . . -75.0 126.54 31.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.834 0.349 . . . . 0.0 111.803 -177.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.1 mm -87.96 108.86 18.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.107 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -129.67 162.18 28.92 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -122.99 128.06 49.67 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.471 0.653 . . . . 0.0 110.559 174.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -128.12 144.63 51.12 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.559 -176.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.2 m -110.32 118.37 36.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.907 0.384 . . . . 0.0 111.354 -175.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -85.45 155.51 21.21 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.871 176.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.563 ' H ' ' HD2' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -122.19 132.88 54.67 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.043 0.449 . . . . 0.0 111.325 -176.186 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.63 138.06 58.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.089 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 108.22 -28.66 11.4 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.401 -177.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -100.83 141.27 33.95 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 177.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.64 142.68 37.02 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.008 0.432 . . . . 0.0 110.264 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.9 t -93.88 125.84 46.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.316 174.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -89.55 113.31 56.18 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 120.917 0.389 . . . . 0.0 110.21 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.01 159.63 41.11 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.606 2.204 . . . . 0.0 112.719 -176.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.412 ' HB2' ' HB2' ' A' ' 14' ' ' SER . . . -114.85 109.52 18.28 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.096 177.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 24.7 ttt -74.19 109.59 7.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.144 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.495 HG13 HG21 ' A' ' 12' ' ' THR . 48.7 mm -96.28 116.83 39.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.835 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.473 ' HB2' ' OG1' ' A' ' 115' ' ' THR . 27.8 mt-10 -96.84 141.51 29.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.506 -176.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -123.08 123.54 41.08 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.723 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.55 ' O ' ' HA ' ' A' ' 112' ' ' GLN . 52.6 mtt180 -124.37 164.33 19.88 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 174.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 10.3 ptm85 -126.72 131.98 51.23 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 176.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.522 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 13.7 mmm -127.01 139.3 53.13 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.265 -170.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -78.44 132.36 37.27 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 175.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.419 ' HB2' ' O ' ' A' ' 109' ' ' MET . 38.6 t80 -75.37 106.93 7.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.137 -174.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.7 mp -97.38 176.01 6.04 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 166.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -146.95 149.91 34.13 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 119.567 -0.853 . . . . 0.0 113.047 -170.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.96 -169.76 3.47 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 113.976 -1.465 . . . . 0.0 107.211 171.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -63.79 144.14 57.28 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 175.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.3 69.68 2.93 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 118.928 -1.606 . . . . 0.0 113.731 -168.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -126.21 -27.71 3.2 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 158.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.55 HD21 ' HB3' ' A' ' 92' ' ' GLU . 26.7 t-20 -140.76 128.45 21.6 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.308 -1.315 . . . . 0.0 109.897 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.495 ' ND1' HD22 ' A' ' 98' ' ' LEU . 47.6 m170 -122.03 148.28 45.03 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.568 0.223 . . . . 0.0 110.466 175.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 41.8 t -102.24 130.48 52.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.085 -175.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.485 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 79.7 m-85 -125.43 133.49 52.45 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.404 ' O ' ' HA ' ' A' ' 70' ' ' MET . 40.7 mtm -105.64 119.2 38.54 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 121.073 -0.251 . . . . 0.0 110.883 -178.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.559 ' HB3' ' H ' ' A' ' 89' ' ' GLU . 10.6 t70 -61.33 123.9 19.09 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.88 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -72.37 -20.83 61.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.833 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -66.58 -51.55 55.18 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.3 p -172.25 92.46 0.12 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 166.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 48.6 27.46 1.48 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 162.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.559 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 48.5 mt-10 -88.79 110.41 21.0 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 121.756 -0.59 . . . . 0.0 110.276 176.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -78.81 133.72 37.03 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.684 -177.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 90.6 m -131.01 120.85 24.07 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.937 174.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.55 ' HB3' HD21 ' A' ' 79' ' ' ASN . 29.1 mt-10 -99.89 127.56 46.05 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.004 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.433 HD12 ' CE1' ' A' ' 82' ' ' PHE . 52.6 mt -103.83 152.06 22.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.98 -177.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.624 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 13.8 m -96.44 170.64 9.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.316 -172.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.0 m -46.92 -38.13 10.04 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.27 0.628 . . . . 0.0 112.595 -175.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -50.34 -44.74 54.59 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.09 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -81.16 -36.92 29.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.323 0.582 . . . . 0.0 110.437 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.624 ' HG ' ' O ' ' A' ' 94' ' ' SER . 11.7 mt -64.68 -27.2 68.76 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.261 -171.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -59.87 -47.5 85.49 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.901 0.381 . . . . 0.0 110.561 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.51 ' HA ' ' ND2' ' A' ' 103' ' ' ASN . 41.9 mt-10 -70.1 -33.47 71.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.486 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.577 ' O ' HD12 ' A' ' 105' ' ' LEU . 72.7 mt-10 -59.74 -45.35 92.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.03 171.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 83.1 mt -66.55 -15.27 63.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.885 0.374 . . . . 0.0 111.068 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.51 ' ND2' ' HA ' ' A' ' 100' ' ' GLU . 77.5 m-20 -75.51 -50.55 15.34 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 172.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -145.96 117.2 7.89 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.543 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.577 HD12 ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -165.41 161.74 19.03 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.909 0.385 . . . . 0.0 110.999 176.247 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.471 ' HD3' ' O ' ' A' ' 130' ' ' GLU . 31.3 mmmt -136.0 142.61 44.51 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 172.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -68.52 130.77 43.84 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.72 0.295 . . . . 0.0 110.828 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.13 -4.9 81.43 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.289 -177.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.419 ' O ' ' HB2' ' A' ' 72' ' ' TYR . 52.3 ttm -62.25 130.02 43.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.874 0.369 . . . . 0.0 111.121 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.522 ' HA ' ' O ' ' A' ' 70' ' ' MET . 46.3 mt-10 -95.78 101.12 12.78 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.14 0.495 . . . . 0.0 109.846 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 26.4 m -100.17 164.24 2.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.397 -176.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.55 ' HA ' ' O ' ' A' ' 68' ' ' ARG . 15.2 mt-30 -102.23 108.28 19.61 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.143 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.464 HD12 ' HG3' ' A' ' 70' ' ' MET . 19.0 mt -84.01 122.79 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.554 ' O ' HG12 ' A' ' 121' ' ' ILE . 16.3 tt0 -99.3 118.77 36.71 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.263 -175.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.473 ' OG1' ' HB2' ' A' ' 66' ' ' GLU . 79.3 p -117.91 155.0 30.94 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.314 0.578 . . . . 0.0 111.854 -174.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -125.75 104.32 8.29 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 173.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 59.37 41.05 20.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.836 0.827 . . . . 0.0 109.852 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 91.16 -23.49 23.91 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.298 -0.865 . . . . 0.0 113.157 178.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -83.36 128.5 34.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.853 0.327 . . . . 0.0 110.946 -175.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.9 t -66.16 120.41 13.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.127 0.489 . . . . 0.0 110.915 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.554 HG12 ' O ' ' A' ' 114' ' ' GLN . 19.9 pt -109.69 -24.68 3.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.437 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -169.44 164.91 38.41 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.372 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 99.3 t -131.62 118.16 37.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.862 0.363 . . . . 0.0 110.195 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 112' ' ' GLN . 42.3 mt-10 -91.13 104.19 16.79 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.867 -176.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 70.3 mt -78.31 138.77 59.79 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 174.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.55 128.65 30.27 Favored 'Trans proline' 0 CA--C 1.515 -0.456 0 C-N-CA 122.771 2.314 . . . . 0.0 111.153 178.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.732 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 95.4 mttt -52.3 -33.7 43.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.479 -169.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.8 p -115.47 109.6 18.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.024 0.44 . . . . 0.0 111.302 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 13.0 p -112.34 143.59 21.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.763 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.471 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 47.3 mt-10 -104.45 124.26 48.93 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 177.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 62.6 mt -126.28 131.41 51.9 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.776 0.322 . . . . 0.0 110.409 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.5 m -74.45 132.84 42.28 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 170' ' ' ASP . 5.0 p -89.43 107.22 17.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.41 0.624 . . . . 0.0 110.338 178.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 13.1 p -105.02 124.53 49.68 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.714 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 70.6 88.87 0.1 Allowed 'General case' 0 C--O 1.237 0.421 0 CA-C-O 122.08 0.943 . . . . 0.0 111.611 -177.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.453 ' O ' ' HD3' ' A' ' 138' ' ' PRO . 15.2 t -151.36 139.85 20.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.512 -1.222 . . . . 0.0 107.839 170.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -82.37 113.0 40.97 Favored Pre-proline 0 C--N 1.322 -0.593 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.293 -170.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 136' ' ' THR . 96.9 Cg_endo -93.75 -179.84 0.87 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.257 2.638 . . . . 0.0 111.858 177.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.19 30.76 24.5 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.819 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.424 HG23 ' HB3' ' A' ' 164' ' ' LEU . 4.2 tp . . . . . 0 C--N 1.324 -0.533 0 CA-C-O 121.607 0.717 . . . . 0.0 110.195 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.6 p . . . . . 0 N--CA 1.452 -0.361 0 CA-C-O 120.649 0.261 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -137.22 151.34 48.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.014 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.9 m -73.08 110.62 7.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.216 0.531 . . . . 0.0 111.246 -174.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -116.21 162.06 18.03 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.729 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 22.7 m -125.86 140.68 52.46 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.739 174.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 12.8 m -101.87 173.08 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.805 175.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -56.98 -27.19 61.19 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.413 HG22 HD13 ' A' ' 105' ' ' LEU . 80.9 p -73.74 -11.89 60.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.79 0.329 . . . . 0.0 111.487 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 91.82 5.0 66.83 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.932 -0.652 . . . . 0.0 111.844 -177.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -85.04 141.68 30.11 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 27.0 m -99.2 129.67 45.45 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.648 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.4 mp -132.61 155.93 47.83 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 120.729 0.299 . . . . 0.0 110.238 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -93.7 99.35 11.78 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 34.6 m -97.34 150.71 37.1 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.082 -174.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -56.48 152.25 41.21 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.535 2.157 . . . . 0.0 111.277 174.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.424 ' HB3' HG23 ' A' ' 140' ' ' ILE . 59.1 mt -64.93 -14.85 61.11 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.612 -169.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -86.65 -7.42 58.34 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 88.0 t -75.6 131.13 35.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.861 0.362 . . . . 0.0 110.831 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -120.64 144.73 48.0 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.33 -175.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.419 ' HB3' HG22 ' A' ' 136' ' ' THR . 9.2 pt-20 -69.56 132.97 47.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.138 0.494 . . . . 0.0 110.987 -176.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 109.78 -16.51 30.95 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.418 -174.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.441 ' OD1' ' HB2' ' A' ' 184' ' ' ARG . 10.7 t70 -84.93 156.71 21.09 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 74.7 t -104.02 116.13 47.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.87 0.367 . . . . 0.0 110.563 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 184' ' ' ARG . 80.1 mt -94.68 145.65 24.7 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.587 -178.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.635 ' O ' ' HB ' ' A' ' 182' ' ' ILE . 26.6 mt -98.66 134.82 35.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 175.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 67.2 mt -135.2 137.6 49.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 O-C-N 122.039 -0.413 . . . . 0.0 110.46 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.732 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 27.0 t-20 -83.68 98.01 9.41 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 175.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 8.9 t -85.37 157.92 20.39 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.855 0.36 . . . . 0.0 110.071 -177.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 94.45 -48.71 2.11 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -173.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . 0.551 ' HB3' ' OD1' ' A' ' 175' ' ' ASN . 33.1 t70 -98.52 -42.3 7.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.001 0.429 . . . . 0.0 110.08 176.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 105.97 5.3 38.39 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.827 -0.701 . . . . 0.0 113.427 173.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 64.0 m -68.61 133.67 48.83 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.957 0.408 . . . . 0.0 111.038 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -86.64 134.41 33.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.1 0.476 . . . . 0.0 110.851 -177.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.635 ' HB ' ' O ' ' A' ' 173' ' ' ILE . 56.0 mt -116.04 155.0 17.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.3 p -75.88 172.7 12.26 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.419 0.152 . . . . 0.0 110.729 -176.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ARG . . . . . 0.441 ' HB2' ' OD1' ' A' ' 170' ' ' ASP . 8.3 ptp180 -57.99 159.15 5.9 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.174 0.511 . . . . 0.0 111.575 -173.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.791 -1.005 . . . . 0.0 111.471 178.722 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.9 mtp . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 120.578 0.228 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.416 HD12 ' HB3' ' A' ' 62' ' ' PRO . 53.7 mt -115.73 137.95 47.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-O 121.209 0.528 . . . . 0.0 111.382 -177.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.0 t -116.97 166.07 12.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.03 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.407 ' O ' HG21 ' A' ' 37' ' ' VAL . 21.2 m -67.96 -7.9 7.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -170.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -86.92 -2.39 58.57 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.637 -176.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -137.62 95.45 3.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.284 0.564 . . . . 0.0 112.198 -178.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -121.1 160.37 23.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.231 173.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -139.94 169.17 18.19 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.585 -0.154 . . . . 0.0 110.585 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.1 t -61.81 -13.1 20.95 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 123.632 0.583 . . . . 0.0 111.828 -173.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.34 113.14 0.66 Allowed Glycine 0 N--CA 1.434 -1.475 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 165.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 62.9 tp -150.93 129.35 12.08 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 2.7 p -98.48 129.4 45.07 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.24 0.543 . . . . 0.0 111.677 -177.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 mp -128.37 138.58 54.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.996 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.7 p -94.66 110.45 22.29 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.042 175.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.7 p -150.67 147.78 15.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -178.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 62.11 30.93 17.92 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.312 0.383 . . . . 0.0 110.864 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 63.3 24.43 14.26 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.94 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -137.83 168.59 19.38 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.255 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 11.1 pt -116.73 127.31 74.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.257 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.551 ' O ' ' HA ' ' A' ' 12' ' ' THR . 15.4 m95 -127.67 157.87 39.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.044 -172.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 44.5 tttm -123.23 119.51 30.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.317 175.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 90.9 t -62.34 117.95 4.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.402 0.62 . . . . 0.0 110.65 175.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 86.8 mt -90.0 -39.07 11.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.4 173.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -152.3 148.0 27.02 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.027 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -135.98 140.67 44.11 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.107 0.48 . . . . 0.0 111.032 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 7.3 tp-100 -117.93 99.89 7.21 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.053 175.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -78.0 89.25 4.15 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.0 p -97.04 131.06 44.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.058 -173.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.403 ' HD3' ' N ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -122.93 105.11 35.18 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.442 179.542 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.46 -10.63 27.21 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.689 2.259 . . . . 0.0 112.793 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.69 22.89 63.3 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.775 176.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -104.18 0.59 29.7 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.991 0.424 . . . . 0.0 110.79 -178.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 130.81 -42.07 1.45 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.765 175.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.4 m -118.83 146.42 44.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.768 0.318 . . . . 0.0 110.692 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.82 160.92 14.06 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.142 0.496 . . . . 0.0 110.945 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -132.49 161.8 32.82 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 53' ' ' THR . 48.1 t -132.24 102.6 5.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 120.842 0.353 . . . . 0.0 110.601 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -79.71 99.09 7.25 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 174.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.1 p -112.5 139.5 48.03 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.129 0.49 . . . . 0.0 112.17 -174.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -89.76 121.22 31.7 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 171.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.473 HD23 ' H ' ' A' ' 41' ' ' LEU . 0.8 OUTLIER -141.23 142.42 33.96 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.491 0.662 . . . . 0.0 111.697 -174.513 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.1 ttp180 -104.67 129.73 52.79 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.483 -174.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -69.09 118.22 11.72 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 173.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.3 mp -66.65 -28.93 68.86 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -175.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.588 ' HA ' ' O ' ' A' ' 121' ' ' ILE . 68.0 mtt85 -73.07 -44.57 60.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.958 0.409 . . . . 0.0 111.65 -176.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.4 p -102.85 -11.61 18.16 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.018 0.437 . . . . 0.0 112.029 -173.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.92 21.82 78.25 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -176.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.8 133.41 34.34 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -172.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.3 mm -89.74 110.05 21.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.926 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.4 ' HG2' ' N ' ' A' ' 51' ' ' GLU . 50.8 tt0 -132.25 172.69 12.1 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.4 ' N ' ' HG2' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -130.28 147.12 51.96 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.022 0.439 . . . . 0.0 110.864 175.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.425 ' HD2' HD11 ' A' ' 41' ' ' LEU . 67.8 mttm -142.75 148.04 36.57 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.908 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 43.7 m -111.44 117.53 33.29 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.006 0.432 . . . . 0.0 110.342 178.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -84.6 140.71 31.18 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.82 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 47.8 mtm105 -107.17 138.44 43.35 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.585 -177.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.53 130.65 46.08 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.795 0.331 . . . . 0.0 110.258 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.67 -29.97 8.92 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -174.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.11 119.83 24.53 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 175.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -71.32 131.8 43.96 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.369 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.9 t -91.34 107.99 19.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.156 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -87.64 113.25 53.51 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.419 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.416 ' HB3' HD12 ' A' ' 2' ' ' ILE . 58.3 Cg_endo -72.94 155.5 53.0 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.503 2.136 . . . . 0.0 112.702 -178.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.31 115.58 27.6 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.328 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 46.1 ttm -76.92 108.47 9.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.781 -178.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.488 HG13 HG21 ' A' ' 12' ' ' THR . 43.2 mm -100.94 139.02 23.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.396 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 114' ' ' GLN . 39.0 mt-10 -105.09 116.73 32.44 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 175.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -99.71 99.08 9.86 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 173.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -111.87 124.73 52.98 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.015 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.589 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 12.8 ptp180 -86.84 120.18 27.84 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.329 0.585 . . . . 0.0 109.485 177.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.817 ' SD ' ' HA ' ' A' ' 84' ' ' ASP . 8.5 mmt -107.32 145.58 32.64 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.724 -178.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -79.58 136.12 36.77 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 172.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.451 ' CZ ' HD23 ' A' ' 105' ' ' LEU . 47.4 t80 -77.13 108.38 10.19 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.807 -176.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 3.3 mm? -99.51 177.33 5.2 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 167.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -146.94 150.73 35.76 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.67 -175.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.05 -162.92 1.65 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.735 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -62.74 137.76 58.35 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 174.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.43 70.19 2.46 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 119.209 -1.472 . . . . 0.0 113.151 -171.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -125.87 -32.56 2.8 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 161.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.501 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 78.6 m-20 -141.29 135.19 30.35 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 114.065 -1.425 . . . . 0.0 109.293 175.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.527 ' CG ' HD22 ' A' ' 98' ' ' LEU . 58.6 m170 -107.66 144.1 35.22 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 175.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 73' ' ' LEU . 49.5 t -94.3 121.91 45.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.794 -175.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.542 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 76.8 m-85 -117.85 126.04 51.65 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 176.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 14.7 tmm? -97.48 117.26 31.33 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.021 -175.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.817 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 17.6 t70 -62.42 114.65 3.63 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.418 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -76.94 -5.11 47.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.414 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -76.9 -50.94 12.17 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 173.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.7 p -170.94 93.95 0.18 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 168.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 50.09 28.83 3.19 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 157.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.57 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 34.1 mt-10 -101.14 115.25 30.04 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 121.466 -0.771 . . . . 0.0 111.287 175.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -82.38 108.98 16.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.316 0.579 . . . . 0.0 110.962 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 54.8 m -101.81 123.21 45.38 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.801 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -99.58 125.25 45.34 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.852 0.358 . . . . 0.0 110.334 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.501 ' O ' ' HA ' ' A' ' 79' ' ' ASN . 42.6 mt -97.85 138.77 34.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.349 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.526 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 29.5 t -79.95 169.23 18.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.716 -174.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.2 p -50.48 -39.41 48.18 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.963 0.505 . . . . 0.0 112.312 -175.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -59.31 -36.09 74.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.648 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -76.07 -35.47 59.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.305 0.574 . . . . 0.0 109.504 177.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.634 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 14.2 mt -64.32 -30.09 71.15 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.238 -176.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -62.6 -32.69 73.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.935 176.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -73.27 -40.52 64.53 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.552 ' O ' HD12 ' A' ' 105' ' ' LEU . 47.8 mt-10 -62.05 -36.76 82.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.732 175.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 79.9 mt -73.52 0.57 12.12 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.078 0.466 . . . . 0.0 110.824 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' A' ' 158' ' ' TYR . 57.5 t30 -93.95 -43.26 8.63 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 170.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -148.34 117.09 6.66 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.26 172.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.552 HD12 ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -160.21 153.39 21.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.926 0.393 . . . . 0.0 110.649 172.255 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.7 mtpt -144.03 146.85 33.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.791 172.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -71.13 132.11 44.57 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.344 -174.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.67 0.68 90.25 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.771 177.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.446 ' SD ' ' HG3' ' A' ' 126' ' ' PRO . 57.5 ttm -82.65 141.74 32.26 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.809 0.338 . . . . 0.0 111.438 -177.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' A' ' 70' ' ' MET . 54.2 mp0 -84.19 123.47 30.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.084 175.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 34.7 m -121.79 158.9 24.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.329 177.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.55 ' HB2' ' HB3' ' A' ' 124' ' ' GLU . 15.8 mm-40 -91.34 101.55 14.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.755 0.312 . . . . 0.0 110.194 -175.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 48.8 mm -94.01 122.03 45.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 178.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 87.2 mt-30 -98.47 117.34 32.68 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.742 0.306 . . . . 0.0 110.539 -178.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.413 ' OG1' ' HB2' ' A' ' 66' ' ' GLU . 35.2 p -112.36 151.22 30.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.915 176.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -135.56 103.12 5.34 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 60.06 31.77 20.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.528 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 104.44 -30.27 10.42 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 121.102 -0.571 . . . . 0.0 113.019 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -76.72 131.21 38.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.561 0.219 . . . . 0.0 111.276 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 17.6 p -73.43 106.6 5.3 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 172.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' A' ' 45' ' ' ARG . 45.2 pt -94.25 -31.2 4.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -174.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -162.38 164.38 35.55 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 119.641 -1.266 . . . . 0.0 113.135 -177.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 59.9 t -133.38 127.57 54.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.55 ' HB3' ' HB2' ' A' ' 112' ' ' GLN . 35.1 tt0 -118.69 122.99 43.81 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.041 0.448 . . . . 0.0 110.337 178.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -86.54 155.67 56.55 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.446 ' HG3' ' SD ' ' A' ' 109' ' ' MET . 10.5 Cg_endo -53.5 132.76 50.4 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.58 2.187 . . . . 0.0 110.982 176.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 95.7 mttt -54.85 -34.77 63.28 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.518 -174.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 19.7 p -122.92 109.08 13.69 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.045 176.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.5 p -106.25 136.81 39.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.499 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -94.3 108.53 20.42 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 177.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.524 HD12 HD13 ' A' ' 174' ' ' ILE . 98.7 mt -117.92 134.4 54.98 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.253 0.549 . . . . 0.0 110.744 -176.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.0 m -81.45 131.25 35.27 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.752 177.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.0 p -81.05 119.36 30.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.685 0.755 . . . . 0.0 111.084 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.482 ' O ' ' HB ' ' A' ' 153' ' ' THR . 41.6 p -125.27 128.9 48.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.555 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 75.94 86.02 0.09 Allowed 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.898 0.856 . . . . 0.0 110.69 -175.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.449 ' O ' ' HD3' ' A' ' 138' ' ' PRO . 13.3 t -150.96 155.02 38.22 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.462 173.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -82.5 110.7 23.35 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 120.424 0.154 . . . . 0.0 110.699 -176.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 136' ' ' THR . 96.6 Cg_endo -91.11 162.7 3.83 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.056 2.504 . . . . 0.0 112.709 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 98.15 -2.62 59.71 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.547 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 9.6 tt . . . . . 0 C--N 1.323 -0.576 0 CA-C-O 121.308 0.575 . . . . 0.0 110.356 -178.827 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 27.6 p . . . . . 0 N--CA 1.449 -0.51 0 CA-C-O 121.267 0.556 . . . . 0.0 112.004 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.402 ' HE3' ' OG1' ' A' ' 136' ' ' THR . 54.0 pttt -130.75 147.46 52.41 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.225 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 17.2 t -73.84 99.76 3.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.343 0.592 . . . . 0.0 110.303 -178.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -106.98 170.07 8.17 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.61 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 134' ' ' THR . 3.5 m -122.75 147.37 46.57 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 175.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.582 HG23 HG22 ' A' ' 156' ' ' THR . 2.6 m -109.68 170.95 2.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.23 173.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -53.24 -33.24 52.11 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -176.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.582 HG22 HG23 ' A' ' 154' ' ' VAL . 15.1 t -74.46 -8.25 55.68 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -176.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 95.91 -4.71 65.84 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.476 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.462 ' H ' HG23 ' A' ' 156' ' ' THR . 90.9 t80 -76.31 137.19 39.72 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.808 0.337 . . . . 0.0 110.719 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.55 130.87 44.57 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.522 177.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.475 HD11 HG13 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -142.99 148.07 36.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.937 0.398 . . . . 0.0 111.357 -175.244 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -85.55 102.41 13.5 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.775 176.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.468 HG13 HD13 ' A' ' 160' ' ' LEU . 26.8 m -102.18 149.78 36.91 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.503 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -51.81 145.38 31.78 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.514 2.143 . . . . 0.0 111.39 175.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 72.4 mt -59.07 -24.61 63.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.622 -169.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -85.89 7.49 23.92 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -175.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.429 HG22 ' HD2' ' A' ' 184' ' ' ARG . 91.1 t -82.91 137.79 20.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 176.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -123.38 156.52 35.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.671 -0.241 . . . . 0.0 110.68 -176.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -59.15 116.7 4.03 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.502 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 121.24 -16.6 9.2 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.535 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -64.57 139.51 58.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.812 0.339 . . . . 0.0 110.989 176.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 55.4 t -100.43 103.73 15.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.414 ' CD1' HD11 ' A' ' 174' ' ' ILE . 0.9 OUTLIER -113.89 150.01 34.28 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.808 -176.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.457 ' O ' ' HB ' ' A' ' 182' ' ' ILE . 55.1 mt -103.03 134.66 43.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.827 -173.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.524 HD13 HD12 ' A' ' 131' ' ' LEU . 4.0 mp -121.68 141.12 43.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.754 0.312 . . . . 0.0 110.325 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.508 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 28.0 t-20 -84.61 105.58 15.52 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 175.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 37.6 p -64.82 158.6 24.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.151 -173.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 77.78 -55.3 3.81 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.415 178.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -84.8 -43.13 14.49 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.737 0.303 . . . . 0.0 110.737 -177.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 101.88 4.15 51.68 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.513 173.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 34.9 m -63.78 142.92 58.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.958 0.409 . . . . 0.0 110.951 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -98.44 124.37 43.11 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.2 0.524 . . . . 0.0 111.177 -175.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.457 ' HB ' ' O ' ' A' ' 173' ' ' ILE . 2.6 mp -95.11 152.87 3.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 173.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 17.4 m -74.85 169.42 17.96 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.234 0.54 . . . . 0.0 111.609 -170.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ARG . . . . . 0.429 ' HD2' HG22 ' A' ' 166' ' ' VAL . 58.6 mtp180 -63.08 147.58 50.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.358 -175.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.097 -1.39 . . . . 0.0 110.904 175.858 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.8 mtt . . . . . 0 N--CA 1.482 1.166 0 CA-C-O 120.776 0.322 . . . . 0.0 110.643 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.434 HD12 HG13 ' A' ' 13' ' ' ILE . 61.0 mt -93.97 131.77 39.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.446 -174.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 p -88.91 158.14 18.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.954 174.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.425 ' O ' HG21 ' A' ' 37' ' ' VAL . 15.8 m -71.28 -3.27 3.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -173.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -99.68 6.57 45.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.459 0.647 . . . . 0.0 109.895 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -124.31 88.94 2.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.244 0.545 . . . . 0.0 111.177 -177.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -142.06 156.3 45.4 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.026 177.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -139.95 165.77 26.44 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.7 t -57.19 -15.24 5.32 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.087 0.47 . . . . 0.0 111.169 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -147.95 113.72 0.65 Allowed Glycine 0 N--CA 1.435 -1.368 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 165.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 55.4 tp -151.63 134.61 15.77 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 1.1 p -98.46 124.44 43.17 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.356 0.598 . . . . 0.0 112.262 -176.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.434 HG13 HD12 ' A' ' 2' ' ' ILE . 4.0 mp -127.49 138.99 53.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.983 -178.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.7 p -100.24 110.32 22.56 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.164 0.507 . . . . 0.0 110.301 176.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.5 p -155.03 156.83 4.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -177.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 61.16 24.59 14.69 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.712 0.291 . . . . 0.0 110.887 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 16.0 m120 65.45 30.18 10.95 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.211 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -145.05 163.98 32.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.306 178.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 13.8 pt -105.97 125.77 61.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.199 0.523 . . . . 0.0 109.886 176.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.601 ' O ' ' HA ' ' A' ' 12' ' ' THR . 82.1 m95 -117.77 161.44 19.69 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.803 -169.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -132.02 101.63 5.5 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.606 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.414 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 89.9 t -62.74 116.55 2.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.901 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.4 mm -88.95 -36.14 8.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.242 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -162.71 113.78 1.51 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.788 -177.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 39' ' ' SER . 19.8 p90 -102.87 146.37 28.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.0 0.429 . . . . 0.0 111.014 -176.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -123.47 104.58 9.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.408 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -77.49 96.26 4.68 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 175.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.4 p -104.1 136.18 38.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.614 -171.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -117.94 89.75 34.97 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.456 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.36 -11.31 31.08 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.736 2.291 . . . . 0.0 113.121 -175.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.46 26.23 25.95 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.446 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -92.93 -11.84 32.37 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.33 0.586 . . . . 0.0 110.354 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.04 -19.85 17.52 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 -176.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.5 m -129.28 140.49 51.41 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.77 152.56 20.09 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.204 0.525 . . . . 0.0 110.824 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -131.64 167.1 20.02 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.929 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.425 HG21 ' O ' ' A' ' 4' ' ' VAL . 46.1 t -132.4 102.47 5.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 120.725 0.297 . . . . 0.0 110.428 178.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -77.45 99.26 5.57 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.461 ' HA ' ' HA ' ' A' ' 25' ' ' PHE . 18.2 m -103.4 126.03 50.32 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.547 -175.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.5 tppt? -84.68 110.22 18.59 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 173.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.453 HD23 ' H ' ' A' ' 41' ' ' LEU . 0.8 OUTLIER -138.01 144.06 40.9 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.893 0.854 . . . . 0.0 112.121 -172.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 42' ' ' ARG . 18.6 ttt180 -100.19 130.15 46.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.519 -175.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -64.48 112.29 3.07 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 173.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.6 tt -71.34 -14.08 62.08 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.209 0.528 . . . . 0.0 110.635 -171.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 45' ' ' ARG . 11.7 mtp180 -86.82 -45.28 11.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.497 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.4 p -101.24 -20.52 15.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.059 0.457 . . . . 0.0 111.868 -173.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.15 10.15 75.34 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.86 -176.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.71 145.4 38.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.116 0.484 . . . . 0.0 111.961 -175.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.6 mm -100.09 113.43 35.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.428 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.511 ' HG2' ' H ' ' A' ' 51' ' ' GLU . 31.8 tt0 -133.32 176.38 8.57 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.511 ' H ' ' HG2' ' A' ' 50' ' ' GLN . 9.6 pt-20 -138.26 142.35 39.87 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.937 0.398 . . . . 0.0 110.24 173.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -130.41 134.08 46.85 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.363 -177.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.4 p -98.19 110.34 22.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.048 0.451 . . . . 0.0 110.857 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -84.64 147.98 26.67 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.917 178.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.643 ' HD3' ' OE2' ' A' ' 58' ' ' GLU . 44.4 ttt180 -112.92 128.96 56.61 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.93 -174.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.3 125.76 24.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.605 178.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.43 -15.88 32.23 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.928 -178.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.643 ' OE2' ' HD3' ' A' ' 55' ' ' ARG . 42.8 mt-10 -119.26 99.71 6.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.899 0.38 . . . . 0.0 110.19 177.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -76.84 153.38 34.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.955 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.0 m -120.4 162.8 18.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.073 0.464 . . . . 0.0 111.446 -176.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -84.07 132.87 46.75 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.425 -177.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.418 ' HB3' HD11 ' A' ' 2' ' ' ILE . 82.2 Cg_endo -79.07 151.75 23.97 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.688 2.259 . . . . 0.0 112.334 176.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -118.99 114.52 22.67 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.387 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 64.8 mtt -94.15 118.12 31.09 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 48.9 mm -89.35 127.57 41.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.582 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -103.23 118.0 35.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.522 -174.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -102.42 125.72 49.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.787 0.327 . . . . 0.0 110.408 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 71.0 mtt-85 -126.18 115.03 19.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.964 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' A' ' 69' ' ' ARG . 13.3 ptm180 -85.49 117.82 24.64 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.369 0.604 . . . . 0.0 109.683 175.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.618 ' SD ' HD12 ' A' ' 113' ' ' ILE . 31.1 mtt -120.75 143.68 48.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.697 -174.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -77.3 132.72 38.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.777 176.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -73.37 104.26 4.32 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.23 -174.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.407 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 60.8 mt -99.06 -175.66 3.1 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 172.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -144.04 149.65 36.99 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.644 0.735 . . . . 0.0 112.518 -170.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.27 -154.23 0.53 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.661 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -79.86 152.06 29.88 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -82.27 66.65 3.84 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 117.858 -2.115 . . . . 0.0 112.787 -174.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -129.14 -31.79 2.08 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 156.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.572 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 81.9 m-20 -141.04 130.34 23.63 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.653 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.428 ' O ' ' HA ' ' A' ' 92' ' ' GLU . 30.1 m170 -110.69 141.52 43.83 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 175.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.407 ' O ' ' HB2' ' A' ' 73' ' ' LEU . 41.5 t -87.52 130.52 37.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.922 -177.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.424 ' CE1' HD12 ' A' ' 93' ' ' LEU . 83.0 m-85 -124.26 128.39 49.09 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 174.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 25.8 ttt -94.34 112.0 23.77 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.46 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.604 ' HB3' ' H ' ' A' ' 89' ' ' GLU . 25.0 t70 -58.59 110.05 0.91 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.168 177.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -80.59 -4.51 54.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.7 -177.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -70.19 -50.7 37.55 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 173.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.6 p -171.85 93.56 0.15 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 165.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 49.79 29.37 3.2 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 159.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.604 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 42.9 mt-10 -100.12 105.97 17.65 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 121.584 -0.697 . . . . 0.0 111.346 176.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -70.08 125.02 25.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.919 0.39 . . . . 0.0 110.22 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 46.6 m -128.16 125.33 38.88 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.161 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.428 ' HA ' ' O ' ' A' ' 80' ' ' HIS . 32.3 mt-10 -104.58 131.74 51.64 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.8 0.333 . . . . 0.0 110.769 -177.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 79' ' ' ASN . 42.3 mt -100.28 146.56 26.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.575 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.634 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 8.3 t -88.08 166.31 14.52 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.924 -172.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.7 t -51.1 -42.8 60.88 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -171.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -55.1 -45.89 75.5 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -178.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -71.8 -39.89 69.57 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.25 0.548 . . . . 0.0 109.562 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 94' ' ' SER . 56.8 mt -60.2 -28.16 67.75 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.851 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -57.82 -43.95 86.08 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.914 0.388 . . . . 0.0 110.913 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -80.17 -43.33 21.76 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.692 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.486 ' HG3' HD11 ' A' ' 125' ' ' LEU . 0.6 OUTLIER -62.94 -27.57 69.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.99 177.626 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 22.3 mt -75.07 -14.44 60.58 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 122.308 -0.245 . . . . 0.0 111.096 177.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -74.6 -43.92 53.24 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.428 ' HB3' HG11 ' A' ' 129' ' ' VAL . 40.9 m-85 -138.18 116.74 12.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.431 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.454 HD22 ' C ' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -170.78 157.99 5.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.302 0.572 . . . . 0.0 111.113 176.141 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.447 ' HD3' ' O ' ' A' ' 130' ' ' GLU . 31.5 mmmt -130.1 139.29 50.95 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.775 172.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -73.21 127.35 32.36 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.28 -0.36 71.64 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.079 -175.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.459 ' SD ' ' HG3' ' A' ' 126' ' ' PRO . 42.1 ttm -87.47 144.18 26.86 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.679 0.276 . . . . 0.0 111.145 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 70' ' ' MET . 45.3 mt-10 -85.51 122.63 29.91 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.963 177.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 24.9 m -112.34 156.34 13.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -101.31 99.27 9.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.086 0.47 . . . . 0.0 110.176 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.618 HD12 ' SD ' ' A' ' 70' ' ' MET . 54.6 mt -83.24 127.11 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.49 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.531 ' O ' HG12 ' A' ' 121' ' ' ILE . 17.6 tt0 -100.31 112.34 24.67 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.392 -174.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 25.7 p -116.16 155.75 27.69 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.857 -176.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.416 ' HB2' HD13 ' A' ' 121' ' ' ILE . 78.6 t80 -132.69 109.46 9.72 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 172.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 60.46 31.48 20.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.029 0.442 . . . . 0.0 110.853 -175.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.68 -12.95 65.51 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.715 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -86.18 126.94 34.61 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 25.5 m -67.67 117.05 9.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.637 0.256 . . . . 0.0 110.658 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 114' ' ' GLN . 12.9 pt -105.64 -23.35 4.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.813 0.34 . . . . 0.0 111.047 178.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -170.65 166.41 39.6 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.013 176.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 61.1 t -133.19 126.11 52.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -107.4 113.38 26.69 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.936 0.398 . . . . 0.0 110.962 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.486 HD11 ' HG3' ' A' ' 101' ' ' GLU . 3.0 mm? -81.02 149.95 67.67 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 173.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.459 ' HG3' ' SD ' ' A' ' 109' ' ' MET . 9.8 Cg_endo -53.38 137.67 64.78 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.559 2.173 . . . . 0.0 111.417 176.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.605 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 31.8 mmtp -61.28 -27.93 68.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.715 -172.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.5 p -124.61 107.46 11.04 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.194 0.521 . . . . 0.0 110.394 174.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.428 HG11 ' HB3' ' A' ' 104' ' ' TYR . 7.1 p -107.27 144.96 15.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.457 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.447 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 35.7 mt-10 -110.36 113.36 25.96 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.906 0.384 . . . . 0.0 110.381 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 73.6 mt -120.5 129.41 53.83 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.406 -176.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.6 m -72.42 131.21 42.28 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.143 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 170' ' ' ASP . 9.6 p -84.16 112.96 22.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.749 0.785 . . . . 0.0 110.515 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.45 ' O ' ' HB ' ' A' ' 153' ' ' THR . 31.9 p -115.81 119.53 36.31 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.184 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 77.37 87.81 0.07 Allowed 'General case' 0 C--O 1.237 0.413 0 O-C-N 123.991 0.807 . . . . 0.0 110.904 -177.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 12.8 t -151.03 152.88 34.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.81 172.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -114.02 109.74 49.36 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 120.73 0.3 . . . . 0.0 111.393 -177.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 164' ' ' LEU . 12.4 Cg_exo -70.87 -176.39 1.78 Allowed 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 123.66 2.907 . . . . 0.0 111.601 172.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 122.99 35.54 0.72 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.059 -1.067 . . . . 0.0 113.246 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.1 tp -48.0 118.27 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 121.258 0.552 . . . . 0.0 109.994 173.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -87.76 56.22 3.81 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -166.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 82.69 -32.01 2.95 Favored Glycine 0 CA--C 1.518 0.224 0 CA-C-N 115.923 -0.581 . . . . 0.0 114.093 171.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -80.43 153.28 28.34 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 117.184 0.492 . . . . 0.0 110.361 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 2.7 m -110.29 45.3 1.13 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.374 0.607 . . . . 0.0 110.057 -178.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.19 128.24 34.92 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.399 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 16.8 p -70.44 -19.44 62.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.394 -177.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -100.12 19.26 53.73 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.152 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.449 ' O ' ' HG ' ' A' ' 164' ' ' LEU . . . -80.66 82.73 6.59 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 177.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 29.6 p -123.43 158.22 31.66 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.746 -175.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.8 ttpp -132.58 161.06 34.82 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 176.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 34.9 p -72.49 107.69 5.16 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.159 0.504 . . . . 0.0 110.513 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.468 ' HB2' HG22 ' A' ' 162' ' ' VAL . . . -107.32 164.08 12.49 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.386 178.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' A' ' 134' ' ' THR . 22.4 m -119.19 136.03 54.39 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.857 175.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 12.4 m -100.77 174.29 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.0 175.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -56.16 -29.01 60.22 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 59.3 p -72.71 -19.31 61.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.986 0.422 . . . . 0.0 111.484 -177.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 100.22 -3.12 56.67 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -174.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -75.63 144.57 41.65 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.871 0.367 . . . . 0.0 110.688 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 18.9 m -106.07 122.71 46.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.3 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.85 158.58 43.85 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -177.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -88.85 108.86 19.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.069 -174.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.468 HG22 ' HB2' ' A' ' 152' ' ' ALA . 32.7 m -102.72 147.36 33.94 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.586 178.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' A' ' 148' ' ' ALA . 51.0 Cg_exo -54.15 144.83 56.93 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.289 1.993 . . . . 0.0 111.51 172.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 138' ' ' PRO . 77.2 mt -63.0 -7.78 5.99 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -172.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -100.55 10.5 41.1 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 93.9 t -87.78 131.87 34.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.532 0.206 . . . . 0.0 110.55 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -110.73 154.2 24.22 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.996 0.427 . . . . 0.0 110.934 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -59.83 127.13 30.41 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.731 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 112.26 -20.9 20.7 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.429 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.454 ' O ' HG12 ' A' ' 133' ' ' VAL . 2.2 m-20 -64.13 143.39 57.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.851 0.358 . . . . 0.0 110.761 177.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 61.8 t -95.09 110.32 23.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.315 0.579 . . . . 0.0 109.843 177.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.42 HD11 ' HB ' ' A' ' 133' ' ' VAL . 47.8 mt -87.35 129.33 35.06 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.5 -176.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.555 ' O ' ' HB ' ' A' ' 182' ' ' ILE . 40.8 mt -94.43 127.96 46.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 59.8 mt -126.39 138.33 54.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.78 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.605 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 0.2 OUTLIER -80.98 91.39 6.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.655 177.557 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.64 133.52 49.51 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.627 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 120.46 -40.33 2.2 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -115.07 -28.87 6.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.24 0.543 . . . . 0.0 110.254 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 88.45 19.34 52.69 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.111 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 19.3 t -79.31 130.83 35.84 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.8 0.333 . . . . 0.0 110.111 -177.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -76.67 127.42 32.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.322 0.582 . . . . 0.0 111.163 -177.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.555 ' HB ' ' O ' ' A' ' 173' ' ' ILE . 59.7 mt -105.8 153.68 7.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 173.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 16.2 p -74.69 146.34 42.4 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.252 0.548 . . . . 0.0 111.113 -168.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -55.93 142.16 36.67 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.077 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.648 -1.085 . . . . 0.0 112.238 -179.005 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ttt . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 121.073 0.463 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.6 mp -111.88 130.7 65.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.0 t -111.78 174.0 6.09 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 22.9 m -72.33 0.91 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -172.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -93.13 -1.57 56.25 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.017 0.437 . . . . 0.0 110.225 176.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -111.06 88.92 2.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.104 -176.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -141.47 147.56 38.06 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 175.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -130.11 174.96 9.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.729 -0.214 . . . . 0.0 110.496 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.4 t -57.84 -24.48 57.62 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 121.343 0.592 . . . . 0.0 110.234 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.624 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -147.13 116.33 0.84 Allowed Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 169.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 57.8 tp -145.94 130.99 18.29 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.567 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 1.7 p -92.87 127.21 38.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.925 0.393 . . . . 0.0 111.957 -177.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mp -127.19 139.69 51.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.247 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.8 t -99.74 107.89 20.08 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.5 p -151.22 150.18 13.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -176.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.8 23.95 14.27 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.803 0.335 . . . . 0.0 110.474 -176.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.7 m120 62.12 33.4 16.99 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.878 -178.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -140.97 162.28 35.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.029 176.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 11.8 pt -104.92 121.0 56.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.344 0.592 . . . . 0.0 110.292 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.567 ' O ' ' HA ' ' A' ' 12' ' ' THR . 70.9 m95 -115.77 164.38 14.46 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.838 -172.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -140.42 109.27 6.01 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 120.935 0.397 . . . . 0.0 110.209 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.624 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 94.2 t -58.66 122.03 7.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.128 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.441 HD11 ' HB2' ' A' ' 42' ' ' ARG . 81.4 mt -87.58 -38.5 12.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.517 174.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -163.2 144.44 9.56 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.24 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -125.24 138.54 54.11 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.095 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -109.52 98.68 8.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.144 175.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 21.5 t-160 -81.08 98.13 7.86 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.9 131.34 48.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.401 0.62 . . . . 0.0 111.458 -174.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.44 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -111.86 101.54 51.68 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.292 -177.818 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -65.87 -46.81 4.4 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.776 2.317 . . . . 0.0 112.47 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.02 17.55 6.28 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.92 -177.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -105.66 10.42 32.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.997 0.427 . . . . 0.0 110.271 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.57 -43.21 3.22 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 -176.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.2 m -89.3 98.33 11.71 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.851 0.358 . . . . 0.0 110.098 176.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -86.73 171.5 10.88 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.504 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -142.13 164.25 30.66 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.355 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 53' ' ' THR . 48.0 t -127.95 107.05 15.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.594 -176.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -80.5 98.17 7.46 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 173.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.6 p -104.97 135.81 45.62 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.99 0.424 . . . . 0.0 111.489 -175.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -95.95 109.87 22.17 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 175.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.555 HD23 ' H ' ' A' ' 41' ' ' LEU . 1.4 pt? -132.5 145.61 51.3 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.405 0.621 . . . . 0.0 111.369 -172.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 22.0 ttp180 -106.39 132.1 52.81 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.657 -175.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -62.03 119.32 8.66 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 172.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.452 HD22 HD12 ' A' ' 121' ' ' ILE . 4.2 tt -64.86 -28.05 69.29 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.795 -171.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 45' ' ' ARG . 52.9 mtt-85 -85.11 -43.65 13.68 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -176.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.6 p -102.05 -9.68 20.37 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -172.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.22 18.94 75.39 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.41 -178.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 42' ' ' ARG . . . -77.01 131.31 38.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.745 0.307 . . . . 0.0 111.553 -177.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.3 mm -89.89 102.14 12.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.062 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.457 ' HG2' ' N ' ' A' ' 51' ' ' GLU . 36.0 tt0 -116.13 169.2 9.45 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.457 ' N ' ' HG2' ' A' ' 50' ' ' GLN . 6.6 pt-20 -136.59 130.05 31.74 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.346 0.593 . . . . 0.0 110.541 172.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -123.22 146.49 47.78 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.306 -176.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 55.3 m -107.55 111.03 23.1 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.979 0.418 . . . . 0.0 110.862 177.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -85.37 142.43 29.3 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.802 177.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 55' ' ' ARG . 36.7 mtp-105 -113.38 135.15 54.17 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.083 -173.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.11 129.34 40.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.478 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.73 -18.37 29.48 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.353 -175.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -99.81 134.81 42.17 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -87.34 133.83 33.65 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.354 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.2 t -94.13 134.99 29.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.331 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -101.47 112.93 65.79 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.885 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.0 163.64 34.93 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.58 2.186 . . . . 0.0 112.606 -177.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -121.89 109.57 14.81 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.701 177.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 64.2 mtt -84.65 109.35 17.93 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.039 0.447 . . . . 0.0 110.903 -177.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.484 HD12 ' CD1' ' A' ' 121' ' ' ILE . 34.6 mm -90.38 120.94 40.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.928 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -94.9 109.27 21.29 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -89.09 131.04 35.43 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.903 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 52.2 mtt180 -130.44 170.39 14.26 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 69' ' ' ARG . 13.7 ptm180 -130.18 125.37 34.81 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.02 0.438 . . . . 0.0 110.07 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.515 ' CB ' ' HB3' ' A' ' 82' ' ' PHE . 2.0 mpt? -117.49 143.22 46.27 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.347 -176.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -84.78 139.46 31.93 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.74 173.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.539 ' CD1' ' HA ' ' A' ' 107' ' ' GLU . 32.7 t80 -71.63 110.15 6.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.861 -176.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.8 mp -100.69 -174.66 2.69 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 169.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -143.02 147.82 35.74 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.437 0.637 . . . . 0.0 111.759 -169.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.5 -165.95 2.38 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.805 176.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -72.51 146.17 46.99 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 174.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.66 68.45 3.0 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 118.683 -1.722 . . . . 0.0 112.857 -171.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -128.13 -33.05 2.21 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 161.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.425 ' OD1' ' HB3' ' A' ' 92' ' ' GLU . 28.3 t30 -143.26 136.82 28.41 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 113.359 -1.746 . . . . 0.0 109.267 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.462 ' ND1' HD22 ' A' ' 98' ' ' LEU . 55.7 m170 -117.58 148.41 41.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.771 0.32 . . . . 0.0 110.539 178.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 45.7 t -100.17 132.23 46.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.079 -176.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.515 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 71.6 m-85 -130.19 124.72 33.25 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 176.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 90.6 mmm -99.7 117.73 34.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.724 0.297 . . . . 0.0 111.52 -175.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.542 ' HB3' ' H ' ' A' ' 89' ' ' GLU . 11.5 t70 -67.63 127.67 33.61 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.496 -178.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -79.64 -16.59 55.5 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.202 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.522 ' HB3' ' OD2' ' A' ' 84' ' ' ASP . 11.6 tp10 -66.92 -52.69 40.06 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 56.0 p -171.43 91.71 0.14 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 167.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 47.41 28.05 1.04 Allowed 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 162.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.542 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 28.0 mm-40 -83.42 101.31 11.28 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 118.392 0.542 . . . . 0.0 110.083 176.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -73.65 96.47 2.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.856 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.9 m -95.6 129.32 42.83 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.476 -175.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.425 ' HB3' ' OD1' ' A' ' 79' ' ' ASN . 35.5 mt-10 -106.68 137.67 44.27 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.931 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.471 HD12 ' CE1' ' A' ' 82' ' ' PHE . 64.7 mt -119.72 133.57 55.57 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.027 0.441 . . . . 0.0 111.189 -178.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.614 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 49.8 m -90.81 179.72 5.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.023 -176.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.0 p -47.73 -41.14 22.32 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -174.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -55.23 -38.14 68.09 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.038 0.446 . . . . 0.0 111.621 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.421 ' HB2' ' HB3' ' A' ' 93' ' ' LEU . 66.0 m-85 -85.68 -34.96 21.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.041 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.614 ' HG ' ' O ' ' A' ' 94' ' ' SER . 20.8 mt -63.63 -22.51 66.94 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.288 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -59.77 -42.77 94.03 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.477 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -66.74 -38.38 86.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.621 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.594 ' O ' HD12 ' A' ' 105' ' ' LEU . 53.5 mt-10 -63.1 -36.4 83.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.097 175.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 82.3 mt -62.42 -21.23 65.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.917 0.389 . . . . 0.0 110.34 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -80.96 -50.99 9.03 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 171.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -142.79 118.53 10.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.546 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.594 HD12 ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -154.17 144.74 22.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.996 0.427 . . . . 0.0 110.312 172.415 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -144.42 139.86 28.64 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 175.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.539 ' HA ' ' CD1' ' A' ' 72' ' ' TYR . 29.0 tt0 -74.44 129.72 38.29 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.091 -177.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.54 1.24 71.64 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.49 -177.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 50.0 ttm -67.74 144.05 55.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.06 0.457 . . . . 0.0 111.501 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -92.59 104.28 16.59 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.822 174.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 26.3 m -105.49 158.76 5.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.704 0.288 . . . . 0.0 110.75 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -111.72 103.39 11.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.834 0.35 . . . . 0.0 110.098 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 60.4 mt -96.52 127.35 48.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.958 0.409 . . . . 0.0 110.394 -177.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.494 ' O ' HG12 ' A' ' 121' ' ' ILE . 76.5 mt-30 -91.04 120.02 31.68 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.928 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 62.4 p -116.32 145.72 42.97 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.319 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -124.98 98.89 5.88 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 60.38 41.8 15.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.691 -173.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 88.93 -18.69 42.55 Favored Glycine 0 CA--C 1.516 0.151 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.874 178.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -82.43 123.68 29.36 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.658 0.266 . . . . 0.0 110.767 -177.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 42.5 p -69.57 107.88 3.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.883 0.373 . . . . 0.0 110.455 178.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.494 HG12 ' O ' ' A' ' 114' ' ' GLN . 21.6 pt -93.94 -28.35 4.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.022 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -164.19 155.05 26.23 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.325 178.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.6 t -120.68 123.27 69.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -106.14 123.27 47.76 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 120.956 0.408 . . . . 0.0 110.351 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.469 ' HB2' HG21 ' A' ' 176' ' ' THR . 75.2 mt -97.08 148.54 34.54 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.725 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.23 135.46 64.92 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.034 2.489 . . . . 0.0 112.123 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 62.5 mttm -67.5 -16.03 63.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.894 -173.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 18.6 p -127.06 109.83 12.3 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.945 0.402 . . . . 0.0 110.671 175.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 12.3 p -120.69 141.79 39.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.513 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -104.02 104.47 14.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.35 0.595 . . . . 0.0 110.784 -178.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 78.0 mt -119.41 129.65 54.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.479 -177.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 3.1 m -75.04 134.09 41.47 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.49 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.468 ' HB ' HD11 ' A' ' 172' ' ' LEU . 3.7 p -79.35 109.1 13.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.683 0.754 . . . . 0.0 109.944 174.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.444 ' O ' ' HB3' ' A' ' 135' ' ' GLU . 36.3 p -114.5 115.36 27.12 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.552 -177.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.444 ' HB3' ' O ' ' A' ' 134' ' ' THR . 15.9 tp10 77.52 101.65 0.07 Allowed 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.928 0.871 . . . . 0.0 110.841 -177.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 14.6 t -150.75 153.74 36.08 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.616 -1.175 . . . . 0.0 108.343 175.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -82.39 147.01 55.41 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-O 120.889 0.376 . . . . 0.0 110.903 -174.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.11 -179.76 2.83 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 123.101 2.534 . . . . 0.0 112.162 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 119.35 32.53 1.23 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.005 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.9 tt -62.09 108.92 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.467 0.651 . . . . 0.0 110.636 176.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -84.52 -56.97 3.34 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.44 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 85.6 -31.41 3.9 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.224 174.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -102.23 -74.51 0.63 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.833 0.349 . . . . 0.0 110.791 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 23.9 m -82.18 76.86 9.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.432 0.634 . . . . 0.0 110.773 -177.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -129.6 -75.41 0.55 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.868 176.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 33.9 p 46.23 58.15 4.73 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.135 0.574 . . . . 0.0 112.443 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 106.26 10.77 29.0 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.347 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -89.35 129.42 35.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.819 0.342 . . . . 0.0 110.208 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 24.1 p -132.24 161.76 32.64 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.112 0.482 . . . . 0.0 111.462 -175.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -129.78 150.1 51.23 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.926 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 18.5 m -73.8 99.83 3.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.092 0.472 . . . . 0.0 111.447 -175.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -104.94 164.94 11.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.782 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 25.9 m -125.75 130.32 51.25 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.004 175.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 14.6 m -86.99 175.01 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.599 -0.441 . . . . 0.0 110.811 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -57.03 -30.0 63.86 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.469 HG22 HD13 ' A' ' 105' ' ' LEU . 64.9 p -72.72 -20.18 61.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.766 0.317 . . . . 0.0 111.477 -177.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 102.78 -1.11 48.59 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.617 -175.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -74.49 129.98 38.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.88 0.372 . . . . 0.0 110.856 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.8 p -91.82 131.94 36.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.709 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -148.71 153.59 38.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.913 0.387 . . . . 0.0 110.321 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -87.83 101.18 13.46 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.205 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 31.7 m -95.86 144.93 28.67 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.635 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.86 150.02 24.14 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 122.478 2.119 . . . . 0.0 111.433 175.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 65.0 mt -61.71 -22.01 64.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.714 -169.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -79.21 -17.15 55.39 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 63.4 t -65.5 131.21 31.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.63 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -119.53 159.02 25.13 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.414 -176.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -57.15 123.58 15.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.666 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 109.95 -12.62 31.95 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.774 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.584 ' OD1' ' HD3' ' A' ' 184' ' ' ARG . 26.2 t70 -68.03 141.02 56.33 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.741 0.305 . . . . 0.0 110.64 178.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 3.7 p -86.1 108.21 17.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.716 0.77 . . . . 0.0 110.425 177.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.468 HD11 ' HB ' ' A' ' 133' ' ' VAL . 85.3 mt -91.59 119.12 31.21 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.256 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.596 ' O ' ' HB ' ' A' ' 182' ' ' ILE . 56.0 mt -90.57 104.47 15.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 173.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 37.1 mt -95.75 130.92 43.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 C-N-CA 120.414 -0.514 . . . . 0.0 109.854 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.563 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 23.3 t-20 -80.07 89.55 5.39 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.976 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.469 HG21 ' HB2' ' A' ' 125' ' ' LEU . 4.7 m -61.43 129.55 41.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.658 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 115.55 -41.98 2.02 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -177.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -106.94 -33.66 7.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.199 0.523 . . . . 0.0 110.086 176.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 95.01 10.78 57.18 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.487 177.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.81 131.18 47.96 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -178.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -100.0 112.41 24.69 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.227 0.537 . . . . 0.0 110.839 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.596 ' HB ' ' O ' ' A' ' 173' ' ' ILE . 4.0 mp -107.63 134.93 47.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 43.0 t -113.43 165.63 12.28 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.477 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.584 ' HD3' ' OD1' ' A' ' 170' ' ' ASP . 30.1 mmt180 69.82 25.7 4.97 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 123.69 0.618 . . . . 0.0 112.095 174.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.626 -1.097 . . . . 0.0 113.009 177.987 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mmt . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 120.947 0.403 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.437 ' HB ' ' HB ' ' A' ' 60' ' ' VAL . 44.4 mm -109.29 145.06 16.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.673 178.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.6 t -94.23 156.28 16.62 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 176.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.9 m -71.69 1.36 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.269 0.557 . . . . 0.0 110.827 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -107.22 11.29 29.47 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.447 176.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -126.92 88.5 2.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.026 0.441 . . . . 0.0 111.041 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -139.86 152.34 46.39 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.372 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.501 ' HG2' ' HG ' ' A' ' 11' ' ' LEU . 19.3 ptpt -143.6 178.19 7.96 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.6 p -56.11 -12.97 1.71 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -160.19 115.56 0.67 Allowed Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.04 172.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.501 ' HG ' ' HG2' ' A' ' 8' ' ' LYS . 8.9 mt -148.66 138.91 22.44 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 122.541 0.336 . . . . 0.0 110.293 174.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 2.9 m -95.28 115.49 27.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.189 0.519 . . . . 0.0 110.743 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.438 HG23 ' O ' ' A' ' 61' ' ' GLU . 1.9 mp -120.95 140.7 44.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.209 -176.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.7 t -98.91 118.0 34.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.953 0.406 . . . . 0.0 110.336 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.7 p -153.09 144.89 15.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 62.45 28.54 16.85 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 122.627 0.371 . . . . 0.0 110.661 -176.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.6 m120 62.52 25.22 15.02 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.396 -177.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.99 159.2 39.44 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 176.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 10.5 pt -106.46 122.96 60.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.233 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.527 ' O ' ' HA ' ' A' ' 12' ' ' THR . 33.3 m95 -119.63 165.52 14.36 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.772 -172.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -128.03 104.88 8.03 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.713 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.507 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 77.3 t -62.8 106.15 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.554 178.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.0 mm -85.0 -33.43 8.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.713 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -152.52 147.08 25.79 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.328 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -136.03 141.87 44.37 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.636 -177.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -124.52 106.35 10.09 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.078 177.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 16.1 t60 -74.07 89.61 1.97 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 176.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.5 p -92.83 128.15 44.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.894 -172.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.3 pttt -126.11 102.57 27.44 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.765 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -57.26 -47.2 23.47 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.357 2.704 . . . . 0.0 112.469 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.72 4.02 17.6 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.763 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -84.8 -12.42 53.66 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.075 0.464 . . . . 0.0 110.183 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.35 -42.25 1.29 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.659 176.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.0 m -99.84 134.34 42.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.868 0.366 . . . . 0.0 110.952 -177.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.55 153.97 18.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.173 0.511 . . . . 0.0 110.887 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -133.76 168.77 18.11 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.264 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 48.2 t -130.32 103.86 8.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 120.992 0.425 . . . . 0.0 110.083 176.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -82.37 98.82 9.04 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.7 p -110.03 139.0 45.63 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.817 -173.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -95.53 114.97 26.78 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 174.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.544 HD23 ' H ' ' A' ' 41' ' ' LEU . 0.9 OUTLIER -136.91 141.88 42.72 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.727 0.775 . . . . 0.0 111.316 -171.335 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -98.73 130.04 45.19 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.621 -176.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -64.24 114.14 4.04 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 171.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.424 HD21 ' OE1' ' A' ' 114' ' ' GLN . 7.8 tt -70.24 -22.16 62.93 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.726 -170.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -83.01 -46.45 12.84 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.4 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.7 p -97.24 -14.27 21.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.196 0.522 . . . . 0.0 111.908 -174.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.9 24.79 71.0 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.952 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.35 133.46 33.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.861 0.363 . . . . 0.0 111.784 -175.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.6 mm -93.36 109.85 22.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.107 178.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -136.78 177.41 7.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.841 0.353 . . . . 0.0 110.44 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -137.98 146.81 43.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.111 0.481 . . . . 0.0 110.517 173.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -135.07 171.41 14.47 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.309 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.8 t -127.77 118.31 23.52 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.416 0.626 . . . . 0.0 110.828 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -85.23 151.79 23.81 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.497 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -123.78 130.38 52.53 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.326 0.584 . . . . 0.0 111.795 -173.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.94 138.48 58.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.112 176.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.92 -19.21 28.17 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 111.341 -0.703 . . . . 0.0 111.341 -174.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -126.25 150.77 48.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.024 0.44 . . . . 0.0 110.415 176.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 20.1 pttm -89.33 152.13 21.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.29 -175.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.437 ' HB ' ' HB ' ' A' ' 2' ' ' ILE . 64.4 t -102.53 136.44 34.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.348 -178.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.438 ' O ' HG23 ' A' ' 13' ' ' ILE . 7.1 tp10 -88.52 121.2 70.29 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.738 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.27 151.64 20.53 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.244 1.963 . . . . 0.0 112.048 175.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.452 ' HB3' HG22 ' A' ' 12' ' ' THR . . . -113.68 116.8 30.01 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.402 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 61.8 mtt -96.73 110.25 22.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.472 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 54.8 mt -109.85 138.93 35.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.839 0.352 . . . . 0.0 111.07 -176.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -112.85 139.51 48.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.441 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -117.09 127.01 53.73 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 177.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.51 ' HG2' ' OE2' ' A' ' 86' ' ' GLU . 40.6 mtm180 -135.82 165.39 25.72 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.402 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 16.5 ptp180 -127.84 125.65 40.15 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.18 0.514 . . . . 0.0 111.262 -176.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.546 ' HG3' ' HA ' ' A' ' 84' ' ' ASP . 1.9 mpt? -119.92 141.02 49.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.557 -176.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -79.31 140.47 37.54 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.102 177.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -74.58 111.59 9.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.745 -174.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -104.86 -179.64 4.0 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 167.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -145.5 142.14 28.95 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.487 -171.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.72 -170.74 3.53 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.664 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -60.67 131.19 49.94 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.68 68.84 2.44 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 119.153 -1.499 . . . . 0.0 114.322 -165.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -126.76 -30.42 2.77 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 154.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.458 ' OD1' ' HB3' ' A' ' 92' ' ' GLU . 55.7 t30 -133.53 132.38 40.87 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 113.59 -1.641 . . . . 0.0 109.477 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.627 ' CD2' ' HG ' ' A' ' 98' ' ' LEU . 14.5 m-70 -124.23 143.65 50.41 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 55.7 t -92.56 134.17 31.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.026 -175.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.519 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 74.4 m-85 -128.9 126.12 39.04 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 174.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.0 mmt -99.15 117.92 34.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.777 0.323 . . . . 0.0 111.332 -175.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.597 ' HB3' ' H ' ' A' ' 89' ' ' GLU . 23.0 t70 -60.23 115.39 3.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.088 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -72.56 -18.75 61.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.315 -176.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.51 ' OE2' ' HG2' ' A' ' 68' ' ' ARG . 46.3 mt-10 -71.76 -45.78 60.56 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 120.669 -0.412 . . . . 0.0 109.949 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.4 p -169.42 91.3 0.23 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 168.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 47.51 28.19 1.12 Allowed 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 156.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.597 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 37.2 tt0 -93.79 118.14 31.03 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 118.711 0.687 . . . . 0.0 110.809 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -77.61 112.63 14.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.264 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 43.0 m -110.21 119.28 38.77 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.37 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.458 ' HB3' ' OD1' ' A' ' 79' ' ' ASN . 36.3 mt-10 -99.19 127.77 45.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.314 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 39.9 mt -118.89 148.9 42.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.018 0.437 . . . . 0.0 111.004 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.2 m -89.99 166.57 13.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.089 -174.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.8 t -55.52 -31.54 62.15 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.462 -177.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -50.35 -49.24 54.65 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.605 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -77.98 -40.67 38.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.362 0.601 . . . . 0.0 109.74 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.627 ' HG ' ' CD2' ' A' ' 80' ' ' HIS . 4.3 mm? -66.09 -13.82 60.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.88 -174.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -57.77 -39.03 76.48 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.915 0.388 . . . . 0.0 110.106 172.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.58 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 8.4 tp10 -78.09 -43.43 29.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.746 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.468 ' O ' HD12 ' A' ' 105' ' ' LEU . 1.2 mp0 -57.47 -46.21 83.93 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.654 175.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 82.4 mt -67.92 -9.07 42.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.98 0.419 . . . . 0.0 111.116 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.58 ' HB3' ' O ' ' A' ' 100' ' ' GLU . 23.1 t30 -78.73 -50.2 11.78 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 173.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -141.1 116.7 10.24 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.293 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.468 HD12 ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -171.64 167.46 6.53 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.251 0.548 . . . . 0.0 111.818 178.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.401 ' N ' HD22 ' A' ' 105' ' ' LEU . 66.1 mttm -141.67 143.67 33.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.842 168.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.5 mp0 -65.09 123.29 19.11 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 175.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.34 -13.43 47.89 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.039 -175.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.414 ' SD ' ' HG2' ' A' ' 126' ' ' PRO . 44.2 ttm -76.67 136.67 39.13 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 70' ' ' MET . 11.7 pt-20 -98.89 126.54 44.59 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.229 0.538 . . . . 0.0 111.142 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 31.4 m -106.71 160.05 6.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.905 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -100.14 100.86 11.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.065 0.46 . . . . 0.0 110.263 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.422 HD12 ' SD ' ' A' ' 70' ' ' MET . 65.1 mt -83.17 129.01 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.581 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.496 ' HG2' HD11 ' A' ' 121' ' ' ILE . 35.3 tt0 -106.8 117.36 33.84 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.925 -176.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 16.5 p -116.19 153.18 32.31 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.088 -174.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -130.03 99.39 5.06 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.935 176.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 61.97 31.79 17.96 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.374 0.607 . . . . 0.0 110.312 -174.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 93.78 -16.69 60.25 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.399 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -80.86 114.86 20.04 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 29.6 m -63.57 112.37 2.77 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.782 0.325 . . . . 0.0 110.604 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.496 HD11 ' HG2' ' A' ' 114' ' ' GLN . 38.7 pt -97.65 -23.97 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.04 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -170.47 163.46 36.68 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.016 -1.087 . . . . 0.0 112.848 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.3 t -127.63 126.63 67.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -106.59 120.6 42.38 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.76 -176.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.441 HD22 ' N ' ' A' ' 125' ' ' LEU . 1.9 mm? -86.18 150.21 51.67 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.414 ' HG2' ' SD ' ' A' ' 109' ' ' MET . 71.9 Cg_exo -51.42 130.89 34.59 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.697 2.265 . . . . 0.0 111.602 174.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.58 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 34.8 mmtp -62.37 -27.25 68.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.329 -170.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 34.9 p -121.32 112.73 18.95 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.97 176.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.1 p -114.8 137.03 49.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.164 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -109.32 99.03 8.34 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.226 0.536 . . . . 0.0 110.703 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.2 mt -106.9 142.05 37.14 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.056 0.455 . . . . 0.0 111.272 -173.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.4 m -84.14 133.7 34.61 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.037 176.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.6 p -87.34 112.37 23.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.629 0.728 . . . . 0.0 111.029 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 27.5 p -111.15 119.66 39.71 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.316 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 75.11 108.27 0.07 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.873 0.844 . . . . 0.0 111.041 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 8.9 t -150.55 153.44 35.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.673 178.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.452 ' O ' ' HD2' ' A' ' 150' ' ' LYS . 52.5 mt-10 -84.2 150.43 57.86 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.245 -176.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.29 179.9 6.07 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.51 2.14 . . . . 0.0 111.863 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 119.81 27.92 2.0 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.431 -177.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.9 tt -66.46 117.09 6.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.277 0.56 . . . . 0.0 110.447 176.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -71.95 -34.42 68.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.454 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 119.54 -26.41 7.31 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.108 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -102.68 170.9 7.73 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.169 0.509 . . . . 0.0 110.805 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.8 t -125.5 21.17 7.87 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.629 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -93.99 -29.48 15.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.185 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.9 t -62.47 144.48 55.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.838 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -96.14 15.35 63.1 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.173 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -86.61 154.32 21.12 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.741 0.305 . . . . 0.0 110.815 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 23.0 p -136.8 174.54 10.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.507 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.452 ' HD2' ' O ' ' A' ' 137' ' ' GLU . 59.6 pttt -133.41 145.86 50.68 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.524 177.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 9.1 t -73.18 118.66 16.4 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.109 0.481 . . . . 0.0 110.338 -176.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -124.02 164.22 19.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.013 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 33.4 m -120.54 135.98 54.92 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 9.7 m -98.73 173.94 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.284 177.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -52.81 -31.23 37.69 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 68.5 p -74.42 -12.6 60.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.712 0.291 . . . . 0.0 111.721 -176.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 95.48 -4.72 66.93 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.015 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -75.53 144.91 41.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.992 0.425 . . . . 0.0 110.603 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 23.3 m -107.24 122.44 46.55 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.178 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.07 161.62 37.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.696 0.284 . . . . 0.0 110.302 -177.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -92.1 111.49 23.06 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.083 -175.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 27.4 m -101.14 155.81 35.89 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.228 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -58.2 152.09 55.12 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.357 2.038 . . . . 0.0 111.4 174.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 72.6 mt -64.08 -18.33 64.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.468 -169.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -91.28 -1.94 57.54 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -176.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 85.8 t -73.11 135.6 27.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.957 0.408 . . . . 0.0 110.694 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -113.98 151.51 32.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.193 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -63.33 125.7 25.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.115 0.483 . . . . 0.0 110.683 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 109.54 -10.5 32.93 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.19 -176.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.592 ' OD2' ' HD3' ' A' ' 184' ' ' ARG . 19.1 t70 -73.39 148.19 43.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.597 0.237 . . . . 0.0 110.676 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.477 ' O ' ' HD2' ' A' ' 184' ' ' ARG . 60.7 t -105.33 99.97 9.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.197 0.522 . . . . 0.0 110.51 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.558 ' H ' HD23 ' A' ' 172' ' ' LEU . 0.7 OUTLIER -96.01 141.17 29.73 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.603 -177.718 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.421 ' O ' ' HB ' ' A' ' 182' ' ' ILE . 59.2 mt -99.22 130.54 48.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.344 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 43.9 mm -117.87 141.43 36.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.58 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 23.6 t-20 -87.85 98.81 11.68 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 177.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.21 127.06 31.23 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.518 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 111.02 -37.25 3.81 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.652 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -104.78 -23.84 12.99 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.099 0.476 . . . . 0.0 110.359 176.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 73.88 17.53 79.36 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.201 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 9.6 p -84.42 152.37 24.06 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.873 0.368 . . . . 0.0 110.633 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -97.33 124.79 41.58 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.19 0.519 . . . . 0.0 110.671 -175.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' A' ' 173' ' ' ILE . 2.8 mp -106.74 151.02 8.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 174.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.2 p -77.15 173.56 11.71 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.377 -173.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.592 ' HD3' ' OD2' ' A' ' 170' ' ' ASP . 7.9 tpt180 -39.59 136.18 1.03 Allowed 'General case' 0 CA--C 1.533 0.319 0 O-C-N 123.754 0.659 . . . . 0.0 112.473 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.488 -1.174 . . . . 0.0 111.698 175.263 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.7 mtt . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 120.477 0.18 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.2 mm -104.29 122.87 57.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.7 0.286 . . . . 0.0 110.425 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.1 m -74.04 146.62 43.57 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 175.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.49 ' O ' HG21 ' A' ' 37' ' ' VAL . 20.7 m -70.11 -10.56 13.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.848 0.356 . . . . 0.0 111.744 -176.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -95.39 7.78 45.18 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.34 0.59 . . . . 0.0 109.542 177.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -120.79 87.79 2.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.687 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -136.9 152.84 50.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.217 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -128.19 167.44 16.83 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.809 -176.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.2 m -54.17 -30.24 48.64 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.344 0.592 . . . . 0.0 110.34 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.524 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -140.36 116.74 1.2 Allowed Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 169.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 54.9 tp -150.46 135.35 17.58 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 1.9 p -94.44 122.43 37.0 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.444 0.64 . . . . 0.0 112.192 -176.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.401 HD12 ' C ' ' A' ' 12' ' ' THR . 1.7 mp -119.39 141.92 37.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.53 -176.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.514 ' O ' ' HB3' ' A' ' 61' ' ' GLU . 43.1 t -107.32 107.73 18.79 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.433 HG12 ' CD1' ' A' ' 20' ' ' TRP . 13.1 p -142.2 140.6 29.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -178.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 61.3 32.77 19.2 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.6 -176.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 64.86 23.01 12.6 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.609 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.39 158.55 37.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.796 0.332 . . . . 0.0 110.514 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.6 pt -107.47 123.73 62.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.665 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.442 ' O ' ' HA ' ' A' ' 12' ' ' THR . 54.1 m95 -122.8 160.03 26.85 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.625 -172.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -130.58 115.04 16.21 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.524 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 94.9 t -64.76 119.14 8.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.705 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.4 mm -90.91 -35.96 7.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.718 176.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -160.82 122.09 2.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.067 177.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -104.45 143.28 33.22 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.735 0.302 . . . . 0.0 110.944 -176.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -118.85 99.43 6.75 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.881 0.372 . . . . 0.0 110.337 177.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -78.07 91.88 4.32 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 176.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 p -101.6 135.8 36.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.517 -171.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -109.1 101.76 46.18 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-O 121.309 0.576 . . . . 0.0 110.58 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -58.02 -48.2 17.24 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 123.345 2.696 . . . . 0.0 112.797 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.2 19.43 8.04 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.887 178.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -110.1 -14.31 14.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.681 0.277 . . . . 0.0 111.46 -177.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.05 -42.86 1.24 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.262 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.1 m -102.1 131.22 48.7 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 177.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.13 155.63 19.68 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 174.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 55' ' ' ARG . 34.9 m-85 -129.66 163.38 26.21 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.094 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.49 HG21 ' O ' ' A' ' 4' ' ' VAL . 52.8 t -132.7 102.7 5.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.179 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -80.73 98.96 7.98 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 175.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 53.2 p -100.64 134.2 43.96 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.134 -175.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -95.43 102.68 14.5 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 174.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.519 HD23 ' H ' ' A' ' 41' ' ' LEU . 1.3 pt? -138.48 150.96 46.96 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.804 0.335 . . . . 0.0 110.853 -171.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -116.96 144.92 44.01 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.543 -175.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.44 ' HB2' ' CZ3' ' A' ' 20' ' ' TRP . 47.4 t-20 -76.58 115.57 16.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.451 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.8 mt -69.77 -24.75 63.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.194 0.521 . . . . 0.0 110.733 -177.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.6 tpp180 -70.13 -38.8 75.64 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.011 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.3 p -113.48 -15.89 12.51 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -174.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.87 20.82 69.78 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.274 -0.489 . . . . 0.0 112.004 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -96.45 141.65 29.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.856 0.36 . . . . 0.0 111.799 -173.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.2 tp -87.92 137.18 21.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.251 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.481 ' HG3' ' N ' ' A' ' 51' ' ' GLU . 8.7 tp-100 -148.46 175.25 11.29 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -178.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.481 ' N ' ' HG3' ' A' ' 50' ' ' GLN . 10.7 pt-20 -140.17 138.16 34.96 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 170.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -126.51 135.11 50.9 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.686 -175.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.2 p -102.23 102.66 13.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.929 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -85.17 149.32 25.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.026 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.426 ' HB3' ' CE2' ' A' ' 36' ' ' PHE . 5.7 ptm180 -120.18 134.96 55.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.974 0.416 . . . . 0.0 111.385 -175.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.05 132.71 54.68 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.915 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 108.03 -29.88 9.68 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -174.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -102.82 99.67 9.63 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -76.6 137.71 39.68 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.415 0.626 . . . . 0.0 110.831 -175.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.3 t -85.36 150.65 3.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.977 -169.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.514 ' HB3' ' O ' ' A' ' 14' ' ' SER . 34.7 tt0 -85.63 130.98 48.94 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.682 176.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -82.73 156.29 15.83 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.505 2.137 . . . . 0.0 112.895 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.441 ' HB2' ' HB2' ' A' ' 14' ' ' SER . . . -123.61 120.5 32.99 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.431 174.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 67.8 mtt -96.38 108.89 21.48 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.174 0.511 . . . . 0.0 110.799 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -110.2 121.6 63.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.485 177.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.583 ' OE1' ' HD2' ' A' ' 68' ' ' ARG . 40.6 tt0 -95.64 107.76 19.98 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.904 -176.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -84.39 100.77 11.5 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.357 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.583 ' HD2' ' OE1' ' A' ' 66' ' ' GLU . 16.2 mtp180 -106.08 170.24 8.03 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.142 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.585 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 7.7 ptm180 -142.71 120.06 11.6 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.459 0.647 . . . . 0.0 111.141 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.623 ' CB ' ' HB3' ' A' ' 82' ' ' PHE . 1.5 mpt? -115.59 139.94 49.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.926 -174.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -71.75 133.7 45.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.541 174.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -77.31 111.17 12.68 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -174.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -111.21 -179.04 3.61 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 169.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -148.7 159.59 43.98 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.312 0.577 . . . . 0.0 111.82 -175.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.23 -149.55 0.31 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.436 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -66.65 136.69 55.94 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 170.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.01 69.09 2.98 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 118.782 -1.675 . . . . 0.0 113.59 -170.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -127.11 -33.2 2.44 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 158.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -128.73 120.07 25.76 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 113.85 -1.523 . . . . 0.0 108.913 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.579 ' CG ' ' HG ' ' A' ' 98' ' ' LEU . 17.0 m-70 -102.39 132.28 48.49 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 57.1 t -83.58 125.64 40.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.081 -173.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.623 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 61.0 m-85 -123.03 120.54 33.63 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 176.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.575 ' SD ' ' HG2' ' A' ' 90' ' ' GLN . 93.5 mmm -95.19 113.3 24.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.917 -176.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.584 ' HB3' ' H ' ' A' ' 89' ' ' GLU . 20.9 t70 -58.46 117.39 4.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.239 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -76.49 -12.56 60.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.48 -177.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -68.91 -50.27 50.92 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 176.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.1 p -170.99 91.65 0.15 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.103 0.478 . . . . 0.0 112.288 164.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 48.31 26.62 1.14 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 160.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.584 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 45.7 mt-10 -87.59 113.16 23.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 118.666 0.666 . . . . 0.0 110.867 176.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.575 ' HG2' ' SD ' ' A' ' 83' ' ' MET . 73.5 mt-30 -74.47 118.14 17.09 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.343 -178.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.9 m -120.14 121.76 39.51 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.23 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -95.91 127.97 42.39 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.947 0.403 . . . . 0.0 110.483 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.434 HD12 ' CE1' ' A' ' 82' ' ' PHE . 59.6 mt -112.69 140.02 47.81 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.433 178.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.5 t -80.29 158.57 26.11 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.772 -177.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.2 p -58.98 -23.9 62.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.842 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.51 -39.45 87.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.808 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -82.75 -41.07 19.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.597 0.713 . . . . 0.0 109.35 177.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.579 ' HG ' ' CG ' ' A' ' 80' ' ' HIS . 3.3 mm? -67.24 -20.05 65.61 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.445 -171.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -60.94 -31.0 70.55 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.212 0.53 . . . . 0.0 110.096 175.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -82.61 -46.23 13.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.25 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.467 ' HA ' HD21 ' A' ' 125' ' ' LEU . 0.9 OUTLIER -62.13 -36.61 82.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.467 179.084 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.486 ' O ' ' HB ' ' A' ' 156' ' ' THR . 56.2 mt -67.21 -6.36 17.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.629 0.252 . . . . 0.0 111.608 -178.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -70.53 -41.47 72.5 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 172.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.504 ' HB3' HG11 ' A' ' 129' ' ' VAL . 68.8 m-85 -142.4 115.2 8.66 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.208 177.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 101' ' ' GLU . 0.7 OUTLIER 179.8 171.41 1.07 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 122.95 0.5 . . . . 0.0 110.739 173.004 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.542 ' HD2' ' O ' ' A' ' 130' ' ' GLU . 30.4 mtpp -142.48 144.73 33.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.306 176.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -62.73 113.79 3.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.862 0.363 . . . . 0.0 110.739 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 109.85 -10.28 32.14 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.402 -177.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.536 ' SD ' ' HG3' ' A' ' 126' ' ' PRO . 53.0 ttm -91.11 144.31 25.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.68 0.276 . . . . 0.0 110.465 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.62 ' HA ' ' O ' ' A' ' 70' ' ' MET . 8.4 pt-20 -94.2 138.91 31.68 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.365 0.602 . . . . 0.0 112.075 -177.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 33.9 m -113.57 158.13 14.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.58 175.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.566 ' HA ' ' O ' ' A' ' 68' ' ' ARG . 27.9 mt-30 -96.83 99.94 11.49 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.048 0.452 . . . . 0.0 110.652 -177.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.497 HD12 ' SD ' ' A' ' 70' ' ' MET . 63.7 mt -84.44 127.98 39.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.223 -178.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.405 ' O ' HG12 ' A' ' 121' ' ' ILE . 91.5 mt-30 -100.13 110.34 22.62 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.485 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 119' ' ' GLU . 43.1 p -107.12 128.7 54.62 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.322 177.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -108.1 110.2 21.82 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 174.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 60.44 29.05 18.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.445 -176.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 98.31 -18.96 56.27 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.984 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 115' ' ' THR . 42.5 tt0 -84.64 126.88 33.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.638 0.219 . . . . 0.0 111.364 -176.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 85.5 m -68.21 100.82 1.08 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 175.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 114' ' ' GLN . 46.7 pt -84.79 -30.77 6.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.064 0.459 . . . . 0.0 110.328 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -170.86 162.38 35.32 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.692 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.4 t -123.81 127.31 73.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 177.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.456 ' HB3' ' HB2' ' A' ' 112' ' ' GLN . 31.0 tt0 -93.74 123.67 37.24 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.007 0.432 . . . . 0.0 109.961 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.477 HD23 ' HB2' ' A' ' 104' ' ' TYR . 7.0 mp -78.25 157.62 77.89 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.311 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.536 ' HG3' ' SD ' ' A' ' 109' ' ' MET . 6.9 Cg_endo -48.45 127.81 16.58 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.02 2.48 . . . . 0.0 112.249 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -56.8 -38.29 72.33 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.348 -178.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 29.7 p -133.18 109.27 9.33 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.832 174.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.504 HG11 ' HB3' ' A' ' 104' ' ' TYR . 10.4 p -111.41 140.86 28.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.731 0.3 . . . . 0.0 110.623 -176.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.542 ' O ' ' HD2' ' A' ' 106' ' ' LYS . 7.4 pt-20 -107.06 100.36 9.85 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.402 0.62 . . . . 0.0 110.481 177.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 89.7 mt -106.2 133.47 50.86 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.343 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.4 m -76.12 130.85 38.92 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.098 178.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.431 ' HB ' HD11 ' A' ' 172' ' ' LEU . 7.5 p -78.88 105.61 8.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.913 0.863 . . . . 0.0 110.652 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 37.0 p -107.53 112.37 25.09 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.427 -178.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 79.06 96.67 0.06 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-O 122.068 0.937 . . . . 0.0 111.036 -177.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.608 ' O ' ' HD3' ' A' ' 138' ' ' PRO . 9.7 t -150.65 153.36 35.49 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.086 -1.415 . . . . 0.0 107.663 174.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -84.29 103.27 2.83 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.608 ' HD3' ' O ' ' A' ' 136' ' ' THR . 68.8 Cg_endo -90.11 172.81 3.56 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.835 2.357 . . . . 0.0 112.356 -175.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.49 21.24 77.54 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.772 176.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 56.5 mt -88.11 122.64 39.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.409 ' HD2' ' N ' ' A' ' 141' ' ' LYS . 11.8 mptt -92.3 172.52 8.35 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.174 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 119.91 -2.39 13.3 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.731 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 62.93 -173.18 0.16 Allowed 'General case' 0 N--CA 1.463 0.197 0 O-C-N 124.067 0.51 . . . . 0.0 111.081 176.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 55.2 m -153.69 87.66 1.24 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.955 0.407 . . . . 0.0 109.933 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -130.54 3.01 4.58 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -176.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.3 m -150.21 36.38 0.67 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.528 0.68 . . . . 0.0 110.654 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 85.07 21.13 56.17 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.596 -0.812 . . . . 0.0 113.855 174.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.28 93.61 3.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.371 0.585 . . . . 0.0 109.894 174.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 18.0 p -122.79 164.83 17.64 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.146 -176.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -125.25 148.18 48.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.953 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 42.5 m -73.72 107.17 5.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.089 0.471 . . . . 0.0 110.76 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -107.9 163.5 13.07 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.852 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 21.1 m -118.79 134.52 55.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.047 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.5 m -98.54 175.79 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.506 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -57.31 -28.2 62.86 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.486 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 44.1 p -73.94 -11.01 60.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.017 0.436 . . . . 0.0 111.652 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.59 1.85 73.71 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -176.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -81.53 143.27 32.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.915 0.388 . . . . 0.0 110.856 -177.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 23.1 m -100.96 126.91 47.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.399 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.92 155.49 41.64 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -85.79 123.69 31.45 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.36 0.6 . . . . 0.0 111.3 -175.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.401 ' HB ' HG21 ' A' ' 166' ' ' VAL . 27.3 m -116.61 155.06 49.23 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.368 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -56.85 150.51 54.14 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.444 2.096 . . . . 0.0 111.65 175.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 80.7 mt -62.95 -17.3 61.78 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -169.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -88.6 -8.32 54.89 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -176.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.401 HG21 ' HB ' ' A' ' 162' ' ' VAL . 74.5 t -69.24 136.6 25.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.81 0.338 . . . . 0.0 111.249 -177.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -122.68 160.89 24.89 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.479 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -59.4 128.04 35.09 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.887 -177.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 109.42 -15.61 32.42 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.536 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.563 ' OD2' ' HD3' ' A' ' 184' ' ' ARG . 23.7 t70 -67.26 145.35 55.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.8 0.3 . . . . 0.0 110.591 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.427 ' CG1' ' HB2' ' A' ' 130' ' ' GLU . 47.2 t -94.7 109.91 22.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.157 0.503 . . . . 0.0 110.379 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.431 HD11 ' HB ' ' A' ' 133' ' ' VAL . 46.7 mt -90.97 117.33 29.48 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.454 -178.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.404 HD12 ' N ' ' A' ' 173' ' ' ILE . 1.8 mp -91.43 106.45 17.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 57.8 mt -107.67 129.62 61.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.573 -176.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -82.22 96.41 7.85 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.373 175.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.458 HG21 ' HB2' ' A' ' 125' ' ' LEU . 6.5 m -61.68 136.59 58.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.006 -175.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 104.11 -33.74 6.33 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -107.66 -26.73 10.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.026 0.441 . . . . 0.0 110.505 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.36 15.32 76.75 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.206 177.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 5.9 m -68.96 112.65 5.74 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -96.22 111.41 23.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.188 0.518 . . . . 0.0 110.957 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 4.5 mp -107.81 102.35 13.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.124 0.488 . . . . 0.0 110.114 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 48.3 t -80.53 166.74 20.89 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.368 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.563 ' HD3' ' OD2' ' A' ' 170' ' ' ASP . 25.1 mmt180 72.46 30.22 1.98 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 172.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.137 0 CA-C-O 118.147 -1.363 . . . . 0.0 113.604 174.345 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.9 mtt . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.507 ' HB ' HG23 ' A' ' 60' ' ' VAL . 3.7 mp -81.76 118.86 30.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.242 0.544 . . . . 0.0 110.757 -176.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 m -97.36 151.95 19.42 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.337 171.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.9 m -67.18 -14.68 18.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -167.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -86.06 -0.1 54.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.427 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -133.6 91.31 2.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.242 0.544 . . . . 0.0 111.786 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -126.27 156.7 39.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.589 172.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -126.94 162.11 26.74 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -177.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 p -53.0 -20.36 3.37 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 123.556 0.535 . . . . 0.0 111.63 175.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.603 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -144.49 115.78 0.89 Allowed Glycine 0 N--CA 1.435 -1.376 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 167.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.72 129.22 20.17 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.56 HG21 ' CG1' ' A' ' 65' ' ' ILE . 1.2 m -103.29 118.27 36.4 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.193 0.52 . . . . 0.0 111.055 -178.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.0 mp -117.94 140.31 41.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.321 -176.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.7 t -102.33 102.02 12.34 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 175.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.5 p -140.34 146.27 24.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.446 -177.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 61.94 28.45 17.32 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.493 -176.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.1 m120 63.86 25.66 14.09 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.445 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.86 163.39 29.61 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.098 177.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 10.1 pt -109.56 126.27 66.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.392 -178.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.553 ' O ' ' HA ' ' A' ' 12' ' ' THR . 64.8 m95 -124.11 146.56 48.55 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.088 -170.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -120.78 104.05 9.58 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.318 -177.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.603 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 78.9 t -63.02 111.91 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.76 177.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.2 mt -92.68 -33.91 5.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.695 176.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.405 ' HB2' ' HD3' ' A' ' 40' ' ' LYS . 33.0 m-20 -143.12 148.78 37.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.022 177.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -141.6 131.75 24.8 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.079 0.466 . . . . 0.0 110.905 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -122.37 110.02 15.13 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.373 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -80.06 101.24 8.6 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.5 p -108.5 134.11 51.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.295 0.569 . . . . 0.0 111.331 -172.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -122.89 100.55 40.2 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.701 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -76.25 -10.49 19.22 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.343 2.029 . . . . 0.0 112.199 177.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.6 25.78 60.17 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.774 -0.648 . . . . 0.0 113.087 175.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -87.56 -12.86 44.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.919 0.39 . . . . 0.0 111.145 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.96 -42.57 1.27 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.685 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.7 p -123.01 132.41 54.12 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 174.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.04 161.65 25.28 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.848 0.356 . . . . 0.0 110.627 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.479 ' HA ' ' O ' ' A' ' 54' ' ' PHE . 86.1 m-85 -128.59 165.46 20.74 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.102 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 53' ' ' THR . 59.5 t -129.67 106.41 13.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 176.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -80.37 99.29 7.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.202 177.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 16.1 p -111.03 137.15 49.02 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.27 -174.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.405 ' HD3' ' HB2' ' A' ' 24' ' ' ASP . 45.9 mtpt -95.28 108.85 21.03 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 175.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.529 HD23 ' H ' ' A' ' 41' ' ' LEU . 1.1 pt? -135.94 141.82 44.53 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.764 0.793 . . . . 0.0 111.899 -172.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 33.0 ttt180 -103.77 129.8 51.23 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.86 -1.063 . . . . 0.0 111.49 -173.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -70.12 117.95 12.34 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 172.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.422 ' H ' HD12 ' A' ' 44' ' ' LEU . 5.9 mp -64.61 -26.82 68.57 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 121.188 -0.205 . . . . 0.0 111.434 -175.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.443 HH11 ' HD2' ' A' ' 45' ' ' ARG . 59.3 mtt180 -76.55 -50.07 14.83 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.825 0.345 . . . . 0.0 111.467 -177.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.4 p -94.54 -17.65 22.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.047 0.451 . . . . 0.0 111.811 -172.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.24 6.57 88.85 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.719 -175.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 42' ' ' ARG . . . -68.64 131.04 44.54 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -174.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.7 mm -91.53 98.84 8.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.416 ' HG2' ' N ' ' A' ' 51' ' ' GLU . 34.7 tt0 -112.47 167.34 10.52 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -178.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.416 ' N ' ' HG2' ' A' ' 50' ' ' GLN . 11.0 pt-20 -132.5 125.91 31.7 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.152 0.501 . . . . 0.0 109.949 173.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.445 ' HD2' HD11 ' A' ' 41' ' ' LEU . 56.3 mttm -115.36 148.19 39.59 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.74 -176.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 10.8 p -112.6 105.06 13.17 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.244 176.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.479 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 88.3 m-85 -84.1 144.96 28.7 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.726 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.554 ' HD3' ' OE2' ' A' ' 58' ' ' GLU . 34.5 ttt180 -111.09 136.08 50.66 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.743 0.306 . . . . 0.0 111.549 -173.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.13 129.79 42.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.818 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 106.27 -16.75 41.51 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -175.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.554 ' OE2' ' HD3' ' A' ' 55' ' ' ARG . 81.1 mt-10 -112.71 149.56 32.75 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -127.67 163.41 24.32 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.298 -176.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.507 HG23 ' HB ' ' A' ' 2' ' ' ILE . 5.6 m -134.16 157.63 41.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.37 0.605 . . . . 0.0 111.469 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -83.59 141.56 41.99 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.03 -0.987 . . . . 0.0 110.443 -176.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.27 154.73 41.47 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.538 2.159 . . . . 0.0 112.454 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.44 113.07 18.85 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.954 175.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 26.3 mmt -88.64 109.03 19.77 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.99 0.424 . . . . 0.0 110.62 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.56 ' CG1' HG21 ' A' ' 12' ' ' THR . 46.9 mm -99.37 125.4 52.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.049 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.498 ' HG3' ' OG1' ' A' ' 115' ' ' THR . 6.0 pt-20 -117.6 138.02 52.22 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.595 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.403 HD22 ' C ' ' A' ' 66' ' ' GLU . 1.0 OUTLIER -112.98 113.86 26.09 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.954 0.406 . . . . 0.0 110.213 178.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.515 ' HB3' ' OD1' ' A' ' 84' ' ' ASP . 68.6 mtt180 -110.36 117.47 33.71 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.17 -178.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 9.2 ptm180 -74.05 121.14 20.62 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 174.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.559 ' HG2' ' HA ' ' A' ' 84' ' ' ASP . 28.7 mtt -124.08 147.72 47.66 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.448 -175.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -77.41 136.56 38.41 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.903 177.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -77.14 103.78 7.26 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.413 -176.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 8.4 mp -104.32 -176.81 3.19 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 170.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -146.79 157.09 43.59 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.621 0.724 . . . . 0.0 112.448 -171.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 79' ' ' ASN . . . -150.57 -160.83 1.22 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.308 -1.314 . . . . 0.0 107.713 174.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -72.08 143.15 49.17 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 175.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.5 68.66 2.41 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 118.879 -1.629 . . . . 0.0 113.879 -167.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.579 ' HA ' ' OG ' ' A' ' 95' ' ' SER . 22.8 m-20 -127.93 -30.43 2.48 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 156.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.47 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 92.6 m-20 -137.07 138.65 40.63 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.512 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -121.69 144.56 48.7 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 173.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.444 ' O ' ' HB2' ' A' ' 73' ' ' LEU . 45.9 t -90.41 132.33 35.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.499 -178.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -126.43 125.53 42.3 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 174.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 37.8 mtt -93.7 113.32 25.37 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.454 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.677 ' HB3' ' H ' ' A' ' 89' ' ' GLU . 20.2 t0 -62.15 115.01 3.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.511 -177.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -85.46 -7.13 59.08 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.023 177.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.59 -52.24 27.84 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 173.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.44 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 12.1 p -164.75 90.03 0.52 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 167.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 47.33 28.26 1.03 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 158.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.677 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 49.2 mt-10 -105.89 116.53 32.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 118.981 0.809 . . . . 0.0 112.408 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -75.86 118.68 18.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.277 0.561 . . . . 0.0 110.027 175.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.1 m -120.99 138.26 54.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.547 -175.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -105.87 134.55 48.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.797 0.332 . . . . 0.0 110.817 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 79' ' ' ASN . 4.5 mm? -112.88 143.01 44.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.427 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.7 m -79.64 166.93 21.35 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -173.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.579 ' OG ' ' HA ' ' A' ' 78' ' ' ASP . 10.2 m -52.93 -33.38 50.41 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.749 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -52.14 -40.69 61.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.734 -176.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -87.64 -41.03 13.69 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.42 0.628 . . . . 0.0 109.953 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.487 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 4.3 mm? -74.32 -20.88 59.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.314 -171.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -60.58 -32.26 71.37 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.126 0.489 . . . . 0.0 110.204 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -87.44 -39.4 15.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.387 177.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.455 ' O ' HD12 ' A' ' 105' ' ' LEU . 40.7 mt-10 -63.57 -25.62 68.32 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.343 178.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 65.8 mt -71.44 -7.4 47.14 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 122.021 -0.424 . . . . 0.0 110.865 177.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -90.09 -43.8 10.24 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 172.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -130.36 116.24 18.02 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.315 176.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.455 HD12 ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -172.4 164.2 5.68 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.728 0.299 . . . . 0.0 110.627 177.459 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -143.16 138.87 30.07 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -63.7 123.13 18.09 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.638 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.32 1.65 71.75 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.751 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.41 ' SD ' ' HD2' ' A' ' 126' ' ' PRO . 51.9 ttm -62.75 147.62 49.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.106 0.479 . . . . 0.0 111.53 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.43 ' HG2' HH21 ' A' ' 69' ' ' ARG . 4.3 tp10 -89.41 100.32 13.14 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.593 175.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 23.1 m -106.55 155.74 7.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.63 -178.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.53 ' HB2' ' HB3' ' A' ' 124' ' ' GLU . 12.8 mm100 -96.99 99.65 11.18 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.447 HD13 HG13 ' A' ' 123' ' ' VAL . 32.8 mm -81.88 116.0 25.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 177.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.419 ' HG2' HD11 ' A' ' 121' ' ' ILE . 27.8 tt0 -91.69 113.16 25.35 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.498 ' OG1' ' HG3' ' A' ' 66' ' ' GLU . 1.7 p -116.11 157.85 24.11 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.705 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -129.64 101.91 6.13 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 176.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 58.55 33.98 23.53 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.225 -173.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 96.49 -22.59 39.27 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.989 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -75.53 131.4 40.03 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.824 -0.221 . . . . 0.0 110.569 -178.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.6 p -75.22 113.24 12.36 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.734 0.302 . . . . 0.0 110.865 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.419 HD11 ' HG2' ' A' ' 114' ' ' GLN . 40.1 pt -105.94 -21.41 5.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.444 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -169.27 163.71 37.35 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.179 -1.01 . . . . 0.0 112.742 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.447 HG13 HD13 ' A' ' 113' ' ' ILE . 59.9 t -130.35 129.53 64.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 177.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.53 ' HB3' ' HB2' ' A' ' 112' ' ' GLN . 35.3 tt0 -108.97 101.12 10.24 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.295 0.569 . . . . 0.0 110.669 178.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -77.66 126.22 84.72 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 173.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.41 ' HD2' ' SD ' ' A' ' 109' ' ' MET . 30.5 Cg_exo -37.74 127.5 0.79 Allowed 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.791 2.994 . . . . 0.0 113.359 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.595 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 75.5 mmtt -62.49 -26.73 68.69 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.9 -172.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 p -119.08 108.85 15.22 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.072 0.463 . . . . 0.0 109.944 172.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.2 p -110.5 136.41 46.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.428 -177.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -96.45 115.08 26.85 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.847 0.356 . . . . 0.0 110.38 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 80.9 mt -124.38 131.9 53.52 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.584 -177.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.9 m -79.29 134.93 36.63 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.36 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.416 HG13 ' HA ' ' A' ' 168' ' ' GLU . 7.4 p -85.13 118.28 31.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.621 0.724 . . . . 0.0 110.868 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.539 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 43.2 p -130.97 126.13 35.2 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.496 178.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.539 ' HB2' ' O ' ' A' ' 134' ' ' THR . 48.7 mm-40 79.4 79.07 0.05 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.675 0.75 . . . . 0.0 111.175 -175.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.587 ' O ' ' HD3' ' A' ' 138' ' ' PRO . 11.1 t -150.23 153.58 36.46 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 171.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -102.12 99.65 13.04 Favored Pre-proline 0 C--N 1.321 -0.646 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.348 -178.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.587 ' HD3' ' O ' ' A' ' 136' ' ' THR . 84.6 Cg_endo -91.54 -179.17 1.29 Allowed 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.08 2.52 . . . . 0.0 112.186 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 94.87 13.67 52.28 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.478 178.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.7 mp -105.76 126.37 61.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -93.09 -33.84 13.91 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.087 0.47 . . . . 0.0 109.966 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.73 -11.83 70.56 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.814 175.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 66.24 -41.1 0.36 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.809 1.244 . . . . 0.0 113.041 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.8 p -94.01 -59.96 1.85 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.93 0.395 . . . . 0.0 111.047 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -139.49 116.75 11.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.698 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.1 t -79.13 -14.07 59.35 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.446 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -74.63 -7.12 79.1 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.137 177.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.544 ' O ' ' HG ' ' A' ' 164' ' ' LEU . . . -62.19 161.26 11.46 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 175.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.514 ' HB ' ' HB3' ' A' ' 161' ' ' ASN . 36.9 p -114.3 155.47 26.16 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -171.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -131.64 152.48 50.81 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.453 178.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.4 p -72.78 117.56 14.63 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.051 0.453 . . . . 0.0 111.358 -177.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 159' ' ' THR . . . -119.66 158.62 26.07 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.954 -178.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 134' ' ' THR . 18.4 m -109.73 138.48 46.03 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 174.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.0 m -105.63 178.87 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.496 175.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -54.97 -30.25 58.75 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 79.4 p -76.41 -8.87 58.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.805 0.336 . . . . 0.0 111.839 -177.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 86.13 3.29 85.17 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.582 -175.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -80.79 143.47 32.83 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.851 0.357 . . . . 0.0 110.555 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 152' ' ' ALA . 30.1 m -101.07 120.22 39.89 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.06 177.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.2 161.49 35.6 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.514 ' HB3' ' HB ' ' A' ' 149' ' ' THR . 89.4 m-20 -92.84 112.93 25.06 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.881 0.372 . . . . 0.0 111.53 -173.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.42 ' HB ' HG21 ' A' ' 166' ' ' VAL . 29.2 m -108.32 148.18 37.1 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.393 178.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 148' ' ' ALA . 53.0 Cg_exo -53.38 149.22 30.51 Favored 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.558 2.172 . . . . 0.0 111.964 174.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 148' ' ' ALA . 59.4 mt -62.38 -11.72 17.24 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -170.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -104.18 10.33 35.81 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -176.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.42 HG21 ' HB ' ' A' ' 162' ' ' VAL . 75.5 t -78.73 142.41 14.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 178.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -114.41 145.22 42.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.437 -175.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.446 ' HG2' HG22 ' A' ' 136' ' ' THR . 48.7 mt-10 -62.53 127.06 29.52 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.615 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 112.12 -16.44 25.1 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.356 -176.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -75.49 154.91 36.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.987 0.422 . . . . 0.0 110.631 177.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 88.6 t -105.04 116.63 49.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.747 -177.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.42 HD22 ' N ' ' A' ' 172' ' ' LEU . 2.5 mm? -99.2 138.36 36.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.073 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.58 ' O ' ' HB ' ' A' ' 182' ' ' ILE . 57.0 mt -97.28 115.37 36.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 33.7 mm -109.85 141.31 25.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.427 -178.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.595 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 27.2 t-20 -86.52 103.1 14.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.991 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.0 m -71.77 113.03 8.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.231 176.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 143.43 -47.1 0.81 Allowed Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -177.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -118.81 -22.73 7.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.982 0.42 . . . . 0.0 110.373 175.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 89.48 17.24 55.51 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.109 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 4.2 m -65.04 136.57 56.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.582 0.23 . . . . 0.0 110.605 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -89.84 117.17 28.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.145 0.498 . . . . 0.0 110.927 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.58 ' HB ' ' O ' ' A' ' 173' ' ' ILE . 4.0 mp -96.87 151.42 4.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 169.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 10.7 p -77.11 173.1 12.22 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.829 -0.169 . . . . 0.0 111.018 -173.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 39.0 mtt180 -46.03 144.3 1.93 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.686 0.616 . . . . 0.0 111.885 -176.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.734 -1.037 . . . . 0.0 111.852 177.928 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 120.917 0.389 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 84.5 mt -75.28 134.68 28.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.036 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 m -94.83 143.79 26.17 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 174.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.525 HG21 ' HA ' ' A' ' 56' ' ' ALA . 10.8 m -69.11 -1.99 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -172.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -90.09 -2.63 58.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.657 0.265 . . . . 0.0 110.593 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -134.0 89.93 2.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.527 0.679 . . . . 0.0 111.518 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.456 ' CE1' ' HA ' ' A' ' 4' ' ' VAL . 61.6 m-85 -119.58 153.01 36.1 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 171.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -119.57 171.64 8.22 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.477 -176.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.1 p -65.17 -14.57 60.91 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.767 0.794 . . . . 0.0 109.978 174.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.49 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -153.13 115.12 0.66 Allowed Glycine 0 N--CA 1.435 -1.369 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 166.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.6 tp -149.99 132.0 15.26 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.671 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 1.7 m -98.39 122.69 41.89 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.321 0.581 . . . . 0.0 112.092 -172.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.0 mp -117.27 143.73 26.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.279 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.462 ' HB2' ' HB2' ' A' ' 63' ' ' ALA . 35.5 t -104.43 107.43 18.36 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 175.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.9 p -153.93 151.28 11.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -176.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 54.78 45.09 27.39 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 -176.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.7 p30 47.29 31.66 1.87 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.314 1.046 . . . . 0.0 112.222 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.7 166.06 25.69 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.466 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.8 pt -112.13 130.58 65.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.83 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.671 ' O ' ' HA ' ' A' ' 12' ' ' THR . 70.2 m95 -126.6 147.91 49.83 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.885 -168.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.4 ttmm -116.95 104.02 10.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.549 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.49 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 84.1 t -62.81 109.06 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.872 0.368 . . . . 0.0 110.303 177.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 77.0 mt -88.85 -38.15 11.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.512 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -142.47 152.53 42.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.481 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -143.77 136.44 27.2 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.991 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -113.26 99.65 7.97 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.708 176.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -76.05 90.02 3.03 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.0 p -96.5 118.95 43.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.567 0.699 . . . . 0.0 111.519 -171.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -119.81 96.83 49.66 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.428 176.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.88 -10.77 15.38 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.482 2.121 . . . . 0.0 113.148 -177.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.2 26.65 39.51 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.958 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -95.46 10.67 35.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.796 0.331 . . . . 0.0 111.265 -176.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.48 -42.03 2.03 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.12 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.1 p -133.18 146.58 51.66 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 177.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -96.35 166.13 11.86 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.113 0.482 . . . . 0.0 111.134 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -136.25 167.07 21.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.492 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.9 t -131.88 102.62 5.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.086 0.47 . . . . 0.0 109.733 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -82.47 99.33 9.4 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 40.5 p -102.76 143.87 31.85 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.916 -173.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -102.52 102.82 13.13 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 174.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.611 HD23 ' H ' ' A' ' 41' ' ' LEU . 1.3 pt? -133.02 150.96 52.11 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.687 0.756 . . . . 0.0 112.36 -169.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 20.3 ttt180 -110.69 129.67 55.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.038 -171.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -69.96 122.52 19.48 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 173.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.9 mp -66.85 -25.67 66.54 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -176.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.1 mtt85 -81.33 -44.83 17.06 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.671 0.272 . . . . 0.0 111.72 -177.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 67.2 p -99.09 -17.07 18.4 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.132 0.492 . . . . 0.0 111.943 -173.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.31 13.64 81.32 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.793 -175.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 42' ' ' ARG . . . -73.53 133.27 43.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.917 0.389 . . . . 0.0 111.672 -175.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 26.4 mm -96.15 99.15 8.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.378 176.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.456 ' O ' HD23 ' A' ' 41' ' ' LEU . 8.9 tt0 -119.75 157.23 29.02 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -177.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 39' ' ' SER . 15.1 pt-20 -113.9 127.02 55.8 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.291 0.567 . . . . 0.0 110.092 175.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -129.09 146.22 51.1 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.626 -175.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.1 m -107.77 120.66 42.87 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.269 0.557 . . . . 0.0 111.899 -175.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -92.03 155.45 18.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.251 173.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -117.6 132.13 56.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.143 0.497 . . . . 0.0 111.429 -176.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.525 ' HA ' HG21 ' A' ' 4' ' ' VAL . . . -67.3 129.66 40.62 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.871 -178.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.19 -16.24 32.63 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -175.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -106.27 137.82 43.55 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -93.4 132.45 37.63 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.122 0.486 . . . . 0.0 110.61 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.5 t -96.03 145.62 8.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.662 -175.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -87.52 125.64 64.68 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.701 0.286 . . . . 0.0 110.493 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -79.12 152.79 24.49 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.563 2.175 . . . . 0.0 112.754 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.462 ' HB2' ' HB2' ' A' ' 14' ' ' SER . . . -117.56 109.39 16.64 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.569 176.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 61.4 mtt -87.25 108.68 19.05 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.168 0.508 . . . . 0.0 110.219 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.462 ' CG1' HG21 ' A' ' 12' ' ' THR . 52.1 mm -90.79 132.67 34.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.073 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -104.72 103.61 13.27 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.955 -177.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -93.99 101.34 13.39 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.938 0.399 . . . . 0.0 110.194 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 41.6 mtm180 -107.05 168.02 9.49 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -134.66 122.11 21.78 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.326 0.584 . . . . 0.0 111.022 -175.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.544 ' CB ' ' HB3' ' A' ' 82' ' ' PHE . 1.9 mpt? -117.39 149.07 41.14 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.348 -173.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -90.87 139.81 30.4 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 174.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -70.74 103.22 2.51 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.773 -174.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -94.49 -175.18 3.54 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 167.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -143.07 142.96 31.68 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 119.764 -0.774 . . . . 0.0 112.511 -167.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 79' ' ' ASN . . . -151.85 -172.83 4.34 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.261 -1.336 . . . . 0.0 108.812 175.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -76.61 145.73 38.71 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.13 68.64 2.59 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 118.984 -1.579 . . . . 0.0 114.095 -167.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -126.89 -30.81 2.7 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 156.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.617 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 21.1 p-10 -140.98 132.74 27.37 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 113.608 -1.633 . . . . 0.0 109.68 177.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.531 ' CG ' HD22 ' A' ' 98' ' ' LEU . 54.7 m170 -114.92 146.96 40.59 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 172.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 44.8 t -95.7 125.45 48.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.91 -176.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.544 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 78.8 m-85 -121.68 117.59 27.04 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 89.0 mmm -91.41 114.24 26.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.849 0.357 . . . . 0.0 111.22 -174.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.562 ' HB3' ' H ' ' A' ' 89' ' ' GLU . 22.4 t70 -62.16 116.49 5.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.39 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -77.68 -11.56 59.88 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.439 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -73.3 -50.52 21.73 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 176.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.6 p -169.09 91.59 0.25 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 168.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 48.42 25.32 0.88 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 157.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.562 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 41.6 mt-10 -95.68 116.76 29.34 Favored 'General case' 0 C--N 1.32 -0.702 0 O-C-N 121.453 -0.78 . . . . 0.0 111.172 176.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -85.35 98.26 10.44 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.392 0.615 . . . . 0.0 110.791 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.8 m -89.02 117.04 27.75 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.325 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 80' ' ' HIS . 44.2 mt-10 -95.95 126.15 40.99 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 177.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.617 ' O ' ' HA ' ' A' ' 79' ' ' ASN . 70.9 mt -104.5 146.72 28.47 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.579 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.605 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 28.5 t -86.05 167.34 15.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.66 -175.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.8 p -49.06 -35.69 16.48 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -175.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -53.8 -40.58 66.47 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.903 0.382 . . . . 0.0 111.536 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -80.53 -35.28 34.71 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.291 0.567 . . . . 0.0 109.798 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 94' ' ' SER . 13.3 mt -67.35 -30.37 70.16 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.137 -172.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -63.04 -43.65 98.09 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.949 0.404 . . . . 0.0 110.666 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -65.84 -36.4 83.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.897 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.489 ' O ' HD12 ' A' ' 105' ' ' LEU . 51.1 mt-10 -62.39 -41.31 98.56 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.508 173.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 73.5 mt -63.74 -20.77 66.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.931 0.396 . . . . 0.0 110.617 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -72.02 -50.14 31.05 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 173.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -138.64 116.02 11.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.071 176.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.489 HD12 ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -164.15 150.69 11.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.898 0.38 . . . . 0.0 110.646 178.003 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -145.83 134.96 22.77 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 172.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -64.79 123.42 19.33 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.909 -177.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 101.57 -6.1 54.99 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.565 -178.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 50.4 ttm -69.7 133.45 47.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.806 0.336 . . . . 0.0 110.65 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -95.33 101.86 13.62 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.09 0.471 . . . . 0.0 110.376 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 32.8 m -100.56 166.82 2.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.567 -177.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -108.57 109.18 20.34 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 46.5 mt -89.81 123.75 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-O 121.233 0.54 . . . . 0.0 109.633 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.492 ' HG2' HD11 ' A' ' 121' ' ' ILE . 31.2 tt0 -96.42 107.67 20.09 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.74 -174.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 40.9 p -109.19 159.06 17.23 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 121.44 0.638 . . . . 0.0 111.771 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -137.58 106.31 5.9 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 60.88 32.26 20.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.865 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 98.82 -18.33 57.01 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.052 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -88.36 134.82 33.72 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 122.798 -0.236 . . . . 0.0 110.927 -176.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.0 p -77.93 108.68 11.36 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.733 0.301 . . . . 0.0 110.36 175.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.492 HD11 ' HG2' ' A' ' 114' ' ' GLN . 36.0 pt -92.02 -27.11 4.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.839 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -169.59 167.74 40.75 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.672 177.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 55.7 t -125.35 121.22 59.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -102.78 112.17 24.83 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.015 0.436 . . . . 0.0 110.508 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 66.0 mt -78.7 152.65 77.94 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 175.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.51 144.23 52.34 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.363 2.042 . . . . 0.0 110.635 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.719 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 14.3 mmmm -64.82 -22.35 66.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.705 -173.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 26.3 p -125.55 113.43 17.42 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.862 0.363 . . . . 0.0 111.334 176.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 9.6 p -114.84 140.44 35.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.614 175.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -112.8 124.52 52.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.553 0.692 . . . . 0.0 111.352 177.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 95.7 mt -129.27 145.63 51.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.911 -175.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.3 m -85.52 132.71 34.15 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.128 176.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 170' ' ' ASP . 5.8 p -85.81 108.84 17.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.815 0.817 . . . . 0.0 110.769 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.679 ' O ' ' HB ' ' A' ' 153' ' ' THR . 26.9 p -116.48 124.59 50.32 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.621 178.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.541 ' HB2' ' O ' ' A' ' 134' ' ' THR . 1.5 mp0 77.36 86.61 0.08 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.904 0.859 . . . . 0.0 111.18 -176.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.448 ' O ' ' HD3' ' A' ' 138' ' ' PRO . 14.4 t -148.7 156.27 42.14 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 173.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -81.2 109.6 14.57 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -175.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 136' ' ' THR . 98.2 Cg_endo -89.08 166.7 5.62 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.947 2.431 . . . . 0.0 112.944 -176.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.31 -1.3 88.6 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.036 -0.602 . . . . 0.0 113.081 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.449 HD12 ' HD3' ' A' ' 150' ' ' LYS . 58.1 mt -78.4 100.69 3.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.315 0.579 . . . . 0.0 110.564 -177.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -75.51 -33.26 60.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.515 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 118.51 -14.16 11.92 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.148 -176.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -66.36 122.54 17.75 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 54.0 p 51.17 36.16 15.05 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 123.807 0.692 . . . . 0.0 111.242 -174.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -165.78 34.01 0.05 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.435 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.4 m -75.93 80.16 2.81 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.236 -174.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -102.85 165.8 16.43 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 175.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.55 -46.61 82.1 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.959 0.379 . . . . 0.0 110.915 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.5 p -146.75 176.05 10.15 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.285 0.564 . . . . 0.0 111.073 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.449 ' HD3' HD12 ' A' ' 140' ' ' ILE . 37.4 ttpt -127.64 136.28 51.41 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.626 -178.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 35.9 p -72.76 120.19 18.04 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.074 0.464 . . . . 0.0 110.404 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 159' ' ' THR . . . -125.13 160.48 29.02 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.159 -178.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.679 ' HB ' ' O ' ' A' ' 134' ' ' THR . 1.6 m -111.45 136.58 50.41 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.4 m -102.48 177.73 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.175 174.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -55.63 -29.27 58.92 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.407 HG22 HD13 ' A' ' 105' ' ' LEU . 80.3 p -75.93 -9.41 58.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.022 0.439 . . . . 0.0 111.529 -177.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 87.56 7.59 75.32 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.091 -0.576 . . . . 0.0 111.898 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -86.14 141.26 29.5 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.666 0.269 . . . . 0.0 110.943 -177.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 152' ' ' ALA . 17.9 m -95.57 115.43 27.42 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.158 176.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.33 161.9 32.39 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -94.52 113.28 25.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.531 0.681 . . . . 0.0 111.54 -174.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 27.3 m -108.59 150.5 40.79 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.971 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.21 150.76 47.12 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.295 1.997 . . . . 0.0 111.481 174.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 54.5 mt -58.28 -23.19 55.42 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -168.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -85.54 -9.36 57.5 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -174.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 94.6 t -70.5 136.18 26.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -122.91 163.45 20.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.868 0.366 . . . . 0.0 110.141 -174.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -60.67 128.05 34.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.733 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 109.43 -16.91 31.59 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.55 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.408 ' OD1' ' HD2' ' A' ' 184' ' ' ARG . 7.1 m-20 -64.85 138.74 58.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.952 0.406 . . . . 0.0 111.404 178.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 61.1 t -97.72 104.02 15.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 172.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.484 ' H ' HD23 ' A' ' 172' ' ' LEU . 0.7 OUTLIER -100.31 143.08 30.91 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.71 -176.427 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.523 ' O ' ' HB ' ' A' ' 182' ' ' ILE . 60.7 mt -99.32 136.97 28.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.649 177.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 61.7 mt -127.18 138.21 55.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.719 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 26.6 t-20 -81.0 91.98 6.14 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.011 176.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.9 118.78 18.24 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.115 0.484 . . . . 0.0 110.62 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 129.43 -48.28 0.98 Allowed Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -175.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.42 ' HB2' ' OD1' ' A' ' 175' ' ' ASN . 17.1 m-20 -106.28 -24.92 12.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.03 0.443 . . . . 0.0 110.098 177.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 86.92 15.12 63.57 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.434 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 6.0 m -72.27 127.05 31.36 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -79.42 122.84 26.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.16 0.505 . . . . 0.0 110.386 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.523 ' HB ' ' O ' ' A' ' 173' ' ' ILE . 9.8 mm -100.41 155.2 4.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 14.7 p -75.68 166.8 23.01 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.59 0.709 . . . . 0.0 111.703 -169.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 172' ' ' LEU . 23.6 ptt180 -85.45 159.37 19.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.549 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.548 -1.14 . . . . 0.0 111.71 175.61 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.425 ' SD ' ' HD3' ' A' ' 59' ' ' LYS . 66.8 mtt . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 120.733 0.301 . . . . 0.0 110.317 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.1 mp -99.41 135.24 35.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.964 0.412 . . . . 0.0 110.136 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.2 m -99.95 156.63 17.04 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.6 m -68.77 -8.66 10.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -170.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -93.48 12.08 26.3 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.648 0.261 . . . . 0.0 110.64 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -140.5 89.36 2.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.282 0.563 . . . . 0.0 111.447 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -122.33 148.55 44.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.531 175.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.413 ' HG3' ' N ' ' A' ' 9' ' ' THR . 20.6 tptm -114.88 161.5 18.16 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.284 -176.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.413 ' N ' ' HG3' ' A' ' 8' ' ' LYS . 8.4 m -49.42 -31.93 10.7 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.2 0.524 . . . . 0.0 111.06 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.548 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -143.38 116.83 1.03 Allowed Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 170.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 66.9 tp -142.07 137.42 31.02 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 2.5 m -100.96 118.97 38.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.011 0.434 . . . . 0.0 110.823 -177.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.8 mp -120.01 137.5 53.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.424 -177.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.6 p -98.48 100.13 11.36 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.7 p -146.81 152.13 13.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.59 -175.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.405 ' CB ' ' HE2' ' A' ' 52' ' ' LYS . 24.2 t70 63.9 27.29 14.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.34 0.591 . . . . 0.0 109.682 178.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 63.75 30.53 14.64 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.401 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.94 167.18 24.63 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.095 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 15.5 pt -109.68 123.52 65.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.078 0.466 . . . . 0.0 110.156 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.501 ' O ' ' HA ' ' A' ' 12' ' ' THR . 34.2 m95 -121.16 160.36 23.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.411 -172.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -129.34 107.96 9.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.567 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.548 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 82.7 t -59.95 118.39 3.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.124 0.488 . . . . 0.0 111.009 179.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.1 mm -93.31 -41.89 12.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.758 175.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -158.25 121.56 3.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.21 -177.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -108.58 139.06 43.88 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.044 0.45 . . . . 0.0 111.571 -173.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -116.41 99.89 7.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.442 176.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 -71.75 96.47 1.62 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 175.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.9 p -99.37 134.3 39.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.448 0.642 . . . . 0.0 111.25 -172.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -116.72 87.46 21.64 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.506 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -65.28 -46.72 5.34 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.635 2.223 . . . . 0.0 112.596 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.56 26.79 3.01 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 121.126 -0.559 . . . . 0.0 111.902 -176.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -97.13 10.32 39.7 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.821 0.343 . . . . 0.0 111.104 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.22 -42.32 1.99 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.995 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.425 ' HB3' ' HB3' ' A' ' 56' ' ' ALA . 70.6 m -115.51 138.53 50.94 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 175.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.68 162.6 22.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.058 0.456 . . . . 0.0 110.75 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -132.04 164.9 25.2 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.342 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.4 t -132.33 102.64 5.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 120.956 0.408 . . . . 0.0 110.34 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -79.19 99.03 6.83 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.2 m -106.53 131.15 54.03 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.535 -173.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.9 mttp -84.34 105.4 15.15 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 171.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.563 HD23 ' H ' ' A' ' 41' ' ' LEU . 0.6 OUTLIER -127.97 138.27 52.55 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.718 0.771 . . . . 0.0 110.813 -172.454 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.9 ttt180 -96.97 128.27 43.77 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.989 -177.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -60.84 113.74 2.67 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 172.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.432 HD21 ' OE1' ' A' ' 114' ' ' GLN . 8.9 tt -66.96 -24.11 66.02 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.656 -170.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -85.99 -45.88 11.05 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.691 -177.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 75.1 p -93.81 -21.71 19.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.067 0.461 . . . . 0.0 111.893 -174.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.7 12.27 75.33 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.177 -176.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.91 131.58 38.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.98 0.419 . . . . 0.0 111.685 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.6 mm -89.49 110.93 22.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.606 177.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.466 ' HG2' ' H ' ' A' ' 51' ' ' GLU . 32.7 tt0 -131.79 174.62 9.95 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -177.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.466 ' H ' ' HG2' ' A' ' 50' ' ' GLN . 9.8 pt-20 -137.72 131.83 31.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.178 0.513 . . . . 0.0 110.623 173.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.405 ' HE2' ' CB ' ' A' ' 16' ' ' ASP . 33.0 mttp -124.28 154.02 40.86 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.53 -177.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 48.9 m -106.84 112.76 25.87 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.825 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -83.6 151.13 25.5 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 175.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.4 ptp85 -122.91 129.76 52.0 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.354 -171.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.425 ' HB3' ' HB3' ' A' ' 34' ' ' SER . . . -63.53 130.77 45.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.304 177.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.59 -18.4 29.8 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -176.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -104.13 131.56 51.28 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.425 ' HD3' ' SD ' ' A' ' 1' ' ' MET . 18.0 ptpt -77.2 140.05 40.04 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.512 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 65.5 t -98.45 117.02 42.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.208 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -90.19 121.8 68.25 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.388 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.64 151.4 36.66 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.45 2.1 . . . . 0.0 112.403 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.483 ' HB3' HG22 ' A' ' 12' ' ' THR . . . -101.81 125.99 48.59 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.131 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 15.8 ptp -85.15 109.58 18.39 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.227 0.537 . . . . 0.0 111.037 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.34 125.23 60.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.038 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -121.82 121.68 37.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.885 0.374 . . . . 0.0 110.468 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -99.63 133.24 44.26 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.487 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -129.91 170.15 14.3 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 0.0 OUTLIER -129.96 127.93 41.04 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.859 0.361 . . . . 0.0 110.285 177.333 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.618 ' CB ' ' HB3' ' A' ' 82' ' ' PHE . 1.6 mpt? -118.52 147.6 43.5 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.678 -176.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -85.17 142.42 29.48 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 172.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -75.46 109.66 9.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.071 -175.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -103.81 -176.63 3.14 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 167.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -145.67 151.81 38.63 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 119.828 -0.749 . . . . 0.0 112.405 -174.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.7 -163.34 1.75 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.595 177.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -68.28 139.19 55.94 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 175.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.88 70.77 2.68 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 119.174 -1.489 . . . . 0.0 113.673 -168.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -125.62 -31.22 2.99 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 159.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.587 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 27.3 m-80 -141.25 135.11 30.35 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 113.83 -1.532 . . . . 0.0 109.209 175.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.557 ' CG ' HD22 ' A' ' 98' ' ' LEU . 64.2 m170 -104.83 145.88 29.77 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 176.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 40.9 t -91.87 127.32 44.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.733 -176.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.618 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 55.0 m-85 -125.16 126.33 45.1 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.659 0.266 . . . . 0.0 110.417 177.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 50.1 ttm -89.92 112.44 23.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.668 -176.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.594 ' HA ' ' HG3' ' A' ' 70' ' ' MET . 16.0 t0 -70.69 119.19 14.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.024 -176.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -75.42 -16.3 60.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.6 178.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -69.5 -54.01 16.34 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.8 p -167.35 91.87 0.39 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 171.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 48.44 28.5 1.71 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 158.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.522 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 47.2 mt-10 -103.51 120.5 40.98 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 118.661 0.664 . . . . 0.0 111.764 178.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -83.69 89.22 7.11 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 173.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.0 m -77.24 116.26 17.72 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.239 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -90.87 118.85 30.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.228 0.537 . . . . 0.0 110.014 177.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.587 ' O ' ' HA ' ' A' ' 79' ' ' ASN . 57.3 mt -93.61 136.29 34.04 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.852 -177.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.522 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 2.2 m -77.7 172.02 14.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.842 -175.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.9 m -50.97 -40.61 58.17 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -175.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -56.14 -40.16 73.38 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.018 0.437 . . . . 0.0 111.775 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.469 ' HB2' ' HB3' ' A' ' 93' ' ' LEU . 45.4 m-85 -77.71 -32.91 53.2 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.818 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.626 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 14.3 mt -64.25 -30.36 71.41 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.473 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -56.8 -46.41 81.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.428 176.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -62.47 -43.71 98.15 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.061 177.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.542 ' O ' HD12 ' A' ' 105' ' ' LEU . 46.4 mt-10 -60.67 -34.16 73.91 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.015 177.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.626 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 55.2 mt -68.58 -6.16 23.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.902 0.382 . . . . 0.0 111.277 -178.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -90.7 -50.02 6.14 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 168.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -136.26 116.79 13.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.312 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.542 HD12 ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -163.65 138.98 6.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.977 0.417 . . . . 0.0 110.837 176.615 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -146.46 147.76 31.55 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 173.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -63.98 130.7 45.11 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.529 0.204 . . . . 0.0 110.537 -176.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.94 -0.6 87.78 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.811 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 56.5 ttp -72.73 142.71 48.17 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.739 -0.271 . . . . 0.0 110.294 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -100.21 119.06 37.78 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.874 0.368 . . . . 0.0 110.448 -177.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 21.1 m -111.88 165.2 7.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.488 -178.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -108.03 105.05 14.63 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 178.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 53.7 mt -92.13 126.68 44.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.181 0.515 . . . . 0.0 109.847 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.432 ' OE1' HD21 ' A' ' 44' ' ' LEU . 24.9 tt0 -99.45 119.13 37.49 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.675 -175.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 64.5 p -116.47 153.54 31.94 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.19 0.519 . . . . 0.0 111.984 -174.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.458 ' HB2' HD13 ' A' ' 121' ' ' ILE . 38.7 t80 -129.67 101.24 5.82 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.276 -0.875 . . . . 0.0 108.962 176.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 61.73 26.93 16.45 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.691 0.758 . . . . 0.0 110.254 -178.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 104.52 -25.8 24.68 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.559 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -79.1 127.45 32.03 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -177.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 43.9 p -69.82 114.16 7.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.761 0.315 . . . . 0.0 110.432 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.458 HD13 ' HB2' ' A' ' 116' ' ' TYR . 22.4 pt -100.52 -26.32 3.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.454 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -164.32 162.43 35.32 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.151 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.482 HG21 HD13 ' A' ' 93' ' ' LEU . 86.3 t -135.01 124.48 43.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.921 0.391 . . . . 0.0 110.207 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -106.6 123.57 48.31 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.948 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.402 HD22 ' N ' ' A' ' 125' ' ' LEU . 2.9 mm? -78.69 156.0 78.0 Favored Pre-proline 0 C--N 1.32 -0.675 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 174.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.434 ' HD3' HG12 ' A' ' 111' ' ' VAL . 47.6 Cg_exo -56.1 123.98 15.16 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.423 2.082 . . . . 0.0 111.446 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.582 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 12.8 mptt -54.85 -34.69 63.18 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.22 -176.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 36.3 p -117.45 108.71 15.87 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 171.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.6 p -122.41 135.85 61.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.432 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -96.48 105.8 17.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.463 0.649 . . . . 0.0 111.116 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 58.0 mt -114.3 129.1 56.63 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.981 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.2 m -75.29 130.88 39.82 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.143 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 170' ' ' ASP . 4.2 p -78.32 105.84 8.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.705 0.764 . . . . 0.0 110.618 178.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.418 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 13.8 p -110.81 123.49 50.19 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.17 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 134' ' ' THR . 42.1 mt-10 76.05 97.3 0.07 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.889 0.852 . . . . 0.0 111.422 -177.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.415 HG22 ' CG ' ' A' ' 168' ' ' GLU . 10.3 t -150.34 155.96 40.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.954 174.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.462 ' O ' ' HD3' ' A' ' 150' ' ' LYS . 25.2 mm-40 -80.96 153.72 72.56 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.123 -170.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -68.86 172.11 12.3 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.531 2.154 . . . . 0.0 111.485 174.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 119.44 32.29 1.26 Allowed Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.961 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 164' ' ' LEU . 24.2 pt -65.16 143.12 16.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 176.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -144.39 121.44 11.42 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.814 0.34 . . . . 0.0 110.922 -174.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.401 ' HA3' ' HB3' ' A' ' 145' ' ' ALA . . . 82.87 -18.98 12.98 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.996 -0.547 . . . . 0.0 113.417 174.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 67.39 -67.99 0.16 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.415 0.686 . . . . 0.0 111.323 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.0 t -84.01 -23.14 31.09 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.962 0.41 . . . . 0.0 110.21 177.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.401 ' HB3' ' HA3' ' A' ' 142' ' ' GLY . . . -63.43 111.71 2.43 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.286 -177.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.9 m -95.21 85.24 4.24 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.407 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.01 140.54 8.69 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.822 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 68.06 153.17 0.09 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.348 0.659 . . . . 0.0 111.526 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.4 p -121.31 163.81 18.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.898 0.856 . . . . 0.0 112.666 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.462 ' HD3' ' O ' ' A' ' 137' ' ' GLU . 26.0 ttmt -137.29 143.07 41.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.007 -1.452 . . . . 0.0 108.987 -174.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 25.0 m -73.77 120.72 19.75 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.103 0.477 . . . . 0.0 110.311 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -129.39 162.53 27.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.137 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 21.3 m -127.35 143.82 51.16 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.476 174.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 15.7 m -103.56 173.55 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.786 0.327 . . . . 0.0 110.717 176.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -62.74 -12.54 24.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.65 -174.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.438 HG22 ' O ' ' A' ' 105' ' ' LEU . 68.6 p -87.76 -13.49 42.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.789 0.328 . . . . 0.0 111.469 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 94.49 3.12 63.09 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.763 -174.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -78.14 141.54 38.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.846 0.355 . . . . 0.0 110.416 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 25.0 m -106.61 133.18 51.68 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.381 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -148.68 165.07 32.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.636 0.255 . . . . 0.0 110.48 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -105.53 108.51 20.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.322 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.429 ' HB ' HG21 ' A' ' 166' ' ' VAL . 27.8 m -102.93 157.39 33.83 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.648 -176.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -62.77 150.52 87.86 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 121.965 1.777 . . . . 0.0 110.828 175.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 140' ' ' ILE . 52.1 mt -55.78 -24.78 37.7 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -169.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -79.24 -13.32 59.76 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -174.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.429 HG21 ' HB ' ' A' ' 162' ' ' VAL . 91.5 t -68.51 129.8 33.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.123 0.487 . . . . 0.0 110.647 -178.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -121.52 155.01 35.89 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.514 -175.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.415 ' CG ' HG22 ' A' ' 136' ' ' THR . 75.5 mt-10 -57.68 121.39 10.29 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.665 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 114.16 -17.41 19.48 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.496 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.588 ' OD2' ' HD3' ' A' ' 184' ' ' ARG . 22.0 t70 -65.41 144.38 57.1 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 177.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 48.5 t -93.24 108.53 20.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.13 0.49 . . . . 0.0 110.294 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 76.2 mt -92.54 117.92 30.46 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.379 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 1.9 mp -90.48 101.97 12.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 175.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 31.9 mm -89.73 124.06 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.421 -175.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.582 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 49.4 t30 -86.44 89.44 7.89 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 174.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.457 HG22 ' HA ' ' A' ' 127' ' ' LYS . 8.9 t -66.74 152.06 46.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.938 0.399 . . . . 0.0 110.463 -176.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 93.42 -45.98 2.38 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.4 -176.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -98.92 -27.73 13.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.107 0.479 . . . . 0.0 110.456 177.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.39 24.06 55.07 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.377 176.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.471 ' HB2' ' HB3' ' A' ' 175' ' ' ASN . 1.3 m -81.76 99.42 8.96 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -77.17 108.26 10.13 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.15 0.5 . . . . 0.0 110.827 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 36.9 mm -96.37 140.95 16.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 44.6 t -120.73 167.92 11.96 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 110.465 -0.198 . . . . 0.0 110.465 -176.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.588 ' HD3' ' OD2' ' A' ' 170' ' ' ASP . 25.8 mmt180 72.03 16.84 5.29 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.278 0.631 . . . . 0.0 112.538 173.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.031 0 CA-C-O 118.749 -1.028 . . . . 0.0 112.721 179.814 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 120.452 0.167 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.403 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 50.6 mm -94.74 143.82 11.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.2 m -104.8 157.67 17.04 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.7 m -66.25 -4.24 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.013 -175.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -76.82 -24.5 52.77 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.841 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -112.72 107.51 16.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.306 0.574 . . . . 0.0 111.774 -175.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -140.69 145.85 37.06 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 171.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.2 mtmm -131.11 175.1 9.38 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.231 -174.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 19.6 m -61.78 -22.1 65.13 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.57 0.7 . . . . 0.0 110.237 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -144.91 114.77 0.8 Allowed Glycine 0 N--CA 1.434 -1.495 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 167.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.4 tp -150.36 122.73 8.43 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 175.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.543 HG21 HG13 ' A' ' 65' ' ' ILE . 2.1 p -87.03 122.95 31.58 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.461 0.648 . . . . 0.0 111.93 -175.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.7 mm -119.22 141.08 40.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.539 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.452 ' HB3' ' HB2' ' A' ' 63' ' ' ALA . 43.0 p -107.69 103.82 13.19 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 176.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.3 p -143.9 148.38 18.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 63.75 24.13 13.72 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.206 -175.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 61.95 28.04 17.05 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.193 -176.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.15 164.09 27.08 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.771 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.6 pt -108.52 126.95 65.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.635 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.498 ' CZ3' ' HB2' ' A' ' 43' ' ' ASN . 11.5 m95 -128.36 166.27 18.99 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.719 -174.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -132.63 108.21 8.91 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.767 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 85.6 t -63.91 115.57 2.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.283 177.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 9' ' ' THR . 77.1 mt -95.88 -38.9 8.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.584 176.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -140.18 153.73 46.71 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.08 178.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 39' ' ' SER . 16.7 p90 -146.8 128.51 15.23 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.828 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -100.9 99.04 9.48 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.038 177.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -78.14 94.33 4.7 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 175.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.2 p -104.86 126.58 59.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.116 -173.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -117.47 103.86 50.55 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.441 -178.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -57.5 -47.35 22.15 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 123.239 2.626 . . . . 0.0 112.671 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 112.7 5.03 24.41 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.588 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -81.53 -14.46 56.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.097 -0.552 . . . . 0.0 110.812 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.42 -15.1 8.14 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.518 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.4 p -134.41 145.94 49.38 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.418 -0.391 . . . . 0.0 110.097 177.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -125.72 168.31 13.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.692 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -143.8 163.51 33.14 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.516 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.9 t -121.32 105.12 16.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.027 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -81.86 99.37 9.0 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 175.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 25' ' ' PHE . 60.7 p -103.07 146.94 27.61 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.135 0.493 . . . . 0.0 112.099 -171.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -103.2 110.04 21.86 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 174.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.543 HD23 ' H ' ' A' ' 41' ' ' LEU . 0.9 OUTLIER -135.43 144.27 46.39 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.517 0.675 . . . . 0.0 111.778 -171.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 35.8 ttt180 -99.84 127.71 45.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.535 -175.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.498 ' HB2' ' CZ3' ' A' ' 20' ' ' TRP . 53.8 t-20 -71.78 119.8 16.46 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 173.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.8 mp -66.03 -24.6 66.78 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.935 0.397 . . . . 0.0 111.169 -176.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -80.21 -42.88 22.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.67 -176.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.6 p -97.63 -22.3 16.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.203 0.525 . . . . 0.0 111.517 -176.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.31 17.71 79.04 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.662 -176.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' A' ' 42' ' ' ARG . . . -92.15 143.67 26.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.97 0.414 . . . . 0.0 111.984 -174.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 44.4 mm -92.2 100.99 12.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.774 175.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.442 ' HG2' ' H ' ' A' ' 51' ' ' GLU . 29.6 tt0 -113.56 173.42 6.42 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.442 ' H ' ' HG2' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -122.03 146.91 46.72 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.117 0.484 . . . . 0.0 110.963 173.356 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.405 ' HB2' HD21 ' A' ' 41' ' ' LEU . 14.3 tppt? -134.3 132.11 39.19 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.597 -177.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.2 m -100.24 103.88 15.34 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.065 0.46 . . . . 0.0 111.136 -177.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -87.34 141.45 28.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.892 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 49.7 mtp180 -115.62 133.75 55.72 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.721 0.296 . . . . 0.0 110.784 -176.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.41 133.32 55.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.771 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 107.42 -31.03 8.45 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -176.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -90.19 141.88 28.26 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 177.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -81.53 137.85 35.51 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.285 0.564 . . . . 0.0 111.305 -176.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.403 ' O ' ' HB ' ' A' ' 2' ' ' ILE . 61.5 t -100.14 112.74 33.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.429 176.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -93.61 120.56 66.13 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-O 120.918 0.39 . . . . 0.0 110.787 -177.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -77.33 157.58 33.18 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 123.003 2.469 . . . . 0.0 112.9 -175.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.452 ' HB2' ' HB3' ' A' ' 14' ' ' SER . . . -106.01 115.85 30.93 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.153 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -73.77 108.13 6.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.352 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.543 HG13 HG21 ' A' ' 12' ' ' THR . 37.4 mm -103.41 129.97 54.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.068 0.461 . . . . 0.0 110.453 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.433 ' HB2' ' OG1' ' A' ' 115' ' ' THR . 21.0 mt-10 -109.77 146.45 34.95 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.354 -177.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -136.89 113.93 10.59 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.891 0.377 . . . . 0.0 110.647 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.452 ' HG2' ' HG3' ' A' ' 86' ' ' GLU . 79.1 mtm180 -123.0 156.76 34.14 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.502 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 8.5 ptm180 -114.77 124.59 52.15 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.104 -178.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.629 ' CB ' ' HB3' ' A' ' 82' ' ' PHE . 1.9 mpt? -116.27 142.63 46.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.408 -178.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -82.07 134.78 35.37 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.09 175.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.588 ' CD1' ' HA ' ' A' ' 107' ' ' GLU . 42.8 t80 -71.84 115.67 11.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.317 -173.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 55.8 mt -115.33 -176.47 2.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.781 168.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -146.75 154.63 41.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.178 0.514 . . . . 0.0 111.473 -177.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -140.21 -149.43 0.28 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.229 -0.896 . . . . 0.0 108.584 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -69.46 132.3 46.1 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 171.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -75.86 69.29 2.15 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.104 -1.522 . . . . 0.0 113.719 -167.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -127.19 -29.96 2.71 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 156.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.542 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 19.4 m120 -133.94 142.02 47.54 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.803 178.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.58 ' ND1' ' HG ' ' A' ' 98' ' ' LEU . 53.2 m80 -119.86 144.34 47.42 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.418 177.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 61.1 t -88.69 136.35 23.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.837 -176.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.629 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 63.5 m-85 -131.02 125.62 33.77 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.452 ' O ' ' HA ' ' A' ' 70' ' ' MET . 72.5 mtm -95.86 114.62 26.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.717 0.294 . . . . 0.0 111.533 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.542 ' HA ' ' HG3' ' A' ' 70' ' ' MET . 19.2 t70 -61.97 116.37 4.84 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.77 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -70.52 -20.29 62.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.022 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.465 ' HB2' ' OD2' ' A' ' 84' ' ' ASP . 11.3 mm-40 -64.08 -51.15 65.45 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.478 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 5.0 p -171.15 91.74 0.15 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 168.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 47.99 29.86 1.84 Allowed 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 159.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.488 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 47.2 mt-10 -100.06 117.83 35.14 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 121.768 -0.582 . . . . 0.0 110.937 177.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -84.07 113.86 21.34 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.347 0.594 . . . . 0.0 110.534 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 56.5 m -110.15 128.14 55.3 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.966 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -102.25 141.5 34.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.047 0.451 . . . . 0.0 110.267 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' A' ' 79' ' ' ASN . 57.3 mt -118.64 144.21 46.31 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.469 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.9 t -83.52 173.24 11.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.583 -174.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.7 t -56.18 -44.24 79.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.935 -173.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.52 -37.22 86.79 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.738 0.304 . . . . 0.0 111.687 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.587 ' O ' ' HG2' ' A' ' 101' ' ' GLU . 97.1 m-85 -67.03 -40.04 87.12 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.58 ' HG ' ' ND1' ' A' ' 80' ' ' HIS . 3.7 mm? -74.6 -11.07 60.1 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.09 178.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -63.75 -44.32 93.84 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.834 0.349 . . . . 0.0 110.589 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.555 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 14.3 tp10 -74.34 -37.0 63.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.122 0.487 . . . . 0.0 109.781 175.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.587 ' HG2' ' O ' ' A' ' 97' ' ' TYR . 9.1 mm-40 -59.38 -43.46 92.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.983 176.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.558 ' O ' ' HB ' ' A' ' 156' ' ' THR . 85.9 mt -71.85 -2.43 17.77 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.006 0.431 . . . . 0.0 111.051 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.555 ' HB3' ' O ' ' A' ' 100' ' ' GLU . 29.3 t30 -80.73 -48.3 12.73 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 171.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.514 ' HB3' HG11 ' A' ' 129' ' ' VAL . 85.5 m-85 -146.99 117.19 7.33 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.523 174.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.476 HD22 ' O ' ' A' ' 101' ' ' GLU . 0.9 OUTLIER -172.94 169.18 4.8 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.588 0.232 . . . . 0.0 110.562 178.476 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.509 ' HD3' ' O ' ' A' ' 130' ' ' GLU . 30.6 mmmt -143.2 149.14 37.57 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 173.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.588 ' HA ' ' CD1' ' A' ' 72' ' ' TYR . 40.4 tt0 -69.57 130.91 43.73 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.071 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.46 -2.29 80.48 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.397 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 58.3 ttm -74.79 140.77 44.24 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 70' ' ' MET . 48.6 mt-10 -103.19 102.71 12.7 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.121 0.486 . . . . 0.0 110.073 -177.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.502 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 19.5 m -99.49 162.8 2.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.152 -174.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.565 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 57.9 mt-30 -104.55 100.36 10.03 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.989 0.423 . . . . 0.0 110.688 -178.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 59.3 mt -74.78 128.18 36.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.94 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.498 ' O ' HG13 ' A' ' 121' ' ' ILE . 7.8 tt0 -105.83 113.91 27.75 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.987 -175.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.433 ' OG1' ' HB2' ' A' ' 66' ' ' GLU . 74.1 p -114.85 155.3 27.06 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.23 -176.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -118.91 99.21 6.6 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 172.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 61.42 41.8 12.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.82 0.819 . . . . 0.0 109.639 -176.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.32 -19.83 37.35 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.506 -0.77 . . . . 0.0 113.192 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -82.02 116.44 21.63 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 24.2 m -65.28 106.01 1.25 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -176.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 114' ' ' GLN . 2.4 pp -100.18 -23.42 4.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.788 -177.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -170.41 175.53 44.28 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.17 -1.014 . . . . 0.0 112.727 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.2 t -135.43 129.76 49.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.849 0.357 . . . . 0.0 110.093 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.565 ' HB2' ' HB2' ' A' ' 112' ' ' GLN . 5.9 mm-40 -98.4 109.69 22.4 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.773 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 77.3 mt -80.6 135.19 53.16 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.784 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.42 131.25 44.63 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.621 2.214 . . . . 0.0 110.641 170.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 0.7 OUTLIER -60.74 -35.09 75.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.731 -167.036 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 18.0 p -96.76 110.53 22.98 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.029 0.442 . . . . 0.0 111.426 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.514 HG11 ' HB3' ' A' ' 104' ' ' TYR . 6.9 p -129.92 135.67 60.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.285 177.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.509 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 6.7 pt-20 -109.65 121.25 44.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.168 0.509 . . . . 0.0 111.352 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 77.9 mt -122.2 130.28 53.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.294 -178.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.1 m -75.1 134.36 41.34 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.172 178.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.446 HG12 ' O ' ' A' ' 170' ' ' ASP . 4.1 p -83.54 100.23 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-O 121.952 0.882 . . . . 0.0 110.702 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 29.8 p -90.88 103.27 16.0 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.466 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.474 ' HA ' ' OE2' ' A' ' 168' ' ' GLU . 44.1 mt-10 77.77 111.49 0.07 Allowed 'General case' 0 C--O 1.238 0.45 0 O-C-N 124.149 0.906 . . . . 0.0 111.998 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.0 t -150.39 152.81 34.94 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.542 -1.208 . . . . 0.0 108.579 174.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.43 ' O ' ' HD2' ' A' ' 150' ' ' LYS . 4.6 mp0 -82.99 123.5 77.61 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 120.762 0.315 . . . . 0.0 110.448 -176.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -82.38 -179.9 4.97 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.824 2.349 . . . . 0.0 112.114 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 119.45 32.98 1.16 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.22 -0.99 . . . . 0.0 113.162 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.573 HG12 ' H ' ' A' ' 142' ' ' GLY . 12.2 tt -51.48 127.3 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-O 121.401 0.62 . . . . 0.0 111.049 178.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -74.28 -10.79 59.94 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.99 -172.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.573 ' H ' HG12 ' A' ' 140' ' ' ILE . . . 82.14 -30.7 2.95 Favored Glycine 0 C--O 1.231 -0.08 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.216 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -63.85 149.03 47.91 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 122.654 0.382 . . . . 0.0 110.404 176.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 4.0 t -67.75 87.0 0.22 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.912 0.863 . . . . 0.0 110.868 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -117.66 57.62 0.81 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.586 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.8 p -73.36 -9.95 59.23 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.39 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -98.74 -1.72 57.46 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.871 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -108.65 158.84 17.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.658 0.266 . . . . 0.0 110.387 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.4 p -140.26 173.67 11.28 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.147 0.499 . . . . 0.0 111.451 -177.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.43 ' HD2' ' O ' ' A' ' 137' ' ' GLU . 63.3 pttt -138.39 158.42 44.32 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.218 175.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.3 p -73.22 132.39 43.13 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.328 0.585 . . . . 0.0 111.751 -178.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.13 163.38 32.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.599 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 26.0 m -132.01 131.37 42.45 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 174.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.7 m -93.45 175.11 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -59.27 -25.94 64.52 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -176.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.558 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 47.1 p -72.5 -16.74 61.79 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.765 0.317 . . . . 0.0 111.563 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 97.22 1.81 59.32 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.593 -176.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -84.73 138.22 32.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.488 -0.356 . . . . 0.0 110.661 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 14.8 t -97.23 136.05 38.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.974 176.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -148.65 164.35 34.57 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -176.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -102.23 111.77 24.18 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.204 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 33.9 m -106.47 147.25 34.59 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.96 -176.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.7 154.97 39.73 Favored 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 122.712 2.275 . . . . 0.0 111.679 176.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.494 ' H ' HD22 ' A' ' 164' ' ' LEU . 1.8 mm? -67.07 -15.14 63.54 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -168.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.442 ' HA ' HD12 ' A' ' 140' ' ' ILE . 22.1 p90 -80.98 -11.11 59.62 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.861 0.362 . . . . 0.0 111.346 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.405 HG13 HD21 ' A' ' 172' ' ' LEU . 92.8 t -76.15 134.07 29.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.147 177.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -120.14 165.73 14.37 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.474 ' OE2' ' HA ' ' A' ' 135' ' ' GLU . 28.5 tt0 -61.42 152.27 30.24 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.595 -176.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 65.68 6.83 31.63 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 114.354 0.501 . . . . 0.0 114.354 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.446 ' O ' HG12 ' A' ' 133' ' ' VAL . 11.2 m-20 -77.7 147.83 35.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.653 0.727 . . . . 0.0 110.137 171.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 62.3 t -94.48 110.45 23.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.068 0.461 . . . . 0.0 109.898 177.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.406 HD23 ' HG2' ' A' ' 184' ' ' ARG . 67.7 mt -94.08 123.61 37.57 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.73 -176.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.535 ' O ' ' HB ' ' A' ' 182' ' ' ILE . 54.4 mt -90.73 128.38 42.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 174.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 37.1 mm -125.11 139.87 49.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -178.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.589 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 26.3 t-20 -87.32 91.69 8.81 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 174.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 11.1 t -74.07 148.29 42.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.964 0.411 . . . . 0.0 110.175 -177.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 105.65 -40.34 2.52 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 -174.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -109.8 -46.35 3.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.135 0.493 . . . . 0.0 110.001 175.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 107.01 11.15 26.75 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.671 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 175' ' ' ASN . 6.6 m -65.11 132.31 48.84 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -83.14 126.08 32.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.253 0.549 . . . . 0.0 110.468 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.535 ' HB ' ' O ' ' A' ' 173' ' ' ILE . 14.1 mm -106.61 156.71 7.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.4 p -74.45 170.19 16.19 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.258 0.551 . . . . 0.0 111.935 -170.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.406 ' HG2' HD23 ' A' ' 172' ' ' LEU . 84.0 mtm180 -70.05 145.27 51.83 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.726 -176.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.946 0 CA-C-O 118.57 -1.128 . . . . 0.0 111.77 178.259 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.8 ttt . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 120.772 0.32 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 46.6 mm -117.64 134.65 60.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 171.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.9 m -88.3 151.14 22.83 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.44 ' O ' HG21 ' A' ' 37' ' ' VAL . 29.7 m -68.5 -1.82 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 121.004 0.43 . . . . 0.0 111.667 -178.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -97.98 0.39 46.28 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.345 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -118.95 89.12 3.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.543 -178.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -134.21 153.29 51.94 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.928 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -129.95 175.94 8.46 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.167 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.2 t -66.33 -9.56 34.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.165 0.507 . . . . 0.0 110.079 175.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.669 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -152.26 115.43 0.69 Allowed Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 110.396 -1.081 . . . . 0.0 110.396 170.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.52 133.09 19.79 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 10.5 p -98.15 123.28 42.12 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.138 0.494 . . . . 0.0 112.023 -177.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.1 mp -125.7 141.93 44.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.14 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.412 ' HB2' ' HB2' ' A' ' 63' ' ' ALA . 23.0 t -106.24 105.27 15.22 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 176.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.7 p -147.52 148.36 16.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -176.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 62.68 24.89 14.82 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.199 0.312 . . . . 0.0 110.62 -174.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 63.74 24.16 13.73 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.611 0.72 . . . . 0.0 110.601 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.62 158.77 37.58 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.857 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.7 pt -105.22 125.8 60.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.281 0.563 . . . . 0.0 110.295 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.538 ' O ' ' HA ' ' A' ' 12' ' ' THR . 74.2 m95 -120.84 161.19 21.94 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.448 -170.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -136.7 110.4 8.09 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.163 176.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.669 ' O ' ' HA2' ' A' ' 10' ' ' GLY . 89.3 t -60.52 117.26 2.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.932 177.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.3 mm -92.14 -30.73 4.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.481 175.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -153.89 140.48 18.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.427 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -126.29 138.68 53.62 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.806 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -118.82 100.07 7.16 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.023 176.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -75.58 101.49 4.94 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 177.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.4 p -109.58 126.47 66.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.391 0.615 . . . . 0.0 111.609 -172.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.8 mtmt -113.91 102.73 55.08 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.438 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -55.85 -47.8 23.22 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.509 2.806 . . . . 0.0 112.788 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.8 11.54 10.14 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.137 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -102.46 3.42 37.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.128 0.49 . . . . 0.0 110.694 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.6 -43.0 1.81 Allowed Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.384 178.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.8 p -93.32 126.34 38.39 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.819 0.342 . . . . 0.0 110.296 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.54 162.03 13.26 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.08 0.467 . . . . 0.0 110.813 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -134.84 166.13 23.7 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.815 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.44 HG21 ' O ' ' A' ' 4' ' ' VAL . 49.9 t -131.83 104.09 7.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 175.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -82.3 99.06 9.12 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.3 p -110.56 135.41 51.25 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.076 0.465 . . . . 0.0 111.892 -173.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -91.39 111.94 23.65 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 172.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.534 HD23 ' H ' ' A' ' 41' ' ' LEU . 1.2 pt? -138.71 145.1 39.9 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.175 0.512 . . . . 0.0 110.935 -173.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 9.9 ptt180 -106.96 143.08 35.57 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.865 -174.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -65.23 119.89 11.73 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 171.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.526 HD22 HD12 ' A' ' 121' ' ' ILE . 3.9 tt -67.38 -25.57 66.03 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.208 -170.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.406 ' CZ ' HG22 ' A' ' 121' ' ' ILE . 11.9 mtp180 -83.44 -46.42 12.53 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.411 -177.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.2 p -94.97 -20.48 19.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.011 0.434 . . . . 0.0 112.151 -173.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.93 17.85 73.84 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.111 -176.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 42' ' ' ARG . . . -75.0 126.54 31.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.834 0.349 . . . . 0.0 111.803 -177.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.1 mm -87.96 108.86 18.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.107 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -129.67 162.18 28.92 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -122.99 128.06 49.67 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.471 0.653 . . . . 0.0 110.559 174.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -128.12 144.63 51.12 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.559 -176.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.2 m -110.32 118.37 36.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.907 0.384 . . . . 0.0 111.354 -175.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -85.45 155.51 21.21 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.871 176.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.563 ' H ' ' HD2' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -122.19 132.88 54.67 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.043 0.449 . . . . 0.0 111.325 -176.186 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.63 138.06 58.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.089 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 108.22 -28.66 11.4 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.401 -177.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -100.83 141.27 33.95 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 177.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.64 142.68 37.02 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.008 0.432 . . . . 0.0 110.264 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.9 t -93.88 125.84 46.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.316 174.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -89.55 113.31 56.18 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 120.917 0.389 . . . . 0.0 110.21 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.01 159.63 41.11 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.606 2.204 . . . . 0.0 112.719 -176.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.412 ' HB2' ' HB2' ' A' ' 14' ' ' SER . . . -114.85 109.52 18.28 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.096 177.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 24.7 ttt -74.19 109.59 7.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.144 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.495 HG13 HG21 ' A' ' 12' ' ' THR . 48.7 mm -96.28 116.83 39.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.835 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.473 ' HB2' ' OG1' ' A' ' 115' ' ' THR . 27.8 mt-10 -96.84 141.51 29.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.506 -176.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -123.08 123.54 41.08 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.723 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.55 ' O ' ' HA ' ' A' ' 112' ' ' GLN . 52.6 mtt180 -124.37 164.33 19.88 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 174.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 10.3 ptm85 -126.72 131.98 51.23 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 176.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.522 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 13.7 mmm -127.01 139.3 53.13 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.265 -170.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -78.44 132.36 37.27 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 175.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.419 ' HB2' ' O ' ' A' ' 109' ' ' MET . 38.6 t80 -75.37 106.93 7.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.137 -174.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.7 mp -97.38 176.01 6.04 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 166.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -146.95 149.91 34.13 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 119.567 -0.853 . . . . 0.0 113.047 -170.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.96 -169.76 3.47 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 113.976 -1.465 . . . . 0.0 107.211 171.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -63.79 144.14 57.28 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 175.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.3 69.68 2.93 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 118.928 -1.606 . . . . 0.0 113.731 -168.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -126.21 -27.71 3.2 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 158.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.55 HD21 ' HB3' ' A' ' 92' ' ' GLU . 26.7 t-20 -140.76 128.45 21.6 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.308 -1.315 . . . . 0.0 109.897 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.495 ' ND1' HD22 ' A' ' 98' ' ' LEU . 47.6 m170 -122.03 148.28 45.03 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.568 0.223 . . . . 0.0 110.466 175.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 41.8 t -102.24 130.48 52.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.085 -175.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.485 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 79.7 m-85 -125.43 133.49 52.45 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.404 ' O ' ' HA ' ' A' ' 70' ' ' MET . 40.7 mtm -105.64 119.2 38.54 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 121.073 -0.251 . . . . 0.0 110.883 -178.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.559 ' HB3' ' H ' ' A' ' 89' ' ' GLU . 10.6 t70 -61.33 123.9 19.09 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.88 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -72.37 -20.83 61.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.833 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -66.58 -51.55 55.18 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.3 p -172.25 92.46 0.12 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 166.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 48.6 27.46 1.48 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 162.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.559 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 48.5 mt-10 -88.79 110.41 21.0 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 121.756 -0.59 . . . . 0.0 110.276 176.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -78.81 133.72 37.03 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.684 -177.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 90.6 m -131.01 120.85 24.07 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.937 174.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.55 ' HB3' HD21 ' A' ' 79' ' ' ASN . 29.1 mt-10 -99.89 127.56 46.05 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.004 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.433 HD12 ' CE1' ' A' ' 82' ' ' PHE . 52.6 mt -103.83 152.06 22.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.98 -177.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.624 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 13.8 m -96.44 170.64 9.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.316 -172.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.0 m -46.92 -38.13 10.04 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.27 0.628 . . . . 0.0 112.595 -175.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -50.34 -44.74 54.59 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.09 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -81.16 -36.92 29.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.323 0.582 . . . . 0.0 110.437 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.624 ' HG ' ' O ' ' A' ' 94' ' ' SER . 11.7 mt -64.68 -27.2 68.76 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.261 -171.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -59.87 -47.5 85.49 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.901 0.381 . . . . 0.0 110.561 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.51 ' HA ' ' ND2' ' A' ' 103' ' ' ASN . 41.9 mt-10 -70.1 -33.47 71.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.486 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.577 ' O ' HD12 ' A' ' 105' ' ' LEU . 72.7 mt-10 -59.74 -45.35 92.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.03 171.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 83.1 mt -66.55 -15.27 63.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.885 0.374 . . . . 0.0 111.068 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.51 ' ND2' ' HA ' ' A' ' 100' ' ' GLU . 77.5 m-20 -75.51 -50.55 15.34 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 172.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -145.96 117.2 7.89 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.543 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.577 HD12 ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -165.41 161.74 19.03 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.909 0.385 . . . . 0.0 110.999 176.247 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.471 ' HD3' ' O ' ' A' ' 130' ' ' GLU . 31.3 mmmt -136.0 142.61 44.51 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 172.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -68.52 130.77 43.84 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.72 0.295 . . . . 0.0 110.828 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.13 -4.9 81.43 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.289 -177.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.419 ' O ' ' HB2' ' A' ' 72' ' ' TYR . 52.3 ttm -62.25 130.02 43.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.874 0.369 . . . . 0.0 111.121 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.522 ' HA ' ' O ' ' A' ' 70' ' ' MET . 46.3 mt-10 -95.78 101.12 12.78 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.14 0.495 . . . . 0.0 109.846 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 26.4 m -100.17 164.24 2.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.397 -176.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.55 ' HA ' ' O ' ' A' ' 68' ' ' ARG . 15.2 mt-30 -102.23 108.28 19.61 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.143 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.464 HD12 ' HG3' ' A' ' 70' ' ' MET . 19.0 mt -84.01 122.79 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.554 ' O ' HG12 ' A' ' 121' ' ' ILE . 16.3 tt0 -99.3 118.77 36.71 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.263 -175.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.473 ' OG1' ' HB2' ' A' ' 66' ' ' GLU . 79.3 p -117.91 155.0 30.94 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.314 0.578 . . . . 0.0 111.854 -174.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -125.75 104.32 8.29 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 173.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 59.37 41.05 20.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.836 0.827 . . . . 0.0 109.852 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 91.16 -23.49 23.91 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.298 -0.865 . . . . 0.0 113.157 178.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -83.36 128.5 34.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.853 0.327 . . . . 0.0 110.946 -175.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.9 t -66.16 120.41 13.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.127 0.489 . . . . 0.0 110.915 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.554 HG12 ' O ' ' A' ' 114' ' ' GLN . 19.9 pt -109.69 -24.68 3.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.437 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -169.44 164.91 38.41 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.372 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 99.3 t -131.62 118.16 37.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.862 0.363 . . . . 0.0 110.195 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 112' ' ' GLN . 42.3 mt-10 -91.13 104.19 16.79 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.867 -176.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 70.3 mt -78.31 138.77 59.79 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 174.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.55 128.65 30.27 Favored 'Trans proline' 0 CA--C 1.515 -0.456 0 C-N-CA 122.771 2.314 . . . . 0.0 111.153 178.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.732 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 95.4 mttt -52.3 -33.7 43.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.479 -169.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.8 p -115.47 109.6 18.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.024 0.44 . . . . 0.0 111.302 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 13.0 p -112.34 143.59 21.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.763 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.471 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 47.3 mt-10 -104.45 124.26 48.93 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 177.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 62.6 mt -126.28 131.41 51.9 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.776 0.322 . . . . 0.0 110.409 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.5 m -74.45 132.84 42.28 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 170' ' ' ASP . 5.0 p -89.43 107.22 17.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.41 0.624 . . . . 0.0 110.338 178.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 13.1 p -105.02 124.53 49.68 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.714 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 70.6 88.87 0.1 Allowed 'General case' 0 C--O 1.237 0.421 0 CA-C-O 122.08 0.943 . . . . 0.0 111.611 -177.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.453 ' O ' ' HD3' ' A' ' 138' ' ' PRO . 15.2 t -151.36 139.85 20.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.512 -1.222 . . . . 0.0 107.839 170.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -82.37 113.0 40.97 Favored Pre-proline 0 C--N 1.322 -0.593 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.293 -170.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 136' ' ' THR . 96.9 Cg_endo -93.75 -179.84 0.87 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.257 2.638 . . . . 0.0 111.858 177.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.19 30.76 24.5 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.819 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.424 HG23 ' HB3' ' A' ' 164' ' ' LEU . 4.2 tp -128.29 99.44 5.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.607 0.717 . . . . 0.0 110.195 178.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -156.46 164.12 38.62 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.476 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 120.16 -28.69 6.24 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.391 177.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -103.14 153.9 19.85 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 26.0 m -71.24 88.73 0.85 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.245 0.545 . . . . 0.0 111.037 -177.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -80.0 72.67 6.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.52 178.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.4 t -68.81 -25.7 64.81 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.004 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -159.87 28.74 0.36 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.342 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -92.09 133.11 36.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.68 0.276 . . . . 0.0 110.664 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.6 p -131.91 168.42 17.9 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.794 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -137.22 151.34 48.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.014 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.9 m -73.08 110.62 7.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.216 0.531 . . . . 0.0 111.246 -174.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -116.21 162.06 18.03 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.729 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 22.7 m -125.86 140.68 52.46 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.739 174.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 12.8 m -101.87 173.08 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.805 175.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -56.98 -27.19 61.19 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.413 HG22 HD13 ' A' ' 105' ' ' LEU . 80.9 p -73.74 -11.89 60.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.79 0.329 . . . . 0.0 111.487 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 91.82 5.0 66.83 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.932 -0.652 . . . . 0.0 111.844 -177.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -85.04 141.68 30.11 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 27.0 m -99.2 129.67 45.45 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.648 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.4 mp -132.61 155.93 47.83 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 120.729 0.299 . . . . 0.0 110.238 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -93.7 99.35 11.78 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 34.6 m -97.34 150.71 37.1 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.082 -174.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -56.48 152.25 41.21 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.535 2.157 . . . . 0.0 111.277 174.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.424 ' HB3' HG23 ' A' ' 140' ' ' ILE . 59.1 mt -64.93 -14.85 61.11 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.612 -169.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -86.65 -7.42 58.34 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 88.0 t -75.6 131.13 35.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.861 0.362 . . . . 0.0 110.831 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -120.64 144.73 48.0 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.33 -175.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.419 ' HB3' HG22 ' A' ' 136' ' ' THR . 9.2 pt-20 -69.56 132.97 47.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.138 0.494 . . . . 0.0 110.987 -176.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 109.78 -16.51 30.95 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.418 -174.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.441 ' OD1' ' HB2' ' A' ' 184' ' ' ARG . 10.7 t70 -84.93 156.71 21.09 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 74.7 t -104.02 116.13 47.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.87 0.367 . . . . 0.0 110.563 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 184' ' ' ARG . 80.1 mt -94.68 145.65 24.7 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.587 -178.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.635 ' O ' ' HB ' ' A' ' 182' ' ' ILE . 26.6 mt -98.66 134.82 35.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 175.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 67.2 mt -135.2 137.6 49.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 O-C-N 122.039 -0.413 . . . . 0.0 110.46 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.732 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 27.0 t-20 -83.68 98.01 9.41 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 175.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 8.9 t -85.37 157.92 20.39 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.855 0.36 . . . . 0.0 110.071 -177.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 94.45 -48.71 2.11 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -173.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.551 ' HB3' ' OD1' ' A' ' 175' ' ' ASN . 33.1 t70 -98.52 -42.3 7.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.001 0.429 . . . . 0.0 110.08 176.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 105.97 5.3 38.39 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.827 -0.701 . . . . 0.0 113.427 173.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 64.0 m -68.61 133.67 48.83 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.957 0.408 . . . . 0.0 111.038 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -86.64 134.41 33.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.1 0.476 . . . . 0.0 110.851 -177.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.635 ' HB ' ' O ' ' A' ' 173' ' ' ILE . 56.0 mt -116.04 155.0 17.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.3 p -75.88 172.7 12.26 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.419 0.152 . . . . 0.0 110.729 -176.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.441 ' HB2' ' OD1' ' A' ' 170' ' ' ASP . 8.3 ptp180 -57.99 159.15 5.9 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.174 0.511 . . . . 0.0 111.575 -173.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.791 -1.005 . . . . 0.0 111.471 178.722 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.9 mtp . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 120.578 0.228 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.416 HD12 ' HB3' ' A' ' 62' ' ' PRO . 53.7 mt -115.73 137.95 47.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-O 121.209 0.528 . . . . 0.0 111.382 -177.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.0 t -116.97 166.07 12.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.03 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.407 ' O ' HG21 ' A' ' 37' ' ' VAL . 21.2 m -67.96 -7.9 7.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -170.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -86.92 -2.39 58.57 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.637 -176.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -137.62 95.45 3.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.284 0.564 . . . . 0.0 112.198 -178.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -121.1 160.37 23.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.231 173.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -139.94 169.17 18.19 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.585 -0.154 . . . . 0.0 110.585 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.1 t -61.81 -13.1 20.95 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 123.632 0.583 . . . . 0.0 111.828 -173.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.34 113.14 0.66 Allowed Glycine 0 N--CA 1.434 -1.475 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 165.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 62.9 tp -150.93 129.35 12.08 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 20' ' ' TRP . 2.7 p -98.48 129.4 45.07 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.24 0.543 . . . . 0.0 111.677 -177.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 mp -128.37 138.58 54.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.996 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.7 p -94.66 110.45 22.29 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.042 175.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.7 p -150.67 147.78 15.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -178.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 62.11 30.93 17.92 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.312 0.383 . . . . 0.0 110.864 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 63.3 24.43 14.26 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.94 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -137.83 168.59 19.38 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.255 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 11.1 pt -116.73 127.31 74.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.257 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.551 ' O ' ' HA ' ' A' ' 12' ' ' THR . 15.4 m95 -127.67 157.87 39.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.044 -172.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 44.5 tttm -123.23 119.51 30.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.317 175.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 90.9 t -62.34 117.95 4.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.402 0.62 . . . . 0.0 110.65 175.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 86.8 mt -90.0 -39.07 11.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.4 173.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -152.3 148.0 27.02 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.027 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -135.98 140.67 44.11 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.107 0.48 . . . . 0.0 111.032 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 7.3 tp-100 -117.93 99.89 7.21 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.053 175.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -78.0 89.25 4.15 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.0 p -97.04 131.06 44.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.058 -173.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.403 ' HD3' ' N ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -122.93 105.11 35.18 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.442 179.542 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.46 -10.63 27.21 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.689 2.259 . . . . 0.0 112.793 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.69 22.89 63.3 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.775 176.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -104.18 0.59 29.7 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.991 0.424 . . . . 0.0 110.79 -178.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 130.81 -42.07 1.45 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.765 175.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.4 m -118.83 146.42 44.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.768 0.318 . . . . 0.0 110.692 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.82 160.92 14.06 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.142 0.496 . . . . 0.0 110.945 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -132.49 161.8 32.82 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 53' ' ' THR . 48.1 t -132.24 102.6 5.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 120.842 0.353 . . . . 0.0 110.601 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -79.71 99.09 7.25 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 174.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.1 p -112.5 139.5 48.03 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.129 0.49 . . . . 0.0 112.17 -174.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -89.76 121.22 31.7 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 171.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.473 HD23 ' H ' ' A' ' 41' ' ' LEU . 0.8 OUTLIER -141.23 142.42 33.96 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.491 0.662 . . . . 0.0 111.697 -174.513 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.1 ttp180 -104.67 129.73 52.79 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.483 -174.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -69.09 118.22 11.72 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 173.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.3 mp -66.65 -28.93 68.86 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -175.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.588 ' HA ' ' O ' ' A' ' 121' ' ' ILE . 68.0 mtt85 -73.07 -44.57 60.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.958 0.409 . . . . 0.0 111.65 -176.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.4 p -102.85 -11.61 18.16 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.018 0.437 . . . . 0.0 112.029 -173.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.92 21.82 78.25 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -176.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.8 133.41 34.34 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -172.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.3 mm -89.74 110.05 21.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.926 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.4 ' HG2' ' N ' ' A' ' 51' ' ' GLU . 50.8 tt0 -132.25 172.69 12.1 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.4 ' N ' ' HG2' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -130.28 147.12 51.96 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.022 0.439 . . . . 0.0 110.864 175.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.425 ' HD2' HD11 ' A' ' 41' ' ' LEU . 67.8 mttm -142.75 148.04 36.57 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.908 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 43.7 m -111.44 117.53 33.29 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.006 0.432 . . . . 0.0 110.342 178.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -84.6 140.71 31.18 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.82 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 47.8 mtm105 -107.17 138.44 43.35 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.585 -177.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.53 130.65 46.08 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.795 0.331 . . . . 0.0 110.258 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.67 -29.97 8.92 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -174.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.11 119.83 24.53 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 175.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -71.32 131.8 43.96 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.369 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.9 t -91.34 107.99 19.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.156 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -87.64 113.25 53.51 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.419 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.416 ' HB3' HD12 ' A' ' 2' ' ' ILE . 58.3 Cg_endo -72.94 155.5 53.0 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.503 2.136 . . . . 0.0 112.702 -178.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.31 115.58 27.6 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.328 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 46.1 ttm -76.92 108.47 9.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.781 -178.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.488 HG13 HG21 ' A' ' 12' ' ' THR . 43.2 mm -100.94 139.02 23.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.396 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 114' ' ' GLN . 39.0 mt-10 -105.09 116.73 32.44 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 175.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -99.71 99.08 9.86 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 173.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -111.87 124.73 52.98 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.015 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.589 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 12.8 ptp180 -86.84 120.18 27.84 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.329 0.585 . . . . 0.0 109.485 177.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.817 ' SD ' ' HA ' ' A' ' 84' ' ' ASP . 8.5 mmt -107.32 145.58 32.64 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.724 -178.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -79.58 136.12 36.77 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 172.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.451 ' CZ ' HD23 ' A' ' 105' ' ' LEU . 47.4 t80 -77.13 108.38 10.19 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.807 -176.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 3.3 mm? -99.51 177.33 5.2 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 167.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -146.94 150.73 35.76 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.67 -175.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.05 -162.92 1.65 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.735 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -62.74 137.76 58.35 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 174.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.43 70.19 2.46 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 119.209 -1.472 . . . . 0.0 113.151 -171.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -125.87 -32.56 2.8 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 161.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.501 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 78.6 m-20 -141.29 135.19 30.35 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 114.065 -1.425 . . . . 0.0 109.293 175.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.527 ' CG ' HD22 ' A' ' 98' ' ' LEU . 58.6 m170 -107.66 144.1 35.22 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 175.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 73' ' ' LEU . 49.5 t -94.3 121.91 45.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.794 -175.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.542 ' HB3' ' CB ' ' A' ' 70' ' ' MET . 76.8 m-85 -117.85 126.04 51.65 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 176.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 14.7 tmm? -97.48 117.26 31.33 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.021 -175.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.817 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 17.6 t70 -62.42 114.65 3.63 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.418 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -76.94 -5.11 47.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.414 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -76.9 -50.94 12.17 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 173.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.7 p -170.94 93.95 0.18 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 168.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 50.09 28.83 3.19 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 157.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.57 ' H ' ' HB3' ' A' ' 84' ' ' ASP . 34.1 mt-10 -101.14 115.25 30.04 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 121.466 -0.771 . . . . 0.0 111.287 175.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -82.38 108.98 16.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.316 0.579 . . . . 0.0 110.962 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 54.8 m -101.81 123.21 45.38 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.801 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -99.58 125.25 45.34 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.852 0.358 . . . . 0.0 110.334 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.501 ' O ' ' HA ' ' A' ' 79' ' ' ASN . 42.6 mt -97.85 138.77 34.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.349 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.526 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 29.5 t -79.95 169.23 18.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.716 -174.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.2 p -50.48 -39.41 48.18 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.963 0.505 . . . . 0.0 112.312 -175.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -59.31 -36.09 74.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.648 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -76.07 -35.47 59.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.305 0.574 . . . . 0.0 109.504 177.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.634 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 14.2 mt -64.32 -30.09 71.15 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.238 -176.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -62.6 -32.69 73.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.935 176.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -73.27 -40.52 64.53 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.552 ' O ' HD12 ' A' ' 105' ' ' LEU . 47.8 mt-10 -62.05 -36.76 82.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.732 175.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 79.9 mt -73.52 0.57 12.12 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.078 0.466 . . . . 0.0 110.824 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' A' ' 158' ' ' TYR . 57.5 t30 -93.95 -43.26 8.63 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 170.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -148.34 117.09 6.66 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.26 172.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.552 HD12 ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -160.21 153.39 21.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.926 0.393 . . . . 0.0 110.649 172.255 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.7 mtpt -144.03 146.85 33.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.791 172.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -71.13 132.11 44.57 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.344 -174.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.67 0.68 90.25 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.771 177.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.446 ' SD ' ' HG3' ' A' ' 126' ' ' PRO . 57.5 ttm -82.65 141.74 32.26 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.809 0.338 . . . . 0.0 111.438 -177.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' A' ' 70' ' ' MET . 54.2 mp0 -84.19 123.47 30.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.084 175.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 34.7 m -121.79 158.9 24.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.329 177.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.55 ' HB2' ' HB3' ' A' ' 124' ' ' GLU . 15.8 mm-40 -91.34 101.55 14.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.755 0.312 . . . . 0.0 110.194 -175.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 48.8 mm -94.01 122.03 45.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 178.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 87.2 mt-30 -98.47 117.34 32.68 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.742 0.306 . . . . 0.0 110.539 -178.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.413 ' OG1' ' HB2' ' A' ' 66' ' ' GLU . 35.2 p -112.36 151.22 30.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.915 176.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -135.56 103.12 5.34 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 60.06 31.77 20.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.528 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 104.44 -30.27 10.42 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 121.102 -0.571 . . . . 0.0 113.019 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -76.72 131.21 38.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.561 0.219 . . . . 0.0 111.276 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 17.6 p -73.43 106.6 5.3 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 172.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' A' ' 45' ' ' ARG . 45.2 pt -94.25 -31.2 4.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -174.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -162.38 164.38 35.55 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 119.641 -1.266 . . . . 0.0 113.135 -177.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 59.9 t -133.38 127.57 54.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.55 ' HB3' ' HB2' ' A' ' 112' ' ' GLN . 35.1 tt0 -118.69 122.99 43.81 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.041 0.448 . . . . 0.0 110.337 178.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -86.54 155.67 56.55 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.446 ' HG3' ' SD ' ' A' ' 109' ' ' MET . 10.5 Cg_endo -53.5 132.76 50.4 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.58 2.187 . . . . 0.0 110.982 176.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 175' ' ' ASN . 95.7 mttt -54.85 -34.77 63.28 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.518 -174.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 19.7 p -122.92 109.08 13.69 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.045 176.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.5 p -106.25 136.81 39.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.499 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -94.3 108.53 20.42 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 177.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.524 HD12 HD13 ' A' ' 174' ' ' ILE . 98.7 mt -117.92 134.4 54.98 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.253 0.549 . . . . 0.0 110.744 -176.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.0 m -81.45 131.25 35.27 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.752 177.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.0 p -81.05 119.36 30.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.685 0.755 . . . . 0.0 111.084 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.482 ' O ' ' HB ' ' A' ' 153' ' ' THR . 41.6 p -125.27 128.9 48.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.555 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 75.94 86.02 0.09 Allowed 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.898 0.856 . . . . 0.0 110.69 -175.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.449 ' O ' ' HD3' ' A' ' 138' ' ' PRO . 13.3 t -150.96 155.02 38.22 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.462 173.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -82.5 110.7 23.35 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 120.424 0.154 . . . . 0.0 110.699 -176.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 136' ' ' THR . 96.6 Cg_endo -91.11 162.7 3.83 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.056 2.504 . . . . 0.0 112.709 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 98.15 -2.62 59.71 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.547 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 9.6 tt -107.37 105.24 18.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.308 0.575 . . . . 0.0 110.356 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -155.15 163.54 40.08 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.058 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.92 -30.4 10.31 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -95.21 86.96 4.7 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 27.6 m -82.76 -50.28 8.85 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.495 -176.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.41 ' O ' ' HB ' ' A' ' 146' ' ' THR . . . 47.63 57.54 5.83 Favored 'General case' 0 N--CA 1.462 0.164 0 O-C-N 123.727 0.642 . . . . 0.0 111.458 177.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 145' ' ' ALA . 98.8 m 71.49 -56.56 0.63 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.31 -177.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -176.51 51.78 0.11 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.161 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.81 135.79 57.59 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.681 0.277 . . . . 0.0 110.297 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 27.6 p -126.93 163.31 23.96 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.267 0.556 . . . . 0.0 112.004 -173.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.402 ' HE3' ' OG1' ' A' ' 136' ' ' THR . 54.0 pttt -130.75 147.46 52.41 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.225 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 17.2 t -73.84 99.76 3.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.343 0.592 . . . . 0.0 110.303 -178.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -106.98 170.07 8.17 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.61 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 134' ' ' THR . 3.5 m -122.75 147.37 46.57 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 175.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.582 HG23 HG22 ' A' ' 156' ' ' THR . 2.6 m -109.68 170.95 2.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.23 173.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -53.24 -33.24 52.11 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -176.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.582 HG22 HG23 ' A' ' 154' ' ' VAL . 15.1 t -74.46 -8.25 55.68 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -176.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 95.91 -4.71 65.84 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.476 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.462 ' H ' HG23 ' A' ' 156' ' ' THR . 90.9 t80 -76.31 137.19 39.72 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.808 0.337 . . . . 0.0 110.719 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.55 130.87 44.57 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.522 177.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.475 HD11 HG13 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -142.99 148.07 36.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.937 0.398 . . . . 0.0 111.357 -175.244 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -85.55 102.41 13.5 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.775 176.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.468 HG13 HD13 ' A' ' 160' ' ' LEU . 26.8 m -102.18 149.78 36.91 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.503 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -51.81 145.38 31.78 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.514 2.143 . . . . 0.0 111.39 175.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 72.4 mt -59.07 -24.61 63.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.622 -169.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -85.89 7.49 23.92 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -175.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.429 HG22 ' HD2' ' A' ' 184' ' ' ARG . 91.1 t -82.91 137.79 20.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 176.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -123.38 156.52 35.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.671 -0.241 . . . . 0.0 110.68 -176.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -59.15 116.7 4.03 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.502 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 121.24 -16.6 9.2 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.535 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -64.57 139.51 58.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.812 0.339 . . . . 0.0 110.989 176.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 55.4 t -100.43 103.73 15.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.414 ' CD1' HD11 ' A' ' 174' ' ' ILE . 0.9 OUTLIER -113.89 150.01 34.28 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.808 -176.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.457 ' O ' ' HB ' ' A' ' 182' ' ' ILE . 55.1 mt -103.03 134.66 43.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.827 -173.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.524 HD13 HD12 ' A' ' 131' ' ' LEU . 4.0 mp -121.68 141.12 43.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.754 0.312 . . . . 0.0 110.325 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.508 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 28.0 t-20 -84.61 105.58 15.52 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 175.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 37.6 p -64.82 158.6 24.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.151 -173.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 77.78 -55.3 3.81 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.415 178.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -84.8 -43.13 14.49 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.737 0.303 . . . . 0.0 110.737 -177.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 101.88 4.15 51.68 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.513 173.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 34.9 m -63.78 142.92 58.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.958 0.409 . . . . 0.0 110.951 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -98.44 124.37 43.11 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.2 0.524 . . . . 0.0 111.177 -175.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.457 ' HB ' ' O ' ' A' ' 173' ' ' ILE . 2.6 mp -95.11 152.87 3.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 173.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 17.4 m -74.85 169.42 17.96 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.234 0.54 . . . . 0.0 111.609 -170.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.429 ' HD2' HG22 ' A' ' 166' ' ' VAL . 58.6 mtp180 -63.08 147.58 50.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.358 -175.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.097 -1.39 . . . . 0.0 110.904 175.858 . . . . . . . . 0 0 . 1 stop_ save_